PMID- 37375715
OWN - NLM
STAT- MEDLINE
DCOM- 20230629
LR  - 20230701
IS  - 2072-6643 (Electronic)
IS  - 2072-6643 (Linking)
VI  - 15
IP  - 12
DP  - 2023 Jun 20
TI  - Effects of a Raisin Supplement on Cognitive Performance, Quality of Life, and 
      Functional Activities in Healthy Older Adults-Randomized Clinical Trial.
LID - 10.3390/nu15122811 [doi]
LID - 2811
AB  - The objective of this study was to evaluate the effects of consuming 50 g of 
      raisins on cognitive performance, quality of life, and functional activities in 
      healthy older adults. This is a parallel randomized controlled clinical trial, in 
      which 80 subjects over 70 years of age participated. For 6 months, the 
      intervention group (IG; n = 40) consumed 50 g of raisins per day added to their 
      usual diet, whereas the control group (CG; n = 40) received no supplement. All 
      variables were measured at baseline and at 6 months. Cognitive performance 
      assessed with the Montreal Cognitive Assessment (MOCA) test shows a difference of 
      3.27 points (95% CI 1.59 to 4.96), p ≤ 0.001, favorable to the IG, after the 
      intervention. Among the cognitive performances, an improvement is observed in the 
      IG in orientation, assessed both with the MOCA test 0.49 (95% CI 0.10 to 0.87), p 
      = 0.014, and with the Mini-Mental State Examination (MMSE) test, 0.36 (95% CI 
      0.02 to 0.70), p = 0.038. In visuospatial/executive capacity and in language, 
      improvements were also observed in the IG, 1.36 (95% CI 0.77 to 1.95), p = 0.001, 
      and 0.54 points (95% CI 0.12 to 0.96), p = 0.014, respectively. Immediate and 
      delayed recall, assessed with the Rey Auditory Verbal Learning Test, improved in 
      the IG. In addition, the IG showed a better quality of life and greater autonomy 
      in instrumental activities of daily living after 6 months. No significant changes 
      were observed in the rest of the variables analyzed. Therefore, the consumption 
      of 50 g of raisins produces a slight improvement in cognitive performance, 
      quality of life, and functional activities in the elderly.
FAU - Rodrigo-Gonzalo, María José
AU  - Rodrigo-Gonzalo MJ
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
FAU - González-Manzano, Susana
AU  - González-Manzano S
AUID- ORCID: 0000-0002-5739-515X
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, Recuperación Funcional y Ejercicio Terapéutico del 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), E-37007 Salamanca, 
      Spain.
FAU - Pablos-Hernández, María Carmen
AU  - Pablos-Hernández MC
AD  - Hospital Universitario de Salamanca, Universidad de Salamanca, E-37007 Salamanca, 
      Spain.
FAU - Méndez-Sánchez, Roberto
AU  - Méndez-Sánchez R
AUID- ORCID: 0000-0002-4486-4076
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, Recuperación Funcional y Ejercicio Terapéutico del 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), E-37007 Salamanca, 
      Spain.
FAU - Ayuda Duran, Begoña
AU  - Ayuda Duran B
AUID- ORCID: 0000-0001-9001-7399
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
FAU - González-Sánchez, Jesús
AU  - González-Sánchez J
AUID- ORCID: 0000-0001-5453-2510
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), E-37007 Salamanca, Spain.
FAU - Barbero-Iglesias, Fausto
AU  - Barbero-Iglesias F
AUID- ORCID: 0000-0001-8407-4127
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, Recuperación Funcional y Ejercicio Terapéutico del 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), E-37007 Salamanca, 
      Spain.
FAU - González-Paramás, Ana María
AU  - González-Paramás AM
AUID- ORCID: 0000-0001-5477-0703
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
FAU - Recio-Rodríguez, José Ignacio
AU  - Recio-Rodríguez JI
AUID- ORCID: 0000-0002-3772-8746
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), E-37007 Salamanca, Spain.
LA  - eng
GR  - PID2019-106167RB-I00/Ministry of Science and Innovation/
GR  - GRS 2381/A/21/Regional Health Management of Castilla y León/
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20230620
PL  - Switzerland
TA  - Nutrients
JT  - Nutrients
JID - 101521595
SB  - IM
MH  - Humans
MH  - Aged
MH  - Aged, 80 and over
MH  - *Cognitive Dysfunction/psychology
MH  - Quality of Life
MH  - Cognition
MH  - *Vitis
MH  - Activities of Daily Living
PMC - PMC10301980
OTO - NOTNLM
OT  - cognitive function
OT  - cognitive performance
OT  - flavanols
OT  - flavonoids
OT  - phenolic compounds
OT  - quality of life and functional activities
OT  - raisins
COIS- The authors declare that they have no conflict of interest. The sponsors had no 
      role in the design of the study, the collection, analysis, and interpretation of 
      the data, the writing of the manuscript, or the decision to publish the results 
      in the same way as the company “El Nogal”, which was responsible for providing 
      the necessary raisins to carry out the study.
EDAT- 2023/06/28 06:42
MHDA- 2023/06/29 06:43
CRDT- 2023/06/28 01:34
PHST- 2023/06/03 00:00 [received]
PHST- 2023/06/16 00:00 [revised]
PHST- 2023/06/18 00:00 [accepted]
PHST- 2023/06/29 06:43 [medline]
PHST- 2023/06/28 06:42 [pubmed]
PHST- 2023/06/28 01:34 [entrez]
AID - nu15122811 [pii]
AID - nutrients-15-02811 [pii]
AID - 10.3390/nu15122811 [doi]
PST - epublish
SO  - Nutrients. 2023 Jun 20;15(12):2811. doi: 10.3390/nu15122811.

PMID- 37373850
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230701
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 12
IP  - 12
DP  - 2023 Jun 20
TI  - Treatment of COVID-19 during the Acute Phase in Hospitalized Patients Decreases 
      Post-Acute Sequelae of COVID-19.
LID - 10.3390/jcm12124158 [doi]
LID - 4158
AB  - BACKGROUND: The post-acute sequelae of SARS-CoV-2 (PASC) infection have caused a 
      significant impact on our health system, but there is limited evidence of 
      approved drugs focused on its prevention. Our objective was to identify risk 
      factors that can determine the presence of PASC, with special attention to the 
      treatment received in the acute phase, and to describe the profile of persistent 
      symptoms in a multidisciplinary Post-Coronavirus Disease-19 (COVID-19) Unit. 
      METHODS: This one-year prospective observational study included patients 
      following an acute COVID-19 infection, irrespective of whether they required 
      hospital admission. A standardized symptom questionnaire and blood sampling were 
      performed at the first follow-up visit, and demographic and clinical electronic 
      data were collected. We compared subjects with PASC with those who had fully 
      recovered. Multivariate logistic regression was performed to identify factors 
      associated with PASC in hospitalized patients, and Kaplan-Meier curves were used 
      to assess duration of symptoms according to disease severity and treatments 
      received in the acute phase. RESULTS: 1966 patients were evaluated; 1081 had mild 
      disease, 542 moderate and 343 severe; around one third of the subjects had PASC, 
      and were more frequently female, with obesity, asthma, and eosinophilia during 
      acute COVID-19 disease. Patients who received treatment with dexamethasone and 
      remdesivir during the course of the acute illness showed a lower median duration 
      of symptoms, compared with those who received none of these treatments. 
      CONCLUSION: Treatment with dexamethasone and/or remdesivir may be useful to 
      reduce the impact of PASC secondary to SARS-CoV-2 infection. In addition, we 
      identified female gender, obesity, asthma, and disease severity as risk factors 
      for having PASC.
FAU - Badenes Bonet, Diana
AU  - Badenes Bonet D
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
FAU - Caguana Vélez, Oswaldo Antonio
AU  - Caguana Vélez OA
AUID- ORCID: 0000-0002-5028-7439
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
FAU - Duran Jordà, Xavier
AU  - Duran Jordà X
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
AD  - Assessoria Metodològica i Bioestadística (AMIB), 08003 Barcelona, Spain.
FAU - Comas Serrano, Merce
AU  - Comas Serrano M
AUID- ORCID: 0000-0003-1926-2740
AD  - Epidemiology and Evaluation Department, Hospital del Mar, REDISSEC, RICAPPS, 
      08003 Barcelona, Spain.
FAU - Posso Rivera, Margarita
AU  - Posso Rivera M
AD  - Epidemiology and Evaluation Department, Hospital del Mar, REDISSEC, RICAPPS, 
      08003 Barcelona, Spain.
FAU - Admetlló, Mireia
AU  - Admetlló M
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Herranz Blasco, Anna
AU  - Herranz Blasco A
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Cuadrado Godia, Elisa
AU  - Cuadrado Godia E
AUID- ORCID: 0000-0002-9147-875X
AD  - Neurology Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Marco Navarro, Ester
AU  - Marco Navarro E
AUID- ORCID: 0000-0002-3412-0356
AD  - Physical Medicine and Rehabilitation Department, Hospital del Mar, 08003 
      Barcelona, Spain.
FAU - Martin Ezquerra, Gemma
AU  - Martin Ezquerra G
AUID- ORCID: 0000-0002-5106-7526
AD  - Dermatology Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Pineiro Aguin, Zenaida
AU  - Pineiro Aguin Z
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Otorrinolaringology Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Cumpli Gargallo, Maria Cinta
AU  - Cumpli Gargallo MC
AUID- ORCID: 0009-0006-4359-0866
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Gonzalez Garcia, Jose Gregorio
AU  - Gonzalez Garcia JG
AUID- ORCID: 0000-0003-4682-8535
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
FAU - Balcells Vilarnau, Eva
AU  - Balcells Vilarnau E
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
AD  - Centro de Investigación en Red de Enfermedades Respiratorias, (CIBERES), 
      Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain.
FAU - Rodriguez Chiaradia, Diego
AU  - Rodriguez Chiaradia D
AUID- ORCID: 0000-0002-8566-4011
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
AD  - Centro de Investigación en Red de Enfermedades Respiratorias, (CIBERES), 
      Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Epidemiology and Evaluation Department, Hospital del Mar, REDISSEC, RICAPPS, 
      08003 Barcelona, Spain.
FAU - Gea, Joaquim
AU  - Gea J
AD  - Respiratory Medicine Department, Hospital del Mar, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
AD  - Centro de Investigación en Red de Enfermedades Respiratorias, (CIBERES), 
      Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain.
FAU - Horcajada, Juan P
AU  - Horcajada JP
AUID- ORCID: 0000-0001-9873-5459
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
AD  - Centro de Investigación en Red de Enfermedades Respiratorias, (CIBERES), 
      Instituto de Salud Carlos III (ISCIII), 08003 Barcelona, Spain.
AD  - Infectious Diseases Department, Hospital del Mar, 08003 Barcelona, Spain.
FAU - Villar-García, Judit
AU  - Villar-García J
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), 08003 
      Barcelona, Spain.
AD  - Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
AD  - Infectious Diseases Department, Hospital del Mar, 08003 Barcelona, Spain.
CN  - MAR Post-COVID-19 Unit
LA  - eng
PT  - Journal Article
DEP - 20230620
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC10299438
OTO - NOTNLM
OT  - SARS-CoV-2
OT  - corticosteroids
OT  - long COVID
OT  - post-acute sequelae of COVID-19 (PASC)
OT  - remdesivir
COIS- The authors declare no conflict of interest.
EDAT- 2023/06/28 06:42
MHDA- 2023/06/28 06:43
CRDT- 2023/06/28 01:23
PHST- 2023/04/22 00:00 [received]
PHST- 2023/05/31 00:00 [revised]
PHST- 2023/06/12 00:00 [accepted]
PHST- 2023/06/28 06:43 [medline]
PHST- 2023/06/28 06:42 [pubmed]
PHST- 2023/06/28 01:23 [entrez]
AID - jcm12124158 [pii]
AID - jcm-12-04158 [pii]
AID - 10.3390/jcm12124158 [doi]
PST - epublish
SO  - J Clin Med. 2023 Jun 20;12(12):4158. doi: 10.3390/jcm12124158.

PMID- 37368462
OWN - NLM
STAT- MEDLINE
DCOM- 20230629
LR  - 20230630
IS  - 2369-2960 (Electronic)
IS  - 2369-2960 (Linking)
VI  - 9
DP  - 2023 Jun 27
TI  - Contribution of Frailty to Multimorbidity Patterns and Trajectories: Longitudinal 
      Dynamic Cohort Study of Aging People.
PG  - e45848
LID - 10.2196/45848 [doi]
AB  - BACKGROUND: Multimorbidity and frailty are characteristics of aging that need 
      individualized evaluation, and there is a 2-way causal relationship between them. 
      Thus, considering frailty in analyses of multimorbidity is important for 
      tailoring social and health care to the specific needs of older people. 
      OBJECTIVE: This study aimed to assess how the inclusion of frailty contributes to 
      identifying and characterizing multimorbidity patterns in people aged 65 years or 
      older. METHODS: Longitudinal data were drawn from electronic health records 
      through the SIDIAP (Sistema d'Informació pel Desenvolupament de la Investigació a 
      l'Atenció Primària) primary care database for the population aged 65 years or 
      older from 2010 to 2019 in Catalonia, Spain. Frailty and multimorbidity were 
      measured annually using validated tools (eFRAGICAP, a cumulative deficit model; 
      and Swedish National Study of Aging and Care in Kungsholmen [SNAC-K], 
      respectively). Two sets of 11 multimorbidity patterns were obtained using fuzzy 
      c-means. Both considered the chronic conditions of the participants. In addition, 
      one set included age, and the other included frailty. Cox models were used to 
      test their associations with death, nursing home admission, and home care need. 
      Trajectories were defined as the evolution of the patterns over the follow-up 
      period. RESULTS: The study included 1,456,052 unique participants (mean follow-up 
      of 7.0 years). Most patterns were similar in both sets in terms of the most 
      prevalent conditions. However, the patterns that considered frailty were better 
      for identifying the population whose main conditions imposed limitations on daily 
      life, with a higher prevalence of frail individuals in patterns like chronic 
      ulcers &peripheral vascular. This set also included a dementia-specific pattern 
      and showed a better fit with the risk of nursing home admission and home care 
      need. On the other hand, the risk of death had a better fit with the set of 
      patterns that did not include frailty. The change in patterns when considering 
      frailty also led to a change in trajectories. On average, participants were in 
      1.8 patterns during their follow-up, while 45.1% (656,778/1,456,052) remained in 
      the same pattern. CONCLUSIONS: Our results suggest that frailty should be 
      considered in addition to chronic diseases when studying multimorbidity patterns 
      in older adults. Multimorbidity patterns and trajectories can help to identify 
      patients with specific needs. The patterns that considered frailty were better 
      for identifying the risk of certain age-related outcomes, such as nursing home 
      admission or home care need, while those considering age were better for 
      identifying the risk of death. Clinical and social intervention guidelines and 
      resource planning can be tailored based on the prevalence of these patterns and 
      trajectories.
CI  - ©Lucía A Carrasco-Ribelles, Margarita Cabrera-Bean, Marc Danés-Castells, Edurne 
      Zabaleta-del-Olmo, Albert Roso-Llorach, Concepción Violán. Originally published 
      in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 
      27.06.2023.
FAU - Carrasco-Ribelles, Lucía A
AU  - Carrasco-Ribelles LA
AUID- ORCID: 0000-0001-9263-1747
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Signal Processing and Communications Group (SPCOM), Department of Signal Theory 
      and Communications, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
AD  - Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari 
      per a la recerca a l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), 
      Mataró, Spain.
AD  - Grup de REcerca en Impacte de les Malalties Cròniques i les seves Trajectòries 
      (GRIMTRA) (2021 SGR 01537), Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      (RD21/0016/0029), Instituto de Salud Carlos III, Madrid, Spain.
FAU - Cabrera-Bean, Margarita
AU  - Cabrera-Bean M
AUID- ORCID: 0000-0001-9058-3825
AD  - Signal Processing and Communications Group (SPCOM), Department of Signal Theory 
      and Communications, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
FAU - Danés-Castells, Marc
AU  - Danés-Castells M
AUID- ORCID: 0000-0002-4723-4053
AD  - Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari 
      per a la recerca a l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), 
      Mataró, Spain.
FAU - Zabaleta-Del-Olmo, Edurne
AU  - Zabaleta-Del-Olmo E
AUID- ORCID: 0000-0002-5072-8548
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Grup de REcerca en Impacte de les Malalties Cròniques i les seves Trajectòries 
      (GRIMTRA) (2021 SGR 01537), Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      (RD21/0016/0029), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
AD  - Nursing Department, Faculty of Nursing, Universitat de Girona, Girona, Spain.
FAU - Roso-Llorach, Albert
AU  - Roso-Llorach A
AUID- ORCID: 0000-0002-9264-0405
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Grup de REcerca en Impacte de les Malalties Cròniques i les seves Trajectòries 
      (GRIMTRA) (2021 SGR 01537), Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      (RD21/0016/0029), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
FAU - Violán, Concepción
AU  - Violán C
AUID- ORCID: 0000-0003-3309-5360
AD  - Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari 
      per a la recerca a l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), 
      Mataró, Spain.
AD  - Grup de REcerca en Impacte de les Malalties Cròniques i les seves Trajectòries 
      (GRIMTRA) (2021 SGR 01537), Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      (RD21/0016/0029), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
AD  - Fundació Institut d'Investigació en ciències de la Salut Germans Trias i Pujol 
      (IGTP), Badalona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230627
PL  - Canada
TA  - JMIR Public Health Surveill
JT  - JMIR public health and surveillance
JID - 101669345
SB  - IM
MH  - Aged
MH  - Humans
MH  - *Frailty/epidemiology
MH  - Cohort Studies
MH  - Multimorbidity
MH  - Frail Elderly
MH  - Aging
OTO - NOTNLM
OT  - clustering
OT  - electronic health record
OT  - frailty
OT  - multimorbidity
OT  - primary care
OT  - trajectory
EDAT- 2023/06/27 13:11
MHDA- 2023/06/29 06:43
CRDT- 2023/06/27 11:52
PHST- 2023/01/19 00:00 [received]
PHST- 2023/05/25 00:00 [accepted]
PHST- 2023/05/02 00:00 [revised]
PHST- 2023/06/29 06:43 [medline]
PHST- 2023/06/27 13:11 [pubmed]
PHST- 2023/06/27 11:52 [entrez]
AID - v9i1e45848 [pii]
AID - 10.2196/45848 [doi]
PST - epublish
SO  - JMIR Public Health Surveill. 2023 Jun 27;9:e45848. doi: 10.2196/45848.

PMID- 37364931
OWN - NLM
STAT- MEDLINE
DCOM- 20230628
LR  - 20230628
IS  - 2755-9734 (Electronic)
IS  - 2755-9734 (Linking)
VI  - 26
IP  - 1
DP  - 2023 Jun
TI  - Population health surveys and screening tools for depressive disorders: aims and 
      uses.
LID - e300757 [pii]
LID - 10.1136/bmjment-2023-300757 [doi]
FAU - Arias de la Torre, Jorge
AU  - Arias de la Torre J
AUID- ORCID: 0000-0001-6908-9611
AD  - Care in Long Term Conditions Research Division, King's College London, London, UK 
      jorge.arias_de_la_torre@kcl.ac.uk.
AD  - CIBER Epidemiology and Public Health, CIBERESP, Barcelona, Spain.
AD  - Universidad de León, Leon, Spain.
FAU - Ronaldson, Amy
AU  - Ronaldson A
AUID- ORCID: 0000-0001-8369-9168
AD  - Health Services and Policy Research Department, King's College London, London, 
      UK.
FAU - Serrano-Blanco, Antoni
AU  - Serrano-Blanco A
AD  - CIBER Epidemiology and Public Health, CIBERESP, Barcelona, Spain.
AD  - Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Barcelona, 
      Spain.
FAU - Martín, Vicente
AU  - Martín V
AD  - CIBER Epidemiology and Public Health, CIBERESP, Barcelona, Spain.
AD  - Universidad de León, Leon, Spain.
FAU - Bellón, Juan Ángel
AU  - Bellón JÁ
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP), Madrid, Spain.
AD  - Biomedical Research Institute of Málaga (IBIMA-Bionand platform), Malaga, Spain.
AD  - El Palo Health Centre, Andalusian Health Service (SAS), Málaga, Spain.
AD  - Department of Public Health and Psychiatry, Universidad de Malaga, Malaga, Spain.
FAU - Valderas, Jose M
AU  - Valderas JM
AD  - Department of Medicine, National University of Singapore, Singapore.
AD  - Department of Family Medicine, National University Health System, Singapore.
AD  - Centre for Research in Health Systems Performance (CRiHSP), National University 
      Health System, Singapore.
FAU - Alonso, Jordi
AU  - Alonso J
AD  - CIBER Epidemiology and Public Health, CIBERESP, Barcelona, Spain.
AD  - Health Services Research Group, Hospital del Mar Medical Research Institute 
      (IMIM), Barcelona, Spain.
AD  - Dept. of Medicine and Life Sciences, Pompeu Fabra University (UPF), Barcelona, 
      Spain.
LA  - eng
PT  - Letter
PL  - England
TA  - BMJ Ment Health
JT  - BMJ mental health
JID - 9918521385306676
SB  - IM
MH  - Humans
MH  - *Depressive Disorder/diagnosis
MH  - Depression/diagnosis
MH  - Surveys and Questionnaires
OTO - NOTNLM
OT  - Adult psychiatry
OT  - Depression & mood disorders
COIS- Competing interests: None declared.
EDAT- 2023/06/27 01:06
MHDA- 2023/06/28 06:42
CRDT- 2023/06/26 20:53
PHST- 2023/05/01 00:00 [received]
PHST- 2023/06/05 00:00 [accepted]
PHST- 2023/06/28 06:42 [medline]
PHST- 2023/06/27 01:06 [pubmed]
PHST- 2023/06/26 20:53 [entrez]
AID - bmjment-2023-300757 [pii]
AID - 10.1136/bmjment-2023-300757 [doi]
PST - ppublish
SO  - BMJ Ment Health. 2023 Jun;26(1):e300757. doi: 10.1136/bmjment-2023-300757.

PMID- 37363179
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230701
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 14
DP  - 2023
TI  - Protocol for an observational cohort study on psychological, addictive, lifestyle 
      behavior and highly prevalent affective disorders in primary health care adults.
PG  - 1121389
LID - 10.3389/fpsyt.2023.1121389 [doi]
LID - 1121389
AB  - BACKGROUND: Depression and anxious symptoms are prevalent in the general 
      population, and their onset and persistence may be linked to biological and 
      psychosocial factors, many of which are lifestyle-related. The way we manage our 
      care, physical and emotional health and/or discomfort is highly influenced by our 
      own abilities, skills and attitudes despite life's circumstances. The main aim of 
      this protocol to analyze the relationship between psychological constructs 
      (self-efficacy, activation, health literacy, resilience, personality traits, 
      sense of coherence, self-esteem), and the presence of affective-emotional 
      problems (anxiety, depression) and addictions in primary health care. METHODS: 
      This is a protocol of a prospective longitudinal cohort study including people of 
      35-74 years old of Aragon primary health care centers (Spain). Three evaluations 
      will be conducted: baseline evaluation, and follow-up assessments five and ten 
      years after recruitment. The primary outcomes will be severity of depression, 
      severity of anxiety, and addictive behaviors. A detailed set of secondary 
      outcomes will be assessed across all three assessments. This will include 
      psychosocial or personal factors on health behavior, social support, lifestyle 
      patterns, quality of life, the use of health and social resources, and chronic 
      comorbid pathology. DISCUSSION: The analysis of the impact of psychological 
      constructs and lifestyles on the mental health of people and communities will 
      provide evidence that will make it possible to better address and prevent these 
      prevalent problems and address their improvement from a more global and holistic 
      perspective. The evaluation of psychological constructs should be incorporated 
      into health services to improve people's ability their self-care, the level of 
      knowledge of managing their disease and their physical, mental and social health. 
      CLINICAL TRIAL REGISTRATION: https://www.isrctn.com/, identifier ISRCTN12820058.
CI  - Copyright © 2023 Méndez-López, Oliván-Blázquez, Domínguez-García, 
      Bartolomé-Moreno, Rabanaque and Magallón-Botaya.
FAU - Méndez-López, Fátima
AU  - Méndez-López F
AD  - Aragonese Primary Care Research Group, Health Research Institute of Aragon 
      (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Aragonese Primary Care Research Group, Health Research Institute of Aragon 
      (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Domínguez-García, Marta
AU  - Domínguez-García M
AD  - Aragonese Primary Care Research Group, Health Research Institute of Aragon 
      (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Aragonese Healthcare Service (SALUD), Zaragoza, Spain.
FAU - Bartolomé-Moreno, Cruz
AU  - Bartolomé-Moreno C
AD  - Aragonese Primary Care Research Group, Health Research Institute of Aragon 
      (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Aragonese Healthcare Service (SALUD), Zaragoza, Spain.
AD  - Department of Family and Community Care Teaching - Sector I, Aragonese Healthcare 
      Service, Zaragoza, Spain.
FAU - Rabanaque, Isabel
AU  - Rabanaque I
AD  - Department of Geography and Territorial Planning, University of Zaragoza, 
      Zaragoza, Spain.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Aragonese Primary Care Research Group, Health Research Institute of Aragon 
      (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 
      Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230609
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
PMC - PMC10288582
OTO - NOTNLM
OT  - anxiety
OT  - behavior and behavior mechanism
OT  - depression
OT  - mental health
OT  - primary health care
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/06/26 19:07
MHDA- 2023/06/26 19:08
CRDT- 2023/06/26 13:15
PHST- 2022/12/11 00:00 [received]
PHST- 2023/05/23 00:00 [accepted]
PHST- 2023/06/26 19:08 [medline]
PHST- 2023/06/26 19:07 [pubmed]
PHST- 2023/06/26 13:15 [entrez]
AID - 10.3389/fpsyt.2023.1121389 [doi]
PST - epublish
SO  - Front Psychiatry. 2023 Jun 9;14:1121389. doi: 10.3389/fpsyt.2023.1121389. 
      eCollection 2023.

PMID- 37361167
OWN - NLM
STAT- MEDLINE
DCOM- 20230628
LR  - 20230701
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 11
DP  - 2023
TI  - Role of personal aptitudes as determinants of incident morbidity, lifestyles, 
      quality of life, use of the health services and mortality (DESVELA cohort): 
      qualitative study protocol for a prospective cohort study in a hybrid analysis.
PG  - 1069957
LID - 10.3389/fpubh.2023.1069957 [doi]
LID - 1069957
AB  - INTRODUCTION: Maintaining or acquiring healthier health-oriented behaviours and 
      promoting physical and mental health amongst the Spanish population is a 
      significant challenge for Primary Health Care. Although the role of personal 
      aptitudes (characteristics of each individual) in influencing health behaviours 
      is not yet clear, these factors, in conjunction with social determinants such as 
      gender and social class, can create axes of social inequity that affect 
      individuals' opportunities to engage in health-oriented behaviours. Additionally, 
      lack of access to health-related resources and opportunities can further 
      exacerbate the issue for individuals with healthy personal aptitudes. Therefore, 
      it is crucial to investigate the relationship between personal aptitudes and 
      health behaviours, as well as their impact on health equity. OBJECTIVES: This 
      paper outlines the development, design and rationale of a descriptive qualitative 
      study that explores in a novel way the views and experiences on the relationship 
      between personal aptitudes (activation, health literacy and personality traits) 
      and their perception of health, health-oriented behaviours, quality of life and 
      current health status. METHOD AND ANALYSIS: This qualitative research is carried 
      out from a phenomenological perspective. Participants will be between 35 and 
      74 years of age, will be recruited in Primary Health Care Centres throughout 
      Spain from a more extensive study called DESVELA Cohort. Theoretical sampling 
      will be carried out. Data will be collected through video and audio recording of 
      16 focus groups in total, which are planned to be held in 8 different Autonomous 
      Communities, and finally transcribed for a triangulated thematic analysis 
      supported by the Atlas-ti program. DISCUSSION: We consider it essential to 
      understand the interaction between health-related behaviours as predictors of 
      lifestyles in the population, so this study will delve into a subset of issues 
      related to personality traits, activation and health literacy.Clinical trial 
      registration: ClinicalTrials.gov, identifier NCT04386135.
CI  - Copyright © 2023 Young-Silva, Berenguera, Jacques-Aviñó, Gil-Girbau, 
      Arroyo-Uriarte, Chela-Alvarez, Ripoll, Martí-Lluch, Ramos, Elizondo-Alzola, 
      Garcia-Martinez, Méndez-López, Tamayo-Morales, Martínez-Andrés, Motrico, 
      Gómez-Gómez, Fernández-Alvarez, Juvinyà-Canal and the DESVELA Cohort 
      investigators.
FAU - Young-Silva, Yudy
AU  - Young-Silva Y
AD  - Unitat de Suport a la recerca Girona, Fundació Institut Universitari per a la 
      recerca a l'Atenció Primària de Salut Jordi Goli Gurina (IDIAPJGol), Girona, 
      Spain.
AD  - Facultat d'Infermeria, Universitat de Girona, Girona, Spain.
FAU - Berenguera, Anna
AU  - Berenguera A
AD  - Facultat d'Infermeria, Universitat de Girona, Girona, Spain.
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Goli Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, Bellaterra, Spain.
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
FAU - Jacques-Aviñó, Constanza
AU  - Jacques-Aviñó C
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Goli Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, Bellaterra, Spain.
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
FAU - Gil-Girbau, Montserrat
AU  - Gil-Girbau M
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de LLobregat, Spain.
AD  - Parc Sanitari Sant Joan de Déu, San Boi de Llobregat, Spain.
FAU - Arroyo-Uriarte, Paula
AU  - Arroyo-Uriarte P
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de LLobregat, Spain.
FAU - Chela-Alvarez, Xenia
AU  - Chela-Alvarez X
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, Palma 
      de Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Health Research Institute of the Balearic Islands (IdISBa), Palma 
      de Mallorca, Spain.
FAU - Ripoll, Joana
AU  - Ripoll J
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, Palma 
      de Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Health Research Institute of the Balearic Islands (IdISBa), Palma 
      de Mallorca, Spain.
FAU - Martí-Lluch, Ruth
AU  - Martí-Lluch R
AD  - Universitat Autònoma de Barcelona, Bellaterra, Spain.
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Vascular Health Research Group of Girona, Institut Universitari per a la Recerca 
      a l'Atenció Primària Jordi Gol I Gurina (IDIAPJGol), Girona, Catalonia, Spain.
AD  - Girona Biomedical Research Institute, Girona, Catalonia, Spain.
FAU - Ramos, Rafel
AU  - Ramos R
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Vascular Health Research Group of Girona, Institut Universitari per a la Recerca 
      a l'Atenció Primària Jordi Gol I Gurina (IDIAPJGol), Girona, Catalonia, Spain.
AD  - Girona Biomedical Research Institute, Girona, Catalonia, Spain.
AD  - Department of Medical Sciences, University of Girona, Girona, Spain.
AD  - Primary Care Services, Catalan Institute of Health, Girona, Catalonia, Spain.
FAU - Elizondo-Alzola, Usue
AU  - Elizondo-Alzola U
AD  - Grupo de Investigación en Ciencias de la Diseminación e Implementación en 
      Servicios Sanitarios, Instituto Investigación de Biocruces, Barakaldo, Spain.
FAU - Garcia-Martinez, Sandra
AU  - Garcia-Martinez S
AD  - Grupo de Investigación en Ciencias de la Diseminación e Implementación en 
      Servicios Sanitarios, Instituto Investigación de Biocruces, Barakaldo, Spain.
FAU - Méndez-López, Fátima
AU  - Méndez-López F
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Aragonese Primary Care Research Group (GAIAP), Institute for Health Research 
      Aragón (IIS Aragón), Zaragoza, Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL) Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
FAU - Martínez-Andrés, Mária
AU  - Martínez-Andrés M
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Faculty of Nursing, Universidad de Castilla La Mancha, Albacete, Spain.
AD  - Social and Health Research Center, Universidad de Castilla La Mancha, Cuenca, 
      Spain.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Department of Psychology, Universidad Loyola Andalucía, Seville, Spain.
FAU - Gómez-Gómez, Irene
AU  - Gómez-Gómez I
AD  - Network on Chronicity, Primary Care, and Health Prevention and Promotion 
      (RICAPPS), Spain.
AD  - Department of Psychology, Universidad Loyola Andalucía, Seville, Spain.
FAU - Fernández-Alvarez, Roberto
AU  - Fernández-Alvarez R
AD  - Ourense Health Area, SERGAS, Ourence, Spain.
AD  - Centro de Saúde de Allariz, SERGAS, Allariz, Spain.
AD  - I-Saúde Grup, South Galicia Health Research Institute, Vigo, Spain.
FAU - Juvinyà-Canal, Dolors
AU  - Juvinyà-Canal D
AD  - Facultat d'Infermeria, Universitat de Girona, Girona, Spain.
AD  - Grup de recerca Salut i Atenció sanitària Universitat de Girona, Girona, Spain.
AD  - Càtedra de Promoció de la Salut Universitat de Girona, Girona, Spain.
CN  - DESVELA Cohort investigators
LA  - eng
SI  - ClinicalTrials.gov/NCT04386135
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230609
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
SB  - IM
MH  - Humans
MH  - *Quality of Life
MH  - *Aptitude
MH  - Prospective Studies
MH  - Life Style
MH  - Qualitative Research
MH  - Health Promotion/methods
PMC - PMC10289184
OTO - NOTNLM
OT  - determinants of health
OT  - focus groups
OT  - health behaviour
OT  - health promotion
OT  - life style
OT  - primary health care
OT  - qualitative research
OT  - quality of life
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/06/26 19:07
MHDA- 2023/06/28 06:42
CRDT- 2023/06/26 12:48
PHST- 2022/11/21 00:00 [received]
PHST- 2023/05/16 00:00 [accepted]
PHST- 2023/06/28 06:42 [medline]
PHST- 2023/06/26 19:07 [pubmed]
PHST- 2023/06/26 12:48 [entrez]
AID - 10.3389/fpubh.2023.1069957 [doi]
PST - epublish
SO  - Front Public Health. 2023 Jun 9;11:1069957. doi: 10.3389/fpubh.2023.1069957. 
      eCollection 2023.

PMID- 37354325
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230701
IS  - 1432-1262 (Electronic)
IS  - 0179-1958 (Print)
IS  - 0179-1958 (Linking)
VI  - 38
IP  - 1
DP  - 2023 Jun 24
TI  - Correction to: Five-year follow-up mortality prognostic index for colorectal 
      patients.
PG  - 177
LID - 10.1007/s00384-023-04472-z [doi]
LID - 177
FAU - Orive, Miren
AU  - Orive M
AUID- ORCID: 0000-0003-1848-6638
AD  - Department of Social Psychology, Faculty of Pharmacy, University of the Basque 
      Country UPV/EHU, Vitoria, Spain. Miren.orive@ehu.eus.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain. Miren.orive@ehu.eus.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain. Miren.orive@ehu.eus.
FAU - Barrio, Irantzu
AU  - Barrio I
AD  - Department of Mathematics, University of the Basque Country UPV/EHU, Leioa, 
      Spain.
AD  - Basque Center for Applied Mathematics, BCAM, Bilbao, Spain.
FAU - Lázaro, Santiago
AU  - Lázaro S
AD  - Servicio de Cirugía General, Hospital de Basurto, Bilbao, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
FAU - Gonzalez, Nerea
AU  - Gonzalez N
AD  - Unidad de Investigación, Hospital de Galdakao-Usansolo, Galdakao, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
FAU - Bare, Marisa
AU  - Bare M
AD  - Unidad de Epidemiología Clínica, Corporacio Parc Tauli, Barcelona, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
FAU - de Larrea, Nerea Fernandez
AU  - de Larrea NF
AD  - Centro Nacional de Epidemiología ISCIII, Madrid, Spain.
AD  - CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AD  - Unidad de Investigación, Hospital Costa del Sol, Malaga, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Cortajarena, Sarai
AU  - Cortajarena S
AD  - Department of Mathematics, University of the Basque Country UPV/EHU, Leioa, 
      Spain.
FAU - Bilbao, Amaia
AU  - Bilbao A
AD  - Unidad de Investigación, Hospital de Basurto, Bilbao, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Aguirre, Urko
AU  - Aguirre U
AD  - Unidad de Investigación, Hospital de Galdakao-Usansolo, Galdakao, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Sarasqueta, Cristina
AU  - Sarasqueta C
AD  - Unidad de Investigación, Hospital Donostia/BioDonostia, Donostia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Quintana, José M
AU  - Quintana JM
AD  - Unidad de Investigación, Hospital de Galdakao-Usansolo, Galdakao, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Galdakao, Spain.
CN  - REDISSEC-CARESS/CCR group
LA  - eng
PT  - Published Erratum
DEP - 20230624
PL  - Germany
TA  - Int J Colorectal Dis
JT  - International journal of colorectal disease
JID - 8607899
SB  - IM
EFR - Int J Colorectal Dis. 2023 Mar 9;38(1):64. PMID: 36892600
PMC - PMC10290581
EDAT- 2023/06/24 21:03
MHDA- 2023/06/24 21:04
CRDT- 2023/06/24 11:13
PHST- 2023/06/24 21:04 [medline]
PHST- 2023/06/24 21:03 [pubmed]
PHST- 2023/06/24 11:13 [entrez]
AID - 10.1007/s00384-023-04472-z [pii]
AID - 4472 [pii]
AID - 10.1007/s00384-023-04472-z [doi]
PST - epublish
SO  - Int J Colorectal Dis. 2023 Jun 24;38(1):177. doi: 10.1007/s00384-023-04472-z.

PMID- 37352753
OWN - NLM
STAT- Publisher
LR  - 20230623
IS  - 1873-5134 (Electronic)
IS  - 0738-3991 (Linking)
VI  - 114
DP  - 2023 Jun 7
TI  - Identifying most important contextual factors for the implementation of 
      self-management interventions: A Delphi study.
PG  - 107843
LID - S0738-3991(23)00223-9 [pii]
LID - 10.1016/j.pec.2023.107843 [doi]
AB  - OBJECTIVE: To reach consensus amongst stakeholders about the most important 
      contextual factors (CFs) that may influence the successful implementation of 
      (components of) self-management interventions (SMIs) for type 2 diabetes, 
      obesity, COPD and heart failure. METHODS: Building on our literature review that 
      identified 31 CFs on different levels we conducted a Delphi with 44 stakeholders 
      to identify which of these CFs, or additional ones, contribute most to successful 
      implementation of SMIs. The Delphi consisted of three rounds in which the CFs 
      were scored, prioritized and discussed. RESULTS: The most important CFs 
      overlapped to a great extent across components of SMIs and diseases. Overall, 
      stakeholders identified 'HCP's ability to adapt the advice, communication or 
      intervention to patients' situation and level of knowledge' as most important CF. 
      CONCLUSION: CFs need to be taken into account when implementing promising SMIs. 
      According to stakeholders, the most important CFs are patient-, HCP- or 
      interaction related. 'Tailoring' was selected as the most crucial aspect for 
      HCPs. PRACTICE IMPLICATIONS: Stakeholders can make informed decisions on the 
      adoption of the most suitable SMIs in a given context. These CFs are available 
      through a self-management platform. Suggestions to implement self-management 
      behaviour and to close the research-to-practice gap are made.
CI  - Copyright © 2023. Published by Elsevier B.V.
FAU - Noordman, Janneke
AU  - Noordman J
AD  - Netherlands institute for health services research (Nivel), Utrecht, the 
      Netherlands. Electronic address: j.noordman@nivel.nl.
FAU - Heijmans, Monique
AU  - Heijmans M
AD  - Netherlands institute for health services research (Nivel), Utrecht, the 
      Netherlands.
FAU - Poortvliet, Rune
AU  - Poortvliet R
AD  - Netherlands institute for health services research (Nivel), Utrecht, the 
      Netherlands.
FAU - Groene, Oliver
AU  - Groene O
AD  - OptiMedis, Burchardstr 17, 20095 Hamburg, Germany; Faculty of Management, 
      Economics and Society, University of Witten/Herdecke, 58455 Witten, Germany.
FAU - Ballester, Marta
AU  - Ballester M
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain; Avedis Donabedian Research 
      Institute (FAD), Barcelona 08037, Spain; Health Services Research Network on 
      Chronic Diseases (REDISSEC), Madrid, Spain; Network for Research on Chronicity, 
      Primary Care, and Health Promotion (RICAPPS), Spain.
FAU - Ninov, Lyudmil
AU  - Ninov L
AD  - European Patients' Forum (EPF), Brussels 1040, Belgium.
FAU - de Guzmán, Ena Niño
AU  - de Guzmán EN
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau-CIBERESP), 08025 Barcelona, Spain.
FAU - Alonso-Coello, Pablo
AU  - Alonso-Coello P
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau-CIBERESP), 08025 Barcelona, Spain.
FAU - Orrego, Carola
AU  - Orrego C
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain; Avedis Donabedian Research 
      Institute (FAD), Barcelona 08037, Spain; Health Services Research Network on 
      Chronic Diseases (REDISSEC), Madrid, Spain; Network for Research on Chronicity, 
      Primary Care, and Health Promotion (RICAPPS), Spain.
FAU - Suñol, Rosa
AU  - Suñol R
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain; Avedis Donabedian Research 
      Institute (FAD), Barcelona 08037, Spain; Health Services Research Network on 
      Chronic Diseases (REDISSEC), Madrid, Spain; Network for Research on Chronicity, 
      Primary Care, and Health Promotion (RICAPPS), Spain.
FAU - Wagner, Cordula
AU  - Wagner C
AD  - Netherlands institute for health services research (Nivel), Utrecht, the 
      Netherlands; Department of Public and Occupational Health, Amsterdam Public 
      Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, the 
      Netherlands.
LA  - eng
PT  - Journal Article
DEP - 20230607
PL  - Ireland
TA  - Patient Educ Couns
JT  - Patient education and counseling
JID - 8406280
OTO - NOTNLM
OT  - Chronic diseases
OT  - Communication
OT  - Contextual factors
OT  - Delphi study
OT  - Implementation
OT  - Self-management interventions
OT  - Stakeholders
COIS- Declaration of Competing Interest None.
EDAT- 2023/06/24 11:42
MHDA- 2023/06/24 11:42
CRDT- 2023/06/23 18:08
PHST- 2023/01/31 00:00 [received]
PHST- 2023/05/23 00:00 [revised]
PHST- 2023/06/06 00:00 [accepted]
PHST- 2023/06/24 11:42 [medline]
PHST- 2023/06/24 11:42 [pubmed]
PHST- 2023/06/23 18:08 [entrez]
AID - S0738-3991(23)00223-9 [pii]
AID - 10.1016/j.pec.2023.107843 [doi]
PST - aheadofprint
SO  - Patient Educ Couns. 2023 Jun 7;114:107843. doi: 10.1016/j.pec.2023.107843.

PMID- 37333911
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230620
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 14
DP  - 2023
TI  - A personalized intervention to prevent depression in primary care based on risk 
      predictive algorithms and decision support systems: protocol of the e-predictD 
      study.
PG  - 1163800
LID - 10.3389/fpsyt.2023.1163800 [doi]
LID - 1163800
AB  - The predictD is an intervention implemented by general practitioners (GPs) to 
      prevent depression, which reduced the incidence of depression-anxiety and was 
      cost-effective. The e-predictD study aims to design, develop, and evaluate an 
      evolved predictD intervention to prevent the onset of major depression in primary 
      care based on Information and Communication Technologies, predictive risk 
      algorithms, decision support systems (DSSs), and personalized prevention plans 
      (PPPs). A multicenter cluster randomized trial with GPs randomly assigned to the 
      e-predictD intervention + care-as-usual (CAU) group or the active-control + CAU 
      group and 1-year follow-up is being conducted. The required sample size is 720 
      non-depressed patients (aged 18-55 years), with moderate-to-high depression risk, 
      under the care of 72 GPs in six Spanish cities. The GPs assigned to the 
      e-predictD-intervention group receive brief training, and those assigned to the 
      control group do not. Recruited patients of the GPs allocated to the e-predictD 
      group download the e-predictD app, which incorporates validated risk algorithms 
      to predict depression, monitoring systems, and DSSs. Integrating all inputs, the 
      DSS automatically proposes to the patients a PPP for depression based on eight 
      intervention modules: physical exercise, social relationships, improving sleep, 
      problem-solving, communication skills, decision-making, assertiveness, and 
      working with thoughts. This PPP is discussed in a 15-min semi-structured 
      GP-patient interview. Patients then choose one or more of the intervention 
      modules proposed by the DSS to be self-implemented over the next 3 months. This 
      process will be reformulated at 3, 6, and 9 months but without the GP-patient 
      interview. Recruited patients of the GPs allocated to the control-group+CAU 
      download another version of the e-predictD app, but the only intervention that 
      they receive via the app is weekly brief psychoeducational messages 
      (active-control group). The primary outcome is the cumulative incidence of major 
      depression measured by the Composite International Diagnostic Interview at 6 and 
      12 months. Other outcomes include depressive symptoms (PHQ-9) and anxiety 
      symptoms (GAD-7), depression risk (predictD risk algorithm), mental and physical 
      quality of life (SF-12), and acceptability and satisfaction ('e-Health Impact' 
      questionnaire) with the intervention. Patients are evaluated at baseline and 3, 
      6, 9, and 12 months. An economic evaluation will also be performed 
      (cost-effectiveness and cost-utility analysis) from two perspectives, societal 
      and health systems. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: 
      NCT03990792.
CI  - Copyright © 2023 Bellón, Rodríguez-Morejón, Conejo-Cerón, Campos-Paíno, 
      Rodríguez-Bayón, Ballesta-Rodríguez, Rodríguez-Sánchez, Mendive, López del Hoyo, 
      Luna, Tamayo-Morales and Moreno-Peral.
FAU - Bellón, Juan A
AU  - Bellón JA
AD  - Biomedical Research Institute of Malaga (IBIMA Plataforma Bionand), Málaga, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - 'El Palo' Health Centre, Servicio Andaluz de Salud (SAS), Málaga, Spain.
AD  - Department of Public Health and Psychiatry, University of Málaga (UMA), Málaga, 
      Spain.
FAU - Rodríguez-Morejón, Alberto
AU  - Rodríguez-Morejón A
AD  - Biomedical Research Institute of Malaga (IBIMA Plataforma Bionand), Málaga, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Department of Personality, Evaluation and Psychological Treatment, University of 
      Málaga (UMA), Málaga, Spain.
FAU - Conejo-Cerón, Sonia
AU  - Conejo-Cerón S
AD  - Biomedical Research Institute of Malaga (IBIMA Plataforma Bionand), Málaga, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
FAU - Campos-Paíno, Henar
AU  - Campos-Paíno H
AD  - Biomedical Research Institute of Malaga (IBIMA Plataforma Bionand), Málaga, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
FAU - Rodríguez-Bayón, Antonina
AU  - Rodríguez-Bayón A
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Centro de Salud San José, Distrito Sanitario Jaén Norte, Servicio Andaluz de 
      Salud (SAS), Linares, Jaén, Spain.
FAU - Ballesta-Rodríguez, María I
AU  - Ballesta-Rodríguez MI
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Centro de Salud Federico del Castillo, Distrito Sanitario Jaén, Servicio Andaluz 
      de Salud (SAS), Jaén, Spain.
FAU - Rodríguez-Sánchez, Emiliano
AU  - Rodríguez-Sánchez E
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Instituto de Investigación Biomédica de Salamanca 
      (IBSAL), Salamanca, Spain.
AD  - Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.
FAU - Mendive, Juan M
AU  - Mendive JM
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - 'La Mina' Health Centre, Institut Català de la Salut (ICS), Barcelona, Spain.
FAU - López Del Hoyo, Yolanda
AU  - López Del Hoyo Y
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Instituto de Investigación Sanitaria de Aragón (IISA), Universidad de Zaragoza 
      (UNIZAR), Zaragoza, Spain.
FAU - Luna, Juan D
AU  - Luna JD
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Department of Statistics and Operational Research, University of Granada (UGR), 
      Granada, Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Instituto de Investigación Biomédica de Salamanca 
      (IBSAL), Salamanca, Spain.
FAU - Moreno-Peral, Patricia
AU  - Moreno-Peral P
AD  - Biomedical Research Institute of Malaga (IBIMA Plataforma Bionand), Málaga, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP), ISCIII, Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Prevention and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain.
AD  - Department of Personality, Evaluation and Psychological Treatment, University of 
      Málaga (UMA), Málaga, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT03990792
PT  - Journal Article
DEP - 20230602
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
PMC - PMC10275079
OTO - NOTNLM
OT  - depression
OT  - internet-based interventions
OT  - mobile applications
OT  - prevention
OT  - primary health care
OT  - randomized controlled trial
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/06/19 06:41
MHDA- 2023/06/19 06:42
CRDT- 2023/06/19 02:57
PHST- 2023/02/11 00:00 [received]
PHST- 2023/05/02 00:00 [accepted]
PHST- 2023/06/19 06:42 [medline]
PHST- 2023/06/19 06:41 [pubmed]
PHST- 2023/06/19 02:57 [entrez]
AID - 10.3389/fpsyt.2023.1163800 [doi]
PST - epublish
SO  - Front Psychiatry. 2023 Jun 2;14:1163800. doi: 10.3389/fpsyt.2023.1163800. 
      eCollection 2023.

PMID- 37331154
OWN - NLM
STAT- MEDLINE
DCOM- 20230620
LR  - 20230620
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Print)
IS  - 0213-9111 (Linking)
VI  - 37
DP  - 2023
TI  - Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community 
      (Spain) as of October 2022.
PG  - 102312
LID - S0213-9111(23)00026-2 [pii]
LID - 10.1016/j.gaceta.2023.102312 [doi]
AB  - OBJECTIVE: To estimate the seroprevalence of SARS-CoV-2 antibodies in the 
      Valencian Community (Spain) in October 2022, when BA.5 was the predominant 
      variant. METHOD: Cross-sectional, region-wide, population-based serosurvey study 
      in 88 randomly selected primary care centers of the Valencian Community. RESULTS: 
      Seroprevalence of anti-nucleocapsid (indicative of past infection) and total 
      receptor binding domain (indicative of past infection or vaccination) antibodies 
      was 71.0% (confidence interval [CI]: 67.8-74.2) and 98.4% (CI: 97.5-99.3), 
      respectively. 66.7% (CI: 63.4-70.0) of the population shows hybrid immunity, but 
      only 43.2% in those 80 and over. CONCLUSIONS: The high proportion of hybrid 
      immunity detected is relevant for public health strategies. A second vaccination 
      booster was advisable in the elderly population.
CI  - Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - García-Sempere, Aníbal
AU  - García-Sempere A
AD  - Health Services Research and Pharmacoepidemiology Unit, Foundation for the 
      Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), 
      València, Spain; Chronicity, Primary Care, and Health Promotion Research Network 
      (RICAPPS), València, Spain. Electronic address: garcia_ani@gva.es.
FAU - Giménez, Estela
AU  - Giménez E
AD  - Microbiology Service, Clinic University Hospital, INCLIVA Health Research 
      Institute, València, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), 
      Spain.
FAU - Vanaclocha, Hermelinda
AU  - Vanaclocha H
AD  - General Directorate of Public Health, Department of Health, Valencian Government, 
      València, Spain.
FAU - Limón, Ramón
AU  - Limón R
AD  - General Directorate of Healthcare, Department of Health, Valencian Government, 
      València, Spain.
FAU - Peiró, Salvador
AU  - Peiró S
AD  - Health Services Research and Pharmacoepidemiology Unit, Foundation for the 
      Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), 
      València, Spain; Chronicity, Primary Care, and Health Promotion Research Network 
      (RICAPPS), València, Spain.
FAU - Navarro, David
AU  - Navarro D
AD  - Microbiology Service, Clinic University Hospital, INCLIVA Health Research 
      Institute, València, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), 
      Spain; Department of Microbiology, School of Medicine, University of Valencia, 
      València, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230518
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Aged
MH  - Humans
MH  - *SARS-CoV-2
MH  - Seroepidemiologic Studies
MH  - Spain/epidemiology
MH  - Cross-Sectional Studies
MH  - *COVID-19/epidemiology
PMC - PMC10192597
OTO - NOTNLM
OT  - Adaptive immunity
OT  - COVID-19
OT  - COVID-19 serological testing
OT  - España
OT  - Estudios seroepidemiológicos
OT  - Inmunidad adaptativa
OT  - Pruebas serológicas de COVID-19
OT  - SARS-CoV-2 variants
OT  - Seroepidemiologic studies
OT  - Spain
OT  - Variantes de SARS-CoV-2
EDAT- 2023/06/19 00:42
MHDA- 2023/06/20 06:42
CRDT- 2023/06/18 18:05
PHST- 2023/01/26 00:00 [received]
PHST- 2023/04/12 00:00 [revised]
PHST- 2023/04/22 00:00 [accepted]
PHST- 2023/06/20 06:42 [medline]
PHST- 2023/06/19 00:42 [pubmed]
PHST- 2023/06/18 18:05 [entrez]
AID - S0213-9111(23)00026-2 [pii]
AID - 102312 [pii]
AID - 10.1016/j.gaceta.2023.102312 [doi]
PST - epublish
SO  - Gac Sanit. 2023 May 18;37:102312. doi: 10.1016/j.gaceta.2023.102312. eCollection 
      2023.

PMID- 37321926
OWN - NLM
STAT- Publisher
LR  - 20230615
IS  - 1934-8150 (Electronic)
IS  - 1551-7411 (Linking)
DP  - 2023 May 19
TI  - Spanish translation of the ABC taxonomy for medication adherence.
LID - S1551-7411(23)00276-0 [pii]
LID - 10.1016/j.sapharm.2023.05.012 [doi]
AB  - BACKGROUND: The Ascertaining Barriers to Compliance (ABC) taxonomy was developed 
      aiming at systematizing definitions and operationalizations of medication 
      adherence. Its translation is crucial to improve the generalizability, 
      application and comparison of study findings. OBJECTIVE: To provide a consensus 
      translation of the ABC taxonomy from English to Spanish. METHODS: A two-phased 
      approach was used, according to the Preferred Methods for the Translation of the 
      ABC Taxonomy for Medication Adherence. Two literature reviews were conducted: to 
      identify Spanish synonyms and definitions of the ABC taxonomy, and to identify a 
      panel of Spanish-speaking experts in medication adherence. A Delphi survey was 
      designed based on the synonyms and definitions found. The experts previously 
      identified were invited to participate in the Delphi. A consensus of ≥85% was 
      established for the first round. A moderate consensus (50-75%), a consensus 
      (75-95%) or a strong consensus (>95%) were considered to be necessary in the 
      second round. RESULTS: Forty potential synonyms of the ABC taxonomy terms were 
      identified from a total of 270 papers. The response rate during the first Delphi 
      round was 32% (63/197) and in the second round 86% (54/63). A strong consensus 
      was reached for the term "inicio del tratamiento" (96%) and consensus for the 
      term "implementación" (83%). A moderate consensus was obtained for "adherencia a 
      la medicación" (70%), "interrupción del tratamiento" (52%), "manejo de la 
      adherencia" (54%) and "disciplinas relacionadas con la adherencia" (74%). No 
      consensus was reached for the term persistence. Five out of the seven definitions 
      reached a consensus in the first round, and two definitions a moderate consensus 
      after the second round. CONCLUSION: The adoption of the Spanish taxonomy will 
      increase transparency, comparability and transferability of results in the field 
      of medication adherence. This may facilitate benchmarking of adherence strategies 
      between Spanish-speaking researchers and practitioners, and other language 
      speakers.
CI  - Copyright © 2023. Published by Elsevier Inc.
FAU - Garcia-Cardenas, Victoria
AU  - Garcia-Cardenas V
AD  - Pharmacy and Pharmaceutical Technology Department, Faculty of Pharmacy, 
      University of Granada, Granada, Spain. Electronic address: vcardenas@ugr.es.
FAU - Hughes, Dyfrig
AU  - Hughes D
AD  - School of Medical and Health Sciences, Bangor University, Bangor, Gwynedd, UK. 
      Electronic address: d.a.hughes@bangor.ac.uk.
FAU - Aguilar-Palacio, Isabel
AU  - Aguilar-Palacio I
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain; Grupo de Investigación en Servicios Sanitarios de Aragón 
      (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 
      Zaragoza, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain. Electronic address: 
      iaguilar@unizar.es.
FAU - Benrimoj, Shalom Isaac
AU  - Benrimoj SI
AD  - Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, 
      Granada, Spain. Electronic address: shalom.benrimoj@gmail.com.
FAU - Rabanaque, Maria Jose
AU  - Rabanaque MJ
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain; Grupo de Investigación en Servicios Sanitarios de Aragón 
      (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 
      Zaragoza, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain. Electronic address: 
      rabanake@unizar.es.
FAU - Martinez-Martinez, Fernando
AU  - Martinez-Martinez F
AD  - Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, 
      Granada, Spain. Electronic address: femartin@ugr.es.
FAU - Malo, Sara
AU  - Malo S
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain; Grupo de Investigación en Servicios Sanitarios de Aragón 
      (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 
      Zaragoza, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), ISCIII, Madrid, Spain. Electronic address: smalo@unizar.es.
LA  - eng
PT  - Journal Article
DEP - 20230519
PL  - United States
TA  - Res Social Adm Pharm
JT  - Research in social & administrative pharmacy : RSAP
JID - 101231974
SB  - IM
EDAT- 2023/06/16 01:08
MHDA- 2023/06/16 01:08
CRDT- 2023/06/15 21:54
PHST- 2022/09/15 00:00 [received]
PHST- 2023/05/10 00:00 [revised]
PHST- 2023/05/18 00:00 [accepted]
PHST- 2023/06/16 01:08 [medline]
PHST- 2023/06/16 01:08 [pubmed]
PHST- 2023/06/15 21:54 [entrez]
AID - S1551-7411(23)00276-0 [pii]
AID - 10.1016/j.sapharm.2023.05.012 [doi]
PST - aheadofprint
SO  - Res Social Adm Pharm. 2023 May 19:S1551-7411(23)00276-0. doi: 
      10.1016/j.sapharm.2023.05.012.

PMID- 37308273
OWN - NLM
STAT- MEDLINE
DCOM- 20230614
LR  - 20230622
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 13
IP  - 6
DP  - 2023 Jun 12
TI  - Validation of diagnosis of acute myocardial infarction and stroke in electronic 
      medical records: a primary care cross-sectional study in Madrid, Spain (the 
      e-MADVEVA Study).
PG  - e068938
LID - 10.1136/bmjopen-2022-068938 [doi]
LID - e068938
AB  - OBJECTIVES: To validate the diagnoses of acute myocardial infarction (AMI) and 
      stroke recorded in electronic medical records (EMR) and to estimate the 
      population prevalence of both diseases in people aged ≥18 years. DESIGN: 
      Cross-sectional validation study. SETTING: 45 primary care centres. PARTICIPANTS: 
      Simple random sampling of diagnoses of AMI and stroke (International 
      Classification of Primary Care-2 codes K75 and K90, respectively) registered by 
      55 physicians and random age-matched and sex-matched sampling of the records that 
      included in primary care EMRs in Madrid (Spain). PRIMARY AND SECONDARY OUTCOME 
      MEASURES: Sensitivity, specificity, positive and negative predictive values and 
      overall agreement were calculated using the kappa statistic. Applied gold 
      standards were ECGs, brain imaging studies, hospital discharge reports, 
      cardiology reports and neurology reports. In the case of AMI, the 
      ESC/ACCF/AHA/WHF Expert Consensus Document was also used. Secondary outcomes were 
      the estimated prevalence of both diseases considering the sensitivity and 
      specificity obtained (true prevalence). RESULTS: The sensitivity of a diagnosis 
      of AMI was 98.11% (95% CI, 96.29 to 99.03), and the specificity was 97.42% (95% 
      CI, 95.44 to 98.55). The sensitivity of a diagnosis of stroke was 97.56% (95% CI, 
      95.56 to 98.68), and the specificity was 94.51% (95% CI, 91.96 to 96.28). No 
      differences in the results were found after stratification by age and sex (both 
      diseases). The prevalence of AMI and stroke was 1.38% and 1.27%, respectively. 
      CONCLUSION: The validation results show that diagnoses of AMI and stroke in 
      primary care EMRs constitute a helpful tool in epidemiological studies. The 
      prevalence of AMI and stroke was lower than 2% in the population aged over 18 
      years.
CI  - © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - de Burgos-Lunar, Carmen
AU  - de Burgos-Lunar C
AD  - Departamento Medicina Preventiva, Hospital Clínico San Carlos, Madrid, Comunidad 
      de Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.
FAU - Del Cura-Gonzalez, Isabel
AU  - Del Cura-Gonzalez I
AUID- ORCID: 0000-0002-3931-5304
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.
AD  - Research Support Unit, Primary Health Care Management, Madrid, Madrid, Spain.
FAU - Cárdenas-Valladolid, Juan
AU  - Cárdenas-Valladolid J
AD  - Research Support Unit, Primary Health Care Management, Madrid, Madrid, Spain.
AD  - Facultad de Ciencias de la Salud, Universidad Alfonso X el Sabio Facultad de 
      Ciencias de la Salud, Villanueva de la Canada, Madrid, Spain.
FAU - Gómez-Campelo, Paloma
AU  - Gómez-Campelo P
AD  - Institute for Health Research (IdIPAZ), Hospital La Paz, Madrid, Madrid, Spain.
FAU - Abánades-Herranz, Juan C
AU  - Abánades-Herranz JC
AD  - Monovar Health Centre, Servicio Madrileño de Salud, Madrid, Madrid, Spain.
FAU - Lopez-de-Andres, Ana
AU  - Lopez-de-Andres A
AD  - Department of Public Health and Maternal and Child, Complutense University of 
      Madrid Faculty of Medicine, Madrid, Comunidad de Madrid, Spain.
FAU - Sotos-Prieto, Mercedes
AU  - Sotos-Prieto M
AD  - Department of Preventive Medicine, Autonoma University, Madrid, Spain.
FAU - Iriarte-Campo, Victor
AU  - Iriarte-Campo V
AD  - MADIABETES Research Group, Foundation for Biomedical Research and Innovation in 
      Primary Care of the Community of Madrid, Madrid, Spain.
FAU - Fuentes-Rodriguez, Carmen Y
AU  - Fuentes-Rodriguez CY
AD  - Departamento Medicina Preventiva, Hospital Clínico San Carlos, Madrid, Comunidad 
      de Madrid, Spain.
FAU - Gómez-Coronado, Rafael
AU  - Gómez-Coronado R
AD  - Departamento Medicina Preventiva, Hospital Clínico San Carlos, Madrid, Comunidad 
      de Madrid, Spain.
FAU - Salinero-Fort, Miguel A
AU  - Salinero-Fort MA
AUID- ORCID: 0000-0002-9450-4116
AD  - Institute for Health Research (IdIPAZ), Hospital La Paz, Madrid, Madrid, Spain 
      miguel.salinero@salud.madrid.org.
AD  - MADIABETES Research Group, Foundation for Biomedical Research and Innovation in 
      Primary Care of the Community of Madrid, Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230612
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - Adult
MH  - Middle Aged
MH  - Adolescent
MH  - Cross-Sectional Studies
MH  - Electronic Health Records
MH  - Spain
MH  - *Stroke
MH  - *Myocardial Infarction
MH  - Patient Discharge
PMC - PMC10277046
OTO - NOTNLM
OT  - EPIDEMIOLOGY
OT  - Myocardial infarction
OT  - PRIMARY CARE
OT  - Stroke
COIS- Competing interests: None declared.
EDAT- 2023/06/13 01:13
MHDA- 2023/06/14 06:42
CRDT- 2023/06/12 21:02
PHST- 2023/06/14 06:42 [medline]
PHST- 2023/06/13 01:13 [pubmed]
PHST- 2023/06/12 21:02 [entrez]
AID - bmjopen-2022-068938 [pii]
AID - 10.1136/bmjopen-2022-068938 [doi]
PST - epublish
SO  - BMJ Open. 2023 Jun 12;13(6):e068938. doi: 10.1136/bmjopen-2022-068938.

PMID- 37301891
OWN - NLM
STAT- MEDLINE
DCOM- 20230612
LR  - 20230613
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 13
IP  - 1
DP  - 2023 Jun 10
TI  - Machine learning algorithms for identifying predictive variables of mortality 
      risk following dementia diagnosis: a longitudinal cohort study.
PG  - 9480
LID - 10.1038/s41598-023-36362-3 [doi]
LID - 9480
AB  - Machine learning (ML) could have advantages over traditional statistical models 
      in identifying risk factors. Using ML algorithms, our objective was to identify 
      the most important variables associated with mortality after dementia diagnosis 
      in the Swedish Registry for Cognitive/Dementia Disorders (SveDem). From SveDem, a 
      longitudinal cohort of 28,023 dementia-diagnosed patients was selected for this 
      study. Sixty variables were considered as potential predictors of mortality risk, 
      such as age at dementia diagnosis, dementia type, sex, body mass index (BMI), 
      mini-mental state examination (MMSE) score, time from referral to initiation of 
      work-up, time from initiation of work-up to diagnosis, dementia medications, 
      comorbidities, and some specific medications for chronic comorbidities (e.g., 
      cardiovascular disease). We applied sparsity-inducing penalties for three ML 
      algorithms and identified twenty important variables for the binary 
      classification task in mortality risk prediction and fifteen variables to predict 
      time to death. Area-under-ROC curve (AUC) measure was used to evaluate the 
      classification algorithms. Then, an unsupervised clustering algorithm was applied 
      on the set of twenty-selected variables to find two main clusters which 
      accurately matched surviving and dead patient clusters. A support-vector-machines 
      with an appropriate sparsity penalty provided the classification of mortality 
      risk with accuracy = 0.7077, AUROC = 0.7375, sensitivity = 0.6436, and 
      specificity = 0.740. Across three ML algorithms, the majority of the identified 
      twenty variables were compatible with literature and with our previous studies on 
      SveDem. We also found new variables which were not previously reported in 
      literature as associated with mortality in dementia. Performance of basic 
      dementia diagnostic work-up, time from referral to initiation of work-up, and 
      time from initiation of work-up to diagnosis were found to be elements of the 
      diagnostic process identified by the ML algorithms. The median follow-up time was 
      1053 (IQR = 516-1771) days in surviving and 1125 (IQR = 605-1770) days in dead 
      patients. For prediction of time to death, the CoxBoost model identified 15 
      variables and classified them in order of importance. These highly important 
      variables were age at diagnosis, MMSE score, sex, BMI, and Charlson Comorbidity 
      Index with selection scores of 23%, 15%, 14%, 12% and 10%, respectively. This 
      study demonstrates the potential of sparsity-inducing ML algorithms in improving 
      our understanding of mortality risk factors in dementia patients and their 
      application in clinical settings. Moreover, ML methods can be used as a 
      complement to traditional statistical methods.
CI  - © 2023. The Author(s).
FAU - Mostafaei, Shayan
AU  - Mostafaei S
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden. shayan.mostafaei@ki.se.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institute, 
      Stockholm, Sweden. shayan.mostafaei@ki.se.
FAU - Hoang, Minh Tuan
AU  - Hoang MT
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institute, 
      Stockholm, Sweden.
FAU - Jurado, Pol Grau
AU  - Jurado PG
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden.
FAU - Xu, Hong
AU  - Xu H
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden.
FAU - Zacarias-Pons, Lluis
AU  - Zacarias-Pons L
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden.
AD  - Vascular Health Research Group of Girona (ISV-Girona), Institut Universitari 
      d'Investigació en Atenció Primària Jordi Gol i Gurina (IDIAP Jordi Gol), Girona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Eriksdotter, Maria
AU  - Eriksdotter M
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden.
AD  - Aging and Inflammation Theme, Karolinska University Hospital, Stockholm, Sweden.
FAU - Chatterjee, Saikat
AU  - Chatterjee S
AD  - Division of Information Science and Engineering, School of Electrical Engineering 
      and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.
FAU - Garcia-Ptacek, Sara
AU  - Garcia-Ptacek S
AD  - Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and 
      Society, Karolinska Institute, Stockholm, Sweden. sara.garcia-ptacek@ki.se.
AD  - Aging and Inflammation Theme, Karolinska University Hospital, Stockholm, Sweden. 
      sara.garcia-ptacek@ki.se.
LA  - eng
GR  - 2022-01658/KI Research Foundation Grants 2022-2023/
GR  - 2022-01658/KI Research Foundation Grants 2022-2023/
GR  - 2022-01282/KI Foundation for Diseases of Aging/
GR  - 2022-01425/Swedish Research Council/
PT  - Journal Article
DEP - 20230610
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Humans
MH  - Longitudinal Studies
MH  - Cohort Studies
MH  - *Machine Learning
MH  - Algorithms
MH  - *Dementia/diagnosis
PMC - PMC10257644
COIS- The authors declare no competing interests.
EDAT- 2023/06/11 01:06
MHDA- 2023/06/12 06:43
CRDT- 2023/06/10 23:19
PHST- 2023/02/14 00:00 [received]
PHST- 2023/06/02 00:00 [accepted]
PHST- 2023/06/12 06:43 [medline]
PHST- 2023/06/11 01:06 [pubmed]
PHST- 2023/06/10 23:19 [entrez]
AID - 10.1038/s41598-023-36362-3 [pii]
AID - 36362 [pii]
AID - 10.1038/s41598-023-36362-3 [doi]
PST - epublish
SO  - Sci Rep. 2023 Jun 10;13(1):9480. doi: 10.1038/s41598-023-36362-3.

PMID- 37297661
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230612
IS  - 2227-9032 (Print)
IS  - 2227-9032 (Electronic)
IS  - 2227-9032 (Linking)
VI  - 11
IP  - 11
DP  - 2023 May 23
TI  - Indications of Induction and Caesarean Sections Performed Using the Robson 
      Classification in a University Hospital in Spain from 2010 to 2021.
LID - 10.3390/healthcare11111521 [doi]
LID - 1521
AB  - Background: The Robson Ten Group Classification System (RTGCS) enables the 
      assessment, monitoring, and comparison of caesarean section rates both within 
      healthcare facilities and between them, and the indications of caesarean sections 
      (CS) performed in a maternity ward. The aims of the present study were to conduct 
      an analysis to assess the levels and distribution of birth from a descriptive 
      approach by CS in La Ribera University Hospital (Spain) between 2010-2021 using 
      the Robson classification; to describe the indications for the induction of 
      labour and the causes of caesarean sections performed; and to examine the 
      association between the induction of labour and CS birth. Methods: A 
      retrospective study between 1 January 2010 and 31 December 2021. All eligible 
      women were classified according to the RTGCS to determine the absolute and 
      relative contribution by each group to the overall CS rate. The odds ratio (OR) 
      of the variables of interest was estimated by logistic regression. In an analysis 
      of the subgroups, the level of significance was adjusted using the Bonferroni 
      method. Results: 20,578 women gave birth during the study period, 19% of them by 
      CS. In 33% of births, induction was performed, and the most common cause was the 
      premature rupture of membranes. Group 2 (nulliparous with induced labour/elective 
      CS before labour) accounted for the largest contribution to the overall rate of 
      CS (31.5%) and showed an upward trend from 23.2% to 39.7% in the time series, 
      increasing the CS rate by 6.7%. The leading cause of CS was suspected fetal 
      distress, followed by induction failure. Conclusions: In our study, Robson Group 
      2 was identified as the main contributor to the hospital's overall CS rate. 
      Determining the causes of induction and CS in a population sample classified 
      using the RTGCS enables the identification of the groups with the greatest 
      deviation from the optimal rate of CS and the establishment of improvement plans 
      to reduce the overall rate of caesarean sections in the maternity unit.
FAU - Vila-Candel, Rafael
AU  - Vila-Candel R
AUID- ORCID: 0000-0002-3734-2480
AD  - Department of Nursing, Universitat de València, 46007 Valencia, Spain.
AD  - Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, 
      46600 Valencia, Spain.
AD  - Foundation for the Promotion of Health and Biomedical Research in the Valencian 
      Region (FISABIO-SP), 46020 Valencia, Spain.
FAU - Piquer-Martín, Nadia
AU  - Piquer-Martín N
AD  - Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, 
      46600 Valencia, Spain.
AD  - Foundation for the Promotion of Health and Biomedical Research in the Valencian 
      Region (FISABIO-SP), 46020 Valencia, Spain.
FAU - Perdomo-Ugarte, Nerea
AU  - Perdomo-Ugarte N
AD  - Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, 
      46600 Valencia, Spain.
AD  - Foundation for the Promotion of Health and Biomedical Research in the Valencian 
      Region (FISABIO-SP), 46020 Valencia, Spain.
FAU - Quesada, José Antonio
AU  - Quesada JA
AUID- ORCID: 0000-0002-6947-7531
AD  - Department of Clinical Medicine, Universidad Miguel Hernández, 03202 Elche, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      03550 Alicante, Spain.
FAU - Escuriet, Ramón
AU  - Escuriet R
AUID- ORCID: 0000-0002-7277-3331
AD  - School of Health Sciences Blanquerna, Universitat Ramon Llull, C/Padilla 326, 
      08025 Barcelona, Spain.
FAU - Martin-Arribas, Anna
AU  - Martin-Arribas A
AUID- ORCID: 0000-0001-9679-595X
AD  - School of Health Sciences Blanquerna, Universitat Ramon Llull, C/Padilla 326, 
      08025 Barcelona, Spain.
LA  - eng
GR  - UGP-20-100/Fundación para el Fomento de la Investigación Sanitaria y Biomédica de 
      la Comunitat Valenciana/
PT  - Journal Article
DEP - 20230523
PL  - Switzerland
TA  - Healthcare (Basel)
JT  - Healthcare (Basel, Switzerland)
JID - 101666525
PMC - PMC10252359
OTO - NOTNLM
OT  - Robson classification
OT  - caesarean section
OT  - indications
OT  - labour induction
OT  - mode of birth
OT  - onset of labour
COIS- The authors declare no conflict of interest.
EDAT- 2023/06/10 15:13
MHDA- 2023/06/10 15:14
CRDT- 2023/06/10 01:08
PHST- 2023/03/12 00:00 [received]
PHST- 2023/05/13 00:00 [revised]
PHST- 2023/05/22 00:00 [accepted]
PHST- 2023/06/10 15:14 [medline]
PHST- 2023/06/10 15:13 [pubmed]
PHST- 2023/06/10 01:08 [entrez]
AID - healthcare11111521 [pii]
AID - healthcare-11-01521 [pii]
AID - 10.3390/healthcare11111521 [doi]
PST - epublish
SO  - Healthcare (Basel). 2023 May 23;11(11):1521. doi: 10.3390/healthcare11111521.

PMID- 37296934
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230612
IS  - 2072-6694 (Print)
IS  - 2072-6694 (Electronic)
IS  - 2072-6694 (Linking)
VI  - 15
IP  - 11
DP  - 2023 May 30
TI  - Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled 
      Clinical Trials.
LID - 10.3390/cancers15112972 [doi]
LID - 2972
AB  - Quality pharmacological treatment can improve survival in many types of cancer. 
      Drug repurposing offers advantages in comparison with traditional drug 
      development procedures, reducing time and risk. This systematic review identified 
      the most recent randomized controlled clinical trials that focus on drug 
      repurposing in oncology. We found that only a few clinical trials were 
      placebo-controlled or standard-of-care-alone-controlled. Metformin has been 
      studied for potential use in various types of cancer, including prostate, lung, 
      and pancreatic cancer. Other studies assessed the possible use of the 
      antiparasitic agent mebendazole in colorectal cancer and of propranolol in 
      multiple myeloma or, when combined with etodolac, in breast cancer. We were able 
      to identify trials that study the potential use of known antineoplastics in other 
      non-oncological conditions, such as imatinib for severe coronavirus disease in 
      2019 or a study protocol aiming to assess the possible repurposing of leuprolide 
      for Alzheimer's disease. Major limitations of these clinical trials were the 
      small sample size, the high clinical heterogeneity of the participants regarding 
      the stage of the neoplastic disease, and the lack of accounting for 
      multimorbidity and other baseline clinical characteristics. Drug repurposing 
      possibilities in oncology must be carefully examined with well-designed trials, 
      considering factors that could influence prognosis.
FAU - Ioakeim-Skoufa, Ignatios
AU  - Ioakeim-Skoufa I
AUID- ORCID: 0000-0002-6518-749X
AD  - WHO Collaborating Centre for Drug Statistics Methodology, Department of Drug 
      Statistics, Division of Health Data and Digitalisation, Norwegian Institute of 
      Public Health, NO-0213 Oslo, Norway.
AD  - EpiChron Research Group, Aragon Health Research Institute (IIS Aragón), Miguel 
      Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III (ISCIII), ES-28029 Madrid, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), ES-08009 Barcelona, Spain.
AD  - Department of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Tobajas-Ramos, Natalia
AU  - Tobajas-Ramos N
AD  - Department of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Menditto, Enrica
AU  - Menditto E
AD  - Centro Interdipartimentale di Ricerca in Farmacoeconomia e Farmacoutilizzazione 
      (CIRFF), Center of Drug Utilization and Pharmacoeconomics, Department of 
      Pharmacy, University of Naples Federico II, IT-80131 Naples, Italy.
FAU - Aza-Pascual-Salcedo, Mercedes
AU  - Aza-Pascual-Salcedo M
AUID- ORCID: 0000-0002-8937-5559
AD  - EpiChron Research Group, Aragon Health Research Institute (IIS Aragón), Miguel 
      Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III (ISCIII), ES-28029 Madrid, Spain.
AD  - Primary Care Pharmacy Service Zaragoza III, Aragon Health Service (SALUD), 
      ES-50017 Zaragoza, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AUID- ORCID: 0000-0002-5440-1710
AD  - EpiChron Research Group, Aragon Health Research Institute (IIS Aragón), Miguel 
      Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III (ISCIII), ES-28029 Madrid, Spain.
FAU - Orlando, Valentina
AU  - Orlando V
AUID- ORCID: 0000-0002-8209-8878
AD  - Centro Interdipartimentale di Ricerca in Farmacoeconomia e Farmacoutilizzazione 
      (CIRFF), Center of Drug Utilization and Pharmacoeconomics, Department of 
      Pharmacy, University of Naples Federico II, IT-80131 Naples, Italy.
FAU - González-Rubio, Francisca
AU  - González-Rubio F
AUID- ORCID: 0000-0001-5939-4436
AD  - EpiChron Research Group, Aragon Health Research Institute (IIS Aragón), Miguel 
      Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), ES-08009 Barcelona, Spain.
FAU - Fanlo-Villacampa, Ana
AU  - Fanlo-Villacampa A
AD  - Department of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Lasala-Aza, Carmen
AU  - Lasala-Aza C
AUID- ORCID: 0000-0002-2178-9130
AD  - Pharmacy Service, Virgen de la Victoria University Hospital, ES-29010 Malaga, 
      Spain.
FAU - Ostasz, Ewelina
AU  - Ostasz E
AD  - Rehabilitation Centre Vikersund Bad AS, NO-3370 Vikersund, Norway.
FAU - Vicente-Romero, Jorge
AU  - Vicente-Romero J
AUID- ORCID: 0000-0003-4629-6743
AD  - Department of Pharmacology, Physiology, and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230530
PL  - Switzerland
TA  - Cancers (Basel)
JT  - Cancers
JID - 101526829
PMC - PMC10251882
OTO - NOTNLM
OT  - antineoplastic agents
OT  - drug repositioning
OT  - etodolac
OT  - imatinib
OT  - leuprolide
OT  - mebendazole
OT  - medical oncology
OT  - metformin
OT  - multimorbidity
OT  - propranolol
COIS- The authors declare no conflict of interest.
EDAT- 2023/06/10 15:13
MHDA- 2023/06/10 15:14
CRDT- 2023/06/10 01:03
PHST- 2023/02/25 00:00 [received]
PHST- 2023/05/19 00:00 [revised]
PHST- 2023/05/27 00:00 [accepted]
PHST- 2023/06/10 15:14 [medline]
PHST- 2023/06/10 15:13 [pubmed]
PHST- 2023/06/10 01:03 [entrez]
AID - cancers15112972 [pii]
AID - cancers-15-02972 [pii]
AID - 10.3390/cancers15112972 [doi]
PST - epublish
SO  - Cancers (Basel). 2023 May 30;15(11):2972. doi: 10.3390/cancers15112972.

PMID- 37296835
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230612
IS  - 2072-6694 (Print)
IS  - 2072-6694 (Electronic)
IS  - 2072-6694 (Linking)
VI  - 15
IP  - 11
DP  - 2023 May 23
TI  - Calcium Homeostasis in the Development of Resistant Breast Tumors.
LID - 10.3390/cancers15112872 [doi]
LID - 2872
AB  - Cancer is one of the main health problems worldwide. Only in 2020, this disease 
      caused more than 19 million new cases and almost 10 million deaths, with breast 
      cancer being the most diagnosed worldwide. Today, despite recent advances in 
      breast cancer treatment, a significant percentage of patients will either not 
      respond to therapy or will eventually experience lethal progressive disease. 
      Recent studies highlighted the involvement of calcium in the proliferation or 
      evasion of apoptosis in breast carcinoma cells. In this review, we provide an 
      overview of intracellular calcium signaling and breast cancer biology. We also 
      discuss the existing knowledge on how altered calcium homeostasis is implicated 
      in breast cancer development, highlighting the potential utility of Ca(2+) as a 
      predictive and prognostic biomarker, as well as its potential for the development 
      of new pharmacological treatments to treat the disease.
FAU - Martin-García, Desirée
AU  - Martin-García D
AD  - Surgical Specialties, Biochemistry and Immunology Department, Faculty of 
      Medicine, University of Málaga, 29010 Málaga, Spain.
AD  - Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND 
      (IBIMA-BIONAND), Severo Ochoa, 35, 29590 Málaga, Spain.
FAU - Téllez, Teresa
AU  - Téllez T
AD  - Surgical Specialties, Biochemistry and Immunology Department, Faculty of 
      Medicine, University of Málaga, 29010 Málaga, Spain.
AD  - Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND 
      (IBIMA-BIONAND), Severo Ochoa, 35, 29590 Málaga, Spain.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) 
      and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Investigación Biomédica de Málaga (IBIMA), 29590 Málaga, 
      Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AD  - Surgical Specialties, Biochemistry and Immunology Department, Faculty of 
      Medicine, University of Málaga, 29010 Málaga, Spain.
AD  - Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND 
      (IBIMA-BIONAND), Severo Ochoa, 35, 29590 Málaga, Spain.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) 
      and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Investigación Biomédica de Málaga (IBIMA), 29590 Málaga, 
      Spain.
AD  - Research and Innovation Unit, Hospital Costa del Sol, Autovia A-7 km 187, 29602 
      Marbella, Spain.
FAU - García-Aranda, Marilina
AU  - García-Aranda M
AUID- ORCID: 0000-0003-3759-4044
AD  - Instituto de Investigación Biomédica de Málaga-Plataforma BIONAND 
      (IBIMA-BIONAND), Severo Ochoa, 35, 29590 Málaga, Spain.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) 
      and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Investigación Biomédica de Málaga (IBIMA), 29590 Málaga, 
      Spain.
AD  - Research and Innovation Unit, Hospital Costa del Sol, Autovia A-7 km 187, 29602 
      Marbella, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230523
PL  - Switzerland
TA  - Cancers (Basel)
JT  - Cancers
JID - 101526829
PMC - PMC10251880
OTO - NOTNLM
OT  - Ca2+ channels
OT  - breast cancer
OT  - calcium
OT  - homeostasis
OT  - resistant tumors
OT  - targeted therapy
COIS- The authors declare no conflict of interest.
EDAT- 2023/06/10 15:14
MHDA- 2023/06/10 15:15
CRDT- 2023/06/10 01:03
PHST- 2023/04/11 00:00 [received]
PHST- 2023/05/16 00:00 [revised]
PHST- 2023/05/21 00:00 [accepted]
PHST- 2023/06/10 15:15 [medline]
PHST- 2023/06/10 15:14 [pubmed]
PHST- 2023/06/10 01:03 [entrez]
AID - cancers15112872 [pii]
AID - cancers-15-02872 [pii]
AID - 10.3390/cancers15112872 [doi]
PST - epublish
SO  - Cancers (Basel). 2023 May 23;15(11):2872. doi: 10.3390/cancers15112872.

PMID- 37280152
OWN - NLM
STAT- Publisher
LR  - 20230606
IS  - 1469-0756 (Electronic)
IS  - 0032-5473 (Linking)
DP  - 2023 Jun 6
TI  - Tackling medical deserts: unearthing factors that influence medical students' 
      attitudes and the path forward.
LID - qgad042 [pii]
LID - 10.1093/postmj/qgad042 [doi]
FAU - Marcec, Robert
AU  - Marcec R
AUID- ORCID: 0000-0002-8750-2083
AD  - School of Medicine, University of Zagreb, Zagreb 10000, Croatia.
FAU - Seils, Laura Alexandra
AU  - Seils LA
AUID- ORCID: 0000-0001-9878-7865
AD  - Avedis Donabedian Research Institute (FAD), Barcelona 08016, Spain.
FAU - Gonzalez, Ana Isabel
AU  - Gonzalez AI
AUID- ORCID: 0000-0001-7167-4211
AD  - Avedis Donabedian Research Institute (FAD), Barcelona 08016, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Madrid 28022, Spain.
FAU - Dubas-Jakobczyk, Katarzyna
AU  - Dubas-Jakobczyk K
AUID- ORCID: 0000-0002-6368-2868
AD  - Institute of Public Health, Jagiellonian University Medical College, Krakow 
      30-010, Poland.
FAU - Domagała, Alicja
AU  - Domagała A
AUID- ORCID: 0000-0001-6162-1810
AD  - Institute of Public Health, Jagiellonian University Medical College, Krakow 
      30-010, Poland.
FAU - Dan, Sorin
AU  - Dan S
AUID- ORCID: 0000-0003-0565-7282
AD  - School of Management, University of Vaasa, Vaasa 65100, Finland.
FAU - Flinterman, Linda
AU  - Flinterman L
AUID- ORCID: 0000-0001-7943-5274
AD  - Netherlands Institute for Health Services Research (NIVEL), Utrecht 3553, The 
      Netherlands.
FAU - Likic, Robert
AU  - Likic R
AUID- ORCID: 0000-0003-1413-4862
AD  - School of Medicine, University of Zagreb, Zagreb 10000, Croatia.
FAU - Batenburg, Ronald
AU  - Batenburg R
AUID- ORCID: 0000-0001-9453-481X
AD  - Netherlands Institute for Health Services Research (NIVEL), Utrecht 3553, The 
      Netherlands.
AD  - Department of Sociology, Radboud University, Nijmegen 6524, The Netherlands.
LA  - eng
GR  - 101018379/European Union's Health Programme (2014-2020)/
PT  - Journal Article
DEP - 20230606
PL  - England
TA  - Postgrad Med J
JT  - Postgraduate medical journal
JID - 0234135
SB  - IM
OTO - NOTNLM
OT  - Attitudes
OT  - Medical deserts
OT  - Medical students
OT  - Recruitment
OT  - Underserved areas
EDAT- 2023/06/07 01:07
MHDA- 2023/06/07 01:07
CRDT- 2023/06/06 22:23
PHST- 2023/05/03 00:00 [received]
PHST- 2023/05/03 00:00 [revised]
PHST- 2023/05/06 00:00 [accepted]
PHST- 2023/06/07 01:07 [medline]
PHST- 2023/06/07 01:07 [pubmed]
PHST- 2023/06/06 22:23 [entrez]
AID - 7191004 [pii]
AID - 10.1093/postmj/qgad042 [doi]
PST - aheadofprint
SO  - Postgrad Med J. 2023 Jun 6:qgad042. doi: 10.1093/postmj/qgad042.

PMID- 37267891
OWN - NLM
STAT- MEDLINE
DCOM- 20230606
LR  - 20230606
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Linking)
VI  - 37
DP  - 2023
TI  - Opinion on the benefits of nurse prescribing in Catalonia. Consensus of health 
      professionals and managers.
PG  - 102310
LID - S0213-9111(23)00024-9 [pii]
LID - 10.1016/j.gaceta.2023.102310 [doi]
AB  - OBJECTIVE: To study the level of agreement among health professionals and 
      managers in Catalonia on the benefits of nurse prescribing (NP). METHOD: An 
      online Real Time Delphi was conducted to collect the level of agreement of health 
      professionals and managers. Participants voted in a 6-point scale (1 low benefit 
      and 6 high benefit) for 12 items describing benefits of NP. A total of 1332 
      professionals participated. The level of consensus was calculated applying 
      interquartile ranges of scores and standardized mean differences among subgroups 
      using effect sizes (ES) and their corresponding 95% confidence intervals. 
      RESULTS: The scores indicate a general agreement on the perceived benefits of NP 
      among participants. Standardized differences among scores on the perceived 
      benefits among professionals were small to high (ES range between 0.2 and 1.2) 
      between nurses and medical doctors and high between nurses and pharmacists (ES 
      range: 1.2 and 2.4). Differences between scores of nurses and those of managers 
      or other professionals in the present study were smaller for most voted benefits. 
      CONCLUSIONS: The study shows an agreement on the benefits of NP. Nevertheless, 
      when standardized scores are taken into consideration, differences among 
      professionals' perceptions emerged, and aligned with documented barriers 
      identified in the literature such as corporative aspects, cultural limitations, 
      institutional and organisational inertia, beliefs and unawareness of what NP 
      implies.
CI  - Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Jodar-Solà, Glòria
AU  - Jodar-Solà G
AD  - Equip d'Atenció Primària Sant Andreu Pallejà, Pallejà, Catalonia, Spain; Col·legi 
      Oficial d'Infermeres i Infermers de Barcelona (COIB), Barcelona, Catalonia, 
      Spain.
FAU - Brugués-Brugués, Alba
AU  - Brugués-Brugués A
AD  - Consorci Castelldefels Agents de Salut (CASAP), Castelldefels (Barcelona), 
      Catalonia, Spain; Associació d'Infermeria Familiar i Comunitària de Catalunya 
      (AIFiCC), Barcelona, Catalonia, Spain.
FAU - Serra-Sutton, Vicky
AU  - Serra-Sutton V
AD  - Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, 
      Catalonia, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, 
      Spain. Electronic address: vserra@gencat.cat.
FAU - Espallargues-Carreras, Mireia
AU  - Espallargues-Carreras M
AD  - Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, 
      Catalonia, Spain; Red de Investigación en Cronicidad, Atención Primaria y 
      Promoción de la Salud (RICAPPS), Barcelona, Spain.
FAU - Trejo-Omeñaca, Alex
AU  - Trejo-Omeñaca A
AD  - Onsanity Solutions S.L., Barcelona, Catalonia, Spain; Universitat Politècnica de 
      Catalunya, Escola Superior d'Enginyeria de Barcelona. Departament de Disseny, 
      Barcelona, Catalonia, Spain.
FAU - Monguet-Fierro, Josep M
AU  - Monguet-Fierro JM
AD  - Universitat Politècnica de Catalunya, Escola Superior d'Enginyeria de Barcelona. 
      Departament de Disseny, Barcelona, Catalonia, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230531
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Humans
MH  - Consensus
MH  - Spain
MH  - *Pharmacists
MH  - *Physicians
MH  - Delphi Technique
OTO - NOTNLM
OT  - Calidad de cuidados de la salud
OT  - Consenso
OT  - Consensus
OT  - Delphi technique
OT  - Enfermería
OT  - Nursing
OT  - Prescripción
OT  - Prescriptions
OT  - Quality of health care
OT  - Técnica Delphi
EDAT- 2023/06/03 11:42
MHDA- 2023/06/06 06:42
CRDT- 2023/06/02 18:09
PHST- 2022/10/04 00:00 [received]
PHST- 2023/04/06 00:00 [revised]
PHST- 2023/04/11 00:00 [accepted]
PHST- 2023/06/06 06:42 [medline]
PHST- 2023/06/03 11:42 [pubmed]
PHST- 2023/06/02 18:09 [entrez]
AID - S0213-9111(23)00024-9 [pii]
AID - 10.1016/j.gaceta.2023.102310 [doi]
PST - epublish
SO  - Gac Sanit. 2023 May 31;37:102310. doi: 10.1016/j.gaceta.2023.102310. eCollection 
      2023.

PMID- 37267809
OWN - NLM
STAT- MEDLINE
DCOM- 20230613
LR  - 20230613
IS  - 1872-8243 (Electronic)
IS  - 1386-5056 (Linking)
VI  - 176
DP  - 2023 Aug
TI  - Development and evaluation of DiabeText, a personalized mHealth intervention to 
      support medication adherence and lifestyle change behaviour in patients with type 
      2 diabetes in Spain: A mixed-methods phase II pragmatic randomized controlled 
      clinical trial.
PG  - 105103
LID - S1386-5056(23)00121-1 [pii]
LID - 10.1016/j.ijmedinf.2023.105103 [doi]
AB  - BACKGROUND: Despite the increasing interest in text-messaging interventions to 
      support healthcare delivery, the available evidence about their effectiveness is 
      still limited. OBJECTIVES: 1) to develop DiabeText, an intervention delivering 
      automated, tailored brief text messages to support diabetes self-management; 2) 
      to explore the potential impact of DiabeText on self-management behavior and 
      glycaemic control, and; 3) to examine the feasibility of conducting a future 
      phase III randomized clinical trial to evaluate the effectiveness of DiabeText. 
      METHODS: 3-month, two-arm, randomized feasibility trial (ClinicalTrials.gov: 
      NCT04738591) with patients with type 2 diabetes (HbA1c > 8%). Participants were 
      allocated to the control (usual care) or DiabeText group (usual care + five text 
      messages per week). Outcomes were: recruitment rate; follow-up rate, missing 
      data; medication adherence; adherence to Mediterranean diet; physical activity; 
      and HbA1c. In addition, after delivering the intervention, we conducted a 
      qualitative study involving 14 semi-structured interviews with participants 
      allocated to the DiabeText group, to understand their views about the 
      intervention. RESULTS: From 444 screened people, we recruited 207 participants 
      (recruitment rate = 47%), of which 179 completed the post-intervention interview 
      (follow-up rate = 86%). We sent 7,355 SMS during the intervention period, of 
      which 99% successfully reached the participants. At post-intervention, DiabeText 
      was associated with non-statistically significant (p > 0.05) improvements in 
      adherence to medication (OR = 2.0; 95%CI 1.0 to 4.2), Mediterranean diet (1.7; 
      0.9 to 3.2), and physical activity (1.7; 0.9 to 3.1). No between-group 
      differences were observed in mean HbA1c (p = 0.670). The qualitative study 
      indicated that participants perceived DiabeText as a helpful resource because it 
      increased their awareness about the importance of adequate self-management and 
      the sense of being cared for. CONCLUSIONS: DiabeText is the first system in Spain 
      to integrate patient-generated and routinely collected clinical data to deliver 
      tailored text messages to support diabetes self-management. More robust trials 
      are needed to determine its effectiveness and cost-efficacy.
CI  - Copyright © 2023 Elsevier B.V. All rights reserved.
FAU - Zamanillo-Campos, Rocío
AU  - Zamanillo-Campos R
AD  - Balearic Islands Health Research Institute (IdISBa) Carretera de Valldemossa, 79, 
      Hospital Universitari Son Espases. Edifici S, 07120 Palma, Spain; Primary Care 
      Research Unit of Mallorca, Balearic Islands Health Service, Carrer de l'Escola 
      Graduada, n° 3, 07002 Palma, Spain.
FAU - Fiol-deRoque, Maria Antonia
AU  - Fiol-deRoque MA
AD  - Balearic Islands Health Research Institute (IdISBa) Carretera de Valldemossa, 79, 
      Hospital Universitari Son Espases. Edifici S, 07120 Palma, Spain; Primary Care 
      Research Unit of Mallorca, Balearic Islands Health Service, Carrer de l'Escola 
      Graduada, n° 3, 07002 Palma, Spain. Electronic address: 
      mariaantonia.fiol@ssib.es.
FAU - Serrano-Ripoll, Maria Jesús
AU  - Serrano-Ripoll MJ
AD  - Balearic Islands Health Research Institute (IdISBa) Carretera de Valldemossa, 79, 
      Hospital Universitari Son Espases. Edifici S, 07120 Palma, Spain; Primary Care 
      Research Unit of Mallorca, Balearic Islands Health Service, Carrer de l'Escola 
      Graduada, n° 3, 07002 Palma, Spain; Research Network on Chronicity, Primary Care 
      and Health Promotion (RICAPPS, RD21/0016/0005), Gran Via de les Corts Catalanes, 
      587, 08007 Barcelona, Spain.
FAU - Mira-Martínez, Sofía
AU  - Mira-Martínez S
AD  - Balearic Islands Health Research Institute (IdISBa) Carretera de Valldemossa, 79, 
      Hospital Universitari Son Espases. Edifici S, 07120 Palma, Spain; Primary Care 
      Research Unit of Mallorca, Balearic Islands Health Service, Carrer de l'Escola 
      Graduada, n° 3, 07002 Palma, Spain.
FAU - Ricci-Cabello, Ignacio
AU  - Ricci-Cabello I
AD  - Balearic Islands Health Research Institute (IdISBa) Carretera de Valldemossa, 79, 
      Hospital Universitari Son Espases. Edifici S, 07120 Palma, Spain; Primary Care 
      Research Unit of Mallorca, Balearic Islands Health Service, Carrer de l'Escola 
      Graduada, n° 3, 07002 Palma, Spain; CIBER de Epidemiología y Salud Pública 
      (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, 28029 Madrid, 
      Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT04738591
PT  - Clinical Trial, Phase II
PT  - Clinical Trial, Phase III
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20230522
PL  - Ireland
TA  - Int J Med Inform
JT  - International journal of medical informatics
JID - 9711057
RN  - 0 (Glycated Hemoglobin)
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/drug therapy
MH  - Glycated Hemoglobin
MH  - Spain
MH  - *Text Messaging
MH  - Life Style
MH  - *Telemedicine
MH  - Medication Adherence
OTO - NOTNLM
OT  - Diabetes self-management
OT  - Glycemic control
OT  - Lifestyle behaviour
OT  - Mobile health
OT  - Randomized controlled trial
OT  - SMS
OT  - Treatment adherence
OT  - Type 2 diabetes mellitus
OT  - mHealth
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2023/06/03 11:42
MHDA- 2023/06/13 06:42
CRDT- 2023/06/02 18:07
PHST- 2023/01/24 00:00 [received]
PHST- 2023/05/16 00:00 [revised]
PHST- 2023/05/18 00:00 [accepted]
PHST- 2023/06/13 06:42 [medline]
PHST- 2023/06/03 11:42 [pubmed]
PHST- 2023/06/02 18:07 [entrez]
AID - S1386-5056(23)00121-1 [pii]
AID - 10.1016/j.ijmedinf.2023.105103 [doi]
PST - ppublish
SO  - Int J Med Inform. 2023 Aug;176:105103. doi: 10.1016/j.ijmedinf.2023.105103. Epub 
      2023 May 22.

PMID- 37265950
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230604
IS  - 1664-1078 (Print)
IS  - 1664-1078 (Electronic)
IS  - 1664-1078 (Linking)
VI  - 14
DP  - 2023
TI  - Editorial: Mental health in primary health care.
PG  - 1190410
LID - 10.3389/fpsyg.2023.1190410 [doi]
LID - 1190410
FAU - Aguilar-Latorre, Alejandra
AU  - Aguilar-Latorre A
AD  - Aragonese Primary Care Research Group (GAIAP), Institute for Health Research 
      Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Aragonese Primary Care Research Group (GAIAP), Institute for Health Research 
      Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
FAU - Porroche-Escudero, Ana
AU  - Porroche-Escudero A
AD  - Centre for Health Inequalities Research, Faculty of Health and Medicine, 
      Lancaster University, Lancaster, United Kingdom.
FAU - Serrano-Ripoll, María J
AU  - Serrano-Ripoll MJ
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma, 
      Spain.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Aragonese Primary Care Research Group (GAIAP), Institute for Health Research 
      Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 
      Zaragoza, Spain.
LA  - eng
PT  - Editorial
DEP - 20230517
PL  - Switzerland
TA  - Front Psychol
JT  - Frontiers in psychology
JID - 101550902
CON - Editorial on the Research Topic Mental health in primary health care
PMC - PMC10230021
OTO - NOTNLM
OT  - anxiety
OT  - depression
OT  - health inequalities
OT  - mental health
OT  - primary care
OT  - psychoeducation
OT  - social determinants of health
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/06/02 13:16
MHDA- 2023/06/02 13:17
CRDT- 2023/06/02 10:52
PHST- 2023/03/20 00:00 [received]
PHST- 2023/05/02 00:00 [accepted]
PHST- 2023/06/02 13:17 [medline]
PHST- 2023/06/02 13:16 [pubmed]
PHST- 2023/06/02 10:52 [entrez]
AID - 10.3389/fpsyg.2023.1190410 [doi]
PST - epublish
SO  - Front Psychol. 2023 May 17;14:1190410. doi: 10.3389/fpsyg.2023.1190410. 
      eCollection 2023.

PMID- 37249860
OWN - NLM
STAT- Publisher
LR  - 20230602
IS  - 1720-8319 (Electronic)
IS  - 1594-0667 (Print)
IS  - 1594-0667 (Linking)
DP  - 2023 May 30
TI  - Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital 
      admission and mortality amongst nursing home residents.
PG  - 1-8
LID - 10.1007/s40520-023-02446-3 [doi]
AB  - BACKGROUND: Nursing home residents (NHRs) have experienced disproportionately 
      high risk of severe outcomes due to COVID-19 infection. AIM: We investigated the 
      impact of COVID-19 vaccinations and previous SARS-CoV-2 episodes in preventing 
      hospitalization and mortality in NHRs. METHODS: Retrospective study of a cohort 
      of all NHRs in our area who were alive at the start of the vaccination campaign. 
      The first three doses of SARS-CoV-2 vaccine and prior COVID-19 infections were 
      registered. The main outcomes were hospital admission and mortality during each 
      follow up. Random effects time-varying Cox models adjusted for age, sex, and 
      comorbidities were fitted to estimate hazard ratios (HRs) according to 
      vaccination status. RESULTS: COVID-19 hospitalization and death rates for 
      unvaccinated NHRs were respectively 2.39 and 1.42 per 10,000 person-days, falling 
      after administration of the second dose (0.37 and 0.34) and rising with the third 
      dose (1.08 and 0.8). Rates were much lower amongst people who had previously had 
      COVID-19. Adjusted HRs indicated a significant decrease in hospital admission 
      amongst those with a two- and three-dose status; those who had had a previous 
      COVID-19 infection had even lower hospital admission rates. Death rates decreased 
      as NHRs received two and three doses, and the probability of death was much lower 
      among those who had previously had the infection. CONCLUSIONS: The effectiveness 
      of current vaccines against severe COVID-19 disease in NHRs remains high and 
      SARS-CoV-2 episodes prior to vaccination entail a major reduction in 
      hospitalization and mortality rates. The protection conferred by vaccines appears 
      to decline in the following months. TRIAL REGISTRATION: ClinicalTrials.gov 
      Identifier: NCT04463706.
CI  - © 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
FAU - España, Pedro P
AU  - España PP
AUID- ORCID: 0000-0001-5723-8253
AD  - Respiratory Service, Osakidetza Basque Health Service, Galdakao-Usansolo 
      University Hospital, Galdakao, Spain. pedropablo.espanayandiola@osakidetza.eus.
AD  - Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. 
      pedropablo.espanayandiola@osakidetza.eus.
AD  - Respiratory Unit, Galdakao-Usansolo University Hospital, Galdakao, Spain. 
      pedropablo.espanayandiola@osakidetza.eus.
FAU - Bilbao-González, Amaia
AU  - Bilbao-González A
AD  - Research and Innovation Unit, Osakidetza Basque Health Service, Basurto 
      University Hospital, Bilbao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Larrea, Nere
AU  - Larrea N
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Castillo-Sintes, Idoia
AU  - Castillo-Sintes I
AD  - Research and Innovation Unit, Osakidetza Basque Health Service, Basurto 
      University Hospital, Bilbao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - García-Gutiérrez, Susana
AU  - García-Gutiérrez S
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Portuondo, Janire
AU  - Portuondo J
AD  - Osakidetza Basque Health Service, Sub-Directorate for Primary Care Coordination, 
      Vitoria-Gasteiz, Spain.
AD  - Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Villanueva, Ane
AU  - Villanueva A
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Uranga, Ane
AU  - Uranga A
AD  - Respiratory Service, Osakidetza Basque Health Service, Galdakao-Usansolo 
      University Hospital, Galdakao, Spain.
AD  - Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
FAU - Legarreta, Maria J
AU  - Legarreta MJ
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Gascon, Maria
AU  - Gascon M
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Quintana, Jose M
AU  - Quintana JM
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network On Chronic Diseases (REDISSEC), Bilbao, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
CN  - COVID-Health Basque Country Research Group
LA  - eng
SI  - ClinicalTrials.gov/NCT04463706
GR  - RD16/0001/0001/Instituto de Salud Carlos III/
GR  - RD21/0016/0017/Instituto de Salud Carlos III/
PT  - Journal Article
DEP - 20230530
PL  - Germany
TA  - Aging Clin Exp Res
JT  - Aging clinical and experimental research
JID - 101132995
SB  - IM
PMC - PMC10228436
OTO - NOTNLM
OT  - COVID-19
OT  - COVID-19 vaccines
OT  - Hospitalization
OT  - Mortality
OT  - SARS-CoV-2
COIS- The author(s) declare that they have no conflict of interest.
FIR - Portuondo, Janire
IR  - Portuondo J
FIR - Garcia, Julia
IR  - Garcia J
FIR - Tiscar, Verónica
IR  - Tiscar V
FIR - Bilbao, Amaia
IR  - Bilbao A
FIR - Castillo, Idoia
IR  - Castillo I
FIR - García-Gutierrez, Susana
IR  - García-Gutierrez S
FIR - Quintana, Jose M
IR  - Quintana JM
FIR - Legarreta, Maria J
IR  - Legarreta MJ
FIR - Villanueva, Ane
IR  - Villanueva A
FIR - Gascón, María
IR  - Gascón M
FIR - Larrea, Nere
IR  - Larrea N
FIR - Lafuente, Iratxe
IR  - Lafuente I
FIR - Esteban, Cristóbal
IR  - Esteban C
FIR - Aramburu, Amaia
IR  - Aramburu A
FIR - España, Pedro Pablo
IR  - España PP
FIR - Uranga, Ane
IR  - Uranga A
FIR - Barrio, Irantzu
IR  - Barrio I
FIR - Lee, Dae-Jin
IR  - Lee DJ
FIR - Monsalve-Cobis, Abelardo-Enrique
IR  - Monsalve-Cobis AE
FIR - Rodríguez, Lander
IR  - Rodríguez L
EDAT- 2023/05/30 13:07
MHDA- 2023/05/30 13:07
CRDT- 2023/05/30 11:15
PHST- 2023/03/13 00:00 [received]
PHST- 2023/05/17 00:00 [accepted]
PHST- 2023/05/30 13:07 [medline]
PHST- 2023/05/30 13:07 [pubmed]
PHST- 2023/05/30 11:15 [entrez]
AID - 10.1007/s40520-023-02446-3 [pii]
AID - 2446 [pii]
AID - 10.1007/s40520-023-02446-3 [doi]
PST - aheadofprint
SO  - Aging Clin Exp Res. 2023 May 30:1-8. doi: 10.1007/s40520-023-02446-3.

PMID- 37248449
OWN - NLM
STAT- MEDLINE
DCOM- 20230531
LR  - 20230601
IS  - 1471-2393 (Electronic)
IS  - 1471-2393 (Linking)
VI  - 23
IP  - 1
DP  - 2023 May 29
TI  - Experiences of water immersion during childbirth: a qualitative thematic 
      synthesis.
PG  - 395
LID - 10.1186/s12884-023-05690-7 [doi]
LID - 395
AB  - BACKGROUND: The increasing demand for childbirth care based on physiological 
      principles has led official bodies to encourage health centers to provide 
      evidence-based care aimed at promoting women's participation in informed 
      decision-making and avoiding excessive medical intervention during childbirth. 
      One of the goals is to reduce pain and find alternative measures to epidural 
      anesthesia to enhance women's autonomy and well-being during childbirth. 
      Currently, water immersion is used as a non-pharmacological method for pain 
      relief. This review aimed to identify and synthesize evidence on women's and 
      midwives' experiences, values, and preferences regarding water immersion during 
      childbirth. METHODS: A systematic review and thematic synthesis of qualitative 
      evidence were conducted. Databases were searched and references were checked 
      according to specific criteria. Studies that used qualitative data collection and 
      analysis methods to examine the opinions of women or midwives in the hospital 
      setting were included. Non-qualitative studies, mixed-methods studies that did 
      not separately report qualitative results, and studies in languages other than 
      English or Spanish were excluded. The Critical Appraisal Skills Program 
      Qualitative Research Checklist was used to assess study quality, and results were 
      synthesized using thematic synthesis. RESULTS: Thirteen studies met the inclusion 
      criteria and were included in this review. The qualitative studies yielded three 
      key themes: 1) reasons identified by women and midwives for choosing a water 
      birth, 2) benefits experienced in water births, and 3) barriers and facilitators 
      of water immersion during childbirth. CONCLUSIONS: The evidence from qualitative 
      studies indicates that women report benefits associated with water birth. From 
      the perspective of midwives, ensuring safe water births requires adequate 
      resources, midwives training, and rigorous standardized protocols to ensure that 
      all pregnant women can safely opt for water immersion during childbirth with 
      satisfactory results.
CI  - © 2023. The Author(s).
FAU - Reviriego-Rodrigo, E
AU  - Reviriego-Rodrigo E
AD  - Osteba, Health Technology Assessment, Knowledge Management and Evaluation, Basque 
      Foundation for Health Innovation and Research (BIOEF), Barakaldo-Bizkaia, Spain. 
      ereviriego@bioef.eus.
FAU - Ibargoyen-Roteta, N
AU  - Ibargoyen-Roteta N
AD  - Osteba, Health Technology Assessment, Knowledge Management and Evaluation, Basque 
      Foundation for Health Innovation and Research (BIOEF), Barakaldo-Bizkaia, Spain.
FAU - Carreguí-Vilar, S
AU  - Carreguí-Vilar S
AD  - La Plana University Hospital, Villarreal-Castellón, Spain.
FAU - Mediavilla-Serrano, L
AU  - Mediavilla-Serrano L
AD  - Osakidetza, OSI Debabarrena, Mendaro Hospital, Mendaro-Gipuzkoa, Spain.
FAU - Uceira-Rey, S
AU  - Uceira-Rey S
AD  - Hospital da Barbanza, Ribeira-A Coruña, Spain.
FAU - Iglesias-Casás, S
AU  - Iglesias-Casás S
AD  - Hospital do Salnés, Vilagarcía de Arousa-Pontevedra, Spain.
FAU - Martín-Casado, A
AU  - Martín-Casado A
AD  - Universidad Internacional de La Rioja UNIR, Logroño-La Rioja, Spain.
FAU - Toledo-Chávarri, A
AU  - Toledo-Chávarri A
AD  - Canary Islands Health Research Institute Foundation, Network for Research on 
      Chronicity, Primary Care, and Health Promotion (RICAPPS), The Spanish Network of 
      Agencies for Health Technology Assessment and Services of the National Health 
      System (RedETS), Madrid, Spain.
FAU - Ares-Mateos, G
AU  - Ares-Mateos G
AD  - Pediatrics Department, Hospital Universitario Rey Juan Carlos, Madrid, Spain.
FAU - Montero-Carcaboso, S
AU  - Montero-Carcaboso S
AD  - Osakidetza, OSI Debabarrena, Mendaro Hospital, Mendaro-Gipuzkoa, Spain.
FAU - Castelló-Zamora, B
AU  - Castelló-Zamora B
AD  - Documentary of the Department of Health of the Basque Government, Territorial 
      Delegation of Health of Bizkaia, Bilbao, Spain.
FAU - Burgos-Alonso, N
AU  - Burgos-Alonso N
AD  - Department of Preventive Medicine and Public Health, Faculty of Medicine and 
      Nursery, UPV/EHU, ES, Leioa, Spain.
FAU - Moreno-Rodríguez, A
AU  - Moreno-Rodríguez A
AD  - Osakidetza, OSI Araba, Hospital Txagorritxu, Vitoria-Gasteiz, Spain.
FAU - Hernández-Tejada, N
AU  - Hernández-Tejada N
AD  - People with Intellectual Disabilities, Vitoria-Gasteiz, Spain.
FAU - Koetsenruyter, C
AU  - Koetsenruyter C
AD  - Mayan Center, Maternity, Yoga and Accompaniment, Bilbao, Spain.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20230529
PL  - England
TA  - BMC Pregnancy Childbirth
JT  - BMC pregnancy and childbirth
JID - 100967799
RN  - 059QF0KO0R (Water)
SB  - IM
MH  - Pregnancy
MH  - Female
MH  - Humans
MH  - *Water
MH  - Immersion
MH  - Parturition
MH  - Delivery, Obstetric
MH  - *Midwifery/methods
MH  - Qualitative Research
PMC - PMC10226235
OTO - NOTNLM
OT  - Childbirth
OT  - Labor
OT  - Natural childbirth
OT  - Water Immersion
OT  - Waterbirth
COIS- The authors declare no competing interests.
EDAT- 2023/05/30 01:06
MHDA- 2023/05/31 06:41
CRDT- 2023/05/29 23:28
PHST- 2023/01/11 00:00 [received]
PHST- 2023/05/08 00:00 [accepted]
PHST- 2023/05/31 06:41 [medline]
PHST- 2023/05/30 01:06 [pubmed]
PHST- 2023/05/29 23:28 [entrez]
AID - 10.1186/s12884-023-05690-7 [pii]
AID - 5690 [pii]
AID - 10.1186/s12884-023-05690-7 [doi]
PST - epublish
SO  - BMC Pregnancy Childbirth. 2023 May 29;23(1):395. doi: 10.1186/s12884-023-05690-7.

PMID- 37242555
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230529
IS  - 1424-8247 (Print)
IS  - 1424-8247 (Electronic)
IS  - 1424-8247 (Linking)
VI  - 16
IP  - 5
DP  - 2023 May 22
TI  - Prescribed Drugs and Self-Directed Violence: A Descriptive Study in the Spanish 
      Pharmacovigilance Database.
LID - 10.3390/ph16050772 [doi]
LID - 772
AB  - Self-inflicted violence is a major and growing public health problem and its 
      prediction and prevention is challenging for healthcare systems worldwide. Our 
      aim was to identify prescribed drugs associated with self-directed violent 
      behaviors in Spain. A descriptive, longitudinal and retrospective study of 
      spontaneous reports of adverse drug reactions corresponding to self-directed 
      violence was recorded in the Spanish Pharmacovigilance Database (FEDRA(®)) from 
      1984 to 31 March 2021. A total of 710 cases were reported in the study period. 
      The mean age was 45.52 years (range 1-94). There were no gender differences 
      except in children, where most reports were of male children. The main 
      therapeutic groups that were involved included drugs for the nervous system 
      (64.5%) and anti-infectives for systemic use (13.2%). The most commonly reported 
      drugs were varenicline, fluoxetine, lorazepam, escitalopram, venlafaxine, 
      veralipride, pregabalin, roflumilast and bupropion. There were reports of 
      montelukast, hydroxychloroquine, isotretinoin, methylphenidate, infliximab, 
      natalizumab, ribavirin and efavirenz, which were less known to be involved in 
      self-directed violence. This study shows that self-directed violence is a rare 
      adverse drug reaction, and can be related to the use of some medicines. It is 
      important for healthcare professionals to consider this risk in their clinical 
      praxis, implementing person-centred approaches. Further studies are needed, 
      considering comorbidities and potential interactions.
FAU - Avedillo-Salas, Ana
AU  - Avedillo-Salas A
AUID- ORCID: 0000-0003-2153-0417
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Pueyo-Val, Javier
AU  - Pueyo-Val J
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Fanlo-Villacampa, Ana
AU  - Fanlo-Villacampa A
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Navarro-Pemán, Cristina
AU  - Navarro-Pemán C
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
AD  - Aragon Pharmacovigilance Center, ES-50017 Zaragoza, Spain.
FAU - Lanuza-Giménez, Francisco Javier
AU  - Lanuza-Giménez FJ
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
FAU - Ioakeim-Skoufa, Ignatios
AU  - Ioakeim-Skoufa I
AUID- ORCID: 0000-0002-6518-749X
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
AD  - WHO Collaborating Centre for Drug Statistics Methodology, Department of Drug 
      Statistics, Division of Health Data and Digitalisation, Norwegian Institute of 
      Public Health, NO-0213 Oslo, Norway.
AD  - EpiChron Research Group, Aragon Health Research Institute (IIS Aragón), Miguel 
      Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III (ISCIII), ES-28029 Madrid, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), ES-08009 Barcelona, Spain.
FAU - Vicente-Romero, Jorge
AU  - Vicente-Romero J
AUID- ORCID: 0000-0003-4629-6743
AD  - Department of Pharmacology, Physiology and Legal and Forensic Medicine, Faculty 
      of Medicine, University of Zaragoza, ES-50009 Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230522
PL  - Switzerland
TA  - Pharmaceuticals (Basel)
JT  - Pharmaceuticals (Basel, Switzerland)
JID - 101238453
PMC - PMC10220841
OTO - NOTNLM
OT  - FEDRA®
OT  - adverse drug reactions
OT  - pharmacovigilance
OT  - self-directed violence
COIS- The authors declare no conflict of interest.
EDAT- 2023/05/27 09:42
MHDA- 2023/05/27 09:43
CRDT- 2023/05/27 01:29
PHST- 2023/04/21 00:00 [received]
PHST- 2023/05/12 00:00 [revised]
PHST- 2023/05/17 00:00 [accepted]
PHST- 2023/05/27 09:43 [medline]
PHST- 2023/05/27 09:42 [pubmed]
PHST- 2023/05/27 01:29 [entrez]
AID - ph16050772 [pii]
AID - pharmaceuticals-16-00772 [pii]
AID - 10.3390/ph16050772 [doi]
PST - epublish
SO  - Pharmaceuticals (Basel). 2023 May 22;16(5):772. doi: 10.3390/ph16050772.

PMID- 37240518
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230530
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 12
IP  - 10
DP  - 2023 May 11
TI  - Treatment of Trochanteric Hip Fractures with Cephalomedullary Nails: Single Head 
      Screw vs. Dual Integrated Compression Screw Systems.
LID - 10.3390/jcm12103411 [doi]
LID - 3411
AB  - Extracapsular hip fractures are very common in the elderly. They are mainly 
      treated surgically with an intramedullary nail. Nowadays, both endomedullary hip 
      nails with single cephalic screw systems and interlocking double screw systems 
      are available on the market. The latter are supposed to increase rotational 
      stability and therefore decrease the risk of collapse and cut-out. A 
      retrospective cohort study was carried out, in which 387 patients with 
      extracapsular hip fracture undergoing internal fixation with an intramedullary 
      nail were included to study the occurrence of complications and reoperations. Of 
      the 387 patients, 69% received a single head screw nail and 31% received a dual 
      integrated compression screw nail. The median follow-up was 1.1 years, and in 
      that time, a total of 17 reoperations were performed (4.2%; 2.1% for single head 
      screw nails vs. 8.7% for double head screws). According to the multivariate 
      logistic regression model adjusted for age, sex and basicervical fracture, the 
      adjusted hazard risk of reoperation required was 3.6 times greater when using 
      double interlocking screw systems (p = 0.017). A propensity scores analysis 
      confirmed this finding. In conclusion, despite the potential benefits of using 
      two interlocking head screw systems and the increased risk of reoperation in our 
      single center, we encourage to other researchers to explore this question in a 
      wider multicenter study.
FAU - Méndez-Ojeda, Marye M
AU  - Méndez-Ojeda MM
AD  - Orthopedic Surgery and Traumatology Service, University Hospital of the Canary 
      Islands, 38320 La Laguna, Spain.
AD  - Orthopaedic Surgery, Health Sciences, Medicine, La Laguna University, 38320 La 
      Laguna, Spain.
FAU - Herrera-Rodríguez, Alejandro
AU  - Herrera-Rodríguez A
AD  - Orthopedic Surgery and Traumatology Service, University Hospital of the Canary 
      Islands, 38320 La Laguna, Spain.
FAU - Álvarez-Benito, Nuria
AU  - Álvarez-Benito N
AD  - Orthopedic Surgery and Traumatology Service, University Hospital of the Canary 
      Islands, 38320 La Laguna, Spain.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AUID- ORCID: 0000-0001-6651-0693
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
FAU - García-Bello, Miguel A
AU  - García-Bello MA
AUID- ORCID: 0000-0001-6913-2552
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion, 
      (RICAPPS), Spain.
FAU - Álvarez-de la Cruz, Javier
AU  - Álvarez-de la Cruz J
AUID- ORCID: 0000-0002-1940-7762
AD  - Orthopedic Surgery and Traumatology Service, University Hospital of the Canary 
      Islands, 38320 La Laguna, Spain.
FAU - Pais-Brito, José L
AU  - Pais-Brito JL
AD  - Orthopedic Surgery and Traumatology Service, University Hospital of the Canary 
      Islands, 38320 La Laguna, Spain.
AD  - Orthopaedic Surgery, Health Sciences, Medicine, La Laguna University, 38320 La 
      Laguna, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230511
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC10219306
OTO - NOTNLM
OT  - Gamma nail
OT  - InterTAN nail
OT  - hip fracture
OT  - trochanteric fracture
COIS- The authors declare no conflict of interest.
EDAT- 2023/05/27 09:42
MHDA- 2023/05/27 09:43
CRDT- 2023/05/27 01:17
PHST- 2023/03/18 00:00 [received]
PHST- 2023/04/29 00:00 [revised]
PHST- 2023/05/01 00:00 [accepted]
PHST- 2023/05/27 09:43 [medline]
PHST- 2023/05/27 09:42 [pubmed]
PHST- 2023/05/27 01:17 [entrez]
AID - jcm12103411 [pii]
AID - jcm-12-03411 [pii]
AID - 10.3390/jcm12103411 [doi]
PST - epublish
SO  - J Clin Med. 2023 May 11;12(10):3411. doi: 10.3390/jcm12103411.

PMID- 37239720
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230530
IS  - 2227-9032 (Print)
IS  - 2227-9032 (Electronic)
IS  - 2227-9032 (Linking)
VI  - 11
IP  - 10
DP  - 2023 May 15
TI  - Effect of Mobile-Based Counselling on Breastfeeding in Spain: A Randomized 
      Controlled Trial Protocol (COMLACT Study).
LID - 10.3390/healthcare11101434 [doi]
LID - 1434
AB  - PURPOSE: The primary aim of this study is to determine the influence of an 
      intervention in women based on a free mobile application (LactApp(®), Barcelona, 
      Spain) in maintaining breastfeeding (BF) up to 6 months postpartum. The secondary 
      aim is to assess the effect of health literacy (HL) on breastfeeding duration. 
      METHODS: A multicenter, randomized controlled clinical trial of parallel groups 
      will be carried out. Women will be randomly assigned to each of the parallel 
      groups. In the control group, usual clinical practice will be followed from the 
      third trimester of pregnancy to promote BF. In the intervention group, and in 
      addition to usual clinical practice, the women will use a free mobile application 
      (LactApp(®)) from the third trimester to 6 months postpartum. The type of BF at 
      birth, at 15 days and at 3 and 6 months postpartum and the causes of cessation of 
      BF in both groups will be monitored. The hypothesis will be tested using 
      inferential analysis, considering an alpha of 5%. The study protocol was approved 
      by the Clinical Research Ethics Committee of Hospital de la Ribera (Alzira, 
      Valencia, Spain) in February 2021. A per protocol analysis and an 
      intention-to-treat analysis will be performed. DISCUSSION: This study will 
      identify the influence of a mobile application on improving BF rates. If the 
      application proves effective, we will have a tool with free information available 
      to any user at any time of day, which may be complemented by normal clinical 
      practice and be integrated into our health care system. TRIAL REGISTRATION: 
      ClinicalTrials.gov ID: NCT05432700.
FAU - Mena-Tudela, Desirée
AU  - Mena-Tudela D
AUID- ORCID: 0000-0003-1596-3064
AD  - Department of Nursing, Feminist Institute University Institute for Feminist and 
      Gender Studies, Universitat Jaume I, 12071 Castellon de la Plana, Spain.
FAU - Soriano-Vidal, Francisco Javier
AU  - Soriano-Vidal FJ
AUID- ORCID: 0000-0002-6210-6471
AD  - Department of Nursing, Universitat de València, 46007 Valencia, Spain.
AD  - Department of Obstetrics and Gynecology, Xativa-Oninyent Health Department, 46800 
      Xativa, Spain.
FAU - Vila-Candel, Rafael
AU  - Vila-Candel R
AUID- ORCID: 0000-0002-3734-2480
AD  - Department of Nursing, Universitat de València, 46007 Valencia, Spain.
AD  - Department of Obstetrics and Gynecology, Hospital Universitario de la Ribera, 
      46600 Alzira, Spain.
FAU - Quesada, José Antonio
AU  - Quesada JA
AUID- ORCID: 0000-0002-6947-7531
AD  - Department of Clinical Medicine, Universidad Miguel Hernández, 03202 Elche, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      03550 Alicante, Spain.
FAU - Aguilar, Laia
AU  - Aguilar L
AD  - Midwifery at Lactapp Women Health, 08011 Barcelona, Spain.
FAU - Franco-Antonio, Cristina
AU  - Franco-Antonio C
AUID- ORCID: 0000-0001-8427-2836
AD  - Department of Nursing, Universidad de Extremadura, 10003 Caceres, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT05432700
GR  - UGP-20-245/Fundación para el Fomento de la Investigación Sanitaria y Biomédica de 
      la Comunitat Valenciana/
PT  - Journal Article
DEP - 20230515
PL  - Switzerland
TA  - Healthcare (Basel)
JT  - Healthcare (Basel, Switzerland)
JID - 101666525
PMC - PMC10218014
OTO - NOTNLM
OT  - breastfeeding
OT  - e-Health
OT  - exclusive breastfeeding
OT  - midwives
OT  - mobile application
OT  - nursing
COIS- The authors declare no conflict of interest. J.A.Q will receive payment in the 
      context of grant UGP-20-245 for the statistical analysis of the data.
EDAT- 2023/05/27 09:42
MHDA- 2023/05/27 09:43
CRDT- 2023/05/27 01:12
PHST- 2023/03/10 00:00 [received]
PHST- 2023/05/11 00:00 [revised]
PHST- 2023/05/11 00:00 [accepted]
PHST- 2023/05/27 09:43 [medline]
PHST- 2023/05/27 09:42 [pubmed]
PHST- 2023/05/27 01:12 [entrez]
AID - healthcare11101434 [pii]
AID - healthcare-11-01434 [pii]
AID - 10.3390/healthcare11101434 [doi]
PST - epublish
SO  - Healthcare (Basel). 2023 May 15;11(10):1434. doi: 10.3390/healthcare11101434.

PMID- 37226131
OWN - NLM
STAT- MEDLINE
DCOM- 20230526
LR  - 20230601
IS  - 1471-227X (Electronic)
IS  - 1471-227X (Linking)
VI  - 23
IP  - 1
DP  - 2023 May 24
TI  - Epidemiology of severe trauma in Navarra for 10 years: out-of-hospital/ 
      in-hospital deaths and survivors.
PG  - 54
LID - 10.1186/s12873-023-00818-6 [doi]
LID - 54
AB  - BACKGROUND: Major trauma is a leading cause of death. Due to the difficulties to 
      keep a registry of these cases, few studies include all subjects, because they 
      exclude out-of-hospital deaths. The purpose of this work was to compare the 
      epidemiological profiles of out-of-hospital deaths, in-hospital deaths, and 
      survivors over a 10-year period (2010-2019) of patients who had been treated by 
      Navarre´s Health Service (Spain). METHODS: Retrospective longitudinal cohort 
      study using data of patients injured by an external physical force of any 
      intentionality and with a New Injury Severity Score above 15. Hangings, 
      drownings, burns, and chokings were excluded. Intergroup differences of 
      demographic and clinical variables were analysed using the Kruskal Wallis test, 
      chi-squared test, or Fisher´s exact test. RESULTS: Data from 2,610 patients were 
      analysed; 624 died out-of-hospital, 439 in-hospital, and 1,547 survived. Trauma 
      incidences remained moderately stable over the 10-year period analysed, with a 
      slight decrease in out-of-hospital deaths and a slight increase in in-hospital 
      deaths. Patients of the out-of-hospital deaths group were younger (50.9 years) in 
      comparison to in-hospital deaths and survivors. Death victims were predominantly 
      male in all study groups. Intergroup differences regarding prior comorbidities 
      and predominant type of injury were observed. CONCLUSIONS: There are significant 
      differences among the three study groups. More than half of the deaths occur 
      out-of-hospital and the causative mechanisms differ in each of them. Thus, when 
      designing strategies, preventive measures were considered for each group on a 
      case-by-case basis.
CI  - © 2023. The Author(s).
FAU - Arbizu-Fernández, Eider
AU  - Arbizu-Fernández E
AUID- ORCID: 0000-0002-8232-7255
AD  - Emergency Department of Universitary Hospital of Navarre, Pamplona, Spain. 
      eider.arbizu@gmail.com.
FAU - Echarri-Sucunza, Alfredo
AU  - Echarri-Sucunza A
AUID- ORCID: 0000-0003-3969-3169
AD  - Subdirección de Urgencias de Navarra, Pamplona, Navarre, Spain.
AD  - Polytrauma group, Navarrabiomed - Universitary Hospital of Navarre, Public 
      University of Navarre, Health investigation institute of Navarre, Pamplona, 
      Navarre, Spain.
FAU - Galbete, Arkaitz
AU  - Galbete A
AUID- ORCID: 0000-0001-5622-5418
AD  - Department of Statistics, Computer Science and Mathematics, Public University of 
      Navarra, RICAPPS, Pamplona, IdiSNA, Spain.
FAU - Fortún-Moral, Mariano
AU  - Fortún-Moral M
AUID- ORCID: 0000-0001-9615-1580
AD  - Subdirección de Urgencias de Navarra, Pamplona, Navarre, Spain.
AD  - Polytrauma group, Navarrabiomed - Universitary Hospital of Navarre, Public 
      University of Navarre, Health investigation institute of Navarre, Pamplona, 
      Navarre, Spain.
FAU - Belzunegui-Otano, Tomas
AU  - Belzunegui-Otano T
AUID- ORCID: 0000-0002-4615-5396
AD  - Emergency Department Hospital Universitario de Navarra, Pamplona, Navarre, Spain.
AD  - Polytrauma group, Navarrabiomed - Universitary Hospital of Navarre, Public 
      University of Navarre, Health investigation institute of Navarre, Pamplona, 
      Navarre, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230524
PL  - England
TA  - BMC Emerg Med
JT  - BMC emergency medicine
JID - 100968543
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - Hospital Mortality
MH  - Longitudinal Studies
MH  - Retrospective Studies
MH  - *Survivors
MH  - *Hospitals
PMC - PMC10210373
OTO - NOTNLM
OT  - Epidemiology
OT  - In-hospital
OT  - Major trauma
OT  - Mortality
OT  - Out-of-hospital
OT  - Survivors
COIS- The authors declare that there is no conflict of interest regarding the 
      publication of this article.
EDAT- 2023/05/25 01:07
MHDA- 2023/05/26 06:42
CRDT- 2023/05/24 23:46
PHST- 2022/10/03 00:00 [received]
PHST- 2023/05/05 00:00 [accepted]
PHST- 2023/05/26 06:42 [medline]
PHST- 2023/05/25 01:07 [pubmed]
PHST- 2023/05/24 23:46 [entrez]
AID - 10.1186/s12873-023-00818-6 [pii]
AID - 818 [pii]
AID - 10.1186/s12873-023-00818-6 [doi]
PST - epublish
SO  - BMC Emerg Med. 2023 May 24;23(1):54. doi: 10.1186/s12873-023-00818-6.

PMID- 37210302
OWN - NLM
STAT- Publisher
LR  - 20230520
IS  - 1878-3562 (Electronic)
IS  - 1590-8658 (Linking)
DP  - 2023 May 18
TI  - Determinants and impact of splanchnic vein thrombosis in acute pancreatitis.
LID - S1590-8658(23)00606-0 [pii]
LID - 10.1016/j.dld.2023.04.026 [doi]
AB  - BACKGROUND: Splanchnic vein thrombosis (SVT) is a well-recognised though 
      little-studied complication in acute pancreatitis (AP). SVT risk factors, its 
      clinical consequences and the role of anticoagulation (AC) therapy is scarce. 
      AIMS: To evaluate the incidence and natural history of SVT in AP. METHODS: Post 
      hoc analysis of a prospective multicentre cohort study involving 23 hospitals in 
      Spain. AP complications were identified by computer tomography, and patients with 
      SVT were re-evaluated after two years. RESULTS: A total of 1655 patients with AP 
      were included. The overall incidence of SVT was 3.6%. SVT was significantly 
      associated with male gender, younger age and alcoholic aetiology. Every local 
      complication increased SVT incidence, and this risk rose gradually with larger 
      extension and infection of necrosis. These patients had a longer hospital stay 
      and underwent a greater number of invasive treatments, regardless of AP severity. 
      Forty-six patients with SVT were followed up. SVT resolution rate was 54.5% in 
      the AC group and 30.8% in the non-AC group with lower thrombotic complications in 
      the SVT resolution group (83.3% vs 22.7%; p<0.001). No AC-related adverse events 
      occurred. CONCLUSION: This study identifies the risk factors and negative 
      clinical impact of SVT in AP. Our results justify future trials to demonstrate 
      the role of AC in this clinical scenario.
CI  - Copyright © 2023 Editrice Gastroenterologica Italiana S.r.l. Published by 
      Elsevier Ltd. All rights reserved.
FAU - Oyón, Daniel
AU  - Oyón D
AD  - Department of Gastroenterology, University Hospital of Galdakao, Biocruces 
      Bizkaia Health Research Institute, Galdakao, Spain. Electronic address: 
      danioyonlara7@hotmail.com.
FAU - Marra-López, Carlos
AU  - Marra-López C
AD  - Department of Gastroenterology, Hospital Costa del Sol, Marbella; Hospital Vithas 
      Málaga. Málaga. Spain.
FAU - Bolado, Federico
AU  - Bolado F
AD  - Department of Gastroenterology, University Hospital of Navarre, Health Research 
      Institute of Navarra IdiSNA, Pamplona, Spain.
FAU - López-López, Soraya
AU  - López-López S
AD  - Department of Gastroenterology, University Hospital of Navarre, Pamplona, Spain.
FAU - Ibáñez-Beroiz, Berta
AU  - Ibáñez-Beroiz B
AD  - Navarrabiomed-HUN-UPNA, Research Network for Health Services and Chronic Diseases 
      (REDISSEC); Research Network for Chronic Diseases, Primary Care and Health 
      Promotion (RICAPPS), Health Research Institute of Navarra IdiSNA, Pamplona, 
      Spain.
FAU - Canaval-Zuleta, Héctor J
AU  - Canaval-Zuleta HJ
AD  - Department of Gastroenterology, Hospital Son Llatzer, Palma de Mallorca, Spain.
FAU - García-Rayado, Guillermo
AU  - García-Rayado G
AD  - Department of Gastroenterology, University Clinic Hospital, Aragón Health 
      Research Institute, Zaragoza, Spain.
FAU - Rivera-Irigoin, Robin
AU  - Rivera-Irigoin R
AD  - Department of Gastroenterology, Hospital Costa del Sol, Marbella, Spain.
FAU - Grau-García, Francisco J
AU  - Grau-García FJ
AD  - Department of Gastroenterology, Hospital Arnau de Vilanova, Valencia, Spain.
FAU - Boadas, Jaume
AU  - Boadas J
AD  - Department of Gastroenterology, Consorci Sanitari Terrassa, Universitat 
      Internacional de Catalunya, Barcelona, Spain.
FAU - Millastre-Bocos, Judith
AU  - Millastre-Bocos J
AD  - Department of Gastroenterology, Hospital Universitario Miguel Servet, Zaragoza, 
      Spain.
FAU - Martínez-Ares, David
AU  - Martínez-Ares D
AD  - Department of Gastroenterology, Hospital QuironSalud A Coruña, A Coruña, Spain.
FAU - de-Madaria, Enrique
AU  - de-Madaria E
AD  - Department of Gastroenterology, Dr. Balmis General University Hospital, 
      Department of Clinical Medicine, Miguel Hernández University, Alicante Institute 
      for Health and Biomedical Research (ISABIAL), Alicante, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230518
PL  - Netherlands
TA  - Dig Liver Dis
JT  - Digestive and liver disease : official journal of the Italian Society of 
      Gastroenterology and the Italian Association for the Study of the Liver
JID - 100958385
SB  - IM
OTO - NOTNLM
OT  - Clot
OT  - Inflammation
OT  - Pancreas
OT  - Risk
COIS- Declaration of Competing Interest The authors have no conflicts of interest to 
      declare.
EDAT- 2023/05/21 01:05
MHDA- 2023/05/21 01:05
CRDT- 2023/05/20 22:00
PHST- 2023/01/28 00:00 [received]
PHST- 2023/04/18 00:00 [revised]
PHST- 2023/04/27 00:00 [accepted]
PHST- 2023/05/21 01:05 [medline]
PHST- 2023/05/21 01:05 [pubmed]
PHST- 2023/05/20 22:00 [entrez]
AID - S1590-8658(23)00606-0 [pii]
AID - 10.1016/j.dld.2023.04.026 [doi]
PST - aheadofprint
SO  - Dig Liver Dis. 2023 May 18:S1590-8658(23)00606-0. doi: 10.1016/j.dld.2023.04.026.

PMID- 37193738
OWN - NLM
STAT- MEDLINE
DCOM- 20230518
LR  - 20230606
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 13
IP  - 1
DP  - 2023 May 16
TI  - Effectiveness of a telerehabilitation intervention using ReCOVery APP of long 
      COVID patients: a randomized, 3-month follow-up clinical trial.
PG  - 7943
LID - 10.1038/s41598-023-35058-y [doi]
LID - 7943
AB  - The main objective of this study is to analyze the clinical efficacy of 
      telerehabilitation in the recovery of Long COVID patients through ReCOVery APP 
      for 3 months, administered in the Primary Health Care context. The second 
      objective is to identify significant models associated with an improvement in the 
      study variables. An open-label randomized clinical trial was conducted using two 
      parallel groups of a total of 100 Long COVID patients. The first group follows 
      the treatment as usual methods established by their general practitioner (control 
      group) and the second follows the same methods and also uses ReCOVery APP 
      (intervention group). After the intervention, no significant differences were 
      found in favour of the group intervention. Regarding adherence, 25% of the 
      participants made significant use of the APP. Linear regression model establishes 
      that the time of use of ReCOVery APP predicts an improvement in physical function 
      (b = 0.001; p = 0.005) and community social support (b = 0.004; p = 0.021). In 
      addition, an increase in self-efficacy and health literacy also contribute to 
      improving cognitive function (b = 0.346; p = 0.001) and reducing the number of 
      symptoms (b = 0.226; p = 0.002), respectively. In conclusion, the significant use 
      of ReCOVery APP can contribute to the recovery of Long COVID patients. Trial 
      Registration No.: ISRCTN91104012.
CI  - © 2023. The Author(s).
FAU - Samper-Pardo, M
AU  - Samper-Pardo M
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
FAU - León-Herrera, S
AU  - León-Herrera S
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Oliván-Blázquez, B
AU  - Oliván-Blázquez B
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain. 
      barbaraolivan@gmail.com.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain. 
      barbaraolivan@gmail.com.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain. barbaraolivan@gmail.com.
FAU - Méndez-López, F
AU  - Méndez-López F
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
FAU - Domínguez-García, M
AU  - Domínguez-García M
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
FAU - Sánchez-Recio, R
AU  - Sánchez-Recio R
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain.
LA  - eng
SI  - ISRCTN/ISRCTN91104012
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20230516
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Humans
MH  - *Telerehabilitation/methods
MH  - Post-Acute COVID-19 Syndrome
MH  - *COVID-19
MH  - Follow-Up Studies
MH  - *Mobile Applications
PMC - PMC10187508
COIS- The authors declare no competing interests.
EDAT- 2023/05/17 01:07
MHDA- 2023/05/18 06:42
CRDT- 2023/05/16 23:18
PHST- 2023/01/27 00:00 [received]
PHST- 2023/05/11 00:00 [accepted]
PHST- 2023/05/18 06:42 [medline]
PHST- 2023/05/17 01:07 [pubmed]
PHST- 2023/05/16 23:18 [entrez]
AID - 10.1038/s41598-023-35058-y [pii]
AID - 35058 [pii]
AID - 10.1038/s41598-023-35058-y [doi]
PST - epublish
SO  - Sci Rep. 2023 May 16;13(1):7943. doi: 10.1038/s41598-023-35058-y.

PMID- 37192203
OWN - NLM
STAT- MEDLINE
DCOM- 20230518
LR  - 20230605
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 18
IP  - 5
DP  - 2023
TI  - Clinical characterization and factors associated with quality of life in Long 
      COVID patients: Secondary data analysis from a randomized clinical trial.
PG  - e0278728
LID - 10.1371/journal.pone.0278728 [doi]
LID - e0278728
AB  - BACKGROUND: Long COVID patients suffer a negative impact on their quality of 
      life, as well as their functioning, productivity or socialization. There is a 
      need to better understand the individual experience and circumstances surrounding 
      these patients. OBJECTIVE: To characterize clinical picture of Long COVID 
      patients and to identify factors associated with quality of life. METHODS: A 
      secondary data analysis from a randomized clinical trial (RCT) was carried out 
      with 100 Long COVID patients treated by Primary Health Care and residents in the 
      territory of Aragon (northeast of Spain). The main variable of the study was 
      quality of life, evaluated using the SF-36 Questionnaire, in relation to 
      socio-demographic and clinical variables. In addition, ten validated scales were 
      used that contemplated their cognitive, affective, functional and social status, 
      as well as personal constructs. Correlation statistics and linear regression 
      model were calculated. RESULTS: Long COVID patients suffer a decrease in their 
      levels of physical and mental health. On the one hand, the higher number of 
      persistent symptoms (b = -0.900, p = 0.008), worse physical functioning (b = 
      1.587, p = 0.002) and sleep quality (b = -0.538, p = 0.035) are predictors of 
      worse quality of life, physical subscale. On the other hand, higher educational 
      level (b = 13.167, p = 0.017), lower number of persistent symptoms (b = -0.621, p 
      = 0.057) and higher affective affectation (b = -1.402, p<0.001) are predictors of 
      worse quality of life, mental subscale. CONCLUSION: It is necessary to design 
      rehabilitation programs that consider both the physical and mental health of 
      these patients, thus obtaining an improvement in their quality of life.
CI  - Copyright: © 2023 Samper-Pardo et al. This is an open access article distributed 
      under the terms of the Creative Commons Attribution License, which permits 
      unrestricted use, distribution, and reproduction in any medium, provided the 
      original author and source are credited.
FAU - Samper-Pardo, Mario
AU  - Samper-Pardo M
AUID- ORCID: 0000-0003-4170-0057
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
FAU - León-Herrera, Sandra
AU  - León-Herrera S
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AUID- ORCID: 0000-0001-6565-9699
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Gascón-Santos, Santiago
AU  - Gascón-Santos S
AUID- ORCID: 0000-0002-3723-0673
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Sánchez-Recio, Raquel
AU  - Sánchez-Recio R
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain.
LA  - eng
SI  - ISRCTN/ISRCTN91104012
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20230516
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Humans
MH  - *Post-Acute COVID-19 Syndrome
MH  - Secondary Data Analysis
MH  - *COVID-19
MH  - Quality of Life/psychology
MH  - Mental Health
PMC - PMC10187923
COIS- The authors have declared that no competing interests exist.
EDAT- 2023/05/16 19:10
MHDA- 2023/05/18 06:42
CRDT- 2023/05/16 13:34
PHST- 2022/11/21 00:00 [received]
PHST- 2023/04/29 00:00 [accepted]
PHST- 2023/05/18 06:42 [medline]
PHST- 2023/05/16 19:10 [pubmed]
PHST- 2023/05/16 13:34 [entrez]
AID - PONE-D-22-31842 [pii]
AID - 10.1371/journal.pone.0278728 [doi]
PST - epublish
SO  - PLoS One. 2023 May 16;18(5):e0278728. doi: 10.1371/journal.pone.0278728. 
      eCollection 2023.

PMID- 37174797
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230515
IS  - 2227-9032 (Print)
IS  - 2227-9032 (Electronic)
IS  - 2227-9032 (Linking)
VI  - 11
IP  - 9
DP  - 2023 Apr 27
TI  - Promoting Physical Activity in a Primary Care Practice in People Living with 
      Dementia and Their Family Caregivers.
LID - 10.3390/healthcare11091255 [doi]
LID - 1255
AB  - People living with dementia (PLWD) and their family caregivers report higher 
      rates of having a sedentary lifestyle than their non-disabled peers do. This 
      study analyzed the effectiveness of an intervention designed to increase physical 
      activity among PLWD and their family caregivers in primary health care settings. 
      A cluster-randomized multicenter clinical trial was conducted. Participants from 
      four health centers were randomly assigned to the intervention group (IG) or the 
      control group (CG) in a 1:1 ratio using Epidat software. After a seven-day period 
      with a digital pedometer (Omron Hj-321 lay-UPS), participants were asked to 
      complete the International Physical Activity Questionnaire Short Form (IPAQ-SF). 
      PLWD and caregivers allocated to the IG were given brief advice, educational 
      materials and an additional 15 min appointment to prescribe an individualized 
      physical activity plan. Seventy PLWD and 80 caregivers were assigned to the CG 
      and 70 PLWD and 96 caregivers were assigned to the IG. Results of the pedometer 
      assessment show that in PLWD, the IG's activity increased by 52.89 aerobic steps 
      at 6 months and the CG's activity decreased by 615.93 aerobic steps, showing a 
      net increase in the IG of 668.82 (95% CI: -444.27 to 1781.91; p = 0.227). For 
      caregivers in the IG, activity increased by 356.91 aerobic steps and in the CG it 
      decreased by 12.95 aerobic steps, showing a net increase in favor of the IG of 
      369.86 (95%CI: -659.33 to 1399.05; p = 0.476). The effectiveness of interventions 
      to increase physical activity in this group of people with dementia and their 
      caregivers did not achieved positive results overall but may have provided 
      suggestions for family physicians and physical therapists to improve physical 
      activity among people with dementia and their families.
FAU - de Dios-Rodríguez, Elena
AU  - de Dios-Rodríguez E
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
FAU - Patino-Alonso, Carmen
AU  - Patino-Alonso C
AUID- ORCID: 0000-0001-8232-6685
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Departamento de Estadística, Universidad de Salamanca, Calle Alfonso X el Sabio 
      s/n, 37007 Salamanca, Spain.
FAU - González-Sánchez, Susana
AU  - González-Sánchez S
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
FAU - Ripoll, Joana
AU  - Ripoll J
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Primary Care Research Unit of Mallorca, Baleares Health Services-IbSalut, Palma, 
      Carrer de l'Escola Graduada, 3, 07002 Palma, Spain.
AD  - Balearic Islands Health Research Institute (IdISBa), Carrer de l'Escola Graduada, 
      3, 07002 Palma, Spain.
FAU - Mora-Simón, Sara
AU  - Mora-Simón S
AUID- ORCID: 0000-0003-2772-6971
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Departamento de Psicología Básica, Psicobiología y Metodología de las Ciencias 
      del Comportamiento, Campus Ciudad Jardín, Universidad de Salamanca, 37005 
      Salamanca, Spain.
FAU - Unzueta-Arce, Jaime
AU  - Unzueta-Arce J
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Departamento de Psicología Básica, Psicobiología y Metodología de las Ciencias 
      del Comportamiento, Campus Ciudad Jardín, Universidad de Salamanca, 37005 
      Salamanca, Spain.
FAU - Gómez-Marcos, Manuel A
AU  - Gómez-Marcos MA
AUID- ORCID: 0000-0003-0133-6123
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Calle Alfonso X el Sabio s/n, 
      37007 Salamanca, Spain.
FAU - García-Ortiz, Luis
AU  - García-Ortiz L
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, 
      Calle Alfonso X el Sabio s/n, 37007 Salamanca, Spain.
FAU - Rodríguez-Sánchez, Emiliano
AU  - Rodríguez-Sánchez E
AUID- ORCID: 0000-0003-3667-7155
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), 08007 Barcelona, Spain.
AD  - Departamento de Estadística, Universidad de Salamanca, Calle Alfonso X el Sabio 
      s/n, 37007 Salamanca, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Calle Alfonso X el Sabio s/n, 
      37007 Salamanca, Spain.
LA  - eng
GR  - RD21/0016/0010/Spanish Ministry of Science and Innovation/
GR  - PI14/01465/Government of Castilla y León/
GR  - (2014)/Vicente-García Corselas Foundation (University of Salamanca)/
PT  - Journal Article
DEP - 20230427
PL  - Switzerland
TA  - Healthcare (Basel)
JT  - Healthcare (Basel, Switzerland)
JID - 101666525
PMC - PMC10178700
OTO - NOTNLM
OT  - caregivers
OT  - dementia
OT  - physical activity
OT  - primary care
OT  - randomized controlled trials
COIS- The authors declare no conflict of interest.
EDAT- 2023/05/13 15:13
MHDA- 2023/05/13 15:14
CRDT- 2023/05/13 01:23
PHST- 2023/02/07 00:00 [received]
PHST- 2023/04/22 00:00 [revised]
PHST- 2023/04/24 00:00 [accepted]
PHST- 2023/05/13 15:14 [medline]
PHST- 2023/05/13 15:13 [pubmed]
PHST- 2023/05/13 01:23 [entrez]
AID - healthcare11091255 [pii]
AID - healthcare-11-01255 [pii]
AID - 10.3390/healthcare11091255 [doi]
PST - epublish
SO  - Healthcare (Basel). 2023 Apr 27;11(9):1255. doi: 10.3390/healthcare11091255.

PMID- 37174240
OWN - NLM
STAT- MEDLINE
DCOM- 20230515
LR  - 20230610
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 9
DP  - 2023 May 4
TI  - Social Inequalities in Mental Health and Self-Perceived Health in the First Wave 
      of COVID-19 Lockdown in Latin America and Spain: Results of an Online 
      Observational Study.
LID - 10.3390/ijerph20095722 [doi]
LID - 5722
AB  - COVID-19 lockdowns greatly affected the mental health of populations and 
      collectives. This study compares the mental health and self-perceived health in 
      five countries of Latin America and Spain, during the first wave of COVID 19 
      lockdown, according to social axes of inequality. This was a cross-sectional 
      study using an online, self-managed survey in Brazil, Chile, Ecuador, Mexico, 
      Peru, and Spain. Self-perceived health (SPH), anxiety (measured through GAD-7) 
      and depression (measured through PHQ-9) were measured along with lockdown, 
      COVID-19, and social variables. The prevalence of poor SPH, anxiety, and 
      depression was calculated. The analyses were stratified by gender (men = M; women 
      = W) and country. The data from 39,006 people were analyzed (W = 71.9%). There 
      was a higher prevalence of poor SPH and bad mental health in women in all 
      countries studied. Peru had the worst SPH results, while Chile and Ecuador had 
      the worst mental health indicators. Spain had the lowest prevalence of poor SPH 
      and mental health. The prevalence of anxiety and depression decreased as age 
      increased. Unemployment, poor working conditions, inadequate housing, and the 
      highest unpaid workload were associated with worse mental health and poor SPH, 
      especially in women. In future policies, worldwide public measures should 
      consider the great social inequalities in health present between and within 
      countries in order to tackle health emergencies while reducing the health breach 
      between populations.
FAU - Salas Quijada, Carmen
AU  - Salas Quijada C
AD  - Facultad de Medicina, Universidad Austral de Chile, Valdivia 5110566, Chile.
FAU - López-Contreras, Natalia
AU  - López-Contreras N
AD  - Vicerrectoría de Investigación y Postgrado, Universidad de La Frontera, Temuco 
      4811230, Chile.
FAU - López-Jiménez, Tomás
AU  - López-Jiménez T
AUID- ORCID: 0000-0001-8255-4936
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
FAU - Medina-Perucha, Laura
AU  - Medina-Perucha L
AUID- ORCID: 0000-0002-2981-2614
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
FAU - León-Gómez, Brenda Biaani
AU  - León-Gómez BB
AUID- ORCID: 0000-0001-5327-4409
AD  - Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari 
      per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 
      08303 Mataró, Spain.
FAU - Peralta, Andrés
AU  - Peralta A
AD  - Public Health Institute, Pontificia Universidad Católica del Ecuador (PUCE), 
      Quito 170525, Ecuador.
FAU - Arteaga-Contreras, Karen M
AU  - Arteaga-Contreras KM
AD  - Servicios de Atención Psiquiátrica, Anillo Periférico #2767, Ed.5 P.B., Alcaldía 
      La Magdalena Contreras, Cuidad de México 10200, Mexico.
FAU - Berenguera, Anna
AU  - Berenguera A
AUID- ORCID: 0000-0002-0889-2002
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
AD  - Departament d'Infermeria, Universitat de Girona, Emili Grahit, 77, 17003 Girona, 
      Spain.
FAU - Queiroga Gonçalves, Alessandra
AU  - Queiroga Gonçalves A
AUID- ORCID: 0000-0003-3272-6861
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
AD  - Unitat de Suport a la Recerca Terres de l'Ebre, Fundació Institut Universitari 
      per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 
      43500 Tortosa, Spain.
AD  - Unitat Docent de Medicina de Família i Comunitària Tortosa-Terres de L'Ebre, 
      Institut Català de la Salut, 43500 Tortosa, Spain.
FAU - Horna-Campos, Olivia Janett
AU  - Horna-Campos OJ
AD  - Escuela de Salud Pública "Salvador Allende", Facultad de Medicina, Universidad de 
      Chile, Santiago 8380000, Chile.
FAU - Mazzei, Marinella
AU  - Mazzei M
AD  - Escuela de Salud Pública "Salvador Allende", Facultad de Medicina, Universidad de 
      Chile, Santiago 8380000, Chile.
FAU - Anigstein, Maria Sol
AU  - Anigstein MS
AUID- ORCID: 0000-0002-4023-2389
AD  - Escuela de Salud Pública "Salvador Allende", Facultad de Medicina, Universidad de 
      Chile, Santiago 8380000, Chile.
AD  - Departamento de Antropología, Universidad de Chile, Santiago 6850331, Chile.
FAU - Ribeiro Barbosa, Jakeline
AU  - Ribeiro Barbosa J
AUID- ORCID: 0000-0001-6238-7173
AD  - Center for Epidemiology and Health Surveillance, Oswaldo Cruz Foundation, 
      Brasília 70904-130, Brazil.
FAU - Bardales-Mendoza, Olga
AU  - Bardales-Mendoza O
AD  - Facultad de Educación, Universidad Peruana Cayetano Heredia, Lima 15102, Peru.
FAU - Benach, Joan
AU  - Benach J
AD  - Research Group on Health Inequalities, Environment, and Employment Conditions 
      (GREDS-EMCONET), Universitat Pompeu Fabra, 08002 Barcelona, Spain.
AD  - Johns Hopkins University-Universitat Pompeu Fabra Public Policy Center (UPF-BSM), 
      08002 Barcelona, Spain.
AD  - Ecological Humanities Research Group (GHECO), Universidad Autónoma de Madrid, 
      28049 Madrid, Spain.
FAU - Borges Machado, Daiane
AU  - Borges Machado D
AUID- ORCID: 0000-0003-2959-4650
AD  - Center of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, 
      Oswaldo Cruz Foundation, Salvador 41745-715, Brazil.
AD  - Department of Global Health and Social Medicine, Harvard Medical School, Boston, 
      MA 02115, USA.
FAU - Torres Castillo, Ana Lucía
AU  - Torres Castillo AL
AUID- ORCID: 0000-0003-1751-1950
AD  - Public Health Institute, Pontificia Universidad Católica del Ecuador (PUCE), 
      Quito 170525, Ecuador.
FAU - Jacques-Aviñó, Constanza
AU  - Jacques-Aviñó C
AUID- ORCID: 0000-0001-8506-780X
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20230504
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Male
MH  - Humans
MH  - Female
MH  - *COVID-19/epidemiology/psychology
MH  - Mental Health
MH  - Latin America/epidemiology
MH  - Spain/epidemiology
MH  - Cross-Sectional Studies
MH  - Communicable Disease Control
MH  - Socioeconomic Factors
MH  - Anxiety/epidemiology
MH  - Health Status
MH  - Depression/epidemiology
PMC - PMC10249008
OTO - NOTNLM
OT  - COVID-19
OT  - inequities
OT  - lockdown
OT  - mental health
OT  - self-perceived health
OT  - social impact
COIS- The authors declare no conflict of interest.
EDAT- 2023/05/13 15:12
MHDA- 2023/05/15 06:42
CRDT- 2023/05/13 01:20
PHST- 2023/01/30 00:00 [received]
PHST- 2023/03/29 00:00 [revised]
PHST- 2023/04/19 00:00 [accepted]
PHST- 2023/05/15 06:42 [medline]
PHST- 2023/05/13 15:12 [pubmed]
PHST- 2023/05/13 01:20 [entrez]
AID - ijerph20095722 [pii]
AID - ijerph-20-05722 [pii]
AID - 10.3390/ijerph20095722 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 May 4;20(9):5722. doi: 
      10.3390/ijerph20095722.

PMID- 37174177
OWN - NLM
STAT- MEDLINE
DCOM- 20230515
LR  - 20230516
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 9
DP  - 2023 Apr 27
TI  - Tomographic Findings in the Retina of Unvaccinated Patients with COVID Pneumonia: 
      Prospective Longitudinal Study.
LID - 10.3390/ijerph20095659 [doi]
LID - 5659
AB  - There is no definitive evidence on the extent of SARS-CoV-2's effect on the 
      retina. This study aims to determine if the natural history of SARS-CoV-2 
      infection affects tomographic findings in the retina of patients with COVID-19 
      pneumonia. This is a prospective cohort study of patients hospitalized with 
      COVID-19 pneumonia. The patients underwent ophthalmological explorations and 
      optical coherence tomography during the acute phase of the infection and at a 
      follow-up 12 weeks later. The primary outcomes were the central retinal thickness 
      and central choroidal thickness, which were compared longitudinally and with 
      non-COVID-19 historical controls. No statistically relevant differences were 
      observed in the longitudinal analysis of the thickness of the central retina (p = 
      0.056), central choroid (p = 0.99), retinal nerve fiber layer (p = 0.21), or 
      ganglion cell layer (p = 0.32). Patients with acute COVID-19 pneumonia showed 
      significantly greater central retinal thickness than non-COVID controls (p = 
      0.006). In conclusion, tomographic measures of the retina and choroid are not 
      influenced by the phase of COVID-19 infection and remain stable during 12 weeks. 
      The central retinal thickness may increase in the acute phase of COVID-19 
      pneumonia, but more epidemiological studies using optical coherence tomography in 
      the early stages of the disease are needed.
FAU - Monera Lucas, Carlos Enrique
AU  - Monera Lucas CE
AUID- ORCID: 0000-0003-0310-2531
AD  - Retina Unit, Ophthalmology Service, General University Hospital of Elche, 03203 
      Elche, Spain.
AD  - Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de 
      Alicante, Spain.
FAU - Baeza Diaz, Manuel Vicente
AU  - Baeza Diaz MV
AUID- ORCID: 0000-0002-1797-7411
AD  - Retina Unit, Ophthalmology Service, General University Hospital of Elche, 03203 
      Elche, Spain.
AD  - Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de 
      Alicante, Spain.
FAU - Quesada, Jose A
AU  - Quesada JA
AUID- ORCID: 0000-0002-6947-7531
AD  - Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      03550 Alicante, Spain.
FAU - Lopez-Pineda, Adriana
AU  - Lopez-Pineda A
AUID- ORCID: 0000-0002-2117-0178
AD  - Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      03550 Alicante, Spain.
FAU - Fernandez Martinez, Cristian
AU  - Fernandez Martinez C
AD  - Retina Unit, Ophthalmology Service, General University Hospital of Elche, 03203 
      Elche, Spain.
FAU - Martinez Toldos, Jose Juan
AU  - Martinez Toldos JJ
AUID- ORCID: 0000-0002-7686-8469
AD  - Retina Unit, Ophthalmology Service, General University Hospital of Elche, 03203 
      Elche, Spain.
AD  - Department of Pathology and Surgery, Miguel Hernandez University, 03550 San Juan 
      de Alicante, Spain.
FAU - Gil-Guillén, Vicente F
AU  - Gil-Guillén VF
AD  - Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      03550 Alicante, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230427
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Prospective Studies
MH  - Longitudinal Studies
MH  - *COVID-19/diagnostic imaging
MH  - SARS-CoV-2
MH  - Retina/diagnostic imaging
MH  - Tomography, Optical Coherence/methods
MH  - *Pneumonia
PMC - PMC10178088
OTO - NOTNLM
OT  - COVID-19
OT  - X-ray computed
OT  - coronavirus infection
OT  - eye
OT  - pneumonia
OT  - retina
OT  - tomography
COIS- The authors declare that they have no conflict of interest.
EDAT- 2023/05/13 15:13
MHDA- 2023/05/15 11:42
CRDT- 2023/05/13 01:19
PHST- 2023/02/24 00:00 [received]
PHST- 2023/03/03 00:00 [revised]
PHST- 2023/04/23 00:00 [accepted]
PHST- 2023/05/15 11:42 [medline]
PHST- 2023/05/13 15:13 [pubmed]
PHST- 2023/05/13 01:19 [entrez]
AID - ijerph20095659 [pii]
AID - ijerph-20-05659 [pii]
AID - 10.3390/ijerph20095659 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Apr 27;20(9):5659. doi: 
      10.3390/ijerph20095659.

PMID- 37170368
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230514
IS  - 2050-2974 (Print)
IS  - 2050-2974 (Electronic)
IS  - 2050-2974 (Linking)
VI  - 11
IP  - 1
DP  - 2023 May 11
TI  - Preliminary assessment of the degree of food addiction through the Spanish Yale 
      Food Addiction Scale for Children (S-YFAS-C) in a pilot pediatric population.
PG  - 72
LID - 10.1186/s40337-023-00798-9 [doi]
LID - 72
AB  - INTRODUCTION: The Spanish Yale Food Addiction Scale for Children (S-YFAS-C) scale 
      is the first tool adapted to Spanish to evaluate food addiction (FA) in the 
      paediatric population. The aim of this study is to preliminarily evaluate the 
      degree of FA in a non-clinical pilot paediatric population. MATERIAL AND METHODS: 
      A transversal observational study was performed on a convenience sample comprised 
      of boys and girls aged 9 to 12 (4th to 6th year primary school). The main outcome 
      measures were evaluation of FA (S-YFAS-C scale), child feeding attitudes (ChEAT 
      scale) and evaluation of body image (CDRS scale). Moreover, sociodemographic and 
      anthropometric data were collected. A descriptive and bivariate analysis of the 
      main characteristics of subjects and outcome measures was performed. RESULTS: A 
      total of 21 boys and 24 girls were preliminarily evaluated and the minimum and 
      maximum values obtained were for age (9.48-12.33), weight in kilograms 
      (26.6-64.5), height in centimetres (131-163), BMI (14.2-27.9) and BMI Z-score 
      (-1.36-2.66). The average number of FA symptoms measured with the S-YFAS-C scale 
      is 1.67 ± 1.45 (range 0-7). A total of 20% of the sample shows three or more 
      symptoms for FA, risk of developing a food disorder and distortion of the body 
      image. Moreover, statistically significant differences were observed between 
      desired body image in boys and girls (P = 0.001). CONCLUSIONS: The S-YFAS-C scale 
      enables evaluating food addiction in Spanish-speaking boys and girls. The data 
      obtained in regard to quantifying symptoms are similar compared to the original 
      scale (S-YFAS-C: 1.67 ± 1.45 vs. YFAS-C: 2 ± 1.81). The option to score the 
      counting of symptoms is the most sensitive measure to evaluate subclinical food 
      behaviours.
CI  - © 2023. The Author(s).
FAU - Benítez-Brito, Néstor
AU  - Benítez-Brito N
AUID- ORCID: 0000-0001-6243-4099
AD  - Chemistry Section, Department of Chemical Engineering and Pharmaceutical 
      Technology, Nutrition and Bromatology Area, Pharmacy Faculty, Science Faculty, 
      University of La Laguna, Avenida Astrofísico Francisco Sánchez, s/n, Apartado 
      456, San Cristóbal de La Laguna, S/C of Tenerife, 38200, Tenerife, Spain. 
      nestorgi@hotmail.com.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AUID- ORCID: 0000-0001-6651-0693
AD  - Canary Islands Health Research Institute Foundation (FIISC), Evaluation Unit 
      (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Pinto-Robayna, Berta
AU  - Pinto-Robayna B
AUID- ORCID: 0000-0002-7084-022X
AD  - Chemistry Section, Department of Chemical Engineering and Pharmaceutical 
      Technology, Nutrition and Bromatology Area, Pharmacy Faculty, Science Faculty, 
      University of La Laguna, Avenida Astrofísico Francisco Sánchez, s/n, Apartado 
      456, San Cristóbal de La Laguna, S/C of Tenerife, 38200, Tenerife, Spain.
FAU - Moreno-Redondo, Francisco
AU  - Moreno-Redondo F
AUID- ORCID: 0000-0001-7791-2073
AD  - Chemistry Section, Department of Chemical Engineering and Pharmaceutical 
      Technology, Nutrition and Bromatology Area, Pharmacy Faculty, Science Faculty, 
      University of La Laguna, Avenida Astrofísico Francisco Sánchez, s/n, Apartado 
      456, San Cristóbal de La Laguna, S/C of Tenerife, 38200, Tenerife, Spain.
FAU - Díaz-Romero, Carlos
AU  - Díaz-Romero C
AUID- ORCID: 0000-0001-8314-4584
AD  - Chemistry Section, Department of Chemical Engineering and Pharmaceutical 
      Technology, Nutrition and Bromatology Area, Pharmacy Faculty, Science Faculty, 
      University of La Laguna, Avenida Astrofísico Francisco Sánchez, s/n, Apartado 
      456, San Cristóbal de La Laguna, S/C of Tenerife, 38200, Tenerife, Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AUID- ORCID: 0000-0002-1541-3989
AD  - Canary Islands Health Research Institute Foundation (FIISC), Evaluation Unit 
      (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
LA  - eng
GR  - PIFIISC20/34/Canarian Foundation Institute of Health Research of the Canary 
      Islands/
GR  - PIFIISC20/34/Canarian Foundation Institute of Health Research of the Canary 
      Islands/
GR  - PIFIISC20/34/Canarian Foundation Institute of Health Research of the Canary 
      Islands/
PT  - Journal Article
DEP - 20230511
PL  - England
TA  - J Eat Disord
JT  - Journal of eating disorders
JID - 101610672
PMC - PMC10173564
OAB - The Spanish Yale Food Addiction Scale for Children (S-YFAS-C) scale is the first 
      tool adapted to Spanish to evaluate food addiction (FA) in the paediatric 
      population. The aim of this study is to preliminarily evaluate the degree of FA 
      in a non-clinical pilot paediatric population. A total of 21 boys and 24 girls 
      were preliminarily evaluated and 20% of the sample shows three or more symptoms 
      for FA, risk of developing a food disorder and distortion of the body image. The 
      S-YFAS-C scale enables evaluating food addiction in Spanish-speaking boys and 
      girls. The data obtained in regard to quantifying symptoms are similar compared 
      to the original scale.
OABL- eng
OTO - NOTNLM
OT  - Addiction
OT  - Eating disorders
OT  - Food addiction
OT  - S-YFAS-C
OT  - Substance dependence
OT  - Substance-use disorders
COIS- The authors declare that they have no conflict of interest. The funders have not 
      participated in the design, analysis, interpretation of the results and 
      publication of the same.
EDAT- 2023/05/12 01:07
MHDA- 2023/05/12 01:08
CRDT- 2023/05/11 23:54
PHST- 2023/01/23 00:00 [received]
PHST- 2023/04/26 00:00 [accepted]
PHST- 2023/05/12 01:08 [medline]
PHST- 2023/05/12 01:07 [pubmed]
PHST- 2023/05/11 23:54 [entrez]
AID - 10.1186/s40337-023-00798-9 [pii]
AID - 798 [pii]
AID - 10.1186/s40337-023-00798-9 [doi]
PST - epublish
SO  - J Eat Disord. 2023 May 11;11(1):72. doi: 10.1186/s40337-023-00798-9.

PMID- 37160394
OWN - NLM
STAT- MEDLINE
DCOM- 20230511
LR  - 20230513
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 13
IP  - 5
DP  - 2023 May 9
TI  - Epidemiological study on gender bias and low-value practices in primary care: a 
      study protocol.
PG  - e070311
LID - 10.1136/bmjopen-2022-070311 [doi]
LID - e070311
AB  - INTRODUCTION: Evidence shows that gender has a substantial impact on health 
      behaviours, access to and use of health systems and health system responses. This 
      study aims to assess gender bias in patients subjected to low-value practices in 
      the primary care setting and to develop recommendations for reducing adverse 
      events that women experience for this reason. METHODS AND ANALYSIS: A Delphi 
      study will be performed to reach a consensus on the 'Do Not Do' recommendations 
      with a possible gender bias. A retrospective cohort study in a random selection 
      of medical records will then be carried out to identify the frequency of adverse 
      events that occur when the selected 'Do Not Do' recommendations are ignored. 
      Qualitative research techniques (consensus conference and nominal group) will be 
      carried out to develop recommendations to address any gender bias detected, 
      considering barriers and facilitators in clinical practice. ETHICS AND 
      DISSEMINATION: The study was approved by the ethics committee of San Juan de 
      Alicante Hospital (San Juan de Alicante, Spain) Reference N. 21/061. We will 
      disseminate the research findings via peer-reviewed articles, presentations at 
      national and international scientific forums and webinars. TRIAL REGISTRATION 
      NUMBER: The study was registered at ClinicalTrials.gov (NCT05233852) on 10 
      February 2022.
CI  - © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Carrillo, Irene
AU  - Carrillo I
AUID- ORCID: 0000-0002-6981-7284
AD  - Department of Health Psychology, Miguel Hernandez University of Elche, Elche, 
      Spain.
FAU - Lopez-Pineda, Adriana
AU  - Lopez-Pineda A
AUID- ORCID: 0000-0002-2117-0178
AD  - Department of Clinical Medicine, Miguel Hernandez University of Elche, San Juan 
      de Alicante, Spain.
AD  - Atenea Research Group, Foundation for the Promotion of Health and Biomedical 
      Research, San Juan de Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      San Juan de Alicante, Spain.
FAU - Pérez-Jover, Virtudes
AU  - Pérez-Jover V
AUID- ORCID: 0000-0001-9089-0497
AD  - Department of Health Psychology, Miguel Hernandez University of Elche, Elche, 
      Spain v.perez@umh.es.
FAU - Guilabert, Mercedes
AU  - Guilabert M
AUID- ORCID: 0000-0002-0706-9911
AD  - Department of Health Psychology, Miguel Hernandez University of Elche, Elche, 
      Spain.
FAU - Vicente, María Asunción
AU  - Vicente MA
AUID- ORCID: 0000-0002-8630-7251
AD  - Department of Health Psychology, Miguel Hernandez University of Elche, Elche, 
      Spain.
FAU - Fernández, César
AU  - Fernández C
AUID- ORCID: 0000-0002-9391-9192
AD  - Department of Health Psychology, Miguel Hernandez University of Elche, Elche, 
      Spain.
FAU - Gil-Guillen, Vicente F
AU  - Gil-Guillen VF
AD  - Department of Clinical Medicine, Miguel Hernandez University of Elche, San Juan 
      de Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      San Juan de Alicante, Spain.
FAU - Orozco-Bletrán, Domingo
AU  - Orozco-Bletrán D
AD  - Department of Clinical Medicine, Miguel Hernandez University of Elche, San Juan 
      de Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      San Juan de Alicante, Spain.
FAU - Chilet-Rosell, Elisa
AU  - Chilet-Rosell E
AUID- ORCID: 0000-0002-9091-7255
AD  - Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica, 
      Madrid, Spain.
AD  - Department of Public Health, Miguel Hernandez University of Elche, San Juan de 
      Alicante, Spain.
FAU - Luzon Oliver, Lourdes
AU  - Luzon Oliver L
AD  - Totana Sur Primary Health Center, Murcia, Spain.
FAU - Astier-Peña, Maria Pilar
AU  - Astier-Peña MP
AUID- ORCID: 0000-0002-3192-7672
AD  - Grupo de investigación IIS-Aragón H36_23D Feminización, Ética y Profesionalidad 
      de las ciencias de la salud (FEPS), Tarragona, Spain.
AD  - Territorial Quality Unit. Management of Camp de Tarragona, Catalan Health 
      Institute, Tarragona, Spain.
FAU - Tella, Susanna
AU  - Tella S
AD  - Health & Wellbeing, LAB University of Applied Sciences-Lappeenrannan kampus, 
      Lappeenranta, Finland.
AD  - Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
FAU - Carratalá-Munuera, Concepción
AU  - Carratalá-Munuera C
AD  - Department of Clinical Medicine, Miguel Hernandez University of Elche, San Juan 
      de Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      San Juan de Alicante, Spain.
FAU - Mira, José Joaquín
AU  - Mira JJ
AUID- ORCID: 0000-0001-6497-083X
AD  - Department of Health Psychology, Miguel Hernandez University of Elche, Elche, 
      Spain.
AD  - Atenea Research Group, Foundation for the Promotion of Health and Biomedical 
      Research, San Juan de Alicante, Spain.
AD  - Alicante-Sant Joan d'Alacant Health Department, San Juan de Alicante, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT05233852
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230509
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - Female
MH  - Male
MH  - Retrospective Studies
MH  - *Sexism
MH  - Consensus
MH  - *Ethics Committees
MH  - Primary Health Care
PMC - PMC10174026
OTO - NOTNLM
OT  - Health & safety
OT  - PRIMARY CARE
OT  - Quality in health care
COIS- Competing interests: None declared.
EDAT- 2023/05/10 00:41
MHDA- 2023/05/11 06:42
CRDT- 2023/05/09 21:23
PHST- 2023/05/11 06:42 [medline]
PHST- 2023/05/10 00:41 [pubmed]
PHST- 2023/05/09 21:23 [entrez]
AID - bmjopen-2022-070311 [pii]
AID - 10.1136/bmjopen-2022-070311 [doi]
PST - epublish
SO  - BMJ Open. 2023 May 9;13(5):e070311. doi: 10.1136/bmjopen-2022-070311.

PMID- 37139389
OWN - NLM
STAT- MEDLINE
DCOM- 20230505
LR  - 20230508
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 11
DP  - 2023
TI  - The relationship between patient empowerment and related constructs, affective 
      symptoms and quality of life in patients with type 2 diabetes: a systematic 
      review and meta-analysis.
PG  - 1118324
LID - 10.3389/fpubh.2023.1118324 [doi]
LID - 1118324
AB  - INTRODUCTION: The aim of this systematic review is to assess the relationship 
      between patient empowerment and other empowerment-related constructs, and 
      affective symptoms and quality of life in patients with type 2 diabetes. METHODS: 
      A systematic review of the literature was conducted, according to the PRISMA 
      guidelines. Studies addressing adult patients with type 2 diabetes and reporting 
      the association between empowerment-related constructs and subjective measures of 
      anxiety, depression and distress, as well as self-reported quality of life were 
      included. The following electronic databases were consulted from inception to 
      July 2022: Medline, Embase, PsycINFO, and Cochrane Library. The methodological 
      quality of the included studies was analyzed using validated tools adapted to 
      each study design. Meta-analyses of correlations were performed using an inverse 
      variance restricted maximum likelihood random-effects. RESULTS: The initial 
      search yielded 2463 references and seventy-one studies were finally included. We 
      found a weak-to-moderate inverse association between patient empowerment-related 
      constructs and both anxiety (r = -0.22) and depression (r = -0.29). Moreover, 
      empowerment-related constructs were moderately negatively correlated with 
      distress (r = -0.31) and moderately positively correlated with general quality of 
      life (r = 0.32). Small associations between empowerment-related constructs and 
      both mental (r = 0.23) and physical quality of life (r = 0.13) were also 
      reported. DISCUSSION: This evidence is mostly from cross-sectional studies. 
      High-quality prospective studies are needed not only to better understand the 
      role of patient empowerment but to assess causal associations. The results of the 
      study highlight the importance of patient empowerment and other 
      empowerment-related constructs such as self-efficacy or perceived control in 
      diabetes care. Thus, they should be considered in the design, development and 
      implementation of effective interventions and policies aimed at improving 
      psychosocial outcomes in patients with type 2 diabetes. SYSTEMATIC REVIEW 
      REGISTRATION: 
      https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020192429, 
      identifier CRD42020192429.
CI  - Copyright © 2023 Duarte-Díaz, Perestelo-Pérez, Rivero-Santana, Peñate, 
      Álvarez-Pérez, Ramos-García, González-Pacheco, Goya-Arteaga, de Bonis-Braun, 
      González-Martín, Ramallo-Fariña, Carrion and Serrano-Aguilar.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Department of Clinical Psychology, Psychobiology and Methodology, Universidad de 
      La Laguna, (ULL), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - Peñate, Wenceslao
AU  - Peñate W
AD  - Department of Clinical Psychology, Psychobiology and Methodology, Universidad de 
      La Laguna, (ULL), Tenerife, Spain.
FAU - Álvarez-Pérez, Yolanda
AU  - Álvarez-Pérez Y
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - Goya-Arteaga, Libertad
AU  - Goya-Arteaga L
AD  - Multiprofessional Unit of Family and Community Care of La Laguna-Norte, Tenerife, 
      Spain.
FAU - de Bonis-Braun, Miriam
AU  - de Bonis-Braun M
AD  - Multiprofessional Unit of Family and Community Care of La Laguna-Norte, Tenerife, 
      Spain.
FAU - González-Martín, Silvia
AU  - González-Martín S
AD  - Multiprofessional Unit of Family and Community Care of La Laguna-Norte, Tenerife, 
      Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - Carrion, Carme
AU  - Carrion C
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - eHealth Lab Research Group, School of Health Sciences, Universitat Oberta de 
      Catalunya (UOC), Barcelona, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
LA  - eng
PT  - Meta-Analysis
PT  - Systematic Review
DEP - 20230417
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
SB  - IM
MH  - Adult
MH  - Humans
MH  - *Quality of Life
MH  - Affective Symptoms
MH  - *Diabetes Mellitus, Type 2
MH  - Patient Participation
MH  - Cross-Sectional Studies
PMC - PMC10150112
OTO - NOTNLM
OT  - affective outcomes
OT  - diabetes
OT  - empowerment
OT  - quality of life
OT  - self-efficacy
OT  - systematic review and meta-analysis
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/05/04 06:41
MHDA- 2023/05/05 06:42
CRDT- 2023/05/04 02:18
PHST- 2022/12/09 00:00 [received]
PHST- 2023/03/27 00:00 [accepted]
PHST- 2023/05/05 06:42 [medline]
PHST- 2023/05/04 06:41 [pubmed]
PHST- 2023/05/04 02:18 [entrez]
AID - 10.3389/fpubh.2023.1118324 [doi]
PST - epublish
SO  - Front Public Health. 2023 Apr 17;11:1118324. doi: 10.3389/fpubh.2023.1118324. 
      eCollection 2023.

PMID- 37117143
OWN - NLM
STAT- Publisher
LR  - 20230428
IS  - 2529-993X (Electronic)
IS  - 2529-993X (Linking)
DP  - 2023 Apr 26
TI  - Elimination of hepatitis C virus in a prison: An 18-year experience.
LID - S2529-993X(23)00128-4 [pii]
LID - 10.1016/j.eimce.2023.04.015 [doi]
AB  - INTRODUCTION: Despite the decrease of hepatitis C in Spanish prisons in the last 
      years, it still remains a reservoir for infection. The aim of this work is to 
      analyze the characteristics of these patients and the response to antiviral 
      treatment over the last 18 years. METHODS: Retrospective observational study in 
      inmates of Araba penitentiary center diagnosed with HCV infection between 2002 
      and 2020. A descriptive analysis of patient characteristics and the response to 
      the three antiviral treatment modalities was performed: peg-interferon and 
      ribavirin, peg-interferon, ribavirin and a first-generation protease inhibitor 
      and different combinations of direct-acting antivirals. RESULTS: A total of 248 
      antiviral treatments were prescribed. Treatment response rate up to 2015 was 65% 
      and 93,7% after that year. Interferon non-responders were the main cause of 
      non-response to treatment in periods 1 and 2 (40%-50%). Conversely, in period 3 
      viral breakthrough (67%) was the main culprit. CONCLUSION: After 18 years, active 
      hepatitis C infection in prison inmates has resolved with treatment according to 
      clinical criteria. Therefore, the stay in prison may represent an opportunity to 
      reduce the reservoir of the disease in the community, together with continued 
      health care for those released from prison.
CI  - Copyright © 2023 Sociedad Española de Enfermedades Infecciosas y Microbiología 
      Clínica. Published by Elsevier España, S.L.U. All rights reserved.
FAU - Nogales-Garcia, Maite
AU  - Nogales-Garcia M
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain; Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, 
      Vitoria-Gasteiz, Spain.
FAU - Parraza Diez, Naiara
AU  - Parraza Diez N
AD  - Instituto de Investigación Sanitaria Bioaraba, Vitoria-Gasteiz, Spain; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS). 
      Electronic address: Naiara.parrazadiez@osakidetza.eus.
FAU - Vargas Axpe, Andoni
AU  - Vargas Axpe A
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain.
FAU - Velasco Garcia, Rafael
AU  - Velasco Garcia R
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain.
FAU - Larrabeiti-Etxebarria, Ane
AU  - Larrabeiti-Etxebarria A
AD  - Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, 
      Vitoria-Gasteiz, Spain.
FAU - Roy Lopez-Cano, Ignacio
AU  - Roy Lopez-Cano I
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain.
FAU - Atrio Alvarez, Inmaculada
AU  - Atrio Alvarez I
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain.
FAU - Lopez de Arcaute Trincado, Asier
AU  - Lopez de Arcaute Trincado A
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain.
FAU - Fernandez Lopez de Vicuña, Eva María
AU  - Fernandez Lopez de Vicuña EM
AD  - Osakidetza Servicio Vasco de Salud, Centro de Salud Zaballa, Vitoria-Gasteiz, 
      Spain; Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, 
      Vitoria-Gasteiz, Spain.
FAU - Saez de Adana Arroniz, Ester
AU  - Saez de Adana Arroniz E
AD  - Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, 
      Vitoria-Gasteiz, Spain.
FAU - Martínez Martínez, Carlos
AU  - Martínez Martínez C
AD  - Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, 
      Vitoria-Gasteiz, Spain.
FAU - Portu Zapirain, Joseba
AU  - Portu Zapirain J
AD  - Osakidetza Servicio Vasco de Salud, Hospital Universitario Araba, 
      Vitoria-Gasteiz, Spain; Instituto de Investigación Sanitaria Bioaraba, 
      Vitoria-Gasteiz, Spain; Universidad del País Vasco UPV/EHU, Vitoria-Gasteiz, 
      Spain.
LA  - eng
PT  - Journal Article
DEP - 20230426
PL  - Spain
TA  - Enferm Infecc Microbiol Clin (Engl Ed)
JT  - Enfermedades infecciosas y microbiologia clinica (English ed.)
JID - 101777541
SB  - IM
OTO - NOTNLM
OT  - Antiviral agents
OT  - Antivirales
OT  - Hepatitis C
OT  - Prisión
OT  - Prison
OT  - Tratamiento
OT  - Treatment
EDAT- 2023/04/29 06:04
MHDA- 2023/04/29 06:04
CRDT- 2023/04/28 22:01
PHST- 2022/08/22 00:00 [received]
PHST- 2023/01/17 00:00 [revised]
PHST- 2023/01/19 00:00 [accepted]
PHST- 2023/04/29 06:04 [medline]
PHST- 2023/04/29 06:04 [pubmed]
PHST- 2023/04/28 22:01 [entrez]
AID - S2529-993X(23)00128-4 [pii]
AID - 10.1016/j.eimce.2023.04.015 [doi]
PST - aheadofprint
SO  - Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr 26:S2529-993X(23)00128-4. doi: 
      10.1016/j.eimce.2023.04.015.

PMID- 37112758
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230501
IS  - 2076-393X (Print)
IS  - 2076-393X (Electronic)
IS  - 2076-393X (Linking)
VI  - 11
IP  - 4
DP  - 2023 Apr 14
TI  - Attitudes and Behaviors towards Vaccination in Portuguese Nursing Students.
LID - 10.3390/vaccines11040847 [doi]
LID - 847
AB  - Knowing the attitudes and behaviors of nursing students in relation to 
      vaccination is important because they will soon be determinant for the health 
      literacy of the population. Vaccination remains the most effective response in 
      the fight against communicable diseases, including COVID-19 and influenza. The 
      objective of this study is to analyze the attitudes and behaviors of Portuguese 
      nursing students with regard to vaccination. A cross-sectional study was carried 
      out, with data collection from nursing students at a university in Lisbon, 
      Portugal. A sample of 216 nursing students was obtained, representing 67.1% of 
      the students enrolled in this university. What stands out from the results of the 
      questionnaire "Attitudes and Behaviors in Relation to Vaccination among Students 
      of Health Sciences" is that for the majority of students the answers were 
      positive; in addition, 84.7% had a completed vaccination schedule for COVID-19. 
      Being a nursing student, being in the final years of the course and being a woman 
      are the factors that most influence the positive attitude of the students. The 
      results obtained are motivating, because these students will be the future health 
      professionals most likely to integrate health promotion programs through 
      vaccination.
FAU - Marques-Vieira, Cristina Maria Alves
AU  - Marques-Vieira CMA
AUID- ORCID: 0000-0002-4409-7911
AD  - Center for Interdisciplinary Research in Health, Institute of Health Sciences, 
      Nursing School (Lisbon), Universidade Católica Portuguesa, Palma de Cima, 
      Edificio 5, Piso 5, 1649-023 Lisbon, Portugal.
AD  - Lisbon Center for Research, Innovation and Development in Nursing (CIDNUR), 
      Higher School of Nursing, 1600-190 Lisbon, Portugal.
FAU - Domingues, Tiago Dias
AU  - Domingues TD
AUID- ORCID: 0000-0002-4034-4276
AD  - Centro de Estatistica e Aplicações da Universidade de Lisboa (CEAUL), Faculdade 
      de Ciências, Universidade de Lisboa, 1649-004 Lisbon, Portugal.
FAU - Tholl, Adriana Dutra
AU  - Tholl AD
AUID- ORCID: 0000-0002-5084-9972
AD  - Department of Nursing, Universidade Federal de Santa Catarina, Florianópolis 
      88040-900, Brazil.
FAU - Nitschke, Rosane Gonçalves
AU  - Nitschke RG
AUID- ORCID: 0000-0002-1963-907X
AD  - Department of Nursing, Universidade Federal de Santa Catarina, Florianópolis 
      88040-900, Brazil.
FAU - Pérez-Rivas, Francisco Javier
AU  - Pérez-Rivas FJ
AUID- ORCID: 0000-0003-4294-8417
AD  - Grupo de Investigación UCM "Salud Pública-Estilos de Vida, Metodología Enfermera 
      y Cuidados en el En-torno Comunitario", Departamento de Enfermería, Facultad de 
      Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud-RICAPPS-(RICORS), Instituto de Investigación Sanitaria Hospital 12 de 
      Octubre (Imas12), 28041 Madrid, Spain.
FAU - Ajejas-Bazán, María Julia
AU  - Ajejas-Bazán MJ
AUID- ORCID: 0000-0001-5343-3377
AD  - Grupo de Investigación UCM "Salud Pública-Estilos de Vida, Metodología Enfermera 
      y Cuidados en el En-torno Comunitario", Departamento de Enfermería, Facultad de 
      Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 
      Madrid, Spain.
AD  - Academia Central de la Defensa, Escuela Militar de Sanidad, Ministerio de 
      Defensa, 28040 Madrid, Spain.
FAU - Roquette-Viana, Maria Clara
AU  - Roquette-Viana MC
AUID- ORCID: 0000-0002-9629-4618
AD  - Center for Interdisciplinary Research in Health, Institute of Health Sciences, 
      Nursing School (Lisbon), Universidade Católica Portuguesa, Palma de Cima, 
      Edificio 5, Piso 5, 1649-023 Lisbon, Portugal.
LA  - eng
GR  - UIDB/04279/2020/Fundação para a Ciência e Tecnologia/
PT  - Journal Article
DEP - 20230414
PL  - Switzerland
TA  - Vaccines (Basel)
JT  - Vaccines
JID - 101629355
PMC - PMC10145144
OTO - NOTNLM
OT  - COVID-19
OT  - attitudes
OT  - behavior
OT  - nursing
OT  - students
OT  - vaccination
COIS- The authors declare no competing interest. The authors declare that they have no 
      known competing financial interests or personal relationships that could have 
      appeared to influence the work reported in this paper.
EDAT- 2023/04/28 06:41
MHDA- 2023/04/28 06:42
CRDT- 2023/04/28 01:53
PHST- 2023/03/22 00:00 [received]
PHST- 2023/04/06 00:00 [revised]
PHST- 2023/04/12 00:00 [accepted]
PHST- 2023/04/28 06:42 [medline]
PHST- 2023/04/28 06:41 [pubmed]
PHST- 2023/04/28 01:53 [entrez]
AID - vaccines11040847 [pii]
AID - vaccines-11-00847 [pii]
AID - 10.3390/vaccines11040847 [doi]
PST - epublish
SO  - Vaccines (Basel). 2023 Apr 14;11(4):847. doi: 10.3390/vaccines11040847.

PMID- 37104204
OWN - NLM
STAT- MEDLINE
DCOM- 20230501
LR  - 20230508
IS  - 2072-6651 (Electronic)
IS  - 2072-6651 (Linking)
VI  - 15
IP  - 4
DP  - 2023 Apr 3
TI  - Proteomics of Vespa velutina nigrithorax Venom Sac Queens and Workers: A 
      Quantitative SWATH-MS Analysis.
LID - 10.3390/toxins15040266 [doi]
LID - 266
AB  - Health risks caused by stings from Vespa velutina nigrithorax (VV), also known as 
      the yellow-legged Asian hornet, have become a public concern, but little is known 
      about its venom composition. This study presents the proteome profile of the VV's 
      venom sac (VS) based on Sequential Window Acquisition of all Theoretical Mass 
      Spectra (SWATH-MS). The study also performed proteomic quantitative analysis and 
      examined the biological pathways and molecular functions of the proteins in the 
      VS of VV gynes (i.e., future queens [SQ]) and workers [SW]. The total protein 
      content per VS was significantly higher in the SW than in the SQ (274 ± 54 µg/sac 
      vs. 175 ± 22 µg/sac; p = 0.02). We quantified a total of 228 proteins in the VS, 
      belonging to 7 different classes: Insecta (n = 191); Amphibia and Reptilia (n = 
      20); Bacilli, γ-Proteobacteria and Pisoniviricetes (n = 12); and Arachnida (n = 
      5). Among the 228 identified proteins, 66 showed significant differential 
      expression between SQ and SW. The potential allergens hyaluronidase A, venom 
      antigen 5 and phospholipase A1 were significantly downregulated in the SQ venom.
FAU - Alonso-Sampedro, Manuela
AU  - Alonso-Sampedro M
AD  - Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), 
      Hospital Clínico, 15706 Santiago de Compostela, Spain.
AD  - Research Methods Group (RESMET), Health Research Institute of Santiago de 
      Compostela (IDIS), Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS-ISCIII/RD21/0016/0022), University Hospital of Santiago de 
      Compostela, 15706 Santiago de Compostela, Spain.
FAU - Feás, Xesús
AU  - Feás X
AUID- ORCID: 0000-0002-8017-470X
AD  - Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), 
      Hospital Clínico, 15706 Santiago de Compostela, Spain.
AD  - Universitat Carlemany, Av. Verge de Canòlich, 47 AD600 Sant Julià de Lòria, 
      Andorra.
AD  - Academy of Veterinary Sciences of Galicia, 15707 Santiago de Compostela, Spain.
FAU - Bravo, Susana Belén
AU  - Bravo SB
AUID- ORCID: 0000-0001-7615-3079
AD  - Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), 
      Hospital Clínico, 15706 Santiago de Compostela, Spain.
AD  - Proteomic Unit, Health Research Institute of Santiago de Compostela (IDIS), 
      University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, 
      Spain.
FAU - Chantada-Vázquez, María Pilar
AU  - Chantada-Vázquez MP
AUID- ORCID: 0000-0001-8652-4961
AD  - Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), 
      Hospital Clínico, 15706 Santiago de Compostela, Spain.
AD  - Proteomic Unit, Health Research Institute of Santiago de Compostela (IDIS), 
      University Hospital of Santiago de Compostela, 15706 Santiago de Compostela, 
      Spain.
FAU - Vidal, Carmen
AU  - Vidal C
AUID- ORCID: 0000-0002-2844-2754
AD  - Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), 
      Hospital Clínico, 15706 Santiago de Compostela, Spain.
AD  - Research Methods Group (RESMET), Health Research Institute of Santiago de 
      Compostela (IDIS), Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS-ISCIII/RD21/0016/0022), University Hospital of Santiago de 
      Compostela, 15706 Santiago de Compostela, Spain.
AD  - Allergy Department, University Hospital of Santiago de Compostela, 15706 Santiago 
      de Compostela, Spain.
AD  - Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, Faculty 
      of Medicine, University of Santiago de Compostela (USC), 15782 Santiago de 
      Compostela, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230403
PL  - Switzerland
TA  - Toxins (Basel)
JT  - Toxins
JID - 101530765
RN  - 0 (Wasp Venoms)
RN  - EC 3.2.1.35 (Hyaluronoglucosaminidase)
SB  - IM
MH  - Animals
MH  - *Wasps
MH  - Proteomics
MH  - Wasp Venoms
MH  - Mass Spectrometry
MH  - Hyaluronoglucosaminidase
PMC - PMC10144020
OTO - NOTNLM
OT  - Asian hornet
OT  - SWATH-MS
OT  - Vespa spp.
OT  - Vespa velutina nigrithorax
OT  - allergy
OT  - hymenopteran
OT  - proteomics
OT  - venom
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses or interpretation of data; in 
      the writing of the manuscript; or in the decision to publish the results.
EDAT- 2023/04/27 18:41
MHDA- 2023/05/01 06:42
CRDT- 2023/04/27 13:23
PHST- 2023/03/10 00:00 [received]
PHST- 2023/03/20 00:00 [revised]
PHST- 2023/03/29 00:00 [accepted]
PHST- 2023/05/01 06:42 [medline]
PHST- 2023/04/27 18:41 [pubmed]
PHST- 2023/04/27 13:23 [entrez]
AID - toxins15040266 [pii]
AID - toxins-15-00266 [pii]
AID - 10.3390/toxins15040266 [doi]
PST - epublish
SO  - Toxins (Basel). 2023 Apr 3;15(4):266. doi: 10.3390/toxins15040266.

PMID- 37098518
OWN - NLM
STAT- MEDLINE
DCOM- 20230427
LR  - 20230428
IS  - 1471-2474 (Electronic)
IS  - 1471-2474 (Linking)
VI  - 24
IP  - 1
DP  - 2023 Apr 25
TI  - Long-term health related quality of life in total knee arthroplasty.
PG  - 327
LID - 10.1186/s12891-023-06399-6 [doi]
LID - 327
AB  - BACKGROUND: To analyze evolution and factors related with greater gains in Health 
      Related Quality of Life (HRQOL) and with a greater probability of exceed their 
      corresponding minimal clinically important differences (MCID) in patients with 
      Osteoarthritis of the knee, undergoing total knee arthroplasty (TKA) at 
      long-term. METHODS: Data were obtained from two previously recruited multicenter 
      cohorts of patients who underwent TKA in the Basque Country. Patients were 
      follow-up at 6 months and 10 years after surgery. Patients completed specific and 
      generic HRQOL questionnaires plus sociodemographic, and clinical data at 10 
      years. Associations were analysed using linear and logistic regression models. 
      RESULTS: A total of 471 patients responded at 10-year follow-up. The 
      multivariable analysis showed that low preoperative HRQOL scores, higher age, 
      higher BMI, some comorbidities and readmissions at 6 months were associated with 
      less gains in HRQOL. Apart from aforementioned, to have a peripheral vascular 
      disease (odd ratio 0.49 (95% CI, 0.24-0.99)), complications (odd ratio 0.31 (95% 
      CI, 0.11-0.91)), and readmissions within 6 months of discharge (odd ratio 2.12 
      (95% CI, 1.18-3.80)) were associated with a lower probability of exceeding the 
      MCID. The effect sizes (ESs) of changes from baseline to 6 months (range, 
      1.20-1.96) and to 10 years (range, 1.54-1.99) were large in all dimensions, 
      nevertheless the ESs from 6 months to 10 years were not appreciable for pain 
      (ES = 0.03) or stiffness (ES = 0.09), and small for function (ES = 0.30). 
      CONCLUSIONS: Low preoperative HRQOL scores, to be elderly, severe obesity, the 
      presence of some comorbidities -depression and rheumatology disease-, having 
      readmissions or complications and not having rehabilitation of discharge, are 
      good predictors of long-term lower gains in HRQOL. Some other non-registered 
      parameters of the follow-up may also influence those outcomes. KEY INDEXING TERMS 
      (MESH TERMS): Health-Related Quality of Life, Knee Arthroplasty, Total, 
      Osteoarthritis.
CI  - © 2023. The Author(s).
FAU - González-Sáenz-de-Tejada, Marta
AU  - González-Sáenz-de-Tejada M
AUID- ORCID: 0000-0003-3826-6587
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain. 
      marta.gonzalezsaenzdetejada@osakidetza.eus.
AD  - Osakidetza Basque Health Service, Research Unit, Basurto University Hospital, 
      Bilbao, Spain. marta.gonzalezsaenzdetejada@osakidetza.eus.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Spain. 
      marta.gonzalezsaenzdetejada@osakidetza.eus.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Bilbao, Spain. marta.gonzalezsaenzdetejada@osakidetza.eus.
AD  - Hospital Universitario de Basurto. Unidad de Investigación, Jado 4º Planta. Avda. 
      Montevideo 18, Bilbao, 48013, Bizkaia, Spain. 
      marta.gonzalezsaenzdetejada@osakidetza.eus.
FAU - Quintana, Jose M
AU  - Quintana JM
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Bilbao, Spain.
AD  - Osakidetza Basque Health Service, Research Unit, Galdakao-Usansolo University 
      Hospital, Galdakao, Bizkaia, Spain.
FAU - Arenaza, Juan C
AU  - Arenaza JC
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Spain.
AD  - Osakidetza Basque Health Service, Traumatology and Orthopedic Surgery Service, 
      Basurto University Hospital, Bilbao, Bizkaia, Spain.
FAU - Azcarate-Garitano, Jesús R
AU  - Azcarate-Garitano JR
AD  - Osakidetza Basque Health Service, Mendaro Hospital, Traumatology and Orthopedic 
      Surgery Service, Mendaro, Spain.
FAU - Esnaola-Guisasola, Pedro M
AU  - Esnaola-Guisasola PM
AD  - Osakidetza Basque Health Service, Traumatology and Orthopedic Surgery Service, 
      Donostia University Hospital, Donostia, Gipuzkoa, Spain.
FAU - García-Sánchez, Isidoro
AU  - García-Sánchez I
AD  - Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, 
      Traumatology and Orthopedic Surgery Service, Galdakao, Bizkaia, Spain.
FAU - Baguer-Antonio, Alejandro
AU  - Baguer-Antonio A
AD  - Osakidetza Basque Health Service, Traumatology and Orthopedic Surgery Service, 
      Donostia University Hospital, Donostia, Gipuzkoa, Spain.
FAU - Bilbao-González, Amaia
AU  - Bilbao-González A
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Osakidetza Basque Health Service, Research Unit, Basurto University Hospital, 
      Bilbao, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Bilbao, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Bilbao, Spain.
LA  - eng
GR  - 2012111011/Department of Health of the Basque Country/
PT  - Journal Article
PT  - Multicenter Study
DEP - 20230425
PL  - England
TA  - BMC Musculoskelet Disord
JT  - BMC musculoskeletal disorders
JID - 100968565
SB  - IM
MH  - Humans
MH  - Aged
MH  - Infant
MH  - *Arthroplasty, Replacement, Knee/adverse effects/methods
MH  - Quality of Life
MH  - *Osteoarthritis/surgery
MH  - Knee Joint/surgery
MH  - Comorbidity
MH  - *Osteoarthritis, Knee/surgery
MH  - Treatment Outcome
PMC - PMC10127408
OTO - NOTNLM
OT  - Health Related Quality of Life
OT  - Long-term
OT  - Minimal clinically important differences
OT  - Osteoarthritis
OT  - Total knee arthroplasty
COIS- The authors declare that they have no competing interests.
EDAT- 2023/04/26 00:42
MHDA- 2023/04/27 06:42
CRDT- 2023/04/25 23:36
PHST- 2022/02/15 00:00 [received]
PHST- 2023/04/04 00:00 [accepted]
PHST- 2023/04/27 06:42 [medline]
PHST- 2023/04/26 00:42 [pubmed]
PHST- 2023/04/25 23:36 [entrez]
AID - 10.1186/s12891-023-06399-6 [pii]
AID - 6399 [pii]
AID - 10.1186/s12891-023-06399-6 [doi]
PST - epublish
SO  - BMC Musculoskelet Disord. 2023 Apr 25;24(1):327. doi: 10.1186/s12891-023-06399-6.

PMID- 37087897
OWN - NLM
STAT- MEDLINE
DCOM- 20230510
LR  - 20230510
IS  - 1873-2054 (Electronic)
IS  - 1353-8292 (Linking)
VI  - 81
DP  - 2023 May
TI  - Exercise facility availability and incidence of type 2 diabetes and complications 
      in Spain: A population-based retrospective cohort 2015-2018.
PG  - 103027
LID - S1353-8292(23)00064-3 [pii]
LID - 10.1016/j.healthplace.2023.103027 [doi]
AB  - BACKGROUND: To study the association between exercise facility availability and 
      type 2 diabetes incidence and its complications, and to explore effect 
      modification by socioeconomic status (SES) and sex in the Madrid adult 
      population. METHODS: A multilevel longitudinal design, based on a 
      population-based retrospective cohort including 1,214,281 residents of Madrid 
      (Spain) aged 40-75 years from 2015 to 2018. Outcomes were type 2 diabetes 
      incidence and macrovascular (cardiac ischemia and/or stroke) and microvascular 
      (chronic kidney disease, retinopathy, and/or peripheral vascular disease) 
      complications in those with diabetes at baseline. Exercise facility availability 
      was defined as the count of exercise facilities in a 1000 m street network buffer 
      around each participant's residence. Poisson regression models with robust 
      standard errors were used to estimate the risk ratios (RR). Interactions were 
      explored with SES tertiles and by sex. RESULTS: Residents living in areas with 
      lower exercise facility availability showed higher risk of type 2 diabetes 
      (RR(tertile3vs1) = 1.25, CI95% 1.21-1.30) as well as macrovascular 
      (RR(Tertile)(3vs1) = 1.09 CI95% 1.00-1.19), and microvascular 
      (RR(Tertile)(3vs1) = 1.10 CI95% 1.01-1.19) complications. Associations were 
      strongest in low SES areas for type 2 diabetes (RR(tertile3vs1-LOW-SES) = 1.22, 
      CI95% 1.12-1.32; RR(tertile3vs1-HIGH-SES) = 0.91, CI95% 0.85-0.98) and 
      microvascular complications (RR(tertile3vs1-LOW-SES) = 1.12, CI95% 0,94-1,33; 
      RR(tertile3vs1-HIGH-SES) = 0.88, CI95% 0.73-1.05). CONCLUSIONS: Living in areas 
      with lower availability of exercise facilities was associated with a greater risk 
      of type 2 diabetes and its complications. Increasing exercise opportunities, 
      particularly in low SES areas, could help reduce the social gradient of diabetes 
      and its complications.
CI  - Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
FAU - Cereijo, Luis
AU  - Cereijo L
AD  - Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento 
      de Cirugía, Ciencias Médicas y Sociales, Grupo de investigación en epidemiología 
      y salud pública, Alcalá de Henares, Madrid, Spain; Universidad de Alcalá, 
      Facultad de Medicina y Ciencias de la Salud, Departamento de Ciencias Biomédicas, 
      Grupo de investigación en gestión y entrenamiento deportivo, Alcalá de Henares, 
      Madrid, Spain; Centre for Urban Research, RMIT University, Melbourne, Australia. 
      Electronic address: luis.cereijo@edu.uah.es.
FAU - Gullón, Pedro
AU  - Gullón P
AD  - Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento 
      de Cirugía, Ciencias Médicas y Sociales, Grupo de investigación en epidemiología 
      y salud pública, Alcalá de Henares, Madrid, Spain; Centre for Urban Research, 
      RMIT University, Melbourne, Australia. Electronic address: pedro.gullon@uah.es.
FAU - Del Cura, Isabel
AU  - Del Cura I
AD  - Unidad de investigación de atención primaria, Gerencia de Atención Primaria, 
      Madrid, Spain; Departamento de especialidades médicas y salud pública, University 
      Rey Juan Carlos, Madrid, Spain; Red de Investigación en Servicios de Salud y 
      Enfermedades Crónicas (REDISSEC) & Red de la Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPs) ISCIII, Madrid, Spain; 
      Instituto de Investigación Sanitaria Gregorio Marañon. IiSGM, Madrid, Spain. 
      Electronic address: isabel.cura@salud.madrid.org.
FAU - Valadés, David
AU  - Valadés D
AD  - Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento 
      de Ciencias Biomédicas, Grupo de investigación en gestión y entrenamiento 
      deportivo, Alcalá de Henares, Madrid, Spain. Electronic address: 
      david.valades@uah.es.
FAU - Bilal, Usama
AU  - Bilal U
AD  - Urban Health Collaborative, Drexel Dornsife School of Public Health, 
      Philadelphia, PA, USA; Department of Epidemiology and Biostatistics, Drexel 
      Dornsife School of Public Health, Philadelphia, PA, USA. Electronic address: 
      ub45@drexel.edu.
FAU - Franco, Manuel
AU  - Franco M
AD  - Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento 
      de Cirugía, Ciencias Médicas y Sociales, Grupo de investigación en epidemiología 
      y salud pública, Alcalá de Henares, Madrid, Spain; Department of Epidemiology, 
      Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic 
      address: manuel.franco@uah.es.
FAU - Badland, Hannah
AU  - Badland H
AD  - Centre for Urban Research, RMIT University, Melbourne, Australia. Electronic 
      address: hannah.badland@rmit.edu.au.
LA  - eng
GR  - DP5 OD026429/OD/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20230421
PL  - England
TA  - Health Place
JT  - Health & place
JID - 9510067
MH  - Adult
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/epidemiology
MH  - Incidence
MH  - Retrospective Studies
MH  - Social Class
MH  - Spain/epidemiology
MH  - *Exercise
MH  - Social Determinants of Health
MH  - Urban Health
MH  - Electronic Health Records
MH  - Diabetes Complications/epidemiology
OTO - NOTNLM
OT  - Cardiovascular diseases
OT  - Diabetes complications
OT  - Electronic medical records
OT  - Exercise
OT  - Inequalities
OT  - Social determinants of health
OT  - Type 2 diabetes
OT  - Urban health
COIS- Declaration of competing interest The authors declare that they have no competing 
      interests.
EDAT- 2023/04/24 00:41
MHDA- 2023/05/08 06:41
CRDT- 2023/04/23 18:06
PHST- 2022/09/23 00:00 [received]
PHST- 2023/04/03 00:00 [revised]
PHST- 2023/04/04 00:00 [accepted]
PHST- 2023/05/08 06:41 [medline]
PHST- 2023/04/24 00:41 [pubmed]
PHST- 2023/04/23 18:06 [entrez]
AID - S1353-8292(23)00064-3 [pii]
AID - 10.1016/j.healthplace.2023.103027 [doi]
PST - ppublish
SO  - Health Place. 2023 May;81:103027. doi: 10.1016/j.healthplace.2023.103027. Epub 
      2023 Apr 21.

PMID- 37080245
OWN - NLM
STAT- MEDLINE
DCOM- 20230602
LR  - 20230607
IS  - 1538-9375 (Electronic)
IS  - 1525-8610 (Print)
IS  - 1525-8610 (Linking)
VI  - 24
IP  - 6
DP  - 2023 Jun
TI  - Impact of Prior SARS-CoV-2 Infection and Vaccination on COVID-19 Infection Among 
      Nursing Home Residents.
PG  - 919-921
LID - S1525-8610(23)00292-X [pii]
LID - 10.1016/j.jamda.2023.03.013 [doi]
FAU - España, Pedro P
AU  - España PP
AD  - Respiratory Service, Osakidetza Basque Health Service, Galdakao-Usansolo 
      University Hospital, Galdakao, Spain; Biocruces Bizkaia Health Research 
      Institute, Barakaldo, Spain. Electronic address: 
      pedropablo.espanayandiola@osakidetza.eus.
FAU - Bilbao-Gonzalez, Amaia
AU  - Bilbao-Gonzalez A
AD  - Research and Innovation Unit, Osakidetza Basque Health Service, Basurto 
      University Hospital, Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain; Health Service Research Network on Chronic Diseases 
      (REDISSEC), Bilbao, Spain; Network for Research on Chronicity, Primary Care, and 
      Health Promotion (RICAPPS), Bilbao, Spain.
FAU - Larrea, Nere
AU  - Larrea N
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Health Service Research Network on Chronic Diseases (REDISSEC), 
      Bilbao, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Bilbao, Spain.
FAU - Castillo-Sintes, Idoia
AU  - Castillo-Sintes I
AD  - Research and Innovation Unit, Osakidetza Basque Health Service, Basurto 
      University Hospital, Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain.
FAU - García-Gutiérrez, Susana
AU  - García-Gutiérrez S
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Health Service Research Network on Chronic Diseases (REDISSEC), 
      Bilbao, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Bilbao, Spain.
FAU - Portuondo, Janire
AU  - Portuondo J
AD  - Osakidetza Basque Health Service, Sub-Directorate for Primary Care Coordination, 
      Vitoria-Gasteiz, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, 
      Spain; Health Service Research Network on Chronic Diseases (REDISSEC), Bilbao, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Bilbao, Spain.
FAU - Villanueva, Ane
AU  - Villanueva A
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Health Service Research Network on Chronic Diseases (REDISSEC), 
      Bilbao, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Bilbao, Spain.
FAU - Uranga, Ane
AU  - Uranga A
AD  - Respiratory Service, Osakidetza Basque Health Service, Galdakao-Usansolo 
      University Hospital, Galdakao, Spain; Biocruces Bizkaia Health Research 
      Institute, Barakaldo, Spain.
FAU - Legarreta, Maria J
AU  - Legarreta MJ
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain; Health 
      Service Research Network on Chronic Diseases (REDISSEC), Bilbao, Spain; Network 
      for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Bilbao, 
      Spain; Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo 
      University Hospital, Galdakao, Spain.
FAU - Gascon, Maria
AU  - Gascon M
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Health Service Research Network on Chronic Diseases (REDISSEC), 
      Bilbao, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Bilbao, Spain.
FAU - Quintana, Jose M
AU  - Quintana JM
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Health Service Research Network on Chronic Diseases (REDISSEC), 
      Bilbao, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Bilbao, Spain.
CN  - COVID-Health Basque Country Research Group
AD  - Research Unit, Osakidetza Basque Health Service, Galdakao-Usansolo University 
      Hospital, Galdakao, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Health Service Research Network on Chronic Diseases (REDISSEC), 
      Bilbao, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Bilbao, Spain.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20230321
PL  - United States
TA  - J Am Med Dir Assoc
JT  - Journal of the American Medical Directors Association
JID - 100893243
SB  - IM
MH  - Humans
MH  - *COVID-19
MH  - SARS-CoV-2
MH  - Vaccination
MH  - Nursing Homes
PMC - PMC10027945
EDAT- 2023/04/21 00:42
MHDA- 2023/06/02 06:42
CRDT- 2023/04/20 19:21
PHST- 2023/03/03 00:00 [received]
PHST- 2023/03/08 00:00 [revised]
PHST- 2023/03/11 00:00 [accepted]
PHST- 2023/06/02 06:42 [medline]
PHST- 2023/04/21 00:42 [pubmed]
PHST- 2023/04/20 19:21 [entrez]
AID - S1525-8610(23)00292-X [pii]
AID - 10.1016/j.jamda.2023.03.013 [doi]
PST - ppublish
SO  - J Am Med Dir Assoc. 2023 Jun;24(6):919-921. doi: 10.1016/j.jamda.2023.03.013. 
      Epub 2023 Mar 21.

PMID- 37079949
OWN - NLM
STAT- MEDLINE
DCOM- 20230515
LR  - 20230524
IS  - 1809-9246 (Electronic)
IS  - 1413-3555 (Print)
IS  - 1413-3555 (Linking)
VI  - 27
IP  - 2
DP  - 2023 Mar-Apr
TI  - Consensus-based recommendations on physical activity and exercise in patients 
      with diabetes at risk of foot ulcerations: a Delphi study.
PG  - 100500
LID - S1413-3555(23)00021-7 [pii]
LID - 10.1016/j.bjpt.2023.100500 [doi]
LID - 100500
AB  - BACKGROUND: Patients with diabetes mellitus are exposed to important 
      complications. Currently little evidence exist on the guidelines that these 
      patients, at some risk of foot ulceration, should follow for physical exercise. 
      OBJECTIVES: To reach a consensus among multidisciplinary and international 
      experts on physical activity/exercise recommendations for patients with diabetes, 
      according to foot ulcer risk. METHODS: Using a three-round Delphi method, a panel 
      composed of 28 multidisciplinary experts in the management of diabetic foot 
      assessed 109 recommendations on physical activity/exercise for patients with 
      diabetes mellitus, according to their risk of foot ulcer. Consensus was assumed 
      when 80% of responses matched the same category (agreement/disagreement). 
      RESULTS: Twenty-nine experts participated in the first and second rounds of 
      consultation, and twenty-eight did so in the third, reaching final agreement on 
      86 of the 109 recommendations considered (78.9%). The study, thus, generated a 
      consensus set of recommendations concerning different aspects of diabetic 
      footcare before, during, and after exercise (e.g. when to examine the foot, how 
      to assess it, what type of sock and insole to use, what types of exercise to 
      perform, and when it is advisable to return to activity after an ulceration). 
      CONCLUSION: This Delphi study generated recommendations based on the consensus of 
      international experts on physical activity and exercise by patient with diabetes 
      at risk of ulceration. Recommendations considered the state of the foot and the 
      patient's history and status before physical activity and included information on 
      intensity, duration, frequency, and progressions of physical activity/exercise, 
      and the use of custom-made plantar orthoses, shoe prescription, and the 
      convenience of returning to physical activity after an ulceration.
CI  - Copyright © 2023 The Authors. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Gracia-Sánchez, Alba
AU  - Gracia-Sánchez A
AD  - Nursing Service, Department of Health and Behavioral Sciences, Faculty of 
      Medicine, University Miguel Hernández de Elche, San Juan de Alicante, Spain.
FAU - López-Pineda, Adriana
AU  - López-Pineda A
AD  - Clinical Medicine Department, University Miguel Hernández de Elche, San Juan de 
      Alicante, Spain; Atenea Research Group, Foundation for the Promotion of Health 
      and Biomedical Research, San Juan de Alicante, Spain; Network for Research on 
      Chronicity, Primary Care, and Health Promotion (RICAPPS), Alicante, Spain. 
      Electronic address: adriana.lopezp@umh.es.
FAU - Lázaro-Martínez, José Luis
AU  - Lázaro-Martínez JL
AD  - Diabetic Foot Unit,Universidad Complutense de Madrid. Instituto de Investigación 
      Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
FAU - Pérez, Antonio
AU  - Pérez A
AD  - Endocrinology and Nutrition Department, Hospital de la Santa Creu i Sant Pau, 
      Barcelona, Medicine Department, Universitat Autònoma de Barcelona, CIBER de 
      Diabetes y Enfermedades metabólicas (CIBERDEM), Barcelona, Spain.
FAU - Pomares-Gómez, Francisco J
AU  - Pomares-Gómez FJ
AD  - Endocrinology and Nutrition, University Hospital San juan de Alicante, San Juan 
      de Alicante, Spain.
FAU - Fernández-Seguín, Lourdes María
AU  - Fernández-Seguín LM
AD  - Physical Therapy Department, University of Seville, Seville, Spain.
FAU - Gil-Guillén, Vicente F
AU  - Gil-Guillén VF
AD  - Clinical Medicine Department, University Miguel Hernández de Elche, San Juan de 
      Alicante, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Alicante, Spain; Research Unit, University General Hospital 
      of Elda, Elda, Spain.
FAU - Chicharro-Luna, Esther
AU  - Chicharro-Luna E
AD  - Nursing Service, Department of Health and Behavioral Sciences, Faculty of 
      Medicine, University Miguel Hernández de Elche, San Juan de Alicante, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230406
PL  - Brazil
TA  - Braz J Phys Ther
JT  - Brazilian journal of physical therapy
JID - 101615124
SB  - IM
MH  - Humans
MH  - *Diabetic Foot/etiology
MH  - Consensus
MH  - Delphi Technique
MH  - Foot
MH  - Exercise
MH  - *Diabetes Mellitus
PMC - PMC10201453
OTO - NOTNLM
OT  - Diabetic foot
OT  - Diabetic neuropathies
OT  - Exercise
OT  - Exercise therapy
OT  - Physical activity
COIS- Conflicts of interest The authors declare that they have no known competing 
      financial interests or personal relationships that could have appeared to 
      influence the work reported in this paper.
EDAT- 2023/04/20 18:41
MHDA- 2023/05/15 06:42
CRDT- 2023/04/20 18:00
PHST- 2022/08/12 00:00 [received]
PHST- 2023/03/08 00:00 [revised]
PHST- 2023/03/24 00:00 [accepted]
PHST- 2023/05/15 06:42 [medline]
PHST- 2023/04/20 18:41 [pubmed]
PHST- 2023/04/20 18:00 [entrez]
AID - S1413-3555(23)00021-7 [pii]
AID - 100500 [pii]
AID - 10.1016/j.bjpt.2023.100500 [doi]
PST - ppublish
SO  - Braz J Phys Ther. 2023 Mar-Apr;27(2):100500. doi: 10.1016/j.bjpt.2023.100500. 
      Epub 2023 Apr 6.

PMID- 37060727
OWN - NLM
STAT- MEDLINE
DCOM- 20230421
LR  - 20230522
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Linking)
VI  - 37
DP  - 2023
TI  - [Health policy priorities. SESPAS meeting at the XXXIII School of Public Health 
      of Menorca].
PG  - 102300
LID - S0213-9111(23)00014-6 [pii]
LID - 10.1016/j.gaceta.2023.102300 [doi]
AB  - OBJECTIVE: In September 2022, the Sociedad Española de Salud Pública y 
      Administración Sanitaria (SESPAS) brought together a panel of experts with the 
      aim of defining and prioritizing health policy proposals, from the perspective of 
      the Spanish State as a whole, to adapt the National Health System (NHS) to 
      current risks and to contemporary/present-day society. METHOD: Expert meeting 
      structured using a mix of procedures adapted from brainstorming, nominal group 
      and Rand consensus method techniques. Relevance and feasibility of proposals 
      identified were assessed individually by each panelist. Proposals were then 
      ordered thematically and ranked according to the median and quartile deviation of 
      relevance scores. RESULTS: Panelists identified and prioritized several proposals 
      in different areas: governance and funding of the NHS, reform of the portfolio of 
      services and benefits and of the NHS human resources, public health and health 
      policy, actions against inequality and poverty, and healthcare delivery reform, 
      including socio-sanitary, primary and end-of-life care. CONCLUSIONS: The results 
      of the meeting show the urgent need to address in-depth changes in many 
      state-wide health policies, including a major reconfiguration of governance, 
      public health, and health care structures. They also point out potential areas of 
      improvement, constituting a tentative guide of prioritized issues to be 
      addressed.
CI  - Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Peiró, Salvador
AU  - Peiró S
AD  - Unidad de Investigación en Servicios de Salud y Farmacoepidemiología, Fundación 
      para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad 
      Valenciana (FISABIO), València, España; Red de Investigación en Cronicidad, 
      Atención Primaria y Prevención y Promoción de la Salud (RICAPPS), València, 
      España; Fundación Instituto de Investigación en Servicios de Salud (fIISS), 
      València, España. Electronic address: peiro_bor@gva.es.
FAU - Meneu, Ricard
AU  - Meneu R
AD  - Fundación Instituto de Investigación en Servicios de Salud (fIISS), València, 
      España.
FAU - Hernández, Ildefonso
AU  - Hernández I
AD  - Departamento de Salud Pública, Historia de la Ciencia y Ginecología, Universidad 
      Miguel Hernández, Elche, Alicante, España; CIBER de Epidemiología y Salud Pública 
      (CIBERESP), España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Prioridades de políticas de salud. Encuentro SESPAS en la XXXIII Escuela de Salud 
      Pública de Menorca.
DEP - 20230413
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Humans
MH  - Consensus
MH  - Delivery of Health Care
MH  - Health Policy
MH  - *Health Priorities
MH  - *Public Health
MH  - Spain
OTO - NOTNLM
OT  - Consensus methods
OT  - Health policy
OT  - Health priorities
OT  - Investigación en sistemas de salud pública
OT  - Métodos de consenso
OT  - Políticas de salud
OT  - Políticas públicas
OT  - Prioridades de salud
OT  - Public health systems research
OT  - Public policy
EDAT- 2023/04/16 06:00
MHDA- 2023/04/19 06:41
CRDT- 2023/04/15 18:05
PHST- 2023/02/14 00:00 [received]
PHST- 2023/02/14 00:00 [accepted]
PHST- 2023/04/19 06:41 [medline]
PHST- 2023/04/15 18:05 [entrez]
PHST- 2023/04/16 06:00 [pubmed]
AID - S0213-9111(23)00014-6 [pii]
AID - 10.1016/j.gaceta.2023.102300 [doi]
PST - epublish
SO  - Gac Sanit. 2023 Apr 13;37:102300. doi: 10.1016/j.gaceta.2023.102300. eCollection 
      2023.

PMID- 37054898
OWN - NLM
STAT- MEDLINE
DCOM- 20230501
LR  - 20230517
IS  - 1573-2517 (Electronic)
IS  - 0165-0327 (Linking)
VI  - 332
DP  - 2023 Jul 1
TI  - One-year follow-up of the effectiveness of a lifestyle modification programme as 
      an adjuvant treatment of depression in primary care: A randomised clinical trial.
PG  - 231-237
LID - S0165-0327(23)00464-0 [pii]
LID - 10.1016/j.jad.2023.04.007 [doi]
AB  - BACKGROUND: An estimated 280 million individuals suffer from depression. Brief 
      group interventions in Primary Healthcare Centres (PHCs) are recommended. One 
      goal of these interventions is to educate people about healthy lifestyle habits, 
      as they prevent the development of depression. This study aims to analyse the 
      one-year follow-up results about the effectiveness of a Lifestyle Modification 
      Programme (LMP) and an LMP plus Information and Communication Technologies 
      (LMP + ICTs) when compared to Treatment as Usual (TAU). METHODS: We conducted an 
      open-label, multicentre, pragmatic, randomised clinical trial. A total of 188 
      individuals that visited a general practitioner and met the inclusion criteria 
      were randomised. LMP consisted of six weekly 90-minute group sessions focusing on 
      lifestyle improvement. LMP + ICTs was a hybrid of the LMP format with the 
      inclusion of a wearable smartwatch. We used linear mixed models (with a random 
      intercept and an unstructured covariance) to evaluate the effectiveness of the 
      interventions, and an intention-to-treat analysis and Multiple Imputation 
      technique for handling missing data. RESULTS: LMP + ICTs showed a statistically 
      significant reduction on depressive symptoms (b = -2.68, 95 % CI = [-4.239, 
      -1.133] p = .001) and sedentarism (b = -37.38, 95 % CI [-62.930, -11.833], 
      p = .004) compared to TAU. LIMITATIONS: Most of the dropouts were due to time 
      restrictions. CONCLUSIONS: In long-term, LMPs plus ICTs administered in PHCs to 
      people suffering from depression were effective in reducing depressive 
      symptomatology and sedentarism comparing to TAU. More research is needed to 
      enhance adherence to lifestyle recommendations. These promising programmes could 
      be easily implemented in PHCs. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov 
      Registry (NCT03951350).
CI  - Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Aguilar-Latorre, Alejandra
AU  - Aguilar-Latorre A
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain; Department of 
      Psychology and Sociology, University of Zaragoza, Zaragoza, Spain; Research 
      Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Carlos III 
      Health Institute, Madrid, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain; Department of 
      Psychology and Sociology, University of Zaragoza, Zaragoza, Spain; Research 
      Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Carlos III 
      Health Institute, Madrid, Spain. Electronic address: bolivan@unizar.es.
FAU - Algorta, Guillermo Pérez
AU  - Algorta GP
AD  - Division of Health Research, Faculty of Health and Medicine, Lancaster 
      University, Lancaster, United Kingdom.
FAU - Serrano-Ripoll, Maria J
AU  - Serrano-Ripoll MJ
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain; Health Research Institute of the 
      Balearic Islands (IdISBa), Palma, Spain; Primary Care Research Unit of Mallorca, 
      Balearic Islands Health Services, Palma, Spain.
FAU - Olszewski, Linda E
AU  - Olszewski LE
AD  - Department of Psychiatry and Biobehavioral Sciences, David Geffen School of 
      Medicine at UCLA, Los Angeles, EEUU.
FAU - Turón-Lanuza, Alberto
AU  - Turón-Lanuza A
AD  - Multi-Criteria Decision Making Group (GDMZ), Faculty of Economics and Business, 
      University of Zaragoza, Zaragoza, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT03951350
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20230411
PL  - Netherlands
TA  - J Affect Disord
JT  - Journal of affective disorders
JID - 7906073
SB  - IM
MH  - Humans
MH  - *Depression/therapy
MH  - Follow-Up Studies
MH  - *Life Style
MH  - Behavior Therapy
MH  - Primary Health Care
MH  - Cost-Benefit Analysis
MH  - Quality of Life
OTO - NOTNLM
OT  - Depression
OT  - Diet
OT  - Lifestyle modification
OT  - Physical exercise
OT  - Primary care
OT  - Sleep quality
COIS- Conflict of interest None.
EDAT- 2023/04/14 06:00
MHDA- 2023/05/01 06:42
CRDT- 2023/04/13 19:24
PHST- 2022/06/13 00:00 [received]
PHST- 2023/03/20 00:00 [revised]
PHST- 2023/04/07 00:00 [accepted]
PHST- 2023/05/01 06:42 [medline]
PHST- 2023/04/14 06:00 [pubmed]
PHST- 2023/04/13 19:24 [entrez]
AID - S0165-0327(23)00464-0 [pii]
AID - 10.1016/j.jad.2023.04.007 [doi]
PST - ppublish
SO  - J Affect Disord. 2023 Jul 1;332:231-237. doi: 10.1016/j.jad.2023.04.007. Epub 
      2023 Apr 11.

PMID- 37036523
OWN - NLM
STAT- MEDLINE
DCOM- 20230421
LR  - 20230518
IS  - 1432-1750 (Electronic)
IS  - 0341-2040 (Linking)
VI  - 201
IP  - 2
DP  - 2023 Apr
TI  - Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD.
PG  - 217-224
LID - 10.1007/s00408-023-00613-x [doi]
AB  - BACKGROUND: Oxygen desaturation during exercise is mainly observed in severe 
      cases of chronic obstructive pulmonary disease (COPD) and is associated with a 
      worse prognosis, but little is known about the type of desaturation that causes 
      the greatest risk of mortality. MATERIAL AND METHODS: We studied all of the 6-min 
      walk tests performed periodically at a tertiary hospital over a period of 
      12 years in patients with moderate or severe COPD. We classified patients as 
      non-desaturators if they did not suffer a drop in oxygen saturation (SpO2 < 88%) 
      during the test, early desaturators if the time until desaturation was < 1 min, 
      and non-early desaturators if it was longer than 1 min. The average length of 
      follow-up per patient was 5.6 years. RESULTS: Of the 319 patients analyzed, 126 
      non-desaturators, 91 non-early desaturators and 102 early desaturators were 
      identified. The mortality analysis showed that early desaturators had a mortality 
      of 73%, while it was 38% for non-early desaturators and 28% for non-desaturators, 
      with a survival of 5.9 years compared to 7.5 years and 9.6 years, respectively 
      (hazard ratio of 3.50; 95% CI 2.3-5.3; p < 0.0001). CONCLUSIONS: The early 
      desaturation seen in patients with chronic obstructive pulmonary disease is 
      associated with greater mortality and is likely responsible for the poor 
      prognosis shown globally in patients who desaturate. The survival of patients 
      with early desaturation is almost 4 years less with respect to non-desaturators, 
      and they, thus, require closer observation.
CI  - © 2023. The Author(s), under exclusive licence to Springer Science+Business 
      Media, LLC, part of Springer Nature.
FAU - García-Talavera, Ignacio
AU  - García-Talavera I
AUID- ORCID: 0000-0001-5389-742X
AD  - Respiratory Department, Research Unit, University Hospital Nuestra Señora de 
      Candelaria, Tenerife, Spain. igarmark@gmail.com.
FAU - Figueira-Gonçalves, Juan Marco
AU  - Figueira-Gonçalves JM
AUID- ORCID: 0000-0002-1564-1172
AD  - Respiratory Department, Research Unit, University Hospital Nuestra Señora de 
      Candelaria, Tenerife, Spain.
AD  - Canary Tropical Disease and Public Health Institute. La Laguna University, La 
      Laguna, Spain.
FAU - Golpe, Rafael
AU  - Golpe R
AUID- ORCID: 0000-0002-3759-5322
AD  - Respiratory Department, University Hospital Lucas Augusti, Lugo, Spain.
FAU - Esteban, Cristobal
AU  - Esteban C
AUID- ORCID: 0000-0001-9878-7806
AD  - Respiratory Department, University Hospital Galdakao, Galdakao, Bizkaia, Spain.
AD  - BioCruces-Bizkaia Health Research Institute, Baracaldo, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC). Red de 
      Investigación en Cronicidad, Atención Primaria Y Promoción de La Salud (RICAPPS), 
      Marbella, Spain.
FAU - Amado, Carlos
AU  - Amado C
AUID- ORCID: 0000-0002-5598-1753
AD  - Respiratory Deptartment, University Hospital Marqués de Valdecilla, Santander, 
      Cantabria, Spain.
FAU - Pérez-Méndez, Lina I
AU  - Pérez-Méndez LI
AUID- ORCID: 0000-0001-8246-333X
AD  - Department of Clinical Epidemiology and Biostatistics, Research Unit, University 
      Hospital Nuestra Señora de Candelaria Tenerife and Primary Care Management, Santa 
      Cruz de Tenerife, Spain.
AD  - Networked Biomedical Research Centre (CIBER) of Respiratory Diseases, Carlos III 
      Health Institute, Madrid, Spain.
FAU - Aramburu, Amaia
AU  - Aramburu A
AD  - Respiratory Department, University Hospital Galdakao, Galdakao, Bizkaia, Spain.
FAU - Conde-Martel, Alicia
AU  - Conde-Martel A
AUID- ORCID: 0000-0002-2540-3880
AD  - Internal Medicine Department, University Hospital Dr Negrín, Las Palmas de Gran 
      Canaria, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230410
PL  - United States
TA  - Lung
JT  - Lung
JID - 7701875
RN  - S88TT14065 (Oxygen)
SB  - IM
MH  - Humans
MH  - Walk Test
MH  - *Oxygen
MH  - *Pulmonary Disease, Chronic Obstructive/diagnosis
MH  - Walking
MH  - Exercise Test/methods
OTO - NOTNLM
OT  - COPD
OT  - Early desaturation
OT  - Exercise desaturation
OT  - Mortality
EDAT- 2023/04/11 06:00
MHDA- 2023/04/21 06:41
CRDT- 2023/04/10 11:15
PHST- 2023/01/02 00:00 [received]
PHST- 2023/03/15 00:00 [accepted]
PHST- 2023/04/21 06:41 [medline]
PHST- 2023/04/11 06:00 [pubmed]
PHST- 2023/04/10 11:15 [entrez]
AID - 10.1007/s00408-023-00613-x [pii]
AID - 10.1007/s00408-023-00613-x [doi]
PST - ppublish
SO  - Lung. 2023 Apr;201(2):217-224. doi: 10.1007/s00408-023-00613-x. Epub 2023 Apr 10.

PMID- 37028280
OWN - NLM
STAT- MEDLINE
DCOM- 20230414
LR  - 20230522
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Print)
IS  - 0213-9111 (Linking)
VI  - 37
DP  - 2023
TI  - [Influence of the social deprivation index on outcomes during the COVID-19 
      pandemic].
PG  - 102301
LID - S0213-9111(23)00015-8 [pii]
LID - 10.1016/j.gaceta.2023.102301 [doi]
AB  - OBJECTIVE: To see the relationship between the population deprivation index and 
      the use of the health services, adverse evolution and mortality during the 
      COVID-19 pandemic. METHOD: Retrospective cohort study of patients with SARS-CoV-2 
      infection from March 1, 2020 to January 9, 2022. The data collected included 
      sociodemographic data, comorbidities and prescribed baseline treatments, other 
      baseline data and the deprivation index, estimated by census section. 
      Multivariable multilevel logistic regression models were performed for each 
      outcome variable: death, poor outcome (defined as death or intensive care unit), 
      hospital admission, and emergency room visits. RESULTS: The cohort consists of 
      371,237 people with SARS-CoV-2 infection. In the multivariable models, a higher 
      risk of death or poor evolution or hospital admission or emergency room visit was 
      observed within the quintiles with the greatest deprivation compared to the 
      quintile with the least. For the risk of being hospitalized or going to the 
      emergency room, there were differences between most quintiles. It has also been 
      observed that these differences occurred in the first and third periods of the 
      pandemic for mortality and poor outcome, and in all due for the risk of being 
      admitted or going to the emergency room. CONCLUSIONS: The groups with the highest 
      level of deprivation have had worse outcomes compared to the groups with lower 
      deprivation rates. It is necessary to carry out interventions that minimize these 
      inequalities.
CI  - Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Portuondo-Jiménez, Janire
AU  - Portuondo-Jiménez J
AD  - Osakidetza Servicio Vasco de Salud, Subdirección de Coordinación de Atención 
      Primaria, Vitoria-Gasteiz, España; Instituto de Investigación Sanitaria Biocruces 
      Bizkaia, Grupo de Investigación en Ciencias de la Diseminación e Implementación 
      en Servicios de Salud, Barakaldo, Bizkaia, España; Red de Investigación en 
      Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), España. 
      Electronic address: janire.portuondojimenez@osakidetza.eus.
FAU - Gascón, María
AU  - Gascón M
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Osakidetza Servicio Vasco de Salud, Hospital Universitario 
      Galdakao-Usansolo, Unidad de Investigación, Galdakao, Bizkaia, España; Red de 
      Investigación de Servicios de Salud en Enfermedades Crónicas (REDISSEC), España; 
      Instituto Kronikgune de Investigación en Servicios Sanitarios, Barakaldo, 
      Bizkaia, España.
FAU - García, Julia
AU  - García J
AD  - Departamento de Salud del Gobierno Vasco, Oficina de Planificación, Organización 
      y Evaluación Sanitaria, País Vasco, España.
FAU - Legarreta, María-José
AU  - Legarreta MJ
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Osakidetza Servicio Vasco de Salud, Hospital Universitario 
      Galdakao-Usansolo, Unidad de Investigación, Galdakao, Bizkaia, España; Red de 
      Investigación de Servicios de Salud en Enfermedades Crónicas (REDISSEC), España; 
      Instituto Kronikgune de Investigación en Servicios Sanitarios, Barakaldo, 
      Bizkaia, España.
FAU - Villanueva, Ane
AU  - Villanueva A
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Osakidetza Servicio Vasco de Salud, Hospital Universitario 
      Galdakao-Usansolo, Unidad de Investigación, Galdakao, Bizkaia, España; Red de 
      Investigación de Servicios de Salud en Enfermedades Crónicas (REDISSEC), España; 
      Instituto Kronikgune de Investigación en Servicios Sanitarios, Barakaldo, 
      Bizkaia, España.
FAU - Larrea, Nere
AU  - Larrea N
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Osakidetza Servicio Vasco de Salud, Hospital Universitario 
      Galdakao-Usansolo, Unidad de Investigación, Galdakao, Bizkaia, España; Red de 
      Investigación de Servicios de Salud en Enfermedades Crónicas (REDISSEC), España; 
      Instituto Kronikgune de Investigación en Servicios Sanitarios, Barakaldo, 
      Bizkaia, España.
FAU - García-Gutiérrez, Susana
AU  - García-Gutiérrez S
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Osakidetza Servicio Vasco de Salud, Hospital Universitario 
      Galdakao-Usansolo, Unidad de Investigación, Galdakao, Bizkaia, España; Red de 
      Investigación de Servicios de Salud en Enfermedades Crónicas (REDISSEC), España; 
      Instituto Kronikgune de Investigación en Servicios Sanitarios, Barakaldo, 
      Bizkaia, España.
FAU - Munitiz, Endika
AU  - Munitiz E
AD  - Instituto de Investigación Sanitaria Biocruces Bizkaia, Grupo de Investigación en 
      Ciencias de la Diseminación e Implementación en Servicios de Salud, Barakaldo, 
      Bizkaia, España.
FAU - Quintana, José M
AU  - Quintana JM
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Osakidetza Servicio Vasco de Salud, Hospital Universitario 
      Galdakao-Usansolo, Unidad de Investigación, Galdakao, Bizkaia, España; Red de 
      Investigación de Servicios de Salud en Enfermedades Crónicas (REDISSEC), España; 
      Instituto Kronikgune de Investigación en Servicios Sanitarios, Barakaldo, 
      Bizkaia, España.
CN  - COVID-Health Basque Country Research Group
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Influencia del índice de privación social en resultados durante la pandemia de 
      COVID-19.
DEP - 20230405
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Humans
MH  - *COVID-19/epidemiology
MH  - Pandemics
MH  - SARS-CoV-2
MH  - Retrospective Studies
MH  - Social Deprivation
PMC - PMC10075210
OTO - NOTNLM
OT  - COVID-19
OT  - Derecho a la salud
OT  - Determinantes sociales de la salud
OT  - Evaluación de resultados
OT  - Outcome assessment
OT  - Right to health
OT  - SARS-CoV-2
OT  - Social determinants of health
EDAT- 2023/04/08 06:00
MHDA- 2023/04/14 06:41
CRDT- 2023/04/07 18:14
PHST- 2022/10/24 00:00 [received]
PHST- 2023/02/17 00:00 [revised]
PHST- 2023/02/17 00:00 [accepted]
PHST- 2023/04/14 06:41 [medline]
PHST- 2023/04/07 18:14 [entrez]
PHST- 2023/04/08 06:00 [pubmed]
AID - S0213-9111(23)00015-8 [pii]
AID - 102301 [pii]
AID - 10.1016/j.gaceta.2023.102301 [doi]
PST - epublish
SO  - Gac Sanit. 2023 Apr 5;37:102301. doi: 10.1016/j.gaceta.2023.102301. eCollection 
      2023.

PMID- 37023870
OWN - NLM
STAT- MEDLINE
DCOM- 20230501
LR  - 20230503
IS  - 1532-3064 (Electronic)
IS  - 0954-6111 (Linking)
VI  - 212
DP  - 2023 Jun
TI  - Change in physical activity related to admission for exacerbation in COPD 
      patients.
PG  - 107236
LID - S0954-6111(23)00124-5 [pii]
LID - 10.1016/j.rmed.2023.107236 [doi]
AB  - INTRODUCTION: The aim of this study was to determine the impact of 
      hospitalizations on levels of physical activity (PA) and whether other factors 
      were associated with subsequent changes in PA. METHODS: Prospective observational 
      cohort study with a nested case-control study, with follow-up 60 days from the 
      index hospital admission. Nine hospitals participated in the study. Patients were 
      recruited consecutively. Several variables and questionnaires of the clinical 
      baseline status of the patients were recorded including: the COPD Assessment Test 
      (CAT), the Hospital Anxiety-Depression scale (HADS), comorbidities and the Yale 
      Physical Activity Survey. Patients' data related to admission and up to two 
      months after discharge were also recorded. RESULTS: 883 patients were studied: 
      79.7% male; FEV1 48%; Charlson index 2; 28.7% active smokers. The baseline PA 
      level for the total sample was 23 points. A statistically significant difference 
      in PA was found between patients readmitted up to 2 months after the index 
      admission and those not readmitted (17vs. 27, p < 0.0001). Multivariable linear 
      regression analysis identified the following as predictors of the decrease of PA 
      from baseline (index admission) up to 2 months follow-up: admission for COPD 
      exacerbation in the two months prior to the index admission; readmission up to 2 
      months after the index admission; baseline HAD depressive symptoms, worse CAT 
      score, and patient-reported "need for help". CONCLUSIONS: In a cohort of admitted 
      COPD patients, we identified a strong relationship between hospitalization for 
      exacerbation and PA. In addition, some other potentially modifiable factors were 
      found associated with the change in PA level after an admission.
CI  - Copyright © 2023. Published by Elsevier Ltd.
FAU - Esteban, Cristóbal
AU  - Esteban C
AD  - Servicio de Respiratorio, Hospital Galdakao, Galdakao, Bizkaia, Spain; 
      BioCruces-Bizkaia Health Research Institute, Baracaldo, Spain; Health Services 
      Research on Chronic Patients Network (REDISSEC), Spain; Red de Investigación en 
      Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Spain. 
      Electronic address: cristobal.est@gmail.com.
FAU - Antón-Ladislao, Ane
AU  - Antón-Ladislao A
AD  - Unidad de Investigación, Hospital Galdakao, Galdakao, Bizkaia, Spain; Health 
      Services Research on Chronic Patients Network (REDISSEC), Spain.
FAU - Aramburu, Amaia
AU  - Aramburu A
AD  - Servicio de Respiratorio, Hospital Galdakao, Galdakao, Bizkaia, Spain; 
      BioCruces-Bizkaia Health Research Institute, Baracaldo, Spain.
FAU - Chasco, Leyre
AU  - Chasco L
AD  - Servicio de Respiratorio, Hospital Galdakao, Galdakao, Bizkaia, Spain; 
      BioCruces-Bizkaia Health Research Institute, Baracaldo, Spain.
FAU - Orive, Miren
AU  - Orive M
AD  - Departamento de Psicología Social, Facultad de Farmacia, UPV/EHU, 
      Vitoria-Gasteiz, Spain; Health Services Research on Chronic Patients Network 
      (REDISSEC), Spain; Red de Investigación en Cronicidad, Atención Primaria y 
      Promoción de la Salud (RICAPPS), Spain.
FAU - Tabernero, Eva
AU  - Tabernero E
AD  - Servicio de Respiratorio, Hospital Cruces, Barakaldo, Spain; BioCruces-Bizkaia 
      Health Research Institute, Baracaldo, Spain.
FAU - Rayón, Monica
AU  - Rayón M
AD  - Servicio de Respiratorio, Hospital de Donostia, Donostia, Spain.
FAU - Cebrián, José Joaquín
AU  - Cebrián JJ
AD  - Unidad de Evaluación, Hospital Costa del Sol, Marbella, Málaga, Spain; Health 
      Services Research on Chronic Patients Network (REDISSEC), Spain; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      Spain.
FAU - Terán, José
AU  - Terán J
AD  - Servicio de Respiratorio, Hospital Gregorio Marañón, Instituto de Investigación 
      Sanitaria Gregorio Marañón (IISGM), Madrid, Spain; Health Services Research on 
      Chronic Patients Network (REDISSEC), Spain; Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), Spain.
FAU - García-Talavera, Ignacio
AU  - García-Talavera I
AD  - Servicio de Respiratorio, Hospital Nuestra Señora de la Candelaria, Santa Cruz de 
      Tenerife, Spain; Health Services Research on Chronic Patients Network (REDISSEC), 
      Spain; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud (RICAPPS), Spain.
FAU - Quintana, José M
AU  - Quintana JM
AD  - Unidad de Investigación, Hospital Galdakao, Galdakao, Bizkaia, Spain; Health 
      Services Research on Chronic Patients Network (REDISSEC), Spain; Kronikgune 
      Research Institute, Baracaldo, Spain; Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), Spain.
CN  - ReEPOC-REDISSEC group
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20230405
PL  - England
TA  - Respir Med
JT  - Respiratory medicine
JID - 8908438
RN  - Pulmonary Disease, Chronic Obstructive, Severe Early-Onset
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - Prospective Studies
MH  - Case-Control Studies
MH  - Hospitalization
MH  - *Pulmonary Disease, Chronic Obstructive/complications
MH  - *Asthma/complications
MH  - Exercise
MH  - Disease Progression
OTO - NOTNLM
OT  - COPD
OT  - Exacerbation
OT  - Physical activity
COIS- Declaration of competing interest The study protocol was approved by the Basque 
      Ethics Committee (reference PI2015124). Ninguno de los autores de este original 
      presenta conflicto de interés alguno (directo o indirecto) en relación al mismo.
FIR - Esteban, Cristóbal
IR  - Esteban C
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Aramburu, Amaia
IR  - Aramburu A
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Aburto, Myriam
IR  - Aburto M
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Villanueva, Ane
IR  - Villanueva A
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Anton, Ane
IR  - Anton A
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Orive, Miren
IR  - Orive M
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Quintana, Jose M
IR  - Quintana JM
IRAD- Hospital Universitario de Galdakao-Usansolo, Spain.
FIR - Iriberri, Milagros
IR  - Iriberri M
IRAD- Hospital Universitario de Cruces, Spain.
FIR - Tabernero, Eva
IR  - Tabernero E
IRAD- Hospital Universitario de Cruces, Spain.
FIR - Sobradillo, Patricia
IR  - Sobradillo P
IRAD- Hospital Universitario de Araba, Spain.
FIR - Rayón, Monica
IR  - Rayón M
IRAD- Hospital Universitario de Donostia, Spain.
FIR - Sánchez, Raquel
IR  - Sánchez R
IRAD- Hospital Universitario de Basurto, Spain.
FIR - Roldan, Lorena López
IR  - Roldan LL
IRAD- Hospital de Santa Marina, Spain.
FIR - Cebrián, José Joaquín
IR  - Cebrián JJ
IRAD- Hospital Costa del Sol, Spain.
FIR - Jiménez-Puente, Alberto
IR  - Jiménez-Puente A
IRAD- Hospital Costa del Sol, Spain.
FIR - Padilla, María
IR  - Padilla M
IRAD- Hospital Costa del Sol, Spain.
FIR - de-Miguel-Díez, Javier
IR  - de-Miguel-Díez J
IRAD- Hospital General Universitario Gregorio Marañón, Spain.
FIR - Terán, José
IR  - Terán J
IRAD- Hospital General Universitario Gregorio Marañón, Spain.
FIR - García-Talavera, Ignacio
IR  - García-Talavera I
IRAD- Hospital Universitario Nuestra Señora de la Candelaria, Spain.
EDAT- 2023/04/07 06:00
MHDA- 2023/05/01 06:42
CRDT- 2023/04/06 19:24
PHST- 2022/11/26 00:00 [received]
PHST- 2023/03/21 00:00 [revised]
PHST- 2023/03/30 00:00 [accepted]
PHST- 2023/05/01 06:42 [medline]
PHST- 2023/04/07 06:00 [pubmed]
PHST- 2023/04/06 19:24 [entrez]
AID - S0954-6111(23)00124-5 [pii]
AID - 10.1016/j.rmed.2023.107236 [doi]
PST - ppublish
SO  - Respir Med. 2023 Jun;212:107236. doi: 10.1016/j.rmed.2023.107236. Epub 2023 Apr 
      5.

PMID- 37022296
OWN - NLM
STAT- MEDLINE
DCOM- 20230620
LR  - 20230620
IS  - 1530-0374 (Electronic)
IS  - 1072-3714 (Linking)
VI  - 30
IP  - 6
DP  - 2023 Jun 1
TI  - Quality of life in Spanish postmenopausal breast cancer patients with localized 
      disease who finish endocrine treatment: a prospective study.
PG  - 613-620
LID - 10.1097/GME.0000000000002178 [doi]
AB  - OBJECTIVE: In this article, the quality of life (QOL) of Spanish postmenopausal 
      early-stage breast cancer patients who have finished endocrine therapy (ET), QOL 
      changes after endocrine therapy cessation, and the differences between two 
      endocrine therapy modalities (tamoxifen or aromatase inhibitor [AI]) are studied. 
      More QOL information after endocrine therapy cessation is needed. METHODS: A 
      prospective cohort study was performed. Participating in the study were 158 
      postmenopausal patients who had received tamoxifen or AI for 5 years. In some 
      cases, endocrine therapy may have changed during those 5 years.Patients completed 
      the European Organisation for Research and Treatment of Cancer QLQ-C30 and 
      QLQ-BR45 questionnaires at baseline, after 6 months, and after 1 year of 
      follow-up. Patients older than 65 years also completed the QLQ-ELD14. Linear 
      mixed-effect models were used to evaluate longitudinal changes in QOL and 
      differences in QOL between endocrine therapy modalities. RESULTS: QOL scores for 
      the whole sample throughout follow-up were high (>80/100 points) in most QOL 
      areas. Moderate limitations (>30 points) occurred in the QLQ-BR45 in sexual 
      functioning and sexual enjoyment, future perspective, and joint symptoms. 
      Moderate limitations also occurred in the QLQ-ELD14 in worries about others, 
      maintaining purpose, joint stiffness, future worries, and family support. In 
      those who had finished endocrine therapy, pain was reduced in all three 
      assessments conducted during the 1-year follow-up period in both groups. 
      Tamoxifen patients showed better QOL in functioning (role functioning, global 
      QOL, financial impact), symptoms (pain), and emotional areas (future perspective 
      and worries about others) than AI patients but worse QOL in skin mucosis 
      symptoms. CONCLUSIONS: The results of this study show that postmenopausal 
      early-stage breast cancer patients adapted well to their disease and endocrine 
      therapy treatment. QOL improvements in the 1-year follow-up period appeared in 
      one key area: pain. Differences between endocrine therapy modalities suggested 
      QOL was better in the tamoxifen group than in the AI group.
CI  - Copyright © 2023 by The North American Menopause Society.
FAU - Arraras, Juan Ignacio
AU  - Arraras JI
AUID- ORCID: 0000-0002-4415-2570
FAU - Illarramendi, Jose Juan
AU  - Illarramendi JJ
AD  - From the Medical Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Manterola, Ana
AU  - Manterola A
AD  - Radiotherapeutic Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - de la Cruz, Susana
AU  - de la Cruz S
AD  - From the Medical Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Zarandona, Uxue
AU  - Zarandona U
FAU - Ibañez, Berta
AU  - Ibañez B
AD  - Navarrabiomed, RICAPPS, Unidad de Metodología, Pamplona, Spain.
FAU - Salgado, Esteban
AU  - Salgado E
AD  - From the Medical Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Visus, Ignacio
AU  - Visus I
AD  - Radiotherapeutic Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Barrado, Marta
AU  - Barrado M
AD  - Radiotherapeutic Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Teiejira, Lucia
AU  - Teiejira L
AD  - From the Medical Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Martinez, María Isabel
AU  - Martinez MI
AD  - Radiotherapeutic Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Martinez, Enrique
AU  - Martinez E
AD  - Radiotherapeutic Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
FAU - Vera, Ruth
AU  - Vera R
AD  - From the Medical Oncology Department, Hospital Universitario de Navarra, 
      Pamplona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230404
PL  - United States
TA  - Menopause
JT  - Menopause (New York, N.Y.)
JID - 9433353
RN  - 094ZI81Y45 (Tamoxifen)
SB  - IM
MH  - Female
MH  - Humans
MH  - *Breast Neoplasms/therapy
MH  - Pain
MH  - Postmenopause
MH  - Prospective Studies
MH  - Quality of Life
MH  - Surveys and Questionnaires
MH  - *Tamoxifen/therapeutic use
COIS- Financial disclosure/conflicts of interest: J.J.I. receives funding from Pfizer 
      and Novartis. The other authors have nothing to disclose.
EDAT- 2023/04/07 06:00
MHDA- 2023/06/01 06:42
CRDT- 2023/04/06 10:33
PHST- 2023/06/01 06:42 [medline]
PHST- 2023/04/07 06:00 [pubmed]
PHST- 2023/04/06 10:33 [entrez]
AID - 00042192-990000000-00174 [pii]
AID - 10.1097/GME.0000000000002178 [doi]
PST - ppublish
SO  - Menopause. 2023 Jun 1;30(6):613-620. doi: 10.1097/GME.0000000000002178. Epub 2023 
      Apr 4.

PMID- 37006532
OWN - NLM
STAT- MEDLINE
DCOM- 20230404
LR  - 20230410
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 11
DP  - 2023
TI  - COVID-19 vaccine hesitancy in Spain and associated factors.
PG  - 1129079
LID - 10.3389/fpubh.2023.1129079 [doi]
LID - 1129079
AB  - INTRODUCTION: The present study explores the reasons of those who have not been 
      vaccinated in the later stage of the vaccine rollout in Spain and its associated 
      determinants. METHODS: Cluster and logistic regression analyses were used to 
      assess differences in claimed reasons for vaccine hesitancy in Spain using two 
      samples of unvaccinated people (18-40 years old) gathered by an online 
      cross-sectional survey from social networks (n = 910) and from a representative 
      panel (n = 963) in October-November 2021. RESULTS: The main reasons for not being 
      vaccinated were believing that the COVID-19 vaccines had been developed too fast, 
      they were experimental, and they were not safe, endorsed by 68.7% participants in 
      the social network sample and 55.4% in the panel sample. The cluster analysis 
      classified the participants into two groups. Logistic regression showed that 
      Cluster 2 (individuals who reported structural constraints and health-related 
      reasons such as pregnancy or medical recommendation) presented a lower trust in 
      information from health professionals, had a lower willingness to get vaccinated 
      in the future, and avoided less social/family events than those in Cluster 1 
      (reasons centered in distrust on COVID-19 vaccines, conspiracy thoughts and 
      complacency). CONCLUSIONS: It is important to promote information campaigns that 
      provide reliable information and fight fake news and myths. Future vaccination 
      intention differs in both clusters, so these results are important for developing 
      strategies target to increase vaccination uptake for those who do not reject the 
      COVID-19 vaccine completely.
CI  - Copyright © 2023 Falcon, Rodríguez-Blázquez, Romay-Barja, Ayala, Burgos, De 
      Tena-Dávila and Forjaz.
FAU - Falcon, Maria
AU  - Falcon M
AD  - Legal Medicine Department, Biomedical Research Institute (IMIB), University of 
      Murcia, Murcia, Spain.
FAU - Rodríguez-Blázquez, Carmen
AU  - Rodríguez-Blázquez C
AD  - National Epidemiology Center, Instituto de Salud Carlos III, Madrid, Spain.
FAU - Romay-Barja, María
AU  - Romay-Barja M
AD  - National Center of Tropical Diseases, Instituto de Salud Carlos III, Madrid, 
      Spain.
AD  - Centro de Investigación Biomédica en Red de Enfermedades Infecciosas 
      (CIBERINFEC), Madrid, Spain.
FAU - Ayala, Alba
AU  - Ayala A
AD  - University Institute on Gender Studies, University Carlos III, Getafe, Spain.
AD  - Research Network on Chronic Diseases, Primary Care, and Health Promotion 
      (RICAPPS), Madrid, Spain.
FAU - Burgos, Alfredo
AU  - Burgos A
AD  - Digital Health Research Unit, Instituto de Salud Carlos III, Madrid, Spain.
FAU - De Tena-Dávila, María José
AU  - De Tena-Dávila MJ
AD  - Digital Health Research Unit, Instituto de Salud Carlos III, Madrid, Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AD  - National Epidemiology Center, Instituto de Salud Carlos III, Madrid, Spain.
AD  - Research Network on Chronic Diseases, Primary Care, and Health Promotion 
      (RICAPPS), Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230316
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
RN  - 0 (COVID-19 Vaccines)
SB  - IM
MH  - Female
MH  - Pregnancy
MH  - Humans
MH  - Adolescent
MH  - Young Adult
MH  - Adult
MH  - *COVID-19 Vaccines
MH  - Spain
MH  - Cross-Sectional Studies
MH  - *COVID-19/prevention & control
MH  - Cluster Analysis
PMC - PMC10061089
OTO - NOTNLM
OT  - COVID-19
OT  - behavioral insights
OT  - hesitancy
OT  - public health
OT  - vaccine
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/04/04 06:00
MHDA- 2023/04/04 06:42
CRDT- 2023/04/03 03:48
PHST- 2022/12/21 00:00 [received]
PHST- 2023/02/21 00:00 [accepted]
PHST- 2023/04/04 06:42 [medline]
PHST- 2023/04/03 03:48 [entrez]
PHST- 2023/04/04 06:00 [pubmed]
AID - 10.3389/fpubh.2023.1129079 [doi]
PST - epublish
SO  - Front Public Health. 2023 Mar 16;11:1129079. doi: 10.3389/fpubh.2023.1129079. 
      eCollection 2023.

PMID- 37001470
OWN - NLM
STAT- Publisher
LR  - 20230403
IS  - 1578-8865 (Electronic)
IS  - 1138-3593 (Print)
IS  - 1138-3593 (Linking)
VI  - 49
IP  - 5
DP  - 2023 Feb 24
TI  - [Attacks on personnel assigned to the Primary Care Management of Tenerife and the 
      SARS-CoV2 pandemic].
PG  - 101951
LID - S1138-3593(23)00030-8 [pii]
LID - 10.1016/j.semerg.2023.101951 [doi]
AB  - OBJECTIVE: To measure and characterize the aggressions suffered by health 
      professionals in the field of primary care in Tenerife between 2018-2019 
      (pre-pandemic) and 2020-2021 (pandemic). Secondly, to analyze the degree of 
      knowledge of the professionals in relation to the procedure for action against 
      aggressions as well as the existing security measures and aspects that could be 
      improved for their protection. MATERIALS AND METHODS: Observational, descriptive 
      and cross-sectional study using a self-completed form electronically. It was 
      disseminated through the different communication channels with health 
      professionals, being available between March and April 2022. The quantitative 
      variables were analyzed using measures of central tendency and dispersion, and 
      the qualitative variables in percentage, also performing a bivariate analysis 
      using the Chi square and Student's T. RESULTS: 72.50% of the participants have 
      suffered some type of aggression in the workplace and they are more frequent 
      causes in the metropolitan area of Tenerife, which are produced fundamentally by 
      the patient and their relatives. These aggressions are mostly verbal and occur in 
      greater quantity towards women with the category of nurse. CONCLUSIONS: Nursing 
      is the category that suffers the most aggressions in primary care in Tenerife, 
      regardless of the area of the island where they carry out their work.
CI  - Copyright © 2023 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). 
      Publicado por Elsevier España, S.L.U. All rights reserved.
FAU - Hernández Hernández, Pablo
AU  - Hernández Hernández P
AD  - Medicina familiar, Centro de Salud Dr. Guigou, Santa Cruz de Tenerife, España. 
      Electronic address: phdezhdez@gmail.com.
FAU - de León Buriel, María Esther
AU  - de León Buriel ME
AD  - Enfermería, Centro de Salud Barrio de la Salud, Santa Cruz de Tenerife, España.
FAU - Mahtani Chugani, Vinita
AU  - Mahtani Chugani V
AD  - Unidad de Investigación del Hospital Universitario Nuestra Señora de la 
      Candelaria. Gerencia de Atención Primaria de Tenerife. Red de Investigación en 
      Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS) España, Santa 
      Cruz de Tenerife, España.
FAU - Rufino Delgado, María de la Trinidad
AU  - Rufino Delgado MT
AD  - Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Tenerife Zona 
      I, Santa Cruz de Tenerife, España.
FAU - Santos González, Nayra
AU  - Santos González N
AD  - Unidad de Prevención de Riesgos Laborales de la Gerencia de Atención Primaria de 
      Tenerife, Santa Cruz de Tenerife, España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Agresiones a personal adscrito a la Gerencia de Atención Primaria de Tenerife y 
      pandemia por SARS-CoV2.
DEP - 20230224
PL  - Spain
TA  - Semergen
JT  - Semergen
JID - 9610769
SB  - IM
PMC - PMC9951044
OTO - NOTNLM
OT  - Agresiones
OT  - Assaults
OT  - Atención primaria
OT  - Health personnel
OT  - Personal sanitario
OT  - Primary health care
OT  - Violencia laboral
OT  - Workplace violence
EDAT- 2023/04/01 06:00
MHDA- 2023/04/01 06:00
CRDT- 2023/03/31 18:11
PHST- 2022/12/26 00:00 [received]
PHST- 2023/02/12 00:00 [revised]
PHST- 2023/02/17 00:00 [accepted]
PHST- 2023/03/31 18:11 [entrez]
PHST- 2023/04/01 06:00 [pubmed]
PHST- 2023/04/01 06:00 [medline]
AID - S1138-3593(23)00030-8 [pii]
AID - 101951 [pii]
AID - 10.1016/j.semerg.2023.101951 [doi]
PST - aheadofprint
SO  - Semergen. 2023 Feb 24;49(5):101951. doi: 10.1016/j.semerg.2023.101951.

PMID- 37001428
OWN - NLM
STAT- MEDLINE
DCOM- 20230411
LR  - 20230424
IS  - 1873-7714 (Electronic)
IS  - 0163-8343 (Linking)
VI  - 82
DP  - 2023 May-Jun
TI  - A multiple health behaviour change intervention to prevent depression: A 
      randomized controlled trial.
PG  - 86-94
LID - S0163-8343(23)00025-7 [pii]
LID - 10.1016/j.genhosppsych.2023.02.004 [doi]
AB  - OBJECTIVE: To examine the effectiveness of a 12-month MHBC intervention in the 
      prevention of onset depression in primary health care (PHC). METHODS: Twenty-two 
      PHC centres took part in the cluster-randomized controlled trial. Patients were 
      randomized to receive either usual care or an MHBC intervention. The endpoints 
      were onset of major depression and reduction of depressive symptoms in 
      participants without baseline depression at a 12-month follow-up. RESULTS: 2531 
      patients agreed and were eligible to participate. At baseline, around 43% were 
      smokers, 82% were non-adherent to the Mediterranean diet and 55% did not perform 
      enough physical activity. The intervention group exhibited a greater positive 
      change in two or more behaviours (OR 1.75 [95%CI: 1.17 to 2.62]; p = 0.006); any 
      behaviour (OR 1.58 [95%CI: 1.13 to 2.20]; p = 0.007); and adherence to the 
      Mediterranean diet (OR 1.94 [95%CI: 1.29 to 2.94]; p = 0.002), while this 
      increase was not statistically significant for smoking and physical activity. The 
      intervention was not effective in preventing major depression (OR 1.17; [95% CI 
      0.53 to 2.59)]; p = 0.690) or reducing depressive symptoms (Mean difference: 
      0.30; [95% CI -0.77 to 1.36]; p = 0.726) during follow-up. CONCLUSIONS: As 
      compared to usual care, the MHBC intervention provided a non-significant 
      reduction in the incidence of major depression. TRIAL REGISTRATION: 
      ClinicalTrials.gov, NCT03136211.
CI  - Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
FAU - Gómez-Gómez, Irene
AU  - Gómez-Gómez I
AD  - Department of Psychology, Universidad Loyola Andalucía, Seville, Spain; Network 
      for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Spain.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Department of Psychology, Universidad Loyola Andalucía, Seville, Spain; Network 
      for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Spain; 
      Prevention and Health Promotion Research Network (redIAPP), Spain. Electronic 
      address: emotrico@uloyola.es.
FAU - Moreno-Peral, Patricia
AU  - Moreno-Peral P
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Biomedical Research Institute of Málaga (IBIMA-Bionand platform), Malaga, Spain.
FAU - Casajuana-Closas, Marc
AU  - Casajuana-Closas M
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; Universitat Autònoma de 
      Barcelona, Bellaterra, Spain.
FAU - López-Jiménez, Tomàs
AU  - López-Jiménez T
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; Universitat Autònoma de 
      Barcelona, Bellaterra, Spain.
FAU - Zabaleta-Del-Olmo, Edurne
AU  - Zabaleta-Del-Olmo E
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; Atenció Primària Barcelona 
      Ciutat, Gerència Territorial de Barcelona, Institut Català de la Salut, 
      Barcelona, Spain; Nursing department, Faculty of Nursing, Universitat de Girona, 
      Girona, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; I-Saúde 
      Group, South Galicia Health Research Institute, Vigo, Spain; Vigo Health Area, 
      SERGAS, Vigo, Spain.
FAU - LLobera, Joan
AU  - LLobera J
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; Primary 
      Care Research Unit of Mallorca, Balearic Islands Health Service (Ib-Salut), 
      Balearic Islands, Spain; Health Research Institute of the Balearic Islands 
      (IdISBa), Spain.
FAU - Martí-Lluch, Ruth
AU  - Martí-Lluch R
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Universitat Autònoma de Barcelona, Bellaterra, Spain; Unitat de suport a la 
      recerca de Girona, Fundació Institut Universitari per a la recerca a l'Atenció 
      Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Girona, Spain.; Group of 
      research in Vascular Health, Girona Biomedical Research Institute (IdibGi), Salt, 
      Spain.
FAU - Ramos, Rafel
AU  - Ramos R
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; Unitat 
      de suport a la recerca de Girona, Fundació Institut Universitari per a la recerca 
      a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Girona, Spain.; 
      Group of research in Vascular Health, Girona Biomedical Research Institute 
      (IdibGi), Salt, Spain; Department of Medical Sciences, School of Medicine, Campus 
      Salut, Universitat de Girona, Girona, Spain.
FAU - Maderuelo-Fernández, José-Ángel
AU  - Maderuelo-Fernández JÁ
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain; Unidad 
      de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain; Health Service of 
      Castilla y León (SACyL), Salamanca, Spain.
FAU - Vicens, Caterine
AU  - Vicens C
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; Primary 
      Care Research Unit of Mallorca, Balearic Islands Health Service (Ib-Salut), 
      Balearic Islands, Spain; Son Serra-La Vileta Health Care Centre, Balearic Health 
      Service (Ib-Salut) Palma, Illes Balears, Spain.
FAU - Domínguez-García, Marta
AU  - Domínguez-García M
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Calatayud Health Center, Aragonese Health Service, Zaragoza, Spain; GIIS011 
      Group, Aragón Health Research Institute, Zaragoza, Spain.
FAU - Bartolomé-Moreno, Cruz
AU  - Bartolomé-Moreno C
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; GIIS011 
      Group, Aragón Health Research Institute, Zaragoza, Spain.
FAU - Recio-Rodriguez, Jose I
AU  - Recio-Rodriguez JI
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, Spain.
FAU - Bellón, Juan Á
AU  - Bellón JÁ
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Prevention and Health Promotion Research Network (redIAPP), Spain; 
      Biomedical Research Institute of Málaga (IBIMA-Bionand platform), Malaga, Spain; 
      El Palo Health Centre, Andalusian Health Service (SAS), Málaga, Spain; Department 
      of Public Health and Psychiatry, University of Málaga (UMA), Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT03136211
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20230222
PL  - United States
TA  - Gen Hosp Psychiatry
JT  - General hospital psychiatry
JID - 7905527
SB  - IM
MH  - Humans
MH  - *Depression/prevention & control
MH  - Health Behavior
MH  - *Depressive Disorder, Major/prevention & control
MH  - Exercise
OTO - NOTNLM
OT  - Health behaviour
OT  - Major depressive disorders
OT  - Primary health care
OT  - Primary prevention
OT  - Randomized controlled trial
COIS- Declaration of Competing Interest The authors declare they have no conflicts of 
      interest.
EDAT- 2023/04/01 06:00
MHDA- 2023/04/11 06:42
CRDT- 2023/03/31 18:09
PHST- 2022/08/26 00:00 [received]
PHST- 2023/02/08 00:00 [revised]
PHST- 2023/02/19 00:00 [accepted]
PHST- 2023/04/11 06:42 [medline]
PHST- 2023/04/01 06:00 [pubmed]
PHST- 2023/03/31 18:09 [entrez]
AID - S0163-8343(23)00025-7 [pii]
AID - 10.1016/j.genhosppsych.2023.02.004 [doi]
PST - ppublish
SO  - Gen Hosp Psychiatry. 2023 May-Jun;82:86-94. doi: 
      10.1016/j.genhosppsych.2023.02.004. Epub 2023 Feb 22.

PMID- 36999663
OWN - NLM
STAT- MEDLINE
DCOM- 20230403
LR  - 20230403
IS  - 2173-9110 (Electronic)
IS  - 1135-5727 (Linking)
VI  - 97
DP  - 2023 Mar 29
TI  - [Scalp cooling for the prevention of chemotherapy-induced alopecia: systematic 
      review and meta-analysis.].
LID - e202303024 [pii]
AB  - OBJECTIVE: Alopecia is one of the most common adverse effects of chemotherapy, 
      having a significant impact on the quality of life of patients who suffer from 
      it. Among the interventions available for its prevention, scalp cooling (SC) is 
      the most widely used. The aim of this study was to assess the efficacy and safety 
      of the use of SC systems during chemotherapy sessions for the prevention or the 
      reduction of the extent of chemotherapy-induced alopecia. METHODS: A systematic 
      review of the literature published up to November 2021 was carried out. 
      Randomized clinical trials were selected. The main outcome measure was alopecia 
      (hair loss>50%) during and after chemotherapy treatment. When possible, a 
      quantitative synthesis of the results was performed through meta-analysis using 
      the Stata v.15.0 software. The risk ratio (RR) of the variable alopecia, was 
      estimated using a random effects model following the Mantel-Haenszel method. 
      Statistical heterogeneity of the results was evaluated graphically and through 
      the test of heterogeneity χ(2) and the Higgins I(2) statistic. Sensitivity 
      analyses and subgroup analyses were performed. RESULTS: 13 studies were included, 
      with a total of 832 participants (97.7% women). In most studies, the main 
      chemotherapy treatment applied was anthracyclines or the combination of 
      anthracyclines and taxanes. The results obtained indicate that SC prevents 
      alopecia (loss>50%) by 43% compared to the control group (RR=0.57; 95% CI=0.46 to 
      0.69; k=9; n=494; I(2)=63.8%). No statistically significant difference was found 
      between the efficacy of automated and non-automated cooling systems (P=0.967). No 
      serious short- or medium-term adverse events related to SC were recorded. 
      CONCLUSIONS: The results suggest that scalp cooling contributes to the prevention 
      of chemotherapy-induced alopecia.
FAU - Trujillo-Martín, María M
AU  - Trujillo-Martín MM
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC). 
      España.
AD  - Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna. Tenerife. 
      España.
FAU - de Armas-Castellano, Aythami
AU  - de Armas-Castellano A
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
FAU - González-Hernández, Yadira
AU  - González-Hernández Y
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
FAU - Infante-Ventura, Diego
AU  - Infante-Ventura D
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
FAU - Del Pino-Sedeño, Tasmania
AU  - Del Pino-Sedeño T
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC). 
      España.
AD  - Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna. Tenerife. 
      España.
FAU - Abt-Sack, Analía
AU  - Abt-Sack A
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC). 
      Tenerife. España.
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
FAU - Rueda Domínguez, Antonio
AU  - Rueda Domínguez A
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC). 
      España.
AD  - Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna. Tenerife. 
      España.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Red Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones 
      del Sistema Nacional de Salud (RedETS). España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS). España.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC). 
      España.
AD  - Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna. Tenerife. 
      España.
AD  - Servicio de Evaluación (SESCS) del Servicio Canario de la Salud (SCS). Tenerife. 
      España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PT  - Systematic Review
TT  - Enfriamiento del cuero cabelludo para la prevención de la alopecia secundaria a 
      quimioterapia: revisión sistemática y metanálisis.
DEP - 20230329
PL  - Spain
TA  - Rev Esp Salud Publica
JT  - Revista espanola de salud publica
JID - 9600212
RN  - 0 (Anthracyclines)
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Humans
MH  - Female
MH  - Male
MH  - Scalp
MH  - Quality of Life
MH  - Spain
MH  - Alopecia/chemically induced/prevention & control
MH  - Anthracyclines/adverse effects
MH  - *Antineoplastic Agents/adverse effects
MH  - *Breast Neoplasms
OTO - NOTNLM
OT  - Alopecia
OT  - Chemotherapy
OT  - Efficacy
OT  - Safety
OT  - Scalp cooling
OT  - Spain
OT  - Systematic review
EDAT- 2023/04/01 06:00
MHDA- 2023/04/03 06:42
CRDT- 2023/03/31 07:23
PHST- 2022/09/14 00:00 [received]
PHST- 2023/03/06 00:00 [accepted]
PHST- 2023/04/03 06:42 [medline]
PHST- 2023/03/31 07:23 [entrez]
PHST- 2023/04/01 06:00 [pubmed]
AID - e202303024 [pii]
PST - epublish
SO  - Rev Esp Salud Publica. 2023 Mar 29;97:e202303024.

PMID- 36991396
OWN - NLM
STAT- MEDLINE
DCOM- 20230331
LR  - 20230408
IS  - 1471-2318 (Electronic)
IS  - 1471-2318 (Linking)
VI  - 23
IP  - 1
DP  - 2023 Mar 29
TI  - Effect of including a dietary supplement of raisins, a food rich in polyphenols, 
      on cognitive function in healthy older adults; a study protocol for a randomized 
      clinical trial.
PG  - 182
LID - 10.1186/s12877-023-03882-6 [doi]
LID - 182
AB  - BACKGROUND: Polyphenols have been shown to be effective against many chronic 
      diseases, including neurodegenerative diseases. Specifically, the consumption of 
      raisins, being a food rich in polyphenols, has been attributed with 
      neuroprotective benefits. Therefore, our main objective is to evaluate the effect 
      of including 50 g of raisins in the diet daily for 6 months, on the improvement 
      of cognitive performance, cardiovascular risk factors and markers of inflammation 
      in a population of older adults without cognitive impairment. METHODS: Design and 
      intervention: This study will be a randomized controlled clinical trial of two 
      parallel groups. Each subject included in the study will be randomly assigned to 
      one of two study groups: control group (no supplement), intervention group (50 g 
      of raisins daily during 6 months). STUDY POPULATION: The participants will be 
      selected by consecutive sampling in the Primary Care consultations of urban 
      health centers in Salamanca and Zamora (Spain), taking into account the selection 
      criteria. STUDY VARIABLES: Two visits will be made, baseline and at 6 months. 
      Cognitive performance will be evaluated (Mini-Mental State Examination test, 
      Rey Auditory Verbal Learning Test, verbal fluency and montreal cognitive 
      assessment (Moca)). It will also be analyzed the level of physical activity, 
      quality of life, activities of daily living, energy and nutritional composition 
      of the diet, body composition, blood pressure, heart rate, markers of 
      inflammation and other laboratory tests of clinical relevance (glycaemia, total 
      cholesterol, HDL cholesterol, LDL cholesterol and triglycerides). In addition, 
      sociodemographic data, personal and family history, medication use and alcohol 
      and tobacco consumption will be collected. DISCUSSION: In this project, it is 
      intended to contribute to minimize the problems derived from cognitive 
      deterioration in older people. TRIAL REGISTRATION: ClincalTrials.gov Identifier: 
      NCT04966455 Registration date: July 1, 2021.
CI  - © 2023. The Author(s).
FAU - Rodrigo-Gonzalo, María J
AU  - Rodrigo-Gonzalo MJ
AD  - Grupo de Investigación de Polifenoles, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
FAU - Recio-Rodríguez, José I
AU  - Recio-Rodríguez JI
AUID- ORCID: 0000-0002-3772-8746
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain. donrecio@gmail.com.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS), 37007, Salamanca, Spain. 
      donrecio@gmail.com.
FAU - Méndez-Sánchez, Roberto
AU  - Méndez-Sánchez R
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, recuperación funcional y ejercicio terapéutico del, 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, 
      Spain.
FAU - Pablos-Hernández, María C
AU  - Pablos-Hernández MC
AD  - Hospital Universitario de Salamanca, Universidad de Salamanca, 37007, Salmanca, 
      Spain.
FAU - González-Ramírez, Alfonso
AU  - González-Ramírez A
AD  - Hospital Universitario de Salamanca, Universidad de Salamanca, 37007, Salmanca, 
      Spain.
FAU - González-Sánchez, Jesús
AU  - González-Sánchez J
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS), 37007, Salamanca, Spain.
FAU - Fermoso-Palmero, María J
AU  - Fermoso-Palmero MJ
AD  - Escuela de Enfermería de Zamora, Universidad de Salamanca, 49022, Zamora, Spain.
FAU - Puente-González, Ana S
AU  - Puente-González AS
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, recuperación funcional y ejercicio terapéutico del, 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, 
      Spain.
FAU - Sánchez-Sánchez, María C
AU  - Sánchez-Sánchez MC
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, recuperación funcional y ejercicio terapéutico del, 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, 
      Spain.
FAU - Barbero-Iglesias, Fausto J
AU  - Barbero-Iglesias FJ
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, recuperación funcional y ejercicio terapéutico del, 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, 
      Spain.
FAU - Rihuete-Galve, María I
AU  - Rihuete-Galve MI
AD  - Hospital Universitario de Salamanca, Universidad de Salamanca, 37007, Salmanca, 
      Spain.
FAU - González-Manzano, Susana
AU  - González-Manzano S
AD  - Grupo de Investigación de Polifenoles, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, 37007, 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, recuperación funcional y ejercicio terapéutico del, 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, 
      Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT04966455
PT  - Clinical Trial Protocol
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230329
PL  - England
TA  - BMC Geriatr
JT  - BMC geriatrics
JID - 100968548
RN  - 0 (Polyphenols)
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Vitis
MH  - Quality of Life
MH  - Polyphenols
MH  - Activities of Daily Living
MH  - Cognition
MH  - *Cognitive Dysfunction
MH  - Dietary Supplements
MH  - Inflammation
MH  - Randomized Controlled Trials as Topic
PMC - PMC10052855
OTO - NOTNLM
OT  - Cognitive performance
OT  - Older adults
OT  - Polyphenols
OT  - Raisins
COIS- The authors declare that they have no competing interests.
EDAT- 2023/03/30 06:00
MHDA- 2023/03/31 06:42
CRDT- 2023/03/29 23:47
PHST- 2022/10/07 00:00 [received]
PHST- 2023/03/09 00:00 [accepted]
PHST- 2023/03/31 06:42 [medline]
PHST- 2023/03/29 23:47 [entrez]
PHST- 2023/03/30 06:00 [pubmed]
AID - 10.1186/s12877-023-03882-6 [pii]
AID - 3882 [pii]
AID - 10.1186/s12877-023-03882-6 [doi]
PST - epublish
SO  - BMC Geriatr. 2023 Mar 29;23(1):182. doi: 10.1186/s12877-023-03882-6.

PMID- 36989281
OWN - NLM
STAT- MEDLINE
DCOM- 20230331
LR  - 20230410
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 18
IP  - 3
DP  - 2023
TI  - Work-family conflict among hotel housekeepers in the Balearic Islands (Spain).
PG  - e0269074
LID - 10.1371/journal.pone.0269074 [doi]
LID - e0269074
AB  - The massive incorporation of women to the labour market has increased academic 
      and applied interest on work-life issues throughout the years. This article aims 
      to describe the domestic burden and difficulties in work-life balance (WLB) and 
      to understand the intersection of work and family spheres among hotel 
      housekeepers (HHs). A cross-sectional study was conducted through Primary Health 
      Care in the Balearic Islands (Spain); 1,043 HHs were enrolled. 56.7% reported 
      difficulties in WLB. Risk factors for perceiving difficulties in WLB were: living 
      with someone else (regardless of the number of co-habitants), having difficulties 
      making ends meet, being the main person in charge of domestic tasks, having a 
      dependant, having an external locus of control, presenting higher levels of 
      stress at work, working more hours a week and being younger. Protective factors 
      from experiencing work-family conflict (WFC) were job and wage satisfaction. WFC 
      is strongly influenced by individual, economic, labour and domestic factors: 
      these relationships show that labour and domestic spheres are non-separate 
      worlds.
CI  - Copyright: © 2023 Chela-Alvarez et al. This is an open access article distributed 
      under the terms of the Creative Commons Attribution License, which permits 
      unrestricted use, distribution, and reproduction in any medium, provided the 
      original author and source are credited.
FAU - Chela-Alvarez, Xenia
AU  - Chela-Alvarez X
AUID- ORCID: 0000-0002-8270-6554
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma, 
      Spain.
AD  - GrAPP-caIB-Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud-Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Garcia-Buades, M Esther
AU  - Garcia-Buades ME
AD  - Department of Psychology, University of the Balearic Islands, Palma, Spain.
FAU - Ferrer-Perez, Victoria A
AU  - Ferrer-Perez VA
AUID- ORCID: 0000-0002-8096-4031
AD  - Department of Psychology, University of the Balearic Islands, Palma, Spain.
FAU - Bulilete, Oana
AU  - Bulilete O
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma, 
      Spain.
AD  - GrAPP-caIB-Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud-Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Llobera, Joan
AU  - Llobera J
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma, 
      Spain.
AD  - GrAPP-caIB-Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud-Carlos III Health Institute (ISCIII), Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230329
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Humans
MH  - Female
MH  - *Family Conflict
MH  - Spain
MH  - Cross-Sectional Studies
MH  - *Job Satisfaction
MH  - Surveys and Questionnaires
PMC - PMC10057743
COIS- The authors have declared that no competing interests exist.
EDAT- 2023/03/30 06:00
MHDA- 2023/03/31 06:42
CRDT- 2023/03/29 13:43
PHST- 2022/05/11 00:00 [received]
PHST- 2023/02/13 00:00 [accepted]
PHST- 2023/03/31 06:42 [medline]
PHST- 2023/03/29 13:43 [entrez]
PHST- 2023/03/30 06:00 [pubmed]
AID - PONE-D-22-13784 [pii]
AID - 10.1371/journal.pone.0269074 [doi]
PST - epublish
SO  - PLoS One. 2023 Mar 29;18(3):e0269074. doi: 10.1371/journal.pone.0269074. 
      eCollection 2023.

PMID- 36981859
OWN - NLM
STAT- MEDLINE
DCOM- 20230330
LR  - 20230419
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 6
DP  - 2023 Mar 11
TI  - Main Challenges of Incorporating Environmental Impacts in the Economic Evaluation 
      of Health Technology Assessment: A Scoping Review.
LID - 10.3390/ijerph20064949 [doi]
LID - 4949
AB  - Health technology assessment (HTA) provides evidence-based information on 
      healthcare technology to support decision making in many countries. Environmental 
      impact is a relevant dimension of a health technology's value, but it has been 
      poorly addressed in HTA processes in spite of the commitment that the health 
      sector must have to contribute to mitigating the effects of climate change. This 
      study aims to identify the state of the art and challenges for quantifying 
      environmental impacts that could be incorporated into the economic evaluation 
      (EE) of HTA. We performed a scoping review that included 22 articles grouped into 
      four types of contribution: (1) concepts to draw up a theoretical framework, (2) 
      HTA reports, (3) parameter designs or suitable indicators, and (4) economic or 
      budgetary impact assessments. This review shows that evaluation of the 
      environmental impact of HTAs is still very incipient. Small steps are being taken 
      in EE, such as carbon footprint estimations from a life-cycle approach of 
      technologies and the entire care pathway.
FAU - Guirado-Fuentes, Carmen
AU  - Guirado-Fuentes C
AUID- ORCID: 0000-0002-4578-8204
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
FAU - Abt-Sacks, Analía
AU  - Abt-Sacks A
AUID- ORCID: 0000-0001-7153-8586
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
FAU - Trujillo-Martín, María Del Mar
AU  - Trujillo-Martín MDM
AUID- ORCID: 0000-0003-2273-2192
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Institute of Biomedical Technologies (ITB), University of La Laguna, 38200 San 
      Cristobal de La Laguna, Spain.
FAU - García-Pérez, Lidia
AU  - García-Pérez L
AUID- ORCID: 0000-0002-5626-8116
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Institute of Biomedical Technologies (ITB), University of La Laguna, 38200 San 
      Cristobal de La Laguna, Spain.
FAU - Rodríguez-Rodríguez, Leticia
AU  - Rodríguez-Rodríguez L
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
FAU - Carrion I Ribas, Carme
AU  - Carrion I Ribas C
AUID- ORCID: 0000-0003-1479-7551
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - eHealth Lab Research Group, School of Health Sciences, Universitat Oberta de 
      Catalunya (UOC), 08035 Barcelona, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Institute of Biomedical Technologies (ITB), University of La Laguna, 38200 San 
      Cristobal de La Laguna, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 Santa Cruz de 
      Tenerife, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230311
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Cost-Benefit Analysis
MH  - *Technology Assessment, Biomedical/methods
MH  - *Biomedical Technology
MH  - Carbon Footprint
MH  - Climate Change
PMC - PMC10049058
OTO - NOTNLM
OT  - carbon footprint
OT  - climate change
OT  - economic evaluation
OT  - environmental impact
OT  - greenhouse gases
OT  - health technology assessment
OT  - life-cycle assessment
COIS- The authors declare that they have no competing interest with the subject matter 
      or materials discussed in the manuscript.
EDAT- 2023/03/30 06:00
MHDA- 2023/03/30 06:11
CRDT- 2023/03/29 01:33
PHST- 2022/12/23 00:00 [received]
PHST- 2023/03/01 00:00 [revised]
PHST- 2023/03/07 00:00 [accepted]
PHST- 2023/03/30 06:11 [medline]
PHST- 2023/03/29 01:33 [entrez]
PHST- 2023/03/30 06:00 [pubmed]
AID - ijerph20064949 [pii]
AID - ijerph-20-04949 [pii]
AID - 10.3390/ijerph20064949 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Mar 11;20(6):4949. doi: 
      10.3390/ijerph20064949.

PMID- 36981602
OWN - NLM
STAT- MEDLINE
DCOM- 20230330
LR  - 20230421
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 6
DP  - 2023 Mar 7
TI  - Preventive Gambling Programs for Adolescents and Young Adults: A Systematic 
      Review.
LID - 10.3390/ijerph20064691 [doi]
LID - 4691
AB  - Gambling disorder in youth is an emerging public health problem, with adolescents 
      and young adults constituting a vulnerable age group for the development of 
      gambling-related problems. Although research has been conducted on the risk 
      factors for gambling disorder, very few rigorous studies can be found on the 
      efficacy of preventive interventions in young people. The aim of this study was 
      to provide best practice recommendations for the prevention of disordered 
      gambling in adolescents and young adults. We reviewed and synthesized the results 
      of existing RCTs and quasi-experimental studies covering nonpharmacological 
      prevention programs for gambling disorder in young adults and adolescents. We 
      applied the PRISMA 2020 statement and guidelines to identify 1483 studies, of 
      which 32 were included in the systematic review. All studies targeted the 
      educational setting, i.e., high school and university students. Most studies 
      followed a universal prevention strategy, that particularly targeted adolescents, 
      and an indicated prevention strategy for university students. The reviewed 
      gambling prevention programs generally showed good results in terms of reducing 
      the frequency and severity of gambling, and also regarding cognitive variables, 
      such as misconceptions, fallacies, knowledge, and attitudes towards gambling. 
      Finally, we highlight the need to develop more comprehensive prevention programs 
      that incorporate rigorous methodological and assessment procedures before they 
      are widely implemented and disseminated.
FAU - Monreal-Bartolomé, Alicia
AU  - Monreal-Bartolomé A
AUID- ORCID: 0000-0003-2088-2007
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Chronicity, Primary Care, and Health Promotion Research Network (RICAPPS), 50015 
      Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Barceló-Soler, Alberto
AU  - Barceló-Soler A
AUID- ORCID: 0000-0002-2116-9257
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Healthcare Research Institute of Navarre (IdiSNA), 31008 Pamplona, Spain.
FAU - García-Campayo, Javier
AU  - García-Campayo J
AUID- ORCID: 0000-0002-3797-4218
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Chronicity, Primary Care, and Health Promotion Research Network (RICAPPS), 50015 
      Zaragoza, Spain.
AD  - Department of Psychiatry, Hospital Miguel Servet, University of Zaragoza, 50009 
      Zaragoza, Spain.
FAU - Bartolomé-Moreno, Cruz
AU  - Bartolomé-Moreno C
AUID- ORCID: 0000-0001-8820-9105
AD  - Primary Care Teaching Unit for Zaragoza Healthcare District 1, 50018 Zaragoza, 
      Spain.
FAU - Cortés-Montávez, Paula
AU  - Cortés-Montávez P
AUID- ORCID: 0009-0008-5588-724X
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Acon, Esther
AU  - Acon E
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Huertes, María
AU  - Huertes M
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Lacasa, Víctor
AU  - Lacasa V
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Crespo, Sofía
AU  - Crespo S
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Lloret-Irles, Daniel
AU  - Lloret-Irles D
AUID- ORCID: 0000-0002-2384-5749
AD  - Department of Health Psychology, Miguel Hernández University, 03202 Elche, Spain.
FAU - Sordo, Luis
AU  - Sordo L
AUID- ORCID: 0000-0003-1760-9472
AD  - Department of Public Health and Maternal and Child Health, Faculty of Medicine, 
      Complutense University of Madrid, 28040 Madrid, Spain.
AD  - CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
FAU - Clotas Bote, Catrina
AU  - Clotas Bote C
AD  - Barcelona Public Health Agency (ASPB), 08023 Barcelona, Spain.
FAU - Puigcorbé, Susanna
AU  - Puigcorbé S
AD  - Public Health Agency of Catalonia (ASPCAT), 08005 Barcelona, Spain.
FAU - López-Del-Hoyo, Yolanda
AU  - López-Del-Hoyo Y
AUID- ORCID: 0000-0002-1690-4130
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Chronicity, Primary Care, and Health Promotion Research Network (RICAPPS), 50015 
      Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Review
PT  - Systematic Review
DEP - 20230307
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Adolescent
MH  - Young Adult
MH  - *Gambling/prevention & control/psychology
MH  - Preventive Health Services
MH  - Risk Factors
MH  - Schools
MH  - *Adolescent Behavior/psychology
PMC - PMC10048743
OTO - NOTNLM
OT  - adolescents
OT  - gambling disorder
OT  - prevention
OT  - problem gambling
OT  - youth
COIS- The authors declare no conflict of interest.
EDAT- 2023/03/30 06:00
MHDA- 2023/03/30 06:11
CRDT- 2023/03/29 01:31
PHST- 2023/02/12 00:00 [received]
PHST- 2023/03/03 00:00 [revised]
PHST- 2023/03/05 00:00 [accepted]
PHST- 2023/03/30 06:11 [medline]
PHST- 2023/03/29 01:31 [entrez]
PHST- 2023/03/30 06:00 [pubmed]
AID - ijerph20064691 [pii]
AID - ijerph-20-04691 [pii]
AID - 10.3390/ijerph20064691 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Mar 7;20(6):4691. doi: 
      10.3390/ijerph20064691.

PMID- 36971145
OWN - NLM
STAT- Publisher
LR  - 20230415
IS  - 1369-7625 (Electronic)
IS  - 1369-6513 (Linking)
DP  - 2023 Mar 27
TI  - A qualitative exploration of patient safety in a hospital setting in Spain: 
      Policy and practice recommendations on patients' and companions' participation.
LID - 10.1111/hex.13758 [doi]
AB  - INTRODUCTION: Patients' and companions' participation in healthcare could help 
      prevent adverse events, which are a significant cause of disease and disability. 
      Before designing interventions to increase participation, it is first necessary 
      to identify attitudes to patient safety. This study aimed to explore patients' 
      and companions' perceptions, attitudes and experiences of patient safety, taking 
      into account contextual factors, such as cultural background, which are not 
      usually captured in the literature. METHODS: We conducted a qualitative study 
      with a theoretical sampling of 13 inpatients and 3 companions in a university 
      hospital in Barcelona, Spain. Information was obtained from individual and 
      triangular interviews. A descriptive thematic content analysis was conducted by 
      four analysts and a consensus was reached within the research team on the key 
      categories that were identified. We also conducted a card-sorting exercise. 
      RESULTS: All informants emphasized the role of good communication with health 
      professionals, a calm environment and the need for patient education. Discursive 
      positions differed by cultural background. Informants from a 
      Pakistani-Bangladeshi background emphasized language barriers, while those from 
      European and Latin-American backgrounds stressed health professionals' lack of 
      time and the need for more interdisciplinary teamwork. The card-sorting exercise 
      identified several opportunities to enhance participation: checking patient 
      identification and medication dispensation, and maintaining personal and 
      environmental hygiene. CONCLUSION: This exploration of informants' discourse on 
      patient safety identified a wide variety of categories not usually considered 
      from institutional perspectives. The findings of this study could enrich 
      interventions in areas with diverse cultural backgrounds, as well as current 
      frameworks based exclusively on institutional perspectives. PATIENT OR PUBLIC 
      CONTRIBUTION: The results of the study were communicated to patients and 
      accompanying persons via telephone or email. Similarly, a focus group was held 
      with a patient forum to comment on the results. In the design of subsequent 
      interventions to improve patient safety at the hospital, the proposals of 
      patients and companions for their participation will be included together with 
      healthcare professionals' opinions.
CI  - © 2023 The Authors. Health Expectations published by John Wiley & Sons Ltd.
FAU - Abiétar, Daniel G
AU  - Abiétar DG
AUID- ORCID: 0000-0002-5268-3574
AD  - Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, Spain.
AD  - Facultad de Ciencias de la Salud y de la Vida, Universidad Pompeu Fabra, 
      Barcelona, Spain.
FAU - Domingo, Laia
AU  - Domingo L
AD  - Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Medina-Perucha, Laura
AU  - Medina-Perucha L
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
FAU - Saavedra, Nuria
AU  - Saavedra N
AD  - Unidad de enfermería de Cirugía Ortopédica y Traumatología, Hospital del Mar, 
      Barcelona, Spain.
FAU - Berenguera, Anna
AU  - Berenguera A
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
FAU - Lacueva, Laia
AU  - Lacueva L
AD  - Servicio de Metodología y Calidad en Cuidados Enfermeros, Hospital del Mar, 
      Barcelona, Spain.
FAU - Hurtado, Marta
AU  - Hurtado M
AD  - Servicio de Atención a la Ciudadanía, Hospital del Mar, Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Sala, María
AU  - Sala M
AUID- ORCID: 0000-0002-9955-8746
AD  - Servicio de Epidemiología y Evaluación, Hospital del Mar, Barcelona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
LA  - eng
GR  - PI19/00056/Instituto de Salud Carlos III/
GR  - RD21/0016/0020/Instituto de Salud Carlos III/
PT  - Journal Article
DEP - 20230327
PL  - England
TA  - Health Expect
JT  - Health expectations : an international journal of public participation in health 
      care and health policy
JID - 9815926
SB  - IM
OTO - NOTNLM
OT  - companions
OT  - hospital setting
OT  - patient participation
OT  - patient safety
EDAT- 2023/03/28 06:00
MHDA- 2023/03/28 06:00
CRDT- 2023/03/27 06:03
PHST- 2023/03/14 00:00 [revised]
PHST- 2022/09/14 00:00 [received]
PHST- 2023/03/23 00:00 [accepted]
PHST- 2023/03/28 06:00 [pubmed]
PHST- 2023/03/28 06:00 [medline]
PHST- 2023/03/27 06:03 [entrez]
AID - 10.1111/hex.13758 [doi]
PST - aheadofprint
SO  - Health Expect. 2023 Mar 27. doi: 10.1111/hex.13758.

PMID- 36968708
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230328
IS  - 1664-1078 (Print)
IS  - 1664-1078 (Electronic)
IS  - 1664-1078 (Linking)
VI  - 14
DP  - 2023
TI  - Mindfulness skills and experiential avoidance as therapeutic mechanisms for 
      treatment-resistant depression through mindfulness-based cognitive therapy and 
      lifestyle modification.
PG  - 1008891
LID - 10.3389/fpsyg.2023.1008891 [doi]
LID - 1008891
AB  - BACKGROUND/OBJECTIVE: The COVID-19 pandemic and consequent physical distancing 
      has made it difficult to provide care for those with Treatment-Resistant 
      Depression (TRD). As a secondary analysis of a clinical trial, the aim of this 
      study was to explore potential mechanisms through which three online-delivered 
      approaches, added to treatment as usual, improve depressive symptoms in TRD 
      patients. METHODS: The three approaches included (a) Minimal Lifestyle 
      Intervention (MLI), (b) Mindfulness-Based Cognitive Therapy (MBCT), and (c) 
      Lifestyle Modification Program (LMP). Sixty-six participants with TRD completed 
      assessments pre-post intervention (mindfulness skills [FFMQ]; self-compassion 
      [SCS]; and experiential avoidance [AAQ-II]) and pre-intervention to follow-up 
      (depressive symptoms [BDI-II]). Data were analyzed using within-subjects 
      regression models to test mediation. RESULTS: Mindfulness skills mediated the 
      effect of MBCT on depressive symptoms (ab = -4.69, 95% CI = -12.93 to-0.32), 
      whereas the lack of experiential avoidance mediated the effect of LMP on 
      depressive symptoms (ab = -3.22, 95% CI = -7.03 to-0.14). CONCLUSION: 
      Strengthening mindfulness skills and decreasing experiential avoidance may 
      promote recovery in patients with TRD, MBCT, and LMP have demonstrated that they 
      may help increase mindfulness skills and decrease experiential avoidance, 
      respectively. Future work will need to unpick the components of these 
      interventions to help isolate active ingredients and increase optimization.
CI  - Copyright © 2023 Garcia-Toro, Aguilar-Latorre, Garcia, Navarro-Guzmán, Gervilla, 
      Seguí, Gazquez, Marino, Gomez-Juanes, Serrano-Ripoll, Oliván-Blázquez, 
      Garcia-Campayo, Maloney and Montero-Marin.
FAU - Garcia-Toro, Mauro
AU  - Garcia-Toro M
AD  - University Institute of Health Science Research (IUNICS), University of the 
      Balearic Islands, Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
AD  - Department of Medicine, University of the Balearic Islands, Palma, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
FAU - Aguilar-Latorre, Alejandra
AU  - Aguilar-Latorre A
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
FAU - Garcia, Aurora
AU  - Garcia A
AD  - University Institute of Health Science Research (IUNICS), University of the 
      Balearic Islands, Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
FAU - Navarro-Guzmán, Capilla
AU  - Navarro-Guzmán C
AD  - Department of Psychology, University of the Balearic Islands, Palma, Spain.
FAU - Gervilla, Elena
AU  - Gervilla E
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
AD  - Department of Psychology, University of the Balearic Islands, Palma, Spain.
FAU - Seguí, Andrea
AU  - Seguí A
AD  - University Institute of Health Science Research (IUNICS), University of the 
      Balearic Islands, Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
FAU - Gazquez, Francisco
AU  - Gazquez F
AD  - University Institute of Health Science Research (IUNICS), University of the 
      Balearic Islands, Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
FAU - Marino, Jose Antonio
AU  - Marino JA
AD  - University Institute of Health Science Research (IUNICS), University of the 
      Balearic Islands, Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
FAU - Gomez-Juanes, Rocío
AU  - Gomez-Juanes R
AD  - University Institute of Health Science Research (IUNICS), University of the 
      Balearic Islands, Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
FAU - Serrano-Ripoll, María J
AU  - Serrano-Ripoll MJ
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma, 
      Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Garcia-Campayo, Javier
AU  - Garcia-Campayo J
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Carlos III Health Institute, Madrid, Spain.
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 
      Zaragoza, Spain.
FAU - Maloney, Shannon
AU  - Maloney S
AD  - Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, 
      United Kingdom.
FAU - Montero-Marin, Jesús
AU  - Montero-Marin J
AD  - Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, 
      United Kingdom.
AD  - Teaching, Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi 
      de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER 
      Epidemiology and Public Health-CIBERESP), Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230309
PL  - Switzerland
TA  - Front Psychol
JT  - Frontiers in psychology
JID - 101550902
PMC - PMC10033944
OTO - NOTNLM
OT  - MBCT
OT  - intervention
OT  - lifestyle modification
OT  - major depressive disorder
OT  - mediation
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest. The reviewer JH declared a shared affiliation with the 
      authors AA-L, BO-B, and JG-C to the handling editor at the time of review.
EDAT- 2023/03/28 06:00
MHDA- 2023/03/28 06:01
CRDT- 2023/03/27 03:29
PHST- 2022/08/02 00:00 [received]
PHST- 2023/02/15 00:00 [accepted]
PHST- 2023/03/27 03:29 [entrez]
PHST- 2023/03/28 06:00 [pubmed]
PHST- 2023/03/28 06:01 [medline]
AID - 10.3389/fpsyg.2023.1008891 [doi]
PST - epublish
SO  - Front Psychol. 2023 Mar 9;14:1008891. doi: 10.3389/fpsyg.2023.1008891. 
      eCollection 2023.

PMID- 36959558
OWN - NLM
STAT- MEDLINE
DCOM- 20230327
LR  - 20230406
IS  - 2731-4553 (Electronic)
IS  - 2731-4553 (Linking)
VI  - 24
IP  - 1
DP  - 2023 Mar 23
TI  - Impact of hypertension diagnosis on morbidity and mortality: a retrospective 
      cohort study in primary care.
PG  - 79
LID - 10.1186/s12875-023-02036-2 [doi]
LID - 79
AB  - BACKGROUND: Hypertension is responsible for a huge burden of disease. The aim of 
      this study was to evaluate the impact of newly diagnosed hypertension on the 
      occurrence of kidney or cardiovascular events (K/CVEs) and on mortality among 
      community dwellers. METHODS: Retrospective cohort study, conducted from January, 
      2007, to December, 2018. All patients (age > 18) newly diagnosed with 
      hypertension and no previous K/CVEs in 2007 and 2008, in the primary care centers 
      of Madrid (Spain) (n = 71,770), were enrolled. The control group (n = 72,946) 
      included patients without hypertension, matched by center, sex and age. The 
      occurrence of kidney or CV events, including mortality from these causes and 
      total mortality were evaluated using Cox regression and multistate models. Data 
      were collected from three sources: personal data from administrative records, 
      clinical data from medical records, and mortality data from regional and national 
      databases. RESULTS: The median follow-up was 138.61 months (IQR: 
      124.68-143.97 months). There were 32,896 K/CVEs (including 3,669 
      deaths from these causes) and 12,999 deaths from other causes. Adjusted for sex, 
      smoking, diabetes and socioeconomic status, K/CVEs HR was 4.36 (95% CI: 
      3.80-5.00) for diagnoses before 45 years of age, 2.45(95% CI: 2.28- 2.63) for 
      diagnosis between 45 to 54 years, and HR decreased to 1.86 (95% CI: 1.64-210) for 
      diagnoses over age 85. Total mortality risk was only higher for hypertension 
      diagnosed before 55 years of age (HR: 2.47, 95% CI: 1.90-3.19 for ages 18 to 44; 
      and HR: 1.14, 95% CI: 1.02-1.28 for ages 45 to 54). CONCLUSION: The diagnosis of 
      hypertension in the community environment, in patients without evidence of 
      previous kidney or CV disease, is associated with a large increase in the risk of 
      K/CVEs, but especially in individuals diagnosed before the age of 55. This 
      diagnosis is only associated with an increase in kidney 
      or cardiovascular mortality or overall mortality when it occurs before age 55.
CI  - © 2023. The Author(s).
FAU - Martín-Fernández, Jesus
AU  - Martín-Fernández J
AUID- ORCID: 0000-0001-9545-1549
AD  - Oeste Family and Community Care Teaching Unit, Primary Care Assistance 
      Management, Madrid Health Service, Madrid, Spain. jmfernandez@salud.madrid.org.
AD  - Department of Medical Specialties and Public Health, Faculty of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain. jmfernandez@salud.madrid.org.
AD  - Health Services Research Network in Chronic Diseases, REDISSEC- ISCIII, Madrid, 
      Spain. jmfernandez@salud.madrid.org.
AD  - Research Network On Chronicity, Primary Care and Health Promotion-RICAPPS 
      (RICORS), ISCIII, Madrid, Spain. jmfernandez@salud.madrid.org.
AD  - Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain. 
      jmfernandez@salud.madrid.org.
FAU - Alonso-Safont, Tamara
AU  - Alonso-Safont T
AUID- ORCID: 0000-0003-3837-0085
AD  - Technical Directorate of Health Information Systems, Primary Care Assistance 
      Management, Madrid Health Service, Madrid, Spain.
FAU - Polentinos-Castro, Elena
AU  - Polentinos-Castro E
AUID- ORCID: 0000-0001-9460-2966
AD  - Department of Medical Specialties and Public Health, Faculty of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain.
AD  - Health Services Research Network in Chronic Diseases, REDISSEC- ISCIII, Madrid, 
      Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion-RICAPPS 
      (RICORS), ISCIII, Madrid, Spain.
AD  - Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain.
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
FAU - Esteban-Vasallo, Maria Dolores
AU  - Esteban-Vasallo MD
AUID- ORCID: 0000-0003-0610-9528
AD  - Health Reports and Studies Service, General Directorate of Public Health, 
      Ministry of Health, Madrid, Spain.
FAU - Ariza-Cardiel, Gloria
AU  - Ariza-Cardiel G
AUID- ORCID: 0000-0002-4635-9604
AD  - Oeste Family and Community Care Teaching Unit, Primary Care Assistance 
      Management, Madrid Health Service, Madrid, Spain.
AD  - Health Services Research Network in Chronic Diseases, REDISSEC- ISCIII, Madrid, 
      Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion-RICAPPS 
      (RICORS), ISCIII, Madrid, Spain.
AD  - Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain.
FAU - González-Anglada, Mª Isabel
AU  - González-Anglada MI
AUID- ORCID: 0000-0002-5510-5323
AD  - Department of Medical Specialties and Public Health, Faculty of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain.
AD  - Internal Medicine Service, Alcorcón Foundation University Hospital, Madrid, 
      Spain.
FAU - Sánchez-Perruca, Luis
AU  - Sánchez-Perruca L
AUID- ORCID: 0000-0001-5915-4184
AD  - Technical Directorate of Health Information Systems, Primary Care Assistance 
      Management, Madrid Health Service, Madrid, Spain.
FAU - Rodríguez-Martínez, Gemma
AU  - Rodríguez-Martínez G
AD  - Don Luis Infant Health Center, Primary Care Assistance Management, Madrid Health 
      Service, Madrid, Spain.
FAU - Rotaeche-Del-Campo, Rafael
AU  - Rotaeche-Del-Campo R
AUID- ORCID: 0000-0001-5594-3768
AD  - Alza Health Center, Osakidetza, OSI Donostia, Research Group in AP IIS 
      Biodonostia, San Sebastián, Spain.
FAU - Bilbao-González, Amaia
AU  - Bilbao-González A
AUID- ORCID: 0000-0002-2202-0753
AD  - Health Services Research Network in Chronic Diseases, REDISSEC- ISCIII, Madrid, 
      Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion-RICAPPS 
      (RICORS), ISCIII, Madrid, Spain.
AD  - Osakidetza, Basque Health Service, Basurto University Hospital, Research and 
      Innovation Unit, Bilbao, Spain.
AD  - Kronikgune Health Services Research Institute, Barakaldo, Spain.
AD  - Department of Medicine, Faculty of Health Sciences, University of Deusto, Bilbao, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230323
PL  - England
TA  - BMC Prim Care
JT  - BMC primary care
JID - 9918300889006676
SB  - IM
MH  - Humans
MH  - Adult
MH  - Middle Aged
MH  - Child, Preschool
MH  - Adolescent
MH  - Young Adult
MH  - Retrospective Studies
MH  - Risk Factors
MH  - *Hypertension/epidemiology
MH  - Morbidity
MH  - Primary Health Care
PMC - PMC10037862
OTO - NOTNLM
OT  - Cardiovascular disease
OT  - Hypertension
OT  - Primary health care
OT  - Survival
COIS- The authors declare no conflicts of interest.
EDAT- 2023/03/25 06:00
MHDA- 2023/03/28 06:00
CRDT- 2023/03/24 00:33
PHST- 2022/09/02 00:00 [received]
PHST- 2023/03/13 00:00 [accepted]
PHST- 2023/03/24 00:33 [entrez]
PHST- 2023/03/25 06:00 [pubmed]
PHST- 2023/03/28 06:00 [medline]
AID - 10.1186/s12875-023-02036-2 [pii]
AID - 2036 [pii]
AID - 10.1186/s12875-023-02036-2 [doi]
PST - epublish
SO  - BMC Prim Care. 2023 Mar 23;24(1):79. doi: 10.1186/s12875-023-02036-2.

PMID- 36958130
OWN - NLM
STAT- MEDLINE
DCOM- 20230411
LR  - 20230517
IS  - 1873-7714 (Electronic)
IS  - 0163-8343 (Print)
IS  - 0163-8343 (Linking)
VI  - 82
DP  - 2023 May-Jun
TI  - Effectiveness of interventions to prevent perinatal depression: An umbrella 
      review of systematic reviews and meta-analysis.
PG  - 47-61
LID - S0163-8343(23)00041-5 [pii]
LID - 10.1016/j.genhosppsych.2023.03.007 [doi]
AB  - BACKGROUND: To date, dozens of systematic reviews (SRs) and meta-analyses (MAs) 
      summarize the effectiveness of preventive interventions for perinatal depression. 
      However, the results are inconclusive, making an urgent need to step up to higher 
      levels of evidence synthesis. AIMS: To summarize and compare the evidence from 
      the SR&MA examining the effectiveness of all types of interventions for 
      preventing perinatal depression. METHOD: PubMed, PsycINFO, Cochrane Database of 
      Systematic Reviews and OpenGrey were searched from inception to December 2022. We 
      selected SR&MA of randomized controlled trials (RCTs) that compared all types of 
      preventive interventions for perinatal depression with control groups whose 
      outcome was the reduction of depressive symptoms and/or incidence of new cases of 
      perinatal depression (PROSPERO: CRD42020173125). RESULTS: A total of 19 SRs and 
      MAs evaluated 152 unique RCTs that included 83,408 women from 26 countries and 
      five continents. The median effect size for any intervention was SMD = 0.29 (95% 
      CI: 0.20 to 0.38). Exercise/physical activity-based, psychological, and any type 
      of intervention showed median effect sizes of 0.43, 0.28 and 0.36, respectively. 
      The degree of overlap among RCTs was slight. According to AMSTAR-2, 79% of them 
      were rated as low or critically low-quality. The strength of evidence, according 
      to GRADE, was poorly reported and, in most cases, was low. CONCLUSIONS: 
      Exercise/physical activity-based and psychological interventions have a 
      small-to-medium effect on reducing perinatal depressive symptoms. There is 
      insufficient evidence to conclude that dietary supplements and pharmacological 
      interventions are effective in preventing perinatal depression. There is a need 
      for high-quality SR&MA of RCTs, mainly focusing on universal preventive 
      interventions.
CI  - Copyright © 2023. Published by Elsevier Inc.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Department of Psychology, University Loyola Andalucía, Spain. Electronic address: 
      emotrico@uloyola.es.
FAU - Bina, Rena
AU  - Bina R
AD  - School of Social Work, Bar Ilan University, Ramat Gan, Israel.
FAU - Kassianos, Angelos P
AU  - Kassianos AP
AD  - Department of Applied Health Research, University College London, 1-19 Torrington 
      Place, London WC1E 7HB, UK; Department of Nursing, Cyprus University of 
      Technology, 30 Archbishop Kyprianos, Limassol 3036, Cyprus.
FAU - Le, Huynh-Nhu
AU  - Le HN
AD  - Department of Psychological and Brain Sciences, George Washington University, 
      Washington, DC, USA.
FAU - Mateus, Vera
AU  - Mateus V
AD  - Portucalense Institute for Human Development (INPP), Department of Psychology and 
      Education, Universidade Portucalense, Porto, Portugal; Center for Research in 
      Neuropsychology and Cognitive Behavioural Intervention (CINEICC), Faculty of 
      Psychology and Educational Sciences, University of Coimbra, Portugal.
FAU - Oztekin, Deniz
AU  - Oztekin D
AD  - Department of Obstetrics and Gynecology, İzmir Bakircay University, İzmir, 
      Turkey.
FAU - Rodriguez-Muñoz, Maria F
AU  - Rodriguez-Muñoz MF
AD  - Faculty of Psychology, Universidad Nacional de Educación a Distancia, (UNED), 
      Spain.
FAU - Moreno-Peral, Patricia
AU  - Moreno-Peral P
AD  - Biomedical Research Institute of Malaga (IBIMA plataforma Bionand), Málaga, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), ISCIII, Spain; Department of Personality, Evaluation and Psychological 
      Treatment, University of Málaga (UMA), Spain.
FAU - Conejo-Cerón, Sonia
AU  - Conejo-Cerón S
AD  - Biomedical Research Institute of Malaga (IBIMA plataforma Bionand), Málaga, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), ISCIII, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20230315
PL  - United States
TA  - Gen Hosp Psychiatry
JT  - General hospital psychiatry
JID - 7905527
SB  - IM
MH  - Female
MH  - Humans
MH  - Pregnancy
MH  - *Depression/prevention & control/diagnosis
MH  - *Depressive Disorder/prevention & control/diagnosis
MH  - Psychosocial Intervention
MH  - Systematic Reviews as Topic
MH  - Meta-Analysis as Topic
PMC - PMC10183436
OTO - NOTNLM
OT  - Perinatal
OT  - Prevention
OT  - Randomized control trial
OT  - depression
OT  - meta-analysis
OT  - systematic review
COIS- Declaration of Competing Interest None.
EDAT- 2023/03/24 06:00
MHDA- 2023/04/11 06:42
CRDT- 2023/03/23 19:04
PHST- 2023/01/07 00:00 [received]
PHST- 2023/03/12 00:00 [revised]
PHST- 2023/03/13 00:00 [accepted]
PHST- 2023/04/11 06:42 [medline]
PHST- 2023/03/24 06:00 [pubmed]
PHST- 2023/03/23 19:04 [entrez]
AID - S0163-8343(23)00041-5 [pii]
AID - 10.1016/j.genhosppsych.2023.03.007 [doi]
PST - ppublish
SO  - Gen Hosp Psychiatry. 2023 May-Jun;82:47-61. doi: 
      10.1016/j.genhosppsych.2023.03.007. Epub 2023 Mar 15.

PMID- 36941056
OWN - NLM
STAT- MEDLINE
DCOM- 20230322
LR  - 20230414
IS  - 2575-1077 (Electronic)
IS  - 2575-1077 (Linking)
VI  - 6
IP  - 6
DP  - 2023 Jun
TI  - Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 
      convalescent subjects.
LID - 10.26508/lsa.202201759 [doi]
LID - e202201759
AB  - The development of new therapies for COVID-19 high-risk patients remains 
      necessary to prevent additional deaths. Here, we studied the phenotypical and 
      functional characteristics of IFN-γ producing-SARS-CoV-2-specific T cells 
      (SC2-STs), obtained from 12 COVID-19 convalescent donors, to determine their 
      potency as an off-the-shelf T cell therapy product. We found that these cells 
      present mainly an effector memory phenotype, characterized by the basal 
      expression of cytotoxicity and activation markers, including granzyme B, 
      perforin, CD38, and PD-1. We demonstrated that SC2-STs could be expanded and 
      isolated in vitro, and they exhibited peptide-specific cytolytic and 
      proliferative responses after antigenic re-challenge. Collectively, these data 
      demonstrate that SC2-STs can be a suitable candidate for the manufacture of a T 
      cell therapy product aimed to treat severe COVID-19.
CI  - © 2023 Gil-Bescós et al.
FAU - Gil-Bescós, Rubén
AU  - Gil-Bescós R
AUID- ORCID: 0000-0002-6824-6862
AD  - Oncohematology Research Group, Navarrabiomed, University Hospital of Navarra, 
      Public University of Navarra, Navarra Medical Research Institute (IdiSNA), 
      Pamplona, Spain.
FAU - Ostiz, Ainhoa
AU  - Ostiz A
AUID- ORCID: 0000-0002-9006-8345
AD  - Oncohematology Research Group, Navarrabiomed, University Hospital of Navarra, 
      Public University of Navarra, Navarra Medical Research Institute (IdiSNA), 
      Pamplona, Spain.
FAU - Zalba, Saioa
AU  - Zalba S
AUID- ORCID: 0000-0003-3201-1882
AD  - Hematology and Hemotherapy Department, University Hospital of Navarra, IdiSNA, 
      Pamplona, Spain.
FAU - Tamayo, Ibai
AU  - Tamayo I
AUID- ORCID: 0000-0003-2860-3359
AD  - Unit of Methodology, Navarrabiomed, University Hospital of Navarra, Public 
      University of Navarra, IdiSNA, Pamplona, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Pamplona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
FAU - Bandrés, Eva
AU  - Bandrés E
AUID- ORCID: 0000-0002-9497-5356
AD  - Immunology Service, University Hospital of Navarra, IdiSNA, Pamplona, Spain.
FAU - Rojas-de-Miguel, Elvira
AU  - Rojas-de-Miguel E
AUID- ORCID: 0000-0002-3085-8935
AD  - Oncohematology Research Group, Navarrabiomed, University Hospital of Navarra, 
      Public University of Navarra, Navarra Medical Research Institute (IdiSNA), 
      Pamplona, Spain.
FAU - Redondo, Margarita
AU  - Redondo M
AUID- ORCID: 0000-0002-0868-6663
AD  - Hematology and Hemotherapy Department, University Hospital of Navarra, IdiSNA, 
      Pamplona, Spain.
FAU - Zabalza, Amaya
AU  - Zabalza A
AUID- ORCID: 0000-0002-3160-2683
AD  - Oncohematology Research Group, Navarrabiomed, University Hospital of Navarra, 
      Public University of Navarra, Navarra Medical Research Institute (IdiSNA), 
      Pamplona, Spain natalia.ramirez.huerto@navarra.es 
      amaya.zabalza.sanmartin@navarra.es.
AD  - Hematology and Hemotherapy Department, University Hospital of Navarra, IdiSNA, 
      Pamplona, Spain.
FAU - Ramírez, Natalia
AU  - Ramírez N
AUID- ORCID: 0000-0003-3669-1053
AD  - Oncohematology Research Group, Navarrabiomed, University Hospital of Navarra, 
      Public University of Navarra, Navarra Medical Research Institute (IdiSNA), 
      Pamplona, Spain natalia.ramirez.huerto@navarra.es 
      amaya.zabalza.sanmartin@navarra.es.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230320
PL  - United States
TA  - Life Sci Alliance
JT  - Life science alliance
JID - 101728869
RN  - 82115-62-6 (Interferon-gamma)
RN  - 0 (Peptides)
SB  - IM
MH  - Humans
MH  - *COVID-19
MH  - SARS-CoV-2
MH  - T-Lymphocytes
MH  - Interferon-gamma
MH  - Peptides
PMC - PMC10027900
COIS- The authors declare that they have no conflict of interest.
EDAT- 2023/03/21 06:00
MHDA- 2023/03/23 06:00
CRDT- 2023/03/20 21:22
PHST- 2022/10/07 00:00 [received]
PHST- 2023/03/07 00:00 [revised]
PHST- 2023/03/07 00:00 [accepted]
PHST- 2023/03/20 21:22 [entrez]
PHST- 2023/03/21 06:00 [pubmed]
PHST- 2023/03/23 06:00 [medline]
AID - 6/6/e202201759 [pii]
AID - LSA-2022-01759 [pii]
AID - 10.26508/lsa.202201759 [doi]
PST - epublish
SO  - Life Sci Alliance. 2023 Mar 20;6(6):e202201759. doi: 10.26508/lsa.202201759. 
      Print 2023 Jun.

PMID- 36936402
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230321
IS  - 2589-5370 (Electronic)
IS  - 2589-5370 (Linking)
VI  - 57
DP  - 2023 Mar
TI  - Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease 
      in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, 
      placebo-controlled, randomised clinical trial.
PG  - 101898
LID - 10.1016/j.eclinm.2023.101898 [doi]
LID - 101898
AB  - BACKGROUND: Anti-COVID-19 hyperimmune immunoglobulin (hIG) can provide 
      standardized and controlled antibody content. Data from controlled clinical 
      trials using hIG for the prevention or treatment of COVID-19 outpatients have not 
      been reported. We assessed the safety and efficacy of subcutaneous anti-COVID-19 
      hyperimmune immunoglobulin 20% (C19-IG20%) compared to placebo in preventing 
      development of symptomatic COVID-19 in asymptomatic individuals with SARS-CoV-2 
      infection. METHODS: We did a multicentre, randomized, double-blind, 
      placebo-controlled trial, in asymptomatic unvaccinated adults (≥18 years of age) 
      with confirmed SARS-CoV-2 infection within 5 days between April 28 and December 
      27, 2021. Participants were randomly assigned (1:1:1) to receive a blinded 
      subcutaneous infusion of 10 mL with 1 g or 2 g of C19-IG20%, or an equivalent 
      volume of saline as placebo. The primary endpoint was the proportion of 
      participants who remained asymptomatic through day 14 after infusion. Secondary 
      endpoints included the proportion of individuals who required oxygen 
      supplementation, any medically attended visit, hospitalisation, or ICU, and viral 
      load reduction and viral clearance in nasopharyngeal swabs. Safety was assessed 
      as the proportion of patients with adverse events. The trial was terminated early 
      due to a lack of potential benefit in the target population in a planned interim 
      analysis conducted in December 2021. ClinicalTrials.gov registry: NCT04847141. 
      FINDINGS: 461 individuals (mean age 39.6 years [SD 12.8]) were randomized and 
      received the intervention within a mean of 3.1 (SD 1.27) days from a positive 
      SARS-CoV-2 test. In the prespecified modified intention-to-treat analysis that 
      included only participants who received a subcutaneous infusion, the primary 
      outcome occurred in 59.9% (91/152) of participants receiving 1 g C19-IG20%, 64.7% 
      (99/153) receiving 2 g, and 63.5% (99/156) receiving placebo (difference in 
      proportions 1 g C19-IG20% vs. placebo, -3.6%; 95% CI -14.6% to 7.3%, p = 0.53; 
      2 g C19-IG20% vs placebo, 1.1%; -9.6% to 11.9%, p = 0.85). None of the secondary 
      clinical efficacy endpoints or virological endpoints were significantly different 
      between study groups. Adverse event rate was similar between groups, and no 
      severe or life-threatening adverse events related to investigational product 
      infusion were reported. INTERPRETATION: Our findings suggested that 
      administration of subcutaneous human hyperimmune immunoglobulin C19-IG20% to 
      asymptomatic individuals with SARS-CoV-2 infection was safe but did not prevent 
      development of symptomatic COVID-19. FUNDING: Grifols.
CI  - © 2023 The Authors.
FAU - Alemany, Andrea
AU  - Alemany A
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
AD  - Facultat de Medicina-Universitat de Barcelona, Barcelona, Spain.
FAU - Millat-Martinez, Pere
AU  - Millat-Martinez P
AD  - ISGlobal, Hospital Clinic - Universitat de Barcelona, Barcelona, Spain.
FAU - Corbacho-Monné, Marc
AU  - Corbacho-Monné M
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
AD  - Facultat de Medicina-Universitat de Barcelona, Barcelona, Spain.
AD  - Hospital Universitari Parc Taulí, I3PT, 08028, Sabadell, Spain.
FAU - Suñer, Clara
AU  - Suñer C
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
FAU - Galvan-Casas, Cristina
AU  - Galvan-Casas C
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Department of Dermatology, Hospital Universitario de Móstoles, Madrid, Spain.
FAU - Carrera, Caty
AU  - Carrera C
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Gerència Territorial de la Catalunya Central, Institut Català de la Salut, 
      Barcelona, Spain.
FAU - Ouchi, Dan
AU  - Ouchi D
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
FAU - Prat, Núria
AU  - Prat N
AD  - Gerència Territorial Metropolitana Nord, Institut Català de la Salut, Barcelona, 
      Spain.
FAU - Ara, Jordi
AU  - Ara J
AD  - Gerència Territorial Metropolitana Nord, Institut Català de la Salut, Barcelona, 
      Spain.
FAU - Nadal, Nuria
AU  - Nadal N
AD  - Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
FAU - Riel, Ricard
AU  - Riel R
AD  - Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
FAU - Funollet, Blanca
AU  - Funollet B
AD  - Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
FAU - Ojeda-Ciurana, Carmen
AU  - Ojeda-Ciurana C
AD  - Gerència Territorial Metropolitana Sud, Institut Català de la Salut, Barcelona, 
      Spain.
FAU - Balague, Lluis Esteve
AU  - Balague LE
AD  - Gerència Territorial Metropolitana Sud, Institut Català de la Salut, Barcelona, 
      Spain.
FAU - Salvador-González, Betlem
AU  - Salvador-González B
AD  - Gerència Territorial Metropolitana Sud, Institut Català de la Salut, Barcelona, 
      Spain.
AD  - Unitat de Suport a la Recerca Costa de Ponent, Fundació Institut Universitari per 
      a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 
      l'Hospitalet de Llobregat, Spain.
FAU - Arcarons, Anna Forcada
AU  - Arcarons AF
AD  - Gerència Territorial de la Catalunya Central, Institut Català de la Salut, 
      Barcelona, Spain.
FAU - Vidal-Alaball, Josep
AU  - Vidal-Alaball J
AD  - Unitat de Suport a la Recerca de la Catalunya Central, Fundació Institut 
      Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, 
      Sant Fruitós de Bages, Spain.
AD  - Health Promotion in Rural Areas Research Group, Gerència Territorial de la 
      Catalunya Central, Institut Català de la Salut, Sant Fruitós de Bages, Spain.
AD  - Facultat de Medicina, Universitat de Vic - Universitat Central de Catalunya 
      (UVIC-UCC), Vic, Spain.
FAU - Del Cura-González, María Isabel
AU  - Del Cura-González MI
AD  - Unidad de Investigación, Gerencia Asistencial de Atención Primaria, Madrid, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      -RICAPPS- ISCIII, Spain.
FAU - Barrientos, Ricardo Rodríguez
AU  - Barrientos RR
AD  - Unidad de Investigación, Gerencia Asistencial de Atención Primaria, Madrid, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      -RICAPPS- ISCIII, Spain.
FAU - Ramos-Blanes, Rafel
AU  - Ramos-Blanes R
AD  - Unitat de Suport a la Recerca de Girona, Fundació Institut Universitari per a la 
      recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Girona, 
      Spain.
FAU - Bou, Alberto Alum
AU  - Bou AA
AD  - Unitat de Suport a la Recerca de Girona, Fundació Institut Universitari per a la 
      recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Girona, 
      Spain.
FAU - Mondou, Elsa
AU  - Mondou E
AD  - Scientific Innovation Office, Grifols, Barcelona, Spain.
FAU - Torres, Mireia
AU  - Torres M
AD  - Scientific Innovation Office, Grifols, Barcelona, Spain.
FAU - Campins, Neus
AU  - Campins N
AD  - Scientific Innovation Office, Grifols, Barcelona, Spain.
FAU - Sanz, Ana
AU  - Sanz A
AD  - Scientific Innovation Office, Grifols, Barcelona, Spain.
FAU - Tang, Yonggiang
AU  - Tang Y
AD  - Scientific Innovation Office, Grifols, Barcelona, Spain.
FAU - Rodriguez-Arias, Miquel Àngel
AU  - Rodriguez-Arias MÀ
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
FAU - Bassat, Quique
AU  - Bassat Q
AD  - ISGlobal, Hospital Clinic - Universitat de Barcelona, Barcelona, Spain.
AD  - Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, 
      Esplugues, Barcelona, Spain.
AD  - Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, 
      Madrid, Spain.
AD  - ICREA, Pg Lluís Companys 23, Barcelona, Spain.
AD  - Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
FAU - Clotet, Bonaventura
AU  - Clotet B
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
AD  - Facultat de Medicina, Universitat de Vic - Universitat Central de Catalunya 
      (UVIC-UCC), Vic, Spain.
AD  - IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute, Can 
      Ruti Campus, Badalona, Spain.
CN  - GC2010 STUDY GROUP
FAU - Mitjà, Oriol
AU  - Mitjà O
AD  - Fight Infectious Diseases Foundation, Badalona, Spain.
AD  - Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
AD  - Facultat de Medicina, Universitat de Vic - Universitat Central de Catalunya 
      (UVIC-UCC), Vic, Spain.
AD  - Lihir Medical Centre, International SOS, Lihir Island, Papua New Guinea.
LA  - eng
SI  - ClinicalTrials.gov/NCT04847141
PT  - Journal Article
DEP - 20230310
PL  - England
TA  - EClinicalMedicine
JT  - EClinicalMedicine
JID - 101733727
PMC - PMC10005687
OTO - NOTNLM
OT  - Antibody therapies
OT  - Asymptomatic individuals
OT  - COVID-19
OT  - Hyperimmune immunoglobulin
OT  - Outpatients
OT  - SARS-CoV-2
COIS- EM, MT, NC, AS, and YT were employees from Grifols. The rest of authors declared 
      no conflict of interest.
FIR - Aguilar-Uroz, Adrià
IR  - Aguilar-Uroz A
FIR - Rosell-García-Ufano, Adrià
IR  - Rosell-García-Ufano A
FIR - Escudero Planas, Adrián
IR  - Escudero Planas A
FIR - Baelo, Aida
IR  - Baelo A
FIR - Villahoz Martín, Ainhoa
IR  - Villahoz Martín A
FIR - Moreno López, Alberto
IR  - Moreno López A
FIR - Roldan Ruiz, Alberto
IR  - Roldan Ruiz A
FIR - Santana Briongos, Alberto
IR  - Santana Briongos A
FIR - Tejera Bodas, Alberto
IR  - Tejera Bodas A
FIR - Alonso-Vallés, Alejandro
IR  - Alonso-Vallés A
FIR - Fletes-Pérez, Alejandro
IR  - Fletes-Pérez A
FIR - Hueso-Mor, Alejandro
IR  - Hueso-Mor A
FIR - Boluda, Alex
IR  - Boluda A
FIR - Santamaria, Alex
IR  - Santamaria A
FIR - Diestro, Alicia Santos
IR  - Diestro AS
FIR - Revuelta-Álvarez, Almudena
IR  - Revuelta-Álvarez A
FIR - Moreno Moreno, Álvaro
IR  - Moreno Moreno Á
FIR - Ortega de Felipe, Ana
IR  - Ortega de Felipe A
FIR - Chen-Ye, Ana
IR  - Chen-Ye A
FIR - Blázquez Valerón, Ana
IR  - Blázquez Valerón A
FIR - Rodríguez Pérez, Ana Belén
IR  - Rodríguez Pérez AB
FIR - Tristán Morgalo, Ana Laura
IR  - Tristán Morgalo AL
FIR - Fernández-Allende, Ana Luisa
IR  - Fernández-Allende AL
FIR - Bagán-Trejo, Andrea
IR  - Bagán-Trejo A
FIR - Fernández Juan, Andrés
IR  - Fernández Juan A
FIR - Zalve-Cano, Ángel
IR  - Zalve-Cano Á
FIR - Mateo-Martínez, Anna
IR  - Mateo-Martínez A
FIR - Galván, Antonio Valero
IR  - Galván AV
FIR - Egidos-Plaja, Antonio
IR  - Egidos-Plaja A
FIR - Jorge, Ariadna
IR  - Jorge A
FIR - Fraile Torres, Arturo
IR  - Fraile Torres A
FIR - Pareja Leal, Azahara Maria
IR  - Pareja Leal AM
FIR - Viader Castro, Bárbara
IR  - Viader Castro B
FIR - Fernandez Beato, Barbara
IR  - Fernandez Beato B
FIR - Naveira Menchen, Barbara
IR  - Naveira Menchen B
FIR - Martin Poyatos, Beatriz
IR  - Martin Poyatos B
FIR - García-Martínez, Beatriz
IR  - García-Martínez B
FIR - Rodrigo Testillano, Belén
IR  - Rodrigo Testillano B
FIR - Blanco Tejedor, Belen
IR  - Blanco Tejedor B
FIR - López Pérez, Blanca
IR  - López Pérez B
FIR - Mencía Hernanz, Blanca
IR  - Mencía Hernanz B
FIR - González-Beiras, Camila
IR  - González-Beiras C
FIR - Batres, Carlos
IR  - Batres C
FIR - Batres, Carlos
IR  - Batres C
FIR - Nuñez Garcia, Carmen
IR  - Nuñez Garcia C
FIR - Merino-Rodríguez, Carmen
IR  - Merino-Rodríguez C
FIR - Rodríguez-Gilabert, Carolina
IR  - Rodríguez-Gilabert C
FIR - Bonilla Penedo, Celia
IR  - Bonilla Penedo C
FIR - Bonilla Penedo, Celia
IR  - Bonilla Penedo C
FIR - Casado Gomez, Christian
IR  - Casado Gomez C
FIR - Gonzalez Perez, Claudia
IR  - Gonzalez Perez C
FIR - Galindo-Tomás, Claudia
IR  - Galindo-Tomás C
FIR - Peral Bolaños, Cristina
IR  - Peral Bolaños C
FIR - Blanco-Montes, Cristina
IR  - Blanco-Montes C
FIR - Lupu-Yakovleva, Cristina
IR  - Lupu-Yakovleva C
FIR - Lopez Ruiz, Cristina
IR  - Lopez Ruiz C
FIR - Perez Mayoral, Cristina
IR  - Perez Mayoral C
FIR - Fornes, Cristina
IR  - Fornes C
FIR - Garcia Corrochano, Cristobal
IR  - Garcia Corrochano C
FIR - Gallardo Álvarez, Daniel
IR  - Gallardo Álvarez D
FIR - Navarro Sanz, Daniel
IR  - Navarro Sanz D
FIR - Sanz Barrio, David
IR  - Sanz Barrio D
FIR - Ramet Meseguer, Debora
IR  - Ramet Meseguer D
FIR - Vera-Jurado, Edna Margarita
IR  - Vera-Jurado EM
FIR - Perez Costa, Eduardo
IR  - Perez Costa E
FIR - Bustillos-Sebastian, Eilen Junet
IR  - Bustillos-Sebastian EJ
FIR - Palomar Casado, Elena
IR  - Palomar Casado E
FIR - Guerrero, Elena Dorrego
IR  - Guerrero ED
FIR - Medina Mateos, Elena
IR  - Medina Mateos E
FIR - Aragón Gaspar, Elisa Rebeca
IR  - Aragón Gaspar ER
FIR - Herrero-Vila, Elisabeth
IR  - Herrero-Vila E
FIR - Paez Herrera, Enriqueta
IR  - Paez Herrera E
FIR - Rojas Powel, Esmeralda
IR  - Rojas Powel E
FIR - Robres Medialdea, Esther
IR  - Robres Medialdea E
FIR - Vall-Ribalta, Esther
IR  - Vall-Ribalta E
FIR - Lopez Perez, Eva
IR  - Lopez Perez E
FIR - Mihaela Fer, Felicia
IR  - Mihaela Fer F
FIR - Vazquez Ángeles, Fernanda
IR  - Vazquez Ángeles F
FIR - Tirado Bejarano, Fernando
IR  - Tirado Bejarano F
FIR - Prats-Domenech, Ferran
IR  - Prats-Domenech F
FIR - Borràs Martí, Ferran
IR  - Borràs Martí F
FIR - Ardila-Mejia, Gabriela
IR  - Ardila-Mejia G
FIR - Costes, Gèlia
IR  - Costes G
FIR - Gómez Arquero, Gema
IR  - Gómez Arquero G
FIR - Flores Mateo, Gemma
IR  - Flores Mateo G
FIR - Pintos-Morell, Guillem
IR  - Pintos-Morell G
FIR - Mira-Centelles, Helena
IR  - Mira-Centelles H
FIR - Astola Requena, Ignacio
IR  - Astola Requena I
FIR - Ortega Martin, Ignacio
IR  - Ortega Martin I
FIR - Leivas-Gutierrez, Iker
IR  - Leivas-Gutierrez I
FIR - Escribano Valenciano, Irene
IR  - Escribano Valenciano I
FIR - Muñoz Gomez, Irene
IR  - Muñoz Gomez I
FIR - Ortega, Irina
IR  - Ortega I
FIR - Montserrat-Lloan, Isabel
IR  - Montserrat-Lloan I
FIR - Gamboa, Itziar
IR  - Gamboa I
FIR - Rodríguez de Torres de Paul, Jacobo
IR  - Rodríguez de Torres de Paul J
FIR - Cahís, Jordi
IR  - Cahís J
FIR - Muñoz-Martinez, Jordi
IR  - Muñoz-Martinez J
FIR - Bermejo, Jorge Iglesias
IR  - Bermejo JI
FIR - Cejas López, Joselvis Virginia
IR  - Cejas López JV
FIR - Canudas, Josep
IR  - Canudas J
FIR - García Lucas, Juan Antonio
IR  - García Lucas JA
FIR - Martínez-Pino, Juan Carlos
IR  - Martínez-Pino JC
FIR - Torres Martínez, Juana
IR  - Torres Martínez J
FIR - Pujol-Corney, Judit
IR  - Pujol-Corney J
FIR - González Jiménez, Judith
IR  - González Jiménez J
FIR - Gurí, Júlia
IR  - Gurí J
FIR - Labella Martín, Julio
IR  - Labella Martín J
FIR - Garcia-Cano, Laia
IR  - Garcia-Cano L
FIR - Perez Plata, Lara Sonsoles
IR  - Perez Plata LS
FIR - Muñoz Álvaro, Laura
IR  - Muñoz Álvaro L
FIR - Rodríguez Andrés, Laura
IR  - Rodríguez Andrés L
FIR - Vega Ruiz, Laura
IR  - Vega Ruiz L
FIR - Cuevas Valiente, Laura
IR  - Cuevas Valiente L
FIR - Díaz Rodríguez, Laura
IR  - Díaz Rodríguez L
FIR - Puigros, Laura
IR  - Puigros L
FIR - Oristina Rciorang, Lavinia
IR  - Oristina Rciorang L
FIR - Escudero, Leticia
IR  - Escudero L
FIR - Figueroa Caballero, Liliana
IR  - Figueroa Caballero L
FIR - Ferrerfàbrega-Costals, Lluna
IR  - Ferrerfàbrega-Costals L
FIR - Costafreda-Hernández, Lucía
IR  - Costafreda-Hernández L
FIR - De-Paúl, Lucía
IR  - De-Paúl L
FIR - González Fernández-Medina, Luis
IR  - González Fernández-Medina L
FIR - Moliner Prada, Ma Carmen
IR  - Moliner Prada MC
FIR - Berriochoa Martínez de Pisón, Ma Cristina
IR  - Berriochoa Martínez de Pisón MC
FIR - Blanco Blasco, Maria
IR  - Blanco Blasco M
FIR - Gil Jorge, Maria
IR  - Gil Jorge M
FIR - Cortijo Caballero, María
IR  - Cortijo Caballero M
FIR - Ubals, Maria
IR  - Ubals M
FIR - Gordillo, Maria
IR  - Gordillo M
FIR - Guilloto López, Maria Alicia
IR  - Guilloto López MA
FIR - Moreno Calvo, Maria Concepción
IR  - Moreno Calvo MC
FIR - Gil García, María Del Rosario
IR  - Gil García MDR
FIR - Dueñas Román, María Inmaculada
IR  - Dueñas Román MI
FIR - Gonzalez Sanchez, Maria Josefa
IR  - Gonzalez Sanchez MJ
FIR - Nicolás Campoy, María Luisa
IR  - Nicolás Campoy ML
FIR - González Velayos, Maria Luz
IR  - González Velayos ML
FIR - Zori, Mario Mejías
IR  - Zori MM
FIR - Maqueda, Mario Oliva
IR  - Maqueda MO
FIR - Caño de la Cruz, Mario
IR  - Caño de la Cruz M
FIR - Palau-Morral, Mariona
IR  - Palau-Morral M
FIR - Martín-Muñoz, Marta
IR  - Martín-Muñoz M
FIR - Cereceda Meca, Marta
IR  - Cereceda Meca M
FIR - Díaz Urbina, Marta
IR  - Díaz Urbina M
FIR - VerónicaPlazas, Martha
IR  - VerónicaPlazas M
FIR - Vall-Mayans, Martí
IR  - Vall-Mayans M
FIR - Blasco, Martí
IR  - Blasco M
FIR - Jane Chu-Sifuentes, Mary
IR  - Jane Chu-Sifuentes M
FIR - García de Villasladad Peñaranda, Miguel
IR  - García de Villasladad Peñaranda M
FIR - Hernanz Sotoca, Miguel
IR  - Hernanz Sotoca M
FIR - Iglesias Gonzalez, Miguel
IR  - Iglesias Gonzalez M
FIR - Labrador-Galván, Miguel Ángel
IR  - Labrador-Galván MÁ
FIR - Rodrigo de Vivar Azcarate, Miguel
IR  - Rodrigo de Vivar Azcarate M
FIR - Gil-Fibla, Miquel
IR  - Gil-Fibla M
FIR - Formentí-Pallarés, Miquel
IR  - Formentí-Pallarés M
FIR - Esteve-Tugues, Mireia
IR  - Esteve-Tugues M
FIR - Juanes Perez, Miriam
IR  - Juanes Perez M
FIR - López Rubio, Miriam
IR  - López Rubio M
FIR - Recuero Renales, Mirian
IR  - Recuero Renales M
FIR - Hijós-Rullo, Mònica
IR  - Hijós-Rullo M
FIR - Lleonart-Abadia, Montserrat
IR  - Lleonart-Abadia M
FIR - Finelli, Nadia
IR  - Finelli N
FIR - Rojas-Bertier, Naiara
IR  - Rojas-Bertier N
FIR - Reyes-Calderón, Nataly
IR  - Reyes-Calderón N
FIR - Casado Larrañaga, Nerea
IR  - Casado Larrañaga N
FIR - Zurita Castrosin, Nerea Nuria
IR  - Zurita Castrosin NN
FIR - Álvarez-Nieto, Noélia
IR  - Álvarez-Nieto N
FIR - Leiva-Mora, Nuria
IR  - Leiva-Mora N
FIR - Tomillo-Martín, Olga
IR  - Tomillo-Martín O
FIR - Belghazi, Omar
IR  - Belghazi O
FIR - Buscà, Oriol
IR  - Buscà O
FIR - Mendoza Cediel, Pablo
IR  - Mendoza Cediel P
FIR - Macedo, Pablo
IR  - Macedo P
FIR - Rodríguez Barroso, Patricia
IR  - Rodríguez Barroso P
FIR - Ruiz Álvarez, Patricia
IR  - Ruiz Álvarez P
FIR - López, Patricia Morales
IR  - López PM
FIR - Vara de Rey, Patricia Jimenez
IR  - Vara de Rey PJ
FIR - Ginés, Paz Lozano
IR  - Ginés PL
FIR - Bris Rodriguez, Pilar
IR  - Bris Rodriguez P
FIR - Martínez-Alamillo, Pilar
IR  - Martínez-Alamillo P
FIR - Salmerón Martínez, Rafa
IR  - Salmerón Martínez R
FIR - Botello Ariza, Raquel
IR  - Botello Ariza R
FIR - Vaquero Mena, Raquel
IR  - Vaquero Mena R
FIR - González-Alonso, Raquel
IR  - González-Alonso R
FIR - Kaczmarczyk, Raul
IR  - Kaczmarczyk R
FIR - Barnadas Vintró, Rita
IR  - Barnadas Vintró R
FIR - Hontecillas Martínez, Rodrigo
IR  - Hontecillas Martínez R
FIR - Ribot-Rodríguez, Rosa
IR  - Ribot-Rodríguez R
FIR - Escobar-Sánchez, Rosa
IR  - Escobar-Sánchez R
FIR - Montes Trinidad, Rosario Paloma
IR  - Montes Trinidad RP
FIR - Martínez Quintana, Rubén
IR  - Martínez Quintana R
FIR - Arnay Arrogante, Ruben
IR  - Arnay Arrogante R
FIR - Berjon Sanchez, Ruben
IR  - Berjon Sanchez R
FIR - Picazo Navarro, Ruben
IR  - Picazo Navarro R
FIR - Bastos, Rubén
IR  - Bastos R
FIR - Martín Molinero, Samuel
IR  - Martín Molinero S
FIR - Israel-Benchaya, Samuel Dan
IR  - Israel-Benchaya SD
FIR - Muñoz-Burguillo, Sandra
IR  - Muñoz-Burguillo S
FIR - Rodríguez-Salvador, Sandra
IR  - Rodríguez-Salvador S
FIR - Avila, Sara
IR  - Avila S
FIR - Corral Gayubas, Sara
IR  - Corral Gayubas S
FIR - Nuñez Sánchez, Sergio
IR  - Nuñez Sánchez S
FIR - Torres Weber, Sofía
IR  - Torres Weber S
FIR - Encabo Lopez, Susana
IR  - Encabo Lopez S
FIR - Torices Rasines, Teresa
IR  - Torices Rasines T
FIR - Sallas, Valentí
IR  - Sallas V
FIR - Curto-Vicente, Verónica
IR  - Curto-Vicente V
FIR - Gómez Hijosa, Verónica
IR  - Gómez Hijosa V
FIR - Daimiel-Pedrote, Verónica
IR  - Daimiel-Pedrote V
FIR - Gozalo, Verónica
IR  - Gozalo V
FIR - Barrios López, Vicente
IR  - Barrios López V
FIR - Castillo Montoya, Virginia Ivette
IR  - Castillo Montoya VI
FIR - Espinoza Pérez, Yuri
IR  - Espinoza Pérez Y
FIR - CristinaBerriochoa Martínez de Pisón, María
IR  - CristinaBerriochoa Martínez de Pisón M
FIR - Muñoz Castillo, David
IR  - Muñoz Castillo D
FIR - Donato, Carlos
IR  - Donato C
FIR - García García, Isabel
IR  - García García I
EDAT- 2023/03/21 06:00
MHDA- 2023/03/21 06:01
CRDT- 2023/03/20 03:46
PHST- 2022/12/04 00:00 [received]
PHST- 2023/02/16 00:00 [revised]
PHST- 2023/02/17 00:00 [accepted]
PHST- 2023/03/20 03:46 [entrez]
PHST- 2023/03/21 06:00 [pubmed]
PHST- 2023/03/21 06:01 [medline]
AID - S2589-5370(23)00075-5 [pii]
AID - 101898 [pii]
AID - 10.1016/j.eclinm.2023.101898 [doi]
PST - epublish
SO  - EClinicalMedicine. 2023 Mar 10;57:101898. doi: 10.1016/j.eclinm.2023.101898. 
      eCollection 2023 Mar.

PMID- 36921481
OWN - NLM
STAT- MEDLINE
DCOM- 20230328
LR  - 20230330
IS  - 1872-8243 (Electronic)
IS  - 1386-5056 (Print)
IS  - 1386-5056 (Linking)
VI  - 173
DP  - 2023 May
TI  - Clinical prediction rules for adverse evolution in patients with COVID-19 by the 
      Omicron variant.
PG  - 105039
LID - S1386-5056(23)00057-6 [pii]
LID - 10.1016/j.ijmedinf.2023.105039 [doi]
AB  - OBJECTIVE: We identify factors related to SARS-CoV-2 infection linked to 
      hospitalization, ICU admission, and mortality and develop clinical prediction 
      rules. METHODS: Retrospective cohort study of 380,081 patients with SARS-CoV-2 
      infection from March 1, 2020 to January 9, 2022, including a subsample of 46,402 
      patients who attended Emergency Departments (EDs) having data on vital signs. For 
      derivation and external validation of the prediction rule, two different periods 
      were considered: before and after emergence of the Omicron variant, respectively. 
      Data collected included sociodemographic data, COVID-19 vaccination status, 
      baseline comorbidities and treatments, other background data and vital signs at 
      triage at EDs. The predictive models for the EDs and the whole samples were 
      developed using multivariate logistic regression models using Lasso penalization. 
      RESULTS: In the multivariable models, common predictive factors of death among 
      EDs patients were greater age; being male; having no vaccination, dementia; heart 
      failure; liver and kidney disease; hemiplegia or paraplegia; coagulopathy; 
      interstitial pulmonary disease; malignant tumors; use chronic systemic use of 
      steroids, higher temperature, low O2 saturation and altered blood pressure-heart 
      rate. The predictors of an adverse evolution were the same, with the exception of 
      liver disease and the inclusion of cystic fibrosis. Similar predictors were found 
      to be related to hospital admission, including liver disease, arterial 
      hypertension, and basal prescription of immunosuppressants. Similarly, models for 
      the whole sample, without vital signs, are presented. CONCLUSIONS: We propose 
      risk scales, based on basic information, easily-calculable, high-predictive that 
      also function with the current Omicron variant and may help manage such patients 
      in primary, emergency, and hospital care.
CI  - Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.
FAU - Portuondo-Jiménez, Janire
AU  - Portuondo-Jiménez J
AD  - Osakidetza Basque Health Service, Sub-Directorate for Primary Care Coordination, 
      Vitoria-Gasteiz, Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Spain.
FAU - Barrio, Irantzu
AU  - Barrio I
AD  - University of the Basque Country UPV/EHU, Department of Mathematics, Leioa, 
      Spain; Basque Center for Applied Mathematics, BCAM, Spain. Electronic address: 
      irantzu.barrio@ehu.eus.
FAU - España, Pedro P
AU  - España PP
AD  - Biocruces Bizkaia Health Research Institute, Barakaldo, Spain; Osakidetza Basque 
      Health Service, Galdakao-Usansolo University Hospital, Respiratory Unit, 
      Galdakao, Spain.
FAU - García, Julia
AU  - García J
AD  - Basque Government Department of Health, Office of Healthcare Planning, 
      Organization and Evaluation, Basque Country, Spain.
FAU - Villanueva, Ane
AU  - Villanueva A
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, 
      Research Unit, Galdakao, Spain; Health Service Research Network on Chronic 
      Diseases (REDISSEC), Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain.
FAU - Gascón, María
AU  - Gascón M
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, 
      Research Unit, Galdakao, Spain; Health Service Research Network on Chronic 
      Diseases (REDISSEC), Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain.
FAU - Rodríguez, Lander
AU  - Rodríguez L
AD  - Basque Center for Applied Mathematics, BCAM, Spain.
FAU - Larrea, Nere
AU  - Larrea N
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, 
      Research Unit, Galdakao, Spain; Health Service Research Network on Chronic 
      Diseases (REDISSEC), Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain.
FAU - García-Gutierrez, Susana
AU  - García-Gutierrez S
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, 
      Research Unit, Galdakao, Spain; Health Service Research Network on Chronic 
      Diseases (REDISSEC), Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain.
FAU - Quintana, José M
AU  - Quintana JM
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain; Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, 
      Research Unit, Galdakao, Spain; Health Service Research Network on Chronic 
      Diseases (REDISSEC), Bilbao, Spain; Kronikgune Institute for Health Services 
      Research, Barakaldo, Spain.
CN  - COVID-Health Basque Country Research Group
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230307
PL  - Ireland
TA  - Int J Med Inform
JT  - International journal of medical informatics
JID - 9711057
RN  - 0 (COVID-19 Vaccines)
RN  - SARS-CoV-2 variants
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - *COVID-19/epidemiology
MH  - SARS-CoV-2
MH  - Clinical Decision Rules
MH  - Retrospective Studies
MH  - COVID-19 Vaccines
MH  - Hospitalization
PMC - PMC9988314
OTO - NOTNLM
OT  - COVID-19
OT  - Clinical decision rules
OT  - Health care
OT  - Outcome assessment
OT  - SARS-CoV-2
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2023/03/16 06:00
MHDA- 2023/03/28 17:15
CRDT- 2023/03/15 19:11
PHST- 2022/11/17 00:00 [received]
PHST- 2023/02/03 00:00 [revised]
PHST- 2023/03/01 00:00 [accepted]
PHST- 2023/03/28 17:15 [medline]
PHST- 2023/03/16 06:00 [pubmed]
PHST- 2023/03/15 19:11 [entrez]
AID - S1386-5056(23)00057-6 [pii]
AID - 105039 [pii]
AID - 10.1016/j.ijmedinf.2023.105039 [doi]
PST - ppublish
SO  - Int J Med Inform. 2023 May;173:105039. doi: 10.1016/j.ijmedinf.2023.105039. Epub 
      2023 Mar 7.

PMID- 36921453
OWN - NLM
STAT- MEDLINE
DCOM- 20230328
LR  - 20230522
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Linking)
VI  - 37
DP  - 2023
TI  - [Narratives on changes in health-related behaviours during lockdown in Spain 
      according to gender].
PG  - 102296
LID - S0213-9111(23)00010-9 [pii]
LID - 10.1016/j.gaceta.2023.102296 [doi]
AB  - OBJECTIVE: To explore experiences related to health-oriented behaviours during 
      lockdown in the Spanish resident population from a gender perspective. METHOD: 
      Qualitative research with a critical and feminist approach. Twenty-nine 
      semi-structured interviews (17 women and 12 men) were conducted between June and 
      July 2020 via telephone with people who had previously answered an online survey. 
      The interviews were transcribed and a thematic content analysis was carried out, 
      differentiating between the experiences of women and men. The data were 
      triangulated by the research team. RESULTS: Among women, greater diversity 
      emerged in terms of health behaviours. Among them, the difficult experiences 
      related to COVID-19, the complexity of living together and doing unpaid care 
      work, as well as the importance of support networks, stood out. Among men, there 
      were different attitudes towards sport, self-care and having time for healthy 
      eating were positively valued, and there was a good assessment of coexistence and 
      organisation in household chores. In both men and women, work overload and 
      economic problems were related to emotional distress and difficulties in carrying 
      out healthy activities. CONCLUSIONS: Health-oriented behaviours during lockdown 
      differed according to gender. They were mostly limited to COVID-19 experiences, 
      socio-economic conditions and burden of care. It is essential to tailor public 
      health and primary care programmes according to people's life moments, taking 
      into account their social context and questioning traditional gender roles.
CI  - Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Jacques-Aviñó, Constanza
AU  - Jacques-Aviñó C
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de 
      Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      España. Electronic address: cjacques@idiapjgol.org.
FAU - Medina-Perucha, Laura
AU  - Medina-Perucha L
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de 
      Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      España.
FAU - Young-Silva, Yudy
AU  - Young-Silva Y
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Unitat de Suport a la Recerca Girona, Girona, 
      España; Departament d'Infermeria, Universitat de Girona, Girona, España.
FAU - Granés, Laura
AU  - Granés L
AD  - Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic, Barcelona, 
      España.
FAU - Lòpez-Jiménez, Tomás
AU  - Lòpez-Jiménez T
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de 
      Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      España.
FAU - Berenguera, Anna
AU  - Berenguera A
AD  - Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, España; Universitat Autònoma de 
      Barcelona, Bellaterra, Cerdanyola del Vallès (Barcelona), España; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      España; Departament d'Infermeria, Universitat de Girona, Girona, España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Narrativas sobre cambios de conductas en salud durante el confinamiento en España 
      según género.
DEP - 20230313
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - Spain/epidemiology
MH  - *Health Behavior
MH  - *Quarantine/psychology/statistics & numerical data
MH  - Sex Factors
MH  - Qualitative Research
MH  - Telephone
MH  - Interviews as Topic
MH  - *COVID-19/epidemiology
MH  - Diet, Healthy/psychology
MH  - Self Care/psychology
MH  - Sports/psychology
MH  - *Stress, Physiological
MH  - Workload/psychology
MH  - Financial Stress/psychology
MH  - Public Health
MH  - Psychosocial Support Systems
OTO - NOTNLM
OT  - COVID-19
OT  - Comportamientos en salud
OT  - Cuarentena
OT  - Gender role
OT  - Health behaviour
OT  - Investigación cualitativa
OT  - Qualitative research
OT  - Quarantine
OT  - Rol de género
EDAT- 2023/03/16 06:00
MHDA- 2023/03/24 06:00
CRDT- 2023/03/15 19:10
PHST- 2022/08/24 00:00 [received]
PHST- 2023/01/16 00:00 [revised]
PHST- 2023/01/17 00:00 [accepted]
PHST- 2023/03/15 19:10 [entrez]
PHST- 2023/03/16 06:00 [pubmed]
PHST- 2023/03/24 06:00 [medline]
AID - S0213-9111(23)00010-9 [pii]
AID - 10.1016/j.gaceta.2023.102296 [doi]
PST - epublish
SO  - Gac Sanit. 2023 Mar 13;37:102296. doi: 10.1016/j.gaceta.2023.102296. eCollection 
      2023.

PMID- 36901448
OWN - NLM
STAT- MEDLINE
DCOM- 20230314
LR  - 20230418
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 5
DP  - 2023 Mar 2
TI  - A Systematic Review of the Adherence to Home-Practice Meditation Exercises in 
      Patients with Chronic Pain.
LID - 10.3390/ijerph20054438 [doi]
LID - 4438
AB  - Mindfulness-, compassion-, and acceptance-based (i.e., "third wave") 
      psychotherapies are effective for treating chronic pain conditions. Many of these 
      programs require that patients engage in the systematic home practice of 
      meditation experiences so they can develop meditation skills. This systematic 
      review aimed at evaluating the frequency, duration, and effects of home practice 
      in patients with chronic pain undergoing a "third wave" psychotherapy. A 
      comprehensive database search for quantitative studies was conducted in PubMed, 
      Embase, and Web of Sciences Core Collection; 31 studies fulfilled the inclusion 
      criteria. The reviewed studies tended to indicate a pattern of moderately 
      frequent practice (around four days/week), with very high variability in terms of 
      time invested; most studies observed significant associations between the amount 
      of practice and positive health outcomes. Mindfulness-Based Stress Reduction and 
      Mindfulness-Based Cognitive Therapy were the most common interventions and 
      presented low levels of adherence to home practice (39.6% of the recommended 
      time). Some studies were conducted on samples of adolescents, who practiced very 
      few minutes, and a few tested eHealth interventions with heterogeneous adherence 
      levels. In conclusion, some adaptations may be required so that patients with 
      chronic pain can engage more easily and, thus, effectively in home meditation 
      practices.
FAU - Barceló-Soler, Alberto
AU  - Barceló-Soler A
AUID- ORCID: 0000-0002-2116-9257
AD  - Institute of Health Research of Aragon (IIS), 50009 Zaragoza, Spain.
AD  - Navarra Medical Research Institute (IdiSNA), 31008 Pamplona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      50009 Zaragoza, Spain.
FAU - Morillo-Sarto, Héctor
AU  - Morillo-Sarto H
AUID- ORCID: 0000-0002-9852-2776
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      50009 Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Fernández-Martínez, Selene
AU  - Fernández-Martínez S
AD  - Institute of Health Research of Aragon (IIS), 50009 Zaragoza, Spain.
AD  - Department of Psychiatry, University of Zaragoza, 50009 Zaragoza, Spain.
FAU - Monreal-Bartolomé, Alicia
AU  - Monreal-Bartolomé A
AUID- ORCID: 0000-0003-2088-2007
AD  - Institute of Health Research of Aragon (IIS), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      50009 Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Chambel, Maria José
AU  - Chambel MJ
AUID- ORCID: 0000-0001-6588-7034
AD  - CicPsi, Faculdade de Psicologia, Universidade de Lisboa, 1649-004 Lisbon, 
      Portugal.
FAU - Gardiner, Paula
AU  - Gardiner P
AD  - Center for Mindfulness and Compassion, Cambridge Health Alliance, Cambridge, MA 
      02141, USA.
AD  - Department of Family Medicine, Medical School, University of Massachusetts, 
      Worcester, MA 01655, USA.
FAU - López-Del-Hoyo, Yolanda
AU  - López-Del-Hoyo Y
AUID- ORCID: 0000-0002-1690-4130
AD  - Institute of Health Research of Aragon (IIS), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      50009 Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - García-Campayo, Javier
AU  - García-Campayo J
AD  - Institute of Health Research of Aragon (IIS), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      50009 Zaragoza, Spain.
AD  - Department of Psychiatry, University of Zaragoza, 50009 Zaragoza, Spain.
FAU - Pérez-Aranda, Adrián
AU  - Pérez-Aranda A
AD  - Institute of Health Research of Aragon (IIS), 50009 Zaragoza, Spain.
AD  - Department of Basic, Developmental and Educational Psychology, 08193 Cerdanyola 
      del Vallès, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PT  - Systematic Review
DEP - 20230302
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Adolescent
MH  - Humans
MH  - *Meditation/psychology
MH  - *Chronic Pain
MH  - *Cognitive Behavioral Therapy
MH  - *Mindfulness
MH  - Chronic Disease
PMC - PMC10001876
OTO - NOTNLM
OT  - adherence
OT  - chronic pain
OT  - home practice
OT  - meditation
OT  - mindfulness
OT  - systematic review
OT  - third wave psychotherapy
COIS- The authors declare no conflict of interest.
EDAT- 2023/03/12 06:00
MHDA- 2023/03/15 06:00
CRDT- 2023/03/11 01:13
PHST- 2023/01/20 00:00 [received]
PHST- 2023/02/28 00:00 [revised]
PHST- 2023/03/01 00:00 [accepted]
PHST- 2023/03/11 01:13 [entrez]
PHST- 2023/03/12 06:00 [pubmed]
PHST- 2023/03/15 06:00 [medline]
AID - ijerph20054438 [pii]
AID - ijerph-20-04438 [pii]
AID - 10.3390/ijerph20054438 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Mar 2;20(5):4438. doi: 
      10.3390/ijerph20054438.

PMID- 36900935
OWN - NLM
STAT- MEDLINE
DCOM- 20230314
LR  - 20230419
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 5
DP  - 2023 Feb 22
TI  - Digital Health Literacy and Person-Centred Care: Co-Creation of a Massive Open 
      Online Course for Women with Breast Cancer.
LID - 10.3390/ijerph20053922 [doi]
LID - 3922
AB  - The diagnosis of breast cancer (BC) can make the affected person vulnerable to 
      suffering the possible consequences of the use of low-quality health information. 
      Massive open online courses (MOOCs) may be a useful and efficient resource to 
      improve digital health literacy and person-centred care in this population. The 
      aim of this study is to co-create a MOOC for women with BC, using a modified 
      design approach based on patients' experience. Co-creation was divided into three 
      sequential phases: exploratory, development and evaluation. Seventeen women in 
      any stage of BC and two healthcare professionals participated. In the exploratory 
      phase, a patient journey map was carried out and empowerment needs related to 
      emotional management strategies and self-care guidelines were identified, as well 
      as information needs related to understanding medical terminology. In the 
      development phase, participants designed the structure and contents of the MOOC 
      through a Moodle platform. A MOOC with five units was developed. In the 
      evaluation phase, participants strongly agreed that their participation was 
      useful for the MOOC's development and participating in the co-creation process 
      made the content more relevant to them (experience in the co-creation); most of 
      the participants positively evaluated the content or interface of the MOOC 
      (acceptability pilot). Educational interventions designed by women with BC is a 
      viable strategy to generate higher-quality, useful resources for this population.
FAU - Álvarez-Pérez, Yolanda
AU  - Álvarez-Pérez Y
AUID- ORCID: 0000-0002-6414-2863
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AUID- ORCID: 0000-0003-1171-9945
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Toledo-Chávarri, Ana
AU  - Toledo-Chávarri A
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Abt-Sacks, Analía
AU  - Abt-Sacks A
AUID- ORCID: 0000-0001-7153-8586
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AUID- ORCID: 0000-0002-9106-2420
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Torres-Castaño, Alezandra
AU  - Torres-Castaño A
AUID- ORCID: 0000-0003-4690-1421
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AUID- ORCID: 0000-0002-5067-3196
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AUID- ORCID: 0000-0002-6113-7313
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28029 Madrid, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 Tenerife, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230222
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Female
MH  - *Education, Distance
MH  - *Health Literacy
MH  - *Breast Neoplasms
MH  - Patient-Centered Care
PMC - PMC10001393
OTO - NOTNLM
OT  - MOOC
OT  - breast cancer
OT  - digital health literacy
OT  - health education
OT  - person-centred care
COIS- The authors declare no conflict of interest.
EDAT- 2023/03/12 06:00
MHDA- 2023/03/15 06:00
CRDT- 2023/03/11 01:09
PHST- 2022/12/21 00:00 [received]
PHST- 2023/02/20 00:00 [revised]
PHST- 2023/02/21 00:00 [accepted]
PHST- 2023/03/11 01:09 [entrez]
PHST- 2023/03/12 06:00 [pubmed]
PHST- 2023/03/15 06:00 [medline]
AID - ijerph20053922 [pii]
AID - ijerph-20-03922 [pii]
AID - 10.3390/ijerph20053922 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Feb 22;20(5):3922. doi: 
      10.3390/ijerph20053922.

PMID- 36899351
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230313
IS  - 1472-6955 (Print)
IS  - 1472-6955 (Electronic)
IS  - 1472-6955 (Linking)
VI  - 22
IP  - 1
DP  - 2023 Mar 10
TI  - Active legs: Impact of physical activity as an adjuvant treatment in the healing 
      of venous ulcers in primary care: a RCT protocol study.
PG  - 65
LID - 10.1186/s12912-023-01214-y [doi]
LID - 65
AB  - BACKGROUND: Venous ulcers usually present a torpid evolution with a negative 
      impact on patients' quality of life. In primary care, they account for 2.5% of 
      nursing consultations and their treatment represents high costs for national 
      health systems. These patients usually have a low level of physical activity, 
      with muscle pump dysfunction of the lower limbs, which may improve with increased 
      physical activity. The purpose of this study is to analyse the effectiveness of a 
      structured intervention involving physical activity and exercise (Active Legs) as 
      an adjuvant treatment in improving healing of chronic venous ulcers at 3 months 
      follow-up. METHODS: A randomized, multicentre clinical trial. A total of 224 
      individuals receiving primary nursing care with a diagnosis of venous ulcer, with 
      a diameter of 1 cm or greater and an ankle-brachial index between 0.8 and 1.3, 
      able to comply with the study requirements and consenting to participate, will be 
      sequentially included (112 per group). Both groups will receive the standard 
      treatment in primary care, with cleansing, debridement and healing in a moist 
      environment together with multilayer compression therapy. The intervention group 
      will also receive a structured educational intervention involving lower limb 
      physical exercise and daily ambulation guidelines. The primary response variables 
      will be complete healing -understood as complete and sustained epithelialisation 
      for at least 2 weeks- and time to healing. The secondary variables will be degree 
      of healing, ulcer area, quality of life, pain and variables related to the 
      healing process, prognosis, and recurrences. Sociodemographic variables, 
      adherence to treatment and satisfaction variables will also be recorded. Data 
      will be collected at baseline, at 3 months and at 6 months follow-up. Survival 
      analysis (Kaplan-Meier and Cox) will be performed to measure primary 
      effectiveness. Intention-to-treat analysis. DISCUSSION: If the intervention is 
      effective, a cost-effectiveness analysis could be conducted and implemented as an 
      additional intervention in the usual venous ulcer treatment in primary care. 
      TRIAL REGISTRATION: NCT04039789. [ https://ClinicalTrials.gov ]. 07/11/2019.
CI  - © 2023. The Author(s).
FAU - Herraiz-Ahijado, Borja
AU  - Herraiz-Ahijado B
AUID- ORCID: 0000-0002-3399-6188
AD  - Sanchinarro Healthcare Center. Primary Care Assistance Management, Madrid Health 
      Service, Calle San Martín de Porres, 6., Madrid, 28035, Spain. 
      borjajesus.herraiz@salud.madrid.org.
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      (RICORS-RICAPPS), Instituto de Salud Carlos III, Madrid, Spain. 
      borjajesus.herraiz@salud.madrid.org.
AD  - Gregorio Marañon Health Research Institute, Madrid Health Service, Madrid, Spain. 
      borjajesus.herraiz@salud.madrid.org.
AD  - Nursing Department. Faculty of Nursing, Physiotherapy and Podiatry, Universidad 
      Complutense de Madrid, Madrid, Spain. borjajesus.herraiz@salud.madrid.org.
AD  - PhD student. Doctoral Program in "Cuidados en Salud", Universidad Complutense de 
      Madrid, Madrid, Spain. borjajesus.herraiz@salud.madrid.org.
FAU - Folguera-Álvarez, Carmen
AU  - Folguera-Álvarez C
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      (RICORS-RICAPPS), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Gregorio Marañon Health Research Institute, Madrid Health Service, Madrid, Spain.
AD  - Nursing Department. Faculty of Nursing, Physiotherapy and Podiatry, Universidad 
      Complutense de Madrid, Madrid, Spain.
AD  - La Paz Healthcare Center. Primary Care Assistance Management, Madrid Health 
      Service, Rivas-Vaciamadrid, Spain.
AD  - Research Group on Public Health - Lifestyles, nursing methodology and care in the 
      community environment, Universidad Complutense de Madrid, Madrid, Spain.
FAU - Verdú-Soriano, José
AU  - Verdú-Soriano J
AD  - Faculty of Health Sciences. Department of Community Nursing, Preventive Medicine, 
      Public Health and History of Science, University of Alicante, Alicante, Spain.
FAU - Mori-Vara, Pilar
AU  - Mori-Vara P
AD  - Nursing Department. Faculty of Nursing, Physiotherapy and Podiatry, Universidad 
      Complutense de Madrid, Madrid, Spain.
AD  - Health Innovation Research Group. Nursing Department. Faculty of Nursing, 
      Physiotherapy and Podiatry, Universidad Complutense de Madrid, Madrid, Spain.
FAU - Rico-Blázquez, Milagros
AU  - Rico-Blázquez M
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      (RICORS-RICAPPS), Instituto de Salud Carlos III, Madrid, Spain.
AD  - Gregorio Marañon Health Research Institute, Madrid Health Service, Madrid, Spain.
AD  - Nursing Department. Faculty of Nursing, Physiotherapy and Podiatry, Universidad 
      Complutense de Madrid, Madrid, Spain.
AD  - Health Innovation Research Group. Nursing Department. Faculty of Nursing, 
      Physiotherapy and Podiatry, Universidad Complutense de Madrid, Madrid, Spain.
AD  - Research Unit. Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT04039789
PT  - Journal Article
DEP - 20230310
PL  - England
TA  - BMC Nurs
JT  - BMC nursing
JID - 101088683
PMC - PMC9999587
OTO - NOTNLM
OT  - Aging
OT  - Exercise
OT  - Nursing
OT  - Primary health care
OT  - Quality of life
OT  - Venous ulcer
OT  - Wound healing
COIS- The authors declare no competing interests.
EDAT- 2023/03/11 06:00
MHDA- 2023/03/11 06:01
CRDT- 2023/03/10 23:35
PHST- 2023/01/26 00:00 [received]
PHST- 2023/02/20 00:00 [accepted]
PHST- 2023/03/10 23:35 [entrez]
PHST- 2023/03/11 06:00 [pubmed]
PHST- 2023/03/11 06:01 [medline]
AID - 10.1186/s12912-023-01214-y [pii]
AID - 1214 [pii]
AID - 10.1186/s12912-023-01214-y [doi]
PST - epublish
SO  - BMC Nurs. 2023 Mar 10;22(1):65. doi: 10.1186/s12912-023-01214-y.

PMID- 36892600
OWN - NLM
STAT- MEDLINE
DCOM- 20230313
LR  - 20230624
IS  - 1432-1262 (Electronic)
IS  - 0179-1958 (Print)
IS  - 0179-1958 (Linking)
VI  - 38
IP  - 1
DP  - 2023 Mar 9
TI  - Five-year follow-up mortality prognostic index for colorectal patients.
PG  - 64
LID - 10.1007/s00384-023-04358-0 [doi]
LID - 64
AB  - PURPOSE: To identify 5-year survival prognostic variables in patients with 
      colorectal cancer (CRC) and to propose a survival prognostic score that also 
      takes into account changes over time in the patient's health-related quality of 
      life (HRQoL) status. METHODS: Prospective observational cohort study of CRC 
      patients. We collected data from their diagnosis, intervention, and at 1, 2, 3, 
      and 5 years following the index intervention, also collecting HRQoL data using 
      the EuroQol-5D-5L (EQ-5D-5L), European Organization for Research and Treatment of 
      Cancer's Quality of Life Questionnaire-Core 30 (EORTC-QLQ-C30), and Hospital 
      Anxiety and Depression Scale (HADS) questionnaires. Multivariate Cox proportional 
      models were used. RESULTS: We found predictors of mortality over the 5-year 
      follow-up to be being older; being male; having a higher TNM stage; having a 
      higher lymph node ratio; having a result of CRC surgery classified as R1 or R2; 
      invasion of neighboring organs; having a higher score on the Charlson comorbidity 
      index; having an ASA IV; and having worse scores, worse quality of life, on the 
      EORTC and EQ-5D questionnaires, as compared to those with higher scores in each 
      of those questionnaires respectively. CONCLUSIONS: These results allow preventive 
      and controlling measures to be established on long-term follow-up of these 
      patients, based on a few easily measurable variables. IMPLICATIONS FOR CANCER 
      SURVIVORS: Patients with colorectal cancer should be monitored more closely 
      depending on the severity of their disease and comorbidities as well as the 
      perceived health-related quality of life, and preventive measures should be 
      established to prevent adverse outcomes and therefore to ensure that better 
      treatment is received. TRIAL REGISTRATION: ClinicalTrials.gov identifier: 
      NCT02488161.
CI  - © 2023. The Author(s).
FAU - Orive, Miren
AU  - Orive M
AUID- ORCID: 0000-0003-1848-6638
AD  - Department of Social Psychology, Faculty of Pharmacy, University of the Basque 
      Country UPV/EHU, Vitoria, Spain. Miren.orive@ehu.eus.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain. Miren.orive@ehu.eus.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain. Miren.orive@ehu.eus.
FAU - Barrio, Irantzu
AU  - Barrio I
AD  - Department of Mathematics, University of the Basque Country UPV/EHU, Leioa, 
      Spain.
AD  - Basque Center for Applied Mathematics, BCAM, Bilbao, Spain.
FAU - Lázaro, Santiago
AU  - Lázaro S
AD  - Servicio de Cirugía General, Hospital Basurto, Bilbao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
FAU - Gonzalez, Nerea
AU  - Gonzalez N
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
FAU - Bare, Marisa
AU  - Bare M
AD  - Unidad de Epidemiología Clínica, Corporacio Parc Tauli, Barcelona, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
FAU - de Larrea, Nerea Fernandez
AU  - de Larrea NF
AD  - Centro Nacional de Epidemiología, ISCIII, Madrid, Spain.
AD  - CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AD  - Unidad de Investigación, Hospital Costa del Sol, Malaga, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Cortajarena, Sarai
AU  - Cortajarena S
AD  - Department of Mathematics, University of the Basque Country UPV/EHU, Leioa, 
      Spain.
FAU - Bilbao, Amaia
AU  - Bilbao A
AD  - Unidad de Investigación, Hospital Basurto, Bilbao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Aguirre, Urko
AU  - Aguirre U
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Sarasqueta, Cristina
AU  - Sarasqueta C
AD  - Unidad de Investigación, Hospital Donostia/BioDonostia, Donostia, Gipuzkoa, 
      Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
FAU - Quintana, José M
AU  - Quintana JM
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de La Salud 
      (RICAPPS), Galdakao, Spain.
CN  - REDISSEC-CARESS/CCR group
LA  - eng
SI  - ClinicalTrials.gov/NCT02488161
GR  - IT1456-22/Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza/
GR  - PS09/00805/Instituto de Salud Carlos III/
GR  - PS09/00746/Instituto de Salud Carlos III/
GR  - PS09/00910/Instituto de Salud Carlos III/
GR  - PI09/90397/Instituto de Salud Carlos III/
GR  - PI09/90490/Instituto de Salud Carlos III/
GR  - PS09/00314/Instituto de Salud Carlos III/
GR  - 2010111098/Osasun Saila, Eusko Jaurlaritzako/
PT  - Journal Article
PT  - Observational Study
DEP - 20230309
PL  - Germany
TA  - Int J Colorectal Dis
JT  - International journal of colorectal disease
JID - 8607899
SB  - IM
EIN - Int J Colorectal Dis. 2023 Jun 24;38(1):177. PMID: 37354325
MH  - Humans
MH  - Male
MH  - Female
MH  - *Quality of Life
MH  - Prognosis
MH  - Prospective Studies
MH  - Follow-Up Studies
MH  - Surveys and Questionnaires
MH  - *Colorectal Neoplasms
PMC - PMC9998584
OTO - NOTNLM
OT  - Cohort studies
OT  - Colorectal cancer
OT  - Health-related quality of life
OT  - Patient-reported outcome measures
OT  - Survival models
COIS- The authors declare no competing interests.
EDAT- 2023/03/10 06:00
MHDA- 2023/03/14 06:00
CRDT- 2023/03/09 11:13
PHST- 2023/02/23 00:00 [accepted]
PHST- 2023/03/09 11:13 [entrez]
PHST- 2023/03/10 06:00 [pubmed]
PHST- 2023/03/14 06:00 [medline]
AID - 10.1007/s00384-023-04358-0 [pii]
AID - 4358 [pii]
AID - 10.1007/s00384-023-04358-0 [doi]
PST - epublish
SO  - Int J Colorectal Dis. 2023 Mar 9;38(1):64. doi: 10.1007/s00384-023-04358-0.

PMID- 36889827
OWN - NLM
STAT- MEDLINE
DCOM- 20230312
LR  - 20230314
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 13
IP  - 3
DP  - 2023 Mar 8
TI  - Analysis of the determinants of sleep quality in a Spanish population: a study 
      protocol for a cross-sectional study.
PG  - e069444
LID - 10.1136/bmjopen-2022-069444 [doi]
LID - e069444
AB  - INTRODUCTION: Sleep problems are a growing public health concern being related, 
      among others, to an increased risk of cardiovascular diseases or worse cognitive 
      functioning. In addition, they can affect aspects related to personal motivation 
      and quality of life. However, very few studies have analysed the possible 
      determinants of sleep quality in the adult population as a whole, establishing 
      patterns based on these determinants.The objectives are to evaluate the 
      determinants of sleep quality in a representative sample of the general adult 
      population between 25 and 65 years old, and to establish patterns of sleep 
      quality based on lifestyles, psychological factors, morbidities, sociodemographic 
      variables, biological markers and other possible determinants. METHODS AND 
      ANALYSIS: Descriptive observational cross-sectional study. The study population 
      will include a representative sample of 500 people between 25 and 65 years old 
      from the cities of Salamanca and Ávila (Spain) selected by random sampling 
      stratified by age groups and sex. A 90-minute visit will be performed, during 
      which sleep quality will be assessed. The variables collected will be: morbidity, 
      lifestyles (physical activity, diet, toxic habits), psychological factors 
      (depression, stress, occupational stress and anxiety), socioeconomic and 
      work-related variables, habitability conditions of the habitual residence and 
      rest area, screen time, relaxation techniques and melatonin as a biological 
      marker related to sleep quality. DISCUSSION: With the results of this work, 
      improved interventions for behaviour modification could be designed, as well as 
      intervention and education programmes or other research aimed at improving sleep 
      quality. ETHICS AND DISSEMINATION: This study has a favourable opinion from the 
      Ethics Committee for Drug Research of the Health Areas of Salamanca and Ávila 
      (CEim Code: PI 2021 07 815). The results of this study will be published in 
      international impact journals of different specialties. TRIAL REGISTRATION 
      NUMBER: NCT05324267.
CI  - © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Jiménez-Vaquero, César
AU  - Jiménez-Vaquero C
AD  - Escuela Universitaria de Enfermería de Ávila, Ávila, Spain.
FAU - Alonso-Dominguez, Rosario
AU  - Alonso-Dominguez R
AUID- ORCID: 0000-0002-5816-4070
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), Gerencia de Atención 
      Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), 
      Salamanca, Spain rosa90alonso@hotmail.com.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, Salamanca, 
      Spain.
FAU - Garcia-Yu, Irene A
AU  - Garcia-Yu IA
AD  - Universidad de Salamanca, Salamanca, Spain.
FAU - Martín-Nogueras, Ana M
AU  - Martín-Nogueras AM
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, Salamanca, 
      Spain.
FAU - Sánchez-Aguadero, Natalia
AU  - Sánchez-Aguadero N
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), Gerencia de Atención 
      Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), 
      Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, Salamanca, 
      Spain.
FAU - Crespo-Sedano, Andrea
AU  - Crespo-Sedano A
AD  - Complejo Asistencial de Palencia, Palencia, Spain.
FAU - Rihuete-Galve, María I
AU  - Rihuete-Galve MI
AD  - Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
FAU - García-Alonso, María A
AU  - García-Alonso MA
AD  - Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
FAU - García-Prieto, María L
AU  - García-Prieto ML
AD  - Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
FAU - González-Sánchez, Jesús
AU  - González-Sánchez J
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), Gerencia de Atención 
      Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), 
      Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, Salamanca, 
      Spain.
FAU - Recio, José-Ignacio
AU  - Recio JI
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), Gerencia de Atención 
      Primaria de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), 
      Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, Salamanca, 
      Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT05324267
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20230308
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Adult
MH  - Aged
MH  - Humans
MH  - Middle Aged
MH  - Anxiety
MH  - Cross-Sectional Studies
MH  - Life Style
MH  - *Quality of Life
MH  - Sleep
MH  - *Sleep Quality
PMC - PMC10008228
OTO - NOTNLM
OT  - PREVENTIVE MEDICINE
OT  - PUBLIC HEALTH
OT  - SLEEP MEDICINE
COIS- Competing interests: None declared.
EDAT- 2023/03/09 06:00
MHDA- 2023/03/11 06:00
CRDT- 2023/03/08 20:53
PHST- 2023/03/08 20:53 [entrez]
PHST- 2023/03/09 06:00 [pubmed]
PHST- 2023/03/11 06:00 [medline]
AID - bmjopen-2022-069444 [pii]
AID - 10.1136/bmjopen-2022-069444 [doi]
PST - epublish
SO  - BMJ Open. 2023 Mar 8;13(3):e069444. doi: 10.1136/bmjopen-2022-069444.

PMID- 36882856
OWN - NLM
STAT- MEDLINE
DCOM- 20230508
LR  - 20230509
IS  - 1099-1611 (Electronic)
IS  - 1057-9249 (Linking)
VI  - 32
IP  - 5
DP  - 2023 May
TI  - Quality of life of early-stage breast-cancer patients diagnosed with COVID-19 in 
      the first three waves of the epidemic treated in the Spanish region of Navarre.
PG  - 730-740
LID - 10.1002/pon.6118 [doi]
AB  - OBJECTIVES: To describe the Quality of Life (QOL) of breast-cancer patients 
      diagnosed with COVID-19 and analyse its evolution, compare the QOL of these 
      patients according to the COVID-19 wave in which they were diagnosed, and examine 
      the clinical and demographic determinants of QOL. METHODS: A total of 260 
      patients with breast cancer (90.8% I-III stages) and COVID-19 (85% 
      light/moderate) were included (February-September 2021) in this study. Most 
      patients were receiving anticancer treatment (mainly hormonotherapy). Patients 
      were grouped according to the date of COVID-19 diagnosis: first wave (March-May 
      2020, 85 patients), second wave (June-December 2020, 107 patients) and third wave 
      (January-September 2021, 68 patients). Quality of Life was assessed 10 months, 
      7 months, and 2 weeks after these dates, respectively. Patients completed 
      QLQ-C30, QLQ-BR45, and Oslo COVID-19 QLQ-PW80 twice over four months. Patients 
      ≥65 also completed QLQ-ELD14. The QOL of each group and changes in QOL for the 
      whole sample were compared (non-parametric tests). Multivariate logistic 
      regression identified patient characteristics related to (1) low global QOL and 
      (2) changes in Global QOL between assessments. RESULTS: Moderate limitations (>30 
      points) appeared in the first assessment in Global QOL, sexual scales, three 
      QLQ-ELD14 scales, and 13 symptoms and emotional COVID-19 areas. Differences 
      between the COVID-19 groups appeared in two QLQ-C30 areas and four QLQ-BR45 
      areas. Quality of Life improvements between assessments appeared in six QLQ-C30, 
      four QLQ-BR45 and 18 COVID-19 questionnaire areas. The best multivariate model to 
      explain global QOL combined emotional functioning, fatigue, endocrine treatment, 
      gastrointestinal symptoms, and targeted therapy (R(2)  = 0.393). The best model 
      to explain changes in global QOL combined physical and emotional functioning, 
      malaise, and sore eyes (R(2)  = 0.575). CONCLUSIONS: Patients with breast cancer 
      and COVID-19 adapted well to illness. The few differences between wave-based 
      groups (differences in follow-up notwithstanding) may have arisen because the 
      second and third waves saw fewer COVID restrictions, more positive COVID 
      information, and more vaccinated patients.
CI  - © 2023 John Wiley & Sons Ltd.
FAU - Arraras, Juan Ignacio
AU  - Arraras JI
AUID- ORCID: 0000-0002-4415-2570
AD  - Oncology Departments, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Illarramendi, Jose Juan
AU  - Illarramendi JJ
AD  - Medical Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Manterola, Ana
AU  - Manterola A
AD  - Radiotherapeutic Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Cruz, Susana de la
AU  - Cruz S
AD  - Medical Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Zarandona, Uxue
AU  - Zarandona U
AD  - Oncology Departments, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Ibañez, Berta
AU  - Ibañez B
AD  - Navarrabiomed, RICAPPS, Unidad de Metodología, Pamplona, Spain.
FAU - Salgado, Esteban
AU  - Salgado E
AD  - Medical Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Visus, Ignacio
AU  - Visus I
AD  - Radiotherapeutic Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Barrado, Marta
AU  - Barrado M
AD  - Radiotherapeutic Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Teijeira, Lucia
AU  - Teijeira L
AD  - Medical Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Martinez, Enrique
AU  - Martinez E
AD  - Radiotherapeutic Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
FAU - Vera, Ruth
AU  - Vera R
AD  - Medical Oncology, Hospital Universitario de Navarra, Pamplona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230317
PL  - England
TA  - Psychooncology
JT  - Psycho-oncology
JID - 9214524
SB  - IM
MH  - Humans
MH  - Female
MH  - Quality of Life/psychology
MH  - *COVID-19/epidemiology
MH  - *Breast Neoplasms/therapy/drug therapy
MH  - Surveys and Questionnaires
MH  - Logistic Models
OTO - NOTNLM
OT  - COVID-19
OT  - EORTC
OT  - breast
OT  - cancer
OT  - oncology
OT  - quality of life
EDAT- 2023/03/08 06:00
MHDA- 2023/05/08 10:17
CRDT- 2023/03/07 23:39
PHST- 2023/02/01 00:00 [revised]
PHST- 2022/09/16 00:00 [received]
PHST- 2023/02/20 00:00 [accepted]
PHST- 2023/05/08 10:17 [medline]
PHST- 2023/03/08 06:00 [pubmed]
PHST- 2023/03/07 23:39 [entrez]
AID - 10.1002/pon.6118 [doi]
PST - ppublish
SO  - Psychooncology. 2023 May;32(5):730-740. doi: 10.1002/pon.6118. Epub 2023 Mar 17.

PMID- 36876482
OWN - NLM
STAT- Publisher
LR  - 20230306
IS  - 1469-8978 (Electronic)
IS  - 0033-2917 (Linking)
DP  - 2023 Mar 6
TI  - Effect of polygenic risk score, family load of schizophrenia and exposome risk 
      score, and their interactions, on the long-term outcome of first-episode 
      psychosis.
PG  - 1-10
LID - 10.1017/S0033291723000351 [doi]
AB  - BACKGROUND: Consistent evidence supports the involvement of genetic and 
      environmental factors, and their interactions, in the etiology of psychosis. 
      First-episode psychosis (FEP) comprises a group of disorders that show great 
      clinical and long-term outcome heterogeneity, and the extent to which genetic, 
      familial and environmental factors account for predicting the long-term outcome 
      in FEP patients remains scarcely known. METHODS: The SEGPEPs is an inception 
      cohort study of 243 first-admission patients with FEP who were followed-up for a 
      mean of 20.9 years. FEP patients were thoroughly evaluated by standardized 
      instruments, with 164 patients providing DNA. Aggregate scores estimated in large 
      populations for polygenic risk score (PRS-Sz), exposome risk score (ERS-Sz) and 
      familial load score for schizophrenia (FLS-Sz) were ascertained. Long-term 
      functioning was assessed by means of the Social and Occupational Functioning 
      Assessment Scale (SOFAS). The relative excess risk due to interaction (RERI) was 
      used as a standard method to estimate the effect of interaction of risk factors. 
      RESULTS: Our results showed that a high FLS-Sz gave greater explanatory capacity 
      for long-term outcome, followed by the ERS-Sz and then the PRS-Sz. The PRS-Sz did 
      not discriminate significantly between recovered and non-recovered FEP patients 
      in the long term. No significant interaction between the PRS-Sz, ERS-Sz or FLS-Sz 
      regarding the long-term functioning of FEP patients was found. CONCLUSIONS: Our 
      results support an additive model of familial antecedents of schizophrenia, 
      environmental risk factors and polygenic risk factors as contributors to a poor 
      long-term functional outcome for FEP patients.
FAU - Cuesta, M J
AU  - Cuesta MJ
AUID- ORCID: 0000-0003-0250-5718
AD  - Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
FAU - Papiol, S
AU  - Papiol S
AD  - Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud 
      Carlos III, Madrid, Spain.
AD  - Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU 
      Munich, Munich, 80336, Germany.
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Ibañez, B
AU  - Ibañez B
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
AD  - Navarrabiomed - Hospital Universitario de Navarra - UPNA, Pamplona, Spain.
AD  - Red de Investigación en Atención Primaria, Servicios Sanitarios y Cronicidad 
      (RICAPPS), Barcelona, Spain.
FAU - García de Jalón, E
AU  - García de Jalón E
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
AD  - Mental Health Department, Servicio Navarro de Salud, Pamplona, Spain.
FAU - Sánchez-Torres, A M
AU  - Sánchez-Torres AM
AD  - Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
FAU - Gil-Berrozpe, G J
AU  - Gil-Berrozpe GJ
AD  - Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
FAU - Moreno-Izco, L
AU  - Moreno-Izco L
AD  - Department of Psychiatry, Hospital Universitario de Navarra, Pamplona, Spain.
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
FAU - Zarzuela, A
AU  - Zarzuela A
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
AD  - Mental Health Department, Servicio Navarro de Salud, Pamplona, Spain.
FAU - Fañanás, L
AU  - Fañanás L
AD  - Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud 
      Carlos III, Madrid, Spain.
AD  - Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty 
      of Biology, University of Barcelona, Biomedicine Institute of the University of 
      Barcelona (IBUB), Barcelona, Spain.
FAU - Peralta, V
AU  - Peralta V
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
AD  - Mental Health Department, Servicio Navarro de Salud, Pamplona, Spain.
CN  - SEGPEPs Group
LA  - eng
GR  - 17/031; 18/41/Departamento de Salud, Gobierno de Navarra/
PT  - Journal Article
DEP - 20230306
PL  - England
TA  - Psychol Med
JT  - Psychological medicine
JID - 1254142
SB  - IM
OTO - NOTNLM
OT  - Exposome risk score (ERS)
OT  - first episode psychosis
OT  - gene-environment interaction
OT  - outcome
OT  - polygenic risk score (PRS)
OT  - schizophrenia
EDAT- 2023/03/07 06:00
MHDA- 2023/03/07 06:00
CRDT- 2023/03/06 05:02
PHST- 2023/03/06 05:02 [entrez]
PHST- 2023/03/07 06:00 [pubmed]
PHST- 2023/03/07 06:00 [medline]
AID - S0033291723000351 [pii]
AID - 10.1017/S0033291723000351 [doi]
PST - aheadofprint
SO  - Psychol Med. 2023 Mar 6:1-10. doi: 10.1017/S0033291723000351.

PMID- 36868175
OWN - NLM
STAT- MEDLINE
DCOM- 20230309
LR  - 20230522
IS  - 1578-1283 (Electronic)
IS  - 0213-9111 (Linking)
VI  - 37
DP  - 2023
TI  - [Cost-effectiveness of universal childhood vaccination against hepatitis A in 
      Spain: a dynamic approach].
PG  - 102292
LID - S0213-9111(23)00006-7 [pii]
LID - 10.1016/j.gaceta.2023.102292 [doi]
AB  - OBJECTIVE: To evaluate the cost-effectiveness of infant universal vaccination 
      against hepatitis A in Spain. METHOD: Using a dynamic model and decision tree 
      model, a cost-effectiveness analysis was performed to compare three vaccination 
      strategies against hepatitis A: non-vaccination strategy versus universal 
      childhood vaccination of hepatitis A with one or two doses. The perspective of 
      the study was that of the National Health System (NHS) and a lifetime horizon was 
      considered. Both costs and effects were discounted at 3% per year. Health 
      outcomes were measured in terms of quality adjusted life years (QALY) and the 
      cost-effectiveness measure used was the incremental cost-effectiveness ratio 
      (ICER). In addition, deterministic sensitivity analysis by scenarios was 
      performed. RESULTS: In the particular case of Spain, with low endemicity for 
      hepatitis A, the difference in health outcomes between vaccination strategies 
      (with 1 or 2 doses) and non-vaccination are practically non-existent, terms of 
      QALY. In addition, the ICER obtained is high, exceeding the limits of willingness 
      to pay from Spain (€22,000-25,000/QALY). The deterministic sensitivity analysis 
      showed that the results are sensitive to the variations of the key parameters, 
      although in no case the vaccination strategies are cost-effective. CONCLUSIONS: 
      Universal infant vaccination strategy against hepatitis A would not be a 
      cost-effective option from the NHS perspective in Spain.
CI  - Copyright © 2023 SESPAS. Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Valcárcel-Nazco, Cristina
AU  - Valcárcel-Nazco C
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa 
      Cruz de Tenerife, Islas Canarias, España; Servicio de Evaluación del Servicio 
      Canario de la Salud (SESCS), Santa Cruz de Tenerife, Islas Canarias, España; Red 
      Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del 
      Sistema Nacional de Salud (RedETS), Madrid, España; Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      Madrid, España. Electronic address: cristina.valcarcelnazco@sescs.es.
FAU - Sanromá-Ramos, Esther
AU  - Sanromá-Ramos E
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa 
      Cruz de Tenerife, Islas Canarias, España; Servicio de Evaluación del Servicio 
      Canario de la Salud (SESCS), Santa Cruz de Tenerife, Islas Canarias, España.
FAU - García-Pérez, Lidia
AU  - García-Pérez L
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa 
      Cruz de Tenerife, Islas Canarias, España; Servicio de Evaluación del Servicio 
      Canario de la Salud (SESCS), Santa Cruz de Tenerife, Islas Canarias, España; Red 
      Española de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del 
      Sistema Nacional de Salud (RedETS), Madrid, España; Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España; Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 
      Madrid, España.
FAU - Villanueva-Micó, Rafael Jacinto
AU  - Villanueva-Micó RJ
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, España; Instituto de Matemática Multidisciplinar, Universitat 
      Politècnica de València, Valencia, España.
FAU - Burgos-Simón, Clara
AU  - Burgos-Simón C
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, España; Instituto de Matemática Multidisciplinar, Universitat 
      Politècnica de València, Valencia, España.
FAU - Mar, Javier
AU  - Mar J
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), 
      Madrid, España; Unidad de Investigación AP-OSIs Gipuzkoa, Organización Sanitaria 
      Integrada Alto Deba, Gipuzkoa, España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Coste-efectividad de la vacunación universal infantil frente a la hepatitis A en 
      España: un enfoque dinámico.
DEP - 20230301
PL  - Spain
TA  - Gac Sanit
JT  - Gaceta sanitaria
JID - 8901623
SB  - IM
MH  - Infant
MH  - Humans
MH  - *Hepatitis A/prevention & control
MH  - Cost-Benefit Analysis
MH  - Spain
MH  - Cost-Effectiveness Analysis
MH  - Quality-Adjusted Life Years
OTO - NOTNLM
OT  - Análisis de coste-beneficio
OT  - Child
OT  - Cost-benefit analysis
OT  - España
OT  - Hepatitis A vaccines
OT  - Infant
OT  - Lactantes
OT  - Mass vaccination
OT  - Preescolares
OT  - Spain
OT  - Vacunación masiva
OT  - Vacunas frente a la hepatitis A
EDAT- 2023/03/04 06:00
MHDA- 2023/03/10 06:00
CRDT- 2023/03/03 18:22
PHST- 2022/07/22 00:00 [received]
PHST- 2022/12/05 00:00 [revised]
PHST- 2022/12/12 00:00 [accepted]
PHST- 2023/03/03 18:22 [entrez]
PHST- 2023/03/04 06:00 [pubmed]
PHST- 2023/03/10 06:00 [medline]
AID - S0213-9111(23)00006-7 [pii]
AID - 10.1016/j.gaceta.2023.102292 [doi]
PST - epublish
SO  - Gac Sanit. 2023 Mar 1;37:102292. doi: 10.1016/j.gaceta.2023.102292. eCollection 
      2023.

PMID- 36858916
OWN - NLM
STAT- MEDLINE
DCOM- 20230403
LR  - 20230403
IS  - 1879-1166 (Electronic)
IS  - 0198-8859 (Linking)
VI  - 84
IP  - 4
DP  - 2023 Apr
TI  - "Geographical distribution of risk genotypes in pediatric patients with celiac 
      disease in Spain".
PG  - 290-295
LID - S0198-8859(23)00025-3 [pii]
LID - 10.1016/j.humimm.2023.01.010 [doi]
AB  - Celiac disease is strongly associated with HLA DQ, specifically with haplotypes. 
      DRB1*03-DQA1*05:01/DQB1*02:01 (DQ2.5),DRB1*07-DQA1*02:01/DQB1*02:02 (DQ2.2), 
      DRB1*11-DQA1*05:05/DQB1*03:01 (DQ7.5), and DRB1*04-DQA1*03:01/DQB1*03:02 (DQ8). 
      The distribution of these risk haplotypes in patients with celiac disease is 
      different in the geographical areas investigated. A high frequency of DRB1*07- 
      DQA1*02:01/DQB1*02:02 (DQ2.2) and DRB1*11-DQA1*05:05/DQB1*03:01 (DQ7.5), has been 
      described in Southern Europe. We analyzed 2102 confirmed CD cases with 
      information on both DQB1* alelles and their distribution by geographical area in 
      Spain. According to the presence of this haplotype in one or two chromosomes, the 
      genotype is classified in: DQ2 homozygous, DQ2 heterozygous (cis or trans), DQ8 
      homozygous, DQ8/DQ2.5, DQ 2.2 homozygous and genotype known as "half DQ2". Two 
      different patterns of risks related to CD were identified. In the Basque Country 
      and Navarre, the Mediterranean Area (Aragon, Catalonia, Valencia, Balearic 
      Islands, and Murcia), the South of Spain (Andalucía and Extremadura), and the 
      Canary Islands, higher frequency of DQ2.5 trans, and more than 80% of DQ2.5/DQ2.2 
      homozygosis were described. The Cantabrian Coast (Cantabria, Asturias, and 
      Galicia) and Central Areas (Castilla-León and Castilla-La Mancha) showed a higher 
      percentage of DQ2.5/DQ2.5 homozygosis and a lower DQ2.5 in trans frequency, as in 
      Northern Europe. Madrid has an intermediate model between the two described 
      above. 17 cases (0.8%) did not carry any CD risk haplotypes.
CI  - Copyright © 2023 American Society for Histocompatibility and Immunogenetics. 
      Published by Elsevier Inc. All rights reserved.
FAU - Sánchez-Valverde, Félix
AU  - Sánchez-Valverde F
AD  - Department of Paediatrics. Navarre Children's Nutrition and Digestive Study Group 
      (GENDINA), NAVARRA BIOMED, University Hospital of Navarra, Pamplona, Spain.
FAU - Martínez-Ojinaga, Eva
AU  - Martínez-Ojinaga E
AD  - Pediatric Gastroenterology and Nutrition Department, University Hospital La Paz, 
      Madrid, Spain.
FAU - Donat, Ester
AU  - Donat E
AD  - Pediatric Gastroenterology and Hepatology Unit, Hospital Universitari i 
      Politècnic La Fe and celiac disease and digestive immunopathology unit, Instituto 
      de Investigación Sanitaria La Fe, Valencia, Spain.
FAU - Bodas, Andrés
AU  - Bodas A
AD  - Hospital Clnico San Carlos, Madrid, Spain.
FAU - Bandrés, Eva
AU  - Bandrés E
AD  - Inmunology Unit, Hematology Service, University Hospital of Navarra, IDISNA 
      Pamplona. Spain.
FAU - Torres, Ricardo
AU  - Torres R
AD  - Hospital Universitario de Salamanca, Salamanca, Spain.
FAU - Ibáñez, Berta
AU  - Ibáñez B
AD  - Navarrabiomed-CHN-UPNA, REDISSEC, RICAPPS, IdiSNA, Pamplona, Spain.
FAU - Cilleruelo, Mª Luz
AU  - Cilleruelo ML
AD  - Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
FAU - Castillejo, Gemma
AU  - Castillejo G
AD  - Pediatric Gastroenterology, Hospital Universitari Sant Joan de Reus, Universitat 
      Rovira i Virgil, IISPV, Reus. Spain.
FAU - Pérez-Solis, David
AU  - Pérez-Solis D
AD  - Hospital Universitario San Agustín, Avilés, Spain.
FAU - Ochoa, Carlos
AU  - Ochoa C
AD  - Hospital Virgen de la Concha. Zamora, Spain.
FAU - Eizaguirre, Francisco Javier
AU  - Eizaguirre FJ
AD  - Hospital Universitario Donostia. Donostia, Spain.
FAU - García, Salvador
AU  - García S
AD  - Hospital Universitario Marqués de Valdecilla, Santander, Spain.
FAU - García, Jose Ignacio
AU  - García JI
AD  - Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
FAU - Barrio, Josefa
AU  - Barrio J
AD  - Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
FAU - Vecino, Raquel
AU  - Vecino R
AD  - Hospital Clnico San Carlos, Madrid, Spain.
FAU - Miranda, María Del Carmen
AU  - Miranda MDC
AD  - Hospital Universitario Infanta Cristina, Parla, Spain.
FAU - Juste, Mercedes
AU  - Juste M
AD  - Hospital Universitario San Juan de Alicante, Alicante, Spain.
FAU - Salazar, Jose Carlos
AU  - Salazar JC
AD  - Hospital Universitario Infantil Virgen del Rocío, Sevilla, Spain.
FAU - Armas, Honorio
AU  - Armas H
AD  - Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
FAU - Ortigosa, Luis
AU  - Ortigosa L
AD  - Hospital Universitario Virgen de la Candelaria, Santa Cruz de Tenerife, Spain.
FAU - Urruzuno, Pedro
AU  - Urruzuno P
AD  - Hospital Universitario Doce de Octubre, Madrid, Spain.
FAU - García, Zuriñe
AU  - García Z
AD  - Hospital Universitario de Araba - Txagorritxu, Vitoria, Spain.
FAU - Balmaseda, Elena
AU  - Balmaseda E
AD  - Complejo Universitario de Albacete, Albacete, Spain.
FAU - Martinez-Costa, Cecilia
AU  - Martinez-Costa C
AD  - Hospital Clínico Universitario de Valencia, Valencia, Spain.
FAU - La Orden, Enrique
AU  - La Orden E
AD  - Hospital Universitario Infanta Elena, Valdemoro, Spain.
FAU - Codoñer, Pilar
AU  - Codoñer P
AD  - Hospital Universitario Dr. Peset, Valencia, Spain.
FAU - Roca, Amadeu
AU  - Roca A
AD  - Hospital Comarcal Sant Jaume de Calella, Calella, Spain.
FAU - Trillo, Carlos
AU  - Trillo C
AD  - Hospital de La Axarquía, Vélez, Spain.
FAU - Sebastian, Mercedes
AU  - Sebastian M
AD  - Hospital Universitario de Móstoles, Móstoles, Spain.
FAU - García, Ruth
AU  - García R
AD  - Hospital Materno Infantil Miguel Servet, Zaragoza, Spain.
FAU - Peña-Quintana, Luis
AU  - Peña-Quintana L
AD  - Unidad de Gastroenterología y Nutrición Pediátrica, Complejo Hospitalario 
      Universitario Insular Materno-Infantil, ACIP, CIBEROBN ISCIII, Universidad de Las 
      Palmas de Gran Canaria, Spain.
FAU - Barros, Patricia
AU  - Barros P
AD  - Complejo Hospitalario Universitario de Caceres, Spain.
FAU - Soria, Marta
AU  - Soria M
AD  - Hospital HM Monteprincipe/Torrelodones, Torrelodones, Spain.
FAU - García, Roger
AU  - García R
AD  - Hospital Mutua de Terrassa, Terrassa, Spain.
FAU - Pérez-Moneo, Begoña
AU  - Pérez-Moneo B
AD  - Hospital Infanta Leonor, Madrid, Spain.
FAU - Polanco, Isabel
AU  - Polanco I
AD  - Pediatric Gastroenterology and Nutrition Department, University Hospital La Paz, 
      Madrid, Spain.
FAU - Ribes, Carmen
AU  - Ribes C
AD  - Pediatric Gastroenterology and Hepatology Unit, Hospital Universitari i 
      Politècnic La Fe and celiac disease and digestive immunopathology unit, Instituto 
      de Investigación Sanitaria La Fe, Valencia, Spain.
FAU - Román, Enriqueta
AU  - Román E
AD  - Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
CN  - Collaborators
LA  - eng
PT  - Journal Article
DEP - 20230228
PL  - United States
TA  - Hum Immunol
JT  - Human immunology
JID - 8010936
RN  - 0 (HLA-DQ Antigens)
RN  - 0 (HLA-DQ beta-Chains)
RN  - 0 (HLA-DQ alpha-Chains)
SB  - IM
MH  - Humans
MH  - Child
MH  - Spain/epidemiology
MH  - *HLA-DQ Antigens/genetics
MH  - *Celiac Disease/genetics
MH  - Genetic Predisposition to Disease
MH  - Alleles
MH  - Genotype
MH  - Haplotypes
MH  - HLA-DQ beta-Chains/genetics
MH  - HLA-DQ alpha-Chains/genetics
OTO - NOTNLM
OT  - Children
OT  - Coeliac disease
OT  - Geographical distribution
OT  - HLA risk genotypes
OT  - Spain
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
FIR - Pich, Margarita
IR  - Pich M
IRAD- Centro Médico Teknon, Barcelona, Spain.
FIR - Arévalo, Ana
IR  - Arévalo A
IRAD- Centro Hospitalario Ciudad de Jaén, Jaén, Spain.
FIR - Fernández, Sonia
IR  - Fernández S
IRAD- Hospital Universitario Severo Ochoa, Leganés, Spain.
FIR - Gil, David
IR  - Gil D
IRAD- Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
FIR - Oliver, Pablo
IR  - Oliver P
IRAD- Hospital de Mendaro, Mendaro, Spain.
FIR - Manuel Bartolomé, Juan
IR  - Manuel Bartolomé J
IRAD- Complejo Asistencial Universitario de Palencia, Palencia, Spain.
FIR - Vicente Arcos, José
IR  - Vicente Arcos J
IRAD- Hospital Sant Joan de Déu, Barcelona, Spain.
FIR - Pérez, Francisco
IR  - Pérez F
IRAD- Hospital Infanta Margarita, Cabra, Spain.
FIR - Expósito, Haydeé
IR  - Expósito H
IRAD- Hospital Nuestra Señora de Sonsoles, Ávila, Spain.
FIR - Rizo, Juana M
IR  - Rizo JM
IRAD- Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Spain.
FIR - Manuel Navas, Víctor
IR  - Manuel Navas V
IRAD- Hospital Materno Infantil de Málaga, Málaga, Spain.
FIR - González de Caldas, Rafael
IR  - González de Caldas R
IRAD- Hospital Universitario Reina Sofía, Cordoba, Spain.
FIR - Jesús Balboa, María
IR  - Jesús Balboa M
IRAD- Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.
FIR - Molinos, Cristina
IR  - Molinos C
IRAD- Hospital Universitario de Cabueñes, Gijón, Spain.
FIR - Alonso, Laura
IR  - Alonso L
IRAD- Hospital Universitario HM Sanchinarro, Madrid, Spain.
FIR - Lorenzo, Helena
IR  - Lorenzo H
IRAD- Hospital Universitario de Basurto, Bilbao, Spain.
FIR - Bernardo González, José
IR  - Bernardo González J
IRAD- Hospital Universitario de Burgos, Burgos, Spain.
FIR - Lluïsa Masiques, María
IR  - Lluïsa Masiques M
IRAD- Hospital General de Granollers, Granollers, Spain.
FIR - Isabel Ruiz, Ana
IR  - Isabel Ruiz A
IRAD- Hospital El Escorial, San Lorenzo del Escorial, Spain.
FIR - Ignacio Olazábal, José
IR  - Ignacio Olazábal J
IRAD- Centro de Salud La Calzada II, Gijón, Spain.
EDAT- 2023/03/02 06:00
MHDA- 2023/04/03 06:41
CRDT- 2023/03/01 22:03
PHST- 2022/08/29 00:00 [received]
PHST- 2022/12/22 00:00 [revised]
PHST- 2023/01/31 00:00 [accepted]
PHST- 2023/04/03 06:41 [medline]
PHST- 2023/03/02 06:00 [pubmed]
PHST- 2023/03/01 22:03 [entrez]
AID - S0198-8859(23)00025-3 [pii]
AID - 10.1016/j.humimm.2023.01.010 [doi]
PST - ppublish
SO  - Hum Immunol. 2023 Apr;84(4):290-295. doi: 10.1016/j.humimm.2023.01.010. Epub 2023 
      Feb 28.

PMID- 36856572
OWN - NLM
STAT- MEDLINE
DCOM- 20230608
LR  - 20230613
IS  - 1536-3686 (Electronic)
IS  - 1075-2765 (Linking)
VI  - 30
IP  - 3
DP  - 2023 May 1
TI  - Antidepressants Are Associated With a Reduction in the Risk of Death in COVID-19 
      Disease Patients.
PG  - e285-e288
LID - 10.1097/MJT.0000000000001618 [doi]
FAU - Cobos-Campos, Raquel
AU  - Cobos-Campos R
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
FAU - Sáez de Lafuente-Moríñigo, Arantza
AU  - Sáez de Lafuente-Moríñigo A
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
FAU - Cordero-Guevara, José Aurelio
AU  - Cordero-Guevara JA
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
FAU - Bermúdez-Ampudia, Cristina
AU  - Bermúdez-Ampudia C
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
FAU - Apiñaniz, Antxon
AU  - Apiñaniz A
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
AD  - Osakidetza Basque Health Service. Aranbizkarra I Health Center. Vitoria-Gasteiz, 
      España.
AD  - Department of Preventive Medicine and Public Health. University of the Basque 
      Country. Vitoria-Gasteiz, España; and.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Argaluza, Julene
AU  - Argaluza J
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
FAU - Parraza, Naiara
AU  - Parraza N
AD  - Bioaraba Health Research Institute. Epidemiology and Public Health Group. 
      Vitoria-Gasteiz, España.
AD  - Osakidetza Basque Health Service. Aranbizkarra I Health Center. Vitoria-Gasteiz, 
      España.
LA  - eng
PT  - Letter
DEP - 20230501
PL  - United States
TA  - Am J Ther
JT  - American journal of therapeutics
JID - 9441347
RN  - 0 (Antidepressive Agents)
SB  - IM
MH  - Humans
MH  - *COVID-19
MH  - Antidepressive Agents
MH  - Depression
COIS- The authors have no conflicts of interest to declare.
EDAT- 2023/03/02 06:00
MHDA- 2023/06/08 06:42
CRDT- 2023/03/01 10:06
PHST- 2023/06/08 06:42 [medline]
PHST- 2023/03/02 06:00 [pubmed]
PHST- 2023/03/01 10:06 [entrez]
AID - 00045391-990000000-00125 [pii]
AID - 10.1097/MJT.0000000000001618 [doi]
PST - epublish
SO  - Am J Ther. 2023 May 1;30(3):e285-e288. doi: 10.1097/MJT.0000000000001618.

PMID- 36854290
OWN - NLM
STAT- MEDLINE
DCOM- 20230302
LR  - 20230327
IS  - 1445-6354 (Electronic)
IS  - 1445-6354 (Linking)
VI  - 23
IP  - 1
DP  - 2023 Feb
TI  - Recruitment and retention of general practitioners in European medical deserts: a 
      systematic review.
PG  - 7477
LID - 10.22605/RRH7477 [doi]
AB  - INTRODUCTION: Despite policies aiming at universal health coverage by ensuring 
      availability and accessibility of general practitioners (GPs), medically 
      underserved areas are still present in Europe. This systematic review aims to 
      summarize and compare literature on interventions and their potential 
      effectiveness of GP recruitment and retention in these underserved areas 
      ('medical deserts') from 2011 onwards. METHODS: PubMed and Embase were used to 
      identify publications, applying a two-stage selection process. All types of study 
      designs, published in the past 10 years, were included if they discussed a 
      possible intervention for GP recruitment or retention covering an underserved 
      area in an EU-27/EEA/EFTA country (part of the European Union, the European 
      Economic Area or the European Free Trade Association). Exclusion criteria were 
      abstracts or full text not available, conference abstracts, poster presentations, 
      books or overlapping secondary literature. Identified interventions were 
      classified into four categories: 'education', 'professional and personal 
      support', 'financial incentives' and 'regulation'. Eligible articles were 
      critically appraisal by two authors (JB, LF), independently, by using the Joanna 
      Briggs Institute checklist. RESULTS: Of the 294 publications initially retrieved, 
      25 publications were included. Of them, 14 (56%) described educational 
      interventions, 13 (52%) professional and personal support, and 11 (40%) financial 
      or regulatory interventions. Overlapping categories were often described (56%). 
      The effectiveness of educational or supportive interventions has mainly been 
      evaluated cross-sectionally, whereby causal inference on future GP availability 
      cannot be implied. Few and mixed results were found for the effectiveness of 
      financial and regulatory interventions, because period co-interventions were not 
      taken into account during the study. CONCLUSION: In the past 10 years, 
      educational and supportive interventions to improve GP recruitment and retention 
      have been reported most frequently, but often overlapping strategies are seen. 
      While multiple strategies have potential to be effective, their limited 
      evaluation makes it difficult to provide suggestions for policymakers to adapt 
      their GP recruitment and retention strategies aiming at a best-practice approach 
      in European medical deserts.
FAU - Bes, Julia M
AU  - Bes JM
AD  - Netherlands Institute for Health Services Research (NIVEL), Utrecht, The 
      Netherlands julia_maria_bes@hotmail.com.
FAU - Flinterman, Linda E
AU  - Flinterman LE
AD  - Netherlands Institute for Health Services Research (NIVEL), Utrecht, The 
      Netherlands l.flinterman@nivel.nl.
FAU - González, Ana I
AU  - González AI
AD  - Avedis Donabedian Research Institute (FAD), Barcelona, Spain; and Universidad 
      Autónoma de Barcelona, Spain; and Network for Research on Chronicity, Primary 
      Care, and Health Promotion (RICAPPS), Spain aigonzalez@fadq.org.
FAU - Batenburg, Ronald S
AU  - Batenburg RS
AD  - Netherlands Institute for Health Services Research (NIVEL), Utrecht, The 
      Netherlands; and Department of Sociology, Radboud University, Nijmegen, The 
      Netherlands r.batenburg@nivel.nl.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20230228
PL  - Australia
TA  - Rural Remote Health
JT  - Rural and remote health
JID - 101174860
SB  - IM
MH  - Humans
MH  - *General Practitioners
MH  - Educational Status
MH  - Medically Underserved Area
OTO - NOTNLM
OT  - general practitioner
OT  - health workforce
OT  - medical deserts
OT  - medically underserved area
OT  - recruitment
OT  - retention
OT  - Europe
EDAT- 2023/03/01 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/28 18:32
PHST- 2023/02/28 18:32 [entrez]
PHST- 2023/03/01 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - 7477 [pii]
AID - 10.22605/RRH7477 [doi]
PST - ppublish
SO  - Rural Remote Health. 2023 Feb;23(1):7477. doi: 10.22605/RRH7477. Epub 2023 Feb 
      28.

PMID- 36844856
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230327
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 11
DP  - 2023
TI  - Effectiveness of health literacy interventions on anxious and depressive 
      symptomatology in primary health care: A systematic review and meta-analysis.
PG  - 1007238
LID - 10.3389/fpubh.2023.1007238 [doi]
LID - 1007238
AB  - BACKGROUND: Affective disorders are a debilitating and very prevalent problem 
      throughout the world. Often these are associated with the onset of comorbidities 
      or a consequence of chronic diseases. Anxiety and depression are associated with 
      poor social and personal relationships, compromised health. We aimed to 
      synthesize evidence from studies measuring the impact of a health literacy (HL) 
      intervention on the improvement of affective disorders. METHODS: For this 
      systematic review and meta-analysis, we searched PubMed/MEDLINE, Embase, Web of 
      Science, Ibecs, Cuiden, Scielo, Science Direct and Dialnet for exclusively 
      randomized controlled trial studies (RCTs) published between 1 Jan 2011, and 31 
      May 2022. The search terms employed were "health literacy," "health knowledge," 
      "anxiety," "anxiety disorder," "depression," "depressive disorder," and "adult." 
      The risk of bias assessment was performed using the Cochrane Collaboration 
      Revised Risk of Bias tool (RoB2). We conducted random-effects meta-analyses and 
      explored heterogeneity using meta-regression and a stratified survey. RESULTS: Of 
      2,863 citations found through the initial screening, 350 records were screened by 
      the title and abstract for their themes and relevance. Finally, nine studies 
      complied with the inclusion criteria for the meta-analysis. 66.66% of studies (n 
      = 6) were rated as having a low risk of bias and 33.33% (n = 3) were judged to 
      raise some concerns. The health literacy interventions were associated with 
      -1.378 reduction in depression and anxiety questionnaires scores [95% CI (-1.850, 
      -0.906)]. Low mood disorder scores are associated with better mental health and 
      wellbeing. CONCLUSION: Our findings demonstrate that an HL intervention in 
      relation to the symptoms associated with affective disorders improves the 
      emotional state of patients in PHC, with a moderately positive effect in reducing 
      depression and anxiety.
CI  - Copyright © 2023 Magallón-Botaya, Méndez-López, Oliván-Blázquez, Carlos 
      Silva-Aycaguer, Lerma-Irureta and Bartolomé-Moreno.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Department of Medicine, Psychiatry and Dermatology, Faculty of Medicine, 
      University of Zaragoza, Zaragoza, Spain.
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
FAU - Méndez-López, Fátima
AU  - Méndez-López F
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Carlos Silva-Aycaguer, Luis
AU  - Carlos Silva-Aycaguer L
AD  - National School of Public Health (ENSAP), University of Medical Sciences of 
      Havana, Havana, Cuba.
FAU - Lerma-Irureta, David
AU  - Lerma-Irureta D
AD  - Department of Medicine, Psychiatry and Dermatology, Faculty of Medicine, 
      University of Zaragoza, Zaragoza, Spain.
FAU - Bartolomé-Moreno, Cruz
AU  - Bartolomé-Moreno C
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Aragonese Healthcare Service (SALUD), Zaragoza, Spain.
AD  - Department of Family and Community Care Teaching - Sector I, Aragonese Healthcare 
      Service, Zaragoza, Spain.
LA  - eng
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
DEP - 20230209
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
SB  - IM
MH  - Adult
MH  - Humans
MH  - *Health Literacy
MH  - Anxiety/therapy
MH  - Anxiety Disorders/therapy
MH  - Comorbidity
MH  - Primary Health Care
MH  - Randomized Controlled Trials as Topic
PMC - PMC9948257
OTO - NOTNLM
OT  - affective disorders
OT  - effectiveness
OT  - health literacy
OT  - mental health
OT  - meta-analysis
OT  - primary health care
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/02/28 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/27 04:40
PHST- 2022/07/30 00:00 [received]
PHST- 2023/01/23 00:00 [accepted]
PHST- 2023/02/27 04:40 [entrez]
PHST- 2023/02/28 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - 10.3389/fpubh.2023.1007238 [doi]
PST - epublish
SO  - Front Public Health. 2023 Feb 9;11:1007238. doi: 10.3389/fpubh.2023.1007238. 
      eCollection 2023.

PMID- 36839216
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230228
IS  - 2072-6643 (Electronic)
IS  - 2072-6643 (Linking)
VI  - 15
IP  - 4
DP  - 2023 Feb 8
TI  - Diet Quality Changes by Educational Level among Adults in Spain from 2017 to 
      2021.
LID - 10.3390/nu15040858 [doi]
LID - 858
AB  - Despite increasing attention on addressing socioeconomic disparities in diet 
      quality, longitudinal studies are scarce. Furthermore, the effects of the 
      COVID-19 pandemic on diet-related outcomes are yet to be fully understood. We 
      examined changes in diet quality by educational level among adults in Madrid, 
      Spain. We used data from recruitment (in 2017) and from 2021. At baseline, our 
      sample included 1358 adults aged 40-75 years who were free of cardiovascular 
      disease and completed a validated diet quality screener. Of them, 931 answered 
      the survey in the follow-up visit in 2021. We used participants' diet quality 
      index scores (range: 18-54; higher scores indicate better diet quality) as the 
      dependent variable. As our independent variable, we assessed participants' 
      educational levels (low, medium, and high). We fitted a multinomial regression 
      using the categories of educational level as the main predictor, adjusting for 
      age, sex, country of origin, and household composition. During the study period, 
      78.0% of participants sustained their diet quality, 11.6% improved it, and 10.4% 
      moved away from a healthier dietary pattern. In descriptive analyses, we observed 
      an increase in diet quality among less-educated females. Unadjusted multinomial 
      models showed that a lower educational level predicted both increases and 
      decreases in diet quality over the period. Even though the median diet quality 
      scores did not change significantly, we observed heterogeneous changes over the 
      four years. Variability within diet, with some improving and some worsening, 
      seems to have increased among participants with lower educational levels. Future 
      studies should look at the determinants of change in these population subgroups.
FAU - Romero, Isabel
AU  - Romero I
AUID- ORCID: 0000-0002-1408-4175
AD  - Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50009 
      Zaragoza, Aragón, Spain.
FAU - Díez, Julia
AU  - Díez J
AD  - Public Health and Epidemiology Research Group, School of Medicine, Universidad de 
      Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
FAU - Del Cura, Isabel
AU  - Del Cura I
AUID- ORCID: 0000-0002-3931-5304
AD  - Primary Care Research Unit, Madrid Health Service, 28035 Madrid, Spain.
AD  - Department of Preventive Medicine and Public Health, Universidad Rey Juan Carlos, 
      28933 Madrid, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC) & Research 
      Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Institute of 
      Health Carlos III, 28029 Madrid, Spain.
AD  - Aging Research Center, Department of Neurobiology, Care Sciences and Society, 
      Karolinska Institute and Stockholm University, 17165 Stockholm, Sweden.
FAU - Franco, Manuel
AU  - Franco M
AUID- ORCID: 0000-0003-1366-9398
AD  - Public Health and Epidemiology Research Group, School of Medicine, Universidad de 
      Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD 21205, USA.
FAU - Gullón, Pedro
AU  - Gullón P
AUID- ORCID: 0000-0002-7641-1514
AD  - Public Health and Epidemiology Research Group, School of Medicine, Universidad de 
      Alcalá, Alcalá de Henares, 28871 Madrid, Spain.
AD  - Center for Urban Research, RMIT University, Melbourne 3004, Australia.
FAU - On Behalf Of The Heart Healthy Hoods Study Group
AU  - On Behalf Of The Heart Healthy Hoods Study Group
LA  - eng
GR  - FP7/2007-2013/ERC Starting Grant Heart Healthy Hoods Agreement no. 623 
      336893/European Research Council/International
PT  - Journal Article
DEP - 20230208
PL  - Switzerland
TA  - Nutrients
JT  - Nutrients
JID - 101521595
SB  - IM
MH  - Female
MH  - Adult
MH  - Humans
MH  - Spain
MH  - *Pandemics
MH  - *COVID-19
MH  - Diet
MH  - Educational Status
PMC - PMC9961002
OTO - NOTNLM
OT  - Spain
OT  - adults
OT  - cohort
OT  - diet
OT  - education
OT  - health inequalities
OT  - longitudinal study
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses, or interpretation of data; in 
      the writing of the manuscript; or in the decision to publish the results.
EDAT- 2023/02/26 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/25 04:06
PHST- 2022/12/07 00:00 [received]
PHST- 2023/02/03 00:00 [revised]
PHST- 2023/02/06 00:00 [accepted]
PHST- 2023/02/25 04:06 [entrez]
PHST- 2023/02/26 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - nu15040858 [pii]
AID - nutrients-15-00858 [pii]
AID - 10.3390/nu15040858 [doi]
PST - epublish
SO  - Nutrients. 2023 Feb 8;15(4):858. doi: 10.3390/nu15040858.

PMID- 36834388
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230301
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 4
DP  - 2023 Feb 19
TI  - Ethical, Legal, Organisational and Social Issues of Teleneurology: A Scoping 
      Review.
LID - 10.3390/ijerph20043694 [doi]
LID - 3694
AB  - BACKGROUND: Neurological disorders are the leading cause of disability and the 
      second leading cause of death worldwide. Teleneurology (TN) allows neurology to 
      be applied when the doctor and patient are not present in the same place, and 
      sometimes not at the same time. In February 2021, the Spanish Ministry of Health 
      requested a health technology assessment report on the implementation of TN as a 
      complement to face-to-face neurological care. METHODS: A scoping review was 
      conducted to answer the question on the ethical, legal, social, organisational, 
      patient (ELSI) and environmental impact of TN. The assessment of these aspects 
      was carried out by adapting the EUnetHTA Core Model 3.0 framework, the criteria 
      established by the Spanish Network of Health Technology Assessment Agencies and 
      the analysis criteria of the European Validate (VALues In Doing Assessments of 
      healthcare TEchnologies) project. Key stakeholders were invited to discuss their 
      concerns about TN in an online meeting. Subsequently, the following electronic 
      databases were consulted from 2016 to 10 June 2021: MEDLINE and EMBASE. RESULTS: 
      79 studies met the inclusion criteria. This scoping review includes 37 studies 
      related to acceptability and equity, 15 studies developed during COVID and 1 
      study on environmental aspects. Overall, the reported results reaffirm the 
      necessary complementarity of TN with the usual face-to-face care. CONCLUSIONS: 
      This need for complementarity relates to factors such as acceptability, 
      feasibility, risk of dehumanisation and aspects related to privacy and the 
      confidentiality of sensitive data.
FAU - Torres-Castaño, Alezandra
AU  - Torres-Castaño A
AUID- ORCID: 0000-0003-4690-1421
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
FAU - Abt-Sacks, Analía
AU  - Abt-Sacks A
AUID- ORCID: 0000-0001-7153-8586
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
FAU - Toledo-Chávarri, Ana
AU  - Toledo-Chávarri A
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
FAU - Suarez-Herrera, José Carlos
AU  - Suarez-Herrera JC
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Tenerife, 
      Spain.
AD  - UNITWIN/UNESCO Chair, Research, Planning and Development of Local Health Systems, 
      Department of Clinical Sciences, University of Las Palmas de Gran Canaria, 35001 
      Las Palmas de Gran Canaria, Spain.
FAU - Delgado-Rodríguez, Janet
AU  - Delgado-Rodríguez J
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
AD  - Department of Philosophy I, University of Granada, 18071 Granada, Spain.
FAU - León-Salas, Beatriz
AU  - León-Salas B
AUID- ORCID: 0000-0001-5803-1756
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
FAU - González-Hernández, Yadira
AU  - González-Hernández Y
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
FAU - Carmona-Rodríguez, Montserrat
AU  - Carmona-Rodríguez M
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), 28071 Madrid, Spain.
AD  - Health Technology Assessment Agency, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Tenerife, 
      Spain.
AD  - Institute of Biomedical Technologies, University of La Laguna, 38200 Tenerife, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230219
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - *COVID-19
MH  - Confidentiality
MH  - Privacy
MH  - *Physicians
PMC - PMC9962592
OTO - NOTNLM
OT  - accessibility
OT  - equity
OT  - ethical
OT  - health technology assessment
OT  - legal
OT  - organizational
OT  - social
OT  - teleneurology
COIS- The authors declare no conflict of interest.
EDAT- 2023/02/26 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/25 02:34
PHST- 2022/12/22 00:00 [received]
PHST- 2023/02/13 00:00 [revised]
PHST- 2023/02/15 00:00 [accepted]
PHST- 2023/02/25 02:34 [entrez]
PHST- 2023/02/26 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - ijerph20043694 [pii]
AID - ijerph-20-03694 [pii]
AID - 10.3390/ijerph20043694 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Feb 19;20(4):3694. doi: 
      10.3390/ijerph20043694.

PMID- 36834333
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230301
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 4
DP  - 2023 Feb 18
TI  - Sex Differences in Multimorbidity, Inappropriate Medication and Adverse Outcomes 
      of Inpatient Care: MoPIM Cohort Study.
LID - 10.3390/ijerph20043639 [doi]
LID - 3639
AB  - There is no published evidence on the possible differences in multimorbidity, 
      inappropriate prescribing, and adverse outcomes of care, simultaneously, from a 
      sex perspective in older patients. We aimed to identify those possible 
      differences in patients hospitalized because of a chronic disease exacerbation. A 
      multicenter, prospective cohort study of 740 older hospitalized patients (≥65 
      years) was designed, registering sociodemographic variables, frailty, Barthel 
      index, chronic conditions (CCs), geriatric syndromes (GSs), polypharmacy, 
      potentially inappropriate prescribing (PIP) according to STOPP/START criteria, 
      and adverse drug reactions (ADRs). Outcomes were length of stay (LOS), discharge 
      to nursing home, in-hospital mortality, cause of mortality, and existence of any 
      ADR and its worst consequence. Bivariate analyses between sex and all variables 
      were performed, and a network graph was created for each sex using CC and GS. A 
      total of 740 patients were included (53.2% females, 53.5% ≥85 years old). Women 
      presented higher prevalence of frailty, and more were living in a nursing home or 
      alone, and had a higher percentage of PIP related to anxiolytics or pain 
      management drugs. Moreover, they presented significant pairwise associations 
      between CC, such as asthma, vertigo, thyroid diseases, osteoarticular diseases, 
      and sleep disorders, and with GS, such as chronic pain, constipation, and 
      anxiety/depression. No significant differences in immediate adverse outcomes of 
      care were observed between men and women in the exacerbation episode.
FAU - Baré, Marisa
AU  - Baré M
AUID- ORCID: 0000-0001-8085-2833
AD  - Institutional Committee for the Improvement of Clinical Practice Adequacy, 
      Clinical Epidemiology and Cancer Screening Department, CRiSP Research Group, Parc 
      Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí 
      (I3PT), 08208 Sabadell, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), Instituto de 
      Salud Carlos III, 28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, 28029 Madrid, Spain.
FAU - Lleal, Marina
AU  - Lleal M
AUID- ORCID: 0000-0002-0015-0725
AD  - Institutional Committee for the Improvement of Clinical Practice Adequacy, 
      Clinical Epidemiology and Cancer Screening Department, CRiSP Research Group, Parc 
      Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí 
      (I3PT), 08208 Sabadell, Spain.
AD  - Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine and 
      Public Health, Autonomous University of Barcelona, Bellaterra, 08193 Barcelona, 
      Spain.
FAU - Sevilla-Sánchez, Daniel
AU  - Sevilla-Sánchez D
AUID- ORCID: 0000-0003-2993-6200
AD  - Pharmacy Department, Parc Sanitari Pere Virgili, 08023 Barcelona, Spain.
FAU - Ortonobes, Sara
AU  - Ortonobes S
AD  - Pharmacy Department, Parc Taulí Hospital Universitari, Institut d'Investigació i 
      Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, 08208 Sabadell, 
      Spain.
FAU - Herranz, Susana
AU  - Herranz S
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), Instituto de 
      Salud Carlos III, 28029 Madrid, Spain.
AD  - Acute Care Geriatric Unit, Parc Taulí Hospital Universitari, Institut 
      d'Investigació i Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, 
      08208 Sabadell, Spain.
FAU - Ferrandez, Olivia
AU  - Ferrandez O
AD  - Pharmacy Department, Consorci Parc de Salut MAR, 08003 Barcelona, Spain.
FAU - Corral-Vázquez, Celia
AU  - Corral-Vázquez C
AUID- ORCID: 0000-0002-0621-4590
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), Instituto de 
      Salud Carlos III, 28029 Madrid, Spain.
FAU - Molist, Núria
AU  - Molist N
AUID- ORCID: 0000-0003-0138-6278
AD  - Geriatrics Department-C3RG Research Ggoup, Consorci Hospitalari de Vic, 08500 
      Vic, Spain.
FAU - Nazco, Gloria Julia
AU  - Nazco GJ
AD  - Pharmacy Department, Hospital Universitario de Canarias, 38320 La Laguna, Spain.
FAU - Martín-González, Candelaria
AU  - Martín-González C
AUID- ORCID: 0000-0002-4702-1840
AD  - Internal Medicine Department, Hospital Universitario de Canarias, 38320 La 
      Laguna, Spain.
FAU - Márquez, Miguel Ángel
AU  - Márquez MÁ
AD  - Geriatrics Department, Consorci Parc de Salut MAR, 08003 Barcelona, Spain.
FAU - On Behalf Of The MoPIM Study Group
AU  - On Behalf Of The MoPIM Study Group
LA  - eng
GR  - PI15/00552/Instituto de Salud Carlos III/
GR  - RD16/0001/0002/the Network for Research into Healthcare in Chronic Diseases 
      (REDISSEC)/
PT  - Journal Article
PT  - Multicenter Study
DEP - 20230218
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Male
MH  - Female
MH  - Aged
MH  - Aged, 80 and over
MH  - Multimorbidity
MH  - Cohort Studies
MH  - Prospective Studies
MH  - *Frailty
MH  - Sex Characteristics
MH  - Inpatients
MH  - Inappropriate Prescribing
MH  - Chronic Disease
MH  - *Drug-Related Side Effects and Adverse Reactions
PMC - PMC9964600
OTO - NOTNLM
OT  - adverse drug reaction
OT  - in-hospital mortality
OT  - multimorbidity
OT  - network analysis
OT  - outcomes of care
OT  - potentially inappropriate medication
OT  - sex perspective
COIS- The authors declare no conflict of interest.
EDAT- 2023/02/26 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/25 02:33
PHST- 2022/11/04 00:00 [received]
PHST- 2023/02/13 00:00 [revised]
PHST- 2023/02/16 00:00 [accepted]
PHST- 2023/02/25 02:33 [entrez]
PHST- 2023/02/26 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - ijerph20043639 [pii]
AID - ijerph-20-03639 [pii]
AID - 10.3390/ijerph20043639 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Feb 18;20(4):3639. doi: 
      10.3390/ijerph20043639.

PMID- 36833878
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230301
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 4
DP  - 2023 Feb 11
TI  - Is Early Initiation of Maternal Lactation a Significant Determinant for 
      Continuing Exclusive Breastfeeding up to 6 Months?
LID - 10.3390/ijerph20043184 [doi]
LID - 3184
AB  - BACKGROUND: The World Health Organization (WHO) recommends early initiation of 
      breastfeeding (EIBF) within the first hour after birth. However, certain 
      perinatal factors, namely caesarean section, may prevent this goal from being 
      achieved. The aim of our study was to examine the relationship between EIBF 
      (maternal lactation in the first hours and degree of latching before hospital 
      discharge) and the maintenance of exclusive breastfeeding (MBF) up to the 
      recommended 6 months of age (as advocated by the WHO). METHODS: This 
      observational, retrospective cohort study included a random sample of all births 
      between 2018 and 2019, characterising the moment of breastfeeding initiation 
      after birth and the infant's level of breast latch (measured by LATCH assessment 
      tool) prior to hospital discharge. Data were collected from electronic medical 
      records and from follow-up health checks of infants up to 6 months postpartum. 
      RESULTS: We included 342 women and their newborns. EIBF occurred most often after 
      vaginal (p < 0.001) and spontaneous births with spontaneous amniorrhexis (p = 
      0.002). LATCH score <9 points was associated with a 1.4-fold relative risk of 
      abandoning MBF (95%CI: 1.2-1.7) compared with a score of 9-10 points. 
      CONCLUSIONS: Although we were unable to find a significant association between 
      EIBF in the first 2 h after birth and MBF at 6 months postpartum, low LATCH 
      scores prior to discharge were associated with low MBF, indicating the importance 
      of reinforcing the education and preparation efforts of mothers in the first days 
      after delivery, prior to the establishment of an infant feeding routine upon 
      returning home.
FAU - Mena-Tudela, Desirée
AU  - Mena-Tudela D
AUID- ORCID: 0000-0003-1596-3064
AD  - Department of Nursing, Universitat Jaume I, 12071 Castellón de la Plana, Spain.
FAU - Soriano-Vidal, Francisco Javier
AU  - Soriano-Vidal FJ
AUID- ORCID: 0000-0002-6210-6471
AD  - Department of Nursing, Universitat de València, 46007 Valencia, Spain.
AD  - Department of Obstetrics and Gynaecology, Xàtiva-Oninyent Health Department, 
      46800 Xàtiva, Spain.
FAU - Vila-Candel, Rafael
AU  - Vila-Candel R
AUID- ORCID: 0000-0002-3734-2480
AD  - Department of Nursing, Universitat de València, 46007 Valencia, Spain.
AD  - Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, 
      46600 Alzira, Spain.
FAU - Quesada, José Antonio
AU  - Quesada JA
AUID- ORCID: 0000-0002-6947-7531
AD  - Department of Clinical Medicine, Universidad Miguel Hernández, 03202 Elche, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      03550 Alicante, Spain.
FAU - Martínez-Porcar, Cristina
AU  - Martínez-Porcar C
AD  - Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, 
      46600 Alzira, Spain.
FAU - Martin-Moreno, Jose M
AU  - Martin-Moreno JM
AUID- ORCID: 0000-0002-8648-5541
AD  - Department of Preventive Medicine and Public Health, Universitat de València, 
      46010 Valencia, Spain.
AD  - Biomedical Research Institute INCLIVA, Clinic University Hospital, 46010 
      Valencia, Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20230211
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Infant
MH  - Pregnancy
MH  - Female
MH  - Infant, Newborn
MH  - Humans
MH  - *Breast Feeding
MH  - *Cesarean Section
MH  - Retrospective Studies
MH  - Mothers
MH  - Lactation
PMC - PMC9966801
OTO - NOTNLM
OT  - caesarean section
OT  - early initiation of breastfeeding
OT  - exclusive breastfeeding
OT  - skin-to-skin contact
OT  - vaginal birth
COIS- The authors declare no conflict of interest.
EDAT- 2023/02/26 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/25 02:24
PHST- 2022/12/17 00:00 [received]
PHST- 2023/02/09 00:00 [revised]
PHST- 2023/02/10 00:00 [accepted]
PHST- 2023/02/25 02:24 [entrez]
PHST- 2023/02/26 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - ijerph20043184 [pii]
AID - ijerph-20-03184 [pii]
AID - 10.3390/ijerph20043184 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Feb 11;20(4):3184. doi: 
      10.3390/ijerph20043184.

PMID- 36827237
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230410
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 18
IP  - 2
DP  - 2023
TI  - Impact of the "Looking after my health after cancer" peer-led active patient 
      education program on cancer survivors and their caregivers: A qualitative study.
PG  - e0282018
LID - 10.1371/journal.pone.0282018 [doi]
LID - e0282018
AB  - BACKGROUND: Cancer survival has doubled and is likely to continue increasing in 
      the near future. Cancer survivors experience long-term adverse effects, with 
      associated psychological changes, and often they have needs that are yet to be 
      met. Recognizing the lack of continuity-of-care initiatives for cancer survivors 
      and caregivers, Osakidetza Basque Health Service has started to implement through 
      primary care a peer-led active patient education program called "Looking after my 
      health after cancer". This study explores how cancer survivors and their 
      caregivers rate the experience of participating in the program, to what extent 
      the program helps them understand and address their unmet felt needs, and helps 
      them improve their activation for self-care and self-management. METHODS: A 
      qualitative exploratory phenomenological study was conducted using five focus 
      groups: four with cancer survivors (n = 29) and caregivers (n = 2), and one with 
      peer leaders (n = 7). Narrative content analysis was performed using the constant 
      comparison method, facilitated by Atlas-ti software. Descriptive analysis of 
      sociodemographic and clinical data was performed. The study was developed 
      according to the Consolidated criteria for reporting qualitative research (COREQ) 
      checklist. RESULTS: Five main themes emerged from the content analysis: 1) 
      satisfaction with the program as a positive learning experience; 2) peer sharing 
      and learning ("if they can, so can I"); 3) fears prior to attending the program; 
      4) becoming more aware of unmet felt needs and feeling understood in the "new 
      normal"; and 5) a more positive view of their experience, helping them become 
      active in self-care and empowered in the self-management of their condition. 
      CONCLUSIONS: The peer education program has shown to have a positive impact on 
      cancer survivors and caregivers. It is necessary to design, implement and 
      evaluate interventions of this type to address unmet felt needs during cancer 
      survivorship and improve their quality of life.
CI  - Copyright: © 2023 Ulibarri-Ochoa et al. This is an open access article 
      distributed under the terms of the Creative Commons Attribution License, which 
      permits unrestricted use, distribution, and reproduction in any medium, provided 
      the original author and source are credited.
FAU - Ulibarri-Ochoa, Ainhoa
AU  - Ulibarri-Ochoa A
AUID- ORCID: 0000-0001-9599-0542
AD  - Bioaraba Health Research Institute, Clinical Nursing and Community Health 
      Research Group, Vitoria-Gasteiz, Spain.
AD  - Osakidetza Basque Health Service, Araba Integrated Health Organisation, 
      Vitoria-Gasteiz, Spain.
AD  - Vitoria-Gasteiz School of Nursing, University of the Basque Country, 
      Vitoria-Gasteiz, Spain.
FAU - Sánchez-Gómez, Sheila
AU  - Sánchez-Gómez S
AD  - Bioaraba Health Research Institute, Healthcare Research Group, Vitoria-Gasteiz, 
      Spain.
AD  - Osakidetza Basque Health Service, Araba Integrated Health Organisation, 
      Directorate for Healthcare Integration, Vitoria-Gasteiz, Spain.
AD  - Osakidetza Basque Health Service, General Directorate, Nursing Subcommittee, 
      Araba Multidisciplinary Teaching Unit for Family and Community Healthcare, 
      Vitoria-Gasteiz, Spain.
FAU - Gamboa-Moreno, Estíbaliz
AU  - Gamboa-Moreno E
AD  - Biodonostia Health Research Institute, Primary Care Research Unit, San 
      Sebastián-Donostia, Spain.
AD  - Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, 
      San Sebastián-Donostia, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
FAU - Duo-Trecet, Irene
AU  - Duo-Trecet I
AD  - Biodonostia Health Research Institute, Primary Care Research Unit, San 
      Sebastián-Donostia, Spain.
AD  - Osakidetza Basque Health Service, Active Patient Program (Paziente Bizia-Paciente 
      Activo), Subdirectorate for Primary Care Coordination, San Sebastián-Donostia, 
      Spain.
FAU - Garate-Echenique, Lucia
AU  - Garate-Echenique L
AD  - Osakidetza Basque Health Service, Coordination of Strategic Plans, Subdirectorate 
      for Nursing, Vitoria-Gasteiz, Spain.
FAU - Belarra-Tellechea, Begoña
AU  - Belarra-Tellechea B
AD  - Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
AD  - Osakidetza Basque Health Service, School of Health (Osasun Eskola), 
      Subdirectorate for Primary Care Coordination, Vitoria-Gasteiz, Spain.
FAU - Retana-García, Lourdes Ochoa de
AU  - Retana-García LO
AD  - Biodonostia Health Research Institute, Primary Care Research Unit, San 
      Sebastián-Donostia, Spain.
AD  - Osakidetza Basque Health Service, Active Patient Program (Paziente Bizia-Paciente 
      Activo), Subdirectorate for Primary Care Coordination, San Sebastián-Donostia, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230224
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Humans
MH  - *Cancer Survivors/psychology
MH  - Caregivers/psychology
MH  - Quality of Life
MH  - Patient Education as Topic
MH  - Qualitative Research
MH  - *Neoplasms
PMC - PMC9955581
COIS- The authors have declared that no competing interests exist.
EDAT- 2023/02/25 06:00
MHDA- 2023/03/03 06:00
CRDT- 2023/02/24 13:34
PHST- 2022/07/14 00:00 [received]
PHST- 2023/02/06 00:00 [accepted]
PHST- 2023/02/24 13:34 [entrez]
PHST- 2023/02/25 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
AID - PONE-D-22-19858 [pii]
AID - 10.1371/journal.pone.0282018 [doi]
PST - epublish
SO  - PLoS One. 2023 Feb 24;18(2):e0282018. doi: 10.1371/journal.pone.0282018. 
      eCollection 2023.

PMID- 36804332
OWN - NLM
STAT- MEDLINE
DCOM- 20230310
LR  - 20230310
IS  - 2341-2879 (Electronic)
IS  - 2341-2879 (Linking)
VI  - 98
IP  - 3
DP  - 2023 Mar
TI  - Trends in hospitalization for urinary tract infection in the paediatric age group 
      in the 2000-2015 period in Spain.
PG  - 175-184
LID - S2341-2879(23)00023-6 [pii]
LID - 10.1016/j.anpede.2023.01.009 [doi]
AB  - OBJECTIVE: To analyse the trends in hospital admissions related to urinary tract 
      infection among children aged 0-14 years in Spain in the 2000-2015 period. 
      METHODS: We conducted a retrospective observational study using the minimum basic 
      hospital discharge dataset system of Spain, which applies the International 
      Classification of Diseases, version 9 (ICD-9) coding system. We included every 
      hospitalisation due to cystitis, pyelonephritis and unspecified UTI among 
      children aged less than 15 years. We collected data on patient sex and age, type 
      of discharge, main diagnosis, comorbidities, length of stay and overall cost. We 
      calculated crude hospitalization rates per 1000 inhabitants aged less than 15 
      years and performed a joinpoint regression analysis to identify temporal trends. 
      RESULTS: In the 2000-2015 period, there were 124 696 hospitalizations in children 
      under 15 years. Of these patients, 72.97% were aged 0-1 year and 60.12% had a 
      diagnosis of unspecified UTI, 39.27% of pyelonephritis, and 0.52% of cystitis. 
      The crude rate of hospitalization due to UTI ranged from 1.24 in year 2000 to 
      0.98 in 2015. The rate of hospitalization was higher in female versus male 
      patients. The joinpoint analysis found a decreasing trend in the rate of 
      hospitalization due to UTI, with an average annual percent change (AAPC) of -1.5% 
      (95% confidence interval [CI], -2.4 a -0.6). The largest decreases occurred in 
      female patients (AAPC, -1.8; 95% CI, -2.5 a -1.0) and children aged 7-10 years 
      (AAPC - 5.9; 95% CI, -6.7 a -5.2). CONCLUSIONS: The rate of hospitalization 
      related to UTI in Spain in patients aged up to 14 years decreased during the 
      2000-2015 period. The highest hospitalization rates occurred in female patients 
      and in the 0-to-1 year age group.
CI  - Copyright © 2022 Asociación Española de Pediatría. Published by Elsevier España, 
      S.L.U. All rights reserved.
FAU - Redondo Sánchez, Jesús
AU  - Redondo Sánchez J
AD  - Centro de Salud Ramon y Cajal, Alcorcón, Spain; Gerencia de Atención Primaria, 
      Servicio Madrileño de Salud, Madrid, Spain; Departamento de Especialidades 
      Médicas y Salud Pública, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain. 
      Electronic address: jesus.redondosa@salud.madrid.org.
FAU - Domínguez Lázaro, Alberto Manuel
AU  - Domínguez Lázaro AM
AD  - Medicina Preventiva y Salud Pública, Complejo Hospitalario Universitario Insular 
      Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain.
FAU - Rodríguez Barrientos, Ricardo
AU  - Rodríguez Barrientos R
AD  - Instituto de Investigación Sanitaria Gregorio Marañón, Servicio Madrileño de 
      Salud, Madrid, Spain; Unidad de Investigación, Gerencia de Atención Primaria, 
      Servicio Madrileño de Salud, Madrid, Spain; Red de Investigación en Servicios de 
      Salud en Enfermedades Crónicas (REDISSEC) y Red de Investigación en Cronicidad, 
      Atención Primaria y Prevención y Promoción de la Salud (RICAPPS), Instituto de 
      Salud Carlos III, Madrid, Spain.
FAU - Barrio Cortes, Jaime
AU  - Barrio Cortes J
AD  - Unidad de Investigación, Gerencia de Atención Primaria, Servicio Madrileño de 
      Salud, Madrid, Spain; Fundación para la Investigación e Innovación Biosanitaria 
      en Atención Primaria, Madrid, Spain.
FAU - Seoane Sanz, Andrea
AU  - Seoane Sanz A
AD  - Servicio de Pediatría, Hospital Universitario 12 de Octubre, Madrid, Spain.
FAU - Bravo Acuna, Juan
AU  - Bravo Acuna J
AD  - Centro de Salud El Greco, Getafe. Gerencia de Atención Primaria, Servicio 
      Madrileño de Salud, Madrid, Spain.
FAU - Del Cura-González, Isabel
AU  - Del Cura-González I
AD  - Departamento de Especialidades Médicas y Salud Pública, Universidad Rey Juan 
      Carlos, Alcorcón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio 
      Marañón, Servicio Madrileño de Salud, Madrid, Spain; Unidad de Investigación, 
      Gerencia de Atención Primaria, Servicio Madrileño de Salud, Madrid, Spain; Red de 
      Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) y Red de 
      Investigación en Cronicidad, Atención Primaria y Prevención y Promoción de la 
      Salud (RICAPPS), Instituto de Salud Carlos III, Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20230217
PL  - Spain
TA  - An Pediatr (Engl Ed)
JT  - Anales de pediatria
JID - 101765626
SB  - IM
MH  - Humans
MH  - Male
MH  - Child
MH  - Female
MH  - Infant, Newborn
MH  - Infant
MH  - Child, Preschool
MH  - Adolescent
MH  - Spain/epidemiology
MH  - Hospitalization
MH  - *Urinary Tract Infections/epidemiology/diagnosis
MH  - *Pyelonephritis
MH  - *Cystitis
OTO - NOTNLM
OT  - Children
OT  - España
OT  - Hospitalización
OT  - Hospitalization
OT  - Infección del tracto urinario
OT  - Niños
OT  - Spain
OT  - Tendencias
OT  - Trends
OT  - Urinary tract infection
EDAT- 2023/02/23 06:00
MHDA- 2023/03/11 06:00
CRDT- 2023/02/22 08:38
PHST- 2022/05/31 00:00 [received]
PHST- 2022/09/07 00:00 [accepted]
PHST- 2023/02/23 06:00 [pubmed]
PHST- 2023/03/11 06:00 [medline]
PHST- 2023/02/22 08:38 [entrez]
AID - S2341-2879(23)00023-6 [pii]
AID - 10.1016/j.anpede.2023.01.009 [doi]
PST - ppublish
SO  - An Pediatr (Engl Ed). 2023 Mar;98(3):175-184. doi: 10.1016/j.anpede.2023.01.009. 
      Epub 2023 Feb 17.

PMID- 36788479
OWN - NLM
STAT- MEDLINE
DCOM- 20230216
LR  - 20230223
IS  - 1471-2288 (Electronic)
IS  - 1471-2288 (Linking)
VI  - 23
IP  - 1
DP  - 2023 Feb 14
TI  - Estimating disease incidence rates and transition probabilities in elderly 
      patients using multi-state models: a case study in fragility fracture using a 
      Bayesian approach.
PG  - 40
LID - 10.1186/s12874-023-01859-y [doi]
LID - 40
AB  - BACKGROUND: Multi-state models are complex stochastic models which focus on 
      pathways defined by the temporal and sequential occurrence of numerous events of 
      interest. In particular, the so-called illness-death models are especially useful 
      for studying probabilities associated to diseases whose occurrence competes with 
      other possible diseases, health conditions or death. They can be seen as a 
      generalization of the competing risks models, which are widely used to estimate 
      disease-incidences among populations with a high risk of death, such as elderly 
      or cancer patients. The main advantage of the aforementioned illness-death models 
      is that they allow the treatment of scenarios with non-terminal competing events 
      that may occur sequentially, which competing risks models fail to do. METHODS: We 
      propose an illness-death model using Cox proportional hazards models with Weibull 
      baseline hazard functions, and applied the model to a study of recurrent hip 
      fracture. Data came from the PREV2FO cohort and included 34491 patients aged 65 
      years and older who were discharged alive after a hospitalization due to an 
      osteoporotic hip fracture between 2008-2015. We used a Bayesian approach to 
      approximate the posterior distribution of each parameter of the model, and thus 
      cumulative incidences and transition probabilities. We also compared these 
      results with a competing risks specification. RESULTS: Posterior transition 
      probabilities showed higher probabilities of death for men and increasing with 
      age. Women were more likely to refracture as well as less likely to die after it. 
      Free-event time was shown to reduce the probability of death. Estimations from 
      the illness-death and the competing risks models were identical for those common 
      transitions although the illness-death model provided additional information from 
      the transition from refracture to death. CONCLUSIONS: We illustrated how 
      multi-state models, in particular illness-death models, may be especially useful 
      when dealing with survival scenarios which include multiple events, with 
      competing diseases or when death is an unavoidable event to consider. 
      Illness-death models via transition probabilities provide additional information 
      of transitions from non-terminal health conditions to absorbing states such as 
      death, what implies a deeper understanding of the real-world problem involved 
      compared to competing risks models.
CI  - © 2023. The Author(s).
FAU - Llopis-Cardona, Fran
AU  - Llopis-Cardona F
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region (FISABIO), Valencia, Spain. 
      llopis_fracar@gva.es.
FAU - Armero, Carmen
AU  - Armero C
AD  - Department of Statistics and Operations Research. Universitat de València, 
      Valencia, Spain.
AD  - Joint research unit FISABIO-UV for the analysis of biomedical data, Valencia, 
      Spain.
FAU - Sanfélix-Gimeno, Gabriel
AU  - Sanfélix-Gimeno G
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region (FISABIO), Valencia, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
LA  - eng
GR  - FI19/00190/Instituto de Salud Carlos III/
GR  - PI14/00993/Instituto de Salud Carlos III/
GR  - PID2019-106341GB-I00/Ministerio de Ciencia e Innovación/
GR  - PI18/01675/Instituto de Salud Carlos III/
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230214
PL  - England
TA  - BMC Med Res Methodol
JT  - BMC medical research methodology
JID - 100968545
SB  - IM
MH  - Male
MH  - Aged
MH  - Humans
MH  - Female
MH  - Incidence
MH  - Bayes Theorem
MH  - Risk Factors
MH  - Proportional Hazards Models
MH  - *Hip Fractures/epidemiology
PMC - PMC9930279
OTO - NOTNLM
OT  - Bayesian inference
OT  - Cause-specific hazard models
OT  - Cumulative incidence function
OT  - Epidemiological data
OT  - Illness-death models
OT  - Transition probabilities
COIS- The authors declare no competing interests.
EDAT- 2023/02/16 06:00
MHDA- 2023/02/17 06:00
CRDT- 2023/02/15 00:22
PHST- 2022/01/28 00:00 [received]
PHST- 2023/02/02 00:00 [accepted]
PHST- 2023/02/15 00:22 [entrez]
PHST- 2023/02/16 06:00 [pubmed]
PHST- 2023/02/17 06:00 [medline]
AID - 10.1186/s12874-023-01859-y [pii]
AID - 1859 [pii]
AID - 10.1186/s12874-023-01859-y [doi]
PST - epublish
SO  - BMC Med Res Methodol. 2023 Feb 14;23(1):40. doi: 10.1186/s12874-023-01859-y.

PMID- 36779532
OWN - NLM
STAT- MEDLINE
DCOM- 20230214
LR  - 20230217
IS  - 1748-2631 (Electronic)
IS  - 1748-2623 (Print)
IS  - 1748-2623 (Linking)
VI  - 18
IP  - 1
DP  - 2023 Dec
TI  - Spanish residents' experiences of care during the first wave of the COVID-19 
      syndemic: a photo-elicitation study.
PG  - 2172798
LID - 10.1080/17482631.2023.2172798 [doi]
LID - 2172798
AB  - PURPOSE: The main aim of this research was to explore experiences of care during 
      the lockdown of the first wave of COVID-19 syndemic in Spain. METHODS: This is a 
      qualitative and explorative study using self-photo-elicitation as a data 
      collection method. Fifteen participants (Twelve women and three men) shared 25 
      photographs and one video between the June 18 and August, 2020. Participants' 
      photographs and texts were collected online. Data were analysed based on Thematic 
      Analysis. RESULTS: Three emerging categories were constructed: 1) the 
      deconstruction of care: self-care and collective care 2) the crisis of care and 
      gendered care, 2) beyond anthropocentrism: animalism and ecology. Findings 
      indicate the need to understand "care" in terms of social reproduction, including 
      self-care, care towards other humans and non-human animals, and collective care. 
      Also, the need to care for planetary health and to be in contact with nature as a 
      form of self-care and social care. CONCLUSIONS: Care in a period of social and 
      health crisis puts human relationships and also non-human life at the centre. 
      Care requires adopting taking an ecological one-health perspective.
FAU - Medina-Perucha, Laura
AU  - Medina-Perucha L
AD  - Unitat Transversal de Recerca, Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autónoma de Barcelona Bellaterra, Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
FAU - Jacques-Aviñó, Constanza
AU  - Jacques-Aviñó C
AUID- ORCID: 0000-0001-8506-780X
AD  - Unitat Transversal de Recerca, Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autónoma de Barcelona Bellaterra, Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
FAU - López-Jiménez, Tomàs
AU  - López-Jiménez T
AD  - Unitat Transversal de Recerca, Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autónoma de Barcelona Bellaterra, Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
FAU - Maiz, Catuxa
AU  - Maiz C
AD  - Unitat Transversal de Recerca, Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
FAU - Berenguera, Anna
AU  - Berenguera A
AD  - Unitat Transversal de Recerca, Fundació Institut Universitari per a la recerca a 
      l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Universitat Autónoma de Barcelona Bellaterra, Cerdanyola del Vallès, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Spain.
AD  - Departament d'Infermeria, Universitat de Girona, Girona, Spain.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Int J Qual Stud Health Well-being
JT  - International journal of qualitative studies on health and well-being
JID - 101256506
SB  - IM
MH  - Humans
MH  - Female
MH  - *COVID-19
MH  - Syndemic
MH  - Qualitative Research
MH  - Communicable Disease Control
MH  - Social Support
PMC - PMC9930786
OTO - NOTNLM
OT  - COVID-19
OT  - Care work
OT  - Spain
OT  - collective care
OT  - gender
OT  - lockdown
OT  - photo-elicitation
OT  - self-care
COIS- No potential conflict of interest was reported by the authors.
EDAT- 2023/02/14 06:00
MHDA- 2023/02/15 06:00
CRDT- 2023/02/13 07:23
PHST- 2023/02/13 07:23 [entrez]
PHST- 2023/02/14 06:00 [pubmed]
PHST- 2023/02/15 06:00 [medline]
AID - 2172798 [pii]
AID - 10.1080/17482631.2023.2172798 [doi]
PST - ppublish
SO  - Int J Qual Stud Health Well-being. 2023 Dec;18(1):2172798. doi: 
      10.1080/17482631.2023.2172798.

PMID- 36757132
OWN - NLM
STAT- MEDLINE
DCOM- 20230210
LR  - 20230215
IS  - 2047-2986 (Electronic)
IS  - 2047-2978 (Print)
IS  - 2047-2978 (Linking)
VI  - 13
DP  - 2023 Feb 3
TI  - Multimorbidity, social determinants and intersectionality in chronic patients. 
      Results from the EpiChron Cohort.
PG  - 04014
LID - 10.7189/13.04014 [doi]
LID - 04014
AB  - BACKGROUND: Multimorbidity is influenced in an interconnected way, both in extent 
      and nature, by the social determinants of health. We aimed at implementing an 
      intersectional approach to analyse the association of multimorbidity with five 
      important axes of social inequality (i.e. gender, age, ethnicity, residence area 
      and socioeconomic class). METHODS: We conducted a cross-sectional observational 
      study of all individuals who presented with at least one chronic disease in 2019 
      (n = 1 086 948) from the EpiChron Cohort (Aragon, Spain). Applying intersectional 
      analysis, the age-adjusted likelihood of multimorbidity was investigated across 
      36 intersectional strata defined by gender, ethnicity, residence area and 
      socioeconomic class. We calculated odds ratios (OR) 95% confidence interval (CI) 
      using high-income urban non-migrant men as the reference category. The area under 
      the receiver operator characteristics curve (AUC) was calculated to evaluate the 
      discriminatory accuracy of multimorbidity. RESULTS: The prevalence of 
      multimorbidity increased with age, female gender and low income. Young and 
      middle-aged low-income individuals showed rates of multimorbidity equivalent to 
      those of high-income people aged about 20 years older. The intersectional 
      analysis showed that low-income migrant women living in urban areas for >15 years 
      were particularly disadvantaged in terms of multimorbidity risk OR = 3.16 (95% 
      CI = 2.79-3.57). Being a migrant was a protective factor for multimorbidity, and 
      newly arrived migrants had lower multimorbidity rates than those with >15 years 
      of stay in Aragon, and even non-migrants. Living in rural vs. urban areas was 
      slightly protective against multimorbidity. All models had a large discriminatory 
      accuracy (AUC = 0.7884-0.7895); the largest AUC was obtained for the model 
      including all intersectional strata. CONCLUSIONS: Our intersectional approach 
      uncovered the large differences in the prevalence of multimorbidity that arise 
      due to the synergies between the different socioeconomic and demographic 
      exposures, beyond their expected additive effects.
CI  - Copyright © 2023 by the Journal of Global Health. All rights reserved.
FAU - Moreno-Juste, Aida
AU  - Moreno-Juste A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - San Pablo Primary Care Health Centre, Aragon Health Service (SALUD), Zaragoza, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
FAU - Calderón-Larrañaga, Amaia
AU  - Calderón-Larrañaga A
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
AD  - Aging Research Center, Department of Neurobiology, Care Sciences and Society, 
      Karolinska Institutet and Stockholm University, Stockholm, Sweden.
FAU - Cano Del Pozo, Mabel
AU  - Cano Del Pozo M
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
AD  - General Directorate of Health Care, Department of Health, Government of Aragon, 
      Zaragoza, Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
AD  - National Center of Epidemiology, Institute of Health Carlos III (ISCIII), Madrid, 
      Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
FAU - Gimeno-Feliú, Luis A
AU  - Gimeno-Feliú LA
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - San Pablo Primary Care Health Centre, Aragon Health Service (SALUD), Zaragoza, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Institute of 
      Health Carlos III (ISCIII), Madrid, Spain.
AD  - University of Zaragoza, Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20230203
PL  - Scotland
TA  - J Glob Health
JT  - Journal of global health
JID - 101578780
SB  - IM
MH  - Middle Aged
MH  - Male
MH  - Humans
MH  - Female
MH  - Aged
MH  - *Multimorbidity
MH  - Cross-Sectional Studies
MH  - *Intersectional Framework
MH  - Social Determinants of Health
MH  - Socioeconomic Factors
PMC - PMC9893716
COIS- Disclosure of interest: The authors completed the ICMJE Disclosure of Interest 
      Form (available upon request from the corresponding author) and disclose no 
      relevant interests.
EDAT- 2023/02/10 06:00
MHDA- 2023/02/11 06:00
CRDT- 2023/02/09 08:13
PHST- 2023/02/09 08:13 [entrez]
PHST- 2023/02/10 06:00 [pubmed]
PHST- 2023/02/11 06:00 [medline]
AID - jogh-13-04014 [pii]
AID - 10.7189/13.04014 [doi]
PST - epublish
SO  - J Glob Health. 2023 Feb 3;13:04014. doi: 10.7189/13.04014.

PMID- 36744382
OWN - NLM
STAT- Publisher
LR  - 20230206
IS  - 1745-9206 (Electronic)
IS  - 1742-3953 (Linking)
DP  - 2023 Feb 6
TI  - Contextual factors for the successful implementation of self-management 
      interventions for chronic diseases: A qualitative review of reviews.
PG  - 17423953231153337
LID - 10.1177/17423953231153337 [doi]
AB  - OBJECTIVES: To identify and describe the most relevant contextual factors (CFs) 
      from the literature that influence the successful implementation of 
      self-management interventions (SMIs) for patients living with type 2 diabetes 
      mellitus, obesity, COPD and/or heart failure. METHODS: We conducted a qualitative 
      review of reviews. Four databases were searched, 929 reviews were identified, 460 
      screened and 61 reviews met the inclusion criteria. CFs in this paper are 
      categorized according to the Tailored Implementation for Chronic Diseases 
      framework. RESULTS: A great variety of CFs was identified on several levels, 
      across all four chronic diseases. Most CFs were on the level of the patient, the 
      professional and the interaction level, while less CFs were obtained on the level 
      of the intervention, organization, setting and national level. No differences in 
      main themes of CFs across all four diseases were found. DISCUSSION: For the 
      successful implementation of SMIs, it is crucial to take CFs on several levels 
      into account simultaneously. Person-centered care, by tailoring SMIs to patients' 
      needs and circumstances, may increase the successful uptake, application and 
      implementation of SMIs in real-life practice. The next step will be to identify 
      the most important CFs according to various stakeholders through a group 
      consensus process.
FAU - Noordman, Janneke
AU  - Noordman J
AUID- ORCID: 0000-0003-4344-7534
AD  - 8123Netherlands institute for health services research (Nivel), Utrecht, The 
      Netherlands.
FAU - Meurs, Maaike
AU  - Meurs M
AD  - 8123Netherlands institute for health services research (Nivel), Utrecht, The 
      Netherlands.
FAU - Poortvliet, Rune
AU  - Poortvliet R
AD  - 8123Netherlands institute for health services research (Nivel), Utrecht, The 
      Netherlands.
FAU - Rusman, Tamara
AU  - Rusman T
AD  - 8123Netherlands institute for health services research (Nivel), Utrecht, The 
      Netherlands.
FAU - Orrego-Villagran, Carola
AU  - Orrego-Villagran C
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
AD  - Avedis Donabedian Research Institute (FAD), Barcelona, Spain.
AD  - Health Services Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Ballester, Marta
AU  - Ballester M
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
AD  - Avedis Donabedian Research Institute (FAD), Barcelona, Spain.
AD  - Health Services Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Ninov, Lyudmil
AU  - Ninov L
AD  - 398174European Patients' Forum, Brussels, Belgium.
FAU - de Guzmán, Ena Niño
AU  - de Guzmán EN
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Barcelona, Spain.
FAU - Alonso-Coello, Pablo
AU  - Alonso-Coello P
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Barcelona, Spain.
FAU - Groene, Oliver
AU  - Groene O
AD  - OptiMedis, Hamburg, Germany.
FAU - Suñol, Rosa
AU  - Suñol R
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
AD  - Avedis Donabedian Research Institute (FAD), Barcelona, Spain.
AD  - Health Services Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Heijmans, Monique
AU  - Heijmans M
AD  - 8123Netherlands institute for health services research (Nivel), Utrecht, The 
      Netherlands.
FAU - Wagner, Cordula
AU  - Wagner C
AD  - 8123Netherlands institute for health services research (Nivel), Utrecht, The 
      Netherlands.
AD  - Department of Public and Occupational Health, Amsterdam Public Health Research 
      Institute, Amsterdam, The Netherlands.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230206
PL  - United States
TA  - Chronic Illn
JT  - Chronic illness
JID - 101253019
SB  - IM
OTO - NOTNLM
OT  - Chronic illness
OT  - contextual factors
OT  - implementation
OT  - review
OT  - self-management interventions
EDAT- 2023/02/07 06:00
MHDA- 2023/02/07 06:00
CRDT- 2023/02/06 04:11
PHST- 2023/02/06 04:11 [entrez]
PHST- 2023/02/07 06:00 [pubmed]
PHST- 2023/02/07 06:00 [medline]
AID - 10.1177/17423953231153337 [doi]
PST - aheadofprint
SO  - Chronic Illn. 2023 Feb 6:17423953231153337. doi: 10.1177/17423953231153337.

PMID- 36739705
OWN - NLM
STAT- MEDLINE
DCOM- 20230328
LR  - 20230502
IS  - 1873-5134 (Electronic)
IS  - 0738-3991 (Print)
IS  - 0738-3991 (Linking)
VI  - 110
DP  - 2023 May
TI  - Self-management interventions for adults living with obesity to improve 
      patient-relevant outcomes: An evidence map.
PG  - 107647
LID - S0738-3991(23)00027-7 [pii]
LID - 10.1016/j.pec.2023.107647 [doi]
LID - 107647
AB  - OBJECTIVES: To conduct an evidence map on self-management interventions and 
      patient-relevant outcomes for adults living with overweight/obesity. METHODS: 
      Following Arksey and O'Malley methodology, we searched in five electronical 
      databases including randomized controlled trials (RCTs) on SMIs for 
      overweight/obesity. We used the terms "self-management", "adult" and "obesity" 
      for content. Two independent reviewers assessed eligible references; one reviewer 
      extracted data, a second checked accuracy. RESULTS: We identified 497 RCTs (58% 
      US, 20% Europe) including 99,741 (median 112, range 11-5145) adults living with 
      overweight/obesity. Most research evaluated clinical outcomes (617, 55%) and 
      behaviors adherence (255, 23%). Empowerment skills, quality of life and 
      satisfaction were less targeted (8%, 7%, 0.2%, respectively). The most frequent 
      techniques included sharing information (858, 99%), goal setting (619, 72%) and 
      self-monitoring training (614, 71%), provided face-to-face (386, 45%) or in 
      combination with remote techniques (256, 30%). Emotional management, social 
      support and shared-decision were less frequent (18%, 26%, 4%). Socio-economic 
      status, minorities or health literacy were seldom reported. CONCLUSION: There is 
      a need of widening the scope of research by focusing on outcomes important to 
      patients, assessing emotional/social/share-decision support, exploring remote 
      techniques and including vulnerable populations.
CI  - Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
FAU - Sunol, Rosa
AU  - Sunol R
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain; Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 
      Barcelona 08103, Spain. Electronic address: rsunol@fadq.org.
FAU - González-González, Ana Isabel
AU  - González-González AI
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain; Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 
      Barcelona 08103, Spain; Network for Research on Chronicity, Primary Care, and 
      Health Promotion (RICAPPS), Madrid, Spain; Institute of General Practice, Goethe 
      University, Theodor-Stern-Kai 7, Frankfurt am Main D-60590, Germany. Electronic 
      address: aigonzalez@fadq.org.
FAU - Valli, Claudia
AU  - Valli C
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain; Iberoamerican Cochrane Centre, Biomedical Research Institute Sant 
      Pau (IIB Sant Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic 
      address: cvalli@fadq.org.
FAU - Ballester, Marta
AU  - Ballester M
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain; Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 
      Barcelona 08103, Spain; Network for Research on Chronicity, Primary Care, and 
      Health Promotion (RICAPPS), Madrid, Spain. Electronic address: 
      mballester@fadq.org.
FAU - Seils, Laura
AU  - Seils L
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain; Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 
      Barcelona 08103, Spain. Electronic address: mir@fadq.org.
FAU - Heijmans, Monique
AU  - Heijmans M
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: m.heymans@nivel.nl.
FAU - Poortvliet, Rune
AU  - Poortvliet R
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: r.poortvliet@nivel.nl.
FAU - van der Gaag, Marieke
AU  - van der Gaag M
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: m.vandergaag@nivel.nl.
FAU - Rocha, Claudio
AU  - Rocha C
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      claudiorochacalderon@gmail.com.
FAU - León-García, Montserrat
AU  - León-García M
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      mleong@santpau.cat.
FAU - Salas-Gama, Karla
AU  - Salas-Gama K
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain; Institute for Health 
      Policy, Management and Evaluation, University of Toronto, Ontario M5T 3M6, 
      Canada. Electronic address: karla.salas@vallhebron.cat.
FAU - de Guzman, Ena Niño
AU  - de Guzman EN
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      e.nino@iconcologia.net.
FAU - Kaloteraki, Chrysoula
AU  - Kaloteraki C
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      xkaloter@gmail.com.
FAU - Santero, Marilina
AU  - Santero M
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      msantero@santpau.cat.
FAU - Spoiala, Cristina
AU  - Spoiala C
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: cristina.spoiala@ons.gov.uk.
FAU - Gurung, Pema
AU  - Gurung P
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: 
      p.gurung@library.leidenuniv.nl.
FAU - Moaddine, Saida
AU  - Moaddine S
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: s.moaddine@lumc.nl.
FAU - Wilemen, Fabienne
AU  - Wilemen F
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: fabiennewillemen@live.nl.
FAU - Cools, Iza
AU  - Cools I
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: izacools@hotmail.com.
FAU - Bleeker, Julia
AU  - Bleeker J
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: julia.bleeker@live.nl.
FAU - Kancheva, Angelina
AU  - Kancheva A
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: angelina.k.kancheva@gmail.com.
FAU - Ertl, Julia
AU  - Ertl J
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: juliaertl@hotmail.com.
FAU - Laure, Tajda
AU  - Laure T
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: laure@essb.eur.nl.
FAU - Kancheva, Ivana
AU  - Kancheva I
AD  - Netherlands Institute for Health Services Research (NIVEL), Otterstraat 118, 
      Utrecht 3513, the Netherlands. Electronic address: 
      ivanakirilova.kancheva@gmail.com.
FAU - Veroniki, Areti Angeliki
AU  - Veroniki AA
AD  - Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's 
      Hospital, Toronto, Ontario M5B 1T8, Canada; Institute for Health Policy, 
      Management and Evaluation, University of Toronto, Ontario M5T 3M6, Canada. 
      Electronic address: areti-angeliki.veroniki@unityhealth.to.
FAU - Zevgiti, Stella
AU  - Zevgiti S
AD  - Department of Primary Education, School of Education, University of Ioannina, 
      Ioannina 45110, Greece. Electronic address: stella.zevgiti@gmail.com.
FAU - Beltrán, Jessica
AU  - Beltrán J
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      jbeltranp@santpau.cat.
FAU - Canelo-Aybar, Carlos
AU  - Canelo-Aybar C
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain. Electronic address: 
      ccanelo@santpau.cat.
FAU - Zafra-Tanaka, Jessica Hanae
AU  - Zafra-Tanaka JH
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain. Electronic address: j.zafra.t@gmail.com.
FAU - Seitidis, Georgios
AU  - Seitidis G
AD  - Department of Primary Education, School of Education, University of Ioannina, 
      Ioannina 45110, Greece. Electronic address: g.seitidis@uoi.gr.
FAU - Mavridis, Dimitris
AU  - Mavridis D
AD  - Department of Primary Education, School of Education, University of Ioannina, 
      Ioannina 45110, Greece. Electronic address: dimi.mavridis@gmail.com.
FAU - Groene, Oliver
AU  - Groene O
AD  - OptiMedis, Burchardstrasse 17, Hamburg 20095, Germany. Electronic address: 
      o.groene@optimedis.de.
FAU - Alonso-Coello, Pablo
AU  - Alonso-Coello P
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), Carrer de Sant Quintí 77, Barcelona 08025, Spain; CIBER de Epidemiología y 
      Salud Pública (CIBERESP), Barcelona, Spain. Electronic address: 
      palonso@santpau.cat.
FAU - Orrego, Carola
AU  - Orrego C
AD  - Avedis Donabedian Research Institute (FAD), Provença, 293, pral., Barcelona 
      08037, Spain; Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 
      Barcelona 08103, Spain; Network for Research on Chronicity, Primary Care, and 
      Health Promotion (RICAPPS), Madrid, Spain. Electronic address: corrego@fadq.org.
CN  - COMPAR-EU consortium
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230124
PL  - Ireland
TA  - Patient Educ Couns
JT  - Patient education and counseling
JID - 8406280
MH  - Humans
MH  - Overweight
MH  - Obesity/therapy
MH  - *Self-Management
MH  - *Health Literacy
MH  - Treatment Outcome
PMC - PMC10109091
COIS- Declaration of competing interests The authors declare no competing interests.
EDAT- 2023/02/06 06:00
MHDA- 2023/03/28 17:13
CRDT- 2023/02/05 18:07
PHST- 2022/09/30 00:00 [received]
PHST- 2023/01/12 00:00 [revised]
PHST- 2023/01/21 00:00 [accepted]
PHST- 2023/03/28 17:13 [medline]
PHST- 2023/02/06 06:00 [pubmed]
PHST- 2023/02/05 18:07 [entrez]
AID - S0738-3991(23)00027-7 [pii]
AID - 107647 [pii]
AID - 10.1016/j.pec.2023.107647 [doi]
PST - ppublish
SO  - Patient Educ Couns. 2023 May;110:107647. doi: 10.1016/j.pec.2023.107647. Epub 
      2023 Jan 24.

PMID- 36735174
OWN - NLM
STAT- MEDLINE
DCOM- 20230512
LR  - 20230512
IS  - 1573-2649 (Electronic)
IS  - 0962-9343 (Linking)
VI  - 32
IP  - 6
DP  - 2023 Jun
TI  - Mapping the EQ-5D-5L from the Spanish national health survey functional 
      disability scale through Bayesian networks.
PG  - 1785-1794
LID - 10.1007/s11136-023-03351-y [doi]
AB  - PURPOSE: Preference-based measures are valuable tools for evaluating therapeutic 
      interventions and for cost-effectiveness studies. Mapping procedures are useful 
      when it is not possible to collect these kind of measures. The objective of this 
      study was to evaluate which mapping method is the most appropriate to estimate 
      the EQ-5D-5L index from the Spanish National Health Survey functional disability 
      scale. METHODS: The sample, formed by 5708 older adults (aged 65 years or older), 
      was drawn from the Spanish National Health Survey ("Encuesta Nacional de Salud en 
      España," ENSE in Spanish 2011-2012). The predictions of EQ-5D-5L index were 
      performed with response mapping using Bayesian network (BN), ordered logit 
      (Ologit), and multinomial logistic (ML). The following direct methods were used: 
      ordinary least squares (OLS) and Tobit regression. The intraclass correlation 
      coefficient (ICC), absolute error (MAE), mean squared error (MSE), and root-mean 
      squared error (RMSE) were calculated to compare all models. The predictions of 
      response models were obtained through the expected value method. RESULTS: BN 
      model showed the highest ICC (0.756, 95% confidence interval, CI 0.733-0.777) and 
      lowest MAE (0.110, 95% CI 0.104-0.115). OLS was the model with worse accuracy 
      results with lowest ICC (0.621, 95% CI 0.553-0.681) and highest MAE (0.159, 
      95%CI: 0.145-0.173). CONCLUSION: Indirect mapping methods (BN, Ologit, and ML) 
      had a better accuracy than the direct methods. The response mapping approach 
      provides a robust method to estimate EQ-5D-5L scores from the functional 
      disability scale.
CI  - © 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
FAU - Ayala, Alba
AU  - Ayala A
AUID- ORCID: 0000-0003-4855-4443
AD  - Department of Statistics, School of Law and Social Sciences, University Carlos 
      III of Madrid, 126-28903, Getafe, Madrid, Spain. aayala@est-econ.uc3m.es.
AD  - Health Service Research Network on Chronic Diseases (REDISSEC), Madrid, Spain. 
      aayala@est-econ.uc3m.es.
AD  - Research Network on Chronic Diseases, Primary Care, and Health Promotion 
      (RICAPPS), Madrid, Spain. aayala@est-econ.uc3m.es.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Santa 
      Cruz de Tenerife, Tenerife, Spain.
AD  - Health Service Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.
AD  - Research Network on Chronic Diseases, Primary Care, and Health Promotion 
      (RICAPPS), Madrid, Spain.
FAU - Bilbao-Gonzalez, Amaia
AU  - Bilbao-Gonzalez A
AD  - Osakidetza Basque Health Service, Basurto University Hospital, Research and 
      Innovation Unit, Bilbao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Health Service Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.
AD  - Research Network on Chronic Diseases, Primary Care, and Health Promotion 
      (RICAPPS), Madrid, Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AD  - National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
AD  - Health Service Research Network on Chronic Diseases (REDISSEC), Madrid, Spain.
AD  - Research Network on Chronic Diseases, Primary Care, and Health Promotion 
      (RICAPPS), Madrid, Spain.
LA  - eng
GR  - PI18CIII/00046/Institute of Health Carlos III, Intramural Strategical Action in 
      Health/
GR  - H2019/HUM-5698/Community of Madrid/
PT  - Journal Article
DEP - 20230203
PL  - Netherlands
TA  - Qual Life Res
JT  - Quality of life research : an international journal of quality of life aspects of 
      treatment, care and rehabilitation
JID - 9210257
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Quality of Life/psychology
MH  - Bayes Theorem
MH  - Surveys and Questionnaires
MH  - Health Surveys
MH  - Least-Squares Analysis
MH  - *Algorithms
OTO - NOTNLM
OT  - Bayesian network
OT  - Cross-walking
OT  - Disability
OT  - EQ-5D
OT  - Mapping
EDAT- 2023/02/04 06:00
MHDA- 2023/05/12 07:06
CRDT- 2023/02/03 11:23
PHST- 2023/01/13 00:00 [accepted]
PHST- 2023/05/12 07:06 [medline]
PHST- 2023/02/04 06:00 [pubmed]
PHST- 2023/02/03 11:23 [entrez]
AID - 10.1007/s11136-023-03351-y [pii]
AID - 10.1007/s11136-023-03351-y [doi]
PST - ppublish
SO  - Qual Life Res. 2023 Jun;32(6):1785-1794. doi: 10.1007/s11136-023-03351-y. Epub 
      2023 Feb 3.

PMID- 36710435
OWN - NLM
STAT- Publisher
LR  - 20230209
IS  - 1469-672X (Electronic)
IS  - 0264-6838 (Linking)
DP  - 2023 Jan 29
TI  - Maternity care changes and postpartum mental health during the COVID-19 pandemic: 
      a Spanish cross-sectional study.
PG  - 1-16
LID - 10.1080/02646838.2023.2171375 [doi]
AB  - BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic led to abrupt 
      changes in maternity care, but the impact of these changes has not yet been 
      deeply evaluated. This study aimed to assess the impact of the unexpected changes 
      in maternity care due to the COVID-19 pandemic on postpartum mental health 
      (depression, anxiety and posttraumatic stress disorder). METHODS: A 
      cross-sectional, web-based study was conducted in Spain during the second half of 
      2020. The eligibility criteria were women≥18 years with a child≤6 months. The 
      Edinburgh Postnatal Depression Scale (EPDS), the Generalized Anxiety Disorder-7 
      Screener (GAD-7) and a subset of the PTSD checklist (PCL-5) were used to assess 
      postpartum mental health. Information regarding sociodemographic characteristics 
      and maternity care changes was collected, and multivariate regression models were 
      used. RESULTS: Among 1781 participants, 29.3% and 33% had clinically significant 
      depressive and anxiety symptoms, respectively. The most prevalent unexpected 
      changes reported were related to the exclusion of supportive relatives during 
      birth and postpartum. Changes reported during birth showed a minor association 
      with PTSD symptomatology, and those that occurred during the postpartum period 
      were associated with clinical depression, anxiety and PTSD symptoms. CONCLUSIONS: 
      The unexpected changes in maternity care due to the COVID-19 pandemic, especially 
      those that occurred during the postpartum period, increased the risk of mental 
      health problems.
FAU - Fuente-Moreno, Marina
AU  - Fuente-Moreno M
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, 
      Spain.
AD  - Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Garcia-Terol, Clara
AU  - Garcia-Terol C
AD  - Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, 
      Spain.
AD  - Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Spain.
FAU - Domínguez-Salas, Sara
AU  - Domínguez-Salas S
AD  - Department of Psychology, Universidad Loyola Andalucía, Seville, Spain.
FAU - Rubio-Valera, María
AU  - Rubio-Valera M
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, 
      Spain.
AD  - Parc Sanitari Sant Joan de Déu,Sant Boi de Llobregat, Spain.
AD  - Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública 
      (CIBERESP), Madrid, Spain.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Department of Psychology, Universidad Loyola Andalucía, Seville, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230129
PL  - England
TA  - J Reprod Infant Psychol
JT  - Journal of reproductive and infant psychology
JID - 8501885
SB  - IM
OTO - NOTNLM
OT  - COVID-19
OT  - Depression
OT  - GENERALIZED ANXIETY
OT  - MATERNAL HEALTH SERVICES
OT  - PTSD
EDAT- 2023/01/31 06:00
MHDA- 2023/01/31 06:00
CRDT- 2023/01/30 00:43
PHST- 2023/01/31 06:00 [pubmed]
PHST- 2023/01/31 06:00 [medline]
PHST- 2023/01/30 00:43 [entrez]
AID - 10.1080/02646838.2023.2171375 [doi]
PST - aheadofprint
SO  - J Reprod Infant Psychol. 2023 Jan 29:1-16. doi: 10.1080/02646838.2023.2171375.

PMID- 36703266
OWN - NLM
STAT- Publisher
LR  - 20230206
IS  - 1365-2702 (Electronic)
IS  - 0962-1067 (Linking)
DP  - 2023 Jan 26
TI  - Effects of eHealth interventions on stress reduction and mental health promotion 
      in healthcare professionals: A systematic review.
LID - 10.1111/jocn.16634 [doi]
AB  - AIMS: To evaluate the effectiveness of eHealth interventions to reduce stress and 
      promote mental health in healthcare professionals, and to compare the efficacy of 
      different types of programs (guided vs. self-guided; 'third-wave' psychotherapies 
      vs. other types). BACKGROUND: Healthcare workers present high levels of stress, 
      which constitutes a risk factor for developing mental health problems such as 
      depression and anxiety. eHealth interventions have been designed to reduce these 
      professional's stress considering that the characteristics of this delivery 
      method make it a cost-effective and very appealing alternative because of its 
      fast and easy access. DESIGN: A systematic review of quantitative studies. 
      METHODS: A comprehensive database search for quantitative studies was conducted 
      in PubMed, EMBASE and Cochrane (until 1 April 2022). The systematic review was 
      conducted in accordance with the PRISMA and SWiM reporting guidelines. The 
      quality of the studies was assessed using the National Heart, Lung and Blood 
      Institute tools. RESULTS: The abstracts of 6349 articles were assessed and 60 
      underwent in-depth review, with 27 fulfilling the inclusion criteria. The 
      interventions were classified according to their format (self-guided vs. guided) 
      and contents ('third-wave' psychotherapies vs. others). Twenty-two interventions 
      emerged, 13 of which produced significant posttreatment reductions in stress 
      levels of health professionals (9 self-guided, 8 'third wave' psychotherapies). 
      Significant effects in improving depressive symptomatology, anxiety, burnout, 
      resilience and mindfulness, amongst others, were also found. CONCLUSION: The 
      evidence gathered in this review highlights the heterogeneity of the eHealth 
      interventions that have been studied; self-guided and 'third-wave' psychotherapy 
      programs are the most common, often with promising results, although the 
      methodological shortcomings of most studies hinder the extraction of sound 
      conclusions. PROTOCOL REGISTRATION: PROSPERO CRD42022310199. No Patient or Public 
      Contribution.
CI  - © 2023 The Authors. Journal of Clinical Nursing published by John Wiley & Sons 
      Ltd.
FAU - López-Del-Hoyo, Yolanda
AU  - López-Del-Hoyo Y
AUID- ORCID: 0000-0002-1690-4130
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Fernández-Martínez, Selene
AU  - Fernández-Martínez S
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Zaragoza, Spain.
FAU - Pérez-Aranda, Adrián
AU  - Pérez-Aranda A
AUID- ORCID: 0000-0002-1602-3413
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Zaragoza, Spain.
AD  - Department of Basic, Developmental and Educational Psychology, Autonomous 
      University of Barcelona, Cerdanyola del Vallès, Spain.
FAU - Barceló-Soler, Alberto
AU  - Barceló-Soler A
AUID- ORCID: 0000-0002-2116-9257
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Zaragoza, Spain.
AD  - Navarra Medical Research Institute (IdiSNA), Pamplona, Spain.
FAU - Bani, Marco
AU  - Bani M
AUID- ORCID: 0000-0002-6500-6513
AD  - School of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
FAU - Russo, Selena
AU  - Russo S
AUID- ORCID: 0000-0002-3024-3316
AD  - School of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
FAU - Urcola-Pardo, Fernando
AU  - Urcola-Pardo F
AUID- ORCID: 0000-0001-7049-8295
AD  - Department of Physiatry and Nursing, University of Zaragoza, Zaragoza, Spain.
AD  - Research Group Water and Environmental Health (B43_20R), University Institute of 
      Research in Environmental Science of Aragon, University of Zaragoza, Zaragoza, 
      Spain.
FAU - Strepparava, Maria Grazia
AU  - Strepparava MG
AUID- ORCID: 0000-0001-5068-8753
AD  - School of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy.
AD  - Clinical Unit "Psicologia Clinica", Fondazione IRCCS San Gerardo dei Tintori, 
      Monza, Italy.
FAU - García-Campayo, Javier
AU  - García-Campayo J
AUID- ORCID: 0000-0002-3797-4218
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, Zaragoza, Spain.
AD  - Psychiatry Department, Faculty of Medicine, University of Zaragoza, Zaragoza, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230126
PL  - England
TA  - J Clin Nurs
JT  - Journal of clinical nursing
JID - 9207302
OTO - NOTNLM
OT  - eHealth
OT  - health personnel
OT  - healthcare professionals
OT  - mental health
OT  - online interventions
OT  - stress
OT  - systematic review
OT  - telehealth
EDAT- 2023/01/28 06:00
MHDA- 2023/01/28 06:00
CRDT- 2023/01/27 00:02
PHST- 2022/12/12 00:00 [revised]
PHST- 2022/11/02 00:00 [received]
PHST- 2023/01/04 00:00 [accepted]
PHST- 2023/01/28 06:00 [pubmed]
PHST- 2023/01/28 06:00 [medline]
PHST- 2023/01/27 00:02 [entrez]
AID - 10.1111/jocn.16634 [doi]
PST - aheadofprint
SO  - J Clin Nurs. 2023 Jan 26. doi: 10.1111/jocn.16634.

PMID- 36698836
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230202
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Measuring depression in Primary Health Care in Spain: Psychometric properties and 
      diagnostic accuracy of HSCL-5 and HSCL-10.
PG  - 1014340
LID - 10.3389/fmed.2022.1014340 [doi]
LID - 1014340
AB  - BACKGROUND: Depression has a high prevalence among European countries. Several 
      instruments have been designed to assess its symptoms in different populations. 
      The Hopkins Symptom Checklist 25 (HSCL-25) scale has been identified as valid, 
      reproducible, effective, and easy to use. There are short versions of this scale 
      that could be useful in Primary Care (PC) settings, but their psychometric 
      properties are unknown. AIM: To assess in PC patients the psychometric properties 
      and diagnostic accuracy of the Spanish version of the HSCL-10 and the HSCL-5 
      consisting of 10 and 5 items, respectively. METHODS: A multicenter, 
      cross-sectional study was carried out at six PC centers in Spain. The HSCL-25 was 
      administered to outpatients aged 45-75 who also participated in the structured 
      Composite International Diagnostic Interview (CIDI). HSCL-10 and HSCL-5 were 
      assessed and compared to HSCL-25 regarding total score correlation, internal 
      consistency, and criterion validity against the gold-standard CIDI. This is a 
      methodological study from a secondary data analysis and the primary data has been 
      previously published. RESULTS: Out of 790 patients, 767 completed the HSCL-25 and 
      736 the CIDI interview (96.0%). Cronbach's Alpha was 0.84 for HSCL-10 and 0.77 
      for HSCL-5. The known-group method and confirmatory factor analysis were 
      acceptable for the establishment of construct validity. Sensitivity was 79.7% 
      (CI95%, 67.7-88.0%) for HSCL-10, and 78.0% (CI95%, 65.9-86.6%) for HSCL-5, 
      whereas specificity was 83% (CI95%, 80.0-85.7%) for HSCL-10, and 72.8% (CI95%, 
      69.3-76.0%) for HSCL-5. Area under the curve against CIDI was 0.88 (CI95%, 
      0.84-0.92%) for HSCL-10, and 0.85 (CI95%, 0.81-0.89%) for HSCL-5. Optimum cutoff 
      point calculated with Youden Index was 1.90 for the HSCL-10 and 1.80 for the 
      HSCL-5. CONCLUSION: HSCL-10 and HSCL-5 are reliable and valid tools to detect 
      depression symptoms and can be used in PC settings.
CI  - Copyright © 2023 Rodríguez-Barragán, Fernández-San-Martín, Clavería, Le Reste, 
      Nabbe, Motrico, Gómez-Gómez and Peguero-Rodríguez.
FAU - Rodríguez-Barragán, María
AU  - Rodríguez-Barragán M
AD  - Primary Health Centre La Mina, Gerència Territorial d'Atenció Primària de 
      Barcelona, Institut Català de la Salut, Sant Adrià de Besòs, Barcelona, Spain.
AD  - Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi 
      Gol), Barcelona, Spain.
AD  - Faculty of Medicine, Department of Pediatrics, Obstetrics, Gynecology and 
      Preventive Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
FAU - Fernández-San-Martín, María Isabel
AU  - Fernández-San-Martín MI
AD  - Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi 
      Gol), Barcelona, Spain.
AD  - Gerència Territorial d'Atenció Primària de Barcelona, Institut Català de la 
      Salut, Barcelona, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - I-Saúde Group, South Galicia Health Research Institute [IISGS-Servicio Gallego de 
      Salud (SERGAS)], Vigo, Spain.
AD  - Vigo Health Area, Servicio Gallego de Salud (SERGAS), Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Vigo, Spain.
FAU - Le Reste, Jean Yves
AU  - Le Reste JY
AD  - Department of General Practice, ER 7479 SPURBO Soins Primaires, Santé Publique, 
      Registre des Cancers de Bretagne Occidentale, Université de Bretagne Occidentale, 
      Brest, France.
FAU - Nabbe, Patrice
AU  - Nabbe P
AD  - Department of General Practice, ER 7479 SPURBO Soins Primaires, Santé Publique, 
      Registre des Cancers de Bretagne Occidentale, Université de Bretagne Occidentale, 
      Brest, France.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Vigo, Spain.
AD  - Department of Psychology, Universidad Loyola, Andalucía, Spain.
FAU - Gómez-Gómez, Irene
AU  - Gómez-Gómez I
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Vigo, Spain.
AD  - Department of Psychology, Universidad Loyola, Andalucía, Spain.
FAU - Peguero-Rodríguez, Eva
AU  - Peguero-Rodríguez E
AD  - Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi 
      Gol), Barcelona, Spain.
AD  - Primary Health Centre El Castell, Gerència Territorial d'Atenció Primària 
      Metropolitana Sud, Institut Català de la Salut, Castelldefels, Barcelona, Spain.
AD  - Departamento de Ciencias Clinicas, Facultad de Medicina, Universidad de 
      Barcelona, Barcelona, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230109
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9869680
OTO - NOTNLM
OT  - Hopkins Symptom Checklist
OT  - Primary Health Care (MeSH)
OT  - depression
OT  - diagnostic accuracy
OT  - patient reported outcome measures (MeSH)
OT  - psychometric properties
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/01/27 06:00
MHDA- 2023/01/27 06:01
CRDT- 2023/01/26 02:39
PHST- 2022/08/08 00:00 [received]
PHST- 2022/12/21 00:00 [accepted]
PHST- 2023/01/26 02:39 [entrez]
PHST- 2023/01/27 06:00 [pubmed]
PHST- 2023/01/27 06:01 [medline]
AID - 10.3389/fmed.2022.1014340 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2023 Jan 9;9:1014340. doi: 10.3389/fmed.2022.1014340. 
      eCollection 2022.

PMID- 36698111
OWN - NLM
STAT- MEDLINE
DCOM- 20230127
LR  - 20230206
IS  - 1471-244X (Electronic)
IS  - 1471-244X (Linking)
VI  - 23
IP  - 1
DP  - 2023 Jan 25
TI  - The emotional well-being of Long COVID patients in relation to their symptoms, 
      social support and stigmatization in social and health services: a qualitative 
      study.
PG  - 68
LID - 10.1186/s12888-022-04497-8 [doi]
LID - 68
AB  - BACKGROUND: Long COVID patients have experienced a decline in their quality of 
      life due to, in part but not wholly, its negative emotional impact. Some of the 
      most prevalent mental health symptoms presented by long COVID patients are 
      anxiety, depression, and sleep disorders. As such, the need has arisen to analyze 
      the personal experiences of these patients to understand how they are managing 
      their daily lives while dealing with the condition. The objective of this study 
      is to increase understanding about the emotional well-being of people diagnosed 
      with long COVID. METHODS: A qualitative design was created and carried out using 
      35 patients, with 17 participants being interviewed individually and 18 of them 
      taking part in two focus groups. The participating patients were recruited in 
      November and December 2021 from Primary Health Care (PHC) centers in the city of 
      Zaragoza (Northern Spain) and from the Association of Long COVID Patients in 
      Aragon. The study topics were emotional well-being, social support networks, and 
      experience of discrimination. All an inductive thematic content analyses were 
      performed iteratively using NVivo software. RESULTS: The Long COVID patients 
      identified low levels of self-perceived well-being due to their persistent 
      symptoms, as well as limitations in their daily lives that had been persistent 
      for many months. Suicidal thoughts were also mentioned by several patients. They 
      referred to anguish and anxiety about the future as well as a fear of reinfection 
      or relapse and returning to work. Many of the participants reported that they 
      have sought the help of a mental health professional. Most participants 
      identified discriminatory situations in health care. CONCLUSIONS: It is necessary 
      to continue researching the impact that Long COVID has had on mental health, as 
      well as to provide Primary Health Care professionals with evidence that can guide 
      the emotional treatment of these patients.
CI  - © 2023. The Author(s).
FAU - Samper-Pardo, M
AU  - Samper-Pardo M
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
FAU - Oliván-Blázquez, B
AU  - Oliván-Blázquez B
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain. 
      barbaraolivan@gmail.com.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain. 
      barbaraolivan@gmail.com.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain. barbaraolivan@gmail.com.
FAU - Magallón-Botaya, R
AU  - Magallón-Botaya R
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Department of Medicine, University of Zaragoza, Zaragoza, Spain.
FAU - Méndez-López, F
AU  - Méndez-López F
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
FAU - Bartolomé-Moreno, C
AU  - Bartolomé-Moreno C
AD  - Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Department of Medicine, University of Zaragoza, Zaragoza, Spain.
FAU - León-Herrera, S
AU  - León-Herrera S
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230125
PL  - England
TA  - BMC Psychiatry
JT  - BMC psychiatry
JID - 100968559
SB  - IM
MH  - Humans
MH  - *Post-Acute COVID-19 Syndrome
MH  - *COVID-19
MH  - Quality of Life/psychology
MH  - Stereotyping
MH  - Social Support
MH  - Health Services
PMC - PMC9875186
OTO - NOTNLM
OT  - Emotional well-being
OT  - Long COVID
OT  - Qualitative study
OT  - Social support
OT  - Stigmatization
COIS- The authors declare that they have no competing interests
EDAT- 2023/01/26 06:00
MHDA- 2023/01/28 06:00
CRDT- 2023/01/25 23:57
PHST- 2022/08/03 00:00 [received]
PHST- 2022/12/26 00:00 [accepted]
PHST- 2023/01/25 23:57 [entrez]
PHST- 2023/01/26 06:00 [pubmed]
PHST- 2023/01/28 06:00 [medline]
AID - 10.1186/s12888-022-04497-8 [pii]
AID - 4497 [pii]
AID - 10.1186/s12888-022-04497-8 [doi]
PST - epublish
SO  - BMC Psychiatry. 2023 Jan 25;23(1):68. doi: 10.1186/s12888-022-04497-8.

PMID- 36674232
OWN - NLM
STAT- MEDLINE
DCOM- 20230124
LR  - 20230329
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 20
IP  - 2
DP  - 2023 Jan 13
TI  - Effects of Ozone Treatment on Health-Related Quality of Life and Toxicity Induced 
      by Radiotherapy and Chemotherapy in Symptomatic Cancer Survivors.
LID - 10.3390/ijerph20021479 [doi]
LID - 1479
AB  - (1) Background: The continuous improvement in cancer treatment has led to 
      improvement in patients’ survival and a subsequent increase in the number of 
      cancer survivors living with adverse side effects of cancer treatments, sometimes 
      with a high and adverse impact on their health-related quality of life (HRQOL). 
      Side effects of cancer treatments are frequently associated with chronic status 
      of oxidative stress, inflammation, and/or ischemia. The potential for ozone 
      treatment to modulate those processes and improve some of those adverse effects 
      has previously been described. The aim of this study was to evaluate the effect 
      of ozone treatment on the HRQOL and grade of toxicity in symptomatic cancer 
      survivors. (2) Methods: Before and after ozone treatment, we assessed (i) the 
      HRQOL (according to the EQ-5D-5L questionnaire) and (ii) the grade of toxicity 
      (according to the Common Terminology Criteria for Adverse Events of the National 
      Cancer Institute of EEUU (CTCAE v.5.0)) in 26 cancer survivors with chronic side 
      effects of radiotherapy and chemotherapy. (3) Results: There was a significant (p 
      < 0.001) improvement in the EQ-5D-5L index as per the self-reported outcome 
      evaluation of patients’ health status. All the dimensions of the EQ-5D-5L 
      questionnaire (mobility, self-care, activities, pain/discomfort, and 
      anxiety/depression) and the self-evaluation of the health status using the visual 
      analog scale were significantly improved (p < 0.05). The grade of toxicity was 
      also significantly decreased (p < 0.001). (4) Conclusions: In cancer survivors 
      with chronic side effects of cancer treatment, ozone treatment can improve the 
      grade of toxicity and the HRQOL. These results merit additional research. Further 
      studies are ongoing.
FAU - Clavo, Bernardino
AU  - Clavo B
AUID- ORCID: 0000-0003-2522-1064
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
AD  - Chronic Pain Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 35019 
      Las Palmas de Gran Canaria, Spain.
AD  - Universitary Institute for Research in Biomedicine and Health (iUIBS), Molecular 
      and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 
      35016 Las Palmas de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, 38296 La Laguna, Spain.
AD  - CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 
      28029 Madrid, Spain.
AD  - Spanish Group of Clinical Research in Radiation Oncology (GICOR), 28290 Madrid, 
      Spain.
FAU - Cánovas-Molina, Angeles
AU  - Cánovas-Molina A
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
AD  - Chronic Pain Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 35019 
      Las Palmas de Gran Canaria, Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 35019 
      Las Palmas de Gran Canaria, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
AD  - Servicio de Evaluación y Planificación del Servicio Canario de Salud (SESCS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Instituto de Tecnologías Biomédicas (ITB), Universidad de la Laguna, 38296 La 
      Laguna, Spain.
FAU - Federico, Mario
AU  - Federico M
AUID- ORCID: 0000-0002-6184-9070
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
FAU - Rodríguez-Abreu, Delvys
AU  - Rodríguez-Abreu D
AD  - Medical Oncology Department, Complejo Hospitalario Universitario Insular 
      Materno-Infantil de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
FAU - Galván, Saray
AU  - Galván S
AD  - Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, 
      35019 Las Palmas de Gran Canaria, Spain.
FAU - Ribeiro, Ivone
AU  - Ribeiro I
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
FAU - Marques da Silva, Susana C
AU  - Marques da Silva SC
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
AD  - Chronic Pain Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran 
      Canaria, Spain.
FAU - Navarro, Minerva
AU  - Navarro M
AD  - Chronic Pain Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran 
      Canaria, Spain.
FAU - González-Beltrán, Damián
AU  - González-Beltrán D
AUID- ORCID: 0000-0002-8057-4279
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
FAU - Díaz-Garrido, Juan A
AU  - Díaz-Garrido JA
AD  - Psychiatry Department, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 
      Las Palmas de Gran Canaria, Spain.
FAU - Cazorla-Rivero, Sara
AU  - Cazorla-Rivero S
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
AD  - Universidad de La Laguna, 38296 La Laguna, Spain.
FAU - Rodríguez-Esparragón, Francisco
AU  - Rodríguez-Esparragón F
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 35019 
      Las Palmas de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, 38296 La Laguna, Spain.
AD  - CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 
      28029 Madrid, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
AD  - Servicio de Evaluación y Planificación del Servicio Canario de Salud (SESCS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Instituto de Tecnologías Biomédicas (ITB), Universidad de la Laguna, 38296 La 
      Laguna, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230113
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Quality of Life
MH  - *Cancer Survivors
MH  - Cross-Sectional Studies
MH  - Health Status
MH  - Surveys and Questionnaires
MH  - *Neoplasms
PMC - PMC9859304
OTO - NOTNLM
OT  - anxiety and depression
OT  - cancer survivors
OT  - chemotherapy-induced neuropathy
OT  - chemotherapy-induced side effects
OT  - health-related quality of life
OT  - ozone therapy
OT  - pain
OT  - radiation-induced side effects
COIS- The authors declare no other conflicts of interest.
EDAT- 2023/01/22 06:00
MHDA- 2023/01/25 06:00
CRDT- 2023/01/21 01:23
PHST- 2022/12/18 00:00 [received]
PHST- 2023/01/05 00:00 [revised]
PHST- 2023/01/09 00:00 [accepted]
PHST- 2023/01/21 01:23 [entrez]
PHST- 2023/01/22 06:00 [pubmed]
PHST- 2023/01/25 06:00 [medline]
AID - ijerph20021479 [pii]
AID - ijerph-20-01479 [pii]
AID - 10.3390/ijerph20021479 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2023 Jan 13;20(2):1479. doi: 
      10.3390/ijerph20021479.

PMID- 36669840
OWN - NLM
STAT- MEDLINE
DCOM- 20230124
LR  - 20230201
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 13
IP  - 1
DP  - 2023 Jan 20
TI  - Cohort Profile: CArdiovascular Risk in patients with DIAbetes in NAvarra 
      (CARDIANA cohort).
PG  - e066052
LID - 10.1136/bmjopen-2022-066052 [doi]
LID - e066052
AB  - PURPOSE: The CArdiovascular Risk in patients with DIAbetes in Navarra (CARDIANA 
      cohort) cohort was established to assess the effects of sociodemographic and 
      clinical variables on the risk of cardiovascular events in patients with type 1 
      (T1D) or type 2 (T2D) diabetes, with a special focus on socioeconomic factors, 
      and to validate and develop cardiovascular risk models for these patients. 
      PARTICIPANTS: The CARDIANA cohort included all patients with T1D and T2D diabetes 
      registered in the Public Health Service of Navarra with prevalent disease on 1 
      January 2012. It consisted of 1067 patients with T1D (ages 2-88 years) and 33842 
      patients with T2D (ages 20-105 years), whose data were retrospectively extracted 
      from the Health and Administrative System Databases. FINDINGS TO DATE: The 
      follow-up period for wave 1 was from 1 January 2012 to 31 December 2016. During 
      these 5 years, 9 patients (0.8%; 95% CI (0.4% to 1.6%)) in the T1D cohort 
      developed a cardiovascular disease event, whereas for the T2D cohort, 2602 (7.7%; 
      95% CI (7.4% to 8.0%)) had an event. For the T2D cohort, physical activity was 
      associated with a reduced risk of cardiovascular events, with adjusted estimated 
      ORs equal to 0.84 (95% CI 0.66 to 1.07) for the partially active group and 0.71 
      (95% CI 0.56 to 0.91) for the active group, compared with patients in the 
      non-active group. FUTURE PLANS: The CARDIANA cohort is currently being used to 
      assess the effect of sociodemographic risk factors on CV risk at 5 years and to 
      externally validate cardiovascular predictive models. A second wave is being 
      conducted in late 2022 and early 2023, to extend the follow-up other 5 years, 
      from 1 January 2016 to 31 December 2021. Periodic data extractions are planned 
      every 5 years.
CI  - © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published 
      by BMJ.
FAU - Tamayo, Ibai
AU  - Tamayo I
AD  - Unidad de Metodología, Navarrabiomed-HUN-UPNA, Pamplona, Navarra, Spain.
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
FAU - Librero-Lopez, Julian
AU  - Librero-Lopez J
AD  - Unidad de Metodología, Navarrabiomed-HUN-UPNA, Pamplona, Navarra, Spain.
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
FAU - Galbete, Arkaitz
AU  - Galbete A
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
AD  - Departamento de Estadística, Universidad Pública de Navarra, Pamplona, Spain.
FAU - Cambra, Koldo
AU  - Cambra K
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
AD  - Departamento de Sanidad, Gobierno Vasco, Pamplona, Spain.
FAU - Enguita-Germán, Mónica
AU  - Enguita-Germán M
AD  - Unidad de Metodología, Navarrabiomed-HUN-UPNA, Pamplona, Navarra, Spain.
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
FAU - Forga, Luis
AU  - Forga L
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Servicio de Endocrinología y Nutrición - HUN, Servicio Navarro de Salud - 
      Osasunbidea, Pamplona, Spain.
FAU - Goñi, María José
AU  - Goñi MJ
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Servicio de Endocrinología y Nutrición - HUN, Servicio Navarro de Salud - 
      Osasunbidea, Pamplona, Spain.
FAU - Lecea, Oscar
AU  - Lecea O
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Atención Primaria, Servicio Navarro de Salud - Osasunbidea, Pamplona, Spain.
FAU - Gorricho, Javier
AU  - Gorricho J
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
AD  - Servicio de Evaluación y Difusión de resultados en Salud, Servicio Navarro de 
      Salud - Osasunbidea, Pamplona, Spain.
FAU - Olazarán, Álvaro
AU  - Olazarán Á
AD  - Servicio Tecnologías de la Salud, Departamento de Universidad, Innovación y 
      Transformación, Pamplona, Spain.
FAU - Arnedo, Laura
AU  - Arnedo L
AD  - Instituto de Estadística de Navarra, Pamplona, Spain.
FAU - Moreno-Iribas, Conchi
AU  - Moreno-Iribas C
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
AD  - Instituto de Salud Pública y Laboral de Navarra, Pamplona, Spain.
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), Pamplona, Spain.
FAU - Lafita, Javier
AU  - Lafita J
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Servicio de Efectividad y Seguridad Asistencial, Servicio Navarro de Salud - 
      Osasunbidea, Pamplona, Spain.
FAU - Ibañez-Beroiz, Berta
AU  - Ibañez-Beroiz B
AUID- ORCID: 0000-0002-7797-4845
AD  - Unidad de Metodología, Navarrabiomed-HUN-UPNA, Pamplona, Navarra, Spain 
      berta.ibanez.beroiz@navarra.es.
AD  - Instituto de Investigación Biomédica de Navarra (IdISNA), Pamplona, Spain.
AD  - Red de Invesitigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Pamplona, Spain.
AD  - Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC), 
      Pamplona, Spain.
LA  - eng
PT  - Journal Article
DEP - 20230120
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - Child, Preschool
MH  - Child
MH  - Adolescent
MH  - Young Adult
MH  - Adult
MH  - Middle Aged
MH  - Aged
MH  - Aged, 80 and over
MH  - *Diabetes Mellitus, Type 1/complications/epidemiology
MH  - *Diabetes Mellitus, Type 2/complications/epidemiology
MH  - Risk Factors
MH  - *Cardiovascular Diseases/etiology/complications
MH  - Retrospective Studies
MH  - Heart Disease Risk Factors
PMC - PMC9872484
OTO - NOTNLM
OT  - Cardiac Epidemiology
OT  - General diabetes
OT  - Health informatics
OT  - Risk management
COIS- Competing interests: None declared.
EDAT- 2023/01/21 06:00
MHDA- 2023/01/25 06:00
CRDT- 2023/01/20 21:03
PHST- 2023/01/20 21:03 [entrez]
PHST- 2023/01/21 06:00 [pubmed]
PHST- 2023/01/25 06:00 [medline]
AID - bmjopen-2022-066052 [pii]
AID - 10.1136/bmjopen-2022-066052 [doi]
PST - epublish
SO  - BMJ Open. 2023 Jan 20;13(1):e066052. doi: 10.1136/bmjopen-2022-066052.

PMID- 36635633
OWN - NLM
STAT- MEDLINE
DCOM- 20230117
LR  - 20230202
IS  - 1471-2261 (Electronic)
IS  - 1471-2261 (Linking)
VI  - 23
IP  - 1
DP  - 2023 Jan 12
TI  - Factors related to early readmissions after acute heart failure: a nested 
      case-control study.
PG  - 17
LID - 10.1186/s12872-022-03029-2 [doi]
LID - 17
AB  - AIMS: To describe the main characteristics of patients who were readmitted to 
      hospital within 1 month after an index episode for acute decompensated heart 
      failure (ADHF). METHODS AND RESULTS: This is a nested case-control study in the 
      ReIC cohort, cases being consecutive patients readmitted after hospitalization 
      for an episode of ADHF and matched controls selected from those who were not 
      readmitted. We collected clinical data and also patient-reported outcome 
      measures, including dyspnea, Minnesota Living with Heart Failure Questionnaire 
      (MLHFQ), Tilburg Frailty Indicator (TFI) and Hospital Anxiety and Depression 
      Scale scores, as well as symptoms during a transition period of 1 month after 
      discharge. We created a multivariable conditional logistic regression model. 
      Despite cases consulted more than controls, there were no statistically 
      significant differences in changes in treatment during this first month. Patients 
      with chronic decompensated heart failure were 2.25 [1.25, 4.05] more likely to be 
      readmitted than de novo patients. Previous diagnosis of arrhythmia and time since 
      diagnosis ≥ 3 years, worsening in dyspnea, and changes in MLWHF and TFI scores 
      were significant in the final model. CONCLUSION: We present a model with 
      explanatory variables for readmission in the short term for ADHF. Our study shows 
      that in addition to variables classically related to readmission, there are 
      others related to the presence of residual congestion, quality of life and 
      frailty that are determining factors for readmission for heart failure in the 
      first month after discharge. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: 
      NCT03300791. First registration: 03/10/2017.
CI  - © 2023. The Author(s).
FAU - Garcia-Gutierrez, Susana
AU  - Garcia-Gutierrez S
AD  - Research Unit, Galdakao-Usansolo University Hospital, Barrio Labeaga s/n, 48960, 
      Galdakao, Vizcaya, Spain. susana.garciagutierrez@osakidetza.eus.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain. 
      susana.garciagutierrez@osakidetza.eus.
AD  - Red de Investigación en Servicios Sanitarios Y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain. susana.garciagutierrez@osakidetza.eus.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Girona, Spain. susana.garciagutierrez@osakidetza.eus.
AD  - Faculty of Health Sciences, Medicine Department, University of Deusto, Bilbo, 
      Spain. susana.garciagutierrez@osakidetza.eus.
FAU - Villanueva, Ane
AU  - Villanueva A
AD  - Research Unit, Galdakao-Usansolo University Hospital, Barrio Labeaga s/n, 48960, 
      Galdakao, Vizcaya, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Red de Investigación en Servicios Sanitarios Y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Girona, Spain.
FAU - Lafuente, Iratxe
AU  - Lafuente I
AD  - Research Unit, Galdakao-Usansolo University Hospital, Barrio Labeaga s/n, 48960, 
      Galdakao, Vizcaya, Spain.
AD  - Fundación Vasca de Innovación e Investigación Sanitarias, BIOEF, Barakaldo, 
      Spain.
FAU - Rodriguez, Ibon
AU  - Rodriguez I
AD  - Cardiology Department, Hospital Galdakao-Usansolo, Galdakao, Spain.
FAU - Lozano-Bahamonde, Ainara
AU  - Lozano-Bahamonde A
AD  - Cardiology Department, Hospital Basurto, Bilbo, Spain.
FAU - Murga, Nekane
AU  - Murga N
AD  - Cardiology Department, Hospital Basurto, Bilbo, Spain.
FAU - Orus, Josefina
AU  - Orus J
AD  - Cardiology Department, Hospital Parc Taulí, Sabadell, Spain.
FAU - Camacho, Emilia Rosa
AU  - Camacho ER
AD  - Internal Medicine Department, Hospital Costa del Sol, Marbella, Spain.
FAU - Quintana, Jose María
AU  - Quintana JM
AD  - Research Unit, Galdakao-Usansolo University Hospital, Barrio Labeaga s/n, 48960, 
      Galdakao, Vizcaya, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Red de Investigación en Servicios Sanitarios Y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Girona, Spain.
FAU - Quiros, Raul
AU  - Quiros R
AD  - Internal Medicine Department, Hospital Costa del Sol, Marbella, Spain.
CN  - ReIC-REDISSEC working group
LA  - eng
SI  - ClinicalTrials.gov/NCT03300791
GR  - PI15/01343/Instituto de Salud Carlos III/
PT  - Clinical Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230112
PL  - England
TA  - BMC Cardiovasc Disord
JT  - BMC cardiovascular disorders
JID - 100968539
SB  - IM
MH  - Humans
MH  - Case-Control Studies
MH  - Dyspnea/diagnosis/therapy
MH  - *Frailty/diagnosis/epidemiology
MH  - *Heart Failure/therapy/drug therapy
MH  - Patient Readmission
MH  - Quality of Life
PMC - PMC9837935
OTO - NOTNLM
OT  - Acute heart failure
OT  - PROMS
OT  - Readmissions
OT  - Transitional period
COIS- Authors declare no competing interests.
FIR - Onaindia, Jose Juan
IR  - Onaindia JJ
FIR - Fernández-Ruiz, Jose
IR  - Fernández-Ruiz J
FIR - Cacicedo, Angela
IR  - Cacicedo A
FIR - Escobar, Vanessa
IR  - Escobar V
FIR - Redondo, Maximino
IR  - Redondo M
FIR - Cabello, Gloria
IR  - Cabello G
FIR - Baré, Marisa
IR  - Baré M
EDAT- 2023/01/13 06:00
MHDA- 2023/01/17 06:00
CRDT- 2023/01/12 23:33
PHST- 2022/06/24 00:00 [received]
PHST- 2022/12/23 00:00 [accepted]
PHST- 2023/01/12 23:33 [entrez]
PHST- 2023/01/13 06:00 [pubmed]
PHST- 2023/01/17 06:00 [medline]
AID - 10.1186/s12872-022-03029-2 [pii]
AID - 3029 [pii]
AID - 10.1186/s12872-022-03029-2 [doi]
PST - epublish
SO  - BMC Cardiovasc Disord. 2023 Jan 12;23(1):17. doi: 10.1186/s12872-022-03029-2.

PMID- 36630397
OWN - NLM
STAT- MEDLINE
DCOM- 20230113
LR  - 20230319
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 18
IP  - 1
DP  - 2023
TI  - Association between sense of coherence and depression in patients with chronic 
      pain: A systematic review and meta-analysis.
PG  - e0279959
LID - 10.1371/journal.pone.0279959 [doi]
LID - e0279959
AB  - BACKGROUND: Chronic pain is a common complaint having distressing consequences 
      for those that suffer from it. Pain and depression concur within the context of 
      comorbidity, and both share underlying stress conditions. Sense of coherence 
      (SOC) is a factor that determines how well an individual manages stress and stays 
      healthy. Its relationship with depression has been frequently reported in the 
      literature. Our objective was to assess the amount of evidence available 
      regarding the association between SOC and depression in patients suffering from 
      chronic pain. METHODS: A systematic review and meta-analysis were performed. 
      Searches were conducted between November 01 and December 31, 2020 in PubMed, Web 
      of Science, Embase, PsycINFO, Psicodoc, ScienceDirect and Dialnet. There were no 
      restrictions regarding the date of publication of the study. Evidence related to 
      the relationship between SOC and depression in patients with chronic pain was 
      summarized and compared. RESULTS: A total of 163 articles were identified. We 
      included 9 papers in the qualitative and quantitative synthesis. The pooled 
      correlation coefficient was -0.55 (95%: -0.70; -0.41) and was not modified after 
      removing any study. The heterogeneity across the studies was considerable (I2 = 
      94.8%; p < 0.001). The random-effects meta-regression models for the association 
      between SOC and depression showed that age (p = 0.148) and percentage of women (p 
      = 0.307) were not related to heterogeneity across studies. No publication bias 
      was detected (p = 0.720). CONCLUSIONS: At first glance, the included studies give 
      the impression that SOC is an important factor in depression levels of patients 
      with chronic pain. Most of the included studies revealed a moderate association 
      between SOC and depressive symptoms.
CI  - Copyright: © 2023 Aguilar-Latorre et al. This is an open access article 
      distributed under the terms of the Creative Commons Attribution License, which 
      permits unrestricted use, distribution, and reproduction in any medium, provided 
      the original author and source are credited.
FAU - Aguilar-Latorre, Alejandra
AU  - Aguilar-Latorre A
AUID- ORCID: 0000-0003-2683-7346
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, Madrid, Spain.
FAU - Asensio-Martínez, Ángela
AU  - Asensio-Martínez Á
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, Madrid, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, Madrid, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
FAU - Álvarez-Bueno, Celia
AU  - Álvarez-Bueno C
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, Madrid, Spain.
AD  - Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, 
      Spain.
AD  - Universidad Politécnica y Artística del Paraguay, Asunción, Paraguay.
FAU - Cavero-Redondo, Iván
AU  - Cavero-Redondo I
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, Madrid, Spain.
AD  - Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, 
      Spain.
AD  - Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
FAU - Lionis, Christos
AU  - Lionis C
AUID- ORCID: 0000-0002-9324-2839
AD  - Clinic of Social and Family Medicine (CSFM), School of Medicine, University of 
      Crete, Heraklion, Crete, Greece.
FAU - Symvoulakis, Emmanouil K
AU  - Symvoulakis EK
AD  - Clinic of Social and Family Medicine (CSFM), School of Medicine, University of 
      Crete, Heraklion, Crete, Greece.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, Madrid, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 
      Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
DEP - 20230111
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Humans
MH  - Female
MH  - *Chronic Pain/complications
MH  - Depression/complications/diagnosis
MH  - *Sense of Coherence
MH  - Comorbidity
MH  - Anxiety
PMC - PMC9833581
COIS- The authors have declared that no competing interests exist.
EDAT- 2023/01/12 06:00
MHDA- 2023/01/14 06:00
CRDT- 2023/01/11 13:43
PHST- 2021/04/30 00:00 [received]
PHST- 2022/12/19 00:00 [accepted]
PHST- 2023/01/11 13:43 [entrez]
PHST- 2023/01/12 06:00 [pubmed]
PHST- 2023/01/14 06:00 [medline]
AID - PONE-D-21-14267 [pii]
AID - 10.1371/journal.pone.0279959 [doi]
PST - epublish
SO  - PLoS One. 2023 Jan 11;18(1):e0279959. doi: 10.1371/journal.pone.0279959. 
      eCollection 2023.

PMID- 36630024
OWN - NLM
STAT- MEDLINE
DCOM- 20230403
LR  - 20230403
IS  - 1573-2649 (Electronic)
IS  - 0962-9343 (Print)
IS  - 0962-9343 (Linking)
VI  - 32
IP  - 4
DP  - 2023 Apr
TI  - Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with 
      non-metastatic breast cancer at diagnosis and 2 years after.
PG  - 989-1003
LID - 10.1007/s11136-022-03327-4 [doi]
AB  - PURPOSE: To obtain reference norms of EORTC QLQ-C30, EORTC QLQ-BR23, and 
      EQ-5D-5L, based on a population of Spanish non-metastatic breast cancer patients 
      at diagnosis and 2 years after, according to relevant demographic and clinical 
      characteristics. METHODS: Multicentric prospective cohort study including 
      consecutive women aged ≥ 18 years with a diagnosis of incident non-metastatic 
      breast cancer from April 2013 to May 2015. Health-related quality of life (HRQoL) 
      questionnaires were administered between diagnosis and beginning the therapy, and 
      2 years after. HRQoL differences according to age, comorbidity and stage were 
      tested with ANOVA or Chi Square test and multivariate linear regression models. 
      RESULTS: 1276 patients were included, with a mean age of 58 years. Multivariate 
      models of EORTC QLQ-C30 summary score and EQ-5D-5L index at diagnosis and at 
      2-year follow-up show the independent association of comorbidity and tumor stage 
      with HRQoL. The standardized multivariate regression coefficient of EORTC QLQ-C30 
      summary score was lower (poorer HRQoL) for women with stage II and III than for 
      those with stage 0 at diagnosis (- 0.11 and - 0.07, p < 0.05) and follow-up 
      (- 0.15 and - 0.10, p < 0.01). The EQ-5D-5L index indicated poorer HRQoL for 
      women with Charlson comorbidity index ≥ 2 than comorbidity 0 both at diagnosis 
      (- 0.13, p < 0.001) and follow-up (- 0.18, p < 0.001). Therefore, we provided the 
      reference norms at diagnosis and at the 2-year follow-up, stratified by age, 
      comorbidity index, and tumor stage. CONCLUSION: These HRQoL reference norms can 
      be useful to interpret the scores of women with non-metastatic breast cancer, 
      comparing them with country-specific reference values for this population.
CI  - © 2023. The Author(s).
FAU - Miret, Carme
AU  - Miret C
AUID- ORCID: 0000-0001-6154-3998
AD  - Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and 
      Public Health, Universitat Autònoma de Barcelona (UAB), 08193, Bellaterra, 
      Barcelona, Spain.
AD  - Preventive Medicine and Public Health Training Unit PSMar-UPF-ASPB, Parc de Salut 
      Mar, Agència de Salut Pública de Barcelona, i Universitat Pompeu Fabra, 
      Barcelona, Spain.
AD  - IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
FAU - Orive, Miren
AU  - Orive M
AUID- ORCID: 0000-0003-1848-6638
AD  - Departamento Psicología Social, Facultad Farmacia, UPV/EHU, Vitoria-Gasteiz, 
      Araba, Spain.
AD  - KRONIKGUNE-Institute for Health Service Research, Barakaldo, Bizkaia, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Sala, Maria
AU  - Sala M
AUID- ORCID: 0000-0002-9955-8746
AD  - Preventive Medicine and Public Health Training Unit PSMar-UPF-ASPB, Parc de Salut 
      Mar, Agència de Salut Pública de Barcelona, i Universitat Pompeu Fabra, 
      Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
FAU - García-Gutiérrez, Susana
AU  - García-Gutiérrez S
AUID- ORCID: 0000-0002-8474-2479
AD  - Osakidetza Basque Health Service, Research Unit, Galdakao-Usansolo University 
      Hospital, Galdakao, Bizkai, Spain.
AD  - KRONIKGUNE-Institute for Health Service Research, Barakaldo, Bizkaia, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Sarasqueta, Cristina
AU  - Sarasqueta C
AUID- ORCID: 0000-0002-8631-9981
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
AD  - Biodonostia Health Research Institute, Donostia University Hospital, Donostia, 
      Gipuzkoa, Spain.
FAU - Legarreta, Maria Jose
AU  - Legarreta MJ
AUID- ORCID: 0000-0002-1778-5196
AD  - Osakidetza Basque Health Service, Research Unit, Galdakao-Usansolo University 
      Hospital, Galdakao, Bizkai, Spain.
AD  - KRONIKGUNE-Institute for Health Service Research, Barakaldo, Bizkaia, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AUID- ORCID: 0000-0001-5559-4246
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
AD  - Research and Innovation Unit, Hospital Costa del Sol, Marbella, Spain.
FAU - Rivero, Amado
AU  - Rivero A
AUID- ORCID: 0000-0002-5067-3196
AD  - Servicio de Evaluación y Planificación del Servicio Canario de la Salud (SESCS), 
      Tenerife, Spain.
FAU - Castells, Xavier
AU  - Castells X
AUID- ORCID: 0000-0002-2528-0382
AD  - Preventive Medicine and Public Health Training Unit PSMar-UPF-ASPB, Parc de Salut 
      Mar, Agència de Salut Pública de Barcelona, i Universitat Pompeu Fabra, 
      Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
FAU - Quintana, José M
AU  - Quintana JM
AUID- ORCID: 0000-0003-2170-7876
AD  - Osakidetza Basque Health Service, Research Unit, Galdakao-Usansolo University 
      Hospital, Galdakao, Bizkai, Spain.
AD  - KRONIKGUNE-Institute for Health Service Research, Barakaldo, Bizkaia, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, 
      Bizkaia, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Garin, Olatz
AU  - Garin O
AUID- ORCID: 0000-0001-6193-0779
AD  - IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
AD  - Health Services Research Group, IMIM (Hospital del Mar Medical Research 
      Institute), Doctor Aiguader 88, 08003, Barcelona, Spain.
FAU - Ferrer, Montse
AU  - Ferrer M
AUID- ORCID: 0000-0001-9867-7391
AD  - Health Services Research Group, IMIM (Hospital del Mar Medical Research 
      Institute), Doctor Aiguader 88, 08003, Barcelona, Spain. mferrer@imim.es.
AD  - CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. 
      mferrer@imim.es.
AD  - Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra (UPF), 
      Barcelona, Spain. mferrer@imim.es.
CN  - REDISSEC-CaMISS Group
LA  - eng
GR  - PI12/01842/Instituto de Salud Carlos III/
GR  - PI12/02493/Instituto de Salud Carlos III/
GR  - 2012111045/Osasun Saila, Eusko Jaurlaritzako/
GR  - 2017 SGR 452/Agència de Gestió d'Ajuts Universitaris i de Recerca/
PT  - Journal Article
DEP - 20230111
PL  - Netherlands
TA  - Qual Life Res
JT  - Quality of life research : an international journal of quality of life aspects of 
      treatment, care and rehabilitation
JID - 9210257
SB  - IM
MH  - Humans
MH  - Female
MH  - Middle Aged
MH  - *Quality of Life/psychology
MH  - Prospective Studies
MH  - *Breast Neoplasms
MH  - Reference Values
MH  - Surveys and Questionnaires
PMC - PMC10063520
OTO - NOTNLM
OT  - Breast cancer
OT  - EORTC
OT  - EQ-5D-5L
OT  - Health-related quality of life
OT  - Reference values
COIS- The authors declare that they have no known competing financial interests or 
      personal relationships that could have appeared to influence the work reported in 
      this paper.
FIR - Comas, Mercè
IR  - Comas M
FIR - Domingo, Laia
IR  - Domingo L
FIR - Macià, Francesc
IR  - Macià F
FIR - Roman, Marta
IR  - Roman M
FIR - Romero, Anabel
IR  - Romero A
FIR - Barata, Teresa
IR  - Barata T
FIR - Diez de la Lastra, Isabel
IR  - Diez de la Lastra I
FIR - de la Vega, Mariola
IR  - de la Vega M
FIR - Bare, Marisa
IR  - Bare M
FIR - Torà, Núria
IR  - Torà N
FIR - Ferrer, Joana
IR  - Ferrer J
FIR - Castanyer, Francesc
IR  - Castanyer F
FIR - Carmona, Carmen
IR  - Carmona C
FIR - García, Susana
IR  - García S
FIR - Martín, Maximina
IR  - Martín M
FIR - Gonzalez, Nerea
IR  - Gonzalez N
FIR - Valverde, Maria Amparo
IR  - Valverde MA
FIR - Saez, Alberto
IR  - Saez A
FIR - Barredo, Inma
IR  - Barredo I
FIR - de Toro, Manuel
IR  - de Toro M
FIR - Ferreiro, Josefa
IR  - Ferreiro J
FIR - Pérez, Jeanette
IR  - Pérez J
FIR - Valcárcel, Cristina
IR  - Valcárcel C
FIR - Padilla, María Del Carmen
IR  - Padilla MDC
FIR - Téllez, Teresa
IR  - Téllez T
FIR - Zarcos, Irene
IR  - Zarcos I
FIR - Churruca, Cristina
IR  - Churruca C
FIR - Perales, Amaia
IR  - Perales A
FIR - Recio, Javier
IR  - Recio J
FIR - Ruiz, Irune
IR  - Ruiz I
FIR - Urraca, Jose María
IR  - Urraca JM
FIR - Michelena, MªJesús
IR  - Michelena M
FIR - Moreno, Julio
IR  - Moreno J
FIR - Mallabiabarrena, Gaizka
IR  - Mallabiabarrena G
FIR - Cobos, Patricia
IR  - Cobos P
FIR - Otero, Borja
IR  - Otero B
FIR - Gorostiaga, Javier
IR  - Gorostiaga J
FIR - Troya, Itsaso
IR  - Troya I
EDAT- 2023/01/12 06:00
MHDA- 2023/04/03 06:42
CRDT- 2023/01/11 11:20
PHST- 2022/12/11 00:00 [accepted]
PHST- 2023/04/03 06:42 [medline]
PHST- 2023/01/12 06:00 [pubmed]
PHST- 2023/01/11 11:20 [entrez]
AID - 10.1007/s11136-022-03327-4 [pii]
AID - 3327 [pii]
AID - 10.1007/s11136-022-03327-4 [doi]
PST - ppublish
SO  - Qual Life Res. 2023 Apr;32(4):989-1003. doi: 10.1007/s11136-022-03327-4. Epub 
      2023 Jan 11.

PMID- 36625693
OWN - NLM
STAT- MEDLINE
DCOM- 20230112
LR  - 20230514
IS  - 2386-5857 (Electronic)
IS  - 1137-6821 (Linking)
VI  - 34
IP  - 6
DP  - 2022 Dec
TI  - Factors associated with short-term mortality after emergency department care of 
      residents living in aged care homes: findings from the multicenter Caregency 
      study.
PG  - 437-443
AB  - OBJECTIVES: To evaluate short-term mortality in people transferred from aged care 
      homes for treatment in a hospital emergency department (ED) and to analyze 
      factors associated with mortality. MATERIAL AND METHODS: Multicenter study of a 
      random sample of retrospective data of patients treated in 5 EDs in Catalonia in 
      2017. The patients were over the age of 65 years and lived in residential care 
      facilities. In addition to short-term mortality (in the ED or within 30 days of 
      discharge), we analyzed sociodemographic characteristics, prior functional and 
      cognitive status, multimorbidity, triage level on arrival, length of stay in the 
      ED, and hospital admission. Odds ratios (ORs) for factors associated with 
      short-term mortality were calculated by multivariate regression analysis. 
      RESULTS: A total of 2444 ED admissions were analyzed. The patients' mean (SD) age 
      was 85.9 (7.1) years, and 67.7% .were women. Short-term mortality (in 15.5%) was 
      associated with age >90 years (OR, 1.50; 95% CI, 1.5-1.95 years), a Charlson 
      index >2 (OR, 1.47; 95% CI, 1.14-1.90), and dependency assessed as moderate (OR, 
      1.50; 95% CI, 1.03- 2.20) or severe (OR, 2.56; 95% CI, 1.84-3.55). Other 
      associated factors were a higher level of urgency on triage, duration of ED stay, 
      and hospital admission. CONCLUSION: Aged residents with the characteristics 
      associated with short-term mortality could benefit from interventions for 
      potentially avoiding unnecessary transfers to an ED, and from the implementation 
      of comprehensive geriatric care within the ED. This could be useful to support 
      good quality of care at the end of life.
FAU - Afonso-Argilés, F Javier
AU  - Afonso-Argilés FJ
AD  - Servicio de Geriatría, Fundació Sanitària Mollet, Barcelona, España. Estudiante 
      de doctorado de la Universitat Autònoma de Barcelona, Barcelona, España.
FAU - Comas Serrano, Mercè
AU  - Comas Serrano M
AD  - Servicio de Epidemiología y Evaluación, Institut Hospital del Mar 
      d'Investigacions Mèdiques (IMIM), Parc de Salut Mar, Barcelona, España. Miembro 
      de la Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud (RICAPPS), Madrid, España. Miembro de la Red de Investigación en Servicios 
      de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España.
FAU - Blázquez-Andión, Marta
AU  - Blázquez-Andión M
AD  - Servicio de Urgencias, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
FAU - Castells Oliveres, Xavier
AU  - Castells Oliveres X
AD  - Servicio de Epidemiología y Evaluación, Institut Hospital del Mar 
      d'Investigacions Mèdiques (IMIM), Parc de Salut Mar, Barcelona, España. Miembro 
      de la Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud (RICAPPS), Madrid, España. Miembro de la Red de Investigación en Servicios 
      de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España.
FAU - Cirera Lorenzo, Isabel
AU  - Cirera Lorenzo I
AD  - Servicio de Urgencias, Hospital Universitari Parc de Salut Mar, Barcelona, 
      España.
FAU - García Pérez, Dolors
AU  - García Pérez D
AD  - Servicio de Urgencias, Fundació Althaia, Xarxa Assistencial Universitaria de 
      Manresa, Barcelona, España.
FAU - Gómez Roldán, J María
AU  - Gómez Roldán JM
AD  - Servicio de Geriatría y Cuidados Paliativos, Badalona Serveis Assistencials, 
      Barcelona, España.
FAU - Pujadas Lafarga, Teresa
AU  - Pujadas Lafarga T
AD  - Servicio de Geriatría y Cuidados Paliativos, Badalona Serveis Assistencials, 
      Barcelona, España.
FAU - Ichart Tomás, Xavier
AU  - Ichart Tomás X
AD  - Servicio de Urgencias, Hospital Universitari Arnau de Vilanova, Lleida, España.
FAU - Puig-Campmany, Mireia
AU  - Puig-Campmany M
AD  - Servicio de Urgencias, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
FAU - Rizzi, Miguel A
AU  - Rizzi MA
AD  - Servicio de Urgencias, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
FAU - Sinfreu Pujol, Alba
AU  - Sinfreu Pujol A
AD  - Servicio de Urgencias, Fundació Althaia, Xarxa Assistencial Universitaria de 
      Manresa, Barcelona, España.
FAU - Tejero Cano, Isabel
AU  - Tejero Cano I
AD  - Servicio de Geriatría, Hospital Universitario Parc de Salut Mar, Barcelona, 
      España.
FAU - Vena Martínez, Ana B
AU  - Vena Martínez AB
AD  - Servicio de Geriatría, Hospital Universitari Arnau de Vilanova, Lleida, España.
FAU - Villanueva Sánchez, Héctor
AU  - Villanueva Sánchez H
AD  - Servicio de Urgencias, Hospital Universitari Parc de Salut Mar, Barcelona, 
      España.
FAU - Renom-Guiteras, Anna
AU  - Renom-Guiteras A
AD  - Miembro de la Red de Investigación en Cronicidad, Atención Primaria y Promoción 
      de la Salud (RICAPPS), Madrid, España. Miembro de la Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España. Servicio 
      de Geriatría, Hospital Universitario Parc de Salut Mar, Barcelona, España.
LA  - eng
LA  - spa
PT  - Journal Article
PT  - Multicenter Study
TT  - Factores asociados con mortalidad a corto plazo en personas que viven en 
      residencias atendidas en servicios de urgencias: resultados del estudio 
      multicéntrico Caregency.
PL  - Spain
TA  - Emergencias
JT  - Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
JID - 9805751
SB  - IM
MH  - Humans
MH  - Female
MH  - Male
MH  - Retrospective Studies
MH  - *Hospitalization
MH  - *Emergency Medical Services
MH  - Emergency Service, Hospital
MH  - Patient Discharge
OTO - NOTNLM
OT  - Aged..
OT  - Anciano.
OT  - Emergency health services.
OT  - Homes for the aged.
OT  - Hospitalización.
OT  - Hospitalization..
OT  - Mortalidad.
OT  - Mortality.
OT  - Residencia.
OT  - Urgencias.
EDAT- 2023/01/11 06:00
MHDA- 2023/01/13 06:00
CRDT- 2023/01/10 09:42
PHST- 2023/01/10 09:42 [entrez]
PHST- 2023/01/11 06:00 [pubmed]
PHST- 2023/01/13 06:00 [medline]
PST - ppublish
SO  - Emergencias. 2022 Dec;34(6):437-443.

PMID- 36619617
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230111
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Effectiveness and safety of tetanus vaccine administration by intramuscular vs. 
      subcutaneous route in anticoagulated patients: Randomized clinical trial in 
      primary care.
PG  - 1054988
LID - 10.3389/fmed.2022.1054988 [doi]
LID - 1054988
AB  - DESIGN: Prospective, double-blind clinical trial comparing tetanus-diphtheria 
      vaccine administration routes, intramuscular (IM) vs. subcutaneous (SC) 
      injection, in patients with oral anticoagulants. ISRCTN69942081. STUDY 
      POPULATION: Patients treated with oral anticoagulants, 15 health centers, Vigo 
      (Spain). Sample size, 117 in each group. OUTCOME VARIABLES: Safety analysis: 
      systemic reactions and, at the vaccine administration site, erythematic, 
      swelling, hematoma, granuloma, pain.Effectiveness analysis: differences in 
      tetanus toxoid antibody titers.Independent variables: route, sex, age, baseline 
      serology, number of doses administered. ANALYSIS: Following the CONSORT 
      guidelines, we performed an intention-to-treat analysis. We conducted a 
      descriptive study of the variables included in both groups (117 in each group) 
      and a bivariate analysis. Fewer than 5% of missing values. Imputation in baseline 
      and final serology with the median was performed. Lost values were assumed to be 
      values missing at random. We conducted a descriptive study of the variables and 
      compared routes. For safety, multivariate logistic regression was applied, with 
      each safety criterion as outcome and the independent variables. Odds ratios (ORs) 
      were calculated. For effectiveness, a generalized additive mixed model, with the 
      difference between final and initial antibody titers as outcome. Due to the 
      bimodal distribution of the outcome, the normal mixture fitting with gamlssMX was 
      used. All statistical analyses were performed with the gamlss.mx and texreg 
      packages of the R free software environment. RESULTS: A previously published 
      protocol was used across the 6-year study period. The breakdown by sex and route 
      showed: 102 women and 132 men; and 117 IM and 117 SC, with one dose administered 
      in over 80% of participants. There were no differences between groups in any 
      independent variable. The second and third doses administered were not analyzed, 
      due to the low number of cases. In terms of safety, there were no severe general 
      reactions. Locally, significant adjusted differences were observed: in pain, by 
      sex (male, OR: 0.39) and route (SC, OR: 0.55); in erythema, by sex (male, OR: 
      0.34) and route (SC, OR: 5.21); and in swelling, by sex (male, OR: 0.37) and 
      route (SC, OR: 2.75). In terms of effectiveness, the model selected was the one 
      adjusted for baseline serology.
CI  - Copyright © 2022 Lago-Deibe, Valladares-Cabaleiro, Fernández-Domínguez, 
      Fernández-Fernández, Clavería, Rodríguez-Pastoriza, Roca-Pardinas and 
      Martín-Miguel.
FAU - Lago-Deibe, Fernando Isidro
AU  - Lago-Deibe FI
AD  - Sárdoma Health Center, Vigo Health Area, Galician Health Service, Vigo, Spain.
AD  - South Galicia Health Research Institute (Instituto de Investigación Sanitaria 
      Galicia Sur), Vigo Health Area, Galician Health Service, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Vigo, Spain.
FAU - Valladares-Cabaleiro, Mercedes
AU  - Valladares-Cabaleiro M
AD  - Moaña Primary Care Emergency Center (Punto de Atención Continuada), Vigo Health 
      Area, Galician Health Service, Moaña, Spain.
FAU - Fernández-Domínguez, María José
AU  - Fernández-Domínguez MJ
AD  - South Galicia Health Research Institute (Instituto de Investigación Sanitaria 
      Galicia Sur), Vigo Health Area, Galician Health Service, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Vigo, Spain.
AD  - Leiro Health Center, Ourense Health Area, Galician Health Service, Ourense, 
      Spain.
FAU - Fernández-Fernández, Isabel
AU  - Fernández-Fernández I
AD  - Redondela Health Center, Vigo Health Area, Galician Health Service, Redondela, 
      Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - South Galicia Health Research Institute (Instituto de Investigación Sanitaria 
      Galicia Sur), Vigo Health Area, Galician Health Service, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Vigo, Spain.
FAU - Rodríguez-Pastoriza, Sara
AU  - Rodríguez-Pastoriza S
AD  - South Galicia Health Research Institute (Instituto de Investigación Sanitaria 
      Galicia Sur), Vigo Health Area, Galician Health Service, Vigo, Spain.
FAU - Roca-Pardinas, Javier
AU  - Roca-Pardinas J
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Vigo, Spain.
AD  - Department of Statistics and Operations Research, University of Vigo, Vigo, 
      Spain.
AD  - Galician Research and Mathematical Technology Center (Centro de Investigación e 
      Tecnoloxía Matemática de Galicia/CITMAga), Santiago de Compostela, Spain.
FAU - Martín-Miguel, María Victoria
AU  - Martín-Miguel MV
AD  - South Galicia Health Research Institute (Instituto de Investigación Sanitaria 
      Galicia Sur), Vigo Health Area, Galician Health Service, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Vigo, Spain.
AD  - Vigo Family and Community Medicine and Nursing Teaching Unit, Vigo Health Area, 
      Galician Health Service, Vigo, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221222
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9813590
OTO - NOTNLM
OT  - clinical trial
OT  - drug administration routes
OT  - primary health care
OT  - tetanus antitoxin/administration and dosage
OT  - vaccines
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/01/10 06:00
MHDA- 2023/01/10 06:01
CRDT- 2023/01/09 03:55
PHST- 2022/09/27 00:00 [received]
PHST- 2022/12/01 00:00 [accepted]
PHST- 2023/01/09 03:55 [entrez]
PHST- 2023/01/10 06:00 [pubmed]
PHST- 2023/01/10 06:01 [medline]
AID - 10.3389/fmed.2022.1054988 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Dec 22;9:1054988. doi: 10.3389/fmed.2022.1054988. 
      eCollection 2022.

PMID- 36614862
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230308
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Dec 21
TI  - Prognostic Impact of Sarcopenia in Patients with Advanced Prostate Carcinoma: A 
      Systematic Review.
LID - 10.3390/jcm12010057 [doi]
LID - 57
AB  - Prostate cancer (PCa) is the second most common cancer in men and the fifth 
      leading cause of death from cancer. The possibility of sarcopenia being a 
      prognostic factor in advanced PCa patients has recently become a subject of 
      interest. The aim of the present study was to evaluate the prognostic value of 
      sarcopenia in advanced prostate carcinoma. A systematic review was conducted in 
      Medline, EMBASE, and Web of Science (March, 2021). The quality of studies was 
      assessed using the Quality in Prognosis Studies tool. Meta-analyses for overall, 
      cancer-specific, and progression-free survival were performed. Nine studies (n = 
      1659) were included. Sarcopenia was borderline associated with a shorter overall 
      survival (HR = 1.20, 95% CI: 1.01, 1.44, P = 0.04, I2 = 43%) but was 
      significantly associated with progression-free survival (HR = 1.61, 95% CI: 1.26, 
      2.06, P < 0.01; k = 3; n = 588). Available evidence supports sarcopenia as an 
      important prognostic factor of progression-free survival in patients with 
      advanced PCa. However, sarcopenia has a weak association with a shorter overall 
      survival. The evidence on the role of sarcopenia in prostate-cancer-specific 
      survival is insufficient and supports the need for further research. Patient 
      summary: The literature was reviewed to determine whether the loss of muscle mass 
      (sarcopenia) affects the survival in patients with advanced PCa. Patients with 
      advanced PCa and sarcopenia were found to have a shorter progression-free 
      survival (the length of time during and after treatment of a cancer that the 
      patient lives with the disease but it does not get worse), but sarcopenia did not 
      have much influence on the overall survival and cancer-specific survival (the 
      length of time from either the date of diagnosis or the start of treatment to the 
      date of death due to the cancer).
FAU - de Pablos-Rodríguez, Pedro
AU  - de Pablos-Rodríguez P
AUID- ORCID: 0000-0003-2286-9893
AD  - Department of Urology, Instituto Valenciano de Oncología (IVO), 46009 Valencia, 
      Spain.
AD  - Doctoral School of University of Las Palmas de Gran Canaria (ULPGC), 35001 Las 
      Palmas de Gran Canaria, Spain.
FAU - Del Pino-Sedeño, Tasmania
AU  - Del Pino-Sedeño T
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
FAU - Infante-Ventura, Diego
AU  - Infante-Ventura D
AUID- ORCID: 0000-0003-4197-7849
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Santa Cruz de 
      Tenerife, Spain.
FAU - de Armas-Castellano, Aythami
AU  - de Armas-Castellano A
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Santa Cruz de 
      Tenerife, Spain.
FAU - Ramírez Backhaus, Miguel
AU  - Ramírez Backhaus M
AD  - Department of Urology, Instituto Valenciano de Oncología (IVO), 46009 Valencia, 
      Spain.
FAU - Ferrer, Juan Francisco Loro
AU  - Ferrer JFL
AUID- ORCID: 0000-0002-0517-8209
AD  - Department of Clinical Sciences, University of Las Palmas de Gran Canaria 
      (ULPGC), 35001 Las Palmas de Gran Canaria, Spain.
FAU - de Pablos-Velasco, Pedro
AU  - de Pablos-Velasco P
AUID- ORCID: 0000-0002-9190-2581
AD  - Department of Endocrinology and Nutrition, University Hospital of Gran Canaria 
      Doctor Negrín, 35012 Las Palmas de Gran Canaria, Spain.
AD  - Research Institute of Biomedical and Health Sciences (IUIBS), University of Las 
      Palmas de Gran Canaria (ULPGC), 35001 Las Palmas de Gran Canaria, Spain.
FAU - Rueda-Domínguez, Antonio
AU  - Rueda-Domínguez A
AUID- ORCID: 0000-0001-5890-0149
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University 
      Hospitals, IBIMA, 29590 Malaga, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
FAU - Trujillo-Martín, María M
AU  - Trujillo-Martín MM
AUID- ORCID: 0000-0003-2273-2192
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), 38109 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20221221
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC9821501
OTO - NOTNLM
OT  - meta-analysis
OT  - prognosis
OT  - prostatic neoplasms
OT  - sarcopenia
OT  - survival
OT  - systematic review
COIS- The authors have no conflict of interest with the subject matter or materials 
      discussed in the manuscript.
EDAT- 2023/01/09 06:00
MHDA- 2023/01/09 06:01
CRDT- 2023/01/08 01:30
PHST- 2022/10/30 00:00 [received]
PHST- 2022/12/01 00:00 [revised]
PHST- 2022/12/15 00:00 [accepted]
PHST- 2023/01/08 01:30 [entrez]
PHST- 2023/01/09 06:00 [pubmed]
PHST- 2023/01/09 06:01 [medline]
AID - jcm12010057 [pii]
AID - jcm-12-00057 [pii]
AID - 10.3390/jcm12010057 [doi]
PST - epublish
SO  - J Clin Med. 2022 Dec 21;12(1):57. doi: 10.3390/jcm12010057.

PMID- 36600196
OWN - NLM
STAT- MEDLINE
DCOM- 20230106
LR  - 20230203
IS  - 2731-4553 (Electronic)
IS  - 2731-4553 (Linking)
VI  - 24
IP  - 1
DP  - 2023 Jan 4
TI  - Real-world data in primary care: validation of diagnosis of atrial fibrillation 
      in primary care electronic medical records and estimated prevalence among 
      consulting patients'.
PG  - 4
LID - 10.1186/s12875-022-01961-y [doi]
LID - 4
AB  - BACKGROUND: Primary care electronic medical records contain 
      clinical-administrative information on a high percentage of the population. 
      Before this information can be used for epidemiological purposes, its quality 
      must be verified. This study aims to validate diagnoses of atrial fibrillation 
      (AF) recorded in primary care electronic medical records and to estimate the 
      prevalence of AF in the population attending primary care consultations. METHODS: 
      We performed a cross-sectional validation study of all diagnoses of AF recorded 
      in primary care electronic medical records in Madrid (Spain). We also performed 
      simple random sampling of diagnoses of AF (ICPC-2 code K78) registered by 55 
      physicians and random age- and sex-matched sampling of the records that included 
      a diagnosis of AF. Electrocardiograms, echocardiograms, and hospital discharge or 
      cardiology clinic reports were matched. Sensitivity, specificity, positive and 
      negative predictive values (PPV and NPV), and overall agreement were calculated 
      using the kappa statistic (κ). The prevalence of AF in the community of Madrid 
      was estimated considering the sensitivity and specificity obtained in the 
      validation. All calculations were performed overall and by sex and age groups. 
      RESULTS: The degree of agreement was very high (κ = 0.952), with a sensitivity of 
      97.84%, specificity of 97.39%, PPV of 97.37%, and NPV of 97.85%. The prevalence 
      of AF in the population aged over 18 years was 2.41% (95%CI 2.39-2.42% [2.25% in 
      women and 2.58% in men]). This increased progressively with age, reaching 16.95% 
      in those over 80 years of age (15.5% in women and 19.44% in men). CONCLUSIONS: 
      The validation results obtained enable diagnosis of AF recorded in primary care 
      to be used as a tool for epidemiological studies. A high prevalence of AF was 
      found, especially in older patients.
CI  - © 2023. The Author(s).
FAU - de Burgos-Lunar, C
AU  - de Burgos-Lunar C
AD  - Department of Preventive Medicine, Hospital Universitario Clínico de San Carlos, 
      Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
FAU - Del Cura-González, I
AU  - Del Cura-González I
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Research Unit, Primary Health Care Management, Madrid, Spain.
AD  - Department of Medical Specialties and Public Health, Faculty of Health Sciences 
      Rey Juan Carlos University, Madrid, Spain.
FAU - Cárdenas-Valladolid, J
AU  - Cárdenas-Valladolid J
AD  - Information Systems Department, Primary Health Care Management, Madrid, Spain.
AD  - Biosanitary Research and Innovation Foundation of Primary Care (FIIBAP), Madrid, 
      Spain.
AD  - The Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
AD  - Alfonso X El Sabio University, Madrid, Spain.
FAU - Gómez-Campelo, P
AU  - Gómez-Campelo P
AD  - The Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
FAU - Abánades-Herranz, J C
AU  - Abánades-Herranz JC
AD  - Monovar Health Center, Madrid, Spain.
FAU - López-de Andrés, A
AU  - López-de Andrés A
AD  - Department of Public Health & Maternal and Child Health, Faculty of Medicine, 
      Universidad Complutense de Madrid, Madrid, Spain.
FAU - Sotos-Prieto, M
AU  - Sotos-Prieto M
AD  - Department of Preventive Medicine and Public health, Universidad Autónoma de 
      Madrid, Madrid, Spain.
AD  - CIBERESP (CIBER of Epidemiology and PublicHealth), Madrid, Spain.
AD  - Department of Environmental Health, Harvard T.H.Chan School of Public Health, 
      Boston, MA, USA.
FAU - Iriarte-Campo, V
AU  - Iriarte-Campo V
AD  - Biosanitary Research and Innovation Foundation of Primary Care (FIIBAP), Madrid, 
      Spain.
FAU - Salinero-Fort, M A
AU  - Salinero-Fort MA
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain. miguel.salinero@salud.madrid.org.
AD  - Biosanitary Research and Innovation Foundation of Primary Care (FIIBAP), Madrid, 
      Spain. miguel.salinero@salud.madrid.org.
AD  - The Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain. 
      miguel.salinero@salud.madrid.org.
AD  - Alfonso X El Sabio University, Madrid, Spain. miguel.salinero@salud.madrid.org.
AD  - General Subdirectorate of Research and Documentation, Department of Health, 
      Madrid, Spain. miguel.salinero@salud.madrid.org.
LA  - eng
GR  - PI13/00632/Instituto de Salud Carlos III/
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20230104
PL  - England
TA  - BMC Prim Care
JT  - BMC primary care
JID - 9918300889006676
SB  - IM
MH  - Male
MH  - Humans
MH  - Female
MH  - Aged, 80 and over
MH  - Adult
MH  - Middle Aged
MH  - Aged
MH  - *Atrial Fibrillation/diagnosis/epidemiology
MH  - Electronic Health Records
MH  - Prevalence
MH  - Cross-Sectional Studies
MH  - Primary Health Care
PMC - PMC9811753
OTO - NOTNLM
OT  - Atrial fibrillation
OT  - Electronic health records
OT  - Prevalence
OT  - Validation
COIS- The authors declare that they have no competing interests.
EDAT- 2023/01/05 06:00
MHDA- 2023/01/07 06:00
CRDT- 2023/01/04 23:33
PHST- 2022/08/13 00:00 [received]
PHST- 2022/12/28 00:00 [accepted]
PHST- 2023/01/04 23:33 [entrez]
PHST- 2023/01/05 06:00 [pubmed]
PHST- 2023/01/07 06:00 [medline]
AID - 10.1186/s12875-022-01961-y [pii]
AID - 1961 [pii]
AID - 10.1186/s12875-022-01961-y [doi]
PST - epublish
SO  - BMC Prim Care. 2023 Jan 4;24(1):4. doi: 10.1186/s12875-022-01961-y.

PMID- 36590942
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230103
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Analysis of the impact of social determinants and primary care morbidity on 
      population health outcomes by combining big data: A research protocol.
PG  - 1012437
LID - 10.3389/fmed.2022.1012437 [doi]
LID - 1012437
AB  - BACKGROUND: In recent years, different tools have been developed to facilitate 
      analysis of social determinants of health (SDH) and apply this to health policy. 
      The possibility of generating predictive models of health outcomes which combine 
      a wide range of socioeconomic indicators with health problems is an approach that 
      is receiving increasing attention. Our objectives are twofold: (1) to predict 
      population health outcomes measured as hospital morbidity, taking primary care 
      (PC) morbidity adjusted for SDH as predictors; and (2) to analyze the geographic 
      variability of the impact of SDH-adjusted PC morbidity on hospital morbidity, by 
      combining data sourced from electronic health records and selected operations of 
      the National Statistics Institute (Instituto Nacional de Estadística/INE). 
      METHODS: The following will be conducted: a qualitative study to select 
      socio-health indicators using RAND methodology in accordance with SDH frameworks, 
      based on indicators published by the INE in selected operations; and a 
      quantitative study combining two large databases drawn from different Spain's 
      Autonomous Regions (ARs) to enable hospital morbidity to be ascertained, i.e., PC 
      electronic health records and the minimum basic data set (MBDS) for hospital 
      discharges. These will be linked to socioeconomic indicators, previously selected 
      by geographic unit. The outcome variable will be hospital morbidity, and the 
      independent variables will be age, sex, PC morbidity, geographic unit, and 
      socioeconomic indicators. ANALYSIS: To achieve the first objective, predictive 
      models will be used, with a test-and-training technique, fitting multiple 
      logistic regression models. In the analysis of geographic variability, penalized 
      mixed models will be used, with geographic units considered as random effects and 
      independent predictors as fixed effects. DISCUSSION: This study seeks to show the 
      relationship between SDH and population health, and the geographic differences 
      determined by such determinants. The main limitations are posed by the collection 
      of data for healthcare as opposed to research purposes, and the time lag between 
      collection and publication of data, sampling errors and missing data in 
      registries and surveys. The main strength lies in the project's multidisciplinary 
      nature (family medicine, pediatrics, public health, nursing, psychology, 
      engineering, geography).
CI  - Copyright © 2022 Couso-Viana, Bentué-Martínez, Delgado-Martín, Cabeza-Irigoyen, 
      León-Latre, Concheiro-Guisán, Rodríguez-Álvarez, Román-Rodríguez, Roca-Pardiñas, 
      Zúñiga-Antón, García-Flaquer, Pericàs-Pulido, Sánchez-Recio, González-Álvarez, 
      Rodríguez-Pastoriza, Gómez-Gómez, Motrico, Jiménez-Murillo, Rabanaque and 
      Clavería.
FAU - Couso-Viana, Sabela
AU  - Couso-Viana S
AD  - I-Saúde Group, South Galicia Health Research Institute (Instituto de 
      Investigación Sanitaria Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
FAU - Bentué-Martínez, Carmen
AU  - Bentué-Martínez C
AD  - Department of Geography, Aragon University Environmental Sciences Research 
      Institute (Instituto Universitario de Investigación en Ciencias Ambientales de 
      Aragón/IUCA), University of Zaragoza, Zaragoza, Spain.
FAU - Delgado-Martín, María Victoria
AU  - Delgado-Martín MV
AD  - I-Saúde Group, South Galicia Health Research Institute (Instituto de 
      Investigación Sanitaria Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
AD  - Moaña Health Center, Vigo Area, SERGAS, Vigo, Spain.
FAU - Cabeza-Irigoyen, Elena
AU  - Cabeza-Irigoyen E
AD  - Health Promotion Service, Ministry of Health and Consumer Affairs, Public Health 
      Research Group (Grup d'Investigació en Salud Pública/GISPIB), Balearic Islands 
      Health Research Institute (IdISBa), Balearic Islands, Spain.
FAU - León-Latre, Montserrat
AU  - León-Latre M
AD  - La Jota Health Center, Aragonese Health Service, Aragon, Spain.
FAU - Concheiro-Guisán, Ana
AU  - Concheiro-Guisán A
AD  - Department of Pediatrics, Álvaro Cunqueiro Hospital, SERGAS, Vigo, Spain.
AD  - Rare Diseases and Pediatric Medicine Group, South Galicia Health Research 
      Institute (Instituto de Investigación Sanitaria Galicia Sur), SERGAS-UVIGO, Vigo, 
      Spain.
FAU - Rodríguez-Álvarez, María Xosé
AU  - Rodríguez-Álvarez MX
AD  - Department of Statistics and Operations Research, Biomedical Research Center 
      (Centro de Investigacións Biomédicas/CINBIO), University of Vigo, Vigo, Spain.
AD  - Galician Research and Mathematical Technology Center (Centro de Investigación e 
      Tecnoloxía Matemática de Galicia/CITMAga), Vigo, Spain.
FAU - Román-Rodríguez, Miguel
AU  - Román-Rodríguez M
AD  - Primary Care Management of Mallorca, Balearic Islands Health Research Institute, 
      Balearic Islands, Spain.
FAU - Roca-Pardiñas, Javier
AU  - Roca-Pardiñas J
AD  - Galician Research and Mathematical Technology Center (Centro de Investigación e 
      Tecnoloxía Matemática de Galicia/CITMAga), Vigo, Spain.
AD  - Department of Statistics and Operations Research, University of Vigo, Vigo, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Galicia, Spain.
FAU - Zúñiga-Antón, María
AU  - Zúñiga-Antón M
AD  - Department of Geography, Aragon University Environmental Sciences Research 
      Institute (Instituto Universitario de Investigación en Ciencias Ambientales de 
      Aragón/IUCA), University of Zaragoza, Zaragoza, Spain.
FAU - García-Flaquer, Ana
AU  - García-Flaquer A
AD  - Balearic Islands Health Research Platform (Plataforma de Investigación en 
      Información en Salud de Las Islas Baleares/PRISIB), Balearic Islands, Spain.
FAU - Pericàs-Pulido, Pau
AU  - Pericàs-Pulido P
AD  - Balearic Islands Health Research Platform (Plataforma de Investigación en 
      Información en Salud de Las Islas Baleares/PRISIB), Balearic Islands, Spain.
FAU - Sánchez-Recio, Raquel
AU  - Sánchez-Recio R
AD  - Aragon Health Services Research Group (Grupo de Investigación en Servicios 
      Sanitarios de Aragón/GRISSA), Aragon, Spain.
AD  - Aragonese Institute of Health, Aragon, Spain.
FAU - González-Álvarez, Beatriz
AU  - González-Álvarez B
AD  - Aragonese Institute of Health, Aragon, Spain.
FAU - Rodríguez-Pastoriza, Sara
AU  - Rodríguez-Pastoriza S
AD  - I-Saúde Group, South Galicia Health Research Institute (Instituto de 
      Investigación Sanitaria Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
FAU - Gómez-Gómez, Irene
AU  - Gómez-Gómez I
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Galicia, Spain.
AD  - Department of Psychology, Loyola University Andalusia, Seville, Spain.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Galicia, Spain.
AD  - Department of Psychology, Loyola University Andalusia, Seville, Spain.
FAU - Jiménez-Murillo, José Luís
AU  - Jiménez-Murillo JL
AD  - Technical Sub-directorate for Information Management, Andalusian Health Service, 
      Seville, Spain.
FAU - Rabanaque, Isabel
AU  - Rabanaque I
AD  - Department of Geography, Aragon University Environmental Sciences Research 
      Institute (Instituto Universitario de Investigación en Ciencias Ambientales de 
      Aragón/IUCA), University of Zaragoza, Zaragoza, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - I-Saúde Group, South Galicia Health Research Institute (Instituto de 
      Investigación Sanitaria Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (Red de 
      Investigación en Cronicidad, Atención Primaria y Promoción de la Salud/RICAPPS), 
      Galicia, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221216
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9800778
OTO - NOTNLM
OT  - big data
OT  - electronic health records—HER
OT  - morbidity
OT  - social determinants of health (MeSH)
OT  - socioeconomic factors (MeSH)
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/01/03 06:00
MHDA- 2023/01/03 06:01
CRDT- 2023/01/02 04:40
PHST- 2022/08/05 00:00 [received]
PHST- 2022/12/01 00:00 [accepted]
PHST- 2023/01/02 04:40 [entrez]
PHST- 2023/01/03 06:00 [pubmed]
PHST- 2023/01/03 06:01 [medline]
AID - 10.3389/fmed.2022.1012437 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Dec 16;9:1012437. doi: 10.3389/fmed.2022.1012437. 
      eCollection 2022.

PMID- 36590935
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230103
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Relationship between initial symptoms and the prognosis, sex, and demographic 
      area of patients with COVID-19.
PG  - 1040062
LID - 10.3389/fmed.2022.1040062 [doi]
LID - 1040062
AB  - BACKGROUND: A method of determining the initial symptoms and main prognostic 
      identifiers for COVID-19 can be a key tool for physicians, especially primary 
      care physicians. Therefore, the objective of this study was to examine the 
      prognosis of patients with COVID-19 from two different demographic regions 
      according to baseline and main symptoms, age, and sex. METHODS: All individuals 
      selected from both urban and rural health centers were over 18 years of age, had 
      COVID-19 before 2 March 2021, and were followed up with a primary care physician. 
      All patients included in this study were recruited in terms of sex, age at the 
      time of infection, type of contact, baseline symptoms, primary and secondary 
      symptomatology, emergency assistance, hospitalization, intensive care unit (ICU) 
      admission, and death. RESULTS: A total of 219 and 214 subjects were recruited 
      from rural and urban health centers, respectively. Subjects with COVID-19 from 
      rural areas were significantly older in age, with a higher proportion of men, and 
      had significantly lower baseline and main symptoms than those from urban areas. 
      In addition, the presence of both fever and dyspnea as the initial or main 
      symptom is significantly associated with emergency assistance, hospitalization, 
      and death, regardless of sex, age, and demographic area. This type of illness was 
      reported to be significantly less frequent in the rural population than in the 
      urban population. CONCLUSION: The presence of both fever and dyspnea as both 
      initial and main symptoms is a poor prognostic factor for COVID-19, regardless of 
      age, sex, and demographic areas. In addition, women reported lower levels of 
      fever and dyspnea, requiring minimal emergency assistance and fewer 
      hospitalization, and a lower rate of mortality than men. During a COVID-19 
      infection follow-up, subjects in rural areas seem to have less access to medical 
      care than those in urban areas.
CI  - Copyright © 2022 Oliván-Blázquez, Bartolomé-Moreno, Gericó-Aseguinolaza, 
      Méndez-López, Lerma-Irureta, Lamiquiz-Moneo, Fernández-Martínez and 
      Magallón-Botaya.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
FAU - Bartolomé-Moreno, Cruz
AU  - Bartolomé-Moreno C
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Aragonese Healthcare Service, Zaragoza, Spain.
AD  - Aragonese Healthcare Service, Department of Family and Community Care Teaching- 
      Sector I, Zaragoza, Spain.
FAU - Gericó-Aseguinolaza, Junkal
AU  - Gericó-Aseguinolaza J
AD  - Osakidetza-Basque Health Service, San Sebastian, Spain.
FAU - Méndez-López, Fátima
AU  - Méndez-López F
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, Faculty of Medicine, 
      University of Zaragoza, Zaragoza, Spain.
FAU - Lerma-Irureta, David
AU  - Lerma-Irureta D
AD  - Department of Medicine, Psychiatry and Dermatology, Faculty of Medicine, 
      University of Zaragoza, Zaragoza, Spain.
FAU - Lamiquiz-Moneo, Itziar
AU  - Lamiquiz-Moneo I
AD  - Miguel Servet University Hospital, Health Research Institute of Aragon (IISA), 
      Zaragoza, Spain.
AD  - Department of Human Anatomy and Histology, Faculty of Medicine, University of 
      Zaragoza, Zaragoza, Spain.
FAU - Fernández-Martínez, Selene
AU  - Fernández-Martínez S
AD  - Group B17-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Group B21-20R, Health Research Institute of Aragon (IISA), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0001, Zaragoza, Spain.
AD  - Aragonese Healthcare Service, Zaragoza, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, Faculty of Medicine, 
      University of Zaragoza, Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221214
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9795186
OTO - NOTNLM
OT  - COVID-19
OT  - demographic area
OT  - primary healthcare
OT  - prognosis
OT  - sex
OT  - signs and symptoms
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2023/01/03 06:00
MHDA- 2023/01/03 06:01
CRDT- 2023/01/02 04:40
PHST- 2022/09/08 00:00 [received]
PHST- 2022/11/21 00:00 [accepted]
PHST- 2023/01/02 04:40 [entrez]
PHST- 2023/01/03 06:00 [pubmed]
PHST- 2023/01/03 06:01 [medline]
AID - 10.3389/fmed.2022.1040062 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Dec 14;9:1040062. doi: 10.3389/fmed.2022.1040062. 
      eCollection 2022.

PMID- 36585793
OWN - NLM
STAT- MEDLINE
DCOM- 20230314
LR  - 20230316
IS  - 1369-7625 (Electronic)
IS  - 1369-6513 (Print)
IS  - 1369-6513 (Linking)
VI  - 26
IP  - 2
DP  - 2023 Apr
TI  - Ethical, legal, organizational and social issues related to the use of scalp 
      cooling for the prevention of chemotherapy-induced alopecia: A systematic review.
PG  - 567-578
LID - 10.1111/hex.13679 [doi]
AB  - INTRODUCTION: Scalp cooling (SC) aims to prevent chemotherapy-induced alopecia. 
      The goal of this systematic review is to tackle ethical, legal, organizational 
      and social issues related to SC. METHODS: A critical appraisal of the literature 
      was carried out using a systematic review design. MEDLINE, Embase and Web of 
      Science databases were searched up until 2 June 2021. Studies addressing these 
      aspects in English or Spanish were considered. Representatives of both patient 
      associations and professional scientific societies related to the topic 
      participated in the design of the protocol and the review of the findings. 
      RESULTS: A total of 17 studies were included. Articles were critically appraised 
      using the MMAT and SANRA. Findings were organized into four categories: (1) 
      ethical aspects focused on equal access, gender equity and doctor-patient 
      communication supported by Patient Decision Aids (PtDAs); (2) patient perspective 
      and acceptability; (3) professional perspective and acceptability; (4) 
      organizational aspects focused on accessibility and feasibility. CONCLUSION: 
      Cancer patients' expectations when using SC need to be adjusted to reduce the 
      potential distress associated with hair loss. PtDAs could help patients clarify 
      their values and preferences regarding SC. Equal access to technology should be 
      guaranteed. PATIENT OR PUBLIC CONTRIBUTION: In this systematic review, the 
      representatives of the patient associations (Ms. María Luz Amador Muñoz of the 
      Spanish Association Against Cancer [AECC] and Ms. Catiana Martinez Cánovas of the 
      Spanish Breast Cancer Federation [FECMA]) participated in the review of the study 
      protocol, as well as in the results, discussion and conclusions, making their 
      contributions. In the type of design of these studies (systematic reviews), it is 
      not usual to have the direct participation of patients, but in this one, we have 
      done so, as it is a systematic review that is part of a report of the Spanish 
      Network of Health Technology Assessment Agencies (ETS).
CI  - © 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.
FAU - Delgado Rodríguez, Janet
AU  - Delgado Rodríguez J
AD  - Department of Philosophy, University of Granada, Granada, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AUID- ORCID: 0000-0002-9106-2420
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Infante-Ventura, Diego
AU  - Infante-Ventura D
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Suarez-Herrera, José Carlos
AU  - Suarez-Herrera JC
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Department of Strategy, Entrepreneurship and Sustainable Development KEDGE 
      Business School, Marseille, France.
AD  - Cátedra UNITWIN/UNESCO de IPD-SILOS Universidad de Las Palmas de Gran Canaria, 
      Las Palmas, Spain.
FAU - Rueda-Domínguez, Antonio
AU  - Rueda-Domínguez A
AD  - Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University 
      Hospitals, IBIMA, Málaga, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Málaga, 
      Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
FAU - Del Mar Trujillo-Martín, María
AU  - Del Mar Trujillo-Martín M
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PT  - Systematic Review
DEP - 20221230
PL  - England
TA  - Health Expect
JT  - Health expectations : an international journal of public participation in health 
      care and health policy
JID - 9815926
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Humans
MH  - Female
MH  - Scalp
MH  - *Breast Neoplasms/drug therapy
MH  - Alopecia/chemically induced/prevention & control
MH  - Communication
MH  - *Antineoplastic Agents/adverse effects
PMC - PMC10010082
OTO - NOTNLM
OT  - chemotherapy-induced alopecia
OT  - ethical, healthcare professional perspective
OT  - legal, organizational and social issues
COIS- J. D. R., V. R. G., D. I.‐V., P. S. A. and M. M. T. work for the same research 
      entity that received the funding. The remaining authors declare no conflict of 
      interest.
EDAT- 2023/01/01 06:00
MHDA- 2023/03/15 06:00
CRDT- 2022/12/31 01:43
PHST- 2022/11/15 00:00 [revised]
PHST- 2022/08/22 00:00 [received]
PHST- 2022/11/16 00:00 [accepted]
PHST- 2023/01/01 06:00 [pubmed]
PHST- 2023/03/15 06:00 [medline]
PHST- 2022/12/31 01:43 [entrez]
AID - HEX13679 [pii]
AID - 10.1111/hex.13679 [doi]
PST - ppublish
SO  - Health Expect. 2023 Apr;26(2):567-578. doi: 10.1111/hex.13679. Epub 2022 Dec 30.

PMID- 36580024
OWN - NLM
STAT- Publisher
LR  - 20221229
IS  - 2385-2070 (Electronic)
IS  - 1723-2007 (Linking)
DP  - 2022 Dec 22
TI  - A comprehensive analysis of the readability of consent forms for blood 
      transfusion in Spain.
LID - 10.2450/2022.0153-22 [doi]
AB  - BACKGROUND: This study aimed to evaluate the readability of consent forms for 
      blood transfusion in public hospitals in Spain. MATERIALS AND METHODS: This was a 
      cross-sectional, national study conducted within the Spanish healthcare system. 
      Data were collected through the online retrieval of consent documents and direct 
      consultation with 223 public hospitals. Consent forms were subjected to 
      readability assessment including typographical, grammatical and lexical 
      dimensions. The INFLESZ scale, a well-validated instrument adapted to the reading 
      habits of Spaniards, was applied to determine the grammatical readability of the 
      documents. The Spanish Mosby's Dictionary and the Dictionary of Spanish were used 
      together to systematically identify the number of medical terms contained in the 
      text. Data were analyzed using descriptive and inferential statistics. RESULTS: 
      Forty-five written consent forms for blood transfusion, in use in 126 general 
      public hospitals were evaluated for various parameters, including font size 
      (=10.41), abbreviations (=10.58), word count (=595, 209 min-1,499 max) and length 
      (1 to 7 pages). The overall readability score (=50.66) was indicative that 
      consent forms are somewhat difficult to read. A heterogeneity of 116 different 
      healthcare terminology words was identified. Word count was statistically and 
      moderately positively related to the number of medical terms identified in the 
      text (rho=0.496, p=0.001) and the INFLESZ score (rho=0.34, p=0.023). DISCUSSION: 
      In this first national study to assess the ease of reading written information on 
      blood transfusion given to patients, deficiencies were found in the three 
      dimensions of readability (typographical, grammatical and lexical) and a lack of 
      uniformity among the written consent forms is pronounced. Further research is 
      needed to develop more person-centered tools to support patients in the process 
      of consenting for blood transfusion.
FAU - Morales-Valdivia, Estela
AU  - Morales-Valdivia E
AD  - Orthopedic Theatre Department, Croom Hospital, UHL Group, Limerick, Ireland.
FAU - Brady, Anne-Marie
AU  - Brady AM
AD  - Trinity Centre for Practice & Healthcare Innovation, School of Nursing & 
      Midwifery, Trinity College Dublin, Dublin Ireland.
FAU - Mariscal-Crespo, María I
AU  - Mariscal-Crespo MI
AD  - Nursing Department, Faculty of Nursing, University of Huelva, Huelva, Spain.
FAU - Camacho-Bejarano, Rafaela
AU  - Camacho-Bejarano R
AD  - Nursing Department, Faculty of Nursing, University of Huelva, Huelva, Spain.
AD  - Nursing and Healthcare Research Unit (Investén-ISCIII), Institute of Health 
      Carlos III, Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221222
PL  - Italy
TA  - Blood Transfus
JT  - Blood transfusion = Trasfusione del sangue
JID - 101237479
SB  - IM
EDAT- 2022/12/30 06:00
MHDA- 2022/12/30 06:00
CRDT- 2022/12/29 10:12
PHST- 2022/07/01 00:00 [received]
PHST- 2022/10/27 00:00 [accepted]
PHST- 2022/12/29 10:12 [entrez]
PHST- 2022/12/30 06:00 [pubmed]
PHST- 2022/12/30 06:00 [medline]
AID - 2022.0153-22 [pii]
AID - 10.2450/2022.0153-22 [doi]
PST - aheadofprint
SO  - Blood Transfus. 2022 Dec 22. doi: 10.2450/2022.0153-22.

PMID- 36573594
OWN - NLM
STAT- MEDLINE
DCOM- 20230314
LR  - 20230316
IS  - 1369-7625 (Electronic)
IS  - 1369-6513 (Print)
IS  - 1369-6513 (Linking)
VI  - 26
IP  - 2
DP  - 2023 Apr
TI  - Understanding support systems for Parkinson's disease management in community 
      settings: A cross-national qualitative study.
PG  - 670-682
LID - 10.1111/hex.13691 [doi]
AB  - BACKGROUND: Health and social care systems face difficulties in managing 
      multimorbidity, disease burden and complex needs in long-term conditions such as 
      Parkinson's disease. OBJECTIVE: This study aimed to develop a European 
      understanding of how health and social care professionals can collaborate with 
      stakeholders from different organizations and sectors to enhance the management 
      of Parkinson's disease in a community setting by identifying the existing gaps in 
      this process and how people with Parkinson's disease and their family carers 
      could benefit from these partnerships. METHODS: A mixed-methods sequential study 
      was conducted in Denmark, Norway, Spain and the United Kingdom. The findings from 
      the qualitative phase are presented. Individual semistructured interviews were 
      analysed using Braun's and Clarke's thematic analysis. A meta-ethnography 
      approach was used to analyse and synthesize cross-national findings. RESULTS: A 
      total of 41 healthcare professionals and 39 stakeholders from different 
      disciplines and sectors were interviewed in the four countries. The participants 
      acknowledged a lack of awareness of available resources and poor communication 
      between the different support systems in the management of Parkinson's disease. 
      To promote multiagency collaborations, the participants highlighted the need to 
      organize services along the Parkinson's disease journey, patient involvement and 
      strategic involvement of carers in organizing resources and Parkinson's disease 
      care pathways. According to the participants, the benefits from multiagency 
      partnerships could lead to an enhanced continuity of care and specialized 
      knowledge, mobilization of resources in the community, personalized support and 
      improved access to services. CONCLUSIONS: Policymakers are called upon to create 
      formal structures that facilitate multisectoral collaborations to promote an 
      integrated system of care for the management of Parkinson's disease in the 
      community. To address this challenge, we propose five strategies showing how 
      organizations can work together to optimize the use of resources and enhance the 
      management of Parkinson's disease throughout the illness trajectory. PATIENT OR 
      PUBLIC CONTRIBUTION: Patient and Public Involvement groups made up of 
      stakeholders, healthcare professionals, patients with Parkinson's disease and 
      family carers participated in the design of the study, the development of the 
      interview guides and the validation of the findings.
CI  - © 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.
FAU - Soilemezi, Dia
AU  - Soilemezi D
AUID- ORCID: 0000-0001-8831-9419
AD  - Department of Psychology, Faculty of Science and Health, University of 
      Portsmouth, Portsmouth, UK.
FAU - Palmar-Santos, Ana
AU  - Palmar-Santos A
AUID- ORCID: 0000-0003-2294-390X
AD  - Nursing Department, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, 
      Spain.
FAU - Navarta-Sánchez, M Victoria
AU  - Navarta-Sánchez MV
AUID- ORCID: 0000-0002-9122-2260
AD  - Nursing Department, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, 
      Spain.
FAU - Roberts, Helen C
AU  - Roberts HC
AUID- ORCID: 0000-0002-5291-1880
AD  - National Institute for Health Research Applied Research Collaboration Wessex, 
      Long Term Conditions, Southampton, UK.
AD  - Academic Geriatric Medicine, Faculty of Medicine, University of Southampton, 
      Southampton, UK.
FAU - Pedraz-Marcos, Azucena
AU  - Pedraz-Marcos A
AUID- ORCID: 0000-0002-4641-6891
AD  - Unidad de Investigación en Cuidados y Sistemas de Salud, The Carlos III Health 
      Institute (ISCIII), Madrid, Spain.
AD  - Grupo de investigación ISCiii, Research Network on Chronicity, Primary Care, and 
      Health Promotion (RICAPPS), Tenerife, Spain.
FAU - Haahr, Anita
AU  - Haahr A
AUID- ORCID: 0000-0002-8373-176X
AD  - Research Centre for Health and Welfare Technology, Programme for Rehabilitation, 
      VIA University College, Aarhus, Denmark.
AD  - Nursing and Healthcare, Department of Public Health, Aarhus University, Aarhus, 
      Denmark.
FAU - Sørensen, Dorthe
AU  - Sørensen D
AUID- ORCID: 0000-0001-6362-3385
AD  - Research Centre for Health and Welfare Technology, Programme for Rehabilitation, 
      VIA University College, Aarhus, Denmark.
FAU - Bragstad, Line K
AU  - Bragstad LK
AUID- ORCID: 0000-0002-9645-3770
AD  - Department of Nursing Science and Research Center for Habilitation and 
      Rehabilitation Services and Models (CHARM), University of Oslo, Oslo, Norway.
AD  - Department of Occupational Therapy, Prosthetics and Orthotics, Oslo Metropolitan 
      University, Oslo, Norway.
FAU - Hjelle, Ellen G
AU  - Hjelle EG
AUID- ORCID: 0000-0003-1983-995X
AD  - Department of Nursing Science and Research Center for Habilitation and 
      Rehabilitation Services and Models (CHARM), University of Oslo, Oslo, Norway.
AD  - Department of Occupational Therapy, Prosthetics and Orthotics, Oslo Metropolitan 
      University, Oslo, Norway.
FAU - Haavaag, Silje Bjørnsen
AU  - Haavaag SB
AD  - Department of Nursing Science, University of Oslo, Oslo, Norway.
FAU - Portillo, Mari Carmen
AU  - Portillo MC
AUID- ORCID: 0000-0003-1583-6612
AD  - National Institute for Health Research Applied Research Collaboration Wessex, 
      Long Term Conditions, Southampton, UK.
AD  - Faculty of Environmental and Life Sciences, School of Health Sciences, University 
      of Southampton, Southampton, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221227
PL  - England
TA  - Health Expect
JT  - Health expectations : an international journal of public participation in health 
      care and health policy
JID - 9815926
SB  - IM
MH  - Humans
MH  - *Parkinson Disease/therapy
MH  - Qualitative Research
MH  - Caregivers
MH  - Health Personnel
MH  - Disease Management
PMC - PMC10010098
OTO - NOTNLM
OT  - health systems
OT  - healthcare utilization
OT  - integrated care
OT  - long-term conditions
OT  - patient and family carer involvement
OT  - professional perspective
OT  - resource optimization
COIS- The authors declare no conflict of interest.
EDAT- 2022/12/28 06:00
MHDA- 2023/03/15 06:00
CRDT- 2022/12/27 07:03
PHST- 2022/09/27 00:00 [revised]
PHST- 2022/05/04 00:00 [received]
PHST- 2022/12/09 00:00 [accepted]
PHST- 2022/12/28 06:00 [pubmed]
PHST- 2023/03/15 06:00 [medline]
PHST- 2022/12/27 07:03 [entrez]
AID - HEX13691 [pii]
AID - 10.1111/hex.13691 [doi]
PST - ppublish
SO  - Health Expect. 2023 Apr;26(2):670-682. doi: 10.1111/hex.13691. Epub 2022 Dec 27.

PMID- 36569128
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221227
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Inequalities in glycemic and multifactorial cardiovascular control of type 2 
      diabetes: The Heart Healthy Hoods study.
PG  - 966368
LID - 10.3389/fmed.2022.966368 [doi]
LID - 966368
AB  - AIM: This study aimed to analyze glycemic control and multifactorial 
      cardiovascular control targets in people with type 2 diabetes (T2DM) in primary 
      care according to sex and socioeconomic status (SES). MATERIALS AND METHODS: This 
      is an observational, cross-sectional, and multicenter study. We analyzed all the 
      patients with T2DMM aged between 40 and 75 years in Madrid city (113,265) through 
      electronic health records from 01 August 2017 to 31 July 2018. SES was defined by 
      an area-level socioeconomic index stratified by quintiles (1st quintile: more 
      affluent). OUTCOMES: Outcomes included glycemic control (HbA1c ≤ 7%), 3-factor 
      cardiovascular control [HbA1c ≤ 7%, blood pressure (BP), < 140/90 mmHg, LDL < 100 
      mg/ml] and 4-factor control [HbA1c ≤ 7%, blood pressure (BP) < 140/90 mmHg, LDL < 
      100 mg/ml, and BMI < 30 kg/m(2)]. Multilevel logistic regression models analyzed 
      factors associated with suboptimal glycemic control. RESULTS: In total 43.2% were 
      women. Glycemic control was achieved by 63% of patients (women: 64.2% vs. men: 
      62.4%). Being more deprived was associated with suboptimal glycemic control (OR: 
      1.20, 95% CI: 1.10-1.32); however, sex was not related (OR: 0.97, 95% CI: 
      0.94-1.01). The optimal 3-factor control target was reached by 10.3% of patients 
      (women: 9.3% vs. men: 11.2%), especially those in the 5th quintile of SES. The 
      4-factor control was achieved by 6.6% of the sample. In the 3-factor control 
      target, being women was related to the suboptimal 3-factor control target (OR: 
      1.26, 95% CI: 1.19- 1.34) but only belonging to SES 4th quintile was related to 
      the unachieved target (OR: 1.47, 95% CI: 1.04-2.07). CONCLUSION: Suboptimal 
      glycemic control was associated with being less affluent and suboptimal 3-factor 
      control target was associated with being women.
CI  - Copyright © 2022 Ares-Blanco, Polentinos-Castro, Rodríguez-Cabrera, Gullón, 
      Franco and del Cura-González.
FAU - Ares-Blanco, Sara
AU  - Ares-Blanco S
AD  - Federica Montseny Health Centre, Gerencia Asistencial Atención Primaria, Servicio 
      Madrileño de Salud, Madrid, Spain.
AD  - Medical Specialties and Public Health, School of Health Sciences, University Rey 
      Juan Carlos, Alcorcón, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
FAU - Polentinos-Castro, Elena
AU  - Polentinos-Castro E
AD  - Medical Specialties and Public Health, School of Health Sciences, University Rey 
      Juan Carlos, Alcorcón, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
AD  - Primary Care Research Unit, Gerencia de Atención Primaria, Servicio Madrileño de 
      Salud, Madrid, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC and RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Rodríguez-Cabrera, Francisco
AU  - Rodríguez-Cabrera F
AD  - Unidad Docente Medicina Preventiva y Salud Pública, National School of Public 
      Health, Madrid, Spain.
FAU - Gullón, Pedro
AU  - Gullón P
AD  - Public Health and Epidemiology Research Group, Universidad de Alcalá, Alcala de 
      Henares, Spain.
FAU - Franco, Manuel
AU  - Franco M
AD  - Public Health and Epidemiology Research Group, Universidad de Alcalá, Alcala de 
      Henares, Spain.
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, MD, United States.
FAU - Del Cura-González, Isabel
AU  - Del Cura-González I
AD  - Medical Specialties and Public Health, School of Health Sciences, University Rey 
      Juan Carlos, Alcorcón, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
AD  - Primary Care Research Unit, Gerencia de Atención Primaria, Servicio Madrileño de 
      Salud, Madrid, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC and RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221207
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9769119
OTO - NOTNLM
OT  - decision making
OT  - primary health care
OT  - sex
OT  - social determinants of health
OT  - type 2 diabetes
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/12/27 06:00
MHDA- 2022/12/27 06:01
CRDT- 2022/12/26 04:06
PHST- 2022/06/10 00:00 [received]
PHST- 2022/09/26 00:00 [accepted]
PHST- 2022/12/26 04:06 [entrez]
PHST- 2022/12/27 06:00 [pubmed]
PHST- 2022/12/27 06:01 [medline]
AID - 10.3389/fmed.2022.966368 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Dec 7;9:966368. doi: 10.3389/fmed.2022.966368. 
      eCollection 2022.

PMID- 36561857
OWN - NLM
STAT- MEDLINE
DCOM- 20221226
LR  - 20230127
IS  - 2296-2565 (Electronic)
IS  - 2296-2565 (Linking)
VI  - 10
DP  - 2022
TI  - Improving Initial Medication Adherence to cardiovascular disease and diabetes 
      treatments in primary care: Pilot trial of a complex intervention.
PG  - 1038138
LID - 10.3389/fpubh.2022.1038138 [doi]
LID - 1038138
AB  - INTRODUCTION: The Initial Medication Adherence (IMA) intervention is a 
      multidisciplinary and shared decision-making intervention to improve initial 
      medication adherence addressed to patients in need of new treatments for 
      cardiovascular diseases and diabetes in primary care (PC). This pilot study aims 
      to evaluate the feasibility and acceptability of the IMA intervention and the 
      feasibility of a cluster-RCT to assess the effectiveness and cost-effectiveness 
      of the intervention. METHODS: A 3-month pilot trial with an embedded process 
      evaluation was conducted in five PC centers in Catalonia (Spain). Electronic 
      health data were descriptively analyzed to test the availability and quality of 
      records of the trial outcomes (initiation, implementation, clinical parameters 
      and use of services). Recruitment and retention rates of professionals were 
      analyzed. Twenty-nine semi-structured interviews with professionals (general 
      practitioners, nurses, and community pharmacists) and patients were conducted to 
      assess the feasibility and acceptability of the intervention. Three discussion 
      groups with a total of fifteen patients were performed to review and redesign the 
      intervention decision aids. Qualitative data were thematically analyzed. RESULTS: 
      A total of 901 new treatments were prescribed to 604 patients. The proportion of 
      missing data in the electronic health records was up to 30% for use of services 
      and around 70% for clinical parameters 5 months before and after a new 
      prescription. Primary and secondary outcomes were within plausible ranges and 
      outliers were barely detected. The IMA intervention and its implementation 
      strategy were considered feasible and acceptable by pilot-study participants. Low 
      recruitment and retention rates, understanding of shared decision-making by 
      professionals, and format and content of decision aids were the main barriers to 
      the feasibility of the IMA intervention. DISCUSSION: Involving patients in the 
      decision-making process is crucial to achieving better clinical outcomes. The IMA 
      intervention is feasible and showed good acceptability among professionals and 
      patients. However, we identified barriers and facilitators to implementing the 
      intervention and adapting it to a context affected by the COVID-19 pandemic that 
      should be considered before launching a cluster-RCT. This pilot study identified 
      opportunities for refining the intervention and improving the design of the 
      definitive cluster-RCT to evaluate its effectiveness and cost-effectiveness. 
      CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, identifier NCT05094986.
CI  - Copyright © 2022 Corral-Partearroyo, Sánchez-Viñas, Gil-Girbau, Peñarrubia-María, 
      Aznar-Lou, Serrano-Blanco, Carbonell-Duacastella, Gallardo-González, 
      Olmos-Palenzuela and Rubio-Valera.
FAU - Corral-Partearroyo, Carmen
AU  - Corral-Partearroyo C
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Univ 
      Autonoma de Barcelona, Bellaterra, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
FAU - Sánchez-Viñas, Alba
AU  - Sánchez-Viñas A
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
AD  - Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, 
      Spain.
FAU - Gil-Girbau, Montserrat
AU  - Gil-Girbau M
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Peñarrubia-María, María Teresa
AU  - Peñarrubia-María MT
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
AD  - Primary Care Centre Bartomeu Fabrés Anglada, Direcció D'Atenció Primària Regió 
      Metropolitana Sud, Institut Català de la Salut, Barcelona, Spain.
AD  - Unitat de Suport a la Recerca Regió Metropolitana Sud, Fundació Institut 
      Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina 
      (IDIAPJGol), Barcelona, Spain.
FAU - Aznar-Lou, Ignacio
AU  - Aznar-Lou I
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
FAU - Serrano-Blanco, Antoni
AU  - Serrano-Blanco A
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
AD  - Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, 
      Spain.
AD  - Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
FAU - Carbonell-Duacastella, Cristina
AU  - Carbonell-Duacastella C
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
AD  - Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain.
FAU - Gallardo-González, Carmen
AU  - Gallardo-González C
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Primary Care Centre Bartomeu Fabrés Anglada, Direcció D'Atenció Primària Regió 
      Metropolitana Sud, Institut Català de la Salut, Barcelona, Spain.
AD  - Unitat de Suport a la Recerca Regió Metropolitana Sud, Fundació Institut 
      Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina 
      (IDIAPJGol), Barcelona, Spain.
FAU - Olmos-Palenzuela, Maria Del Carmen
AU  - Olmos-Palenzuela MDC
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Primary Care Centre Bartomeu Fabrés Anglada, Direcció D'Atenció Primària Regió 
      Metropolitana Sud, Institut Català de la Salut, Barcelona, Spain.
FAU - Rubio-Valera, Maria
AU  - Rubio-Valera M
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
AD  - Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en 
      Epidemiología y Salud Pública), Madrid, Spain.
AD  - Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT05094986
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221206
PL  - Switzerland
TA  - Front Public Health
JT  - Frontiers in public health
JID - 101616579
SB  - IM
MH  - Humans
MH  - Pilot Projects
MH  - *Cardiovascular Diseases/drug therapy
MH  - Pandemics
MH  - *COVID-19
MH  - *Diabetes Mellitus/drug therapy
MH  - Medication Adherence
MH  - Primary Health Care
PMC - PMC9764337
OTO - NOTNLM
OT  - complex intervention
OT  - feasibility study
OT  - medication adherence
OT  - pilot
OT  - primary care
OT  - shared decision-making (SDM)
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest. The handling editor declared a shared research network 
      (Research Network in Chronicity, Primary Care and Health Promotion RICAPPS) with 
      the authors MG-G, MO-P, and CG-G at the time of the review.
EDAT- 2022/12/24 06:00
MHDA- 2022/12/27 06:00
CRDT- 2022/12/23 02:37
PHST- 2022/09/06 00:00 [received]
PHST- 2022/11/10 00:00 [accepted]
PHST- 2022/12/23 02:37 [entrez]
PHST- 2022/12/24 06:00 [pubmed]
PHST- 2022/12/27 06:00 [medline]
AID - 10.3389/fpubh.2022.1038138 [doi]
PST - epublish
SO  - Front Public Health. 2022 Dec 6;10:1038138. doi: 10.3389/fpubh.2022.1038138. 
      eCollection 2022.

PMID- 36557324
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221227
IS  - 2218-1989 (Print)
IS  - 2218-1989 (Electronic)
IS  - 2218-1989 (Linking)
VI  - 12
IP  - 12
DP  - 2022 Dec 17
TI  - Efficacy of Different Modalities and Frequencies of Physical Exercise on Glucose 
      Control in People with Prediabetes (GLYCEX Randomised Trial).
LID - 10.3390/metabo12121286 [doi]
LID - 1286
AB  - To assess the efficacy of different modalities and frequencies of physical 
      exercise on glycaemic control in adults with prediabetes. A two-phase, parallel, 
      randomised, controlled clinical trial will be carried out, in 210 participants. 
      In phase 1, 120 participants will be randomized into four arms: (1) aerobic 
      exercise, (2) aerobic exercise combined with resistance, (3) high-intensity 
      intervallic exercise and (4) control group. In phase 2, 90 new participants will 
      be randomized into three arms, using the exercise modality that showed the best 
      glycaemic control in phase 1 in the following manner: (1) frequency of 5 
      days/week, (2) frequency of 3 days/week and (3) frequency of 2 days/week. The 
      control group (n = 30) will be included in phase 1 to evaluate the effect of any 
      type of intervention versus no intervention. Data collection will be performed at 
      baseline and after 15 weeks of follow up. Sociodemographic data, medication, 
      comorbidity, blood biochemical parameters, blood pressure, anthropometric 
      measurements, body composition, physical activity, sedentary lifestyle, diet, 
      smoking, alcohol consumption, quality of life and sleep questionnaires will be 
      collected. Physical activity, sedentary behaviour and sleep will be further 
      determined with an accelerometer, and continuous glycaemia will be determined 
      with a glycaemic monitor, both during seven days, at two time points. The main 
      dependent variable will be the reduction in the mean amplitude of glycaemic 
      excursions. The impact of these interventions on health will also be evaluated 
      through gene expression analysis in peripheral blood cells. The results of this 
      study will contribute to a better understanding of the mechanisms behind the 
      glucose response to physical exercise in a population with prediabetes as well as 
      improve physical exercise prescriptions for diabetes prevention. Increasing 
      glycaemic control in people with prediabetes through physical exercise offers an 
      opportunity to prevent diabetes and reduce associated comorbidities and health 
      costs.
FAU - Galmes-Panades, Aina M
AU  - Galmes-Panades AM
AUID- ORCID: 0000-0001-6977-9874
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Research group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07120 Palma, Spain.
AD  - Physical Activity and Sport Sciences Research Group (GICAFE), Institute for 
      Educational Research and Innovation (IRIE), University of the Balearic Islands, 
      07120 Palma, Spain.
FAU - Bennasar-Veny, Miquel
AU  - Bennasar-Veny M
AUID- ORCID: 0000-0003-1668-2141
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma, Spain.
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos 
      III, 28029 Madrid, Spain.
FAU - Oliver, Paula
AU  - Oliver P
AUID- ORCID: 0000-0002-7821-8806
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Nutrigenomics, Biomarkers and Risk Evaluation (NuBE) Group, University of the 
      Balearic Islands (UIB), 07120 Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
FAU - Garcia-Coll, Natalia
AU  - Garcia-Coll N
AD  - Research group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07120 Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
FAU - Chaplin, Alice
AU  - Chaplin A
AUID- ORCID: 0000-0003-0685-4237
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology 
      (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), 
      University Hospital Son Espases (HUSE), 07120 Palma, Spain.
FAU - Fresneda, Sergio
AU  - Fresneda S
AUID- ORCID: 0000-0002-1208-8981
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Research group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07120 Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
FAU - Gallardo-Alfaro, Laura
AU  - Gallardo-Alfaro L
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Health Research Institute of the Balearic Islands (IdISBa), 07003 
      Palma, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - García-Ruano, Carmen
AU  - García-Ruano C
AUID- ORCID: 0000-0001-5421-3296
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Nutrigenomics, Biomarkers and Risk Evaluation (NuBE) Group, University of the 
      Balearic Islands (UIB), 07120 Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
FAU - Konieczna, Jadwiga
AU  - Konieczna J
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology 
      (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), 
      University Hospital Son Espases (HUSE), 07120 Palma, Spain.
FAU - Leiva, Alfonso
AU  - Leiva A
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Health Research Institute of the Balearic Islands (IdISBa), 07003 
      Palma, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Masmiquel, Lluis
AU  - Masmiquel L
AUID- ORCID: 0000-0002-6549-5652
AD  - Vascular and Metabolic Diseases Research Group, Health Research Institute of the 
      Balearic Islands [IdISBa], 07120 Palma, Spain.
AD  - Endocrinology Department, Son Llàtzer University Hospital, 07005 Palma, Spain.
FAU - Pico, Catalina
AU  - Pico C
AUID- ORCID: 0000-0001-6759-5844
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Nutrigenomics, Biomarkers and Risk Evaluation (NuBE) Group, University of the 
      Balearic Islands (UIB), 07120 Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
FAU - Ricci-Cabello, Ignacio
AU  - Ricci-Cabello I
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos 
      III, 28029 Madrid, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Health Research Institute of the Balearic Islands (IdISBa), 07003 
      Palma, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
FAU - Romaguera, Dora
AU  - Romaguera D
AUID- ORCID: 0000-0002-5762-8558
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology 
      (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), 
      University Hospital Son Espases (HUSE), 07120 Palma, Spain.
FAU - Rivera, Rosmeri
AU  - Rivera R
AD  - Vascular and Metabolic Diseases Research Group, Health Research Institute of the 
      Balearic Islands [IdISBa], 07120 Palma, Spain.
AD  - Endocrinology Department, Son Llàtzer University Hospital, 07005 Palma, Spain.
FAU - Sanchis, Pilar
AU  - Sanchis P
AUID- ORCID: 0000-0001-8565-1811
AD  - CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud 
      Carlos III, 28029 Madrid, Spain.
AD  - Vascular and Metabolic Diseases Research Group, Health Research Institute of the 
      Balearic Islands [IdISBa], 07120 Palma, Spain.
AD  - Chemistry Department, University of Balearic Islands (UIB), 07120 Palma, Spain.
FAU - Vidal-Conti, Josep
AU  - Vidal-Conti J
AUID- ORCID: 0000-0003-4782-2178
AD  - Physical Activity and Sport Sciences Research Group (GICAFE), Institute for 
      Educational Research and Innovation (IRIE), University of the Balearic Islands, 
      07120 Palma, Spain.
AD  - Institute for Educational Research and Innovation (IRIE), University of the 
      Balearic Islands (UIB), 07122 Palma, Spain.
FAU - Yañez, Aina M
AU  - Yañez AM
AUID- ORCID: 0000-0001-8527-3937
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Research group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07120 Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221217
PL  - Switzerland
TA  - Metabolites
JT  - Metabolites
JID - 101578790
PMC - PMC9785307
OTO - NOTNLM
OT  - aerobic exercise
OT  - exercise
OT  - prediabetes
OT  - resistance training
OT  - type 2 diabetes
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses, or interpretation of data; in 
      the writing of the manuscript; or in the decision to publish the results.
EDAT- 2022/12/24 06:00
MHDA- 2022/12/24 06:01
CRDT- 2022/12/23 01:46
PHST- 2022/11/25 00:00 [received]
PHST- 2022/12/13 00:00 [revised]
PHST- 2022/12/14 00:00 [accepted]
PHST- 2022/12/23 01:46 [entrez]
PHST- 2022/12/24 06:00 [pubmed]
PHST- 2022/12/24 06:01 [medline]
AID - metabo12121286 [pii]
AID - metabolites-12-01286 [pii]
AID - 10.3390/metabo12121286 [doi]
PST - epublish
SO  - Metabolites. 2022 Dec 17;12(12):1286. doi: 10.3390/metabo12121286.

PMID- 36554679
OWN - NLM
STAT- MEDLINE
DCOM- 20221226
LR  - 20230120
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 24
DP  - 2022 Dec 14
TI  - Barriers and Facilitating Factors of Adherence to Antidepressant Treatments: An 
      Exploratory Qualitative Study with Patients and Psychiatrists.
LID - 10.3390/ijerph192416788 [doi]
LID - 16788
AB  - This study examines the experiences and expectations of patients with depressive 
      disorders regarding the disease and different antidepressants, as well as 
      examining the barriers and facilitating factors that could affect their adherence 
      to medications. An exploratory qualitative study was carried out. The study 
      involved two focus groups made up of patients and caregivers and six 
      semi-structured interviews with psychiatrists. In both cases, the participants 
      were selected by intentional theoretical sampling, seeking maximum significance 
      variation of social types. Prejudice about the side effects of medication was 
      relevant. The importance of patients being well informed about the 
      disease/treatments was noteworthy. The stigmatization of antidepressants by 
      patients was identified as a barrier to medication adherence. The involvement of 
      family members and the motivation of patients to be actively involved in the 
      process to recover from the disease were identified as facilitating factors. The 
      work carried out suggests the need for patients to have rigorous information 
      about the disease/treatment to reduce the possible prejudices generated by 
      beliefs. Maintaining greater contact and monitoring of patients/caregivers to 
      help therapeutic adherence in patients with depressive disorders was also 
      identified as being of great importance.
FAU - González de León, Beatriz
AU  - González de León B
AUID- ORCID: 0000-0001-5398-104X
AD  - Multiprofessional Teaching Unit of Family and Community Care La Laguna-Tenerife 
      Norte, Management of Primary Care of Tenerife, 38320 Santa Cruz de Tenerife, 
      Spain.
FAU - Abt-Sacks, Analía
AU  - Abt-Sacks A
AUID- ORCID: 0000-0001-7153-8586
AD  - Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
FAU - Acosta Artiles, Francisco Javier
AU  - Acosta Artiles FJ
AD  - Department of Mental Health, General Management of Healthcare Programs, Canary 
      Islands Health Service, 35071 Las Palmas de Gran Canaria, Spain.
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Department of Psychiatry, Insular University Hospital of Gran Canaria, 35016 Las 
      Palmas de Gran Canaria, Spain.
FAU - Del Pino-Sedeño, Tasmania
AU  - Del Pino-Sedeño T
AD  - Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AUID- ORCID: 0000-0002-9106-2420
AD  - Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
FAU - Rodríguez Álvarez, Cristobalina
AU  - Rodríguez Álvarez C
AUID- ORCID: 0000-0003-3553-3213
AD  - Department of Preventive Medicine and Public Health, University of La Laguna, 
      38071 Santa Cruz de Tenerife, Spain.
FAU - Bejarano-Quisoboni, Daniel
AU  - Bejarano-Quisoboni D
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Center for Public Health Research (CSISP-FISABIO), 46020 Valencia, Spain.
AD  - Institute of Biomedical Technologies, University of La Laguna, 38200 Santa Cruz 
      de Tenerife, Spain.
FAU - Trujillo-Martín, María M
AU  - Trujillo-Martín MM
AUID- ORCID: 0000-0003-2273-2192
AD  - Canary Islands Health Research Institute Foundation, 38320 Santa Cruz de 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Research Network on Health Services for Chronic Conditions (REDISSEC), Carlos III 
      Health Institute, 28029 Madrid, Spain.
AD  - Institute of Biomedical Technologies, University of La Laguna, 38200 Santa Cruz 
      de Tenerife, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221214
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
RN  - 0 (Antidepressive Agents)
SB  - IM
MH  - Humans
MH  - *Medication Adherence
MH  - Antidepressive Agents/therapeutic use
MH  - Caregivers
MH  - Qualitative Research
MH  - *Psychiatry
PMC - PMC9779577
OTO - NOTNLM
OT  - antidepressants
OT  - depressive disorders
OT  - medication adherence
OT  - qualitative research
COIS- The authors declare that they have no competing interest with the subject matter 
      or materials discussed in the manuscript.
EDAT- 2022/12/24 06:00
MHDA- 2022/12/27 06:00
CRDT- 2022/12/23 01:29
PHST- 2022/10/31 00:00 [received]
PHST- 2022/11/30 00:00 [revised]
PHST- 2022/12/10 00:00 [accepted]
PHST- 2022/12/23 01:29 [entrez]
PHST- 2022/12/24 06:00 [pubmed]
PHST- 2022/12/27 06:00 [medline]
AID - ijerph192416788 [pii]
AID - ijerph-19-16788 [pii]
AID - 10.3390/ijerph192416788 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Dec 14;19(24):16788. doi: 
      10.3390/ijerph192416788.

PMID- 36554508
OWN - NLM
STAT- MEDLINE
DCOM- 20221226
LR  - 20230123
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 24
DP  - 2022 Dec 10
TI  - The Impact of COVID-19 on Nursing Homes: Study Design and Population Description.
LID - 10.3390/ijerph192416629 [doi]
LID - 16629
AB  - Nursing homes for the elderly in Spain have experienced high rates of infection 
      and mortality from COVID-19, although rates have varied from one region to 
      another. Madrid is the region where most institutionalized older adults have died 
      from the coronavirus. However, there is little known about the psychosocial and 
      environmental factors involved in the high incidence of COVID-19 among the 
      institutionalised population in this region. This article describes the protocol 
      of a study on nursing homes during the SARS-CoV-2 pandemic in the Autonomous 
      Community of Madrid (hereafter: Region of Madrid or Madrid Region) and provides 
      information on the study design, measures used, and characteristics of the 
      population studied. A questionnaire about life in nursing homes during the 
      COVID-19 pandemic was designed and a total of 447 persons over 60 years of age 
      without cognitive impairment-220 in private nursing homes and 227 in public 
      nursing homes-participated by answering questions about different topics: 
      personal situations during the pandemic, feelings and methods of coping, 
      residential environment, health, quality of life, ageism, and self-perception of 
      ageing. The institutionalised person profile discussed in this study was an old 
      woman, widowed, without children, with a low level of education, with 
      multimorbidity, and who perceived her health and quality of life positively. Most 
      of the participants were very concerned about COVID-19 and its effects. In fact, 
      38% had been diagnosed with COVID-19, of whom 20% were admitted to hospital and 
      20% had suffered negative impacts, such as pain and neurological problems. In 
      addition, 70% of the residents remained confined to their rooms, which increased 
      their perceptions of loneliness and social isolation. The worst-rated aspects of 
      the nursing home resulted from the restrictive measures imposed on nursing homes 
      during the pandemic. This research offers useful material for understanding the 
      pandemic and its consequences from the perspective of the older institutionalised 
      population, which could provide insights for designing public policies.
FAU - Rodriguez-Rodriguez, Vicente
AU  - Rodriguez-Rodriguez V
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Rojo-Perez, Fermina
AU  - Rojo-Perez F
AUID- ORCID: 0000-0001-9935-2548
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Perez de Arenaza Escribano, Carmen
AU  - Perez de Arenaza Escribano C
AUID- ORCID: 0000-0002-4632-4583
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Molina-Martínez, María-Ángeles
AU  - Molina-Martínez MÁ
AD  - Departamento de Personalidad, Evaluación y Tratamiento Psicológico, Facultad de 
      Psicología, Universidad Nacional de Educación a Distancia (UNED), 28040 Madrid, 
      Spain.
FAU - Fernandez-Mayoralas, Gloria
AU  - Fernandez-Mayoralas G
AUID- ORCID: 0000-0002-1075-0812
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Sánchez-González, Diego
AU  - Sánchez-González D
AUID- ORCID: 0000-0002-4174-4546
AD  - Departamento de Geografía, Universidad Nacional de Educación a Distancia (UNED), 
      28040 Madrid, Spain.
FAU - Rojo-Abuin, Jose-Manuel
AU  - Rojo-Abuin JM
AD  - Unidad de Analisis Estadistico (UAE), CCHS, CSIC, 28037 Madrid, Spain.
FAU - Rodríguez-Blázquez, Carmen
AU  - Rodríguez-Blázquez C
AUID- ORCID: 0000-0003-3829-0675
AD  - National Epidemiology Centre, Carlos III Institute of Health, Network Centre for 
      Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28029 Madrid, 
      Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AUID- ORCID: 0000-0003-3935-962X
AD  - National Epidemiology Centre, Carlos III Institute of Health, Health Service 
      Research Network on Chronic Diseases (REDISSEC) and Research Network on 
      Chronicity, Primary Care and Health Promotion (RICAPPS), 28029 Madrid, Spain.
FAU - Martín García, Salomé
AU  - Martín García S
AD  - EULEN Servicios Sociosanitarios, 28023 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221210
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Female
MH  - Child
MH  - Aged
MH  - Middle Aged
MH  - *COVID-19/epidemiology
MH  - Homes for the Aged
MH  - Quality of Life
MH  - SARS-CoV-2
MH  - Pandemics
MH  - Nursing Homes
PMC - PMC9779101
OTO - NOTNLM
OT  - COVID-19
OT  - ageism
OT  - coping
OT  - feelings
OT  - mental health
OT  - nursing homes
OT  - perception
OT  - physical health
OT  - quality of life
OT  - residential environment
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; data collection, analysis or interpretation; writing of the 
      manuscript; or the decision to publish the results. EULEN Servicios Sanitarios 
      had no role in the design of the study; in the collection, analyses, or 
      interpretation of data; in the writing of the manuscript, or in the decision to 
      publish the results.
EDAT- 2022/12/24 06:00
MHDA- 2022/12/27 06:00
CRDT- 2022/12/23 01:27
PHST- 2022/10/27 00:00 [received]
PHST- 2022/11/30 00:00 [revised]
PHST- 2022/12/06 00:00 [accepted]
PHST- 2022/12/23 01:27 [entrez]
PHST- 2022/12/24 06:00 [pubmed]
PHST- 2022/12/27 06:00 [medline]
AID - ijerph192416629 [pii]
AID - ijerph-19-16629 [pii]
AID - 10.3390/ijerph192416629 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Dec 10;19(24):16629. doi: 
      10.3390/ijerph192416629.

PMID- 36547009
OWN - NLM
STAT- MEDLINE
DCOM- 20230203
LR  - 20230303
IS  - 2050-6414 (Electronic)
IS  - 2050-6406 (Print)
IS  - 2050-6406 (Linking)
VI  - 11
IP  - 1
DP  - 2023 Feb
TI  - Subclinical bowel inflammation increases healthcare resources utilization and 
      steroid use before diagnosis of inflammatory bowel disease.
PG  - 9-18
LID - 10.1002/ueg2.12352 [doi]
AB  - BACKGROUND: Previous data support that the inflammatory process underlying 
      ulcerative colitis (UC) and Crohn's disease (CD) can start years before the 
      diagnosis. The aim of this study was to determine if patients with an incidental 
      diagnosis of UC or CD demonstrate an increase in healthcare utilization in the 
      years preceding the symptomatic onset of the disease. METHODS: We performed a 
      multicenter, retrospective, hospital-based, case-control study. Patients with an 
      incidental diagnosis of UC or CD during the colorectal cancer screening program 
      at 9 hospitals were included. Cases were matched 1:3 and compared separately with 
      two control populations: one including healthy non-IBD subjects adjusted by 
      gender, age, and date, excluding those with visits to Gastroenterology; and a 
      second control cohort of UC/CD patients with symptomatic onset. RESULTS: A total 
      of 124 patients with preclinical inflammatory bowel disease (IBD) were included 
      (87 UC, 30 CD, 7 IBD unclassified; median age 56 years). Patients with 
      preclinical IBD showed an increase in the number of visits to Primary Care up to 
      3 and 5 years before diagnosis (aIRR 1.59, 95% CI [1.37-1.86], p = 0.001; aIRR 
      1.43, 95% CI [1.24-1.67], p = 0.01) and more frequent use of steroids (aOR 2.84, 
      95% CI [1.21-6.69], p = 0.03; aOR 2.25, 95% CI [1.06-4.79], p = 0.04) compared to 
      matched non-IBD healthy controls, respectively. In contrast, patients with a 
      symptomatic onset visited Primary Care less frequently, but they had an increase 
      in the number of visits to Emergency Department, specialist care, sick-leaves, 
      CT/ultrasound examinations, and use of antibiotics or systemic steroids. 
      CONCLUSIONS: There is an increased need for medical assistance and use of 
      systemic steroids during the presymptomatic phase of IBD. These results will help 
      in establishing new tools for early identification of IBD in the future.
CI  - © 2022 The Authors. United European Gastroenterology Journal published by Wiley 
      Periodicals LLC on behalf of United European Gastroenterology.
FAU - Rodríguez-Lago, Iago
AU  - Rodríguez-Lago I
AUID- ORCID: 0000-0003-1133-4578
AD  - Gastroenterology Department, Hospital Universitario de Galdakao, Biocruces 
      Bizkaia Health Research Institute, Deusto University, Galdakao, Spain.
FAU - Aguirre, Urko
AU  - Aguirre U
AUID- ORCID: 0000-0002-8049-3030
AD  - Research Unit, Hospital Universitario de Galdakao, Galdakao, Spain.
AD  - Research Network on Chronic Disease (REDISSEC), Network for Research on 
      Chronicity, Primary Care and Health Promotion (RICAPPS), Galdakao, Spain.
AD  - Deusto University, Galdakao, Spain.
FAU - Ramírez de la Piscina, Patricia
AU  - Ramírez de la Piscina P
AUID- ORCID: 0000-0001-9318-730X
AD  - Gastroenterology Department, Hospital Universitario Araba, Vitoria, Spain.
FAU - Muñagorri, Ana
AU  - Muñagorri A
AUID- ORCID: 0000-0001-5318-1317
AD  - Gastroenterology Department, Hospital Universitario Donostia, Donostia, Spain.
FAU - Zapata, Eva
AU  - Zapata E
AD  - Gastroenterology Department, Hospital de Mendaro, Mendaro, Spain.
FAU - Higuera, Rebeca
AU  - Higuera R
AUID- ORCID: 0000-0002-2818-998X
AD  - Gastroenterology Department, Hospital de Urduliz, Urduliz, Spain.
FAU - Montalvo, Isabel
AU  - Montalvo I
AD  - Gastroenterology Department, Onkologikoa, Donostia, Spain.
FAU - Iriarte, Ainara
AU  - Iriarte A
AUID- ORCID: 0000-0002-5642-2136
AD  - Gastroenterology Department, Hospital de Bidasoa, Hondarribia, Spain.
FAU - Fernández-Calderón, María
AU  - Fernández-Calderón M
AUID- ORCID: 0000-0001-9121-2794
AD  - Gastroenterology Department, Hospital de Mondragón, Mondragón, Spain.
FAU - Arreba, Paz
AU  - Arreba P
AUID- ORCID: 0000-0002-0027-5181
AD  - Gastroenterology Department, Hospital Universitario de Basurto, Bilbao, Spain.
FAU - Carrascosa, Juan
AU  - Carrascosa J
AUID- ORCID: 0000-0002-1024-4709
AD  - Gastroenterology Department, Hospital de Zumárraga, Zumárraga, Spain.
FAU - Cabriada, José Luis
AU  - Cabriada JL
AUID- ORCID: 0000-0002-3068-5659
AD  - Gastroenterology Department, Hospital Universitario de Galdakao, Biocruces 
      Bizkaia Health Research Institute, Deusto University, Galdakao, Spain.
FAU - Barreiro-de Acosta, Manuel
AU  - Barreiro-de Acosta M
AUID- ORCID: 0000-0001-5915-1477
AD  - Gastroenterology Department, Hospital Clínico Universitario de Santiago, Santiago 
      de Compostela, Spain.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20221222
PL  - England
TA  - United European Gastroenterol J
JT  - United European gastroenterology journal
JID - 101606807
SB  - IM
CIN - United European Gastroenterol J. 2023 Feb;11(1):5-6. PMID: 36650633
MH  - Humans
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Case-Control Studies
MH  - *Inflammatory Bowel Diseases/diagnosis/epidemiology
MH  - *Colitis, Ulcerative/diagnosis/drug therapy
MH  - *Crohn Disease/diagnosis
MH  - Inflammation
MH  - Patient Acceptance of Health Care
PMC - PMC9892483
OTO - NOTNLM
OT  - Crohn's disease
OT  - diagnostic tests
OT  - early
OT  - primary care
OT  - ulcerative colitis
COIS- Iago Rodríguez‐Lago has received financial support for travelling and educational 
      activities or has served as an advisory board member for MSD, Pfizer, Abbvie, 
      Takeda, Janssen, Tillotts Pharma, Kern, Celltrion, Roche, Ferring, Dr. Falk 
      Pharma, Galapagos, Otsuka Pharmaceutical and Adacyte. Financial support for 
      research from Tillotts Pharma. Rebeca Higuera received financial support for 
      travelling and educational activities or has served as an advisory board member 
      for MSD, Pfizer, Abbvie, Takeda, Janssen, Tillotts Pharma, Ferring, Chiesi, Dr. 
      Falk Pharma and Shire. Manuel Barreiro‐de Acosta has received financial support 
      for travelling and educational activities or has served as an advisory board 
      member for Pfizer, MSD, Takeda, AbbVie, Kern, Janssen, Fresenius Kabi, Biogen, 
      Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Chiesi, Gebro 
      Pharma, Otsuka Pharmaceuticals, and Tillotts Pharma. The remaining authors 
      declare no conflicts of interest.
EDAT- 2022/12/23 06:00
MHDA- 2023/02/04 06:00
CRDT- 2022/12/22 09:44
PHST- 2022/08/10 00:00 [received]
PHST- 2022/11/17 00:00 [accepted]
PHST- 2022/12/23 06:00 [pubmed]
PHST- 2023/02/04 06:00 [medline]
PHST- 2022/12/22 09:44 [entrez]
AID - UEG212352 [pii]
AID - 10.1002/ueg2.12352 [doi]
PST - ppublish
SO  - United European Gastroenterol J. 2023 Feb;11(1):9-18. doi: 10.1002/ueg2.12352. 
      Epub 2022 Dec 22.

PMID- 36533004
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221222
IS  - 1664-1078 (Print)
IS  - 1664-1078 (Electronic)
IS  - 1664-1078 (Linking)
VI  - 13
DP  - 2022
TI  - The role of aggression and maladjustment in the teacher-student relationship on 
      burnout in secondary school teachers.
PG  - 1059899
LID - 10.3389/fpsyg.2022.1059899 [doi]
LID - 1059899
AB  - INTRODUCTION: Multiple studies have examined the individual and socio-demographic 
      variables that can contribute to the development of burnout in teachers. Although 
      the evidence supports that this syndrome is generated through the interaction 
      between the aspects of the organization and those of the person, little attention 
      has been spent on the impact of the teacher-student relationship adjustment and, 
      especially, on the role of violence exercised by students or their families 
      toward secondary school teachers, who seem to be more vulnerable than teaching 
      professionals in general. OBJECTIVE: To analyze the role of the possible mismatch 
      in the student-teacher relationship, as well as, the physical and verbal violence 
      toward teachers from pupils or their parents, on the professional wear of high 
      school educators. MATERIALS AND METHODS: A cross-sectional study was carried out 
      on a teacher sample (n = 677) in Aragón, Spain, through a questionnaire with 
      socio-demographic data; the "Maslach Burnout Inventory" (MBI), "Areas of Worklife 
      Scale," the "Fears and Rejection in Education Questionnaire" (FREQ), and a list 
      of the possible aggressions received in the development of the teaching activity. 
      RESULTS: While 3.8% of teachers have been a victim of physical attacks, 34.9% 
      have suffered verbal abuse at least once. Although physical violence is extremely 
      rare (and low intensity), verbal victimization or threats are associated with 
      burnout in a highly significant manner, which confirms previous findings about 
      school violence and burnout. Also, FEAR and REJECTION dimensions, defined as 
      discomfort, tension, anxiety, and pressure caused by pupils, which contributed 
      considerably on two dimensions of burnout (emotional exhaustion and cynicism). 
      Different covariates such as maladjustment in the teacher-pupil relationship, 
      violence experienced at work, and complaints received explain the 56.4% variance 
      of exhaustion, 48.8% variance in cynicism, and 35.5% for efficacy. CONCLUSION: 
      Very different variables can contribute to the development of burnout syndrome, 
      both personal, and organizational variables. Therefore, when designing prevention 
      programs in each work environment, the possible areas of risk and the 
      interactions between them must be considered.
CI  - Copyright © 2022 Masluk, Gascón-Santos, Oliván-Blázquez, Bartolomé-Moreno, 
      Albesa, Alda and Magallón-Botaya.
FAU - Masluk, Barbara
AU  - Masluk B
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Preventive Activities and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Gascón-Santos, Santiago
AU  - Gascón-Santos S
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Preventive Activities and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Preventive Activities and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Bartolomé-Moreno, Cruz
AU  - Bartolomé-Moreno C
AD  - Research Network on Preventive Activities and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Aragón Health Service, Government of Aragón, Zaragoza, Spain.
FAU - Albesa, Agustín
AU  - Albesa A
AD  - Research Network on Preventive Activities and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Alda, Marta
AU  - Alda M
AD  - Institute of Health Research of Aragón (IIS Aragón), Miguel Servet University 
      Hospital, Zaragoza, Spain.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Research Network on Preventive Activities and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Aragón Health Service, Government of Aragón, Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221124
PL  - Switzerland
TA  - Front Psychol
JT  - Frontiers in psychology
JID - 101550902
PMC - PMC9756840
OTO - NOTNLM
OT  - adjustment in teacher-student relationship
OT  - burnout
OT  - compulsory education
OT  - secondary school teachers
OT  - violence
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/12/20 06:00
MHDA- 2022/12/20 06:01
CRDT- 2022/12/19 04:27
PHST- 2022/10/02 00:00 [received]
PHST- 2022/11/03 00:00 [accepted]
PHST- 2022/12/19 04:27 [entrez]
PHST- 2022/12/20 06:00 [pubmed]
PHST- 2022/12/20 06:01 [medline]
AID - 10.3389/fpsyg.2022.1059899 [doi]
PST - epublish
SO  - Front Psychol. 2022 Nov 24;13:1059899. doi: 10.3389/fpsyg.2022.1059899. 
      eCollection 2022.

PMID- 36507542
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221221
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Multicomponent, high-intensity, and patient-centered care intervention for 
      complex patients in transitional care: SPICA program.
PG  - 1033689
LID - 10.3389/fmed.2022.1033689 [doi]
LID - 1033689
AB  - Multimorbidity is increasingly present in our environment. Besides, this is 
      accompanied by a deterioration of social and environmental conditions and affects 
      the self-care ability and access to health resources, worsening health outcomes 
      and determining a greater complexity of care. Different multidisciplinary and 
      multicomponent programs have been proposed for the care of complex patients 
      around hospital discharge, and patient-centered coordination models may lead to 
      better results than the traditional ones for this type of patient. However, 
      programs with these characteristics have not been systematically implemented in 
      our country, despite the positive results obtained. Hospital Universitario de 
      Canarias cares for patients from the northern area of Tenerife and La Palma, 
      Spain. In this hospital, a multicomponent and high-intensity care program is 
      carried out by a multidisciplinary team (made up of family doctors and nurses 
      together with social workers) with complex patients in the transition of care 
      (SPICA program). The aim of this program is to guarantee social and family 
      reintegration and improve the continuity of primary healthcare for discharged 
      patients, following the patient-centered clinical method. Implementing 
      multidisciplinary and high-intensity programs would improve clinical outcomes and 
      would be cost-effective. This kind of program is directly related to the current 
      clinical governance directions. In addition, as the SPICA program is integrated 
      into a Family and Community Care Teaching Unit for the training of both 
      specialist doctors and specialist nurses, it becomes a place where the specific 
      methodology of those specialties can be carried out in transitional care. During 
      these 22 years of implementation, its continuous quality management system has 
      allowed it to generate an important learning curve and incorporate constant 
      improvements in its work processes and procedures. Currently, research projects 
      are planned to reevaluate the effectiveness of individualized care plans and the 
      cost-effectiveness of the program.
CI  - Copyright © 2022 García-Hernández, González de León, Barreto-Cruz and 
      Vázquez-Díaz.
FAU - García-Hernández, Miguel
AU  - García-Hernández M
AD  - Unidad Docente de Atención Familiar y Comunitaria La Laguna-Tenerife Norte, 
      Gerencia de Atención Primaria del Área de Salud de Tenerife, Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - González de León, Beatriz
AU  - González de León B
AD  - Unidad Docente de Atención Familiar y Comunitaria La Laguna-Tenerife Norte, 
      Gerencia de Atención Primaria del Área de Salud de Tenerife, Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Barreto-Cruz, Silvia
AU  - Barreto-Cruz S
AD  - Unidad Docente de Atención Familiar y Comunitaria La Laguna-Tenerife Norte, 
      Gerencia de Atención Primaria del Área de Salud de Tenerife, Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Vázquez-Díaz, José Ramón
AU  - Vázquez-Díaz JR
AD  - Unidad Docente de Atención Familiar y Comunitaria La Laguna-Tenerife Norte, 
      Gerencia de Atención Primaria del Área de Salud de Tenerife, Santa Cruz de 
      Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221124
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9729702
OTO - NOTNLM
OT  - family practice
OT  - internship and residency
OT  - multimorbidity
OT  - patient care management
OT  - patient discharge
OT  - patient-centered care
OT  - primary health care
OT  - transitional care
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/12/13 06:00
MHDA- 2022/12/13 06:01
CRDT- 2022/12/12 11:38
PHST- 2022/08/31 00:00 [received]
PHST- 2022/11/01 00:00 [accepted]
PHST- 2022/12/12 11:38 [entrez]
PHST- 2022/12/13 06:00 [pubmed]
PHST- 2022/12/13 06:01 [medline]
AID - 10.3389/fmed.2022.1033689 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Nov 24;9:1033689. doi: 10.3389/fmed.2022.1033689. 
      eCollection 2022.

PMID- 36498426
OWN - NLM
STAT- MEDLINE
DCOM- 20221216
LR  - 20221221
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 23
DP  - 2022 Dec 6
TI  - Residential Environment Assessment by Older Adults in Nursing Homes during 
      COVID-19 Outbreak.
LID - 10.3390/ijerph192316354 [doi]
LID - 16354
AB  - The most vulnerable residential settings during the COVID-19 pandemic were older 
      adult's nursing homes, which experienced high rates of incidence and death from 
      this cause. This paper aims to ascertain how institutionalized older people 
      assessed their residential environment during the pandemic and to examine the 
      differences according to personal and contextual characteristics. The COVID-19 
      Nursing Homes Survey (Madrid region, Spain) was used. The residential environment 
      assessment scale (EVAER) and personal and contextual characteristics were 
      selected. Descriptive and multivariate statistical analysis were applied. The 
      sample consisted of 447 people (mean age = 83.8, 63.1% = women, 50.8% = widowed, 
      40% = less than primary studies). Four residential assessment subscales 
      (relationships, mobility, residential aspects, privacy space) and three clusters 
      according to residential rating (medium-high with everything = 71.5% of cases, 
      low with mobility = 15.4%, low with everything = 13.1%) were obtained. The 
      logistic regression models for each cluster category showed to be statistically 
      significant. Showing a positive affect (OR = 1.08), fear of COVID-19 (OR = 1.06), 
      high quality of life (OR = 1.05), not having suspicion of depression (OR = 0.75) 
      and performing volunteer activities (OR = 3.67) were associated with the largest 
      cluster. It is concluded that a better residential evaluation was related to more 
      favourable personal and contextual conditions. These results can help in the 
      design of nursing homes for older adults in need of accommodation and care to 
      facilitate an age-friendly environment.
FAU - Rojo-Perez, Fermina
AU  - Rojo-Perez F
AUID- ORCID: 0000-0001-9935-2548
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Rodriguez-Rodriguez, Vicente
AU  - Rodriguez-Rodriguez V
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Fernandez-Mayoralas, Gloria
AU  - Fernandez-Mayoralas G
AUID- ORCID: 0000-0002-1075-0812
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Sánchez-González, Diego
AU  - Sánchez-González D
AUID- ORCID: 0000-0002-4174-4546
AD  - Department of Geography, National Distance Education University (UNED), 28040 
      Madrid, Spain.
FAU - Perez de Arenaza Escribano, Carmen
AU  - Perez de Arenaza Escribano C
AD  - Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, 
      Spain.
FAU - Rojo-Abuin, Jose-Manuel
AU  - Rojo-Abuin JM
AD  - Unidad de Analisis Estadistico (UAE), CCHS, CSIC, 28037 Madrid, Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AUID- ORCID: 0000-0003-3935-962X
AD  - National Centre of Epidemiology and Health Service Research Network on Chronic 
      Diseases (REDISSEC) and Research Network on Chronicity, Primary Care and Health 
      Promotion (RICAPPS), Carlos III Institute of Health, 28029 Madrid, Spain.
FAU - Molina-Martínez, María-Ángeles
AU  - Molina-Martínez MÁ
AD  - Department of Personality, Evaluation and Psychological Treatment, Faculty of 
      Psychology, National Distance Education University (UNED), 28040 Madrid, Spain.
FAU - Rodriguez-Blazquez, Carmen
AU  - Rodriguez-Blazquez C
AUID- ORCID: 0000-0003-3829-0675
AD  - National Centre of Epidemiology and Network Centre for Biomedical Research in 
      Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, 28029 
      Madrid, Spain.
LA  - eng
GR  - 202010E158 and SGL2103055/CSIC COVID-19 Research AIDS (Urgent Measures to address 
      the Economic and Social Impact of COVID-19. PTI+ Global Health, CSIC Next 
      Generation Funding (REC_EU)./
PT  - Journal Article
DEP - 20221206
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Female
MH  - Humans
MH  - Aged
MH  - *Pandemics
MH  - *COVID-19/epidemiology
MH  - Quality of Life
MH  - Nursing Homes
MH  - Environment
PMC - PMC9739633
OTO - NOTNLM
OT  - COVID-19
OT  - Madrid region
OT  - Spain
OT  - long-term care settings
OT  - older adults
OT  - residential assessment
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses, or interpretation of data; in 
      the writing of the manuscript; or in the decision to publish the results.
EDAT- 2022/12/12 06:00
MHDA- 2022/12/15 06:00
CRDT- 2022/12/11 01:12
PHST- 2022/10/25 00:00 [received]
PHST- 2022/11/29 00:00 [revised]
PHST- 2022/12/01 00:00 [accepted]
PHST- 2022/12/11 01:12 [entrez]
PHST- 2022/12/12 06:00 [pubmed]
PHST- 2022/12/15 06:00 [medline]
AID - ijerph192316354 [pii]
AID - ijerph-19-16354 [pii]
AID - 10.3390/ijerph192316354 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Dec 6;19(23):16354. doi: 
      10.3390/ijerph192316354.

PMID- 36498256
OWN - NLM
STAT- MEDLINE
DCOM- 20221216
LR  - 20230308
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 23
DP  - 2022 Dec 3
TI  - Validation of the Spanish Version of the Fear of COVID-19 Scale (FCV-19S) in 
      Long-Term Care Settings.
LID - 10.3390/ijerph192316183 [doi]
LID - 16183
AB  - Fear of coronavirus disease 2019 (COVID-19) is one of the main psychological 
      impacts of the actual pandemic, especially among the population groups with 
      higher mortality rates. The Fear of COVID-19 Scale (FCV-19S) has been used in 
      different scenarios to assess fear associated with COVID-19, but this has not 
      been done frequently in people living in long-term care (LTC) settings. The 
      present study is aimed at measuring the psychometric properties of the Spanish 
      version of the FCV-19S in residents in LTC settings, following both the classical 
      test theory (CTT) and Rasch model frameworks. The participants (n = 447), aged 60 
      years or older, were asked to complete the FCV-19S and to report, among other 
      issues, their levels of depression, resilience, emotional wellbeing and 
      health-related quality of life with validated scales. The mean FCV-19S score was 
      18.36 (SD 8.28, range 7−35), with higher scores for women, participants with 
      lower education (primary or less) and higher adherence to preventive measures 
      (all, p < 0.05). The Cronbach’s alpha for the FCV-19S was 0.94. After eliminating 
      two items due to a lack of fit, the FCV-19S showed a good fit to the Rasch model 
      (χ2 (20) = 30.24, p = 0.019, PSI = 0.87), with unidimensionality (binomial 95% CI 
      0.001 to 0.045) and item local independency. Question 5 showed differential item 
      functioning by sex. The present study shows that the FCV-19S has satisfactory 
      reliability and validity, which supports its use to effectively measure fear in 
      older people living in LTC settings. This tool could help identify risk groups 
      that may need specific health education and effective communication strategies to 
      lower fear levels. This might have a beneficial impact on adherence to preventive 
      measures.
FAU - Cárdenas Soriano, Pilar
AU  - Cárdenas Soriano P
AD  - Department of Preventive Medicine, University Hospital of Albacete, ES-02006 
      Albacete, Spain.
FAU - Rodriguez-Blazquez, Carmen
AU  - Rodriguez-Blazquez C
AUID- ORCID: 0000-0003-3829-0675
AD  - National Centre of Epidemiology and Network Centre for Biomedical Research in 
      Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, ES-28029 
      Madrid, Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AUID- ORCID: 0000-0003-3935-962X
AD  - National Centre of Epidemiology and Health Service Research Network on Chronic 
      Diseases (REDISSEC) and Research Network on Chronicity, Primary Care and Health 
      Promotion (RICAPPS), Carlos III Institute of Health, ES-28029 Madrid, Spain.
FAU - Ayala, Alba
AU  - Ayala A
AUID- ORCID: 0000-0003-4855-4443
AD  - Department of Statistics, University Carlos III of Madrid, and Health Service 
      Research Network on Chronic Diseases (REDISSEC), Carlos III Institute of Health, 
      ES-28029 Madrid, Spain.
FAU - Rojo-Perez, Fermina
AU  - Rojo-Perez F
AUID- ORCID: 0000-0001-9935-2548
AD  - Grupo de Investigacion Sobre Envejecimiento (GIE), IEGD, CSIC, ES-28037 Madrid, 
      Spain.
FAU - Fernandez-Mayoralas, Gloria
AU  - Fernandez-Mayoralas G
AUID- ORCID: 0000-0002-1075-0812
AD  - Grupo de Investigacion Sobre Envejecimiento (GIE), IEGD, CSIC, ES-28037 Madrid, 
      Spain.
FAU - Molina-Martinez, Maria-Angeles
AU  - Molina-Martinez MA
AD  - Faculty of Psychology, National University of Distance Education (UNED), ES-28037 
      Madrid, Spain.
FAU - de Arenaza Escribano, Carmen Perez
AU  - de Arenaza Escribano CP
AD  - Grupo de Investigacion Sobre Envejecimiento (GIE), IEGD, CSIC, ES-28037 Madrid, 
      Spain.
FAU - Rodriguez-Rodriguez, Vicente
AU  - Rodriguez-Rodriguez V
AD  - Grupo de Investigacion Sobre Envejecimiento (GIE), IEGD, CSIC, ES-28037 Madrid, 
      Spain.
LA  - eng
GR  - 202010E158/CSIC COVID-19 Research AIDS (Urgent Measures to address the Economic 
      and Social Impact of COVID-19/
GR  - SGL2103055/PTI+ Global Health, CSIC Next Generation Funding (REC_EU)/
GR  - H2019/HUM-5698/R&amp;D Activities Program between research groups, funded by the 
      Madrid Region and the Euro-pean Social Fund, ENCAGEn-CM: "Active Ageing, Quality 
      of Life and Gender"/
PT  - Journal Article
DEP - 20221203
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Female
MH  - Humans
MH  - Aged
MH  - *Long-Term Care
MH  - *COVID-19/epidemiology
MH  - Quality of Life
MH  - Reproducibility of Results
MH  - Fear
PMC - PMC9741095
OTO - NOTNLM
OT  - COVID-19
OT  - Fear of COVID-19 Scale (FCV-19S)
OT  - Rasch analysis
OT  - classical test theory
OT  - fear
OT  - long-term care
OT  - older people
OT  - psychometric properties
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study, in the collection, analyses, or interpretation of the data, 
      in the writing of the manuscript or in the decision to publish the results.
EDAT- 2022/12/12 06:00
MHDA- 2022/12/15 06:00
CRDT- 2022/12/11 01:11
PHST- 2022/10/26 00:00 [received]
PHST- 2022/11/29 00:00 [revised]
PHST- 2022/12/01 00:00 [accepted]
PHST- 2022/12/11 01:11 [entrez]
PHST- 2022/12/12 06:00 [pubmed]
PHST- 2022/12/15 06:00 [medline]
AID - ijerph192316183 [pii]
AID - ijerph-19-16183 [pii]
AID - 10.3390/ijerph192316183 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Dec 3;19(23):16183. doi: 
      10.3390/ijerph192316183.

PMID- 36497976
OWN - NLM
STAT- MEDLINE
DCOM- 20221219
LR  - 20221222
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 23
DP  - 2022 Nov 29
TI  - Comprehensive Multimorbidity Patterns in Older Patients Are Associated with 
      Quality Indicators of Medication-MoPIM Cohort Study.
LID - 10.3390/ijerph192315902 [doi]
LID - 15902
AB  - Multimorbidity is increasing and poses a challenge to the clinical management of 
      patients with multiple conditions and drug prescriptions. The objectives of this 
      work are to evaluate if multimorbidity patterns are associated with quality 
      indicators of medication: potentially inappropriate prescribing (PIP) or adverse 
      drug reactions (ADRs). A multicentre prospective cohort study was conducted 
      including 740 older (≥65 years) patients hospitalised due to chronic pathology 
      exacerbation. Sociodemographic, clinical and medication related variables 
      (polypharmacy, PIP according to STOPP/START criteria, ADRs) were collected. 
      Bivariate analyses were performed comparing previously identified multimorbidity 
      clusters (osteoarticular, psychogeriatric, minor chronic disease, 
      cardiorespiratory) to presence, number or specific types of PIP or ADRs. 
      Significant associations were found in all clusters. The osteoarticular cluster 
      presented the highest prevalence of PIP (94.9%) and ADRs (48.2%), mostly related 
      to anxiolytics and antihypertensives, followed by the minor chronic disease 
      cluster, associated with ADRs caused by antihypertensives and insulin. The 
      psychogeriatric cluster presented PIP and ADRs of neuroleptics and the 
      cardiorespiratory cluster indicators were better overall. In conclusion, the 
      associations that were found reinforce the existence of multimorbidity patterns 
      and support specific medication review actions according to each patient profile. 
      Thus, determining the relationship between multimorbidity profiles and quality 
      indicators of medication could help optimise healthcare processes. Trial 
      registration number: NCT02830425.
FAU - Lleal, Marina
AU  - Lleal M
AUID- ORCID: 0000-0002-0015-0725
AD  - Institutional Committee for the Improvement of Clinical Practice Adequacy, 
      Clinical Epidemiology and Cancer Screening Department, Parc Taulí Hospital 
      Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 
      Sabadell, Catalonia, Spain.
AD  - Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine and 
      Public Health, Autonomous University of Barcelona (UAB), 08193 Bellaterra, 
      Catalonia, Spain.
FAU - Baré, Marisa
AU  - Baré M
AUID- ORCID: 0000-0001-8085-2833
AD  - Institutional Committee for the Improvement of Clinical Practice Adequacy, 
      Clinical Epidemiology and Cancer Screening Department, Parc Taulí Hospital 
      Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 
      Sabadell, Catalonia, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, 28029 Madrid, Spain.
FAU - Ortonobes, Sara
AU  - Ortonobes S
AD  - Pharmacy Department, Parc Taulí Hospital Universitari, Institut d'Investigació i 
      Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
FAU - Sevilla-Sánchez, Daniel
AU  - Sevilla-Sánchez D
AUID- ORCID: 0000-0003-2993-6200
AD  - Pharmacy Department, Parc Sanitari Pere Virgili, 08023 Barcelona, Catalonia, 
      Spain.
FAU - Jordana, Rosa
AU  - Jordana R
AD  - Internal Medicine Department, Parc Taulí Hospital Universitari, Institut 
      d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
FAU - Herranz, Susana
AU  - Herranz S
AD  - Acute Care Geriatric Unit, Parc Taulí Hospital Universitari, Institut 
      d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
FAU - Gorgas, Maria Queralt
AU  - Gorgas MQ
AD  - Pharmacy Department, Parc Taulí Hospital Universitari, Institut d'Investigació i 
      Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain.
FAU - Espaulella-Ferrer, Mariona
AU  - Espaulella-Ferrer M
AUID- ORCID: 0000-0003-3416-7792
AD  - Geriatrics Department, Consorci Hospitalari de Vic, 08500 Vic, Catalonia, Spain.
FAU - Arellano, Marta
AU  - Arellano M
AD  - Geriatrics Department, Consorci Parc de Salut MAR, 08003 Barcelona, Catalonia, 
      Spain.
FAU - de Antonio, Marta
AU  - de Antonio M
AD  - Pharmacy Department, Consorci Parc de Salut MAR, 08003 Barcelona, Catalonia, 
      Spain.
FAU - Nazco, Gloria Julia
AU  - Nazco GJ
AD  - Pharmacy Department, Hospital Universitario de Canarias, 38320 La Laguna, 
      Canarias, Spain.
FAU - Hernández-Luis, Rubén
AU  - Hernández-Luis R
AD  - Internal Medicine Department, Hospital Universitario de Canarias, 38320 La 
      Laguna, Canarias, Spain.
FAU - On Behalf Of The MoPIM Study Group
AU  - On Behalf Of The MoPIM Study Group
LA  - eng
SI  - ClinicalTrials.gov/NCT02830425
GR  - PI15/00552/Instituto de Salud Carlos III/
GR  - RD16/0001/0002/Network for Research into Healthcare in Chronic Diseases 
      (REDISSEC)/
PT  - Clinical Study
PT  - Journal Article
PT  - Multicenter Study
DEP - 20221129
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Aged
MH  - Humans
MH  - Chronic Disease
MH  - Cohort Studies
MH  - *Drug-Related Side Effects and Adverse Reactions/epidemiology
MH  - Inappropriate Prescribing
MH  - Multimorbidity
MH  - Potentially Inappropriate Medication List
MH  - Prospective Studies
MH  - *Quality Indicators, Health Care
PMC - PMC9739326
OTO - NOTNLM
OT  - adverse drug reaction
OT  - cluster analysis
OT  - healthcare quality indicator
OT  - multimorbidity
OT  - older patient
OT  - polypharmacy
OT  - potential prescribing omission
OT  - potentially inappropriate medication
COIS- The authors declare no conflict of interest.
EDAT- 2022/12/12 06:00
MHDA- 2022/12/15 06:00
CRDT- 2022/12/11 01:09
PHST- 2022/11/04 00:00 [received]
PHST- 2022/11/22 00:00 [revised]
PHST- 2022/11/23 00:00 [accepted]
PHST- 2022/12/11 01:09 [entrez]
PHST- 2022/12/12 06:00 [pubmed]
PHST- 2022/12/15 06:00 [medline]
AID - ijerph192315902 [pii]
AID - ijerph-19-15902 [pii]
AID - 10.3390/ijerph192315902 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Nov 29;19(23):15902. doi: 
      10.3390/ijerph192315902.

PMID- 36497572
OWN - NLM
STAT- MEDLINE
DCOM- 20221216
LR  - 20230120
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 23
DP  - 2022 Nov 23
TI  - Factors Influencing eHealth Literacy among Spanish Primary Healthcare Users: 
      Cross-Sectional Study.
LID - 10.3390/ijerph192315497 [doi]
LID - 15497
AB  - BACKGROUND: Adequate eHealth literacy levels empower people to make informed 
      decisions, enhancing their autonomy. The current study assessed a group using 
      primary care services for their eHealth literacy and examined its relationship 
      with sociodemographic characteristics. METHODS: Adult patients in need of primary 
      care nursing services participated in this cross-sectional study, which was 
      carried out in a healthcare center in the Madrid region of Spain. Through 
      systematic random sampling, 166 participants were chosen for the study. The 
      eHealth Literacy Questionnaire was used to assess eHealth literacy (eHLQ). 
      RESULTS: The studied population showed higher eHealth literacy scores in 
      dimensions 2 ("understanding of health concepts and language") and 4 ("feel safe 
      and in control"); the lowest scores were recorded for dimensions 1 ("using 
      technology to process health information"), 3 ("ability to actively engage with 
      digital services"), and 7 ("digital services that suit individual needs"). People 
      with completed secondary education and a better-perceived health status who were 
      younger and employed showed a higher level of eHealth literacy. CONCLUSIONS: The 
      findings advance our knowledge of the variables affecting eHealth literacy. We 
      may be able to understand patients' needs and provide them with greater support 
      if we can pinpoint the areas where they demonstrate the lowest eHealth literacy.
FAU - García-García, David
AU  - García-García D
AUID- ORCID: 0000-0003-0898-9565
AD  - Nursing Primary Health Care Service of Madrid, 28004 Madrid, Spain.
FAU - Ajejas Bazán, María Julia
AU  - Ajejas Bazán MJ
AUID- ORCID: 0000-0001-5343-3377
AD  - Academia Central de la Defensa, Escuela Militar de Sanidad, Ministerio de 
      Defensa, 28040 Madrid, Spain.
AD  - Grupo de Investigación UCM "Salud Pública-Estilos de Vida, Metodología Enfermera 
      y Cuidados en el Entorno Comunitario", Departamento de Enfermería, Facultad de 
      Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 
      Madrid, Spain.
FAU - Pérez-Rivas, Francisco Javier
AU  - Pérez-Rivas FJ
AUID- ORCID: 0000-0003-4294-8417
AD  - Grupo de Investigación UCM "Salud Pública-Estilos de Vida, Metodología Enfermera 
      y Cuidados en el Entorno Comunitario", Departamento de Enfermería, Facultad de 
      Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud-RICAPPS-(RICORS), Instituto de Investigación Sanitaria Hospital 12 de 
      Octubre (imas12), 28041 Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221123
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Adult
MH  - Humans
MH  - Cross-Sectional Studies
MH  - Computer Literacy
MH  - *Telemedicine/methods
MH  - *Health Literacy/methods
MH  - Surveys and Questionnaires
MH  - Language
MH  - Primary Health Care
PMC - PMC9738798
OTO - NOTNLM
OT  - eHealth literacy
OT  - primary care nursing
OT  - primary healthcare
OT  - public health
OT  - sociodemographic factors
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/12/12 06:00
MHDA- 2022/12/15 06:00
CRDT- 2022/12/11 01:06
PHST- 2022/10/21 00:00 [received]
PHST- 2022/11/20 00:00 [revised]
PHST- 2022/11/21 00:00 [accepted]
PHST- 2022/12/11 01:06 [entrez]
PHST- 2022/12/12 06:00 [pubmed]
PHST- 2022/12/15 06:00 [medline]
AID - ijerph192315497 [pii]
AID - ijerph-19-15497 [pii]
AID - 10.3390/ijerph192315497 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Nov 23;19(23):15497. doi: 
      10.3390/ijerph192315497.

PMID- 36477740
OWN - NLM
STAT- MEDLINE
DCOM- 20230314
LR  - 20230314
IS  - 1365-2362 (Electronic)
IS  - 0014-2972 (Linking)
VI  - 53
IP  - 4
DP  - 2023 Apr
TI  - Dysphagia in hospitalized patients: Prevalence, related factors and impact on 
      aspiration pneumonia and mortality.
PG  - e13930
LID - 10.1111/eci.13930 [doi]
AB  - BACKGROUND: Oropharyngeal dysphagia can be highly concerning in hospitalized 
      patients, increasing morbidity and mortality, making its early identification 
      essential. We aimed to characterize dysphagia and its association with aspiration 
      pneumonia and mortality in a tertiary hospital in Barcelona, Spain. METHODS: 
      Using data from all hospital discharges during the period 2018-2021, we 
      identified the characteristics of patients with dysphagia and their distribution 
      among hospital departments through the minimum data set, which codifies patients' 
      diagnoses according to the International Classification of Diseases 10th Revision 
      (ICD-10). We used logistic regression models to assess the association between 
      dysphagia, aspiration pneumonia and mortality. RESULTS: Dysphagia was present in 
      2.4% of all hospital discharges and was more frequent in older patients and in 
      men. The diagnoses most frequently associated with dysphagia were aspiration 
      pneumonia (48.2%) and stroke (14%). Higher prevalence of dysphagia was found in 
      the acute geriatric unit (10.3%), neurology (7.6%) and internal medicine (7.5%) 
      wards. Dysphagia was associated with aspiration pneumonia, aOR = 8.04 (95%CI, 
      6.31-10.25), and independently increased the odds of death among hospitalized 
      patients, aOR = 1.43 (95%CI, 1.19-1.73). CONCLUSIONS: We conclude that dysphagia 
      is a prevalent and transversal condition, increasing the risk of mortality in all 
      patients, and efforts should be intensified to increase its early detection and 
      correct management.
CI  - © 2022 Stichting European Society for Clinical Investigation Journal Foundation. 
      Published by John Wiley & Sons Ltd.
FAU - Bosch, Guillermo
AU  - Bosch G
AUID- ORCID: 0000-0001-5862-0913
AD  - Department of Epidemiology and Evaluation, Parc de Salut MAR (PSMAR), Barcelona, 
      Spain.
AD  - Preventive Medicine and Public Health Training Unit PSMar-UPF-ASPB (Parc de Salut 
      Mar - Pompeu Fabra University - Agència de Salut Pública de Barcelona), 
      Barcelona, Spain.
FAU - Comas, Mercè
AU  - Comas M
AD  - Department of Epidemiology and Evaluation, Parc de Salut MAR (PSMAR), Barcelona, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Domingo, Laia
AU  - Domingo L
AD  - Department of Epidemiology and Evaluation, Parc de Salut MAR (PSMAR), Barcelona, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Guillen-Sola, Anna
AU  - Guillen-Sola A
AD  - Department of Physical Medicine and Rehabilitation, PSMAR, Barcelona. 
      Rehabilitation Research Group, Institut Hospital del Mar d'Investigacions 
      Mèdiques (IMIM), Barcelona, Spain.
FAU - Duarte, Esther
AU  - Duarte E
AD  - Department of Physical Medicine and Rehabilitation, PSMAR, Barcelona. 
      Rehabilitation Research Group, Institut Hospital del Mar d'Investigacions 
      Mèdiques (IMIM), Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Department of Epidemiology and Evaluation, Parc de Salut MAR (PSMAR), Barcelona, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Sala, Maria
AU  - Sala M
AD  - Department of Epidemiology and Evaluation, Parc de Salut MAR (PSMAR), Barcelona, 
      Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
LA  - eng
GR  - Grant RD21/0016/0020 funded by Instituto de Salud/Instituto de Salud Carlos III/
GR  - European Union/
PT  - Journal Article
DEP - 20221216
PL  - England
TA  - Eur J Clin Invest
JT  - European journal of clinical investigation
JID - 0245331
SB  - IM
MH  - Male
MH  - Humans
MH  - Aged
MH  - *Deglutition Disorders
MH  - Prevalence
MH  - *Pneumonia, Aspiration/diagnosis/epidemiology
MH  - *Stroke
MH  - Risk Assessment
OTO - NOTNLM
OT  - aspiration pneumonia
OT  - dysphagia
OT  - epidemiology
OT  - mortality
OT  - quality of care
EDAT- 2022/12/09 06:00
MHDA- 2023/03/15 06:00
CRDT- 2022/12/08 12:13
PHST- 2022/11/16 00:00 [revised]
PHST- 2022/09/28 00:00 [received]
PHST- 2022/11/30 00:00 [accepted]
PHST- 2022/12/09 06:00 [pubmed]
PHST- 2023/03/15 06:00 [medline]
PHST- 2022/12/08 12:13 [entrez]
AID - 10.1111/eci.13930 [doi]
PST - ppublish
SO  - Eur J Clin Invest. 2023 Apr;53(4):e13930. doi: 10.1111/eci.13930. Epub 2022 Dec 
      16.

PMID- 36473409
OWN - NLM
STAT- MEDLINE
DCOM- 20230207
LR  - 20230223
IS  - 1578-1275 (Electronic)
IS  - 0212-6567 (Print)
IS  - 0212-6567 (Linking)
VI  - 55
IP  - 2
DP  - 2023 Feb
TI  - [Knowledge, use and opinion about written informed consent in primary healthcare 
      nurses: CONOSER pilot project].
PG  - 102525
LID - S0212-6567(22)00245-1 [pii]
LID - 10.1016/j.aprim.2022.102525 [doi]
LID - 102525
AB  - OBJECTIVE: To know the knowledge, implementation and opinion on informed consent 
      of generalist nurses, specialists and primary care residents. DESIGN: Descriptive 
      cross-sectional study using an online self-administered 'ad hoc' questionnaire. 
      SETTING: Primary care nurses in Madrid, from November 2020 to March 2021. 
      PARTICIPANTS: Sample of 114 nurses: 91 generalist, 20 specialists and 3 
      residents. MAIN MEASUREMENTS: Sociodemographics, knowledge, implementation and 
      opinion. RESULTS: The response rate was 27.7%. As a general rule, 48.2% indicated 
      that informed consent was collected verbally, as established by law, with 
      differences being found between categories, this percentage being higher in 
      specialists and residents (P=0.004), and within specialists in those who had 
      obtained their speciality by internal resident nurse (IRN) (P<0.0001). In 
      addition, specialists and residents were those who most identified the legal norm 
      regulating informed consent (P<0.0001). In terms of implementation and opinion, 
      all groups obtained similar results. DISCUSSION: There are no previous studies 
      that have analysed these aspects of informed consent comparing the different 
      categories. Studies from other healthcare and geographical areas show that nurses 
      have greater knowledge, although the demand for specific training in bioethics 
      and biolaw is greater in the nurses participating in this study. CONCLUSIONS: 
      Nurses have adequate knowledge about informed consent, use it in clinical 
      practice and have an appropriate conception of it, being higher in some items in 
      specialist nurses IRN and in residents.
CI  - Copyright © 2022 The Author(s). Publicado por Elsevier España, S.L.U. All rights 
      reserved.
FAU - Cabrera-Rodríguez, Airam
AU  - Cabrera-Rodríguez A
AD  - Programa de Doctorado Medicina Clínica y Salud Pública, Departamento de 
      Enfermería, Universidad de Granada, Granada, España; Departamento de Enfermería y 
      Nutrición, Facultad de Ciencias Biomédicas y de la Salud, Universidad Europea de 
      Madrid, Madrid, España; Gerencia Asistencial de Atención Primaria, Servicio 
      Madrileño de Salud, Madrid, España. Electronic address: airamcabrera89@gmail.com.
FAU - Rico-Blázquez, Milagros
AU  - Rico-Blázquez M
AD  - Unidad de Investigación de la Gerencia Asistencial de Atención Primaria, Servicio 
      Madrileño de Salud, Madrid, España; Red de Investigación en Cronicidad, Atención 
      Primaria y Promoción de la Salud RICAPPS (RICORS), España; Instituto de 
      Investigación Sanitaria Gregorio Marañón, Servicio Madrileño de Salud, Madrid, 
      España; Departamento de Enfermería, Facultad de Enfermería, Fisioterapia y 
      Podología, Universidad Complutense de Madrid, Madrid, España.
FAU - Sanz-Álvarez, Emilio José
AU  - Sanz-Álvarez EJ
AD  - Departamento de Medicina Física y Farmacología, Facultad de Medicina, Universidad 
      de La Laguna, Santa Cruz de Tenerife, España; Hospital Universitario de Canarias, 
      Servicio Canario de Salud, La Laguna (Santa Cruz de Tenerife), España.
FAU - Schmidt-RioValle, Jacqueline
AU  - Schmidt-RioValle J
AD  - Programa de Doctorado Medicina Clínica y Salud Pública, Departamento de 
      Enfermería, Universidad de Granada, Granada, España; Grupo de Investigación 
      CTS-436, Centro de Investigación Mente, Cerebro y Comportamiento CIMCYC, 
      Departamento de Enfermería, Facultad de Ciencias de la Salud, Universidad de 
      Granada, Granada, España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Conocimiento, implementación y opinión acerca del consentimiento informado por 
      escrito de las enfermeras de atención primaria: proyecto piloto CONOSER.
DEP - 20221205
PL  - Spain
TA  - Aten Primaria
JT  - Atencion primaria
JID - 9111075
SB  - IM
MH  - Humans
MH  - Pilot Projects
MH  - Cross-Sectional Studies
MH  - *Informed Consent
MH  - Surveys and Questionnaires
MH  - *Primary Health Care
PMC - PMC9723936
OTO - NOTNLM
OT  - Atención Primaria de Salud
OT  - Bioethics
OT  - Bioética
OT  - Consentimiento informado
OT  - Derecho sanitario
OT  - Ethics nursing
OT  - Health law
OT  - Informed consent
OT  - Primary health care
OT  - Ética en Enfermería
EDAT- 2022/12/07 06:00
MHDA- 2023/02/08 06:00
CRDT- 2022/12/06 18:24
PHST- 2022/10/25 00:00 [received]
PHST- 2022/11/02 00:00 [accepted]
PHST- 2022/12/07 06:00 [pubmed]
PHST- 2023/02/08 06:00 [medline]
PHST- 2022/12/06 18:24 [entrez]
AID - S0212-6567(22)00245-1 [pii]
AID - 102525 [pii]
AID - 10.1016/j.aprim.2022.102525 [doi]
PST - ppublish
SO  - Aten Primaria. 2023 Feb;55(2):102525. doi: 10.1016/j.aprim.2022.102525. Epub 2022 
      Dec 5.

PMID- 36470938
OWN - NLM
STAT- MEDLINE
DCOM- 20221207
LR  - 20230118
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Dec 5
TI  - The challenge of community mental health interventions with patients, relatives, 
      and health professionals during the COVID-19 pandemic: a real-world 9-month 
      follow-up study.
PG  - 20996
LID - 10.1038/s41598-022-25297-w [doi]
LID - 20996
AB  - Since the beginning of the COVID-19 pandemic, the need to implement protocols 
      that respond to the mental health demands of the population has been 
      demonstrated. The PASMICOR programme started in March 2020, involving a total of 
      210 requests for treatment. Out of those subjects, the intervention was performed 
      in 53 patients with COVID-19 without history of past psychiatric illness, 57 
      relatives and 60 health professionals, all of them within the area of Salamanca 
      (Spain). Interventions were carried out by professionals of the public mental 
      health service mostly by telephone. Depending on clinical severity, patients 
      received basic (level I) or complex psychotherapeutic care combined with 
      psychiatric care (level II). The majority of attended subjects were women 
      (76.5%). Anxious-depressive symptoms were predominant, although sadness was more 
      frequent in patients, insomnia in relatives and anxiety and fear in health 
      professionals. 80% of the sample, particularly most of the health professionals, 
      required a high-intensity intervention (level II). Nearly 50% of the people 
      treated were discharged after an average of 5 interventions. Providing early care 
      to COVID-19 patients, relatives and professionals by using community mental 
      health resources can help to reduce the negative impact of crises, such as the 
      pandemic, on the most affected population groups.
CI  - © 2022. The Author(s).
FAU - Roncero, Carlos
AU  - Roncero C
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain. croncero@saludcastillayleon.es.
AD  - Psychiatric Unit. School of Medicine, University of Salamanca, Campus Miguel de 
      Unamuno, Calle Alfonso X El Sabio S/N, 37007, Salamanca, Spain. 
      croncero@saludcastillayleon.es.
AD  - Institute of Biomedicine, University of Salamanca (IBSAL), Hospital Virgen de la 
      Vega, 10ª Planta, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain. 
      croncero@saludcastillayleon.es.
FAU - González-Sánchez, Armando
AU  - González-Sánchez A
AD  - Institute of Biomedicine, University of Salamanca (IBSAL), Hospital Virgen de la 
      Vega, 10ª Planta, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain.
AD  - Department of Statistics, University of Salamanca, Campus Miguel de Unamuno. C/ 
      Alfonso X El Sabio S/N, 37007, Salamanca, Spain.
FAU - Pérez-Laureano, Ángela
AU  - Pérez-Laureano Á
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain.
AD  - Institute of Biomedicine, University of Salamanca (IBSAL), Hospital Virgen de la 
      Vega, 10ª Planta, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain.
FAU - Ortiz-Fune, Carmen
AU  - Ortiz-Fune C
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain.
FAU - Díaz-Trejo, Sara
AU  - Díaz-Trejo S
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain.
FAU - Bersabé-Pérez, Miriam
AU  - Bersabé-Pérez M
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain.
FAU - Braquehais, María Dolores
AU  - Braquehais MD
AD  - Galatea Care Programme for Sick Health Professionals, Galatea Clinic, Carrer 
      Palafolls, 17-19, 08017, Barcelona, Spain.
AD  - Mental Health Research Group, Vall d'Hebron Research Institute, Universitat 
      Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, 08035, Barcelona, Spain.
AD  - School of Medicine, Universitat Internacional de Catalunya, Carrer Casanova, 143, 
      08036, Barcelona, Spain.
FAU - Pérez-Rodríguez, Javier
AU  - Pérez-Rodríguez J
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain.
FAU - Maderuelo-Fernández, José Ángel
AU  - Maderuelo-Fernández JÁ
AD  - Institute of Biomedicine, University of Salamanca (IBSAL), Hospital Virgen de la 
      Vega, 10ª Planta, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain.
AD  - Gerencia de Atención Primaria de Salamanca, Gerencia Regional de salud de 
      Castilla y León (SACyL), C/Arapiles, 25-33, 37007, Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Avenida de 
      Portugal, 83, 37005, Salamanca, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      S/N, 28029, Madrid, Spain.
FAU - Benito-Sánchez, José Antonio
AU  - Benito-Sánchez JA
AD  - Psychiatry Service, University of Salamanca Health Care Complex, Paseo de San 
      Vicente 58-182, 37007, Salamanca, Spain.
AD  - Psychiatric Unit. School of Medicine, University of Salamanca, Campus Miguel de 
      Unamuno, Calle Alfonso X El Sabio S/N, 37007, Salamanca, Spain.
AD  - Institute of Biomedicine, University of Salamanca (IBSAL), Hospital Virgen de la 
      Vega, 10ª Planta, Paseo de San Vicente, 58-182, 37007, Salamanca, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221205
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Humans
MH  - Female
MH  - Male
MH  - *COVID-19/epidemiology
MH  - Pandemics
MH  - Follow-Up Studies
MH  - Mental Health
MH  - SARS-CoV-2
PMC - PMC9722651
COIS- The authors declare no competing interests.
EDAT- 2022/12/06 06:00
MHDA- 2022/12/10 06:00
CRDT- 2022/12/05 23:27
PHST- 2022/09/13 00:00 [received]
PHST- 2022/11/28 00:00 [accepted]
PHST- 2022/12/05 23:27 [entrez]
PHST- 2022/12/06 06:00 [pubmed]
PHST- 2022/12/10 06:00 [medline]
AID - 10.1038/s41598-022-25297-w [pii]
AID - 25297 [pii]
AID - 10.1038/s41598-022-25297-w [doi]
PST - epublish
SO  - Sci Rep. 2022 Dec 5;12(1):20996. doi: 10.1038/s41598-022-25297-w.

PMID- 36467078
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221206
IS  - 1663-9812 (Print)
IS  - 1663-9812 (Electronic)
IS  - 1663-9812 (Linking)
VI  - 13
DP  - 2022
TI  - Real-world patterns of opioid therapy initiation in Spain, 2012-2018: A 
      population-based, retrospective cohort study with 957,080 patients and 1,509,488 
      initiations.
PG  - 1025340
LID - 10.3389/fphar.2022.1025340 [doi]
LID - 1025340
AB  - Introduction: Europe has seen a steady increase in the use of prescription 
      opioids, especially in non-cancer indications. Epidemiological data on the 
      patterns of use of opioids is required to optimize prescription. We aim to 
      describe the patterns of opioid therapy initiation for non-cancer pain and 
      characteristics of patients treated in a region with five million inhabitants in 
      the period 2012 to 2018. Methods: Population-based retrospective cohort study of 
      all adult patients initiating opioid therapy for non-cancer pain in the region of 
      Valencia. We described patient characteristics at baseline and the 
      characteristics of baseline and subsequent treatment initiation. We used 
      multinominal regression models to identify individual factors associated with 
      initiation. Results: A total of 957,080 patients initiated 1,509,488 opioid 
      treatments (957,080 baseline initiations, 552,408 subsequent initiations). For 
      baseline initiations, 738,749 were with tramadol (77.19%), 157,098 with codeine 
      (16.41%) 58,436 (6.11%) with long-acting opioids, 1,518 (0.16%) with short-acting 
      opioids and 1,279 (0.13%) with ultrafast drugs. When compared to tramadol, 
      patients initiating with short-acting, long-acting and ultrafast opioids were 
      more likely to be older and had more comorbidities, whereas initiators with 
      codeine were more prone to be healthier and younger. Treatments lasting less than 
      7 days accounted for 41.82% of initiations, and 11.89% lasted more than 30 days. 
      19.55% of initiators with ultrafast fentanyl received more than 120 daily 
      Morphine Milligram Equivalents (MME), and 16.12% of patients initiating with 
      long-acting opioids were prescribed more than 90 daily MME (p < 0.001). 
      Musculoskeletal indications accounted for 65.05% of opioid use. Overlap with 
      benzodiazepines was observed in 24.73% of initiations, overlap with 
      gabapentinoids was present in 11.04% of initiations with long-acting opioids and 
      28.39% of initiators with short-acting opioids used antipsychotics concomitantly. 
      In subsequent initiations, 55.48% of treatments included three or more 
      prescriptions (vs. 17.60% in baseline initiations) and risk of overlap was also 
      increased. Conclusion: Opioids are initiated for a vast array of non-oncological 
      indications, and, despite clinical guidelines, short-acting opioids are used 
      marginally, and a significant number of patients is exposed to potentially 
      high-risk patterns of initiation, such as treatments lasting more than 14 days, 
      treatments surpassing 50 daily MMEs, initiating with long-acting opioids, or 
      hazardous overlapping with other therapies.
CI  - Copyright © 2022 Hurtado, Robles, Peiró, García-Sempere, Llopis-Cardona, 
      Sánchez-Sáez, Rodríguez-Bernal and Sanfélix-Gimeno.
FAU - Hurtado, Isabel
AU  - Hurtado I
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - Robles, Celia
AU  - Robles C
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - Peiró, Salvador
AU  - Peiró S
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - García-Sempere, Aníbal
AU  - García-Sempere A
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - Llopis-Cardona, Fran
AU  - Llopis-Cardona F
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - Sánchez-Sáez, Francisco
AU  - Sánchez-Sáez F
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - Rodríguez-Bernal, Clara
AU  - Rodríguez-Bernal C
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
FAU - Sanfélix-Gimeno, Gabriel
AU  - Sanfélix-Gimeno G
AD  - Health Services Research Unit, Foundation for the Promotion of Health and 
      Biomedical Research of Valencia Region, Valencia, Fisabio.
AD  - Network for Research on Chronicity Primary Care and Health Promotion (RICAPPS), 
      Valencia, Fisabio.
LA  - eng
PT  - Journal Article
DEP - 20221116
PL  - Switzerland
TA  - Front Pharmacol
JT  - Frontiers in pharmacology
JID - 101548923
PMC - PMC9709437
OTO - NOTNLM
OT  - non-cancer pain
OT  - opioids
OT  - patient characteristics
OT  - patterns of initiation
OT  - population-based study
COIS- The authors are employed by FISABIO, a research body in Spain affiliated with the 
      Health Department of the Valencia Government. FISABIO signed a Collaboration 
      agreement (2018-2019) with Grünenthal Pharma S.A., to conduct independent 
      research on “Patterns of use of opioids in the National Health System”, unrelated 
      to the present work.
EDAT- 2022/12/06 06:00
MHDA- 2022/12/06 06:01
CRDT- 2022/12/05 04:17
PHST- 2022/08/22 00:00 [received]
PHST- 2022/11/01 00:00 [accepted]
PHST- 2022/12/05 04:17 [entrez]
PHST- 2022/12/06 06:00 [pubmed]
PHST- 2022/12/06 06:01 [medline]
AID - 1025340 [pii]
AID - 10.3389/fphar.2022.1025340 [doi]
PST - epublish
SO  - Front Pharmacol. 2022 Nov 16;13:1025340. doi: 10.3389/fphar.2022.1025340. 
      eCollection 2022.

PMID- 36462141
OWN - NLM
STAT- MEDLINE
DCOM- 20230313
LR  - 20230613
IS  - 1724-6059 (Electronic)
IS  - 1121-8428 (Linking)
VI  - 36
IP  - 2
DP  - 2023 Mar
TI  - Elevated urinary alpha-1 microglobulin levels are associated with decreased 
      survival among chronic kidney disease patients: a real-world population study.
PG  - 285-288
LID - 10.1007/s40620-022-01499-3 [doi]
FAU - Oliva-Damaso, Nestor
AU  - Oliva-Damaso N
AUID- ORCID: 0000-0003-0849-1054
AD  - Department of Medicine, Division of Nephrology, Hospital Costa del Sol, A-7, Km 
      187, 29305, Marbella, Malaga, Spain. nestorod@hotmail.com.
FAU - Lendinez, Ana
AU  - Lendinez A
AD  - Department of Laboratory, Hospital Costa del Sol, Marbella, Malaga, Spain.
FAU - Rivas-Ruiz, Francisco
AU  - Rivas-Ruiz F
AD  - Department of Research Unit, Hospital Costa del Sol, Marbella, Malaga, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Lopez, Francisca
AU  - Lopez F
AD  - Department of Medicine, Division of Nephrology, Hospital Costa del Sol, A-7, Km 
      187, 29305, Marbella, Malaga, Spain.
FAU - Castilla, Maria Del Mar
AU  - Castilla MDM
AD  - Department of Medicine, Division of Nephrology, Hospital Costa del Sol, A-7, Km 
      187, 29305, Marbella, Malaga, Spain.
FAU - Oliva-Damaso, Elena
AU  - Oliva-Damaso E
AD  - Department of Medicine, Division of Nephrology, Hospital Universitario Doctor 
      Negrin, Las Palmas de Gran Canaria, Spain.
FAU - Ramirez, Almudena
AU  - Ramirez A
AD  - Department of Research Unit, Hospital Costa del Sol, Marbella, Malaga, Spain.
FAU - Payan, Juan
AU  - Payan J
AD  - Department of Medicine, Division of Nephrology, Hospital Costa del Sol, A-7, Km 
      187, 29305, Marbella, Malaga, Spain.
LA  - eng
PT  - Letter
DEP - 20221203
PL  - Italy
TA  - J Nephrol
JT  - Journal of nephrology
JID - 9012268
RN  - 0 (beta 2-Microglobulin)
RN  - 0 (Alpha-Globulins)
SB  - IM
MH  - Humans
MH  - *Renal Insufficiency, Chronic/diagnosis/therapy
MH  - *Vesico-Ureteral Reflux
MH  - beta 2-Microglobulin
MH  - Alpha-Globulins/urine
MH  - Kidney
EDAT- 2022/12/04 06:00
MHDA- 2023/03/14 06:00
CRDT- 2022/12/03 11:17
PHST- 2022/09/01 00:00 [received]
PHST- 2022/10/10 00:00 [accepted]
PHST- 2022/12/04 06:00 [pubmed]
PHST- 2023/03/14 06:00 [medline]
PHST- 2022/12/03 11:17 [entrez]
AID - 10.1007/s40620-022-01499-3 [pii]
AID - 10.1007/s40620-022-01499-3 [doi]
PST - ppublish
SO  - J Nephrol. 2023 Mar;36(2):285-288. doi: 10.1007/s40620-022-01499-3. Epub 2022 Dec 
      3.

PMID- 36456022
OWN - NLM
STAT- MEDLINE
DCOM- 20221205
LR  - 20221208
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 12
IP  - 12
DP  - 2022 Dec 1
TI  - Revisiting systematic geographical variations in tonsils surgery in children in 
      the Spanish National Health System: spatiotemporal ecological study on hospital 
      administrative data.
PG  - e064009
LID - 10.1136/bmjopen-2022-064009 [doi]
LID - e064009
AB  - OBJECTIVE: To provide new evidence on how tonsils surgery in children has 
      geographically varied over time in the context of the Spanish National Health 
      System. DESIGN: Observational ecological spatiotemporal study on geographical 
      variations in medical practice, using linked administrative datasets, including 
      virtually all surgeries performed from 2003 to 2015. SETTING: The Spanish 
      National Health System, a quasi-federal structure with 17 autonomous communities 
      (ACs), and 203 healthcare areas (HCAs). PARTICIPANTS: Patients aged 19 and 
      younger residing in the HCAs and ACs. INTERVENTIONS: Tonsillectomy with 
      adenoidectomy (T&A); and tonsillectomies alone (T). MAIN ENDPOINTS: (1) Evolution 
      of T&A and T rates; (2) spatiotemporal variation in the risk of receiving T&A or 
      T surgery at regional level (ACs) and HCAs; and (3) the fraction of the variation 
      (FV) attributed to each of the components of variation-ACs, HCAs, year and 
      interaction ACs year. RESULTS: T&A age-sex standardised rates increased over the 
      period of analysis from 15.2 to 20.9 (5.7 points per 10 000 inhabitants). T alone 
      remained relatively lower than T&A rates, evolving from 3.6 in 2003 to 3.9 in 
      2015 (0.3 points per 10 000 inhabitants). Most of the risk variation was captured 
      at the HCAs level in both procedures (FV: 55.3% in T&A and 72.5% in T). The ACs 
      level explained 27.6% of the FV in the risk in T&A versus 8% in T. The 
      interaction ACs year was similar in both procedures (FV: 15.5% in T&A and 17.5% 
      in T). The average trend hardly explained 1.46% and 1.83% of the variation, 
      respectively. CONCLUSION: Our study showed wide persistent variations with a 
      steady increase in rates and risk of T&A and a stagnation of T alone, where most 
      of the variation risk was explained at HCA level.
CI  - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Castaño-Riera, Eusebio
AU  - Castaño-Riera E
AD  - Servicio de Planificación, Govern de les Illes Balears Conselleria de Salut, 
      Palma de Mallorca, Spain.
FAU - Ridao, Manuel
AU  - Ridao M
AD  - Data Science for Health Services and Policy Research, Instituto Aragonés de 
      Ciencias de la Salud, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Librero, Julian
AU  - Librero J
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
AD  - Navarrabiomed-Unidad de metodología, Navarre Institute of Health Research, 
      Pamplona, Spain.
FAU - Martínez-Lizaga, Natalia
AU  - Martínez-Lizaga N
AD  - Data Science for Health Services and Policy Research, Instituto Aragonés de 
      Ciencias de la Salud, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Comendeiro-Maaløe, Micaela
AU  - Comendeiro-Maaløe M
AD  - Data Science for Health Services and Policy Research, Instituto Aragonés de 
      Ciencias de la Salud, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Angulo-Pueyo, Ester
AU  - Angulo-Pueyo E
AD  - Data Science for Health Services and Policy Research, Instituto Aragonés de 
      Ciencias de la Salud, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
FAU - Peiro, Salvador
AU  - Peiro S
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
AD  - Fundacion para el Fomento de la Investigación Sanitaria y Biomédica de la 
      Comunidad Valenciana, FISABIO, Valencia, Spain.
FAU - Bernal-Delgado, Enrique
AU  - Bernal-Delgado E
AUID- ORCID: 0000-0002-0961-3298
AD  - Data Science for Health Services and Policy Research, Instituto Aragonés de 
      Ciencias de la Salud, Zaragoza, Spain ebernal.iacs@aragon.es.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20221201
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Child
MH  - Humans
MH  - *Palatine Tonsil/surgery
MH  - Adenoidectomy
MH  - *Tonsillectomy
MH  - Medical Assistance
MH  - Hospitals
PMC - PMC9716779
OTO - NOTNLM
OT  - Health economics
OT  - Health policy
OT  - Paediatric otolaryngology
COIS- Competing interests: None declared.
EDAT- 2022/12/02 06:00
MHDA- 2022/12/06 06:00
CRDT- 2022/12/01 20:53
PHST- 2022/12/01 20:53 [entrez]
PHST- 2022/12/02 06:00 [pubmed]
PHST- 2022/12/06 06:00 [medline]
AID - bmjopen-2022-064009 [pii]
AID - 10.1136/bmjopen-2022-064009 [doi]
PST - epublish
SO  - BMJ Open. 2022 Dec 1;12(12):e064009. doi: 10.1136/bmjopen-2022-064009.

PMID- 36452250
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221202
IS  - 2052-4374 (Print)
IS  - 2052-4374 (Electronic)
IS  - 2052-4374 (Linking)
VI  - 34
DP  - 2022
TI  - Hotel housekeepers and occupational health: experiences and perceived risks.
PG  - e29
LID - 10.35371/aoem.2022.34.e29 [doi]
LID - e29
AB  - BACKGROUND: Hotel housekeepers are one of the most important occupational group 
      within tourism hotel sector; various health problems related to their job have 
      been described, above all musculoskeletal disorders. The objective of this study 
      is to understand the experiences and perceptions of hotel housekeepers and key 
      informants from the Balearic Islands (Spain) regarding occupational health 
      conditions and the strategies employed to mitigate them. METHODS: A qualitative 
      study was carried out. Six focus groups with hotel housekeepers and 10 
      semi-structured interviews with key informants were conducted. Next, we carried 
      out a content analysis. RESULTS: Hotel housekeepers reported musculoskeletal 
      disorders, anxiety and stress as main occupational health problems; health 
      professionals underscored the physical problems. Hotel housekeepers perceived 
      that their work (physically demanding and with repetitive movements) caused their 
      health conditions. To solve health issues, they used medication 
      (anti-inflammatory agents, painkillers, sedatives and anxiolytics), which allowed 
      them to continue working; health public services, generally rated as 
      satisfactory; individual protective equipment; ergonomics (with difficulties due 
      to high work pace and hotel facilities) and physical activity. Two contrasting 
      attitudes were identified regarding sick leave: HHs who refused to accept a 
      doctor-prescribed sick leave (due to fear of being fired, sense of 
      responsibility, ...), and those who accepted it (because they could not continue 
      working, they prioritised health before work). CONCLUSIONS: Our results might 
      contribute to plan improvement strategies and programs to address health problems 
      among hotel housekeepers. These programs should include interventions, such as 
      coping strategies for the work-related risk factors (i.e., stress) and strategies 
      to reduce medicine consumption. Additionally, hotel facilities should adopt 
      policies focused on making workplaces more ergonomic (i.e., furniture) and to 
      diminish the work pace.
CI  - Copyright © 2022 Korean Society of Occupational & Environmental Medicine.
FAU - Chela-Alvarez, Xènia
AU  - Chela-Alvarez X
AUID- ORCID: 0000-0002-8270-6554
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Bulilete, Oana
AU  - Bulilete O
AUID- ORCID: 0000-0002-9264-5142
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Garcia-Illan, Encarna
AU  - Garcia-Illan E
AUID- ORCID: 0000-0002-0397-3874
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
FAU - Vidal-Thomàs, MClara
AU  - Vidal-Thomàs M
AUID- ORCID: 0000-0002-9861-278X
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Llobera, Joan
AU  - Llobera J
AUID- ORCID: 0000-0003-4113-4251
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
CN  - Arenal Group
LA  - eng
PT  - Journal Article
DEP - 20221025
PL  - Korea (South)
TA  - Ann Occup Environ Med
JT  - Annals of occupational and environmental medicine
JID - 101609244
PMC - PMC9685295
OTO - NOTNLM
OT  - Hotel housekeepers
OT  - Occupational health
OT  - Perceived health
OT  - Qualitative research
COIS- Competing interests: The authors declare that they have no competing interests.
EDAT- 2022/12/02 06:00
MHDA- 2022/12/02 06:01
CRDT- 2022/12/01 02:41
PHST- 2022/07/11 00:00 [received]
PHST- 2022/09/08 00:00 [revised]
PHST- 2022/09/25 00:00 [accepted]
PHST- 2022/12/01 02:41 [entrez]
PHST- 2022/12/02 06:00 [pubmed]
PHST- 2022/12/02 06:01 [medline]
AID - 10.35371/aoem.2022.34.e29 [doi]
PST - epublish
SO  - Ann Occup Environ Med. 2022 Oct 25;34:e29. doi: 10.35371/aoem.2022.34.e29. 
      eCollection 2022.

PMID- 36452233
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221202
IS  - 1663-9812 (Print)
IS  - 1663-9812 (Electronic)
IS  - 1663-9812 (Linking)
VI  - 13
DP  - 2022
TI  - Patterns of statin adherence in primary cardiovascular disease prevention during 
      the pandemic.
PG  - 980391
LID - 10.3389/fphar.2022.980391 [doi]
LID - 980391
AB  - Background: Study of medication adherence patterns can help identify patients who 
      would benefit from effective interventions to improve adherence. Objectives: To 
      identify and compare groups of statin users based on their adherence patterns 
      before and during the COVID-19 pandemic, to characterize the profile of users in 
      each group, and to analyze predictors of distinct adherence patterns. Methods: 
      Participants of the CARhES (CArdiovascular Risk factors for HEalth Services 
      research) cohort, comprising individuals aged >16 years, residing in Aragón 
      (Spain), with hypertension, diabetes mellitus and/or dyslipidemia, took part in 
      this observational longitudinal study. Individuals who began statin therapy 
      during January-June 2019 were selected and followed up until June 2021. Those 
      with a cardiovascular event before or during follow-up were excluded. Data were 
      obtained from healthcare system data sources. Statin treatment adherence during 
      the implementation phase was estimated bimonthly using the Continuous Medication 
      Availability (CMA9) function in the AdhereR package. Group-based trajectory 
      models were developed to group statin users according to their adherence pattern 
      during July 2019-June 2021. Group characteristics were compared and predictors of 
      each adherence pattern were analyzed using multinomial logistic regression. 
      Results: Of 15,332 new statin users, 30.8% had a mean CMA9 ≥80% for the entire 
      study period. Four distinct adherence patterns were identified: high adherence 
      (37.2% of the study population); poor adherence (35.6%); occasional use (14.9%); 
      and gradual decline (12.3%). The latter two groups included users who showed a 
      change in adherence (increase or decrease) during the pandemic emergence. Users 
      with suboptimal adherence were likely to be younger, not pensioners, not 
      institutionalized, with low morbidity burden and a low number of comorbidities. 
      Female sex and switching between statins of different intensity increased the 
      likelihood of belonging to the occasional use group, in which improved adherence 
      coincided with the pandemic. Conclusion: We identified four distinct adherence 
      patterns in a population of new statin users; two of them modified their 
      adherence during the pandemic. Characterization of these groups could enable more 
      effective distribution of resources in future similar crisis and the routine 
      implementation of patient-centered interventions to improve medication adherence.
CI  - Copyright © 2022 Malo, Maldonado, Rabanaque, Gimeno-Miguel, Castel-Feced, Lallana 
      and Aguilar-Palacio.
FAU - Malo, Sara
AU  - Malo S
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain.
AD  - Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación 
      Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, Health Promotion (RICAPPS), 
      ISCIII, Madrid, Spain.
FAU - Maldonado, Lina
AU  - Maldonado L
AD  - Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación 
      Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Department of Applied Economics, University of Zaragoza, Zaragoza, Spain.
FAU - Rabanaque, María José
AU  - Rabanaque MJ
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain.
AD  - Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación 
      Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, Health Promotion (RICAPPS), 
      ISCIII, Madrid, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AD  - Network for Research on Chronicity, Primary Care, Health Promotion (RICAPPS), 
      ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - Castel-Feced, Sara
AU  - Castel-Feced S
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain.
AD  - Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación 
      Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
FAU - Lallana, María Jesús
AU  - Lallana MJ
AD  - Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación 
      Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Primary Care Pharmacy Service, Sector Zaragoza III, Servicio Aragonés de Salud 
      (SALUD), Zaragoza, Spain.
FAU - Aguilar-Palacio, Isabel
AU  - Aguilar-Palacio I
AD  - Department of Preventive Medicine and Public Health, University of Zaragoza, 
      Zaragoza, Spain.
AD  - Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación 
      Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, Health Promotion (RICAPPS), 
      ISCIII, Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221114
PL  - Switzerland
TA  - Front Pharmacol
JT  - Frontiers in pharmacology
JID - 101548923
PMC - PMC9702325
OTO - NOTNLM
OT  - COVID-19
OT  - chronic disease
OT  - cluster analysis
OT  - computer modeling
OT  - disease management
OT  - healthcare system
OT  - medication adherence
OT  - statin
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/12/02 06:00
MHDA- 2022/12/02 06:01
CRDT- 2022/12/01 02:40
PHST- 2022/06/28 00:00 [received]
PHST- 2022/09/30 00:00 [accepted]
PHST- 2022/12/01 02:40 [entrez]
PHST- 2022/12/02 06:00 [pubmed]
PHST- 2022/12/02 06:01 [medline]
AID - 980391 [pii]
AID - 10.3389/fphar.2022.980391 [doi]
PST - epublish
SO  - Front Pharmacol. 2022 Nov 14;13:980391. doi: 10.3389/fphar.2022.980391. 
      eCollection 2022.

PMID- 36432446
OWN - NLM
STAT- MEDLINE
DCOM- 20221129
LR  - 20221213
IS  - 2072-6643 (Electronic)
IS  - 2072-6643 (Linking)
VI  - 14
IP  - 22
DP  - 2022 Nov 10
TI  - Long-Term Effectiveness of a Smartphone App and a Smart Band on Arterial 
      Stiffness and Central Hemodynamic Parameters in a Population with Overweight and 
      Obesity (Evident 3 Study): Randomised Controlled Trial.
LID - 10.3390/nu14224758 [doi]
LID - 4758
AB  - BACKGROUND: mHealth technologies could help to improve cardiovascular health; 
      however, their effect on arterial stiffness and hemodynamic parameters has not 
      been explored to date. OBJECTIVE: To evaluate the effect of a mHealth 
      intervention, at 3 and 12 months, on arterial stiffness and central hemodynamic 
      parameters in a sedentary population with overweight and obesity. METHODS: 
      Randomised controlled clinical trial (Evident 3 study). 253 subjects were 
      included: 127 in the intervention group (IG) and 126 in the control group (CG). 
      The IG subjects were briefed on the use of the Evident 3 app and a smart band (Mi 
      Band 2, Xiaomi) for 3 months to promote healthy lifestyles. All measurements were 
      recorded in the baseline visit and at 3 and 12 months. The carotid-femoral pulse 
      wave velocity (cfPWV) and the central hemodynamic parameters were measured using 
      a SphigmoCor System(®) device, whereas the brachial-ankle pulse wave velocity 
      (baPWV) and the Cardio Ankle Vascular Index (CAVI) were measured using a VaSera 
      VS-2000(®) device. RESULTS: Of the 253 subjects who attended the initial visit, 
      237 (93.7%) completed the visit at 3 months of the intervention, and 217 (85.3%) 
      completed the visit at 12 months of the intervention. At 12 months, IG showed a 
      decrease in peripheral augmentation index (PAIx) (-3.60; 95% CI -7.22 to -0.00) 
      and ejection duration (ED) (-0.82; 95% CI -1.36 to -0.27), and an increase in 
      subendocardial viability ratio (SEVR) (5.31; 95% CI 1.18 to 9.44). In CG, cfPWV 
      decreased at 3 months (-0.28 m/s; 95% CI -0.54 to -0.02) and at 12 months (-0.30 
      m/s, 95% CI -0.54 to -0.05), central diastolic pressure (cDBP) decreased at 12 
      months (-1.64 mm/Hg; 95% CI -3.19 to -0.10). When comparing the groups we found 
      no differences between any variables analyzed. CONCLUSIONS: In sedentary adults 
      with overweight or obesity, the multicomponent intervention (Smartphone app and 
      an activity-tracking band) for 3 months did not modify arterial stiffness or the 
      central hemodynamic parameters, with respect to the control group. However, at 12 
      months, CG presented a decrease of cfPWV and cDBP, whereas IG showed a decrease 
      of PAIx and ED and an increase of SEVR.
FAU - Gómez-Sánchez, Leticia
AU  - Gómez-Sánchez L
AUID- ORCID: 0000-0001-8663-9339
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
FAU - Gómez-Sánchez, Marta
AU  - Gómez-Sánchez M
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
FAU - Lugones-Sánchez, Cristina
AU  - Lugones-Sánchez C
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
FAU - Rodríguez-Sánchez, Emiliano
AU  - Rodríguez-Sánchez E
AUID- ORCID: 0000-0003-3667-7155
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Calle Alfonso X el Sabio s/n, 
      37007 Salamanca, Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
FAU - Gonzalez-Sánchez, Susana
AU  - Gonzalez-Sánchez S
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AUID- ORCID: 0000-0002-5494-6550
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
AD  - Centro de Salud Arrabal, Grupo Aragonés de Investigación en Atención Primaria, 
      Instituto de Investigaciones Sanitarias de Aragón (IIS), Servicio de Salud de 
      Aragón, 50002 Zaragoza, Spain.
AD  - Departamento de Medicina y Dermatología. Universidad de Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Ramirez-Manent, Jose Ignacio
AU  - Ramirez-Manent JI
AUID- ORCID: 0000-0001-6887-4562
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
AD  - Centro de salud de Calvià, Instituto de Investigación Sanitaria de Baleares 
      (IDISBA), Servicio de Salud de las Islas Baleares, 07180 Mallorca, Spain.
AD  - Departamento de Medicina Universidad de las Islas Baleares, 07003 Islas Baleares, 
      Spain.
FAU - Recio-Rodriguez, Jose I
AU  - Recio-Rodriguez JI
AUID- ORCID: 0000-0002-3772-8746
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
FAU - Agudo-Conde, Cristina
AU  - Agudo-Conde C
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
FAU - García-Ortiz, Luis
AU  - García-Ortiz L
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Calle Alfonso X el Sabio s/n, 
      37007 Salamanca, Spain.
AD  - Departamento de Biomedicina y Diagnostico de la Ciencia, Universidad de 
      Salamanca, Calle Alfonso X el Sabio s/n, 37007 Salamanca, Spain.
FAU - Gómez-Marcos, Manuel A
AU  - Gómez-Marcos MA
AUID- ORCID: 0000-0003-0133-6123
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Avenida de Portugal 83, 37005 Salamanca, Spain.
AD  - Instituto de Investigación Biomédica de Salamanca (IBSAL). Paseo de San Vicente 
      58-182, 37007 Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), 08007 Barcelona, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Calle Alfonso X el Sabio s/n, 
      37007 Salamanca, Spain.
LA  - eng
GR  - GRS 1277/B/16, GRS 1580/B/17/Gerencia Regional de Salud de Castilla y Leon/
GR  - (RD21/0016/0010, RD21/0016/0005, RD21/0016/0025, RD21/0016/0009) and (PI16/00101, 
      PI16/00952, PI16/00765, PI16/00659, PI16/00421, PI16/00170, FI17/00040)/Instituto 
      de Salud Carlos III España/
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20221110
PL  - Switzerland
TA  - Nutrients
JT  - Nutrients
JID - 101521595
SB  - IM
MH  - Adult
MH  - Humans
MH  - *Vascular Stiffness
MH  - Overweight/therapy
MH  - Pulse Wave Analysis
MH  - *Mobile Applications
MH  - Ankle Brachial Index
MH  - Obesity/therapy
MH  - Blood Pressure
PMC - PMC9695348
OTO - NOTNLM
OT  - arterial stiffness
OT  - central hemodynamic parameters
OT  - eHealth
OT  - mobile app
OT  - mobile phone
OT  - telemedicine
OT  - weight control
COIS- The authors declare no conflict of interest.
EDAT- 2022/11/27 06:00
MHDA- 2022/11/30 06:00
CRDT- 2022/11/26 01:30
PHST- 2022/10/02 00:00 [received]
PHST- 2022/11/02 00:00 [revised]
PHST- 2022/11/09 00:00 [accepted]
PHST- 2022/11/26 01:30 [entrez]
PHST- 2022/11/27 06:00 [pubmed]
PHST- 2022/11/30 06:00 [medline]
AID - nu14224758 [pii]
AID - nutrients-14-04758 [pii]
AID - 10.3390/nu14224758 [doi]
PST - epublish
SO  - Nutrients. 2022 Nov 10;14(22):4758. doi: 10.3390/nu14224758.

PMID- 36429423
OWN - NLM
STAT- MEDLINE
DCOM- 20221129
LR  - 20230130
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 22
DP  - 2022 Nov 9
TI  - Development and Evaluation of a Digital Health Intervention to Prevent Type 2 
      Diabetes in Primary Care: The PREDIABETEXT Study Protocol for a Randomised 
      Clinical Trial.
LID - 10.3390/ijerph192214706 [doi]
LID - 14706
AB  - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a highly prevalent disease 
      associated with an increased risk of comorbidities, premature death, and health 
      costs. Prediabetes is a stage of glucose alteration previous to T2DM, that can be 
      reversed. The aim of the study is to develop and evaluate a low-intensity, 
      multifaceted, digital intervention to prevent T2DM. The intervention comprises: 
      (1) the use of mobile health technology to send tailored text messages promoting 
      lifestyle changes to people at risk of T2DM and (2) the provision of online 
      education to primary healthcare physicians and nurses about management of 
      prediabetes. METHODS: In stages 1-4 we will design, develop and pilot-test the 
      intervention. In Stage 5 we will conduct a phase II, six-month, three-arm, 
      cluster randomized, clinical trial with 42 primary care professionals and 420 
      patients at risk of T2DM. Patients will be allocated to a control group (usual 
      care), intervention A (patient messaging intervention), or intervention B 
      (patient messaging intervention plus online education to their primary healthcare 
      professionals). The primary outcome will be glycated haemoglobin. All the 
      procedures obtained ethical approval in June 2021 (CEI-IB Ref No: IB4495/21PI). 
      DISCUSSION: Digital health interventions can effectively prevent T2DM and reduce 
      important T2DM risk factors such as overweight or hypertension. In Spain, this 
      type of intervention is understudied. Moreover, there is controversy regarding 
      the type of digital health interventions that are more effective. Findings from 
      this study may contribute to address T2DM prevention, through a low-cost and 
      easily implementable intervention.
FAU - Galmes-Panades, Aina M
AU  - Galmes-Panades AM
AUID- ORCID: 0000-0001-6977-9874
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120 Palma, 
      Spain.
AD  - Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), 
      Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
FAU - Angullo, Escarlata
AU  - Angullo E
AD  - Escola Graduada Primary Health Care Center, Balearic Health Service, 07002 Palma 
      de Mallorca, Spain.
AD  - Research Group on Community Nutrition & Oxidative Stress, University of Balearic 
      Islands-IUNICS, IDISBA & CIBEROBN (Physiopathology of Obesity and Nutrition), 
      07120 Palma de Mallorca, Spain.
FAU - Mira-Martínez, Sofía
AU  - Mira-Martínez S
AUID- ORCID: 0000-0002-6402-4760
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
FAU - Bennasar-Veny, Miquel
AU  - Bennasar-Veny M
AUID- ORCID: 0000-0003-1668-2141
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120 Palma, 
      Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma de Mallorca, Spain.
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos 
      III, 28029 Madrid, Spain.
FAU - Zamanillo-Campos, Rocío
AU  - Zamanillo-Campos R
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
FAU - Gómez-Juanes, Rocío
AU  - Gómez-Juanes R
AUID- ORCID: 0000-0002-9040-5508
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma de Mallorca, Spain.
AD  - Department of Medicine, University of the Balearic Islands, 07122 Palma, Spain.
FAU - Konieczna, Jadwiga
AU  - Konieczna J
AD  - Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), 
      Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
AD  - Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology 
      (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), 
      University Hospital Son Espases (HUSE), 07120 Palma de Mallorca, Spain.
FAU - Jiménez, Rafael
AU  - Jiménez R
AUID- ORCID: 0000-0002-1181-3221
AD  - Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), 
      Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Department of Psychology, University of the Balearic Islands (UIB), 07120 Palma, 
      Spain.
FAU - Serrano-Ripoll, Maria Jesús
AU  - Serrano-Ripoll MJ
AUID- ORCID: 0000-0002-1869-1132
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Fiol-deRoque, Maria Antonia
AU  - Fiol-deRoque MA
AUID- ORCID: 0000-0001-8566-0929
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
FAU - Miralles, Jerónima
AU  - Miralles J
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
FAU - Yañez, Aina M
AU  - Yañez AM
AUID- ORCID: 0000-0001-8527-3937
AD  - Global Health and Lifestyle (EVES Group), Health Research Institute of the 
      Balearic Islands (IdISBa), University Hospital Son Espases (HUSE), 07120 Palma, 
      Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands 
      (UIB), 07120 Palma, Spain.
AD  - Research Group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07120 Palma, Spain.
FAU - Romaguera, Dora
AU  - Romaguera D
AUID- ORCID: 0000-0002-5762-8558
AD  - Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), 
      Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
AD  - Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology 
      (NUTRECOR), Health Research Institute of the Balearic Islands (IdISBa), 
      University Hospital Son Espases (HUSE), 07120 Palma de Mallorca, Spain.
FAU - Vidal-Thomas, Maria Clara
AU  - Vidal-Thomas MC
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
FAU - Llobera-Canaves, Joan
AU  - Llobera-Canaves J
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - García-Toro, Mauro
AU  - García-Toro M
AUID- ORCID: 0000-0002-2251-1368
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma de Mallorca, Spain.
AD  - Department of Medicine, University of the Balearic Islands, 07122 Palma, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Vicens, Catalina
AU  - Vicens C
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Department of Medicine, University of the Balearic Islands, 07122 Palma, Spain.
AD  - Son Serra-La Vileta Primary Health Care Center, Balearic Health Service, 07013 
      Palma, Spain.
FAU - Gervilla-García, Elena
AU  - Gervilla-García E
AUID- ORCID: 0000-0003-3194-5499
AD  - Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), 
      Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Department of Psychology, University of the Balearic Islands (UIB), 07120 Palma, 
      Spain.
FAU - Oña, José Iván
AU  - Oña JI
AD  - Dra. Teresa Piqué Primary Health Care Center, Balearic Health Service, 07003 
      Palma, Spain.
FAU - Malih, Narges
AU  - Malih N
AUID- ORCID: 0000-0002-5184-0881
AD  - Research Group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07120 Palma, Spain.
FAU - Leiva, Alfonso
AU  - Leiva A
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Bulilete, Oana
AU  - Bulilete O
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Montaño, Juan José
AU  - Montaño JJ
AUID- ORCID: 0000-0002-1116-1964
AD  - Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), 
      Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Department of Psychology, University of the Balearic Islands (UIB), 07120 Palma, 
      Spain.
FAU - Gili, Margalida
AU  - Gili M
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma de Mallorca, Spain.
AD  - Department of Medicine, University of the Balearic Islands, 07122 Palma, Spain.
AD  - Statistical and Psychometric Procedures Applied in Health Sciences (PSICOMEST), 
      Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Roca, Miquel
AU  - Roca M
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Institute of Health Sciences (IUNICS), University of Balearic Islands, 
      07120 Palma de Mallorca, Spain.
AD  - Department of Medicine, University of the Balearic Islands, 07122 Palma, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, 28029 Madrid, Spain.
FAU - Ricci-Cabello, Ignacio
AU  - Ricci-Cabello I
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma de 
      Mallorca, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), 07120 Palma de Mallorca, Spain.
AD  - Primary Care Research Unit of Mallorca (IB-Salut), Balearic Health Service, 07002 
      Palma de Mallorca, Spain.
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos 
      III, 28029 Madrid, Spain.
LA  - eng
PT  - Clinical Trial Protocol
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221109
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/prevention & control
MH  - *Prediabetic State/therapy
MH  - Life Style
MH  - *Text Messaging
MH  - Primary Health Care
MH  - Randomized Controlled Trials as Topic
MH  - Clinical Trials, Phase II as Topic
PMC - PMC9690330
OTO - NOTNLM
OT  - SMS intervention
OT  - diet advice
OT  - digital health intervention
OT  - mHealth
OT  - nursing
OT  - physical activity
OT  - prediabetes
OT  - prevention
OT  - type 2 diabetes mellitus
COIS- The authors declare no conflict of interest.
EDAT- 2022/11/27 06:00
MHDA- 2022/11/30 06:00
CRDT- 2022/11/26 01:09
PHST- 2022/10/14 00:00 [received]
PHST- 2022/11/03 00:00 [revised]
PHST- 2022/11/04 00:00 [accepted]
PHST- 2022/11/26 01:09 [entrez]
PHST- 2022/11/27 06:00 [pubmed]
PHST- 2022/11/30 06:00 [medline]
AID - ijerph192214706 [pii]
AID - ijerph-19-14706 [pii]
AID - 10.3390/ijerph192214706 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Nov 9;19(22):14706. doi: 
      10.3390/ijerph192214706.

PMID- 36419332
OWN - NLM
STAT- MEDLINE
DCOM- 20230303
LR  - 20230303
IS  - 1741-2854 (Electronic)
IS  - 0020-7640 (Linking)
VI  - 69
IP  - 2
DP  - 2023 Mar
TI  - Effectiveness of social support-based interventions in preventing depression in 
      people without clinical depression: A systematic review and meta-analysis of 
      randomized controlled trials.
PG  - 253-266
LID - 10.1177/00207640221134232 [doi]
AB  - BACKGROUND: The evidence available on the association between social support and 
      prevention of depression has been basically obtained from observational studies. 
      AIM: We evaluated the effectiveness of social support-based interventions for the 
      prevention of depression in people without clinical depression. METHODS: 
      Systematic review and meta-analysis (SR/MA) of randomized controlled trials 
      (RCT), which were searched for in MEDLINE, EMBASE, CENTRAL, WOS, PsycINFO, 
      OpenGrey and other sources from the inception dates to June 8, 2022. We selected 
      RCTs that assessed the effectiveness of social support-based interventions as 
      compared to controls, included subjects without baseline clinical depression, and 
      measured as results a reduction in depressive symptoms and/or the incidence of 
      new cases of depression. Pooled standardized mean differences (SMDs) were 
      calculated from random effects models. RESULTS: Nine RCTs involving 927 patients 
      from North America, Asia and Europe were included. The pooled SMD was -0.43 [95% 
      confidence interval (CI) -0.82 to -0.04; p = .031]. Sensitivity analyses 
      confirmed the robustness of results. Heterogeneity was substantial [I(2) = 80% 
      (95% CI: 64% to 89%)]. A meta-regression model that included usual care as 
      comparator and the continent (Europe), explained 53% of heterogeneity. Eight RCTs 
      had a moderate overall risk of bias and one had a high risk of bias. Follow-up 
      was ⩾1 year in only three RCTs. There was no statistical evidence of publication 
      bias. The quality of evidence, as measured on GRADE guidelines, was low. 
      CONCLUSION: Social support-based interventions had a small preventive effect on 
      depression. Longer RCTs with a low risk of bias are necessary.
FAU - Campos-Paíno, Henar
AU  - Campos-Paíno H
AUID- ORCID: 0000-0002-0563-3080
AD  - Biomedical Research Institute of Malaga (IBIMA Platform Bionand), Malaga, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
FAU - Moreno-Peral, Patricia
AU  - Moreno-Peral P
AUID- ORCID: 0000-0003-4130-9090
AD  - Biomedical Research Institute of Malaga (IBIMA Platform Bionand), Malaga, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
AD  - Department of Personality, Assessment and Psychological Treatment, University of 
      Malaga(UMA), Spain.
FAU - Gómez-Gómez, Irene
AU  - Gómez-Gómez I
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
AD  - Department of Psychology, Universidad Loyola Andalucía, Sevilla, Spain.
FAU - Conejo-Cerón, Sonia
AU  - Conejo-Cerón S
AD  - Biomedical Research Institute of Malaga (IBIMA Platform Bionand), Malaga, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
FAU - Galán, Santiago
AU  - Galán S
AD  - Biomedical Research Institute of Malaga (IBIMA Platform Bionand), Malaga, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
FAU - Reyes-Martín, Sara
AU  - Reyes-Martín S
AD  - Biomedical Research Institute of Malaga (IBIMA Platform Bionand), Malaga, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
FAU - Bellón, Juan Ángel
AU  - Bellón JÁ
AUID- ORCID: 0000-0002-4268-4979
AD  - Biomedical Research Institute of Malaga (IBIMA Platform Bionand), Malaga, Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP) & Chronicity, Primary 
      Care and Health Promotion Research Network, (RICAPPS), ISCIII, Madrid, Spain.
AD  - El Palo Health Centre, Andalusian Health Service (SAS), Malaga, Spain.
AD  - Department of Public Health and Psychiatry, University of Malaga, Spain.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PT  - Systematic Review
DEP - 20221123
PL  - England
TA  - Int J Soc Psychiatry
JT  - The International journal of social psychiatry
JID - 0374726
SB  - IM
MH  - Humans
MH  - *Depression
MH  - Randomized Controlled Trials as Topic
MH  - *Depressive Disorder, Major
MH  - Asia
OTO - NOTNLM
OT  - Depression
OT  - meta-analysis
OT  - randomized controlled trial
OT  - social support
OT  - systematic review
EDAT- 2022/11/25 06:00
MHDA- 2023/03/04 06:00
CRDT- 2022/11/24 01:23
PHST- 2022/11/25 06:00 [pubmed]
PHST- 2023/03/04 06:00 [medline]
PHST- 2022/11/24 01:23 [entrez]
AID - 10.1177/00207640221134232 [doi]
PST - ppublish
SO  - Int J Soc Psychiatry. 2023 Mar;69(2):253-266. doi: 10.1177/00207640221134232. 
      Epub 2022 Nov 23.

PMID- 36414309
OWN - NLM
STAT- MEDLINE
DCOM- 20221124
LR  - 20221126
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 12
IP  - 11
DP  - 2022 Nov 22
TI  - Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic 
      characteristics in the development of SARS-CoV-2 health outcomes: protocol for 
      systematic reviews of population-based studies.
PG  - e063573
LID - 10.1136/bmjopen-2022-063573 [doi]
LID - e063573
AB  - INTRODUCTION: There is growing evidence that the impact of COVID-19 crisis may be 
      stronger for individuals with multimorbidity, frailty and lower socioeconomic 
      status. Existing reviews focus on few, mainly short-term effects of COVID-19 
      illness and patients with single chronic disease. Information is also largely 
      missing for population representative samples.Applying population-based approach, 
      the systematic reviews will have two objectives: (1) to evaluate the aetiological 
      roles of frailty, multimorbidity and socioeconomic status on SARS-CoV-2 infection 
      probability, hospitalisation, intensive care unit (ICU) admission, mechanical 
      ventilation and COVID-19 related mortality among general population and (2) to 
      investigate the prognostic roles of frailty, multimorbidity and socioeconomic 
      characteristics on the risk of hospitalisation, ICU admission, mechanical 
      ventilation, COVID-19 mortality, functioning, quality of life, disability, mental 
      health and work absence. METHODS AND ANALYSIS: For this ongoing work, four 
      databases were searched: PubMed, Embase, WHO COVID-19 Global literature on 
      coronavirus disease and PsycINFO, for the period between January 2020 and April 7 
      2021. Peer-reviewed published literature in English and all types of 
      population-based studies will be considered. Studies using standard tools to 
      assess multimorbidity such as disease count, comorbidity indices or disease 
      combinations will be retained, as well as studies with standard scales and scores 
      for frailty or measurement of a socioeconomic gradient. Initial search included 
      10 139 articles, 411 for full-text reading. Results will be summarised by risk 
      factor, objective and outcome. The feasibility of meta-analysis will be 
      determined by the findings and will aim to better understand uncertainties of the 
      results. Quality of studies will be assessed using standardised scales. ETHICS 
      AND DISSEMINATION: The study will be based on published evidence, and it is 
      exempt from the ethical approval. This work is part of the Population Health 
      Information Research Infrastructure (PHIRI) project. Dissemination of the results 
      will imply conference presentation, submission for scientific publication and 
      PHIRI project report. PROSPERO REGISTRATION NUMBER: CRD42021249444.
CI  - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published 
      by BMJ.
FAU - Makovski, Tatjana T
AU  - Makovski TT
AUID- ORCID: 0000-0002-3334-4809
AD  - Department of non-communicable diseases and injuries, Santé publique France, 
      Saint-Maurice, Île-de-France, France tatjana.makovski@santepubliquefrance.fr.
FAU - Ghattas, Jinane
AU  - Ghattas J
AD  - Institut de recherche santé et société (IRSS), Université catholique de Louvain, 
      Woluwe-Saint-Lambert, Brussels, Belgium.
FAU - Monnier Besnard, Stephanie
AU  - Monnier Besnard S
AD  - Department of non-communicable diseases and injuries, Santé publique France, 
      Saint-Maurice, Île-de-France, France.
FAU - Ambrozova, Monika
AU  - Ambrozova M
AD  - Institute of Health Information and Statistics of the Czech Republic, Prague, 
      Czech Republic.
FAU - Vasinova, Barbora
AU  - Vasinova B
AD  - Institute of Health Information and Statistics of the Czech Republic, Prague, 
      Czech Republic.
FAU - Feteira-Santos, Rodrigo
AU  - Feteira-Santos R
AD  - Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, 
      Lisboa, Portugal.
AD  - Área Disciplinar Autónoma de Bioestatística, Faculdade de Medicina, Universidade 
      de Lisboa, Lisboa, Portugal.
FAU - Bezzegh, Peter
AU  - Bezzegh P
AD  - Directorate for Project Management, National Directorate General for Hospitals, 
      Budapest, Hungary.
FAU - Ponce Bollmann, Felipe
AU  - Ponce Bollmann F
AD  - Universidad Nacional de Educación a Distancia, Madrid, Spain.
FAU - Cottam, James
AU  - Cottam J
AD  - Department of Epidemiology and Public Health, Sciensano, Brussel, Belgium.
AD  - Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
FAU - Haneef, Romana
AU  - Haneef R
AD  - Department of non-communicable diseases and injuries, Santé publique France, 
      Saint-Maurice, Île-de-France, France.
FAU - Devleesschauwer, Brecht
AU  - Devleesschauwer B
AD  - Department of Epidemiology and Public Health, Sciensano, Brussel, Belgium.
AD  - Department of Translational Physiology, Infectiology and Public Health, Ghent 
      University, Merelbeke, Belgium.
FAU - Speybroeck, Niko
AU  - Speybroeck N
AD  - Institut de recherche santé et société (IRSS), Université catholique de Louvain, 
      Woluwe-Saint-Lambert, Brussels, Belgium.
FAU - Nogueira, Paulo
AU  - Nogueira P
AUID- ORCID: 0000-0001-8316-5035
AD  - Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, 
      Lisboa, Portugal.
AD  - Área Disciplinar Autónoma de Bioestatística, Faculdade de Medicina, Universidade 
      de Lisboa, Lisboa, Portugal.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AD  - National Center of Epidemiology, Instituto de Salud Carlos III, REDISSEC and 
      RICAPPS, Madrid, Spain.
FAU - Coste, Joel
AU  - Coste J
AD  - Department of non-communicable diseases and injuries, Santé publique France, 
      Saint-Maurice, Île-de-France, France.
FAU - Carcaillon-Bentata, Laure
AU  - Carcaillon-Bentata L
AD  - Department of non-communicable diseases and injuries, Santé publique France, 
      Saint-Maurice, Île-de-France, France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221122
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - *Frailty/epidemiology
MH  - Multimorbidity
MH  - SARS-CoV-2
MH  - Prognosis
MH  - *COVID-19/epidemiology
MH  - Quality of Life
MH  - Systematic Reviews as Topic
MH  - Socioeconomic Factors
MH  - Meta-Analysis as Topic
PMC - PMC9684277
OTO - NOTNLM
OT  - COVID-19
OT  - epidemiology
OT  - public health
COIS- Competing interests: None declared.
EDAT- 2022/11/23 06:00
MHDA- 2022/11/25 06:00
CRDT- 2022/11/22 20:43
PHST- 2022/11/22 20:43 [entrez]
PHST- 2022/11/23 06:00 [pubmed]
PHST- 2022/11/25 06:00 [medline]
AID - bmjopen-2022-063573 [pii]
AID - 10.1136/bmjopen-2022-063573 [doi]
PST - epublish
SO  - BMJ Open. 2022 Nov 22;12(11):e063573. doi: 10.1136/bmjopen-2022-063573.

PMID- 36401247
OWN - NLM
STAT- MEDLINE
DCOM- 20221122
LR  - 20221127
IS  - 1471-2458 (Electronic)
IS  - 1471-2458 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Nov 19
TI  - Effectiveness of a multiple health-behaviour-change intervention in increasing 
      adherence to the Mediterranean Diet in adults (EIRA study): a randomized 
      controlled hybrid trial.
PG  - 2127
LID - 10.1186/s12889-022-14590-y [doi]
LID - 2127
AB  - BACKGROUND: The present study describes the effectiveness of a complex 
      intervention that addresses multiple lifestyles to promote healthy behaviours in 
      increasing adherence to the Mediterranean diet (MD).  METHODS: 
      Cluster-randomised, hybrid clinical trial controlled with two parallel groups. 
      The study was carried out in 26 primary Spanish healthcare centres. People aged 
      45-75 years who presented at least two of the following criteria were included: 
      smoker, low adherence to the MD or insufficient level of physical activity. The 
      intervention group (IG) had three different levels of action: individual, group, 
      and community, with the aim of acting on the behaviours related to smoking, diet 
      and physical activity at the same time. The individual intervention included 
      personalised recommendations and agreements on the objectives to attain. Group 
      sessions were adapted to the context of each healthcare centre. The community 
      intervention was focused on the social prescription of resources and activities 
      performed in the environment of the community of each healthcare centre. Control 
      group (CG) received brief advice given in the usual visits to the doctor's 
      office. The primary outcome was the change, after 12 months, in the number of 
      participants in each group with good adherence to the MD pattern. Secondary 
      outcomes included the change in the total score of the MD adherence score (MEDAS) 
      and the change in some cardiovascular risk factors. RESULTS: Three thousand 
      sixty-two participants were included (IG = 1,481, CG = 1,581). Low adherence to 
      the MD was present in 1,384 (93.5%) participants, of whom 1,233 initiated the 
      intervention and conducted at least one individual visit with a healthcare 
      professional. A greater increase (13.7%; 95% CI, 9.9-17.5; p < 0.001) was 
      obtained by IG in the number of participants who reached 9 points or more (good 
      adherence) in the MEDAS at the final visit. Moreover, the effect attributable to 
      the intervention obtained a greater increase (0.50 points; 95% CI, 0.35 to 0.66; 
      p < 0.001) in IG. CONCLUSIONS: A complex intervention modelled and carried out by 
      primary healthcare professionals, within a real clinical healthcare context, 
      achieved a global increase in the adherence to the MD compared to the brief 
      advice. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03136211. 
      Retrospectively registered on 02/05/2017 
      https://clinicaltrials.gov/ct2/show/NCT03136211.
CI  - © 2022. The Author(s).
FAU - Recio-Rodriguez, Jose I
AU  - Recio-Rodriguez JI
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Facultad de 
      Enfermería Y Fisioterapia (Universidad de Salamanca), Salamanca, Spain. 
      donrecio@usal.es.
FAU - Garcia-Ortiz, Luis
AU  - Garcia-Ortiz L
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Gerencia de Atención Primaria de 
      Salamanca, Departamento de Ciencias Biomédicas Y del Diagnóstico (Universidad de 
      Salamanca), Gerencia Regional de Salud de Castilla Y León (SACyL), 37007, 
      Salamanca, Spain.
FAU - Garcia-Yu, Irene A
AU  - Garcia-Yu IA
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
FAU - Lugones-Sanchez, Cristina
AU  - Lugones-Sanchez C
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Gerencia de Atención Primaria de 
      Salamanca, Gerencia Regional de Salud de Castilla Y León (SACyL), Salamanca, 
      Spain.
FAU - Olmo, Edurne Zabaleta-Del
AU  - Olmo EZ
AD  - Nursing Department, Nursing Faculty (Universitat de Girona), Fundació Institut 
      Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol I Gurina 
      (IDIAPJGol), Gerència Territorial de Barcelona (Institut Català de La Salut), 
      UniversitatAutònoma de Barcelona, Barcelona, Spain.
FAU - Bolibar, Bonaventura
AU  - Bolibar B
AD  - Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Universitat Autònoma de Barcelona, Barcelona, 
      Spain.
FAU - Casajuana-Closas, Marc
AU  - Casajuana-Closas M
AD  - Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Universitat Autònoma de Barcelona, Barcelona, 
      Spain.
FAU - Lopez-Jimenez, Tomas
AU  - Lopez-Jimenez T
AD  - Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
FAU - Llobera, Joan
AU  - Llobera J
AD  - Unitat de Recerca, Atenció Primària de Mallorca. Servei de Salut de Les Illes 
      Balears. IdISBa, Palma, Spain.
FAU - Ramos, Rafel
AU  - Ramos R
AD  - Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut 
      Jordi Gol I Gurina (IDIAPJGol), Group of Research in Vascular Health, Unitat de 
      Suport a La Recerca de Girona, Girona Biomedical Research Institute (IdibGi), 
      Girona, Spain.
FAU - Pombo, Haizea
AU  - Pombo H
AD  - Bizkaia, Deputy Directorate of Healthcare Assistance, 
      Ezkerraldea-Enkarterri-Cruces Integrated Health Organisation-Biocruces Bizkaia 
      Health Research Institute Innovation Unit, Osakidetza-Servicio Vasco de Salud, 
      Araba, Spain.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Universidad Loyola Andalucía, Seville, Spain.
FAU - Gil-Girbau, Montserrat
AU  - Gil-Girbau M
AD  - Research and Development Unit, Institut de Recerca Sant Joan de Déu, Sant Boi de 
      Llobregat, Spain.
FAU - Lopez-Mendez, Fatima
AU  - Lopez-Mendez F
AD  - Instituto de Investigación Sanitaria Aragón, Saragossa, Spain.
FAU - Represas-Carrera, Francisco
AU  - Represas-Carrera F
AD  - Atención Primaria, Área Sanitaria de Vigo, Servicio Gallego de Salud (SERGAS), 
      Grupo I-Saúde (Instituto de Investigación Sanitaria Galicia Sur), Galicia, Spain.
FAU - Maderuelo-Fernandez, Jose A
AU  - Maderuelo-Fernandez JA
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Gerencia de Atención Primaria de 
      Salamanca, Gerencia Regional de Salud de Castilla Y León (SACyL), Salamanca, 
      Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT03136211
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20221119
PL  - England
TA  - BMC Public Health
JT  - BMC public health
JID - 100968562
SB  - IM
MH  - Adult
MH  - Humans
MH  - *Diet, Mediterranean
MH  - Health Behavior
MH  - Smoking
MH  - Exercise
MH  - Life Style
PMC - PMC9675247
OTO - NOTNLM
OT  - Complex interventions
OT  - Cost-effectiveness analysis
OT  - Health behavior
OT  - Health promotion
OT  - Hybrid trial
OT  - Implementation research
OT  - Mediterranean diet
OT  - Physical activity
OT  - Primary health care
OT  - Smoking
COIS- The authors declare that they have no competing interests.
EDAT- 2022/11/20 06:00
MHDA- 2022/11/23 06:00
CRDT- 2022/11/19 00:08
PHST- 2021/11/19 00:00 [received]
PHST- 2022/11/10 00:00 [accepted]
PHST- 2022/11/19 00:08 [entrez]
PHST- 2022/11/20 06:00 [pubmed]
PHST- 2022/11/23 06:00 [medline]
AID - 10.1186/s12889-022-14590-y [pii]
AID - 14590 [pii]
AID - 10.1186/s12889-022-14590-y [doi]
PST - epublish
SO  - BMC Public Health. 2022 Nov 19;22(1):2127. doi: 10.1186/s12889-022-14590-y.

PMID- 36397211
OWN - NLM
STAT- MEDLINE
DCOM- 20230203
LR  - 20230415
IS  - 1099-0968 (Electronic)
IS  - 1072-4133 (Print)
IS  - 1072-4133 (Linking)
VI  - 31
IP  - 2
DP  - 2023 Mar
TI  - 'Mindful eating' for reducing emotional eating in patients with overweight or 
      obesity in primary care settings: A randomized controlled trial.
PG  - 303-319
LID - 10.1002/erv.2958 [doi]
AB  - OBJECTIVE: The primary aim of this study was to analyse the efficacy of a 
      'mindful eating' programme for reducing emotional eating in patients with 
      overweight or obesity. METHOD: A cluster randomized controlled trial (reg. 
      NCT03927534) was conducted with 76 participants with overweight/obesity who were 
      assigned to 'mindful eating' (7 weeks) + treatment as usual (TAU), or to TAU 
      alone. They were assessed at baseline, posttreatment and 12-month follow-up. The 
      main outcome was 'emotional eating' (Dutch Eating Behaviour Questionnaire, DEBQ); 
      other eating behaviours were also assessed along with psychological and 
      physiological variables. RESULTS: 'Mindful eating' + TAU reduced emotional eating 
      both at posttreatment (B = -0.27; p = 0.006; d = 0.35) and follow-up (B = -0.53; 
      p < 0.001; d = 0.69) compared to the control group (TAU alone). 'External eating' 
      (DEBQ) was also significantly improved by the intervention at both timepoints. 
      Significant effects at follow-up were observed for some secondary outcomes 
      related to bulimic behaviours, mindful eating, mindfulness, and self-compassion. 
      Weight and other physiological parameters were not significantly affected by 
      'mindful eating' + TAU. CONCLUSIONS: These findings support the efficacy of the 
      'mindful eating' + TAU programme for reducing emotional and external eating, 
      along with some other secondary measures, but no significant changes in weight 
      reduction were observed.
CI  - © 2022 The Authors. European Eating Disorders Review published by Eating 
      Disorders Association and John Wiley & Sons Ltd.
FAU - Morillo-Sarto, Héctor
AU  - Morillo-Sarto H
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion RD21/0016/0005, 
      RICAPPS, Zaragoza, Spain.
FAU - López-Del-Hoyo, Yolanda
AU  - López-Del-Hoyo Y
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion RD21/0016/0005, 
      RICAPPS, Zaragoza, Spain.
AD  - Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.
FAU - Pérez-Aranda, Adrián
AU  - Pérez-Aranda A
AUID- ORCID: 0000-0002-1602-3413
AD  - Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.
AD  - Department of Basic, Developmental and Educational Psychology, Autonomous 
      University of Barcelona, Barcelona, Spain.
AD  - AGORA Research Group, Teaching, Research & Innovation Unit, Parc Sanitari Sant 
      Joan de Déu, St. Boi de Llobregat, Spain.
FAU - Modrego-Alarcón, Marta
AU  - Modrego-Alarcón M
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion RD21/0016/0005, 
      RICAPPS, Zaragoza, Spain.
AD  - Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.
FAU - Barceló-Soler, Alberto
AU  - Barceló-Soler A
AD  - Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.
AD  - Navarra Medical Research Institute (IdiSNA), Pamplona, Spain.
FAU - Borao, Luis
AU  - Borao L
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion RD21/0016/0005, 
      RICAPPS, Zaragoza, Spain.
FAU - Puebla-Guedea, Marta
AU  - Puebla-Guedea M
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion RD21/0016/0005, 
      RICAPPS, Zaragoza, Spain.
AD  - Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.
FAU - Demarzo, Marcelo
AU  - Demarzo M
AD  - Mente Aberta, Brazilian Center for Mindfulness and Health Promotion, Department 
      of Preventive Medicine, Universidade Federal de São Paulo, São Paulo, Brazil.
AD  - Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
FAU - García-Campayo, Javier
AU  - García-Campayo J
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion RD21/0016/0005, 
      RICAPPS, Zaragoza, Spain.
AD  - Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.
FAU - Montero-Marin, Jesús
AU  - Montero-Marin J
AD  - AGORA Research Group, Teaching, Research & Innovation Unit, Parc Sanitari Sant 
      Joan de Déu, St. Boi de Llobregat, Spain.
AD  - Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20221117
PL  - England
TA  - Eur Eat Disord Rev
JT  - European eating disorders review : the journal of the Eating Disorders 
      Association
JID - 9436977
SB  - IM
MH  - Humans
MH  - *Overweight/therapy/psychology
MH  - *Mindfulness
MH  - Obesity/therapy/psychology
MH  - Feeding Behavior/psychology
MH  - Primary Health Care
PMC - PMC10100015
OTO - NOTNLM
OT  - RCT
OT  - emotional eating
OT  - mindful eating
OT  - mindfulness
OT  - obesity
OT  - overweight
COIS- The author declares that there is no conflict of interest that could be perceived 
      as prejudicing the impartiality of the research reported.
EDAT- 2022/11/19 06:00
MHDA- 2023/02/04 06:00
CRDT- 2022/11/18 00:20
PHST- 2022/10/16 00:00 [revised]
PHST- 2022/06/16 00:00 [received]
PHST- 2022/11/04 00:00 [accepted]
PHST- 2022/11/19 06:00 [pubmed]
PHST- 2023/02/04 06:00 [medline]
PHST- 2022/11/18 00:20 [entrez]
AID - ERV2958 [pii]
AID - 10.1002/erv.2958 [doi]
PST - ppublish
SO  - Eur Eat Disord Rev. 2023 Mar;31(2):303-319. doi: 10.1002/erv.2958. Epub 2022 Nov 
      17.

PMID- 36395339
OWN - NLM
STAT- MEDLINE
DCOM- 20221121
LR  - 20230105
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 17
IP  - 11
DP  - 2022
TI  - Use of health care services according to functional performance in 
      community-dwelling older adults in Spain. An approach using GAMLSS models.
PG  - e0277681
LID - 10.1371/journal.pone.0277681 [doi]
LID - e0277681
AB  - Functional performance in older adults is a predictor of survival and other 
      health outcomes and its measurement is highly recommended in primary care 
      settings. Functional performance and frailty are closely related concepts, and 
      frailty status is associated with the use of health care services. However, there 
      is insufficient evidence on the utilization of services profile according to the 
      functional performance of older adults. The aim of this study was to assess the 
      relationship between functional performance and the use of a wide range of health 
      services in community-dwelling older adults. Generalized additive models for 
      location, scale and shape were used to study these complex data of services 
      utilization, from primary to hospital care. A total of 749 participants from two 
      Spanish regions were followed up for 2 years. Of those, 276 (37%) presented low 
      functional performance and 473 (63%) normal performance according to the Timed Up 
      and Go test. The results showed that even after adjusting for burden of 
      comorbidity and polypharmacy, participants with low functional performance used 
      primary and secondary care health services more intensively, visited emergency 
      rooms more often, and were hospitalized more frequently and for longer periods of 
      time. A negative binomial distribution and a variant thereof were found to be the 
      best models to describe health service utilization data. In conclusion, 
      functionality should be considered as an important health indicator for tailoring 
      the provision of health services for older adults.
CI  - Copyright: © 2022 Mateo-Abad et al. This is an open access article distributed 
      under the terms of the Creative Commons Attribution License, which permits 
      unrestricted use, distribution, and reproduction in any medium, provided the 
      original author and source are credited.
FAU - Mateo-Abad, Maider
AU  - Mateo-Abad M
AUID- ORCID: 0000-0003-2541-8166
AD  - Instituto de Investigación Sanitaria Biodonostia, Grupo de Atención Primaria, 
      Donostia-San Sebastián, Gipuzkoa, España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Salamanca, España.
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
FAU - Vrotsou, Kalliopi
AU  - Vrotsou K
AD  - Instituto de Investigación Sanitaria Biodonostia, Grupo de Atención Primaria, 
      Donostia-San Sebastián, Gipuzkoa, España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Salamanca, España.
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
FAU - Padilla Ruiz, María
AU  - Padilla Ruiz M
AUID- ORCID: 0000-0002-2321-9211
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Salamanca, España.
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
AD  - Unidad de Investigación, Agencia Sanitaria Costa del Sol, Marbella, Málaga, 
      España.
FAU - Montiel-Luque, Alonso
AU  - Montiel-Luque A
AUID- ORCID: 0000-0003-4576-8112
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
AD  - Centro de Salud San Miguel, Distrito Sanitario Costa del Sol, Torremolinos, 
      Málaga, España.
FAU - Saucedo Figueredo, María Del Carmen
AU  - Saucedo Figueredo MDC
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
AD  - Centro de Salud Los Boliches, Distrito Sanitario Costa del Sol, Fuengirola, 
      Málaga, España.
FAU - Machón, Mónica
AU  - Machón M
AD  - Instituto de Investigación Sanitaria Biodonostia, Grupo de Atención Primaria, 
      Donostia-San Sebastián, Gipuzkoa, España.
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
FAU - Rivas Ruiz, Francisco
AU  - Rivas Ruiz F
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Salamanca, España.
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
AD  - Unidad de Investigación, Agencia Sanitaria Costa del Sol, Marbella, Málaga, 
      España.
FAU - Vergara, Itziar
AU  - Vergara I
AD  - Instituto de Investigación Sanitaria Biodonostia, Grupo de Atención Primaria, 
      Donostia-San Sebastián, Gipuzkoa, España.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Salamanca, España.
AD  - Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC), 
      Marbella, España.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221117
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Independent Living
MH  - *Frailty
MH  - Spain
MH  - Postural Balance
MH  - Time and Motion Studies
MH  - Polypharmacy
MH  - Physical Functional Performance
PMC - PMC9671440
COIS- The authors have declared that no competing interests exist
EDAT- 2022/11/18 06:00
MHDA- 2022/11/22 06:00
CRDT- 2022/11/17 14:23
PHST- 2022/04/05 00:00 [received]
PHST- 2022/11/01 00:00 [accepted]
PHST- 2022/11/17 14:23 [entrez]
PHST- 2022/11/18 06:00 [pubmed]
PHST- 2022/11/22 06:00 [medline]
AID - PONE-D-22-08890 [pii]
AID - 10.1371/journal.pone.0277681 [doi]
PST - epublish
SO  - PLoS One. 2022 Nov 17;17(11):e0277681. doi: 10.1371/journal.pone.0277681. 
      eCollection 2022.

PMID- 36388432
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221119
IS  - 2666-1683 (Electronic)
IS  - 2666-1691 (Print)
IS  - 2666-1683 (Linking)
VI  - 46
DP  - 2022 Dec
TI  - Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: 
      A Systematic Review and Meta-analysis.
PG  - 105-127
LID - 10.1016/j.euros.2022.10.017 [doi]
AB  - CONTEXT: Prostate cancer (PCa) is the second most common type of cancer in men. 
      Individualized risk stratification is crucial to adjust decision-making. A 
      variety of molecular biomarkers have been developed in order to identify patients 
      at risk of clinically significant PCa (csPCa) defined by the most common PCa risk 
      stratification systems. OBJECTIVE: The present study aims to examine the 
      effectiveness (diagnostic accuracy) of blood or urine-based PCa biomarkers to 
      identify patients at high risk of csPCa. EVIDENCE ACQUISITION: A systematic 
      review of the literature was conducted. Medline and EMBASE were searched from 
      inception to March 2021. Randomized or nonrandomized clinical trials, and cohort 
      and case-control studies were eligible for inclusion. Risk of bias was assessed 
      using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. 
      Pooled estimates of sensitivity, specificity, and area under the curve were 
      obtained. EVIDENCE SYNTHESIS: Sixty-five studies (N = 34 287) were included. Not 
      all studies included prostate-specific antigen-selected patients. The pooled data 
      showed that the Prostate Health Index (PHI), with any cutoff point between 15 and 
      30, had sensitivity of 0.95-1.00 and specificity of 0.14-0.33 for csPCa 
      detection. The pooled estimates for SelectMDx test sensitivity and specificity 
      were 0.84 and 0.49, respectively. CONCLUSIONS: The PHI test has a high diagnostic 
      accuracy rate for csPCa detection, and its incorporation in the diagnostic 
      process could reduce unnecessary biopsies. However, there is a lack of evidence 
      on patient-important outcomes and thus more research is needed. PATIENT SUMMARY: 
      It has been possible to verify that the application of biomarkers could help 
      detect prostate cancer (PCa) patients with a higher risk of poorer evolution. The 
      Prostate Health Index shows an ability to identify 95-100 for every 100 patients 
      suffering from clinically significant PCa who take the test, preventing 
      unnecessary biopsies in 14-33% of men without PCa or insignificant PCa.
CI  - © 2022 The Authors.
FAU - Del Pino-Sedeño, Tasmania
AU  - Del Pino-Sedeño T
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
AD  - European University of the Canary Islands (UEC), Santa Cruz de Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Infante-Ventura, Diego
AU  - Infante-Ventura D
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - de Armas Castellano, Aythami
AU  - de Armas Castellano A
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
FAU - de Pablos-Rodríguez, Pedro
AU  - de Pablos-Rodríguez P
AD  - Department of Urology, Valencian Institute of Oncology Foundation, Valencia, 
      Spain.
AD  - Doctoral School of University of Las Palmas de Gran Canaria, Las Palmas, Spain.
AD  - Research Institute of Biochemical and Health Sciences, Barcelona, Spain.
FAU - Rueda-Domínguez, Antonio
AU  - Rueda-Domínguez A
AD  - Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University 
      Hospitals, IBIMA, Málaga, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Institute of Biomedical Technologies (ITB). University of La Laguna, Tenerife, 
      Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
FAU - Trujillo-Martín, María M
AU  - Trujillo-Martín MM
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Institute of Biomedical Technologies (ITB). University of La Laguna, Tenerife, 
      Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20221110
PL  - Netherlands
TA  - Eur Urol Open Sci
JT  - European urology open science
JID - 101771568
PMC - PMC9664479
OTO - NOTNLM
OT  - Clinically significant cancer
OT  - Meta-analysis
OT  - Molecular markers
OT  - Prostatic neoplasms
OT  - Systematic review
EDAT- 2022/11/18 06:00
MHDA- 2022/11/18 06:01
CRDT- 2022/11/17 12:12
PHST- 2022/10/18 00:00 [accepted]
PHST- 2022/11/17 12:12 [entrez]
PHST- 2022/11/18 06:00 [pubmed]
PHST- 2022/11/18 06:01 [medline]
AID - S2666-1683(22)02346-1 [pii]
AID - 10.1016/j.euros.2022.10.017 [doi]
PST - epublish
SO  - Eur Urol Open Sci. 2022 Nov 10;46:105-127. doi: 10.1016/j.euros.2022.10.017. 
      eCollection 2022 Dec.

PMID- 36362643
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230308
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 11
IP  - 21
DP  - 2022 Oct 29
TI  - Comorbidity Patterns in Patients with Atopic Dermatitis Using Network Analysis in 
      the EpiChron Study.
LID - 10.3390/jcm11216413 [doi]
LID - 6413
AB  - Background: Atopic dermatitis (AD) is associated with different comorbidities. 
      Methods: Retrospective, observational study based on clinical information from 
      the individuals of the EpiChron Cohort Study (Aragon, Spain) with a diagnosis of 
      AD between 1 January 2010 and 31 December 2018. We calculated the tetrachoric 
      correlations of each pair of comorbidities to analyze the weight of the 
      association between them. We used a cut-off point for statistical significance of 
      p-value < 0.01. Results: The prevalence of AD in the EpiChron Cohort was 3.83%. 
      The most frequently found comorbidities were respiratory, cardio-metabolic, 
      cardiovascular, and mental health disorders. Comorbidities were combined into 17 
      disease patterns (15 in men and 11 in women), with some sex and age 
      specificities. An infectious respiratory pattern was the most consistently 
      described pattern across all ages and sexes, followed by a cardiometabolic 
      pattern that appeared in patients over 18 years of age. Conclusions: Our study 
      revealed the presence of different clinically meaningful comorbidity patterns in 
      patients with AD. Our results can help to identify which comorbidities deserve 
      special attention in these types of patients and to better understand the 
      physio-pathological mechanisms underlying the disease associations identified. 
      Further studies are encouraged to validate the results obtained in different 
      clinical settings and populations.
FAU - Almenara-Blasco, Manuel
AU  - Almenara-Blasco M
AUID- ORCID: 0000-0002-4350-401X
AD  - Department of Dermatology, Miguel Servet University Hospital IIS Aragon, Paseo 
      Isabel la Católica 1-3, 50009 Zaragoza, Spain.
FAU - Carmona-Pírez, Jonás
AU  - Carmona-Pírez J
AUID- ORCID: 0000-0002-6268-8803
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Network for 
      Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      28029 Madrid, Spain.
AD  - Subdirección Técnica Asesora de Gestión de la Información, Andalusian Health 
      Service, 41071 Seville, Spain.
FAU - Gracia-Cazaña, Tamara
AU  - Gracia-Cazaña T
AUID- ORCID: 0000-0002-0523-2076
AD  - Department of Dermatology, Miguel Servet University Hospital IIS Aragon, Paseo 
      Isabel la Católica 1-3, 50009 Zaragoza, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AUID- ORCID: 0000-0002-5119-5093
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Network for 
      Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      28029 Madrid, Spain.
FAU - Pérez-Gilaberte, Juan Blas
AU  - Pérez-Gilaberte JB
AUID- ORCID: 0000-0002-0547-2600
AD  - Department of Internal Medicine, Miguel Servet University Hospital IIS Aragon, 
      50009 Zaragoza, Spain.
FAU - Navarro-Bielsa, Alba
AU  - Navarro-Bielsa A
AUID- ORCID: 0000-0003-1171-6007
AD  - Department of Dermatology, Miguel Servet University Hospital IIS Aragon, Paseo 
      Isabel la Católica 1-3, 50009 Zaragoza, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AUID- ORCID: 0000-0002-5440-1710
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Network for 
      Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      28029 Madrid, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AUID- ORCID: 0000-0002-5704-6056
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Network for 
      Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      28029 Madrid, Spain.
FAU - Gilaberte, Yolanda
AU  - Gilaberte Y
AUID- ORCID: 0000-0001-8034-3617
AD  - Department of Dermatology, Miguel Servet University Hospital IIS Aragon, Paseo 
      Isabel la Católica 1-3, 50009 Zaragoza, Spain.
LA  - eng
GR  - CM19/00164/Instituto de Salud Carlos III/
GR  - RD21/0016/0019/Instituto de Investigación Sanitaria Aragón/
GR  - B01_20R and DECRETO-LEY 3/2020, de 3 de junio, del Gobierno de Aragón/Gobierno de 
      Aragón/
GR  - NextGenerationEU/European Union/
GR  - Private financial/Sanofi-Genzyme/
PT  - Journal Article
DEP - 20221029
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC9658108
OTO - NOTNLM
OT  - atopic dermatitis
OT  - comorbidities
OT  - network analysis
OT  - patterns
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses, or interpretation of data; in 
      the writing of the manuscript; or in the decision to publish the results.
EDAT- 2022/11/12 06:00
MHDA- 2022/11/12 06:01
CRDT- 2022/11/11 01:31
PHST- 2022/09/18 00:00 [received]
PHST- 2022/10/19 00:00 [revised]
PHST- 2022/10/26 00:00 [accepted]
PHST- 2022/11/11 01:31 [entrez]
PHST- 2022/11/12 06:00 [pubmed]
PHST- 2022/11/12 06:01 [medline]
AID - jcm11216413 [pii]
AID - jcm-11-06413 [pii]
AID - 10.3390/jcm11216413 [doi]
PST - epublish
SO  - J Clin Med. 2022 Oct 29;11(21):6413. doi: 10.3390/jcm11216413.

PMID- 36357881
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221117
IS  - 1472-6955 (Print)
IS  - 1472-6955 (Electronic)
IS  - 1472-6955 (Linking)
VI  - 21
IP  - 1
DP  - 2022 Nov 10
TI  - Effectiveness and implementation of an online intervention (MINDxYOU) for 
      reducing stress and promote mental health among healthcare workers in Spain: a 
      study protocol for a stepped-wedge cluster randomized trial.
PG  - 308
LID - 10.1186/s12912-022-01089-5 [doi]
LID - 308
AB  - BACKGROUND: The World Health Organization has formally recognized that healthcare 
      professionals are at risk of developing mental health problems; finding ways to 
      reduce their stress is mandatory to improve both their quality of life and, 
      indirectly, their job performance. In recent years, particularly since the 
      COVID-19 pandemic outbreak, there has been a proliferation of online 
      interventions with promising results. The purpose of the present study is 
      twofold: to test the effectiveness of an online, self-guided intervention, 
      MINDxYOU, to reduce the stress levels of healthcare workers; and to conduct an 
      implementation study of this intervention. Additionally, an economic evaluation 
      of the intervention will be conducted. METHODS: The current study has a hybrid 
      effectiveness-implementation type 2 design. A stepped wedge cluster randomized 
      trial design will be used, with a cohort of 180 healthcare workers recruited in 
      two Spanish provinces (Malaga and Zaragoza). The recruitment stage will commence 
      in October 2022. Frontline health workers who provide direct care to people in a 
      hospital, primary care center, or nursing home setting in both regions will 
      participate. The effectiveness of the intervention will be studied, with 
      perceived stress as the main outcome (Perceived Stress Scale), while other 
      psychopathological symptoms and process variables (e.g., mindfulness, compassion, 
      resilience, and psychological flexibility) will be also assessed as secondary 
      outcomes. The implementation study will include analysis of feasibility, 
      acceptability, adoption, appropriateness, fidelity, penetration, and 
      sustainability. The incremental costs and benefits, in terms of quality-adjusted 
      life years, will be examined by means of cost-utility and cost-effectiveness 
      analyses. DISCUSSION: MINDxYOU is designed to reduce healthcare workers' stress 
      levels through the practice of mindfulness, acceptance, and compassion, with a 
      special focus on how to apply these skills to healthy habits and considering the 
      particular stressors that these professionals face on a daily basis. The present 
      study will show how implementation studies are useful for establishing the 
      framework in which to address barriers to and promote facilitators for 
      acceptability, appropriateness, adoption, feasibility, fidelity, penetration, and 
      sustainability of online interventions. The ultimate goal is to reduce the 
      research-to-practice gap. TRIAL REGISTRATION: This study was registered in 
      ClinicalTrials.gov on 29/06/2022; registration number: NCT05436717.
CI  - © 2022. The Author(s).
FAU - López-Del-Hoyo, Yolanda
AU  - López-Del-Hoyo Y
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain.
AD  - Departamento de Psicología Y Sociología, Facultad de Ciencias Humanas Y de La 
      Educación, Universidad de Zaragoza, Saragossa/Huesca, Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, Saragossa, Spain.
FAU - Fernández-Martínez, Selene
AU  - Fernández-Martínez S
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain.
FAU - Pérez-Aranda, Adrián
AU  - Pérez-Aranda A
AUID- ORCID: 0000-0002-1602-3413
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain. adrian.peara@gmail.com.
AD  - Department of Basic, Developmental and Educational Psychology, Autonomous 
      University of Barcelona, Cerdanyola Del Vallès, Spain. adrian.peara@gmail.com.
FAU - Barceló-Soler, Alberto
AU  - Barceló-Soler A
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain. abarcelosoler@hotmail.com.
AD  - Navarra Medical Research Institute (IdiSNA), Pamplona, Spain. 
      abarcelosoler@hotmail.com.
FAU - Guzman-Parra, Jose
AU  - Guzman-Parra J
AD  - Mental Health Clinical Management Unit, Regional University Hospital of Malaga, 
      Málaga, Spain.
AD  - Malaga Biomedical Research Institute (IBIMA), Málaga, Spain.
FAU - Varela-Moreno, Esperanza
AU  - Varela-Moreno E
AD  - Mental Health Clinical Management Unit, Regional University Hospital of Malaga, 
      Málaga, Spain.
AD  - Malaga Biomedical Research Institute (IBIMA), Málaga, Spain.
AD  - Department of Personality, Evaluation and Psychological Treatment, Faculty of 
      Psychology, University of Malaga, Málaga, Spain.
FAU - Campos, Daniel
AU  - Campos D
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain.
AD  - Departamento de Psicología Y Sociología, Facultad de Ciencias Humanas Y de La 
      Educación, Universidad de Zaragoza, Saragossa/Huesca, Spain.
FAU - Monreal-Bartolomé, Alicia
AU  - Monreal-Bartolomé A
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, Saragossa, Spain.
FAU - Beltrán-Ruiz, María
AU  - Beltrán-Ruiz M
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, Saragossa, Spain.
FAU - Moreno-Küstner, Berta
AU  - Moreno-Küstner B
AD  - Malaga Biomedical Research Institute (IBIMA), Málaga, Spain.
AD  - Department of Personality, Evaluation and Psychological Treatment, Faculty of 
      Psychology, University of Malaga, Málaga, Spain.
AD  - MARISTAN Network, Málaga, Spain.
FAU - Mayoral-Cleries, Fermín
AU  - Mayoral-Cleries F
AD  - Mental Health Clinical Management Unit, Regional University Hospital of Malaga, 
      Málaga, Spain.
AD  - Malaga Biomedical Research Institute (IBIMA), Málaga, Spain.
FAU - García-Campayo, Javier
AU  - García-Campayo J
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, Saragossa, Spain.
AD  - Research Network On Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, Saragossa, Spain.
AD  - Department of Psychiatry, Faculty of Medicine, University of Zaragoza, Saragossa, 
      Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT05436717
GR  - CD20/00181/Instituto de Salud Carlos III/
GR  - PI21/01338/Instituto de Salud Carlos III/
GR  - RD21/0016/0005/Research Network on Chronicity, Primary Care and Health Promotion/
GR  - B17_20R/Gobierno de Aragón/
PT  - Journal Article
DEP - 20221110
PL  - England
TA  - BMC Nurs
JT  - BMC nursing
JID - 101088683
PMC - PMC9647243
OTO - NOTNLM
OT  - Acceptance
OT  - Cluster randomized trial
OT  - Compassion
OT  - Cost-utility
OT  - EHealth
OT  - Healthcare workers
OT  - Implementation
OT  - Mindfulness
OT  - Stress
COIS- The authors declare that they have no competing interests.
EDAT- 2022/11/12 06:00
MHDA- 2022/11/12 06:01
CRDT- 2022/11/11 00:08
PHST- 2022/08/03 00:00 [received]
PHST- 2022/10/27 00:00 [accepted]
PHST- 2022/11/11 00:08 [entrez]
PHST- 2022/11/12 06:00 [pubmed]
PHST- 2022/11/12 06:01 [medline]
AID - 10.1186/s12912-022-01089-5 [pii]
AID - 1089 [pii]
AID - 10.1186/s12912-022-01089-5 [doi]
PST - epublish
SO  - BMC Nurs. 2022 Nov 10;21(1):308. doi: 10.1186/s12912-022-01089-5.

PMID- 36351434
OWN - NLM
STAT- MEDLINE
DCOM- 20221215
LR  - 20230324
IS  - 1437-4331 (Electronic)
IS  - 1434-6621 (Linking)
VI  - 61
IP  - 2
DP  - 2023 Jan 27
TI  - Diagnostic performance of machine learning models using cell population data for 
      the detection of sepsis: a comparative study.
PG  - 356-365
LID - 10.1515/cclm-2022-0713 [doi]
AB  - OBJECTIVES: To compare the artificial intelligence algorithms as powerful machine 
      learning methods for evaluating patients with suspected sepsis using data from 
      routinely available blood tests performed on arrival at the hospital. Results 
      were compared with those obtained from the classical logistic regression method. 
      METHODS: The study group consisted of consecutive patients with fever and 
      suspected infection admitted to the Emergency Department. The complete blood 
      counts (CBC) were acquired using the Mindray BC-6800 Plus analyser (Mindray 
      Diagnostics, Shenzhen, China). Cell Population Data (CPD) were also recorded. The 
      ML and artificial intelligence (AI) models were developed; their performance was 
      evaluated using several indicators, such as the area under the receiver operating 
      curve (AUC), calibration plots and decision curve analysis (DCA). RESULTS: 
      Overall, all the tested approaches obtained an AUC>0.90. The logistic regression 
      (LR) performed well compared to the ML/AI models. The naïve Bayes and the 
      K-nearest neighbour (KNN) methods did not show good calibration properties. The 
      multi-layer perceptron (MLP) model was the best in terms of discrimination, 
      calibration and clinical usefulness. CONCLUSIONS: The best performance in the 
      early detection of sepsis was achieved using the ML and AI models. However, 
      external validation studies are needed to strengthen model derivation and 
      procedure updating.
CI  - © 2022 Walter de Gruyter GmbH, Berlin/Boston.
FAU - Aguirre, Urko
AU  - Aguirre U
AUID- ORCID: 0000-0002-8049-3030
AD  - Research Unit, Osakidetza Basque Health Service, Barrualde-Galdakao Integrated 
      Health Organisation, Galdakao-Usansolo Hospital, Galdakao, Spain.
AD  - Kronikgune Institute for Health Services Research, Barakaldo, Spain.
AD  - Research Network in Health Services in Chronic Diseases (Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas, REDISSEC), Galdakao, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Galdakao, Spain.
FAU - Urrechaga, Eloísa
AU  - Urrechaga E
AUID- ORCID: 0000-0002-9610-7392
AD  - CORE Laboratory, Hospital Galdakao-Usansolo, Galdakao, Vizcaya, Spain.
AD  - Biocruces Bizkaia Health Research Institute, Barakaldo, Vizcaya, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221111
PL  - Germany
TA  - Clin Chem Lab Med
JT  - Clinical chemistry and laboratory medicine
JID - 9806306
SB  - IM
MH  - Humans
MH  - *Artificial Intelligence
MH  - Bayes Theorem
MH  - Machine Learning
MH  - Logistic Models
MH  - *Sepsis/diagnosis
OTO - NOTNLM
OT  - Mindray BC 6800 Plus
OT  - artificial intelligence
OT  - cell population data
OT  - leukocytes
OT  - machine learning
OT  - sepsis
EDAT- 2022/11/10 06:00
MHDA- 2022/12/16 06:00
CRDT- 2022/11/09 18:43
PHST- 2022/07/24 00:00 [received]
PHST- 2022/10/18 00:00 [accepted]
PHST- 2022/11/10 06:00 [pubmed]
PHST- 2022/12/16 06:00 [medline]
PHST- 2022/11/09 18:43 [entrez]
AID - cclm-2022-0713 [pii]
AID - 10.1515/cclm-2022-0713 [doi]
PST - epublish
SO  - Clin Chem Lab Med. 2022 Nov 11;61(2):356-365. doi: 10.1515/cclm-2022-0713. Print 
      2023 Jan 27.

PMID- 36316078
OWN - NLM
STAT- MEDLINE
DCOM- 20221102
LR  - 20221104
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 12
IP  - 10
DP  - 2022 Oct 31
TI  - Complex multidisciplinary intervention to improve Initial Medication Adherence to 
      cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT 
      study): mixed-methods process evaluation protocol.
PG  - e067468
LID - 10.1136/bmjopen-2022-067468 [doi]
LID - e067468
AB  - INTRODUCTION: Medication non-initiation, or primary non-adherence, is a 
      persistent public health problem that increases the risk of adverse clinical 
      outcomes. The initial medication adherence (IMA) intervention is a complex 
      multidisciplinary intervention to improve adherence to cardiovascular and 
      diabetes treatments in primary care by empowering the patient and promoting 
      informed prescriptions based on shared decision-making. This paper presents the 
      development and implementation strategy of the IMA intervention and the process 
      evaluation protocol embedded in a cluster randomised controlled trial (the 
      IMA-cRCT) to understand and interpret the outcomes of the trial and comprehend 
      the extent of implementation and fidelity, the active mechanisms of the IMA 
      intervention and in what context the intervention is implemented and works. 
      METHODS AND ANALYSIS: We present the protocol for a mixed-methods process 
      evaluation including quantitative and qualitative methods to measure 
      implementation and fidelity and to explore the active mechanisms and the 
      interactions between the intervention, participants and its context. The process 
      evaluation will be conducted in primary care centres and community pharmacies 
      from the IMA-cRCT, and participants include healthcare professionals (general 
      practitioners, nurses and community pharmacists) as well as patients. 
      Quantitative data collection methods include data extraction from the 
      intervention operative records, patient clinical records and participant feedback 
      questionnaires, whereas qualitative data collection involves semistructured 
      interviews, focus groups and field diaries. Quantitative and qualitative data 
      will be analysed separately and triangulated to produce deeper insights and 
      robust results. ETHICS AND DISSEMINATION: Ethical approval has been obtained from 
      the Research Ethics Comittee (CEIm) at IDIAP Jordi Gol (codeCEIm 21/051 P). 
      Findings will be disseminated through publications and conferences, as well as 
      presentations to healthcare professionals and stakeholders from healthcare 
      organisations. TRIAL REGISTRATION NUMBER: NCT05026775.
CI  - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published 
      by BMJ.
FAU - Corral-Partearroyo, Carmen
AU  - Corral-Partearroyo C
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain.
AD  - Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, 
      Universitat Autonoma de Barcelona, Bellaterra, Catalunya, Spain.
FAU - Sánchez-Viñas, Alba
AU  - Sánchez-Viñas A
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain.
AD  - Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, 
      Catalunya, Spain.
FAU - Gil-Girbau, Montserrat
AU  - Gil-Girbau M
AUID- ORCID: 0000-0002-4396-6492
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain mariamontserrat.gil@sjd.es.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Peñarrubia-María, Maria Teresa
AU  - Peñarrubia-María MT
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain.
AD  - Unitat de Suport a la Recerca Regió Metropolitana Sud, Fundació Institut 
      Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina 
      (IDIAPJGol), Barcelona, Catalunya, Spain.
FAU - Aznar-Lou, Ignacio
AU  - Aznar-Lou I
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain.
AD  - Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública 
      (CIBERESP), Madrid, Comunidad de Madrid, Spain.
FAU - Gallardo-González, Carmen
AU  - Gallardo-González C
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain.
AD  - Unitat de Suport a la Recerca Regió Metropolitana Sud, Fundació Institut 
      Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina 
      (IDIAPJGol), Barcelona, Catalunya, Spain.
FAU - Olmos-Palenzuela, María Del Carmen
AU  - Olmos-Palenzuela MDC
AD  - Primary Care Centre Bartomeu Fabrés Anglada, Institut Català de la Salut Gerència 
      Territorial Metropolitana Sud, Barcelona, Catalunya, Spain.
FAU - Rubio-Valera, Maria
AU  - Rubio-Valera M
AD  - Health Technology Assessment in Primary Care and Mental Health (PRISMA) Research 
      Group, Parc Sanitari Sant Joan de Deu, Institut de Recerca Sant Joan de Deu, St 
      Boi de Llobregat, Catalunya, Spain.
AD  - Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública 
      (CIBERESP), Madrid, Comunidad de Madrid, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT05026775
PT  - Clinical Trial Protocol
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221031
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - *Cardiovascular Diseases/drug therapy
MH  - Medication Adherence
MH  - *Diabetes Mellitus/drug therapy
MH  - Surveys and Questionnaires
MH  - Primary Health Care
MH  - Randomized Controlled Trials as Topic
PMC - PMC9628671
OTO - NOTNLM
OT  - primary care
OT  - protocols & guidelines
OT  - public health
OT  - statistics & research methods
COIS- Competing interests: None declared.
EDAT- 2022/11/01 06:00
MHDA- 2022/11/03 06:00
CRDT- 2022/10/31 21:12
PHST- 2022/10/31 21:12 [entrez]
PHST- 2022/11/01 06:00 [pubmed]
PHST- 2022/11/03 06:00 [medline]
AID - bmjopen-2022-067468 [pii]
AID - 10.1136/bmjopen-2022-067468 [doi]
PST - epublish
SO  - BMJ Open. 2022 Oct 31;12(10):e067468. doi: 10.1136/bmjopen-2022-067468.

PMID- 36293832
OWN - NLM
STAT- MEDLINE
DCOM- 20221028
LR  - 20230118
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 20
DP  - 2022 Oct 14
TI  - LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate 
      Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
LID - 10.3390/ijerph192013241 [doi]
LID - 13241
AB  - Potentially inappropriate medication (PIM) increases adverse drug reactions and 
      mortality, especially in excessively polymedicated patients. General 
      practitioners are often in charge of this process. Some tools have been created 
      to support them in this matter. This study aimed to measure the amount of 
      potentially inappropriate medication among excessively polymedicated patients 
      using several supporting tools and assess the feasibility of these tools in 
      primary care. Several explicit deprescribing criteria were used to identify 
      potentially inappropriate medications. The level of agreement between all the 
      criteria and the acceptance by the general practitioner (GP) was also measured. 
      We analysed whether the drugs proposed for deprescribing were eventually 
      withdrawn after twelve months. The total number of drugs prescribed was 2038. Six 
      hundred and forty-nine drugs (31.8%) were considered potentially inappropriate by 
      at least one of the tools. GPs agreed with the tools in 56.7% of the cases. In a 
      12-month period, 109 drugs, representing 29.6% of the drugs that GPs agreed to 
      deprescribe, were withdrawn. Elderly excessively polymedicated patients 
      accumulated a great number of PIMs. The use of deprescribing supporting tools, 
      such as explicit criteria, is feasible in primary care, and these tools are well 
      accepted by the GPs. However, eventual withdrawal was carried out in less than 
      half of the cases.
FAU - Reus, Xisco
AU  - Reus X
AUID- ORCID: 0000-0003-1249-7061
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, 07013 
      Palma, Spain.
FAU - Sastre, Maria Lluisa
AU  - Sastre ML
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, 07013 
      Palma, Spain.
FAU - Leiva, Alfonso
AU  - Leiva A
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Balearic Islands Health Research Institute (IdISBa), 07120 Palma, Spain.
AD  - Balearic Health Service IbSalut, Reseach Unit Primary Care Mallorca, 07013 Palma, 
      Spain.
FAU - Sánchez, Belén
AU  - Sánchez B
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, 07013 
      Palma, Spain.
FAU - García-Serra, Cristina
AU  - García-Serra C
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, 07013 
      Palma, Spain.
FAU - Ioakeim-Skoufa, Ignatios
AU  - Ioakeim-Skoufa I
AUID- ORCID: 0000-0002-6518-749X
AD  - Department of Drug Statistics, Division of Health Data and Digitalisation, 
      Norwegian Institute of Public Health, 0213 Oslo, Norway.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), 08009 Barcelona, Spain.
AD  - EpiChron Research Group, IIS Aragón, Miguel Servet University Hospital, 50009 
      Zaragoza, Spain.
FAU - Vicens, Caterina
AU  - Vicens C
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, 07013 
      Palma, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Balearic Islands Health Research Institute (IdISBa), 07120 Palma, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), 08009 Barcelona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20221014
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Humans
MH  - Aged
MH  - *Potentially Inappropriate Medication List
MH  - Polypharmacy
MH  - *Deprescriptions
MH  - Inappropriate Prescribing/prevention & control
MH  - Primary Health Care
PMC - PMC9603607
OTO - NOTNLM
OT  - deprescribing
OT  - elderly
OT  - polypharmacy
OT  - potentially inappropriate medication
COIS- The authors declare no conflict of interest.
EDAT- 2022/10/28 06:00
MHDA- 2022/10/29 06:00
CRDT- 2022/10/27 01:27
PHST- 2022/09/03 00:00 [received]
PHST- 2022/10/10 00:00 [revised]
PHST- 2022/10/11 00:00 [accepted]
PHST- 2022/10/27 01:27 [entrez]
PHST- 2022/10/28 06:00 [pubmed]
PHST- 2022/10/29 06:00 [medline]
AID - ijerph192013241 [pii]
AID - ijerph-19-13241 [pii]
AID - 10.3390/ijerph192013241 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Oct 14;19(20):13241. doi: 
      10.3390/ijerph192013241.

PMID- 36272932
OWN - NLM
STAT- Publisher
LR  - 20221022
IS  - 2603-6479 (Electronic)
IS  - 2603-6479 (Linking)
DP  - 2022 Oct 19
TI  - [Factors associated with the hospital at home workload: A Delphi consensus 
      study].
LID - S2603-6479(22)00075-6 [pii]
LID - 10.1016/j.jhqr.2022.09.001 [doi]
AB  - OBJECTIVES: To identify and prioritize a list of factors that contribute to the 
      workload of the hospital at home (HaH) professionals. MATERIAL AND METHODS: A 
      qualitative methodology study performed between January and December 2019 in the 
      10 HAH units of the Basque Country. The data were obtained in 4phases: 1. 
      Systematic literature search and review; 2. Expert group meeting; 3. Consensus 
      method: Delphi technique (2 survey rounds) and nominal group meeting; 4. Meeting 
      of the research team. RESULTS: In the systematic literature search and review 85 
      factors were initially identified. These were reduced to 38 after the 8-person 
      expert group meeting, in which 10 new factors were added. After the 2 Delphi 
      rounds (106 and 57 professionals, respectively), 17 factors were maintained and 
      12 remained in doubt. The latter were evaluated at the nominal group meeting, 
      consisting of 13 professionals who decided to eliminate 5 factors, include 3, and 
      keep 3 as doubt. After the 8-person research team meeting, 14 potential factors 
      were finally selected. They are related to the place of residence, the health 
      state and social situation of the patients, as well as the health care provided 
      at home. CONCLUSIONS: The identified factors could serve for improving the 
      organization and optimize the daily word of the HaH professionals.
CI  - Copyright © 2022 FECA. Publicado por Elsevier España, S.L.U. All rights reserved.
FAU - Vrotsou, K
AU  - Vrotsou K
AD  - Instituto de Investigación Sanitaria Biodonostia, Grupo de Atención Primaria, San 
      Sebastián, Guipúzcoa, España; Red de Investigación en Servicios de Salud en 
      Enfermedades Crónicas (REDISSEC); Red de Investigación en Cronicidad, Atención 
      Primaria y Promoción de la Salud (RICAPPS), España. Electronic address: 
      kalliopi.vrotsoukanari@osakidetza.eus.
FAU - Orive-Calzada, M
AU  - Orive-Calzada M
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC); 
      Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Departamento de Psicología Social, Universidad del País Vasco 
      UPV/EHU, Vitoria-Gasteiz, Araba, España.
FAU - González, N
AU  - González N
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC); 
      Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), España; Instituto de Investigación en Servicios de Salud Kronikgune, 
      Barakaldo, Bizkaia, España; Osakidetza, Unidad de Investigación, Hospital 
      Galdakao-Usansolo, Galdakao, Bizkaia, España.
FAU - Vergara, I
AU  - Vergara I
AD  - Instituto de Investigación Sanitaria Biodonostia, Grupo de Atención Primaria, San 
      Sebastián, Guipúzcoa, España; Red de Investigación en Servicios de Salud en 
      Enfermedades Crónicas (REDISSEC); Red de Investigación en Cronicidad, Atención 
      Primaria y Promoción de la Salud (RICAPPS), España.
FAU - Pascual-Fernández, N
AU  - Pascual-Fernández N
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital Bidasoa, Hondarribia, 
      Gipuzkoa, España.
FAU - Guerra-López, C
AU  - Guerra-López C
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital Bidasoa, Hondarribia, 
      Gipuzkoa, España.
FAU - García-Montes, R
AU  - García-Montes R
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital Universitario 
      Donostia, San Sebastián, Gipuzkoa, España.
FAU - Ortiz-Ribes, J
AU  - Ortiz-Ribes J
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital Universitario 
      Donostia, San Sebastián, Gipuzkoa, España.
FAU - Onaindia-Ecenarro, M J
AU  - Onaindia-Ecenarro MJ
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital de Galdakao-Usansolo, 
      Galdakao, Bizkaia, España.
FAU - Regalado-de Los Cobos, J
AU  - Regalado-de Los Cobos J
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital Universitario de 
      Araba, Vitoria-Gasteiz, Araba, España.
FAU - Millet-Sampedro, M
AU  - Millet-Sampedro M
AD  - Osakidetza, Unidad de Hospitalización a Domicilio, Hospital Bidasoa, Hondarribia, 
      Gipuzkoa, España.
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Factores relacionados con la carga de trabajo en hospitalización a domicilio: 
      estudio de consenso Delphi.
DEP - 20221019
PL  - Spain
TA  - J Healthc Qual Res
JT  - Journal of healthcare quality research
JID - 101735273
SB  - IM
OTO - NOTNLM
OT  - Carga de trabajo
OT  - Delphi technique
OT  - Factores
OT  - Factors
OT  - Health professionals
OT  - Hospital at home
OT  - Hospitalización a domicilio
OT  - Profesionales sanitarios
OT  - Técnica Delphi
OT  - Workload
EDAT- 2022/10/23 06:00
MHDA- 2022/10/23 06:00
CRDT- 2022/10/22 22:07
PHST- 2022/04/11 00:00 [received]
PHST- 2022/06/20 00:00 [revised]
PHST- 2022/09/06 00:00 [accepted]
PHST- 2022/10/22 22:07 [entrez]
PHST- 2022/10/23 06:00 [pubmed]
PHST- 2022/10/23 06:00 [medline]
AID - S2603-6479(22)00075-6 [pii]
AID - 10.1016/j.jhqr.2022.09.001 [doi]
PST - aheadofprint
SO  - J Healthc Qual Res. 2022 Oct 19:S2603-6479(22)00075-6. doi: 
      10.1016/j.jhqr.2022.09.001.

PMID- 36258639
OWN - NLM
STAT- Publisher
LR  - 20221019
IS  - 1469-8978 (Electronic)
IS  - 0033-2917 (Linking)
DP  - 2022 Oct 19
TI  - Utility of PHQ-2, PHQ-8 and PHQ-9 for detecting major depression in primary 
      health care: a validation study in Spain.
PG  - 1-11
LID - 10.1017/S0033291722002835 [doi]
AB  - BACKGROUND: Primary health care (PHC) professionals may play a crucial role in 
      improving early diagnosis of depressive disorders. However, only 50% of cases are 
      detected in PHC. The most widely used screening instrument for major depression 
      is the Patient Health Questionnaire (PHQ), including the two-, eight- and 
      nine-item versions. Surprisingly, there is neither enough evidence about the 
      validity of PHQ in PHC patients in Spain nor indications about how to interpret 
      the total scores. This study aimed to gather validity evidence to support the use 
      of the three PHQ versions to screen for major depression in PHC in Spain. 
      Additionally, the present study provided information for helping professionals to 
      choose the best PHQ version according to the context. METHODS: The sample was 
      composed of 2579 participants from 22 Spanish PHC centers participating in the 
      EIRA-3 study. The reliability and validity of the three PHQ versions for Spanish 
      PHC patients were assessed based on responses to the questionnaire. RESULTS: The 
      PHQ-8 and PHQ-9 showed high internal consistency. The results obtained confirm 
      the theoretically expected relationship between PHQ results and anxiety, social 
      support and health-related QoL. A single-factor solution was confirmed. Regarding 
      to the level of agreement with the CIDI interview (used as the criterion), our 
      results indicate that the PHQ has a good discrimination power. The optimal 
      cut-off values were: ⩾2 for PHQ-2, ⩾7 for PHQ-8 and ⩾8 for PHQ-9. CONCLUSIONS: 
      PHQ is a good and valuable tool for detecting major depression in PHC patients in 
      Spain.
FAU - Gómez-Gómez, Irene
AU  - Gómez-Gómez I
AUID- ORCID: 0000-0001-8014-6955
AD  - Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Seville, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
FAU - Benítez, Isabel
AU  - Benítez I
AD  - Department of Methodology of Behavioral Sciences, Universidad de Granada, 
      Granada, Spain.
FAU - Bellón, Juan
AU  - Bellón J
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Biomedical Research Institute of Málaga (IBIMA), Málaga, Spain.
AD  - El Palo Health Centre, Andalusian Health Service (SAS), Málaga, Spain.
AD  - Department of Public Health and Psychiatry, University of Málaga (UMA), Málaga, 
      Spain.
FAU - Moreno-Peral, Patricia
AU  - Moreno-Peral P
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Biomedical Research Institute of Málaga (IBIMA), Málaga, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Department of Psychology and Sociology, Universidad de Zaragoza, Zaragoza, Spain.
AD  - Institute for Health Research Aragón (IISA), Zaragoza, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Primary Care Research Unit, Área de Vigo, SERGAS, Vigo, Spain.
AD  - I-Saúde Group, Galicia Sur Health Research Institute (IIS Galicia Sur), 
      SERGAS-UVIGO, Vigo, Spain.
FAU - Zabaleta-Del-Olmo, Edurne
AU  - Zabaleta-Del-Olmo E
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
AD  - Atenció Primària Barcelona Ciutat, Gerència Territorial de Barcelona, Institut 
      Català de la Salut, Barcelona, Spain.
AD  - Nursing department, Faculty of Nursing, Universitat de Girona, Girona, Spain.
FAU - Llobera, Joan
AU  - Llobera J
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma 
      de Mallorca, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 
      Spain.
FAU - Serrano-Ripoll, Maria J
AU  - Serrano-Ripoll MJ
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma 
      de Mallorca, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 
      Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
FAU - Motrico, Emma
AU  - Motrico E
AD  - Department of Psychology, Universidad Loyola Andalucía, Dos Hermanas, Seville, 
      Spain.
AD  - Prevention and Health Promotion Research Network (redIAPP)/Network for Research 
      on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221019
PL  - England
TA  - Psychol Med
JT  - Psychological medicine
JID - 1254142
SB  - IM
OTO - NOTNLM
OT  - Diagnostic accuracy
OT  - major depression
OT  - patient health questionnaire
OT  - primary health care
OT  - validity study
EDAT- 2022/10/20 06:00
MHDA- 2022/10/20 06:00
CRDT- 2022/10/19 01:12
PHST- 2022/10/19 01:12 [entrez]
PHST- 2022/10/20 06:00 [pubmed]
PHST- 2022/10/20 06:00 [medline]
AID - S0033291722002835 [pii]
AID - 10.1017/S0033291722002835 [doi]
PST - aheadofprint
SO  - Psychol Med. 2022 Oct 19:1-11. doi: 10.1017/S0033291722002835.

PMID- 36256522
OWN - NLM
STAT- MEDLINE
DCOM- 20221216
LR  - 20230224
IS  - 1468-1331 (Electronic)
IS  - 1351-5101 (Linking)
VI  - 30
IP  - 1
DP  - 2023 Jan
TI  - Telemedicine for neurological diseases: A systematic review and meta-analysis.
PG  - 241-254
LID - 10.1111/ene.15599 [doi]
AB  - BACKGROUND AND PURPOSE: The aim was to systematically review the effectiveness 
      and safety of telemedicine combined with usual care (in-person visits) compared 
      to usual care for the therapeutic management and follow-up assessment of 
      neurological diseases. METHODS: The electronic databases MEDLINE, Embase, Web of 
      Science and Cochrane Central Register of Controlled Trials were searched (June 
      2021). Randomized controlled trials (RCTs) on patients of any age with 
      neurological diseases were considered. Two reviewers screened and abstracted data 
      in duplicate and independently and assessed risk of bias using the Cochrane 
      risk-of-bias tool for randomized trials (RoB 2). When possible, pooled effect 
      estimates were calculated. RESULTS: Of a total of 3018 records initially 
      retrieved, 25 RCTs (n = 2335) were included: 11 (n = 804) on stroke, four 
      (n = 520) on Parkinson's disease, three (n = 110) on multiple sclerosis, two 
      (n = 320) on epilepsy, one (n = 63) on dementia, one (n = 23) on spina bifida, 
      one (n = 40) on migraine, one (n = 22) on cerebral palsy and one (n = 433) on 
      brain damage. Types of telemedicine assessed were online visits (11 studies), 
      tele-rehabilitation (seven studies), telephone calls (three), smartphone apps 
      (two) and online computer software (two). The evidence was quite limited except 
      for stroke. Compared to usual care alone, telemedicine plus usual care was found 
      to improve depressive symptoms, functional status, motor function, executive 
      function, generic quality of life, healthcare utilization and healthy lifestyle 
      in patients in post-stroke follow-up. CONCLUSIONS: Well-designed and executed 
      RCTs are needed to confirm our findings on stroke and to have more scientific 
      evidence available for the other neurological diseases.
CI  - © 2022 European Academy of Neurology.
FAU - León-Salas, Beatriz
AU  - León-Salas B
AUID- ORCID: 0000-0001-5803-1756
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Spanish Network of Agencies for Health Technology Assessment and Services of the 
      National Health System (RedETS), Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - González-Hernández, Yadira
AU  - González-Hernández Y
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Spanish Network of Agencies for Health Technology Assessment and Services of the 
      National Health System (RedETS), Madrid, Spain.
FAU - Infante-Ventura, Diego
AU  - Infante-Ventura D
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Spanish Network of Agencies for Health Technology Assessment and Services of the 
      National Health System (RedETS), Madrid, Spain.
FAU - de Armas-Castellano, Aythami
AU  - de Armas-Castellano A
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Spanish Network of Agencies for Health Technology Assessment and Services of the 
      National Health System (RedETS), Madrid, Spain.
FAU - García-García, Javier
AU  - García-García J
AD  - Quality and Patient Safety Unit, Nuestra Señora de Candelaria University 
      Hospital, Tenerife, Spain.
FAU - García-Hernández, Miguel
AU  - García-Hernández M
AD  - Teaching Unit of Family and Community Medicine 'La Laguna-Tenerife Norte', 
      Primary Care Management of Tenerife, Canary Islands Health Service (SCS), 
      Tenerife, Spain.
FAU - Carmona-Rodríguez, Montserrat
AU  - Carmona-Rodríguez M
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - Health Technology Assessment Agency, Instituto de Salud Carlos III, Madrid, 
      Spain.
FAU - Olazarán, Javier
AU  - Olazarán J
AD  - Neurology Service, Gregorio Marañón University Hospital, Madrid, Spain.
FAU - Dobato, José Luis
AU  - Dobato JL
AD  - Neurology Service, Alcorcón Foundation University Hospital, Madrid, Spain.
FAU - Rodríguez-Rodríguez, Leticia
AU  - Rodríguez-Rodríguez L
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Spanish Network of Agencies for Health Technology Assessment and Services of the 
      National Health System (RedETS), Madrid, Spain.
FAU - Trujillo-Martín, María M
AU  - Trujillo-Martín MM
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Spanish Network of Agencies for Health Technology Assessment and Services of the 
      National Health System (RedETS), Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PT  - Systematic Review
DEP - 20221114
PL  - England
TA  - Eur J Neurol
JT  - European journal of neurology
JID - 9506311
SB  - IM
MH  - Humans
MH  - *Telemedicine
MH  - Quality of Life
MH  - *Stroke/therapy
MH  - Executive Function
MH  - *Brain Injuries
OTO - NOTNLM
OT  - effectiveness
OT  - meta-analysis
OT  - neurological diseases
OT  - safety
OT  - telemedicine
OT  - teleneurology
EDAT- 2022/10/19 06:00
MHDA- 2022/12/17 06:00
CRDT- 2022/10/18 12:13
PHST- 2022/09/26 00:00 [revised]
PHST- 2022/08/09 00:00 [received]
PHST- 2022/10/10 00:00 [accepted]
PHST- 2022/10/19 06:00 [pubmed]
PHST- 2022/12/17 06:00 [medline]
PHST- 2022/10/18 12:13 [entrez]
AID - 10.1111/ene.15599 [doi]
PST - ppublish
SO  - Eur J Neurol. 2023 Jan;30(1):241-254. doi: 10.1111/ene.15599. Epub 2022 Nov 14.

PMID- 36243636
OWN - NLM
STAT- MEDLINE
DCOM- 20221206
LR  - 20230505
IS  - 1579-2129 (Electronic)
IS  - 0300-2896 (Print)
IS  - 0300-2896 (Linking)
VI  - 58
IP  - 12
DP  - 2022 Dec
TI  - Utility of Differential White Cell Count and Cell Population Data for Ruling Out 
      COVID-19 Infection in Patients With Community-Acquired Pneumonia.
PG  - 802-808
LID - S0300-2896(22)00529-4 [pii]
LID - 10.1016/j.arbres.2022.08.011 [doi]
AB  - INTRODUCTION: The main aim of this study was to assess the utility of 
      differential white cell count and cell population data (CPD) for the detection of 
      COVID-19 in patients admitted for community-acquired pneumonia (CAP) of different 
      etiologies. METHODS: This was a multicenter, observational, prospective study of 
      adults aged ≥18 years admitted to three teaching hospitals in Spain from November 
      2019 to November 2021 with a diagnosis of CAP. At baseline, a Sysmex XN-20 
      analyzer was used to obtain detailed information related to the activation status 
      and functional activity of white cells. RESULTS: The sample was split into 
      derivation and validation cohorts of 1065 and 717 patients, respectively. In the 
      derivation cohort, COVID-19 was confirmed in 791 patients and ruled out in 274 
      patients, with mean ages of 62.13 (14.37) and 65.42 (16.62) years, respectively 
      (p<0.001). There were significant differences in all CPD parameters except MO-Y. 
      The multivariate prediction model showed that lower NE-X, NE-WY, LY-Z, LY-WY, 
      MO-WX, MO-WY, and MO-Z values and neutrophil-to-lymphocyte ratio were related to 
      COVID-19 etiology with an AUC of 0.819 (0.790, 0.846). No significant differences 
      were found comparing this model to another including biomarkers (p=0.18). 
      CONCLUSIONS: Abnormalities in white blood cell morphology based on a few cell 
      population data values as well as NLR were able to accurately identify COVID-19 
      etiology. Moreover, systemic inflammation biomarkers currently used were unable 
      to improve the predictive ability. We conclude that new peripheral blood 
      biomarkers can help determine the etiology of CAP fast and inexpensively.
CI  - Copyright © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.
FAU - Uranga, Ane
AU  - Uranga A
AD  - Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain; BioCruces Bizkaia Health Reasearch Institute, Baracaldo, Spain. Electronic 
      address: ane.urangaecheverria@osakidetza.eus.
FAU - Urrechaga, Eloisa
AU  - Urrechaga E
AD  - BioCruces Bizkaia Health Reasearch Institute, Baracaldo, Spain; Laboratory, 
      Universitary Hospital of Galdakao-Usansolo, Galdakao, Spain.
FAU - Aguirre, Urko
AU  - Aguirre U
AD  - Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, Research 
      Unit, Galdakao, Spain; Health Service Research Network on Chronic Diseases 
      (REDISSEC), Bizkaia, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Spain.
FAU - Intxausti, Maider
AU  - Intxausti M
AD  - Department of Pneumology, Universitary Hospital of Basurto, Bilbao, Spain.
FAU - Ruiz-Martinez, Carlos
AU  - Ruiz-Martinez C
AD  - Department of Pneumology, Universitary Hospital of San Pedro Logroño, La Rioja, 
      Spain.
FAU - Lopez de Goicoechea, Maria Jose
AU  - Lopez de Goicoechea MJ
AD  - Department of Microbiology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
FAU - Ponga, Cristina
AU  - Ponga C
AD  - BioCruces Bizkaia Health Reasearch Institute, Baracaldo, Spain; Laboratory, 
      Universitary Hospital of Galdakao-Usansolo, Galdakao, Spain.
FAU - Quintana, Jose María
AU  - Quintana JM
AD  - Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, Research 
      Unit, Galdakao, Spain; Health Service Research Network on Chronic Diseases 
      (REDISSEC), Bizkaia, Spain; Kronikgune Institute for Health Services Research, 
      Barakaldo, Spain; Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), Spain.
FAU - Sancho, Cristina
AU  - Sancho C
AD  - Department of Pneumology, Universitary Hospital of Basurto, Bilbao, Spain.
FAU - Sanz, Pilar
AU  - Sanz P
AD  - Department of Biomedical Diagnostics, Universitary Hospital of San Pedro Logroño, 
      La Rioja, Spain.
FAU - España, Pedro Pablo
AU  - España PP
AD  - Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain; BioCruces Bizkaia Health Reasearch Institute, Baracaldo, Spain.
CN  - LEUCOCAP STUDY GROUP
CN  - LEUCOCAP STUDY GROUP
LA  - eng
LA  - spa
PT  - Journal Article
PT  - Multicenter Study
PT  - Observational Study
DEP - 20220921
PL  - Spain
TA  - Arch Bronconeumol
JT  - Archivos de bronconeumologia
JID - 0354720
RN  - 0 (Biomarkers)
SB  - IM
MH  - Adult
MH  - Humans
MH  - Adolescent
MH  - *COVID-19/diagnosis
MH  - Prospective Studies
MH  - Leukocyte Count
MH  - *Community-Acquired Infections/diagnosis
MH  - *Pneumonia/diagnosis
MH  - Biomarkers
PMC - PMC9489980
OTO - NOTNLM
OT  - Biomarkers
OT  - COVID-19
OT  - Cell population data
OT  - Leucocytes
OT  - Pneumonia
OT  - Symex XN
FIR - Uranga, Ane
IR  - Uranga A
IRAD- Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
FIR - Artaraz, Amaia
IR  - Artaraz A
IRAD- Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
FIR - Ballaz, Aitor
IR  - Ballaz A
IRAD- Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
FIR - Dorado, Sandra
IR  - Dorado S
IRAD- Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
FIR - Pascual, Silvia
IR  - Pascual S
IRAD- Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
FIR - Aguirre, Urko
IR  - Aguirre U
IRAD- Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, Research 
      Unit, Galdakao, Spain.
FIR - Quintana, Jose María
IR  - Quintana JM
IRAD- Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, Research 
      Unit, Galdakao, Spain.
FIR - Villanueva, Ane
IR  - Villanueva A
IRAD- Osakidetza Basque Health Service, Galdakao-Usansolo University Hospital, Research 
      Unit, Galdakao, Spain.
FIR - Mar, Carmen
IR  - Mar C
IRAD- Laboratory, Universitary Hospital of Galdakao-Usansolo, Galdakao, Spain.
FIR - Urrechaga, Eloisa
IR  - Urrechaga E
IRAD- Laboratory, Universitary Hospital of Galdakao-Usansolo, Galdakao, Spain.
FIR - Ponga, Cristina
IR  - Ponga C
IRAD- Laboratory, Universitary Hospital of Galdakao-Usansolo, Galdakao, Spain.
FIR - Arriaga, Ignacio
IR  - Arriaga I
IRAD- Department of Pneumology, Universitary Hospital of Basurto, Bilbao, Spain.
FIR - Intxausti, Maider
IR  - Intxausti M
IRAD- Department of Pneumology, Universitary Hospital of Basurto, Bilbao, Spain.
FIR - Fernandez, Domingo
IR  - Fernandez D
IRAD- Department of Microbiology, Universitary Hospital of basurto, Bilbao, Spain.
FIR - Benito, Itziar
IR  - Benito I
IRAD- Laboratoty, Universitary Hospital of basurto, Bilbao, Spain.
FIR - Ruiz-Martinez, Carlos
IR  - Ruiz-Martinez C
IRAD- Department of Pneumology, Universitary Hospital of San Pedro Logroño, La Rioja, 
      Spain.
FIR - Ugeda, Javier
IR  - Ugeda J
IRAD- Department of Pneumology, Universitary Hospital of San Pedro Logroño, La Rioja, 
      Spain.
FIR - Sanz, Pilar
IR  - Sanz P
IRAD- Department of Biomedical Diagnostics, Universitary Hospital of San Pedro Logroño, 
      La Rioja, Spain.
FIR - Bernardo, Ivan
IR  - Bernardo I
IRAD- Department of Biomedical Diagnostics, Universitary Hospital of San Pedro Logroño, 
      La Rioja, Spain.
FIR - España, Pedro Pablo
IR  - España PP
IRAD- Department of Pneumology, Universitary Hospital of Galdakao-Usansolo, Galdakao, 
      Spain.
EDAT- 2022/10/16 06:00
MHDA- 2022/12/07 06:00
CRDT- 2022/10/15 22:16
PHST- 2022/06/18 00:00 [received]
PHST- 2022/08/08 00:00 [revised]
PHST- 2022/08/12 00:00 [accepted]
PHST- 2022/10/16 06:00 [pubmed]
PHST- 2022/12/07 06:00 [medline]
PHST- 2022/10/15 22:16 [entrez]
AID - S0300-2896(22)00529-4 [pii]
AID - 10.1016/j.arbres.2022.08.011 [doi]
PST - ppublish
SO  - Arch Bronconeumol. 2022 Dec;58(12):802-808. doi: 10.1016/j.arbres.2022.08.011. 
      Epub 2022 Sep 21.

PMID- 36242652
OWN - NLM
STAT- MEDLINE
DCOM- 20221018
LR  - 20221022
IS  - 1590-9999 (Electronic)
IS  - 1590-9921 (Print)
IS  - 1590-9921 (Linking)
VI  - 23
IP  - 1
DP  - 2022 Oct 15
TI  - Efficacy and safety of robotic spine surgery: systematic review and 
      meta-analysis.
PG  - 49
LID - 10.1186/s10195-022-00669-0 [doi]
LID - 49
AB  - BACKGROUND: Robotic surgery (RS) may offer benefits compared with 
      freehand/conventional surgery (FS) in the treatment of patients with spinal 
      disease. The aim of this study was to evaluate the efficacy and safety of RS 
      versus FS in spinal fusion. METHODS: A systematic review and meta-analysis was 
      performed. Data analysis and risk of bias assessment were analysed using REVMAN 
      V5.3. RESULTS: We found 11 randomised clinical trials involving 817 patients (FS: 
      408, RS: 409). The main diagnosis was degenerative spine disease. SpineAssist, 
      Renaissance (Mazor Robotics), Tianji Robot and TiRobot robots (TINAVI Medical 
      Technologies) were used. Pedicle screw placement within the safety zone (grades 
      A + B according to the Gertzbein and Robbins scale) ranged from 93% to 100% in FS 
      versus 85-100% in RS (relative risk 1.01, 95% CI  1.00-1.03, p = 0.14). Regarding 
      intervention time, the meta-analysis showed a mean difference (MD) of 6.45 min 
      (95% CI  -13.59 to 26.49, p = 0.53). Mean hospital stay was MD of -0.36 days (95% 
      CI  -1.03 to 0.31, p = 0.30) with no differences between groups. Contradictory 
      results were found regarding fluoroscopy time, although there seems to be a lower 
      radiation dose in RS versus FS (p < 0.05). Regarding safety, the studies included 
      surgical revision frequency. CONCLUSIONS: No conclusive results were found 
      suggesting that there are benefits in using RS over FS for spinal fusion. Further 
      research with adequate patient selection, robot type and quality-of-life 
      variables is needed. LEVEL OF EVIDENCE: level 1.
CI  - © 2022. The Author(s).
FAU - Luengo-Matos, Setefilla
AU  - Luengo-Matos S
AUID- ORCID: 0000-0001-6785-4447
AD  - Health Technology Assessment Agency (Agencia de Evaluación de Tecnologías 
      Sanitarias, AETS), Carlos III Institute of Health, Madrid, Spain.
FAU - Sánchez-Gómez, Luis María
AU  - Sánchez-Gómez LM
AUID- ORCID: 0000-0003-4358-6032
AD  - Health Technology Assessment Agency (Agencia de Evaluación de Tecnologías 
      Sanitarias, AETS), Carlos III Institute of Health, Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Hijas-Gómez, Ana Isabel
AU  - Hijas-Gómez AI
AUID- ORCID: 0000-0002-7748-7529
AD  - Health Technology Assessment Agency (Agencia de Evaluación de Tecnologías 
      Sanitarias, AETS), Carlos III Institute of Health, Madrid, Spain.
FAU - García-Carpintero, Esther Elena
AU  - García-Carpintero EE
AUID- ORCID: 0000-0002-7804-1449
AD  - Health Technology Assessment Agency (Agencia de Evaluación de Tecnologías 
      Sanitarias, AETS), Carlos III Institute of Health, Madrid, Spain. 
      esther.carpintero@cchs.csic.es.
AD  - Consejo Superior de Investigaciones Científicas, Madrid, Spain. 
      esther.carpintero@cchs.csic.es.
FAU - Ballesteros-Massó, Rafael
AU  - Ballesteros-Massó R
AD  - Servicio de Traumatología, Hospital Quirónsalud Sur, Alcorcón, Spain.
FAU - Polo-deSantos, Mar
AU  - Polo-deSantos M
AUID- ORCID: 0000-0002-4426-1128
AD  - Health Technology Assessment Agency (Agencia de Evaluación de Tecnologías 
      Sanitarias, AETS), Carlos III Institute of Health, Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Madrid, Spain.
LA  - eng
PT  - Meta-Analysis
PT  - Systematic Review
DEP - 20221015
PL  - Italy
TA  - J Orthop Traumatol
JT  - Journal of orthopaedics and traumatology : official journal of the Italian 
      Society of Orthopaedics and Traumatology
JID - 101090931
SB  - IM
MH  - Humans
MH  - Lumbar Vertebrae/surgery
MH  - *Pedicle Screws
MH  - Retrospective Studies
MH  - *Robotic Surgical Procedures/adverse effects/methods
MH  - *Robotics
MH  - *Spinal Diseases/surgery
MH  - *Spinal Fusion/methods
MH  - Spine/surgery
PMC - PMC9569281
OTO - NOTNLM
OT  - Pedicle
OT  - Robotic surgery
OT  - Spine
OT  - Systematic review
COIS- The authors have no conflicts of interest to declare that are relevant to the 
      content of this article.
EDAT- 2022/10/16 06:00
MHDA- 2022/10/19 06:00
CRDT- 2022/10/15 11:15
PHST- 2021/06/21 00:00 [received]
PHST- 2022/09/24 00:00 [accepted]
PHST- 2022/10/15 11:15 [entrez]
PHST- 2022/10/16 06:00 [pubmed]
PHST- 2022/10/19 06:00 [medline]
AID - 10.1186/s10195-022-00669-0 [pii]
AID - 669 [pii]
AID - 10.1186/s10195-022-00669-0 [doi]
PST - epublish
SO  - J Orthop Traumatol. 2022 Oct 15;23(1):49. doi: 10.1186/s10195-022-00669-0.

PMID- 36231985
OWN - NLM
STAT- MEDLINE
DCOM- 20221017
LR  - 20230117
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 19
DP  - 2022 Oct 4
TI  - Using a Taxonomy to Systematically Identify and Describe Self-Management 
      Interventions Components in Randomized Trials for COPD.
LID - 10.3390/ijerph191912685 [doi]
LID - 12685
AB  - Self-management interventions (SMIs) may improve outcomes in Chronic Obstructive 
      Pulmonary Disease (COPD). However, accurate comparisons of their relative 
      effectiveness are challenging, partly due to a lack of clarity and detail 
      regarding the intervention content being evaluated. This study systematically 
      describes intervention components and characteristics in randomized controlled 
      trials (RCTs) related to COPD self-management using the COMPAR-EU taxonomy as a 
      framework, identifying components that are insufficiently incorporated into the 
      design of the intervention or insufficiently reported. Overall, 235 RCTs 
      published between 2010 and 2018, from a systematic review were coded using the 
      taxonomy, which includes 132 components across four domains: intervention 
      characteristics, expected patient (or caregiver) self-management behaviours, 
      patient relevant outcomes, and target population characteristics. Risk of bias 
      was also assessed. Interventions mainly focused on physical activity (67.4%), and 
      condition-specific behaviours like breathing exercise (63.5%), self-monitoring 
      (50.8%), and medication use (33.9%). Support techniques like education and 
      skills-training, self-monitoring, and goal setting (over 35% of the RCTs) were 
      mostly used for this. Emotional-based techniques, problem-solving, and shared 
      decision-making were less frequently reported (less than 15% of the studies). 
      Numerous SMIs components were insufficiently incorporated into the design of COPD 
      SMIs or insufficiently reported. Characteristics like mode of delivery, 
      intensity, location, and providers involved were often not described. Only 8% of 
      the interventions were tailored to the target population's characteristics. 
      Outcomes that are considered important by patients were hardly taken into 
      account. There is still a lot to improve in both the design and description of 
      SMIs for COPD. Using a framework such as the COMPAR-EU SMI taxonomy may 
      contribute to better reporting and to better informing of replication efforts. In 
      addition, prospective use of the taxonomy for developing and reporting 
      intervention content would further aid in building a cumulative science of 
      effective SMIs in COPD.
FAU - Heijmans, Monique
AU  - Heijmans M
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Poortvliet, Rune
AU  - Poortvliet R
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Van der Gaag, Marieke
AU  - Van der Gaag M
AUID- ORCID: 0000-0001-5459-2118
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - González-González, Ana I
AU  - González-González AI
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
FAU - Beltran Puerta, Jessica
AU  - Beltran Puerta J
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Canelo-Aybar, Carlos
AU  - Canelo-Aybar C
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Valli, Claudia
AU  - Valli C
AUID- ORCID: 0000-0002-4393-3690
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Ballester, Marta
AU  - Ballester M
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
FAU - Rocha, Claudio
AU  - Rocha C
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Garcia, Montserrat León
AU  - Garcia ML
AUID- ORCID: 0000-0001-8567-4685
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Salas-Gama, Karla
AU  - Salas-Gama K
AUID- ORCID: 0000-0003-4845-4899
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Kaloteraki, Chrysoula
AU  - Kaloteraki C
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Santero, Marilina
AU  - Santero M
AUID- ORCID: 0000-0001-5371-0979
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Niño de Guzmán, Ena
AU  - Niño de Guzmán E
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Spoiala, Cristina
AU  - Spoiala C
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Gurung, Pema
AU  - Gurung P
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Moaddine, Saida
AU  - Moaddine S
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Willemen, Fabienne
AU  - Willemen F
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Cools, Iza
AU  - Cools I
AUID- ORCID: 0000-0003-2953-3268
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Bleeker, Julia
AU  - Bleeker J
AUID- ORCID: 0000-0002-8543-0290
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Kancheva, Angelina
AU  - Kancheva A
AUID- ORCID: 0000-0002-0077-3543
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Ertl, Julia
AU  - Ertl J
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Laure, Tajda
AU  - Laure T
AUID- ORCID: 0000-0001-6854-7668
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Kancheva, Ivana
AU  - Kancheva I
AUID- ORCID: 0000-0002-1151-6243
AD  - Netherlands Institute for Health Services Research (NIVEL), 3513 Utrecht, The 
      Netherlands.
FAU - Pacheco-Barrios, Kevin
AU  - Pacheco-Barrios K
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, 
      Spain.
FAU - Zafra-Tanaka, Jessica
AU  - Zafra-Tanaka J
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, 
      Spain.
FAU - Mavridis, Dimitris
AU  - Mavridis D
AUID- ORCID: 0000-0003-1041-4592
AD  - Department of Primary Education, School of Education, University of Ioannina, 
      45110 Ioannina, Greece.
FAU - Angeliki Veroniki, Areti
AU  - Angeliki Veroniki A
AD  - Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's 
      Hospital, Toronto, ON M5B 1W8, Canada.
AD  - Institute for Health Policy, Management, and Evaluation, University of Toronto, 
      Toronto, ON M5S 3G8, Canada.
FAU - Zevgiti, Stella
AU  - Zevgiti S
AUID- ORCID: 0000-0002-9999-1697
AD  - Department of Primary Education, School of Education, University of Ioannina, 
      45110 Ioannina, Greece.
FAU - Seitidis, Georgios
AU  - Seitidis G
AUID- ORCID: 0000-0003-0856-1892
AD  - Department of Primary Education, School of Education, University of Ioannina, 
      45110 Ioannina, Greece.
FAU - Alonso-Coello, Pablo
AU  - Alonso-Coello P
AUID- ORCID: 0000-0002-8001-8504
AD  - Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau), 08025 Barcelona, Spain.
FAU - Groene, Oliver
AU  - Groene O
AD  - OptiMedis, 20095 Hamburg, Germany.
FAU - Sunol, Rosa
AU  - Sunol R
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, 
      Spain.
FAU - Orrego, Carola
AU  - Orrego C
AUID- ORCID: 0000-0002-2978-6268
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
DEP - 20221004
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Exercise
MH  - Humans
MH  - *Pulmonary Disease, Chronic Obstructive/therapy
MH  - Quality of Life
MH  - Randomized Controlled Trials as Topic
MH  - *Self-Management
PMC - PMC9566761
OTO - NOTNLM
OT  - COPD
OT  - complex interventions
OT  - intervention content
OT  - quality improvement
OT  - self-management
OT  - taxonomy
COIS- The authors declare no conflict of interest.
EDAT- 2022/10/15 06:00
MHDA- 2022/10/18 06:00
CRDT- 2022/10/14 02:02
PHST- 2022/08/16 00:00 [received]
PHST- 2022/09/26 00:00 [revised]
PHST- 2022/09/30 00:00 [accepted]
PHST- 2022/10/14 02:02 [entrez]
PHST- 2022/10/15 06:00 [pubmed]
PHST- 2022/10/18 06:00 [medline]
AID - ijerph191912685 [pii]
AID - ijerph-19-12685 [pii]
AID - 10.3390/ijerph191912685 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Oct 4;19(19):12685. doi: 
      10.3390/ijerph191912685.

PMID- 36227619
OWN - NLM
STAT- MEDLINE
DCOM- 20230224
LR  - 20230224
IS  - 1941-9260 (Electronic)
IS  - 0032-5481 (Linking)
VI  - 135
IP  - 2
DP  - 2023 Mar
TI  - Trends in premature mortality from diabetes mellitus in Costa Rica in the period 
      2000-2020.
PG  - 128-140
LID - 10.1080/00325481.2022.2135865 [doi]
AB  - OBJECTIVES: To analyze the temporal trends of premature mortality from diabetes 
      in Costa Rica in the period 2000-2020, at a national level and by province, and 
      the effect of the COVID-19 pandemic on diabetes mortality during the year 2020. 
      METHODS: We studied the temporal trends of mortality from diabetes in Costa Rica 
      in the period between 2000 and 2020. Age-standardized mortality rates and 
      corresponding 95% confidence intervals were calculated for each year, sex and 
      province. RESULTS: We analyzed the data of 17,968 deceased persons. The mean age 
      was 72.5 years (range 1 to 109 years), and 51.5% of the population (n = 9253) was 
      younger than 75 years. In both men and women, we observed a significant decrease 
      in mortality from 2000 to 2014, followed by the opposite trend from 2014 to 2020, 
      with average yearly increases of 13.9% in men and 11.6% in women. CONCLUSIONS: 
      Premature mortality from diabetes has been growing from 2014. The COVID-19 
      pandemic changed the mortality pattern, increasing premature diabetes deaths in 
      Costa Rica in 2020.
FAU - Quesada, Jose A
AU  - Quesada JA
AUID- ORCID: 0000-0002-6947-7531
AD  - Department of Clinical Medicine, Miguel Hernández University, San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
FAU - Carratalá-Munuera, Concepción
AU  - Carratalá-Munuera C
AUID- ORCID: 0000-0002-1303-6294
AD  - Department of Clinical Medicine, Miguel Hernández University, San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
FAU - Carbonell-Soliva, Alvaro
AU  - Carbonell-Soliva A
AUID- ORCID: 0000-0002-1587-5649
AD  - Fisabio: Foundation for the Promotion of Health and Biomedical Research in the 
      Valencian Community. San Juan de Alicante, Alicante.
FAU - Segura-Aparicio, Jean Carlo
AU  - Segura-Aparicio JC
AUID- ORCID: 0000-0003-1079-1398
AD  - Medical Integration Section. Faculty of Medicine, University of Costa Rica. 
      Rodrigo Facio University City, San José, Costa Rica.
FAU - González-Fernández, Jessica
AU  - González-Fernández J
AUID- ORCID: 0000-0002-2478-9275
AD  - Faculty of Medicine, University of Costa Rica. Rodrigo Facio University City, San 
      José, Costa Rica.
FAU - Salazar-Sánchez, Lizbeth
AU  - Salazar-Sánchez L
AUID- ORCID: 0000-0003-0068-5655
AD  - Faculty of Medicine, University of Costa Rica. Rodrigo Facio University City, San 
      José, Costa Rica.
FAU - Gil-Guillén, Vicente F
AU  - Gil-Guillén VF
AUID- ORCID: 0000-0003-3793-9786
AD  - Department of Clinical Medicine, Miguel Hernández University, San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
AD  - Fisabio: Foundation for the Promotion of Health and Biomedical Research in the 
      Valencian Community. San Juan de Alicante, Alicante.
AD  - Isabial: Institute of Sanitary and Biomedical Research of Alicante, San José, 
      Costa Rica.
FAU - López-Pineda, Adriana
AU  - López-Pineda A
AUID- ORCID: 0000-0002-2117-0178
AD  - Department of Clinical Medicine, Miguel Hernández University, San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
AD  - Fisabio: Foundation for the Promotion of Health and Biomedical Research in the 
      Valencian Community. San Juan de Alicante, Alicante.
FAU - Nouni-García, Rauf
AU  - Nouni-García R
AUID- ORCID: 0000-0002-8459-0081
AD  - Department of Clinical Medicine, Miguel Hernández University, San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
AD  - Isabial: Institute of Sanitary and Biomedical Research of Alicante, San José, 
      Costa Rica.
FAU - Orozco-Beltrán, Domingo
AU  - Orozco-Beltrán D
AUID- ORCID: 0000-0002-8231-2635
AD  - Department of Clinical Medicine, Miguel Hernández University, San Juan de 
      Alicante, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS).
LA  - eng
PT  - Journal Article
DEP - 20221021
PL  - England
TA  - Postgrad Med
JT  - Postgraduate medicine
JID - 0401147
SB  - IM
MH  - Male
MH  - Humans
MH  - Female
MH  - Infant
MH  - Child, Preschool
MH  - Child
MH  - Adolescent
MH  - Young Adult
MH  - Adult
MH  - Middle Aged
MH  - Aged
MH  - Aged, 80 and over
MH  - Costa Rica/epidemiology
MH  - Mortality, Premature
MH  - Pandemics
MH  - *COVID-19/epidemiology
MH  - *Diabetes Mellitus/epidemiology
OTO - NOTNLM
OT  - Costa Rica
OT  - Diabetes mellitus
OT  - premature mortality
OT  - trends
EDAT- 2022/10/14 06:00
MHDA- 2023/02/25 06:00
CRDT- 2022/10/13 11:33
PHST- 2022/10/14 06:00 [pubmed]
PHST- 2023/02/25 06:00 [medline]
PHST- 2022/10/13 11:33 [entrez]
AID - 10.1080/00325481.2022.2135865 [doi]
PST - ppublish
SO  - Postgrad Med. 2023 Mar;135(2):128-140. doi: 10.1080/00325481.2022.2135865. Epub 
      2022 Oct 21.

PMID- 36226900
OWN - NLM
STAT- MEDLINE
DCOM- 20221129
LR  - 20221129
IS  - 1365-2354 (Electronic)
IS  - 0961-5423 (Linking)
VI  - 31
IP  - 6
DP  - 2022 Nov
TI  - Information needs and research priorities in long-term survivorship of breast 
      cancer: Patients and health professionals' perspectives.
PG  - e13730
LID - 10.1111/ecc.13730 [doi]
AB  - OBJECTIVE: The objective of this work is to identify unmet information needs of 
      long-term-survivors of breast cancer (BC) and future research needs from the 
      perspectives of patients and health care professionals. METHODS: Two online 
      Delphi surveys were conducted. Participants in Survey 1 were patients. 
      Participants in Survey 2 were health care professionals from both primary and 
      secondary care involved in BC care. Both surveys included three successive 
      rounds. The first round aimed to identify research and information needs; the 
      second round aimed to rank the relative importance of those needs; the third 
      round aimed to find consensus. RESULTS: The most important information needs were 
      self-management recommendations of common health problems after treatment and 
      complications of breast reconstruction after 5 years. The most important research 
      priorities were related to interventions and tools to increase information 
      provision by professionals about certain tests, diet, and coordinated action 
      between primary and specialised care during follow-up, and indications and safety 
      issues of pregnancy in survivors. CONCLUSIONS: Two fundamental ideas were 
      identified: (1) Patients request information about self-management common health 
      problems after treatment and breast reconstruction complications. (2) Health care 
      professionals emphasise the need for a standardised approach based on protocols, 
      recommendations, and coordinated actions in the provision of information. 
      IMPLICATIONS FOR CANCER SURVIVORS: Given the increasing number of BC survivors, 
      it is essential to identify information and research needs to improve their care 
      and health outcomes.
CI  - © 2022 John Wiley & Sons Ltd.
FAU - León-Salas, Beatriz
AU  - León-Salas B
AUID- ORCID: 0000-0001-5803-1756
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Álvarez-Pérez, Yolanda
AU  - Álvarez-Pérez Y
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - University of La Laguna (ULL), Santa Cruz de Tenerife, Spain.
FAU - Del Mar Trujillo-Martín, Mª
AU  - Del Mar Trujillo-Martín M
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - de Pascual Y Medina, Ana María
AU  - de Pascual Y Medina AM
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
FAU - Esteva, Magdalena
AU  - Esteva M
AD  - Research Unit, Majorca Primary Care Department, Palma de Mallorca, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, 
      Spain.
AD  - Red de Investigación de Actividades Preventivas y Promoción de la Salud 
      (RedIAPP), Madrid, Spain.
FAU - Brito-García, Noé
AU  - Brito-García N
AD  - Research Unit, Spanish Society of Rheumatology, Madrid, Spain.
FAU - González-Hernández, Nerea
AU  - González-Hernández N
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - Kronikgune Institute for Health Services Research, Bizkaia, Basque Country, 
      Spain.
AD  - Research Unit, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
FAU - Bohn-Sarmiento, Uriel
AU  - Bohn-Sarmiento U
AD  - Medical Oncology Service, University Hospital of Gran Canaria "Dr. Negrin", Las 
      Palmas de Gran Canaria, Spain.
FAU - Biurrun-Martínez, M Concepción
AU  - Biurrun-Martínez MC
AD  - Patient Advocate, Spanish Federation of Breast Cancer (FECMA), Madrid, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
LA  - eng
GR  - OA19/078/DISA Foundation/
GR  - RD21/0016/0013/Carlos III Institute of Health, Spanish Ministry of Economy and 
      Competitiveness/
PT  - Journal Article
DEP - 20221013
PL  - England
TA  - Eur J Cancer Care (Engl)
JT  - European journal of cancer care
JID - 9301979
MH  - Pregnancy
MH  - Female
MH  - Humans
MH  - *Breast Neoplasms/therapy/complications
MH  - Survivorship
MH  - Survivors
MH  - Health Personnel
MH  - Surveys and Questionnaires
MH  - Research
OTO - NOTNLM
OT  - breast cancer
OT  - information need
OT  - research need
OT  - survivors
EDAT- 2022/10/14 06:00
MHDA- 2022/11/30 06:00
CRDT- 2022/10/13 08:43
PHST- 2022/09/19 00:00 [revised]
PHST- 2022/05/24 00:00 [received]
PHST- 2022/09/27 00:00 [accepted]
PHST- 2022/10/14 06:00 [pubmed]
PHST- 2022/11/30 06:00 [medline]
PHST- 2022/10/13 08:43 [entrez]
AID - 10.1111/ecc.13730 [doi]
PST - ppublish
SO  - Eur J Cancer Care (Engl). 2022 Nov;31(6):e13730. doi: 10.1111/ecc.13730. Epub 
      2022 Oct 13.

PMID- 36219303
OWN - NLM
STAT- MEDLINE
DCOM- 20230120
LR  - 20230307
IS  - 1525-1497 (Electronic)
IS  - 0884-8734 (Print)
IS  - 0884-8734 (Linking)
VI  - 38
IP  - 1
DP  - 2023 Jan
TI  - Home Blood Pressure Self-monitoring plus Self-titration of Antihypertensive 
      Medication for Poorly Controlled Hypertension in Primary Care: the ADAMPA 
      Randomized Clinical Trial.
PG  - 81-89
LID - 10.1007/s11606-022-07791-z [doi]
AB  - BACKGROUND: Patient empowerment through pharmacological self-management is a 
      common strategy in some chronic diseases such as diabetes, but it is rarely used 
      for controlling blood pressure. OBJECTIVE: This study aimed to assess 
      self-monitoring plus self-titration of antihypertensive medication versus usual 
      care for reducing systolic blood pressure (SBP) at 12 months in poorly controlled 
      hypertensive patients. DESIGN: The ADAMPA study was a pragmatic, controlled, 
      randomized, non-masked clinical trial with two parallel arms in Valencia, Spain. 
      PARTICIPANTS: Hypertensive patients older than 40 years, with SBP over 145 mmHg 
      and/or diastolic blood pressure (DBP) over 90 mmHg, were recruited from July 2017 
      to June 2018. INTERVENTION: Participants were randomized 1:1 to usual care versus 
      an individualized, pre-arranged plan based on self-monitoring plus 
      self-titration. MAIN MEASURE: The primary outcome was the adjusted mean 
      difference (AMD) in SBP between groups at 12 months. KEY RESULTS: Primary outcome 
      data were available for 312 patients (intervention n=156, control n=156) of the 
      366 who were initially recruited. The AMD in SBP at 12 months (main analysis) was 
      -2.9 mmHg (95% CI, -5.9 to 0.1, p=0.061), while the AMD in DBP was -1.9 mmHg (95% 
      CI, -3.7 to 0.0, p=0.052). The results of the subgroup analysis were consistent 
      with these for the main outcome measures. More patients in the intervention group 
      achieved good blood pressure control (<140/90 mmHg) at 12 months than in the 
      control group (55.8% vs 42.3%, difference 13.5%, 95% CI, 2.5 to 24.5%, p=0.017). 
      At 12 months, no differences were observed in behavior, quality of life, use of 
      health services, or adverse events. CONCLUSION: Self-monitoring plus 
      self-titration of antihypertensive medication based on an individualized 
      pre-arranged plan used in primary care may be a promising strategy for reducing 
      blood pressure at 12 months compared to usual care, without increasing healthcare 
      utilization or adverse events. TRIAL REGISTRATION: EudraCT, number 2016-003986-25 
      (registered 17 March 2017) and clinicaltrials.gov , NCT03242785.
CI  - © 2022. The Author(s).
FAU - Martínez-Ibáñez, Patricia
AU  - Martínez-Ibáñez P
AD  - INCLIVA Health Research Institute, Valencia, Spain.
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
FAU - Marco-Moreno, Irene
AU  - Marco-Moreno I
AD  - INCLIVA Health Research Institute, Valencia, Spain.
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
FAU - Peiró, Salvador
AU  - Peiró S
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Department of Statistics and Operations Research, Universidad de Valencia, 
      Valencia, Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
FAU - Martínez-Ibáñez, Lucia
AU  - Martínez-Ibáñez L
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Barreira-Franch, Ignacio
AU  - Barreira-Franch I
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Bellot-Pujalte, Laura
AU  - Bellot-Pujalte L
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Avelino-Hidalgo, Eugenia
AU  - Avelino-Hidalgo E
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Escrig-Veses, Marina
AU  - Escrig-Veses M
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Bóveda-García, María
AU  - Bóveda-García M
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Calleja-Del-Ser, Mercedes
AU  - Calleja-Del-Ser M
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Ferrero-Gregori, Andreu
AU  - Ferrero-Gregori A
AD  - INCLIVA Health Research Institute, Valencia, Spain.
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
FAU - Iftimi, Adina A
AU  - Iftimi AA
AD  - INCLIVA Health Research Institute, Valencia, Spain.
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Department of Statistics and Operations Research, Universidad de Valencia, 
      Valencia, Spain.
FAU - Hurtado, Isabel
AU  - Hurtado I
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, 
      Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
FAU - García-Sempere, Aníbal
AU  - García-Sempere A
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, 
      Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
FAU - Rodríguez-Bernal, Clara L
AU  - Rodríguez-Bernal CL
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, 
      Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain.
FAU - Giménez-Loreiro, Margarita
AU  - Giménez-Loreiro M
AD  - INCLIVA Health Research Institute, Valencia, Spain.
FAU - Sanfélix-Gimeno, Gabriel
AU  - Sanfélix-Gimeno G
AUID- ORCID: 0000-0001-7098-4576
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain. 
      sanfelix_gab@gva.es.
AD  - Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, 
      Spain. sanfelix_gab@gva.es.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Valencia, Spain. sanfelix_gab@gva.es.
FAU - Sanfélix-Genovés, José
AU  - Sanfélix-Genovés J
AD  - INCLIVA Health Research Institute, Valencia, Spain.
AD  - Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
AD  - Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, 
      Spain.
CN  - ADAMPA research group
LA  - eng
SI  - ClinicalTrials.gov/NCT03242785
SI  - EudraCT/2016-003986-25
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20221011
PL  - United States
TA  - J Gen Intern Med
JT  - Journal of general internal medicine
JID - 8605834
RN  - 0 (Antihypertensive Agents)
SB  - IM
MH  - Humans
MH  - *Antihypertensive Agents/therapeutic use/pharmacology
MH  - Blood Pressure
MH  - Quality of Life
MH  - *Hypertension/drug therapy
MH  - Primary Health Care
PMC - PMC9849508
OTO - NOTNLM
OT  - blood pressure self-management
OT  - blood pressure self-monitoring
OT  - patient empowerment
OT  - primary care
OT  - randomized clinical trial
COIS- The authors declare that they do not have a conflict of interest.
FIR - Abad Carrasco, J
IR  - Abad Carrasco J
FIR - Agudo Escagüés, M V
IR  - Agudo Escagüés MV
FIR - Avelino-Hidalgo, E
IR  - Avelino-Hidalgo E
FIR - Barreira-Franch, I
IR  - Barreira-Franch I
FIR - Bartual Penella, R M
IR  - Bartual Penella RM
FIR - Bellot-Pujalte, L
IR  - Bellot-Pujalte L
FIR - Bóveda-García, M
IR  - Bóveda-García M
FIR - Calleja Del Ser, M
IR  - Calleja Del Ser M
FIR - Carrión Villanueva, R
IR  - Carrión Villanueva R
FIR - Costa Alcaraz, A
IR  - Costa Alcaraz A
FIR - Cristófol López, I
IR  - Cristófol López I
FIR - Escrig-Veses, M
IR  - Escrig-Veses M
FIR - Ferrero-Gregori, A
IR  - Ferrero-Gregori A
FIR - García-Sempere, A
IR  - García-Sempere A
FIR - Giménez-Loreiro, M
IR  - Giménez-Loreiro M
FIR - González Candelas, R
IR  - González Candelas R
FIR - González Espadas, R
IR  - González Espadas R
FIR - González Luján, L
IR  - González Luján L
FIR - Gosalbes, V
IR  - Gosalbes V
FIR - Guinot Martínez, E
IR  - Guinot Martínez E
FIR - Hurtado, I
IR  - Hurtado I
FIR - Iftimi, A A
IR  - Iftimi AA
FIR - López Torres, E L
IR  - López Torres EL
FIR - Marco-Moreno, I
IR  - Marco-Moreno I
FIR - Martinez-Ibañez, P
IR  - Martinez-Ibañez P
FIR - Martinez Ibañez, L
IR  - Martinez Ibañez L
FIR - Molla Llosa, S
IR  - Molla Llosa S
FIR - Moreno Comins, V
IR  - Moreno Comins V
FIR - Moreno Prat, M
IR  - Moreno Prat M
FIR - Navarro-Pérez, J
IR  - Navarro-Pérez J
FIR - Peiró, S
IR  - Peiró S
FIR - Puchades Company, M J
IR  - Puchades Company MJ
FIR - Ramos García, A
IR  - Ramos García A
FIR - Ramos Ruiz, P
IR  - Ramos Ruiz P
FIR - Roca Navarro, P
IR  - Roca Navarro P
FIR - Rodríguez-Bernal, C
IR  - Rodríguez-Bernal C
FIR - Saiz Rodriguez, R
IR  - Saiz Rodriguez R
FIR - Salanova Chilet, J L
IR  - Salanova Chilet JL
FIR - Sanfélix-Genovés, J
IR  - Sanfélix-Genovés J
FIR - Sanfélix-Gimeno, G
IR  - Sanfélix-Gimeno G
FIR - Tchang Sanchez, A
IR  - Tchang Sanchez A
FIR - Torres Asensi, F
IR  - Torres Asensi F
FIR - Uribes Fillol, R
IR  - Uribes Fillol R
FIR - Valle García, C
IR  - Valle García C
FIR - Villar Ruiz, M
IR  - Villar Ruiz M
EDAT- 2022/10/12 06:00
MHDA- 2023/01/21 06:00
CRDT- 2022/10/11 11:19
PHST- 2021/11/27 00:00 [received]
PHST- 2022/09/06 00:00 [accepted]
PHST- 2022/10/12 06:00 [pubmed]
PHST- 2023/01/21 06:00 [medline]
PHST- 2022/10/11 11:19 [entrez]
AID - 10.1007/s11606-022-07791-z [pii]
AID - 7791 [pii]
AID - 10.1007/s11606-022-07791-z [doi]
PST - ppublish
SO  - J Gen Intern Med. 2023 Jan;38(1):81-89. doi: 10.1007/s11606-022-07791-z. Epub 
      2022 Oct 11.

PMID- 36203135
OWN - NLM
STAT- MEDLINE
DCOM- 20221010
LR  - 20221019
IS  - 1471-2318 (Electronic)
IS  - 1471-2318 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Oct 6
TI  - Changes in lifestyles, cognitive impairment, quality of life and activity day 
      living after combined use of smartphone and smartband technology: a randomized 
      clinical trial (EVIDENT-Age study).
PG  - 782
LID - 10.1186/s12877-022-03487-5 [doi]
LID - 782
AB  - BACKGROUND: The aim of this study was to assess the efficacy of the combined use 
      of smartphone and smartband technology for 3-months alongside brief lifestyle 
      counselling, versus counselling alone, in increasing physical activity. As 
      secondary objectives, the effects of the intervention on dietary habits, body 
      composition, quality of life, level of functionality and cognitive performance 
      were assessed. METHODS: This study employed a randomized clinical trial of 
      two-parallel groups design - control group (CG) and intervention group (IG). The 
      study was conducted in 3 Spanish health-centres between October 2018-February 
      2020. Eligible participants were people of both sexes and aged between 
      65-80 years attending the health-centres with a score ≥ 24 points on the 
      Mini-Mental State Examination. Key variables included physical activity, dietary 
      pattern, body composition, cognitive performance, level of functionality and 
      quality of life. All variables were measured at baseline and after 3-months. Both 
      groups received a brief nutritional and physical activity advice. Intervention 
      group participants were instructed to use a smartphone application for a period 
      of 3-months. This application integrates information on physical activity 
      received from a fitness bracelet and self-reported information on the patient's 
      daily nutritional composition. RESULTS: The study population comprised 160 
      participants (IG = 81, CG = 79), with a mean age of 70.8 ± 4.0 years (61.3% 
      women). No difference was found in the primary and secondary outcomes analyzed 
      (physical activity (steps/min -0.4 (-1.0 to 0.2) p = 0.174), and dietary habits 
      (Mediterranean diet score 0.0 (-0.6 to 0.6) p = 0.956) that could be attributed 
      to either group after an ANCOVA test. A difference attributable to the 
      intervention was observed in the total Clock test score (0.7 (0.1 to 1.2) 
      p = 0.018. CONCLUSIONS: In a sample of people over 65 years of age, the combined 
      use of the EVIDENT 3 smartphone app and an activity tracking bracelet for 
      3-months did not result in lifestyles changes related to the amount and level of 
      physical activity or the eating habits, compared to brief lifestyle advice. Other 
      clinical parameters were not changed either, although at the cognitive level, a 
      slight improvement was observed in the score on the Clock test assessing a 
      variety of cognitive functions such as memory. TRIAL REGISTRATION: The study was 
      registered in ClinicalTrials.gov Identifier: NCT03574480. Date of trial 
      Registration 02/07/2018.
CI  - © 2022. The Author(s).
FAU - Recio-Rodríguez, José I
AU  - Recio-Rodríguez JI
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain. donrecio@usal.es.
AD  - Facultad de Enfermería Y Fisioterapia, Universidad de Salamanca, Donantes de 
      Sangre S/N, 37007, Salamanca, Spain. donrecio@usal.es.
FAU - Gonzalez-Sanchez, Susana
AU  - Gonzalez-Sanchez S
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain.
FAU - Gómez-Marcos, Manuel A
AU  - Gómez-Marcos MA
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
FAU - Garcia-Ortiz, Luis
AU  - Garcia-Ortiz L
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain.
AD  - Departamento de Ciencias Biomédicas Y del Diagnóstico, Universidad de Salamanca, 
      Salamanca, Spain.
FAU - Niño-Martín, Virtudes
AU  - Niño-Martín V
AD  - Facultad de Enfermeria, Universidad de Valladolid, Valladolid, Spain.
FAU - Lugones-Sanchez, Cristina
AU  - Lugones-Sanchez C
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain.
FAU - Rodriguez-Sanchez, Emiliano
AU  - Rodriguez-Sanchez E
AD  - Unidad de Investigación de Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de investigación en cronicidad, 
      Atención Primaria Y Promoción de La Salud (RICAPPS) (RD21/0016), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de Salud de Castilla Y León 
      (SACyL), Salamanca, Spain.
AD  - Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT03574480
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20221006
PL  - England
TA  - BMC Geriatr
JT  - BMC geriatrics
JID - 100968548
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *Cognitive Dysfunction
MH  - *Diet, Mediterranean
MH  - Female
MH  - Humans
MH  - Life Style
MH  - Male
MH  - Quality of Life
MH  - Smartphone
PMC - PMC9535859
OTO - NOTNLM
OT  - Body composition
OT  - Nutrition
OT  - Older adult
OT  - Physical activity
OT  - Quality of life
COIS- The authors declare that they have no competing interests.
EDAT- 2022/10/07 06:00
MHDA- 2022/10/12 06:00
CRDT- 2022/10/06 23:41
PHST- 2022/03/29 00:00 [received]
PHST- 2022/09/28 00:00 [accepted]
PHST- 2022/10/06 23:41 [entrez]
PHST- 2022/10/07 06:00 [pubmed]
PHST- 2022/10/12 06:00 [medline]
AID - 10.1186/s12877-022-03487-5 [pii]
AID - 3487 [pii]
AID - 10.1186/s12877-022-03487-5 [doi]
PST - epublish
SO  - BMC Geriatr. 2022 Oct 6;22(1):782. doi: 10.1186/s12877-022-03487-5.

PMID- 36199014
OWN - NLM
STAT- MEDLINE
DCOM- 20221007
LR  - 20221011
IS  - 1471-2393 (Electronic)
IS  - 1471-2393 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Oct 5
TI  - Women's values and preferences on low-molecular-weight heparin and pregnancy: a 
      mixed-methods systematic review.
PG  - 747
LID - 10.1186/s12884-022-05042-x [doi]
LID - 747
AB  - BACKGROUND: Venous thromboembolism (VTE) in pregnancy is an important cause of 
      maternal morbidity and mortality. Low-molecular-weight heparin (LMWH) is the 
      cornerstone of prophylaxis and treatment of thrombotic events during pregnancy. 
      LMWH has fewer adverse effects than other anticoagulants, does not cross the 
      placenta, and is safe for the fetus. However, the use of LMWH during pregnancy is 
      sensitive to womens' underlying preferences. The objective of this review is to 
      systematically assess women's values and preferences research evidence on this 
      topic. METHODS: We searched four electronic databases from inception to March 
      2022, and included studies examining values and preferences of using LMWH among 
      pregnant women at risk of VTE. We followed a convergent integrated mixed-methods 
      design to compare and contrast quantitative outcomes (utility and non-utility 
      measures) and qualitative findings. We assessed the certainty of the values and 
      preferences evidence with the GRADE approach for quantitative findings, and with 
      GRADE-CERqual for qualitative evidence. Results were presented in a conjoint 
      display. RESULTS: We screened 3,393 references and identified seven eligible 
      studies. The mixed methods analysis resulted in four themes. Datasets confirmed 
      each other in that: 1) the majority of women consider that benefits of treatment 
      outweigh the inconveniences of daily injections; and 2) main concerns around 
      medication are safety and injections administration. Quantitative outcomes 
      expanded on the qualitative findings in that: 3) participants who perceived a 
      higher risk of VTE were more willing to take LMWH. Finally, we found a 
      discrepancy between the datasets around: 4) the amount of information preferred 
      to make the decision; however, qualitative data expanded to clarify that women 
      prefer making informed decisions and receive support from their clinician in 
      their decision-making process. CONCLUSIONS: We are moderately confident that in 
      the context of pregnancy, using LMWH is preferred by women given its net 
      beneficial balance. Integrating data from different sources of evidence, and 
      representing them in a jointly manner helps to identify patient's values and 
      preferences. Our results may inform clinical practice guidelines and support 
      shared decision-making process in the clinical encounter for the management of 
      VTE in the context of pregnancy.
CI  - © 2022. The Author(s).
FAU - León-García, Montserrat
AU  - León-García M
AD  - Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain. 
      mleong@santpau.cat.
AD  - Department of Pediatrics, Obstetrics, Gynaecology and Preventive Medicine, 
      Universidad Autónoma de Barcelona, Barcelona, Spain. mleong@santpau.cat.
AD  - Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 
      Rochester, MN, USA. mleong@santpau.cat.
FAU - Humphries, Brittany
AU  - Humphries B
AD  - Cytel Inc, Toronto, ON, Canada.
AD  - Department of Health Research Methods, Evidence and Impact, McMaster University, 
      Hamilton, ON, Canada.
FAU - Maraboto, Andrea
AU  - Maraboto A
AD  - Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 
      Rochester, MN, USA.
FAU - Rabassa, Montserrat
AU  - Rabassa M
AD  - Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
FAU - Boehmer, Kasey R
AU  - Boehmer KR
AD  - Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, 
      Rochester, MN, USA.
AD  - Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN, USA.
FAU - Perestelo-Perez, Lilisbeth
AU  - Perestelo-Perez L
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Research Network On Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Xie, Feng
AU  - Xie F
AD  - Department of Health Research Methods, Evidence and Impact, McMaster University, 
      Hamilton, ON, Canada.
AD  - Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, 
      ON, Canada.
FAU - Pelayo, Irene
AU  - Pelayo I
AD  - Department of Obstetrics and Gynecology, Ramón y Cajal Hospital, Madrid, Spain.
AD  - Faculty of Medicine, Alcalá de Henares University, Madrid, Spain.
FAU - Eckman, Mark
AU  - Eckman M
AD  - Division of General Internal Medicine and Center for Clinical Effectiveness, 
      University of Cincinnati School of Medicine, Cincinnati, OH, USA.
FAU - Bates, Shannon
AU  - Bates S
AD  - Department of Medicine, McMaster University, Hamilton, ON, Canada.
FAU - Selva, Anna
AU  - Selva A
AD  - Department of Pediatrics, Obstetrics, Gynaecology and Preventive Medicine, 
      Universidad Autónoma de Barcelona, Barcelona, Spain.
AD  - Clinical Epidemiology and Cancer Screening, Corporació Sanitaria Parc Taulí, 
      Sabadell, Barcelona, Spain.
FAU - Alonso-Coello, Pablo
AU  - Alonso-Coello P
AD  - Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
AD  - CIBER of Epidemiology and Public Health, CIBERESP, Madrid, Spain.
LA  - eng
GR  - PI17/01874/Instituto de Salud Carlos III/
GR  - PI17/01874/Instituto de Salud Carlos III/
PT  - Journal Article
PT  - Review
DEP - 20221005
PL  - England
TA  - BMC Pregnancy Childbirth
JT  - BMC pregnancy and childbirth
JID - 100967799
RN  - 0 (Anticoagulants)
RN  - 0 (Heparin, Low-Molecular-Weight)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Anticoagulants/adverse effects
MH  - Female
MH  - Heparin/adverse effects
MH  - Heparin, Low-Molecular-Weight/adverse effects
MH  - Humans
MH  - Pregnancy
MH  - *Pregnancy Complications, Cardiovascular/drug therapy/prevention & control
MH  - *Thrombosis
MH  - *Venous Thromboembolism/drug therapy/prevention & control
PMC - PMC9533610
OTO - NOTNLM
OT  - Low-molecular-weight-heparin
OT  - Pregnancy
OT  - Values and preferences
OT  - Venous thromboembolism
COIS- Nothing to declare.
EDAT- 2022/10/06 06:00
MHDA- 2022/10/12 06:00
CRDT- 2022/10/05 23:35
PHST- 2022/07/07 00:00 [received]
PHST- 2022/09/09 00:00 [accepted]
PHST- 2022/10/05 23:35 [entrez]
PHST- 2022/10/06 06:00 [pubmed]
PHST- 2022/10/12 06:00 [medline]
AID - 10.1186/s12884-022-05042-x [pii]
AID - 5042 [pii]
AID - 10.1186/s12884-022-05042-x [doi]
PST - epublish
SO  - BMC Pregnancy Childbirth. 2022 Oct 5;22(1):747. doi: 10.1186/s12884-022-05042-x.

PMID- 36190489
OWN - NLM
STAT- MEDLINE
DCOM- 20221221
LR  - 20221223
IS  - 1528-1132 (Electronic)
IS  - 0009-921X (Print)
IS  - 0009-921X (Linking)
VI  - 481
IP  - 1
DP  - 2023 Jan 1
TI  - Has Arthroscopic Meniscectomy Use Changed in Response to the Evidence? A 
      Large-database Study From Spain.
PG  - 7-16
LID - 10.1097/CORR.0000000000002421 [doi]
AB  - BACKGROUND: Several randomized clinical trials on the treatment of meniscal tears 
      have shown that surgery is not superior to nonoperative treatment in middle-aged 
      and older adults. However, clinical practice has not changed consistently 
      worldwide in response to this evidence, and arthroscopic meniscectomy remains one 
      of the most frequently performed operations. QUESTIONS/PURPOSES: (1) How has the 
      use of arthroscopic meniscectomy changed in Spain between 2003 and 2018, 
      particularly in middle-aged (35 to 59 years) and older patients (over 60 years) 
      relative to younger patients? (2) How have surgical volumes changed across 
      different healthcare areas in the same health system? (3) How has the proportion 
      of outpatient versus inpatient arthroscopic procedures changed over time? 
      METHODS: Data on all 420,228 arthroscopic meniscectomies performed in Spain 
      between 2003 and 2018 were obtained through the Atlas of Variations in Medical 
      Practice project (these years were chosen because data in that atlas for 2002 and 
      2019 were incomplete). This database has been promoted by the Spanish Health 
      Ministry since 2002, and it collects basic information on all admissions to 
      public and public-private partnership hospitals. The Spanish population of 2003 
      was used to calculate age- and sex-standardized rates of interventions per 10,000 
      inhabitants and year. To assess the change in standardized rates among the age 
      groups over the study period, a linear regression analysis was used. Standard 
      small-area variation statistics were used to analyze variation among healthcare 
      areas. Data on outpatient surgery and length of stay for inpatient procedures 
      were also included. RESULTS: The standardized rate of arthroscopic meniscectomy 
      in Spain in 2003 was 4.8 procedures per 10,000 population (95% CI 3.9 to 5.6), 
      while in 2018, there were 6.3 procedures per 10,000 population (95% CI 5.4 to 
      7.3), which represents an increase of 33%. Standardized rates increased slightly 
      in the age group < 35 years (0.06 interventions per 10,000 inhabitants per year 
      [95% CI 0.05 to 0.08]), whereas they increased more markedly in the age groups of 
      35 to 59 years (0.14 interventions per 10,000 inhabitants per year [95% CI 0.11 
      to 0.17]) and in those 60 years and older (0.13 interventions per 10,000 
      inhabitants per year [95% CI 0.09 to 0.17]). The variability among healthcare 
      areas in the meniscectomy rate progressively decreased from 2003 to 2018. In 
      2003, 32% (6544 of 20,384) of knee arthroscopies were performed on an outpatient 
      basis, while in 2018, these accounted for 67% (19,573 of 29,430). CONCLUSION: We 
      observed a progressive increase in arthroscopic meniscectomies in Spain; this 
      procedure was more prevalent in older patients presumed to have degenerative 
      pathologic findings. This increase occurred despite increasing high-level 
      evidence of a lack of the additional benefit of meniscectomy over other 
      less-invasive treatments in middle-aged and older people. Our study highlights 
      the need for action in health systems with the use of financial, regulatory, or 
      incentive strategies to reduce the use of low-value procedures, as well as 
      interventions to disseminate the available evidence to clinicians and patients. 
      Research is needed to identify the barriers that are preventing the reversal of 
      interventions that high-quality evidence shows are ineffective. LEVEL OF 
      EVIDENCE: Level III, therapeutic study.
CI  - Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on 
      behalf of the Association of Bone and Joint Surgeons.
FAU - López-Vega, Marcos
AU  - López-Vega M
AUID- ORCID: 0000-0001-7732-7472
AD  - Department of Orthopaedic Surgery, Arnau de Vilanova Hospital, Valencia, Spain.
FAU - Doménech-Fernández, Julio
AU  - Doménech-Fernández J
AUID- ORCID: 0000-0001-9488-8159
AD  - Department of Orthopaedic Surgery, Arnau de Vilanova Hospital, Valencia, Spain.
FAU - Peiró, Salvador
AU  - Peiró S
AUID- ORCID: 0000-0002-3902-569
AD  - Foundation for the Promotion of Health and Biomedical Research of the Valencian 
      Community (FISABIO), Valencia, Spain.
AD  - Spanish Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Spain.
FAU - Ridao-López, Manuel
AU  - Ridao-López M
AUID- ORCID: 0000-0001-7837-5759
AD  - Spanish Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Spain.
AD  - Instituto Aragonés de Ciencias de la Salud (IIS Aragón), Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20221003
PL  - United States
TA  - Clin Orthop Relat Res
JT  - Clinical orthopaedics and related research
JID - 0075674
SB  - IM
CIN - Clin Orthop Relat Res. 2023 Jan 1;481(1):2-6. PMID: 36534472
MH  - Middle Aged
MH  - Humans
MH  - Aged
MH  - Adult
MH  - *Meniscectomy/methods
MH  - *Arthroscopy/methods
MH  - Spain
MH  - Knee Joint
MH  - Hospitals
PMC - PMC9750592
COIS- Each author certifies that there are no funding or commercial associations 
      (consultancies, stock ownership, equity interest, patent/licensing arrangements, 
      etc.) that might pose a conflict of interest in connection with the submitted 
      article related to the author or any immediate family members. All ICMJE Conflict 
      of Interest Forms for authors and Clinical Orthopaedics and Related Research® 
      editors and board members are on file with the publication and can be viewed on 
      request.
EDAT- 2022/10/04 06:00
MHDA- 2022/12/22 06:00
PMCR- 2024/01/01
CRDT- 2022/10/03 10:52
PHST- 2022/04/30 00:00 [received]
PHST- 2022/09/02 00:00 [accepted]
PHST- 2024/01/01 00:00 [pmc-release]
PHST- 2022/10/04 06:00 [pubmed]
PHST- 2022/12/22 06:00 [medline]
PHST- 2022/10/03 10:52 [entrez]
AID - 00003086-202301000-00003 [pii]
AID - CORR-D-22-00577 [pii]
AID - 10.1097/CORR.0000000000002421 [doi]
PST - ppublish
SO  - Clin Orthop Relat Res. 2023 Jan 1;481(1):7-16. doi: 
      10.1097/CORR.0000000000002421. Epub 2022 Oct 3.

PMID- 36175279
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230228
IS  - 2603-6479 (Electronic)
IS  - 2603-6479 (Linking)
VI  - 38
IP  - 2
DP  - 2023 Mar-Apr
TI  - Evaluation of consent forms for clinical practice in Spanish Public Hospitals.
PG  - 84-92
LID - S2603-6479(22)00070-7 [pii]
LID - 10.1016/j.jhqr.2022.08.006 [doi]
AB  - OBJECTIVE: To evaluate the access, development, and quality of consents forms for 
      clinical practice within the Spanish Public Hospitals. METHOD: A cross-sectional 
      study was conducted in a two-stage process (January 2018-September 2021). In 
      stage 1, A nationwide survey was undertaken across all public general hospitals 
      (n=223) in the Spanish Healthcare System. In stage 2, Data was taken from the 
      regional health services websites and Spanish regulations. Health Regional 
      Departments were contacted to verify the accuracy of the findings. Data was 
      analyzed using a descriptive and inferential statistics (frequencies, 
      percentages, Chi-square & Fisher's exact tests). RESULTS: The response rate was 
      123 (55.16%) of Spanish Public Hospitals. The results revealed a range of 
      hospital departments involved in the development of consent documents and the 
      absence of a standardized approach to consent forms nationally. Consent audits 
      are undertaken in 43.09% hospitals and translation of written consents into other 
      languages is limited to a minority of hospitals (35.77%). The validation process 
      of consent documentation is not in evidence in 13% of Spanish Hospitals. Regional 
      Informed Consent Committees are not place in the majority (70.7%) of hospitals. 
      Citizens can freely access to consent documents through the regional websites of 
      Andalusia and Valencia only. CONCLUSION: Variability is found on access, 
      development and quality of written consent across the Spanish Public Hospitals. 
      This points to the need for a national informed consent strategy to establish 
      policy, standards and an effective quality control system. National audits at 
      regular intervals are necessary to improve the consistency and compliance of 
      consent practice.
CI  - Copyright © 2022 FECA. Publicado por Elsevier España, S.L.U. All rights reserved.
FAU - Morales-Valdivia, E
AU  - Morales-Valdivia E
AD  - PhD Candidate in Nursing, Orthopaedic Theatre Department, Croom Hospital, UHL 
      Group, Limerick, Ireland.
FAU - Camacho-Bejarano, R
AU  - Camacho-Bejarano R
AD  - Nursing Department, Faculty of Nursing, University of Huelva, Campus El Carmen, 
      Huelva, Spain; Nursing and Healthcare Research Unit (Investén-isciii), Institute 
      of Health Carlos III, Madrid, Spain; Red de Investigación en Cronicidad, Atención 
      Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain. Electronic address: 
      rafaela.camacho@denf.uhu.es.
FAU - Brady, A M
AU  - Brady AM
AD  - Trinity Centre for Practice & Healthcare Innovation, School of Nursing & 
      Midwifery, Trinity College Dublin, Dublin 2, Ireland.
FAU - Mariscal-Crespo, M I
AU  - Mariscal-Crespo MI
AD  - Nursing Department, Faculty of Nursing, University of Huelva, Campus El Carmen, 
      Huelva, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220927
PL  - Spain
TA  - J Healthc Qual Res
JT  - Journal of healthcare quality research
JID - 101735273
SB  - IM
MH  - Humans
MH  - *Consent Forms
MH  - Cross-Sectional Studies
MH  - *Hospitals, Public
MH  - Informed Consent
MH  - Surveys and Questionnaires
OTO - NOTNLM
OT  - Administración de los servicios de salud
OT  - Administración hospitalaria
OT  - Consent forms
OT  - Consentimiento informado
OT  - Documento de consentimiento informado
OT  - España
OT  - Formularios de consentimiento
OT  - Health services administration
OT  - Hospital administration
OT  - Hospitales
OT  - Hospitals
OT  - Informed consent
OT  - Informed consent document
OT  - Spain
EDAT- 2022/09/30 06:00
MHDA- 2023/03/03 06:00
CRDT- 2022/09/29 22:06
PHST- 2022/05/15 00:00 [received]
PHST- 2022/07/08 00:00 [revised]
PHST- 2022/08/18 00:00 [accepted]
PHST- 2022/09/30 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2022/09/29 22:06 [entrez]
AID - S2603-6479(22)00070-7 [pii]
AID - 10.1016/j.jhqr.2022.08.006 [doi]
PST - ppublish
SO  - J Healthc Qual Res. 2023 Mar-Apr;38(2):84-92. doi: 10.1016/j.jhqr.2022.08.006. 
      Epub 2022 Sep 27.

PMID- 36142082
OWN - NLM
STAT- MEDLINE
DCOM- 20220926
LR  - 20230112
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 18
DP  - 2022 Sep 19
TI  - Health Literacy and Its Sociodemographic Predictors: A Cross-Sectional Study of a 
      Population in Madrid (Spain).
LID - 10.3390/ijerph191811815 [doi]
LID - 11815
AB  - BACKGROUND: Health literacy enhances a population's self-care capacity and helps 
      to reduce health inequalities. This work examines the health literacy of a 
      population attending primary care services and explores its relationship with 
      sociodemographic factors. METHODS: This cross-sectional study, conducted at a 
      healthcare center in the Madrid region (Spain), involved adult patients requiring 
      primary care nursing services. One hundred and sixty-six participants were 
      recruited via systematic random sampling. Health literacy was measured using the 
      Health Literacy Questionnaire (HLQ). RESULTS: The studied population showed 
      higher health literacy scores for literacy dimensions 1 (feeling understood and 
      supported by healthcare providers) and 4 (social support for health); the lowest 
      scores were recorded for dimensions 5 (appraisal of health information) and 8 
      (ability to find good health information). People with a better perceived health 
      status showed a higher level of health literacy. People over 65 years of age, 
      those with an incomplete secondary education, and those who were unemployed 
      returned lower scores for several literacy dimensions. CONCLUSIONS: The results 
      contribute to our understanding of the factors that influence health literacy. 
      Identifying the areas in which patients show the poorest health literacy may help 
      us comprehend their needs and better support them.
FAU - García-García, David
AU  - García-García D
AUID- ORCID: 0000-0003-0898-9565
AD  - Nursing Primary Health Care Service of Madrid, 28004 Madrid, Spain.
FAU - Pérez-Rivas, Francisco Javier
AU  - Pérez-Rivas FJ
AUID- ORCID: 0000-0003-4294-8417
AD  - Grupo de Investigación UCM "Salud Pública-Estilos de Vida, Metodología Enfermera 
      y Cuidados en el Entorno Comunitario", Departamento de Enfermería, Facultad de 
      Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud-RICAPPS-(RICORS), Instituto de Investigación Sanitaria Hospital 12 de 
      Octubre (imas12), 28041 Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220919
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Adult
MH  - Cross-Sectional Studies
MH  - *Health Literacy
MH  - Health Status
MH  - Humans
MH  - Spain
MH  - Surveys and Questionnaires
PMC - PMC9517037
OTO - NOTNLM
OT  - global health
OT  - health literacy
OT  - nursing
OT  - primary health care
OT  - public health
COIS- The authors declare no conflict of interest.
EDAT- 2022/09/24 06:00
MHDA- 2022/09/28 06:00
CRDT- 2022/09/23 01:21
PHST- 2022/07/22 00:00 [received]
PHST- 2022/09/14 00:00 [revised]
PHST- 2022/09/16 00:00 [accepted]
PHST- 2022/09/23 01:21 [entrez]
PHST- 2022/09/24 06:00 [pubmed]
PHST- 2022/09/28 06:00 [medline]
AID - ijerph191811815 [pii]
AID - ijerph-19-11815 [pii]
AID - 10.3390/ijerph191811815 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Sep 19;19(18):11815. doi: 
      10.3390/ijerph191811815.

PMID- 36111149
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220917
IS  - 1664-042X (Print)
IS  - 1664-042X (Electronic)
IS  - 1664-042X (Linking)
VI  - 13
DP  - 2022
TI  - Long-term improvement by ozone treatment in chronic pain secondary to 
      chemotherapy-induced peripheral neuropathy: A preliminary report.
PG  - 935269
LID - 10.3389/fphys.2022.935269 [doi]
LID - 935269
AB  - Background: Pain secondary to chemotherapy-induced peripheral neuropathy (CIPN) 
      can limit the administration of chemotherapy, cancer-treatment outcomes, and the 
      quality of life of patients. Oxidative stress and inflammation are some of the 
      key mechanisms involved in CIPN. Successful treatments for CIPN are limited. This 
      report shows our preliminary experience using ozone treatment as a modulator of 
      oxidative stress in chronic pain secondary to CIPN. Methods: Ozone treatment, by 
      rectal insufflation, was administered in seven patients suffering from pain 
      secondary to grade II or III CIPN. Pain was assessed by the visual analog scale 
      (VAS). Results: All patients, except one, showed clinically relevant pain 
      improvement. Median pain score according to the VAS was 7 (range: 5-8) before 
      ozone treatment, 4 (range: 2-6) at the end of ozone treatment (p = 0.004), 5.5 
      (range: 1.8-6.3) 3 months after the end of ozone treatment (p = 0.008), and 6 
      (range: 2.6-6.6) 6 months after the end of ozone treatment (p = 0.008). The 
      toxicity grade, according to the Common Terminology Criteria for Adverse Events 
      (CTCAE v.5.0), improved in half of the patients. Conclusion: This report shows 
      that most patients obtained clinically relevant and long-lasting improvement in 
      chronic pain secondary to CIPN after treatment with ozone. These observed effects 
      merit further research and support our ongoing randomized clinical trial 
      (NCT04299893).
CI  - Copyright © 2022 Clavo, Rodríguez-Abreu, Galván, Federico, Martínez-Sánchez, 
      Ramallo-Fariña, Antonelli, Benítez, Rey-Baltar, Jorge, Rodríguez-Esparragón and 
      Serrano-Aguilar.
FAU - Clavo, Bernardino
AU  - Clavo B
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de 
      Gran Canaria, Spain.
AD  - Chronic Pain Unit, Dr. Negrín University Hospital, Las Palmas de Gran Canaria, 
      Spain.
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, Las Palmas de 
      Gran Canaria, Spain.
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las 
      Palmas de Gran Canaria, Spain.
AD  - Molecular and Translational Pharmacology Group, Universitary Institute for 
      Research in Biomedicine and Health (iUIBS), University of Las Palmas de Gran 
      Canaria, Las Palmas de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias de 
      la Universidad de La Laguna, Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de 
      Salud Carlos III, Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 
      Madrid, Spain.
AD  - Spanish Group of Clinical Research in Radiation Oncology (GICOR), Madrid, Spain.
FAU - Rodríguez-Abreu, Delvys
AU  - Rodríguez-Abreu D
AD  - Medical Oncology Department, Complejo Hospitalario Universitario Insular 
      Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain.
FAU - Galván, Saray
AU  - Galván S
AD  - Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, 
      Las Palmas de Gran Canaria, Spain.
FAU - Federico, Mario
AU  - Federico M
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, Las Palmas de 
      Gran Canaria, Spain.
FAU - Martínez-Sánchez, Gregorio
AU  - Martínez-Sánchez G
AD  - Scientific Advisor, Freelance, Ancona, Italy.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las 
      Palmas de Gran Canaria, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de 
      Salud Carlos III, Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Antonelli, Carla
AU  - Antonelli C
AD  - Medical Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín, 
      Las Palmas de Gran Canaria, Spain.
FAU - Benítez, Gretel
AU  - Benítez G
AD  - Medical Oncology Department, Complejo Hospitalario Universitario Insular 
      Materno-Infantil de Gran Canaria, Las Palmas de Gran Canaria, Spain.
FAU - Rey-Baltar, Dolores
AU  - Rey-Baltar D
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, Las Palmas de 
      Gran Canaria, Spain.
FAU - Jorge, Ignacio J
AU  - Jorge IJ
AD  - Chronic Pain Unit, Dr. Negrín University Hospital, Las Palmas de Gran Canaria, 
      Spain.
FAU - Rodríguez-Esparragón, Francisco
AU  - Rodríguez-Esparragón F
AD  - Research Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de 
      Gran Canaria, Spain.
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las 
      Palmas de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias de 
      la Universidad de La Laguna, Tenerife, Spain.
AD  - CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 
      Madrid, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Instituto de 
      Salud Carlos III, Madrid, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Servicio de Evaluación y Planificación del Servicio Canario de Salud (SESCS), 
      Santa Cruz de Tenerife, Spain.
AD  - Red de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del 
      Sistema Nacional de Salud (RedETS), Madrid, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT04299893
PT  - Journal Article
DEP - 20220830
PL  - Switzerland
TA  - Front Physiol
JT  - Frontiers in physiology
JID - 101549006
PMC - PMC9468657
OTO - NOTNLM
OT  - antioxidants
OT  - cancer survivorship
OT  - cancer therapy-induced side effects
OT  - chemotherapy-induced peripheral neuropathy
OT  - neuropathic pain
OT  - oxidative stress
OT  - ozone therapy
OT  - pain
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/09/17 06:00
MHDA- 2022/09/17 06:01
CRDT- 2022/09/16 02:43
PHST- 2022/05/03 00:00 [received]
PHST- 2022/08/09 00:00 [accepted]
PHST- 2022/09/16 02:43 [entrez]
PHST- 2022/09/17 06:00 [pubmed]
PHST- 2022/09/17 06:01 [medline]
AID - 935269 [pii]
AID - 10.3389/fphys.2022.935269 [doi]
PST - epublish
SO  - Front Physiol. 2022 Aug 30;13:935269. doi: 10.3389/fphys.2022.935269. eCollection 
      2022.

PMID- 36090835
OWN - NLM
STAT- MEDLINE
DCOM- 20220913
LR  - 20220913
IS  - 1661-8564 (Electronic)
IS  - 1661-8556 (Print)
IS  - 1661-8556 (Linking)
VI  - 67
DP  - 2022
TI  - Sex Differences in Clinical Parameters, Pharmacological and Health-Resource 
      Utilization in a Population With Hypertension Without a Diagnosis of COVID-19.
PG  - 1604913
LID - 10.3389/ijph.2022.1604913 [doi]
LID - 1604913
AB  - Objectives: Determine the changes in clinical, pharmacological and healthcare 
      resource use parameters, between the 6 months prior to the lockdown and the 
      6 months following its end, in a population with hypertension who did not have a 
      diagnosis of COVID-19. Methods: Real world data observational study of 245,979 
      persons aged >16 years with hypertension in Aragon (Spain). Clinical 
      (systolic-diastolic blood pressure, estimated glomerular filtration rate (eGFR), 
      blood creatinine, cholesterol, triglycerides and anthropometric measures); 
      pharmacological (diuretics, calcium channel antagonists, and ACE inhibitors); and 
      utilization of healthcare resources were considered. We performed the Student's 
      T-test for matched samples (quantitative) and the Chi-squared test (qualitative) 
      to analyze differences between periods. Results: SBP, DBP, parameters of renal 
      function and triglycerides displayed a significant, albeit clinically irrelevant, 
      worsening in women. In men only DBP and eGFR showed a worsening, although to a 
      lesser extent than in women. Certain antihypertensive drugs and health-resource 
      utilization remained below pre-pandemic levels across the 6 months post-lockdown. 
      Conclusion: Changes in lifestyles, along with difficulties in access to routine 
      care has not substantially compromised the health and quality of life of patients 
      with hypertension.
CI  - Copyright © 2022 Lear-Claveras, Oliván-Blázquez, Clavería, Couso-Viana, 
      Puente-Comesaña and Magallón Botaya.
FAU - Lear-Claveras, Ana
AU  - Lear-Claveras A
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragón Health Research Institute, Zaragoza, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragón Health Research Institute, Zaragoza, Spain.
AD  - Department of Psychology and Sociology, Faculty of Social Sciences, University of 
      Zaragoza, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - I-Saúde Group, Galicia South Health Research Institute, Vigo, Spain.
AD  - Vigo Health Area, SERGAS, Vigo, Spain.
FAU - Couso-Viana, Sabela
AU  - Couso-Viana S
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Vigo Health Area, SERGAS, Vigo, Spain.
FAU - Puente-Comesaña, Jesús
AU  - Puente-Comesaña J
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Vigo Health Area, SERGAS, Vigo, Spain.
FAU - Magallón Botaya, Rosa
AU  - Magallón Botaya R
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragón Health Research Institute, Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 
      Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20220825
PL  - Switzerland
TA  - Int J Public Health
JT  - International journal of public health
JID - 101304551
RN  - 0 (Triglycerides)
SB  - IM
MH  - *COVID-19/epidemiology
MH  - COVID-19 Testing
MH  - Communicable Disease Control
MH  - Female
MH  - Humans
MH  - *Hypertension/drug therapy/epidemiology
MH  - Male
MH  - Quality of Life
MH  - Sex Characteristics
MH  - Triglycerides
PMC - PMC9453807
OTO - NOTNLM
OT  - COVID-19 epidemic
OT  - hypertension (HTN)
OT  - lifestyle behaviours
OT  - lockdown
OT  - pharmacoepidemiology
OT  - utilization
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/09/13 06:00
MHDA- 2022/09/14 06:00
CRDT- 2022/09/12 03:50
PHST- 2022/03/11 00:00 [received]
PHST- 2022/07/20 00:00 [accepted]
PHST- 2022/09/12 03:50 [entrez]
PHST- 2022/09/13 06:00 [pubmed]
PHST- 2022/09/14 06:00 [medline]
AID - 1604913 [pii]
AID - 10.3389/ijph.2022.1604913 [doi]
PST - epublish
SO  - Int J Public Health. 2022 Aug 25;67:1604913. doi: 10.3389/ijph.2022.1604913. 
      eCollection 2022.

PMID- 36064159
OWN - NLM
STAT- MEDLINE
DCOM- 20220929
LR  - 20221221
IS  - 1873-6815 (Electronic)
IS  - 0531-5565 (Print)
IS  - 0531-5565 (Linking)
VI  - 168
DP  - 2022 Oct 15
TI  - Evolution of physical function, cognition, depressive mood, and quality of life 
      during the Covid-19 pandemic in prefrail elderly people: A longitudinal cohort 
      study (Covid-Mefap).
PG  - 111946
LID - S0531-5565(22)00254-6 [pii]
LID - 10.1016/j.exger.2022.111946 [doi]
AB  - Confinement due to the COVID-19 pandemic has had a major impact on the living 
      habits and health of the population, notably in the pre-frail elderly. This study 
      aimed to study the effect of the COVID-19 pandemic on the physical function, 
      mental function (cognition and mood), and quality of life of pre-frail elderly 
      individuals over 70 years of age following confinement as well as to analyze the 
      variables associated with the observed changes. METHODS: Observational study of a 
      cohort of pre-frail community-dwelling older adults over 70 years of age during 
      the COVID-19 pandemic conducted in primary care. VARIABLES: The main outcome 
      variables were recorded during face-to-face interviews between December 14 of 
      2020 and August 12 of 2021 using scales for the evaluation of physical function 
      (Short Physical Performance Battery), cognition (Lobo's Mini-Examen 
      Cognoscitivo), depressive mood (Geriatric Depression Scale), and quality of life 
      (EuroQol-5D-3L). Covariates: sociodemographic data and variables related to the 
      pandemic and general health (social support network, COVID-19 infection, 
      exercising, and leisure activities) were also collected. ANALYSIS: The Student's 
      t-test for paired samples and multivariate linear regression models were employed 
      for the statistical analyses. RESULTS: Ninety-two subjects were included in the 
      study. Physical function, cognition, and depressive mood improved during the 
      pandemic, whereas no changes were observed in quality of life. Suffering from 
      COVID-19 was associated with deterioration of the cognitive function (-1.460; 
      CI95%: -2.710 to -0.211). CONCLUSION: Confinement due to the COVID-19 pandemic 
      was not associated with a decline in physical function, cognition, depressive 
      mood, or quality of life in pre-frail individuals over 70 years of age.
CI  - Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
FAU - Castell-Alcalá, María Victoria
AU  - Castell-Alcalá MV
AD  - Dr. Castroviejo Primary Care Health Center, Northern health directorate, Madrid 
      Health Service (SERMAS), Madrid, Spain; Department of Medicine, Unit of Family 
      Medicine and Primary Care, Faculty of Medicine, Universidad Autónoma de Madrid, 
      Spain; Hospital La Paz Institute for Health Research IdiPAZ, Madrid, Spain. 
      Electronic address: mariavictoria.castell@uam.es.
FAU - Rodríguez-Barrientos, Ricardo
AU  - Rodríguez-Barrientos R
AD  - Primary Care Research Unit, Primary Care Health Management, Madrid Health Service 
      (SERMAS), Madrid, Spain; Research Network on Health Services in Chronic Diseases 
      (REDISSEC) and Research Network On Chronicity, Primary Health Care and Health 
      Promotion (RICORS-RICAPPS), Instituto de Salud Carlos III (ISCIII), Madrid, 
      Spain.
FAU - Polentinos-Castro, Elena
AU  - Polentinos-Castro E
AD  - Primary Care Research Unit, Primary Care Health Management, Madrid Health Service 
      (SERMAS), Madrid, Spain; Research Network on Health Services in Chronic Diseases 
      (REDISSEC) and Research Network On Chronicity, Primary Health Care and Health 
      Promotion (RICORS-RICAPPS), Instituto de Salud Carlos III (ISCIII), Madrid, 
      Spain; Institute for Health Research Gregorio Marañon (IiSGM), Madrid Health 
      Service (SERMAS), Madrid, Spain; Preventive Medicine and Public Health Area, 
      Faculty of Health Sciences, Rey Juan Carlos University, Alcorcón, Madrid, Spain.
FAU - Caballero, Bárbara Moreno
AU  - Caballero BM
AD  - Guayaba Primary Care Health Center, Center health directorate, Madrid Health 
      Service (SERMAS), Madrid, Spain.
FAU - Tejera, David Morales
AU  - Tejera DM
AD  - International Doctoral School, Department of Physical Therapy, Occupational 
      Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 
      Alcorcón, Spain; Department of Physiotherapy, Human Physiology and Anatomy, 
      Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, 
      Brussels, Belgium; Pain in Motion Research Group (PAIN), Department of 
      Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and 
      Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium.
FAU - Beriso, Elena Plans
AU  - Beriso EP
AD  - Research group for Epidemiology and Public Health, Department of Surgery and 
      Medical and Social Sciences, Faculty of Medicine and Health Sciences, University 
      of Alcalá, Alcalá de Henares, Madrid, Spain.
FAU - Gutiérrez-Misis, Alicia
AU  - Gutiérrez-Misis A
AD  - Department of Medicine, Unit of Family Medicine and Primary Care, Faculty of 
      Medicine, Universidad Autónoma de Madrid, Spain; Hospital La Paz Institute for 
      Health Research IdiPAZ, Madrid, Spain.
CN  - MEFAP group
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220905
PL  - England
TA  - Exp Gerontol
JT  - Experimental gerontology
JID - 0047061
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *COVID-19/epidemiology
MH  - Cognition
MH  - Cohort Studies
MH  - Cross-Sectional Studies
MH  - Depression/epidemiology
MH  - Frail Elderly/psychology
MH  - Geriatric Assessment
MH  - Humans
MH  - Longitudinal Studies
MH  - Observational Studies as Topic
MH  - *Quality of Life/psychology
PMC - PMC9443616
OTO - NOTNLM
OT  - COVID-19
OT  - Cognitive function
OT  - Mood
OT  - Physical function
OT  - Prefrail elderly
OT  - Quality of life
COIS- Declaration of competing interest No potential conflict of interest by the 
      authors.
EDAT- 2022/09/06 06:00
MHDA- 2022/09/30 06:00
CRDT- 2022/09/05 19:28
PHST- 2022/06/13 00:00 [received]
PHST- 2022/08/10 00:00 [revised]
PHST- 2022/08/27 00:00 [accepted]
PHST- 2022/09/06 06:00 [pubmed]
PHST- 2022/09/30 06:00 [medline]
PHST- 2022/09/05 19:28 [entrez]
AID - S0531-5565(22)00254-6 [pii]
AID - 111946 [pii]
AID - 10.1016/j.exger.2022.111946 [doi]
PST - ppublish
SO  - Exp Gerontol. 2022 Oct 15;168:111946. doi: 10.1016/j.exger.2022.111946. Epub 2022 
      Sep 5.

PMID- 36047480
OWN - NLM
STAT- MEDLINE
DCOM- 20221129
LR  - 20221216
IS  - 1369-7625 (Electronic)
IS  - 1369-6513 (Print)
IS  - 1369-6513 (Linking)
VI  - 25
IP  - 6
DP  - 2022 Dec
TI  - Factors associated with patient empowerment in Spanish adults with type 2 
      diabetes: A cross-sectional analysis.
PG  - 2762-2774
LID - 10.1111/hex.13501 [doi]
AB  - OBJECTIVE: The aim of the present study is to identify factors associated with 
      patient empowerment in people living with type 2 diabetes mellitus (T2DM) in the 
      Canary Islands (Spain). METHODS: Secondary cross-sectional analysis was carried 
      out of data obtained in the INDICA study: A 24-month cluster 
      randomized-controlled trial evaluating the effectiveness of educational 
      interventions supported by new technology decision tools for T2DM patients. 
      Sociodemographic variables, clinical data (years since diagnosis, glycated 
      haemoglobin level, creatine, triglycerides, waist hip index, body mass index and 
      number of comorbidities), diabetes knowledge (DIATEK), affective outcomes (Beck 
      Depression Inventory-II, the State subscale of the State-Trait Anxiety Inventory 
      and The Diabetes Distress Scale) and diabetes-related quality of life (The Audit 
      of Diabetes-Dependent Quality of life) were assessed as potential correlates of 
      patient empowerment, assessed using the Diabetes Empowerment Scale-Short Form. 
      Multilevel mixed linear regression models on patient empowerment were developed. 
      RESULTS: The analysis included the baseline data of 2334 patients. Results showed 
      that age (B = -0.14; p < .001), diabetes knowledge (B = 0.61; p < .001) and 
      state-anxiety (B = -0.09; p < .001) are significantly associated with patient 
      empowerment. Sex, education level, living alone, employment status, country of 
      birth, time since diagnosis, number of comorbidities, glycated haemoglobin level, 
      depression and distress were not independently associated with patient 
      empowerment in the multivariate analyses. CONCLUSION: Younger age, lower 
      state-anxiety and greater diabetes-specific knowledge are important correlates of 
      patient empowerment. In line with the results of the INDICA study, interventions 
      based on patient-centred care might be effective in improving patient empowerment 
      in adults with T2DM. Understanding the factors associated with empowerment may 
      help clinicians and policymakers to identify high-risk groups, prioritize 
      resources and target evidence-based interventions to better support people with 
      T2DM to be actively involved in their own care. PATIENT OR PUBLIC CONTRIBUTION: 
      Patients with T2DM were actively involved in the design of the INDICA study. Two 
      patient associations were included as part of the research team and actively 
      participated in designing the interventions and selecting outcome measures.
CI  - © 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AUID- ORCID: 0000-0003-1171-9945
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Department of Clinical Psychology, Psychobiology and Methodology, University of 
      La Laguna (ULL), Tenerife, Spain.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AUID- ORCID: 0000-0001-6651-0693
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AUID- ORCID: 0000-0002-5067-3196
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AUID- ORCID: 0000-0002-1541-3989
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AUID- ORCID: 0000-0002-6113-7313
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
FAU - Peñate, Wenceslao
AU  - Peñate W
AUID- ORCID: 0000-0001-9168-9920
AD  - Department of Clinical Psychology, Psychobiology and Methodology, University of 
      La Laguna (ULL), Tenerife, Spain.
FAU - Carrion, Carme
AU  - Carrion C
AUID- ORCID: 0000-0003-1479-7551
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - eHealth Lab Research Group, School of Health Sciences, Universitat Oberta de 
      Catalunya (UOC), Barcelona, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AUID- ORCID: 0000-0002-5373-410X
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
CN  - INDICA Team
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20220901
PL  - England
TA  - Health Expect
JT  - Health expectations : an international journal of public participation in health 
      care and health policy
JID - 9815926
RN  - 0 (Glycated Hemoglobin A)
SB  - IM
MH  - Adult
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/therapy/psychology
MH  - Glycated Hemoglobin/analysis
MH  - Patient Participation
MH  - Cross-Sectional Studies
MH  - Quality of Life
PMC - PMC9700189
OTO - NOTNLM
OT  - Spain
OT  - correlates
OT  - patient empowerment
OT  - type 2 diabetes mellitus
COIS- The authors declare no conflicts of interest.
EDAT- 2022/09/02 06:00
MHDA- 2022/11/30 06:00
CRDT- 2022/09/01 05:43
PHST- 2022/03/14 00:00 [revised]
PHST- 2021/11/12 00:00 [received]
PHST- 2022/04/02 00:00 [accepted]
PHST- 2022/09/02 06:00 [pubmed]
PHST- 2022/11/30 06:00 [medline]
PHST- 2022/09/01 05:43 [entrez]
AID - HEX13501 [pii]
AID - 10.1111/hex.13501 [doi]
PST - ppublish
SO  - Health Expect. 2022 Dec;25(6):2762-2774. doi: 10.1111/hex.13501. Epub 2022 Sep 1.

PMID- 36030578
OWN - NLM
STAT- MEDLINE
DCOM- 20220928
LR  - 20220928
IS  - 1532-8511 (Electronic)
IS  - 1052-3057 (Linking)
VI  - 31
IP  - 10
DP  - 2022 Oct
TI  - Drip and ship and mothership models of mechanical thrombectomy result in similar 
      outcomes in acute ischemic stroke of the anterior circulation.
PG  - 106733
LID - S1052-3057(22)00427-X [pii]
LID - 10.1016/j.jstrokecerebrovasdis.2022.106733 [doi]
AB  - BACKGROUND: Stroke therapy has been transformed in recent years due to the 
      availability of thrombolysis and mechanical thrombectomy (MT). Whether 
      transferring the patient directly to a comprehensive stroke center (CSC, 
      mothership model) is better than taking them to a primary stroke center (PSC) and 
      then to a CSC for MT (drip and ship) is unclear but has important implications. 
      We compared the performance of both models in a district of the Basque country, 
      Spain. METHODS: This is a retrospective analysis of prospectively collected data 
      of all acute ischemic stroke patients consecutively admitted to the Neurology 
      Department of two institutions and eligible for MT over a 36-month period with 
      anterior circulation large vessel occlusion (LVO). One center applied the 
      mothership model and the other the drip-and-ship. The two models were compared in 
      terms of mortality and functional status assessed by modified Rankin (mRS) scale 
      at 90 days. As a surrogate of the effectiveness of the two models, all times 
      pertinent to stroke therapy were recorded. RESULTS: A total of 187 patients were 
      evaluated subjected to MT with the drip-and-ship model and 188 with mothership, 
      with a median NIHSS of 15. Prior to MT, 17% of the drip-and-ship patients 
      received thrombolysis and 26% in the mothership. Neither mortality rate nor mRS 
      showed statistically significant differences 90 days after stroke. The time lapse 
      from stroke to MT was optimal in both models; albeit being 10 minutes longer in 
      the drip-and-ship model, it had no impact on patients' outcomes. CONCLUSIONS: 
      Drip-and-ship and mothership models can provide optimal and similar results in 
      acute stroke patients in terms of mortality and functional status at 90 days. 
      Their coexistence may alleviate the burden of CSC thus facilitating the access of 
      more stroke patients to advanced therapies in an equitable manner.
CI  - Copyright © 2022 Elsevier Inc. All rights reserved.
FAU - Brochado, Ana Pinedo
AU  - Brochado AP
AD  - Osakidetza Basque Health Service, Galdakao University Hospital, Department of 
      Neurology, Vizcaya, Spain; Biocruces Bizkaia Health Research Institute.
FAU - Muras, Antonio Cabrera
AU  - Muras AC
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - Oyarzun-Irazu, Iñigo
AU  - Oyarzun-Irazu I
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - Rodriguez-Sainz, Aida
AU  - Rodriguez-Sainz A
AD  - Osakidetza Basque Health Service, Galdakao University Hospital, Department of 
      Neurology, Vizcaya, Spain; Biocruces Bizkaia Health Research Institute.
FAU - Caballero-Romero, Ivan
AU  - Caballero-Romero I
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - Aguilera-Irazabal, Borja
AU  - Aguilera-Irazabal B
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - García-Sánchez, Juan Manuel
AU  - García-Sánchez JM
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - Sustatxa-Zárraga, Irene
AU  - Sustatxa-Zárraga I
AD  - Osakidetza Basque Health Service, Galdakao University Hospital, Department of 
      Neurology, Vizcaya, Spain; Biocruces Bizkaia Health Research Institute.
FAU - Martínez-Condor, Daniel
AU  - Martínez-Condor D
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - Gutierrez-Albizuri, Clea
AU  - Gutierrez-Albizuri C
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain.
FAU - Bilbao-González, Amaia
AU  - Bilbao-González A
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Research and Innovation Unit, Vizcaya, Spain; 
      Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) 
      Kronikgune, Vizcaya, Spain.
FAU - Gómez-Beldarrain, Marian
AU  - Gómez-Beldarrain M
AD  - Osakidetza Basque Health Service, Galdakao University Hospital, Department of 
      Neurology, Vizcaya, Spain; Biocruces Bizkaia Health Research Institute.
FAU - García-Moncó, Juan Carlos
AU  - García-Moncó JC
AD  - Biocruces Bizkaia Health Research Institute.; Osakidetza Basque Health Service, 
      Basurto University Hospital, Department of Neurology, Vizcaya, Spain. Electronic 
      address: hospit05@sarenet.es.
LA  - eng
PT  - Journal Article
DEP - 20220826
PL  - United States
TA  - J Stroke Cerebrovasc Dis
JT  - Journal of stroke and cerebrovascular diseases : the official journal of National 
      Stroke Association
JID - 9111633
SB  - IM
MH  - *Brain Ischemia/diagnosis/etiology/therapy
MH  - Humans
MH  - *Ischemic Stroke
MH  - Retrospective Studies
MH  - *Stroke/diagnosis/etiology/therapy
MH  - Thrombectomy
MH  - Thrombolytic Therapy/adverse effects/methods
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Drip-and-ship
OT  - Mechanical thrombectomy
OT  - Mothership
OT  - Stroke
OT  - Thrombectomy
COIS- Declaration of Competing Interest The authors declare no conflict of interest 
      regarding this manuscript.
EDAT- 2022/08/29 06:00
MHDA- 2022/09/28 06:00
CRDT- 2022/08/28 18:07
PHST- 2022/04/15 00:00 [received]
PHST- 2022/08/05 00:00 [revised]
PHST- 2022/08/14 00:00 [accepted]
PHST- 2022/08/29 06:00 [pubmed]
PHST- 2022/09/28 06:00 [medline]
PHST- 2022/08/28 18:07 [entrez]
AID - S1052-3057(22)00427-X [pii]
AID - 10.1016/j.jstrokecerebrovasdis.2022.106733 [doi]
PST - ppublish
SO  - J Stroke Cerebrovasc Dis. 2022 Oct;31(10):106733. doi: 
      10.1016/j.jstrokecerebrovasdis.2022.106733. Epub 2022 Aug 26.

PMID- 36013031
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220830
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 11
IP  - 16
DP  - 2022 Aug 16
TI  - Associations between Psychological Variables, Knowledge, Attitudes, Risk 
      Perceptions and Health Behaviours towards COVID-19 among Adolescents.
LID - 10.3390/jcm11164793 [doi]
LID - 4793
AB  - There is currently little scientific evidence available that allows us to 
      understand patterns of knowledge, risk perception, attitudes, and behaviours 
      among adolescents in relation to COVID-19. This study aims to analyse the 
      relationship between knowledge about COVID-19, risk perception, and psychological 
      variables and the adherence to preventive measures among the adolescent 
      population. It is a descriptive cross-sectional study, which included adolescents 
      between the ages of 12 and 18 (n = 354). The questionnaire was sent to several 
      secondary schools chosen by convenience sampling and following a 
      non-probabilistic snowball sampling. Descriptive, univariate, and multivariate 
      analyses were carried out in order to determine whether knowledge about COVID-19, 
      risk perception, tolerance of frustration, planning and decision-making, family 
      functionality, self-efficacy, self-esteem, and social skills are related to 
      preventive measures. The adoption among adolescents of behaviours which protect 
      them against COVID-19 depends on knowledge about the disease, the perception of 
      the risk it poses to them, as well as their tolerance of frustration and planning 
      and decision-making abilities. The relationship between the individual variables 
      among adolescents with the adoption of behaviours which protect them against 
      COVID-19 has been confirmed. The development of intervention and communication 
      strategies that take the psychosocial situation of adolescents into account will 
      help to increase the adoption of protective health behaviours in the context of a 
      pandemic.
FAU - Asensio-Martínez, Ángela
AU  - Asensio-Martínez Á
AD  - Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, 28029 Madrid, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Aguilar-Latorre, Alejandra
AU  - Aguilar-Latorre A
AUID- ORCID: 0000-0003-2683-7346
AD  - Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, 28029 Madrid, Spain.
FAU - García-Sanz, Olga
AU  - García-Sanz O
AD  - Institute of Secondary Education San Miguel (Ministry of Education, Universities, 
      Culture and Sports of the Government of the Canary Islands), 38618 Santa Cruz de 
      Tenerife, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AUID- ORCID: 0000-0001-6565-9699
AD  - Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, 28029 Madrid, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - López-Del-Hoyo, Yolanda
AU  - López-Del-Hoyo Y
AD  - Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, 28029 Madrid, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
FAU - Magallón-Botaya, Rosa
AU  - Magallón-Botaya R
AD  - Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS, 
      RD21/0016/0005), Carlos III Health Institute, 28029 Madrid, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 50009 
      Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220816
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC9409859
OTO - NOTNLM
OT  - COVID-19
OT  - adolescents
OT  - health behaviours
OT  - psychological variables
OT  - risk perceptions
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses, or interpretation of data; in 
      the writing of the manuscript; or in the decision to publish the results.
EDAT- 2022/08/27 06:00
MHDA- 2022/08/27 06:01
CRDT- 2022/08/26 01:27
PHST- 2022/06/28 00:00 [received]
PHST- 2022/07/27 00:00 [revised]
PHST- 2022/08/10 00:00 [accepted]
PHST- 2022/08/26 01:27 [entrez]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/08/27 06:01 [medline]
AID - jcm11164793 [pii]
AID - jcm-11-04793 [pii]
AID - 10.3390/jcm11164793 [doi]
PST - epublish
SO  - J Clin Med. 2022 Aug 16;11(16):4793. doi: 10.3390/jcm11164793.

PMID- 36011970
OWN - NLM
STAT- MEDLINE
DCOM- 20220829
LR  - 20220907
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 16
DP  - 2022 Aug 19
TI  - Global Healthcare Needs Related to COVID-19: An Evidence Map of the First Year of 
      the Pandemic.
LID - 10.3390/ijerph191610332 [doi]
LID - 10332
AB  - The COVID-19 pandemic has exposed gaps and areas of need in health systems 
      worldwide. This work aims to map the evidence on COVID-19-related healthcare 
      needs of adult patients, their family members, and the professionals involved in 
      their care during the first year of the pandemic. We searched the databases 
      MEDLINE, Embase, and Web of Science. Two reviewers independently screened titles 
      and abstracts and assessed full texts for eligibility. Disagreements were 
      resolved by consensus. Descriptive data were extracted and inductive qualitative 
      content analysis was used to generate codes and derive overarching themes. 
      Thirty-six studies met inclusion criteria, with the majority reporting needs from 
      the perspective of professionals (35/36). Professionals' needs were grouped into 
      three main clusters (basic, occupational, and psycho-socio-emotional needs); 
      patients' needs into four (basic, healthcare, psycho-socio-emotional, and other 
      support needs); and family members' needs into two (psycho-socio-emotional and 
      communication needs). Transversal needs across subgroups were also identified and 
      grouped into three main clusters (public safety, information and communication, 
      and coordination and support needs). This evidence map provides valuable insight 
      on COVID-19-related healthcare needs. More research is needed to assess 
      first-person perspectives of patients and their families, examine whether needs 
      differ by country or region, and evaluate how needs have evolved over time.
FAU - Aparicio Betancourt, Mariana
AU  - Aparicio Betancourt M
AUID- ORCID: 0000-0001-5114-4168
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, 
      Spain.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AUID- ORCID: 0000-0003-1171-9945
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
FAU - Vall-Roqué, Helena
AU  - Vall-Roqué H
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, 
      Spain.
FAU - Seils, Laura
AU  - Seils L
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
FAU - Orrego, Carola
AU  - Orrego C
AD  - Avedis Donabedian Research Institute (FAD), 08037 Barcelona, Spain.
AD  - Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AUID- ORCID: 0000-0002-6113-7313
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 El Rosario, 
      Spain.
FAU - Barrio-Cortes, Jaime
AU  - Barrio-Cortes J
AUID- ORCID: 0000-0002-2582-0203
AD  - Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, 
      Spain.
AD  - Fundación para la Investigación e Innovación Biosanitaria en Atención Primaria, 
      28003 Madrid, Spain.
FAU - Beca-Martínez, María Teresa
AU  - Beca-Martínez MT
AUID- ORCID: 0000-0001-9915-7750
AD  - Servicio de Medicina Preventiva del Complejo Hospitalario de Toledo, 45004 
      Toledo, Spain.
FAU - Molina Serrano, Almudena
AU  - Molina Serrano A
AD  - Hermanas Hospitalarias, 28939 Madrid, Spain.
FAU - Bermejo-Caja, Carlos Jesús
AU  - Bermejo-Caja CJ
AUID- ORCID: 0000-0003-1425-6691
AD  - Unidad de Apoyo Técnico Dirección Técnica de Sistemas de información, Gerencia 
      Asistencial Atención Primaria, Servicio Madrileño de Salud, 28035 Madrid, Spain.
AD  - Departamento de Enfermería. Universidad Autónoma de Madrid, 28034 Madrid, Spain.
FAU - González-González, Ana Isabel
AU  - González-González AI
AUID- ORCID: 0000-0002-1707-0596
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, 
      Spain.
AD  - Unidad de Innovación y Proyectos Internacionales, Dirección General de 
      Investigación, Docencia y Documentación, Consejería de Sanidad, 28034 Madrid, 
      Spain.
AD  - Institute of General Practice, Goethe University, 60323 Frankfurt, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20220819
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Adult
MH  - *COVID-19/epidemiology
MH  - Delivery of Health Care
MH  - Family/psychology
MH  - Health Facilities
MH  - Humans
MH  - *Pandemics
PMC - PMC9408445
OTO - NOTNLM
OT  - COVID-19
OT  - evidence map
OT  - family members’ needs
OT  - healthcare needs
OT  - healthcare professionals’ needs
OT  - needs assessment
OT  - pandemic
OT  - patients’ needs
OT  - systematic review
COIS- The authors declare no conflict of interest.
EDAT- 2022/08/27 06:00
MHDA- 2022/08/30 06:00
CRDT- 2022/08/26 01:20
PHST- 2022/06/30 00:00 [received]
PHST- 2022/08/10 00:00 [revised]
PHST- 2022/08/14 00:00 [accepted]
PHST- 2022/08/26 01:20 [entrez]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/08/30 06:00 [medline]
AID - ijerph191610332 [pii]
AID - ijerph-19-10332 [pii]
AID - 10.3390/ijerph191610332 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Aug 19;19(16):10332. doi: 
      10.3390/ijerph191610332.

PMID- 36011814
OWN - NLM
STAT- MEDLINE
DCOM- 20220829
LR  - 20220908
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 16
DP  - 2022 Aug 17
TI  - Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort.
LID - 10.3390/ijerph191610180 [doi]
LID - 10180
AB  - Multimorbidity is challenging for both patients and healthcare systems due to its 
      increasing prevalence and high impact on people's health and well-being. The risk 
      of multimorbidity increases with age, but there is still more to discover 
      regarding the clinical profile of the oldest old. In this study, we used 
      information from the EpiChron Cohort Study to identify multimorbidity patterns in 
      individuals who died during the period 2010-2019 at the ages of 80-89, 90-99, and 
      ≥100. This cohort links the demographic, clinical, and drug dispensation 
      information of public health system users in Aragón, Spain. We saw a 
      significantly lower number of chronic diseases and drugs and a lower prevalence 
      of polypharmacy in centenarians compared to those aged 80-99. K-means clustering 
      revealed different multimorbidity clusters by sex and age group. We observed 
      clusters of cardiovascular and metabolic diseases, obstructive pulmonary 
      conditions, and neoplasms, amongst other profiles. One in three octogenarian 
      women had a metabolic pattern (diabetes, dyslipidaemia, and other 
      endocrine-metabolic disorders) with the highest number of diseases (up to seven) 
      and prevalence of polypharmacy (64%). We observed clusters of dementia and 
      genitourinary disorders in individuals on medication with anticholinergic 
      activity. Our study offers an opportunity to better understand the urgency of 
      adequately addressing multimorbidity in our older adults.
FAU - Ioakeim-Skoufa, Ignatios
AU  - Ioakeim-Skoufa I
AUID- ORCID: 0000-0002-6518-749X
AD  - WHO Collaborating Centre for Drug Statistics Methodology, Department of Drug 
      Statistics, Division of Health Data and Digitalisation, Norwegian Institute of 
      Public Health, NO-0213 Oslo, Norway.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), ES-08009 Barcelona, Spain.
FAU - Clerencia-Sierra, Mercedes
AU  - Clerencia-Sierra M
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Aragon Health Service (SALUD), Miguel Servet University Hospital, ES-50009 
      Zaragoza, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, ES-28029 Madrid, Spain.
FAU - Moreno-Juste, Aida
AU  - Moreno-Juste A
AUID- ORCID: 0000-0002-8819-3278
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Aragon Health Service (SALUD), Miguel Servet University Hospital, ES-50009 
      Zaragoza, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, ES-28029 Madrid, Spain.
FAU - Elías de Molins Peña, Carmen
AU  - Elías de Molins Peña C
AD  - Aragon Health Service (SALUD), Miguel Servet University Hospital, ES-50009 
      Zaragoza, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AUID- ORCID: 0000-0002-5119-5093
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, ES-28029 Madrid, Spain.
FAU - Aza-Pascual-Salcedo, Mercedes
AU  - Aza-Pascual-Salcedo M
AUID- ORCID: 0000-0002-8937-5559
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, ES-28029 Madrid, Spain.
AD  - Primary Care Pharmacy Service Zaragoza III, Aragon Health Service (SALUD), 
      ES-50017 Zaragoza, Spain.
FAU - González-Rubio, Francisca
AU  - González-Rubio F
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (semFYC), ES-08009 Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AUID- ORCID: 0000-0002-5704-6056
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, ES-28029 Madrid, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AUID- ORCID: 0000-0002-5440-1710
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, ES-50009 Zaragoza, Spain.
AD  - Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 
      ES-28029 Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      ISCIII, ES-28029 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220817
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Chronic Disease
MH  - Cohort Studies
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - *Metabolic Diseases
MH  - *Multimorbidity
MH  - Polypharmacy
MH  - Prevalence
PMC - PMC9408216
OTO - NOTNLM
OT  - aged
OT  - cluster
OT  - clustering
OT  - electronic health records
OT  - epidemiology
OT  - multimorbidity
OT  - multiple chronic conditions
OT  - noncommunicable diseases
OT  - public health
OT  - routinely collected health data
COIS- The authors declare no conflict of interest.
EDAT- 2022/08/27 06:00
MHDA- 2022/08/30 06:00
CRDT- 2022/08/26 01:19
PHST- 2022/07/19 00:00 [received]
PHST- 2022/08/15 00:00 [revised]
PHST- 2022/08/15 00:00 [accepted]
PHST- 2022/08/26 01:19 [entrez]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/08/30 06:00 [medline]
AID - ijerph191610180 [pii]
AID - ijerph-19-10180 [pii]
AID - 10.3390/ijerph191610180 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Aug 17;19(16):10180. doi: 
      10.3390/ijerph191610180.

PMID- 36009271
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220830
IS  - 2076-3921 (Print)
IS  - 2076-3921 (Electronic)
IS  - 2076-3921 (Linking)
VI  - 11
IP  - 8
DP  - 2022 Aug 10
TI  - Effect of Polyphenolic Complements on Cognitive Function in the Elderly: A 
      Systematic Review.
LID - 10.3390/antiox11081549 [doi]
LID - 1549
AB  - Polyphenols have been shown to be effective against many chronic diseases. These 
      compounds could have a beneficial effect at the cognitive level. The exact 
      mechanism by which they provide positive effects at the cognitive level is not 
      well known, but it is believed that they could counteract neuroinflammation. The 
      objective of this study is to review nutritional interventions that include foods 
      or supplements rich in flavanols, flavonols, or stilbenes to the usual diet on 
      cognitive deterioration in people over 50 years of age. Clinical trials published 
      in PubMed and Web of Science from 1 March 2010 to 1 March 2020 were explored, 
      from which 14 studies were selected. All of them showed some improvement after 
      the intervention. In interventions with flavanols and stilbenes, relevant 
      improvements have been observed both in healthy patients and in patients with 
      established cognitive impairment. Most studies agree that the greatest benefits 
      are found with high doses and longer duration treatments. The changes were 
      fundamentally assessed through cognitive tests, and in some of the studies, 
      through magnetic resonance imaging (fMRI). The type of cognitive test used to 
      assess the effect of the intervention was revealed to be critical. Several 
      studies have also shown improvements in analytical parameters and blood pressure.
FAU - Rodrigo-Gonzalo, María José
AU  - Rodrigo-Gonzalo MJ
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
FAU - González-Manzano, Susana
AU  - González-Manzano S
AUID- ORCID: 0000-0002-5739-515X
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, Recuperación Funcional y Ejercicio Terapéutico del 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), E-37007 Salamanca, 
      Spain.
FAU - Mendez-Sánchez, Roberto
AU  - Mendez-Sánchez R
AUID- ORCID: 0000-0002-4486-4076
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Grupo de Fisioterapia, Recuperación Funcional y Ejercicio Terapéutico del 
      Instituto de Investigación Biomédica de Salamanca (IBSAL), E-37007 Salamanca, 
      Spain.
FAU - Santos-Buelga, Celestino
AU  - Santos-Buelga C
AUID- ORCID: 0000-0001-6592-5299
AD  - Grupo de Investigación de Polifenoles (GIP-USAL), Universidad de Salamanca, 
      E-37007 Salamanca, Spain.
FAU - Recio-Rodríguez, Jose Ignacio
AU  - Recio-Rodríguez JI
AUID- ORCID: 0000-0002-3772-8746
AD  - Facultad de Enfermería y Fisioterapia, Universidad de Salamanca, E-37007 
      Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Instituto de 
      Investigación Biomédica de Salamanca (IBSAL), Red de Investigación en Cronicidad, 
      Atención Primaria y Promoción de la Salud (RICAPPS), E-37007 Salamanca, Spain.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220810
PL  - Switzerland
TA  - Antioxidants (Basel)
JT  - Antioxidants (Basel, Switzerland)
JID - 101668981
PMC - PMC9404940
OTO - NOTNLM
OT  - cognitive function
OT  - cognitive impairment and neurophysicological function
OT  - flavanols
OT  - flavonoids
OT  - stilbenes
COIS- The authors declare no conflict of interest.
EDAT- 2022/08/27 06:00
MHDA- 2022/08/27 06:01
CRDT- 2022/08/26 01:04
PHST- 2022/07/11 00:00 [received]
PHST- 2022/08/05 00:00 [revised]
PHST- 2022/08/06 00:00 [accepted]
PHST- 2022/08/26 01:04 [entrez]
PHST- 2022/08/27 06:00 [pubmed]
PHST- 2022/08/27 06:01 [medline]
AID - antiox11081549 [pii]
AID - antioxidants-11-01549 [pii]
AID - 10.3390/antiox11081549 [doi]
PST - epublish
SO  - Antioxidants (Basel). 2022 Aug 10;11(8):1549. doi: 10.3390/antiox11081549.

PMID- 35998967
OWN - NLM
STAT- MEDLINE
DCOM- 20220825
LR  - 20220907
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 12
IP  - 8
DP  - 2022 Aug 23
TI  - Effectiveness of exercise and physical activity interventions to improve 
      long-term patient-relevant cognitive and non-cognitive outcomes in people living 
      with mild cognitive impairment: a protocol of a systematic review and 
      meta-analysis.
PG  - e063396
LID - 10.1136/bmjopen-2022-063396 [doi]
LID - e063396
AB  - INTRODUCTION: Mild cognitive impairment (MCI) is a clinical syndrome 
      characterised by persistent cognitive deficits that do not yet fulfil the 
      criteria of dementia. Delaying the onset of dementia using secondary preventive 
      measures such as physical activity and exercise can be a safe way of reducing the 
      risk of further cognitive decline and maintaining independence and improving 
      quality of life. The aim is to systematically review the literature to assess the 
      effectiveness of physical activity and exercise interventions to improve 
      long-term patient-relevant cognitive and non-cognitive outcomes in people living 
      with MCI, including meta-analyses if applicable. METHODS AND ANALYSIS: We will 
      systematically search five electronic databases from 1995 onward to identify 
      trials reporting on the effectiveness of physical activity and exercise 
      interventions to improve long-term (12+ months) patient-relevant cognitive and 
      non-cognitive outcomes in adults (50+ years) with MCI. Screening procedures, 
      selection of eligible full-texts, data extraction and risk of bias assessment 
      will be performed in dual-review mode. Additionally, the reporting quality of the 
      exercise interventions will be assessed using the Consensus on Exercise Reporting 
      Template. A quantitative synthesis will only be conducted if studies are 
      homogeneous enough for effect sizes to be pooled. Where quantitative analysis is 
      not applicable, data will be represented in a tabular form and synthesised 
      narratively. People living with MCI will be involved in defining outcome measures 
      most relevant to them in order to assess in how far randomised controlled trials 
      report endpoints that matter to those concerned. ETHICS AND DISSEMINATION: 
      Results will be disseminated to both scientific and lay audiences by creating a 
      patient-friendly video abstract. This work will inform professionals in primary 
      care about the effectiveness of physical activity and exercise interventions and 
      support them to make evidence-based exercise recommendations for the secondary 
      prevention of dementia in people living with MCI. No ethical approval required. 
      PROSPERO REGISTRATION NUMBER: CRD42021287166.
CI  - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Dieckelmann, Mirjam
AU  - Dieckelmann M
AUID- ORCID: 0000-0002-5243-7840
AD  - Institute of General Practice, Goethe-Universitat Frankfurt am Main, Frankfurt, 
      Germany.
FAU - Gonzalez-Gonzalez, Ana Isabel
AU  - Gonzalez-Gonzalez AI
AUID- ORCID: 0000-0002-1707-0596
AD  - Institute of General Practice, Goethe-Universitat Frankfurt am Main, Frankfurt, 
      Germany.
AD  - Atención Primaria y Promoción de la Salud (RICAPPS), Red de Investigación en 
      Cronicidad, Madrid, Spain.
FAU - Banzer, Winfried
AU  - Banzer W
AD  - Institute for Occupational, Social and Environmental Medicine, Goethe University, 
      Frankfurt, Germany.
FAU - Berghold, Andrea
AU  - Berghold A
AUID- ORCID: 0000-0001-5187-9105
AD  - Institute for Medical Informatics, Statistics and Documentation, Medical 
      University of Graz, Graz, Austria.
FAU - Jeitler, Klaus
AU  - Jeitler K
AD  - Institute for Medical Informatics, Statistics and Documentation, Medical 
      University of Graz, Graz, Austria.
AD  - Institute of General Practice and Evidence-based Health Services Research, 
      Medical University of Graz, Graz, Austria.
FAU - Pantel, Johannes
AU  - Pantel J
AD  - Institute of General Practice, Goethe-Universitat Frankfurt am Main, Frankfurt, 
      Germany.
FAU - Schall, Arthur
AU  - Schall A
AD  - Institute of General Practice, Goethe-Universitat Frankfurt am Main, Frankfurt, 
      Germany.
FAU - Tesky, Valentina A
AU  - Tesky VA
AD  - Institute of General Practice, Goethe-Universitat Frankfurt am Main, Frankfurt, 
      Germany.
FAU - Siebenhofer, Andrea
AU  - Siebenhofer A
AUID- ORCID: 0000-0002-6980-2103
AD  - Institute of General Practice, Goethe-Universitat Frankfurt am Main, Frankfurt, 
      Germany andrea.siebenhofer@medunigraz.at.
AD  - Institute of General Practice and Evidence-based Health Services Research, 
      Medical University of Graz, Graz, Austria.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Video-Audio Media
DEP - 20220823
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - *Cognition Disorders
MH  - *Cognitive Dysfunction/psychology/therapy
MH  - *Dementia/psychology
MH  - Exercise
MH  - Humans
MH  - Meta-Analysis as Topic
MH  - Middle Aged
MH  - Quality of Life
MH  - Systematic Reviews as Topic
PMC - PMC9403149
OTO - NOTNLM
OT  - dementia
OT  - preventive medicine
OT  - primary care
OT  - sports medicine
COIS- Competing interests: None declared.
EDAT- 2022/08/24 06:00
MHDA- 2022/08/26 06:00
CRDT- 2022/08/23 20:53
PHST- 2022/08/23 20:53 [entrez]
PHST- 2022/08/24 06:00 [pubmed]
PHST- 2022/08/26 06:00 [medline]
AID - bmjopen-2022-063396 [pii]
AID - 10.1136/bmjopen-2022-063396 [doi]
PST - epublish
SO  - BMJ Open. 2022 Aug 23;12(8):e063396. doi: 10.1136/bmjopen-2022-063396.

PMID- 35996104
OWN - NLM
STAT- MEDLINE
DCOM- 20220824
LR  - 20220829
IS  - 1471-2407 (Electronic)
IS  - 1471-2407 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Aug 22
TI  - Relationship between time from symptom's onset to diagnosis and prognosis in 
      patients with symptomatic colorectal cancer.
PG  - 910
LID - 10.1186/s12885-022-09990-7 [doi]
LID - 910
AB  - BACKGROUND: Controversy exists regarding the relationship of the outcome of 
      patients with colorectal cancer (CRC) with the time from symptom onset to 
      diagnosis. The aim of this study is to investigate this association, with the 
      assumption that this relationship was nonlinear and with adjustment for multiple 
      confounders, such as tumor grade, symptoms, or admission to an emergency 
      department. METHODS: This multicenter study with prospective follow-up was 
      performed in five regions of Spain from 2010 to 2012. Symptomatic cases of 
      incident CRC from a previous study were examined. At the time of diagnosis, each 
      patient was interviewed, and the associated hospital and clinical records were 
      reviewed. During follow-up, the clinical records were reviewed again to assess 
      survival. Cox survival analysis with a restricted cubic spline was used to model 
      overall and CRC-specific survival, with adjustment for variables related to the 
      patient, health service, and tumor. RESULTS: A total of 795 patients had 
      symptomatic CRC and 769 of them had complete data on diagnostic delay and 
      survival. Univariate analysis indicated a lower HR for death in patients who had 
      diagnostic intervals less than 4.2 months. However, after adjustment for 
      variables related to the patient, tumor, and utilized health service, there was 
      no relationship of the diagnostic delay with survival of patients with colon and 
      rectal cancer, colon cancer alone, or rectal cancer alone. Cubic spline analysis 
      indicated an inverse association of the diagnostic delay with 5-year survival. 
      However, this association was not statistically significant. CONCLUSIONS: Our 
      results indicated that the duration of diagnostic delay had no significant effect 
      on the outcome of patients with CRC. We suggest that the most important 
      determinant of the duration of diagnostic delay is the biological profile of the 
      tumor. However, it remains the responsibility of community health centers and 
      authorities to minimize diagnostic delays in patients with CRC and to implement 
      initiatives that improve early diagnosis and provide better outcomes.
CI  - © 2022. The Author(s).
FAU - Esteva, Magdalena
AU  - Esteva M
AD  - Department of Primary Care, Primary Care Research Unit, Majorca, Baleares Health 
      Service [IbSalut]. Escola Graduada 3, 07001, Palma, Spain. 
      magdalena.estevacanto@ssib.es.
AD  - Balearic Islands Health Research Institute (IdISBa), University Hospital Son 
      Espases, Edificio S, Carretera de Valldemossa, 79, 07120, Palma, Majorca, Spain. 
      magdalena.estevacanto@ssib.es.
AD  - Preventive Activities and Health Promotion Research Network (REDIAPP), Barcelona, 
      Spain. magdalena.estevacanto@ssib.es.
FAU - Leiva, Alfonso
AU  - Leiva A
AD  - Department of Primary Care, Primary Care Research Unit, Majorca, Baleares Health 
      Service [IbSalut]. Escola Graduada 3, 07001, Palma, Spain.
AD  - Balearic Islands Health Research Institute (IdISBa), University Hospital Son 
      Espases, Edificio S, Carretera de Valldemossa, 79, 07120, Palma, Majorca, Spain.
AD  - Preventive Activities and Health Promotion Research Network (REDIAPP), Barcelona, 
      Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS) , 
      Madrid, Spain.
AD  - University of the Balearic Islands (UIB), Carretera de Valldemossa, km 7.5, 
      07122, Palma, Spain.
FAU - Ramos-Monserrat, María
AU  - Ramos-Monserrat M
AD  - Balearic Islands Health Research Institute (IdISBa), University Hospital Son 
      Espases, Edificio S, Carretera de Valldemossa, 79, 07120, Palma, Majorca, Spain.
AD  - Preventive Activities and Health Promotion Research Network (REDIAPP), Barcelona, 
      Spain.
AD  - Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS) , 
      Madrid, Spain.
AD  - Balearic Islands Public Health Department, C/ Jesus 38A, 07010, Palma, Spain.
FAU - Espí, Alejandro
AU  - Espí A
AD  - Department of Surgery, University of Valencia, Avenida Blasco Ibáñez 15, 46010, 
      Valencia, Spain.
FAU - González-Luján, Luis
AU  - González-Luján L
AD  - Serrería II Primary Care Centre, Valencia Institute of Health, Pedro de Valencia 
      26, 46022, Valencia, Spain.
FAU - Macià, Francesc
AU  - Macià F
AD  - Epidemiology and Evaluation Unit, Hospital del Mar, Passeig Marítim 25-29, 08003, 
      Barcelona, Spain.
FAU - Murta-Nascimento, Cristiane
AU  - Murta-Nascimento C
AD  - Epidemiology and Evaluation Unit, Hospital del Mar, Passeig Marítim 25-29, 08003, 
      Barcelona, Spain.
FAU - Sánchez-Calavera, María A
AU  - Sánchez-Calavera MA
AD  - Department of Medicine, University of Zaragoza, Building A, 50009, Saragossa, 
      Spain.
AD  - Las Fuentes Norte Health Center, Calle Dr. Iranzo 69, 50002, Saragossa, Spain.
FAU - Magallón, Rosa
AU  - Magallón R
AD  - University of the Balearic Islands (UIB), Carretera de Valldemossa, km 7.5, 
      07122, Palma, Spain.
AD  - Department of Medicine, University of Zaragoza, Building A, 50009, Saragossa, 
      Spain.
AD  - Instituto de Investigación Sanitaria Aragón (IIS Aragón), Saragossa, Spain.
AD  - Centro de Salud Arrabal, Andador Aragüés del Puerto, 3, 50015, Saragossa, Spain.
FAU - Balboa-Barreiro, Vanesa
AU  - Balboa-Barreiro V
AD  - Nursing and Healthcare Research Group, Rheumatology and Health Research Group, 
      Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario 
      Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), As 
      Xubias, 15006. A, Coruña, Spain.
FAU - Seoane-Pillado, Teresa
AU  - Seoane-Pillado T
AD  - Nursing and Healthcare Research Group, Rheumatology and Health Research Group, 
      Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario 
      Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), As 
      Xubias, 15006. A, Coruña, Spain.
FAU - Pertega-Díaz, Sonia
AU  - Pertega-Díaz S
AD  - Nursing and Healthcare Research Group, Rheumatology and Health Research Group, 
      Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario 
      Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), As 
      Xubias, 15006. A, Coruña, Spain.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
DEP - 20220822
PL  - England
TA  - BMC Cancer
JT  - BMC cancer
JID - 100967800
SB  - IM
MH  - *Colorectal Neoplasms/diagnosis
MH  - *Delayed Diagnosis/statistics & numerical data
MH  - Follow-Up Studies
MH  - Humans
MH  - Prognosis
MH  - Prospective Studies
MH  - Time Factors
PMC - PMC9394014
OTO - NOTNLM
OT  - Cancer-specific mortality
OT  - Colorectal neoplasm
OT  - Delayed diagnosis
OT  - Prognosis
OT  - Time factors
COIS- The authors declare no conflicts of interest.
EDAT- 2022/08/23 06:00
MHDA- 2022/08/25 06:00
CRDT- 2022/08/22 23:36
PHST- 2022/03/30 00:00 [received]
PHST- 2022/08/04 00:00 [accepted]
PHST- 2022/08/22 23:36 [entrez]
PHST- 2022/08/23 06:00 [pubmed]
PHST- 2022/08/25 06:00 [medline]
AID - 10.1186/s12885-022-09990-7 [pii]
AID - 9990 [pii]
AID - 10.1186/s12885-022-09990-7 [doi]
PST - epublish
SO  - BMC Cancer. 2022 Aug 22;22(1):910. doi: 10.1186/s12885-022-09990-7.

PMID- 35987700
OWN - NLM
STAT- MEDLINE
DCOM- 20220823
LR  - 20220826
IS  - 2042-6410 (Electronic)
IS  - 2042-6410 (Linking)
VI  - 13
IP  - 1
DP  - 2022 Aug 20
TI  - Association of physical activity with vascular aging in a population with 
      intermediate cardiovascular risk, analysis by sex: MARK study.
PG  - 46
LID - 10.1186/s13293-022-00456-w [doi]
LID - 46
AB  - BACKGROUND: The aim of this study was to analyze the association of physical 
      activity and its intensity with arterial stiffness and vascular aging and 
      differences by sex in a Spanish population with intermediate cardiovascular risk. 
      METHODS: Cross-sectional study. A total of 2475 individuals aged 35-75 years 
      participated in the study. Brachial-ankle pulse wave velocity (baPWV) was 
      measured using a VaSera VS-1500(®) device. Based on the age and sex percentile 
      presented by the participants, the latter were classified as follows: those with 
      a percentile above 90 and presenting established cardiovascular disease were 
      classified as early vascular aging (EVA); those with a percentile between 10 and 
      90 were classified as normal vascular aging (NVA) and those with a percentile 
      below 10 were classified as healthy vascular aging (HVA). Physical activity was 
      analyzed through the short version of the Minnesota Leisure Time Physical 
      Activity Questionnaire (MLTPAQ). RESULTS: The mean age of the participants was 
      61.34 ± 7.70 years, with 61.60% men. Of the total sample, 86% were sedentary (83% 
      men vs 90% women). The total physical activity showed a negative association with 
      baPWV (β = - 0.045; 95% CI - 0.080 to - 0.009). Intense physical activity showed 
      a negative relationship with baPWV (β = - 0.084; 95% CI - 0.136 to - 0.032). The 
      OR of the total physical activity and the intense physical activity carried out 
      by the subjects classified as NVA with respect to those classified as HVA was 
      OR = 0.946; (95% CI 0.898 to 0.997) and OR = 0.903; (95% CI 0.840 to 0.971), and 
      of those classified as EVA it was OR = 0.916; (95% CI 0.852 to 0.986) and 
      OR = 0.905; (95% CI 0.818 to 1.000). No association was found with moderate- or 
      low-intensity physical activity. CONCLUSIONS: The results of this study suggest 
      that, when intense physical activity is performed, the probability of presenting 
      vascular aging is lower. In the analysis by sex, this association is only 
      observed in men.
CI  - © 2022. The Author(s).
FAU - Gómez-Sánchez, Leticia
AU  - Gómez-Sánchez L
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain. 
      magomez@usal.es.
FAU - Rodríguez-Sánchez, Emiliano
AU  - Rodríguez-Sánchez E
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
AD  - Health Service of Castilla and Leon (SACyL), Avenida de Portugal 83, 37005, 
      Salamanca, Spain.
AD  - Department of Medicine, University of Salamanca, Alfonso X el Sabio s/n, 37007, 
      Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
FAU - Ramos, Rafel
AU  - Ramos R
AD  - Unitat of Suport the Recerca of Girona, Institut Universitari d'Investigacio in 
      Atencion Primària Jordi Gol (IDIAP Jordi Gol), Girona, Spain.
AD  - Institut d'InvestigacioÂ Biomèdica of Girona Dr. Josep Trueta (IDBGI), Girona, 
      Spain.
AD  - Departament of CiènciesMèdiques, Facultat of Medicina, Universitat of Girona, 
      Girona, Spain.
FAU - Marti, Ruth
AU  - Marti R
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
AD  - Unitat of Suport the Recerca of Girona, Institut Universitari d'Investigacio in 
      Atencion Primària Jordi Gol (IDIAP Jordi Gol), Girona, Spain.
AD  - Institut d'InvestigacioÂ Biomèdica of Girona Dr. Josep Trueta (IDBGI), Girona, 
      Spain.
FAU - Gómez-Sánchez, Marta
AU  - Gómez-Sánchez M
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
FAU - Lugones-Sánchez, Cristina
AU  - Lugones-Sánchez C
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
FAU - Tamayo-Morales, Olaya
AU  - Tamayo-Morales O
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
FAU - Sánchez, Susana Gonzalez
AU  - Sánchez SG
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
FAU - Rigo, Fernando
AU  - Rigo F
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
AD  - San Agustin Health Center, Illes Balears Health Service (IBSALUT), Palma of 
      Mallorca, Spain.
FAU - García-Ortiz, Luis
AU  - García-Ortiz L
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
AD  - Health Service of Castilla and Leon (SACyL), Avenida de Portugal 83, 37005, 
      Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
AD  - Department of Biomedical and Diagnostic Sciences, University of Salamanca, calle 
      Alfonso X el Sabio s/n, 37007, Salamanca, Spain.
FAU - Gómez-Marcos, Manuel A
AU  - Gómez-Marcos MA
AUID- ORCID: 0000-0003-0133-6123
AD  - Primary Care Research Unit of Salamanca (APISAL), Biomedical Research Institute 
      of Salamanca (IBSAL), Avenida de Portugal 83, 37005, Salamanca, Spain.
AD  - Health Service of Castilla and Leon (SACyL), Avenida de Portugal 83, 37005, 
      Salamanca, Spain.
AD  - Department of Medicine, University of Salamanca, Alfonso X el Sabio s/n, 37007, 
      Salamanca, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS) (RD21/0016), Barcelona, Spain.
CN  - MARK Investigators
LA  - eng
SI  - ClinicalTrials.gov/NCT01428934
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220820
PL  - England
TA  - Biol Sex Differ
JT  - Biology of sex differences
JID - 101548963
SB  - IM
MH  - Aged
MH  - Aging
MH  - Ankle Brachial Index/methods
MH  - *Cardiovascular Diseases/epidemiology
MH  - Cross-Sectional Studies
MH  - Exercise
MH  - Female
MH  - Heart Disease Risk Factors
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Pulse Wave Analysis/methods
MH  - Risk Factors
PMC - PMC9392339
OTO - NOTNLM
OT  - Physical activity
OT  - Spanish population
OT  - Vascular aging
COIS- Authors declare no conflict of interest. The funding bodies did not play any role 
      in the design of the study and collection, analysis, or interpretation of data 
      and writing.
FIR - Ramos, Rafel
IR  - Ramos R
FIR - Ramos, Rafel
IR  - Ramos R
FIR - Martí, Ruth
IR  - Martí R
FIR - Parramon, Dídac
IR  - Parramon D
FIR - Ponjoan, Anna
IR  - Ponjoan A
FIR - Quesada, Miquel
IR  - Quesada M
FIR - Garcia-Gil, Maria
IR  - Garcia-Gil M
FIR - Sidera, Martina
IR  - Sidera M
FIR - Camós, Lourdes
IR  - Camós L
FIR - Montesinos, Fernando
IR  - Montesinos F
FIR - Montoya, Ignacio
IR  - Montoya I
FIR - López, Carlos
IR  - López C
FIR - Agell, Anna
IR  - Agell A
FIR - Pagès, Núria
IR  - Pagès N
FIR - Gil, Irina
IR  - Gil I
FIR - Maria-Castro, Anna
IR  - Maria-Castro A
FIR - Rigo, Fernando
IR  - Rigo F
FIR - Frontera, Guillermo
IR  - Frontera G
FIR - Rotger, Antònia
IR  - Rotger A
FIR - Feuerbach, Natalia
IR  - Feuerbach N
FIR - Pons, Susana
IR  - Pons S
FIR - Garcia, Natividad
IR  - Garcia N
FIR - Guillaumet, John
IR  - Guillaumet J
FIR - Llull, Micaela
IR  - Llull M
FIR - Gutierrez, Mercedes
IR  - Gutierrez M
FIR - Agudo-Conde, Cristina
IR  - Agudo-Conde C
FIR - Gómez-Sanchez, Leticia
IR  - Gómez-Sanchez L
FIR - Castaño-Sanchez, Carmen
IR  - Castaño-Sanchez C
FIR - Rodriguez-Martín, Carmela
IR  - Rodriguez-Martín C
FIR - Sanchez-Salgado, Benigna
IR  - Sanchez-Salgado B
FIR - de Cabo-Laso, Angela
IR  - de Cabo-Laso A
FIR - Gómez-Sánchez, Marta
IR  - Gómez-Sánchez M
FIR - Rodriguez-Sanchez, Emiliano
IR  - Rodriguez-Sanchez E
FIR - MaderueloFernandez, Jose Angel
IR  - MaderueloFernandez JA
FIR - Ramos-Delgado, Emilio
IR  - Ramos-Delgado E
FIR - Patino-Alonso, Carmen
IR  - Patino-Alonso C
FIR - Recio-Rod-Riguez, Jose I
IR  - Recio-Rod-Riguez JI
FIR - Gomez-Marcos, Manuel A
IR  - Gomez-Marcos MA
FIR - Garcia-Ortiz, Luis
IR  - Garcia-Ortiz L
EDAT- 2022/08/21 06:00
MHDA- 2022/08/24 06:00
CRDT- 2022/08/20 23:37
PHST- 2022/04/10 00:00 [received]
PHST- 2022/08/13 00:00 [accepted]
PHST- 2022/08/20 23:37 [entrez]
PHST- 2022/08/21 06:00 [pubmed]
PHST- 2022/08/24 06:00 [medline]
AID - 10.1186/s13293-022-00456-w [pii]
AID - 456 [pii]
AID - 10.1186/s13293-022-00456-w [doi]
PST - epublish
SO  - Biol Sex Differ. 2022 Aug 20;13(1):46. doi: 10.1186/s13293-022-00456-w.

PMID- 35957845
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220813
IS  - 2296-858X (Print)
IS  - 2296-858X (Electronic)
IS  - 2296-858X (Linking)
VI  - 9
DP  - 2022
TI  - Effectiveness of a lifestyle modification programme in the treatment of 
      depression symptoms in primary care.
PG  - 954644
LID - 10.3389/fmed.2022.954644 [doi]
LID - 954644
AB  - BACKGROUND: Depression symptoms are prevalent in the general population, and 
      their onset and continuation may be related to biological and psychosocial 
      factors, many of which are related to lifestyle aspects. Health promotion and 
      lifestyle modification programmes (LMPs) may be effective on reducing the 
      symptoms. The objective of this study was to analyse the clinical effectiveness 
      of a LMP and a LMP plus Information and Communication Technologies, when compared 
      to Treatment as Usual (TAU) over 6 months. The interventions were offered as an 
      adjuvant treatment delivered in Primary Healthcare Centers (PHCs) for people with 
      depression symptoms. METHODS: We conducted an open-label, multicentre, pragmatic, 
      randomized clinical trial. Participants were recruited from several PHCs. Those 
      participants visiting general practitioner for any reason, who also met the 
      inclusion criteria (scoring 10 to 30 points on the Beck II Self-Applied 
      Depression Inventory) were invited to take part in the study. TAU+LMP consisted 
      of six weekly 90-min group sessions focused on improving lifestyle. TAU+LMP + 
      ICTs replicated the TAU+LMP format, plus the addition of a wearable smartwatch to 
      measure daily minutes walked and sleep patterns. A total of 188 participants 
      consented to participate in the study and were randomized. We used linear mixed 
      models, with a random intercept and an unstructured covariance to evaluate the 
      impact of the interventions compared to TAU. RESULTS: Both interventions showed a 
      statistically significant reduction on depressive symptoms compared to TAU 
      (TAU+LMP vs. TAU slope difference, b = -3.38, 95% CI= [-5.286, -1.474] p = 0.001 
      and TAU+LMP+ICTs vs. TAU slope difference, b = -4.05, 95% CI = [-5.919, -2.197], 
      p < 0.001). These reductions imply a moderate effect size. In the TAU+LMP+ICTs 
      there was a significant increase regarding minutes walking per week (b = 99.77) 
      and adherence to Mediterranean diet (b = 0.702). In the TAU+LMP there was a 
      significant decrease regarding bad sleep quality (b = -1.24). CONCLUSION: 
      TAU+LMPs administered in PHCs to people experiencing depression symptoms were 
      effective on reducing these symptoms compared to TAU. They also have a positive 
      impact on changing several lifestyle factors. These findings indicate that these 
      interventions can be promising strategies for PHCs.
CI  - Copyright © 2022 Aguilar-Latorre, Pérez Algorta, Navarro-Guzmán, Serrano-Ripoll 
      and Oliván-Blázquez.
FAU - Aguilar-Latorre, Alejandra
AU  - Aguilar-Latorre A
AD  - Primary Healthcare Center Arrabal, Institute for Health Research Aragón (IIS 
      Aragón), Zaragoza, Spain.
FAU - Pérez Algorta, Guillermo
AU  - Pérez Algorta G
AD  - Division of Health Research, Faculty of Health and Medicine, Lancaster 
      University, Lancaster, United Kingdom.
FAU - Navarro-Guzmán, Capilla
AU  - Navarro-Guzmán C
AD  - Department of Psychology, University of the Balearic Islands, Palma, Spain.
FAU - Serrano-Ripoll, María J
AU  - Serrano-Ripoll MJ
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Services, Palma, 
      Spain.
AD  - Research in Preventive Activities and Promotion and in Cancer Illes Balears 
      (GRAPP-CAIB), Balearic Islands Health Research Institute (IdISBa), Palma, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Primary Healthcare Center Arrabal, Institute for Health Research Aragón (IIS 
      Aragón), Zaragoza, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220726
PL  - Switzerland
TA  - Front Med (Lausanne)
JT  - Frontiers in medicine
JID - 101648047
PMC - PMC9361711
OTO - NOTNLM
OT  - depression
OT  - health promotion
OT  - lifestyle modification
OT  - primary care
OT  - randomized controlled trial (RCT)
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/08/13 06:00
MHDA- 2022/08/13 06:01
CRDT- 2022/08/12 02:47
PHST- 2022/05/27 00:00 [received]
PHST- 2022/07/07 00:00 [accepted]
PHST- 2022/08/12 02:47 [entrez]
PHST- 2022/08/13 06:00 [pubmed]
PHST- 2022/08/13 06:01 [medline]
AID - 10.3389/fmed.2022.954644 [doi]
PST - epublish
SO  - Front Med (Lausanne). 2022 Jul 26;9:954644. doi: 10.3389/fmed.2022.954644. 
      eCollection 2022.

PMID- 35957569
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221202
IS  - 2149-2530 (Electronic)
IS  - 2148-7197 (Print)
IS  - 2148-7197 (Linking)
VI  - 23
IP  - 6
DP  - 2022 Nov
TI  - Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 
      Antitrypsin Deficiency.
PG  - 376-382
LID - 10.5152/TurkThoracJ.2022.22001 [doi]
AB  - OBJECTIVE: Respiratory disease is the major cause of morbidity and mortality in 
      patients with alpha-1 antitrypsin deficiency, mainly in homozygous PI*ZZ 
      individuals. However, this association is uncertain in subjects with other 
      deficiency genotypes. The objective of this study was to assess, in the context 
      of alpha-1 antitrypsin deficiency, the existence of further risk factors that 
      have been associated with respiratory diseases. MATERIAL AND METHODS: Lung 
      function was assessed by spirometry in a sample of 1334 patients with a known 
      genotype for the SERPINA1 gene whose serum alpha-1 antitrypsin levels had been 
      previously determined. Patients with a normal genotype (PI*MM) were compared to 
      389 patients carrying a deficiency allele. RESULTS: Statistically significant 
      associations were detected between (i) PI*ZZ genotype and abnormal FEV1 values 
      (χ2 = 26.45; P <.0002), FEV1/FVC (χ2 = 14.8; P < .02) or forced mid-expiratory 
      flow 25%-75% (χ2 =22.66; P < .0009); (ii) chronic obstructive pulmonary disease 
      and PI*ZZ odds ratio: 26.5; 95% CI: (2.6-265.9); P <.005 and or PI*SS genotype 
      odds ratio: 9; 95% CI: (2-40.1); P < .004; (iii) prevalence of COPD in PI*MZ 
      subjects and smoking habit (P < .01), low body weight (P < .01) or older age (P < 
      .0001). CONCLUSION: The PI*ZZ and PI*SS genotypes seem to be associated with the 
      prevalence of chronic obstructive pulmonary disease. Tobacco use, low body 
      weight, and older age are risk factors that increase the probability of 
      prevalence of chronic obstructive pulmonary disease by up to 70% in PI*MZ 
      individuals.
FAU - Hernández Pérez, José María
AU  - Hernández Pérez JM
AD  - Department of Pulmonology, Hospital Universitario Nuestra Señora de Candelaria 
      [Our Lady of Candelaria University Hospital], Santa Cruz de Tenerife, Canary 
      Islands, Spain.
FAU - Suárez Sánchez, Juan José
AU  - Suárez Sánchez JJ
AD  - Faculty of Health Sciences, Universidad de Las Palmas de Gran Canaria [Las Palmas 
      de Gran Canaria University], Canary Islands, Spain.
FAU - López Charry, Claudia Viviana
AU  - López Charry CV
AD  - Department of Pulmonology, Hospital Universitario Nuestra Señora de Candelaria 
      [Our Lady of Candelaria University Hospital], Santa Cruz de Tenerife, Canary 
      Islands, Spain.
FAU - Fariña, Yolanda Ramallo
AU  - Fariña YR
AD  - Foundation of the Canary Islands Health Research Institute (FIISC), Santa Cruz de 
      Tenerife, Spain; Health Services Research on Chronic Patients Network (REDISSEC), 
      Madrid, Spain; Research Network on Chronic Disease, Primary Care, and Health 
      Promotion (RICAPPS), Madrid, Spain.
FAU - Pérez Pérez, José Antonio
AU  - Pérez Pérez JA
AD  - Department of Biochemistry, Microbiology, Cellular Biology and Genetics, Canary 
      Islands, Spain.
LA  - eng
PT  - Journal Article
PL  - Turkey
TA  - Turk Thorac J
JT  - Turkish thoracic journal
JID - 101648545
PMC - PMC9682966
EDAT- 2022/08/13 06:00
MHDA- 2022/08/13 06:01
CRDT- 2022/08/12 02:13
PHST- 2022/08/13 06:00 [pubmed]
PHST- 2022/08/13 06:01 [medline]
PHST- 2022/08/12 02:13 [entrez]
AID - ttj-23-6-376 [pii]
AID - 10.5152/TurkThoracJ.2022.22001 [doi]
PST - ppublish
SO  - Turk Thorac J. 2022 Nov;23(6):376-382. doi: 10.5152/TurkThoracJ.2022.22001.

PMID- 35895702
OWN - NLM
STAT- MEDLINE
DCOM- 20220729
LR  - 20220731
IS  - 1932-6203 (Electronic)
IS  - 1932-6203 (Linking)
VI  - 17
IP  - 7
DP  - 2022
TI  - Sex differences in social support perceived by polymedicated older adults with 
      multimorbidity. MULTIPAP study.
PG  - e0268218
LID - 10.1371/journal.pone.0268218 [doi]
LID - e0268218
AB  - The beneficial effects of social support on morbidity, mortality, and quality of 
      life are well known. Using the baseline data of the MULTIPAP study (n = 593), an 
      observational, descriptive, cross-sectional study was carried out that analyzed 
      the sex differences in the social support perceived by polymedicated adults aged 
      65 to 74 years with multimorbidity. The main outcome variable was social support 
      measured through the Duke-UNC-11 Functional Social Support (DUFSS) questionnaire 
      in its two dimensions (confident support and affective support). For both sexes, 
      the perception of functional social support was correlated with being married or 
      partnered and having a higher health-related quality of life utility index. In 
      women, it was correlated with a higher level of education, living alone, and 
      treatment adherence, and in men with higher monthly income, prescribed drugs and 
      fewer diagnosed diseases.
FAU - Lozano-Hernández, Cristina M
AU  - Lozano-Hernández CM
AUID- ORCID: 0000-0002-6981-303X
AD  - Research Unit, Primary Health Care Management, Madrid, Spain.
AD  - Interuniversity Doctoral Program in Epidemiology and Public Health, Rey Juan 
      Carlos University, Alcorcon (Madrid), Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Biosanitary Research and Innovation Foundation of Primary Care (FIIBAP), Madrid, 
      Spain.
FAU - López-Rodríguez, Juan Antonio
AU  - López-Rodríguez JA
AUID- ORCID: 0000-0002-4985-2314
AD  - Research Unit, Primary Health Care Management, Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Biosanitary Research and Innovation Foundation of Primary Care (FIIBAP), Madrid, 
      Spain.
AD  - Department of Medical Specialties and Public Health, Faculty of Health Sciences 
      Rey Juan Carlos University, Madrid, Spain.
AD  - General Ricardos Primary Health Care Centre, Madrid, Spain.
FAU - Rico-Blázquez, Milagros
AU  - Rico-Blázquez M
AUID- ORCID: 0000-0001-7308-4450
AD  - Research Unit, Primary Health Care Management, Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Department of Nursing, Faculty of Nursing, Physiotherapy and Podiatry of the 
      Complutense University of Madrid, Madrid, Spain.
FAU - Calderón-Larrañaga, Amaia
AU  - Calderón-Larrañaga A
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Joint Action on Chronic Diseases (JA-CHRODIS) European Commission, Brussels, 
      Belgium.
AD  - Department of Neurobiology, Aging Research Centre, Care Sciences and Society, 
      Karolinska Institute & Stockholm University, Stockholm, Sweden.
AD  - EpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - Leiva-Fernández, Francisca
AU  - Leiva-Fernández F
AUID- ORCID: 0000-0001-6919-4817
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Multiprofessional Teaching Unit for Family and Community Care Primary Care 
      District Málaga-Guadarhorce, Málaga, Spain.
AD  - Biomedical Research Institute of Malaga-IBIMA, Andalusian Health Service, Málaga, 
      Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AUID- ORCID: 0000-0002-5704-6056
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - EpiChron Research Group on Chronic Diseases, Aragon Health Sciences Institute, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - Del Cura-González, Isabel
AU  - Del Cura-González I
AD  - Research Unit, Primary Health Care Management, Madrid, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion 
      -RICAPPS-(RICORS), Madrid, Spain.
AD  - Department of Medical Specialties and Public Health, Faculty of Health Sciences 
      Rey Juan Carlos University, Madrid, Spain.
CN  - MULTIPAP GROUP
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220727
PL  - United States
TA  - PLoS One
JT  - PloS one
JID - 101285081
SB  - IM
MH  - Aged
MH  - Cross-Sectional Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - *Multimorbidity
MH  - *Quality of Life/psychology
MH  - Sex Characteristics
MH  - Social Support
PMC - PMC9328549
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/07/28 06:00
MHDA- 2022/07/30 06:00
CRDT- 2022/07/27 13:43
PHST- 2021/09/17 00:00 [received]
PHST- 2022/04/25 00:00 [accepted]
PHST- 2022/07/27 13:43 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/30 06:00 [medline]
AID - PONE-D-21-30179 [pii]
AID - 10.1371/journal.pone.0268218 [doi]
PST - epublish
SO  - PLoS One. 2022 Jul 27;17(7):e0268218. doi: 10.1371/journal.pone.0268218. 
      eCollection 2022.

PMID- 35887529
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220731
IS  - 2075-4426 (Print)
IS  - 2075-4426 (Electronic)
IS  - 2075-4426 (Linking)
VI  - 12
IP  - 7
DP  - 2022 Jun 24
TI  - Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive 
      Application.
LID - 10.3390/jpm12071032 [doi]
LID - 1032
AB  - Although long-term smoking has been associated with chronic kidney disease, its 
      effect on kidney function in early stages has not been clarified. Therefore, the 
      proposed objectives were: (1) to identify subclinical kidney damage in smokers, 
      through a panel of biomarkers; (2) to evaluate the progression of subclinical 
      kidney damage after two years of consumption in these patients; and (3) study 
      whether quitting smoking reduces kidney damage. A prospective study was carried 
      out (patients recruited from a primary care centre and a clinical smoking unit). 
      Kidney function was assessed using a panel of biomarkers and compared between 
      smokers and non-smokers, taking into account potential risk factors for kidney 
      damage. These results show, for the first time in the literature, the 
      relationship between smoking and early (subclinical) kidney damage and provide a 
      panel of biomarkers capable of detecting this condition (Neutrophil 
      gelatinase-associated lipocalin, Kidney injury molecule-1, 
      N-acetyl-beta-D-glucosaminidase, transferrin, and ganglioside-activating protein 
      GM2). This study also indicates that subclinical damage is maintained when use 
      continues, but can be reversed if patients stop smoking. The use of these 
      biomarkers as diagnostic tools can be a preventive measure in the development of 
      chronic kidney disease associated with smoking and in the prevention of acute 
      events associated with potentially nephrotoxic pharmacological treatment in 
      smokers. Trial registration number: NCT03850756.
FAU - Tascón, Javier
AU  - Tascón J
AUID- ORCID: 0000-0002-8690-446X
AD  - Toxicology Unit, Universidad de Salamanca, 37007 Salamanca, Spain.
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), 
      37007 Salamanca, Spain.
AD  - RICORS2040-Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Prieto, Marta
AU  - Prieto M
AUID- ORCID: 0000-0002-2540-4461
AD  - Toxicology Unit, Universidad de Salamanca, 37007 Salamanca, Spain.
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), 
      37007 Salamanca, Spain.
AD  - RICORS2040-Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Casanova, Alfredo G
AU  - Casanova AG
AUID- ORCID: 0000-0002-0725-6637
AD  - Toxicology Unit, Universidad de Salamanca, 37007 Salamanca, Spain.
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), 
      37007 Salamanca, Spain.
AD  - RICORS2040-Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Sanz, Francisco J
AU  - Sanz FJ
AD  - Coria Primary Health Care Center, Health Service of Extremadura (SES), 10800 
      Coria, Spain.
FAU - Hernández Mezquita, Miguel A
AU  - Hernández Mezquita MA
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Department of Pulmonology, University Hospital, 37007 Salamanca, Spain.
FAU - Barrueco Ferrero, Miguel
AU  - Barrueco Ferrero M
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Department of Pulmonology, University Hospital, 37007 Salamanca, Spain.
FAU - Gomez-Marcos, Manuel A
AU  - Gomez-Marcos MA
AUID- ORCID: 0000-0003-0133-6123
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud (RICAPPS), 37007 Salamanca, Spain.
AD  - Department of Medicine, Universidad de Salamanca, 37007 Salamanca, Spain.
FAU - Garcia-Ortiz, Luis
AU  - Garcia-Ortiz L
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Unidad de Investigación en Atención Primaria de Salamanca (APISAL), Gerencia de 
      Atención Primaria de Salamanca, Gerencia Regional de salud de Castilla y León 
      (SACyL), Red de Investigación en Cronicidad, Atención Primaria y Promoción de la 
      Salud (RICAPPS), 37007 Salamanca, Spain.
AD  - Department of Biomedical and Diagnostic Sciences, Universidad de Salamanca, 37008 
      Salamanca, Spain.
FAU - Vicente-Vicente, Laura
AU  - Vicente-Vicente L
AUID- ORCID: 0000-0002-6273-4005
AD  - Toxicology Unit, Universidad de Salamanca, 37007 Salamanca, Spain.
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), 
      37007 Salamanca, Spain.
AD  - RICORS2040-Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Morales, Ana I
AU  - Morales AI
AUID- ORCID: 0000-0001-6836-6138
AD  - Toxicology Unit, Universidad de Salamanca, 37007 Salamanca, Spain.
AD  - Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
AD  - Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), 
      37007 Salamanca, Spain.
AD  - RICORS2040-Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - On Behalf Of Biotab Team
AU  - On Behalf Of Biotab Team
LA  - eng
SI  - ClinicalTrials.gov/NCT03850756
GR  - PI17/01979 and PI20/01351; RETICS RD016/0009/0025 (REDINREN); RD21/0016/0010 
      (RICAPPS))/Instituto de Salud Carlos III/
PT  - Journal Article
DEP - 20220624
PL  - Switzerland
TA  - J Pers Med
JT  - Journal of personalized medicine
JID - 101602269
PMC - PMC9325290
OTO - NOTNLM
OT  - biomarkers
OT  - early diagnosis
OT  - subclinical kidney damage
OT  - tobacco
COIS- The authors declare no conflict of interest.
EDAT- 2022/07/28 06:00
MHDA- 2022/07/28 06:01
CRDT- 2022/07/27 01:25
PHST- 2022/05/18 00:00 [received]
PHST- 2022/06/21 00:00 [revised]
PHST- 2022/06/22 00:00 [accepted]
PHST- 2022/07/27 01:25 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/28 06:01 [medline]
AID - jpm12071032 [pii]
AID - jpm-12-01032 [pii]
AID - 10.3390/jpm12071032 [doi]
PST - epublish
SO  - J Pers Med. 2022 Jun 24;12(7):1032. doi: 10.3390/jpm12071032.

PMID- 35886529
OWN - NLM
STAT- MEDLINE
DCOM- 20220728
LR  - 20220830
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 14
DP  - 2022 Jul 16
TI  - Ozone Eliminates SARS-CoV-2 from Difficult-to-Clean Office Supplies and Clinical 
      Equipment.
LID - 10.3390/ijerph19148672 [doi]
LID - 8672
AB  - (1) Background: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) 
      continues to cause profound health, economic, and social problems worldwide. The 
      management and disinfection of materials used daily in health centers and common 
      working environments have prompted concerns about the control of coronavirus 
      disease 2019 (COVID-19) infection risk. Ozone is a powerful oxidizing agent that 
      has been widely used in disinfection processes for decades. The aim of this study 
      was to assess the optimal conditions of ozone treatment for the elimination of 
      heat-inactivated SARS-CoV-2 from office supplies (personal computer monitors, 
      keyboards, and computer mice) and clinical equipment (continuous positive airway 
      pressure tubes and personal protective equipment) that are difficult to clean. 
      (2) Methods: The office supplies and clinical equipment were contaminated in an 
      area of 1 cm(2) with 1 × 10(4) viral units of a heat-inactivated SARS-CoV-2 
      strain, then treated with ozone using two different ozone devices: a specifically 
      designed ozonation chamber (for low-medium ozone concentrations over large 
      volumes) and a clinical ozone generator (for high ozone concentrations over small 
      volumes). SARS-CoV-2 gene detection was carried out using quantitative real-time 
      polymerase chain reaction (RT-qPCR). (3) Results: At high ozone concentrations 
      over small surfaces, the ozone eliminated SARS-CoV-2 RNA in short time 
      periods-i.e., 10 min (at 4000 ppm) or less. The optimum ozone concentration over 
      large volumes was 90 ppm for 120 min in ambient conditions (24 °C and 60-75% 
      relative humidity). (4) Conclusions: This study showed that the appropriate ozone 
      concentration and exposure time eliminated heat-inactivated SARS-CoV-2 RNA from 
      the surfaces of different widely used clinical and office supplies, decreasing 
      their risk of transmission, and improving their reutilization. Ozone may provide 
      an additional tool to control the spread of the COVID-19 pandemic.
FAU - Torres-Mata, Laura B
AU  - Torres-Mata LB
AUID- ORCID: 0000-0003-3304-4176
AD  - Research Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), 
      35019 Las Palmas de Gran Canaria, Spain.
AD  - BioPharm Group, Instituto Universitario de Investigaciones Biomédicas y 
      Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas 
      de Gran Canaria, Spain.
AD  - Chemical Engineering & Materials Department, Universidad Complutense, 28040 
      Madrid, Spain.
FAU - García-Pérez, Omar
AU  - García-Pérez O
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - Departamento de Medicina Interna, Dermatología y Psiquiatría, Universidad de La 
      Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos 
      III, 28029 Madrid, Spain.
FAU - Rodríguez-Esparragón, Francisco
AU  - Rodríguez-Esparragón F
AUID- ORCID: 0000-0003-1663-3673
AD  - Research Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), 
      35019 Las Palmas de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
FAU - Blanco, Angeles
AU  - Blanco A
AUID- ORCID: 0000-0001-6820-7698
AD  - Chemical Engineering & Materials Department, Universidad Complutense, 28040 
      Madrid, Spain.
FAU - Villar, Jesús
AU  - Villar J
AUID- ORCID: 0000-0001-5687-3562
AD  - Research Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
AD  - Li Ka Shing Knowledge Institute at St Michael's Hospital, Toronto, ON M5B 1T8, 
      Canada.
FAU - Ruiz-Apodaca, Fernando
AU  - Ruiz-Apodaca F
AD  - Lighting Dynamic Technology, SL, 35001 Las Palmas, Spain.
FAU - Martín-Barrasa, José L
AU  - Martín-Barrasa JL
AUID- ORCID: 0000-0002-3280-9838
AD  - Research Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), 
      35019 Las Palmas de Gran Canaria, Spain.
AD  - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
AD  - Aquaculture and Wild Species Health, Infectious Diseases, Universitary Institute 
      of Animal Health and Food Safety (IUSA), Universidad de Las Palmas de Gran 
      Canaria, 35413 Arucas, Spain.
FAU - González-Martín, Jesús M
AU  - González-Martín JM
AD  - Research Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), 
      35019 Las Palmas de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Salud Carlos III, 28029 Madrid, Spain.
AD  - Servicio de Evaluación y Planificación del Servicio Canario de Salud (SESCS), 
      38109 Santa Cruz de Tenerife, Spain.
AD  - Red de Agencias de Evaluación de Tecnologías Sanitarias y Prestaciones del 
      Sistema Nacional de Salud (RedETS), 28071 Madrid, Spain.
FAU - Piñero, José E
AU  - Piñero JE
AUID- ORCID: 0000-0001-6233-8224
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos 
      III, 28029 Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
AD  - Departamento de Obstetricia, Ginecología, Pediatría, Medicina Preventiva y Salud 
      Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La 
      Laguna, Tenerife, 38200 La Laguna, Spain.
FAU - Córdoba-Lanús, Elizabeth
AU  - Córdoba-Lanús E
AUID- ORCID: 0000-0001-5534-8280
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - Departamento de Medicina Interna, Dermatología y Psiquiatría, Universidad de La 
      Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos 
      III, 28029 Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
FAU - Lorenzo-Morales, Jacob
AU  - Lorenzo-Morales J
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos 
      III, 28029 Madrid, Spain.
AD  - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
AD  - Departamento de Obstetricia, Ginecología, Pediatría, Medicina Preventiva y Salud 
      Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La 
      Laguna, Tenerife, 38200 La Laguna, Spain.
FAU - Clavo, Bernardino
AU  - Clavo B
AUID- ORCID: 0000-0003-2522-1064
AD  - Research Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), 
      35019 Las Palmas de Gran Canaria, Spain.
AD  - BioPharm Group, Instituto Universitario de Investigaciones Biomédicas y 
      Sanitarias (IUIBS), Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas 
      de Gran Canaria, Spain.
AD  - Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, 
      Universidad de La Laguna, Tenerife, 38200 La Laguna, Spain.
AD  - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, 
      Spain.
AD  - Chronic Pain Unit, Hospital Universitario Dr. Negrín, 35019 Las Palmas de Gran 
      Canaria, Spain.
AD  - Radiation Oncology Department, Hospital Universitario Dr. Negrín, 35019 Las 
      Palmas de Gran Canaria, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220716
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
RN  - 0 (RNA, Viral)
RN  - 66H7ZZK23N (Ozone)
SB  - IM
MH  - *COVID-19/prevention & control
MH  - Humans
MH  - *Ozone
MH  - Pandemics/prevention & control
MH  - RNA, Viral
MH  - SARS-CoV-2
PMC - PMC9321385
OTO - NOTNLM
OT  - COVID-19
OT  - SARS-CoV-2
OT  - clinical equipment
OT  - office supplies
OT  - ozone
OT  - surface disinfection
COIS- The authors declare no conflict of interest.
EDAT- 2022/07/28 06:00
MHDA- 2022/07/29 06:00
CRDT- 2022/07/27 01:20
PHST- 2022/06/14 00:00 [received]
PHST- 2022/07/11 00:00 [revised]
PHST- 2022/07/14 00:00 [accepted]
PHST- 2022/07/27 01:20 [entrez]
PHST- 2022/07/28 06:00 [pubmed]
PHST- 2022/07/29 06:00 [medline]
AID - ijerph19148672 [pii]
AID - ijerph-19-08672 [pii]
AID - 10.3390/ijerph19148672 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Jul 16;19(14):8672. doi: 
      10.3390/ijerph19148672.

PMID- 35850681
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220726
IS  - 1472-6947 (Electronic)
IS  - 1472-6947 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Jul 18
TI  - Correction to: Decision aids linked to the recommendations in clinical practice 
      guidelines: results of the acceptability of a decision aid for patients with 
      generalized anxiety disorder.
PG  - 188
LID - 10.1186/s12911-022-01930-6 [doi]
LID - 188
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Facultad de Ciencias de la Salud - Sección de Psicología, University of La Laguna 
      (ULL), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain. 
      lilisbeth.peresteloperez@sescs.es.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain. lilisbeth.peresteloperez@sescs.es.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain. lilisbeth.peresteloperez@sescs.es.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain. 
      lilisbeth.peresteloperez@sescs.es.
AD  - Servicio de Evaluación del Servicio Canario de la Salud, Camino de Candelaria nº 
      44, Centro de Salud San Isidro-El Chorrillo 1ª planta, 38109, Tenerife, Spain. 
      lilisbeth.peresteloperez@sescs.es.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Peñate-Castro, Wenceslao
AU  - Peñate-Castro W
AD  - Facultad de Ciencias de la Salud - Sección de Psicología, University of La Laguna 
      (ULL), Tenerife, Spain.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Facultad de Ciencias de la Salud - Sección de Psicología, University of La Laguna 
      (ULL), Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Álvarez-Pérez, Yolanda
AU  - Álvarez-Pérez Y
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Trujillo-Martín, María Del Mar
AU  - Trujillo-Martín MDM
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Del Cura-González, María Isabel
AU  - Del Cura-González MI
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - Unidad de Apoyo a la Investigación, Gerencia Asistencial de Atención Primaria, 
      Madrid, Spain.
AD  - Department Preventive Medicine and Public Health, University Rey Juan Carlos, 
      Madrid, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
LA  - eng
PT  - Published Erratum
DEP - 20220718
PL  - England
TA  - BMC Med Inform Decis Mak
JT  - BMC medical informatics and decision making
JID - 101088682
SB  - IM
EFR - BMC Med Inform Decis Mak. 2022 Jun 30;22(1):171. PMID: 35773665
PMC - PMC9290259
EDAT- 2022/07/20 06:00
MHDA- 2022/07/20 06:01
CRDT- 2022/07/19 07:40
PHST- 2022/07/19 07:40 [entrez]
PHST- 2022/07/20 06:00 [pubmed]
PHST- 2022/07/20 06:01 [medline]
AID - 10.1186/s12911-022-01930-6 [pii]
AID - 1930 [pii]
AID - 10.1186/s12911-022-01930-6 [doi]
PST - epublish
SO  - BMC Med Inform Decis Mak. 2022 Jul 18;22(1):188. doi: 10.1186/s12911-022-01930-6.

PMID- 35843888
OWN - NLM
STAT- MEDLINE
DCOM- 20221013
LR  - 20221013
IS  - 1423-0410 (Electronic)
IS  - 0042-9007 (Print)
IS  - 0042-9007 (Linking)
VI  - 117
IP  - 10
DP  - 2022 Oct
TI  - COVID-19 infection and complications according to ABO blood group in the elderly: 
      A population-based subcohort and meta-analysis.
PG  - 1230-1234
LID - 10.1111/vox.13334 [doi]
AB  - BACKGROUND AND OBJECTIVES: It is reported that ABO antibodies have a role in 
      COVID-19 infection and severity; however, ABO antibody titres vary with advanced 
      age. The aim was to analyse the association between ABO blood group and risk of 
      COVID-19 infection and complications in elderly patients, and to contrast this 
      data with findings in the overall adult population. MATERIALS AND METHODS: A 
      prospective cohort study of the Navarre (Spain) population aged ≥60 years and a 
      meta-analysis of published studies including participants of ≥60 years were 
      carried out. RESULTS: In the Navarre elderly population, a higher risk of 
      COVID-19 infection was identified in the A versus non-A and O group and lower 
      risk in O versus non-O, with no significant association between hospitalization, 
      intensive care unit admission or mortality and any of the blood groups, results 
      that coincide with those of the overall Navarre adult population. The 
      meta-analyses using studies that included participants of ≥60 years demonstrated 
      a higher risk of hospitalization and mortality in A versus non-A and a lower 
      mortality risk with B versus non-B. Similar mortality results were found in the 
      meta-analyses of the overall adult population. CONCLUSION: There are no relevant 
      differences between the overall adult population and population aged ≥60 years in 
      the risk of COVID-19 infection and severity according to ABO blood groups, 
      suggesting that age-related changes in ABO would be of limited clinical 
      significance.
CI  - © 2022 International Society of Blood Transfusion.
FAU - Leache, Leire
AU  - Leache L
AUID- ORCID: 0000-0003-2272-7086
AD  - Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain.
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
FAU - Gutiérrez-Valencia, Marta
AU  - Gutiérrez-Valencia M
AUID- ORCID: 0000-0002-3229-6614
AD  - Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain.
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
FAU - Enguita-Germán, Mónica
AU  - Enguita-Germán M
AUID- ORCID: 0000-0002-2890-1252
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
AD  - Unit of Methodology, Navarrabiomed, Pamplona, Spain.
AD  - University Hospital of Navarra (HUN), Pamplona, Spain.
AD  - Public University of Navarre (UPNA), Pamplona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Librero, Julián
AU  - Librero J
AUID- ORCID: 0000-0002-4859-9054
AD  - Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
AD  - Unit of Methodology, Navarrabiomed, Pamplona, Spain.
AD  - University Hospital of Navarra (HUN), Pamplona, Spain.
AD  - Public University of Navarre (UPNA), Pamplona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Madrid, Spain.
FAU - Gorricho, Javier
AU  - Gorricho J
AUID- ORCID: 0000-0003-3609-9922
AD  - Service of Evaluation and Dissemination of Results, Navarre Health Service, 
      Pamplona, Spain.
FAU - Jericó, Carlos
AU  - Jericó C
AUID- ORCID: 0000-0003-1049-4027
AD  - Department of Internal Medicine, Hospital Sant Joan Despí-Moisès Broggi, Consorci 
      Sanitari Integral, Barcelona, Spain.
FAU - García-Erce, Jose Antonio
AU  - García-Erce JA
AUID- ORCID: 0000-0001-7662-6286
AD  - Blood and Tissue Bank of Navarre, Navarre Health Service, Pamplona, Spain.
AD  - Grupo Español de Rehabilitación Multimodal (GERM), Aragon Health Sciences 
      Institute (IACS), Zaragoza, Spain.
AD  - PBM Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
DEP - 20220717
PL  - England
TA  - Vox Sang
JT  - Vox sanguinis
JID - 0413606
RN  - 0 (ABO Blood-Group System)
SB  - IM
MH  - ABO Blood-Group System
MH  - Adult
MH  - Aged
MH  - Blood Grouping and Crossmatching
MH  - *COVID-19
MH  - Humans
MH  - Intensive Care Units
MH  - Prospective Studies
PMC - PMC9349979
OTO - NOTNLM
OT  - ABO
OT  - COVID-19
OT  - blood groups
OT  - cohort
OT  - meta-analysis
COIS- The authors declare no conflict of interest for this study.
EDAT- 2022/07/18 06:00
MHDA- 2022/10/14 06:00
CRDT- 2022/07/17 22:33
PHST- 2022/05/24 00:00 [revised]
PHST- 2022/03/15 00:00 [received]
PHST- 2022/06/12 00:00 [accepted]
PHST- 2022/07/18 06:00 [pubmed]
PHST- 2022/10/14 06:00 [medline]
PHST- 2022/07/17 22:33 [entrez]
AID - VOX13334 [pii]
AID - 10.1111/vox.13334 [doi]
PST - ppublish
SO  - Vox Sang. 2022 Oct;117(10):1230-1234. doi: 10.1111/vox.13334. Epub 2022 Jul 17.

PMID- 35816382
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220910
IS  - 2369-1999 (Print)
IS  - 2369-1999 (Electronic)
IS  - 2369-1999 (Linking)
VI  - 8
IP  - 3
DP  - 2022 Jul 11
TI  - Exploring the Association of Cancer and Depression in Electronic Health Records: 
      Combining Encoded Diagnosis and Mining Free-Text Clinical Notes.
PG  - e39003
LID - 10.2196/39003 [doi]
LID - e39003
AB  - BACKGROUND: A cancer diagnosis is a source of psychological and emotional stress, 
      which are often maintained for sustained periods of time that may lead to 
      depressive disorders. Depression is one of the most common psychological 
      conditions in patients with cancer. According to the Global Cancer Observatory, 
      breast and colorectal cancers are the most prevalent cancers in both sexes and 
      across all age groups in Spain. OBJECTIVE: This study aimed to compare the 
      prevalence of depression in patients before and after the diagnosis of breast or 
      colorectal cancer, as well as to assess the usefulness of the analysis of 
      free-text clinical notes in 2 languages (Spanish or Catalan) for detecting 
      depression in combination with encoded diagnoses. METHODS: We carried out an 
      analysis of the electronic health records from a general hospital by considering 
      the different sources of clinical information related to depression in patients 
      with breast and colorectal cancer. This analysis included ICD-9-CM (International 
      Classification of Diseases, Ninth Revision, Clinical Modification) diagnosis 
      codes and unstructured information extracted by mining free-text clinical notes 
      via natural language processing tools based on Systematized Nomenclature of 
      Medicine Clinical Terms that mentions symptoms and drugs used for the treatment 
      of depression. RESULTS: We observed that the percentage of patients diagnosed 
      with depressive disorders significantly increased after cancer diagnosis in the 2 
      types of cancer considered-breast and colorectal cancers. We managed to identify 
      a higher number of patients with depression by mining free-text clinical notes 
      than the group selected exclusively on ICD-9-CM codes, increasing the number of 
      patients diagnosed with depression by 34.8% (441/1269). In addition, the number 
      of patients with depression who received chemotherapy was higher than those who 
      did not receive this treatment, with significant differences (P<.001). 
      CONCLUSIONS: This study provides new clinical evidence of the depression-cancer 
      comorbidity and supports the use of natural language processing for extracting 
      and analyzing free-text clinical notes from electronic health records, 
      contributing to the identification of additional clinical data that complements 
      those provided by coded data to improve the management of these patients.
CI  - ©Angela Leis, David Casadevall, Joan Albanell, Margarita Posso, Francesc Macià, 
      Xavier Castells, Juan Manuel Ramírez-Anguita, Jordi Martínez Roldán, Laura I 
      Furlong, Ferran Sanz, Francesco Ronzano, Miguel A Mayer. Originally published in 
      JMIR Cancer (https://cancer.jmir.org), 11.07.2022.
FAU - Leis, Angela
AU  - Leis A
AUID- ORCID: 0000-0003-4780-7111
AD  - Research Programme on Biomedical Informatics, Hospital del Mar Medical Research 
      Institute, Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 
      Spain.
FAU - Casadevall, David
AU  - Casadevall D
AUID- ORCID: 0000-0002-3986-2084
AD  - Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.
AD  - Medical Oncology Department, Hospital del Mar, Barcelona, Spain.
FAU - Albanell, Joan
AU  - Albanell J
AUID- ORCID: 0000-0003-1239-4580
AD  - Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.
AD  - Medical Oncology Department, Hospital del Mar, Barcelona, Spain.
FAU - Posso, Margarita
AU  - Posso M
AUID- ORCID: 0000-0002-5053-257X
AD  - Department of Epidemiology, Hospital del Mar Research Institute, Barcelona, 
      Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Macià, Francesc
AU  - Macià F
AUID- ORCID: 0000-0002-6090-5894
AD  - Department of Epidemiology, Hospital del Mar Research Institute, Barcelona, 
      Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AUID- ORCID: 0000-0002-2528-0382
AD  - Department of Epidemiology, Hospital del Mar Research Institute, Barcelona, 
      Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Ramírez-Anguita, Juan Manuel
AU  - Ramírez-Anguita JM
AUID- ORCID: 0000-0002-8509-0927
AD  - Research Programme on Biomedical Informatics, Hospital del Mar Medical Research 
      Institute, Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 
      Spain.
FAU - Martínez Roldán, Jordi
AU  - Martínez Roldán J
AUID- ORCID: 0000-0002-4565-6228
AD  - Innovation and Digital Transformation Area, Hospital del Mar, Barcelona, Spain.
FAU - Furlong, Laura I
AU  - Furlong LI
AUID- ORCID: 0000-0002-9383-528X
AD  - Research Programme on Biomedical Informatics, Hospital del Mar Medical Research 
      Institute, Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 
      Spain.
FAU - Sanz, Ferran
AU  - Sanz F
AUID- ORCID: 0000-0002-7534-7661
AD  - Research Programme on Biomedical Informatics, Hospital del Mar Medical Research 
      Institute, Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 
      Spain.
FAU - Ronzano, Francesco
AU  - Ronzano F
AUID- ORCID: 0000-0001-5037-9061
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 
      Spain.
FAU - Mayer, Miguel A
AU  - Mayer MA
AUID- ORCID: 0000-0003-0362-6298
AD  - Research Programme on Biomedical Informatics, Hospital del Mar Medical Research 
      Institute, Barcelona, Spain.
AD  - Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, 
      Spain.
LA  - eng
PT  - Journal Article
DEP - 20220711
PL  - Canada
TA  - JMIR Cancer
JT  - JMIR cancer
JID - 101666844
PMC - PMC9315897
OTO - NOTNLM
OT  - cancer
OT  - depression
OT  - electronic health records
OT  - natural language processing
OT  - text mining
COIS- Conflicts of Interest: None declared.
EDAT- 2022/07/12 06:00
MHDA- 2022/07/12 06:01
CRDT- 2022/07/11 11:53
PHST- 2022/04/26 00:00 [received]
PHST- 2022/06/20 00:00 [accepted]
PHST- 2022/06/17 00:00 [revised]
PHST- 2022/07/11 11:53 [entrez]
PHST- 2022/07/12 06:00 [pubmed]
PHST- 2022/07/12 06:01 [medline]
AID - v8i3e39003 [pii]
AID - 10.2196/39003 [doi]
PST - epublish
SO  - JMIR Cancer. 2022 Jul 11;8(3):e39003. doi: 10.2196/39003.

PMID- 35805867
OWN - NLM
STAT- MEDLINE
DCOM- 20220712
LR  - 20220812
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 13
DP  - 2022 Jul 5
TI  - Health-Related Quality of Life and Perceived Burden of Informal Caregivers of 
      Patients with Rare Diseases in Selected European Countries.
LID - 10.3390/ijerph19138208 [doi]
LID - 8208
AB  - Most of rare disease (RD) patients are assisted in their homes by their family as 
      informal caregivers, causing a substantial burden among family members devoted to 
      care. The role of informal caregivers has been associated with increased levels 
      of stress, poor physical/mental health and impaired HRQOL. The present study 
      assessed the impact on HRQOL and perceived burden of long-term informal 
      caregiving, as well as the inter-relationships of individuals affected by 
      different RD in six European countries, taking advantage of the data provided by 
      the BURQOL-RD project (France, Germany, Italy, Spain, Sweden and UK). Correlation 
      analysis was used to explore the relation between caregiver HRQOL and caregiver 
      burden (Zarit Burden Interview). Multinomial logistic regression models were used 
      to explore the role of explanatory variables on each domain of caregivers HRQOL 
      measured by EQ-5D. Caregivers' HRQOL is inversely correlated with burden of 
      caring. Mobility dimension of EQ-5D was significantly associated with patients 
      age, time devoted to care by secondary caregivers, patient gender and patient 
      utility index. Patients' age, burden scores and patient utility index 
      significantly predict the capacity of caregivers to perform activities of daily 
      living. Employed caregivers are less likely of reporting 'slight problems' in 
      pain/discomfort dimensions than unemployed caregivers. The EQ-5D instrument is 
      sensitive to measure differences in HRQOL between caregivers with different 
      levels of burden of care.
FAU - Valcárcel-Nazco, Cristina
AU  - Valcárcel-Nazco C
AUID- ORCID: 0000-0003-4833-7967
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 38109 
      Santa Cruz de Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 28029 Madrid, 
      Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 38109 
      Santa Cruz de Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 28029 Madrid, 
      Spain.
FAU - Linertová, Renata
AU  - Linertová R
AUID- ORCID: 0000-0002-0138-9252
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 38109 
      Santa Cruz de Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 28029 Madrid, 
      Spain.
FAU - Ramos-Goñi, Juan Manuel
AU  - Ramos-Goñi JM
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 28029 Madrid, 
      Spain.
AD  - EuroQol Research Foundation, 3068 AV Rotterdam, The Netherlands.
FAU - García-Pérez, Lidia
AU  - García-Pérez L
AUID- ORCID: 0000-0002-5626-8116
AD  - Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), 38109 
      Santa Cruz de Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 28029 Madrid, 
      Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      28029 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 28029 Madrid, 
      Spain.
AD  - Servicio de Evaluación del Servicio Canario de la Salud (SESCS), 38109 Santa Cruz 
      de Tenerife, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220705
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Activities of Daily Living
MH  - *Caregivers/psychology
MH  - Cost of Illness
MH  - Cross-Sectional Studies
MH  - Humans
MH  - *Quality of Life/psychology
MH  - Rare Diseases
MH  - Surveys and Questionnaires
PMC - PMC9266302
OTO - NOTNLM
OT  - EQ-5D-5L
OT  - caregiver burden
OT  - caregivers
OT  - health-related quality of life
OT  - informal care
OT  - rare diseases
COIS- The authors declare no conflict of interest. The funders had no role in the 
      design of the study; in the collection, analyses or interpretation of data; in 
      the writing of the manuscript, or in the decision to publish the results.
EDAT- 2022/07/10 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/09 01:09
PHST- 2022/04/12 00:00 [received]
PHST- 2022/06/30 00:00 [revised]
PHST- 2022/07/01 00:00 [accepted]
PHST- 2022/07/09 01:09 [entrez]
PHST- 2022/07/10 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - ijerph19138208 [pii]
AID - ijerph-19-08208 [pii]
AID - 10.3390/ijerph19138208 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Jul 5;19(13):8208. doi: 
      10.3390/ijerph19138208.

PMID- 35805810
OWN - NLM
STAT- MEDLINE
DCOM- 20220712
LR  - 20220812
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 13
DP  - 2022 Jul 2
TI  - Attachment-Based Compassion Therapy for Reducing Anxiety and Depression in 
      Fibromyalgia.
LID - 10.3390/ijerph19138152 [doi]
LID - 8152
AB  - Fibromyalgia patients often experience anxiety and depressive symptoms; however, 
      validated interventions show only limited efficacy. This pilot study analyzed the 
      effects of a 16-session version of attachment-based compassion therapy (ABCT-16) 
      for improving anxiety and depressive symptomatology, as well as self-compassion 
      and decentering, in 11 fibromyalgia patients. Scales were assessed at four time 
      points: baseline, after sessions 8 and 16, and 3.5 months after the completion of 
      the program. Significant improvements were found in all outcomes after the 
      program, and most remained significant in the follow-up assessment. Our 
      preliminary results suggest that ABCT-16 can be effective for improving anxiety 
      and depressive symptomatology in fibromyalgia patients. Nonetheless, further 
      studies with larger samples and control groups are necessary to confirm these 
      results.
FAU - Santos, Alicia
AU  - Santos A
AD  - Endocrinology and Internal Medicine Departments, Hospital Sant Pau, Universitat 
      Autònoma de Barcelona (UAB), 08025 Barcelona, Spain.
AD  - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unit 
      747), 08025 Barcelona, Spain.
AD  - Institut d'Investigació Biomèdica-Sant Pau (IIB-SANT PAU), 08025 Barcelona, 
      Spain.
FAU - Crespo, Iris
AU  - Crespo I
AD  - Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unit 
      747), 08025 Barcelona, Spain.
AD  - Department of Basic Sciences, School of Medicine and Health Sciences, Universitat 
      Internacional de Catalunya (UIC), 08195 Barcelona, Spain.
FAU - Pérez-Aranda, Adrián
AU  - Pérez-Aranda A
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Department of Basic, Developmental and Educational Psychology, Autonomous 
      University of Barcelona, 08193 Cerdanyola del Vallès, Spain.
FAU - Beltrán-Ruiz, María
AU  - Beltrán-Ruiz M
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, 50015 Zaragoza, Spain.
FAU - Puebla-Guedea, Marta
AU  - Puebla-Guedea M
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Psychiatry Department, Faculty of Medicine, University of Zaragoza, 50009 
      Zaragoza, Spain.
FAU - García-Campayo, Javier
AU  - García-Campayo J
AUID- ORCID: 0000-0002-3797-4218
AD  - Institute of Health Research of Aragon (IIS Aragón), Miguel Servet University 
      Hospital, 50009 Zaragoza, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS) 
      RD21/0016/0005, 50015 Zaragoza, Spain.
AD  - Psychiatry Department, Faculty of Medicine, University of Zaragoza, 50009 
      Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220702
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Anxiety/therapy
MH  - Depression/therapy
MH  - Empathy
MH  - *Fibromyalgia/therapy
MH  - Humans
MH  - Pilot Projects
MH  - Psychiatric Status Rating Scales
PMC - PMC9265807
OTO - NOTNLM
OT  - anxiety
OT  - attachment-based compassion therapy
OT  - decentering
OT  - depression
OT  - fibromyalgia
OT  - self-compassion
COIS- The authors declare no conflict of interest.
EDAT- 2022/07/10 06:00
MHDA- 2022/07/14 06:00
CRDT- 2022/07/09 01:09
PHST- 2022/04/27 00:00 [received]
PHST- 2022/06/10 00:00 [revised]
PHST- 2022/06/28 00:00 [accepted]
PHST- 2022/07/09 01:09 [entrez]
PHST- 2022/07/10 06:00 [pubmed]
PHST- 2022/07/14 06:00 [medline]
AID - ijerph19138152 [pii]
AID - ijerph-19-08152 [pii]
AID - 10.3390/ijerph19138152 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Jul 2;19(13):8152. doi: 
      10.3390/ijerph19138152.

PMID- 35773665
OWN - NLM
STAT- MEDLINE
DCOM- 20220704
LR  - 20220726
IS  - 1472-6947 (Electronic)
IS  - 1472-6947 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Jun 30
TI  - Decision aids linked to the recommendations in clinical practice guidelines: 
      results of the acceptability of a decision aid for patients with generalized 
      anxiety disorder.
PG  - 171
LID - 10.1186/s12911-022-01899-2 [doi]
LID - 171
AB  - BACKGROUND: Generalized anxiety disorder (GAD) is one of the most prevalent 
      mental health problems. Patients with GAD have unmet needs related to the 
      information received about their disorder, its treatments and their participation 
      in the decision-making process. The aim of this study is to develop and assess 
      the acceptability of a patient decision aid (PtDA) for patients with GAD. METHOD: 
      The PtDA was developed following the International Patient Decision Aid 
      Standards. The recommendations of the Spanish clinical practice guideline (CPG) 
      for patients with GAD were used as the basis. The first prototype was developed 
      by an expert committee, further improvements were made with patients (n = 2), 
      clinical experts (n = 13) and the project management group (n = 7). The 
      acceptability of this second draft was assessed by patients non-involved in the 
      previous phases (n = 11). RESULTS: The final PtDA version included a brief 
      description of GAD and its treatments. Most participants agreed that the PtDA was 
      easy to use, visually appealing and useful. At least half of the participants 
      learned new things about treatments and adverse effects. CONCLUSIONS: A PtDA was 
      developed for patients with GAD based on recommendations from the Spanish CPG. It 
      was improved and accepted by patients and clinical experts involved. An 
      evaluation of its effectiveness on the shared decision-making process during the 
      clinical encounter is planned.
CI  - © 2022. The Author(s).
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Facultad de Ciencias de La Salud - Sección de Psicología, University of La Laguna 
      (ULL), Tenerife, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain. 
      lilisbeth.peresteloperez@sescs.es.
AD  - Research Network On Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain. lilisbeth.peresteloperez@sescs.es.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain. lilisbeth.peresteloperez@sescs.es.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain. 
      lilisbeth.peresteloperez@sescs.es.
AD  - Servicio de Evaluación del Servicio Canario de la Salud, Camino de Candelaria nº 
      44, Centro de Salud San Isidro-El Chorrillo 1ª planta, 38109, Tenerife, Spain. 
      lilisbeth.peresteloperez@sescs.es.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Research Network On Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Peñate-Castro, Wenceslao
AU  - Peñate-Castro W
AD  - Facultad de Ciencias de La Salud - Sección de Psicología, University of La Laguna 
      (ULL), Tenerife, Spain.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Facultad de Ciencias de La Salud - Sección de Psicología, University of La Laguna 
      (ULL), Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Álvarez-Pérez, Yolanda
AU  - Álvarez-Pérez Y
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Trujillo-Martín, María Del Mar
AU  - Trujillo-Martín MDM
AD  - Canary Islands Health Research Institute Foundation, Tenerife, Spain.
AD  - Research Network On Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
FAU - Del Cura-González, María Isabel
AU  - Del Cura-González MI
AD  - Research Network On Health Services in Chronic Diseases (REDISSEC), Madrid, 
      Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Madrid, Spain.
AD  - Unidad de Apoyo a La Investigación, Gerencia Asistencial de Atención Primaria, 
      Madrid, Spain.
AD  - Department Preventive Medicine and Public Health, University Rey Juan Carlos, 
      Madrid, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Tenerife, Spain.
AD  - Research Network On Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - The Spanish Network of Agencies for Health Technology Assessment and Services of 
      the National Health System (RedETS), Tenerife, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220630
PL  - England
TA  - BMC Med Inform Decis Mak
JT  - BMC medical informatics and decision making
JID - 101088682
SB  - IM
EIN - BMC Med Inform Decis Mak. 2022 Jul 18;22(1):188. PMID: 35850681
MH  - Anxiety Disorders/therapy
MH  - *Decision Making
MH  - *Decision Support Techniques
MH  - Humans
MH  - Patient Participation
MH  - Practice Guidelines as Topic
PMC - PMC9243714
OTO - NOTNLM
OT  - Acceptability
OT  - Generalized anxiety disorder
OT  - Patient decision aid
OT  - Practice guideline
OT  - Shared decision-making
COIS- The authors declare that they have no competing interest.
EDAT- 2022/07/01 06:00
MHDA- 2022/07/06 06:00
CRDT- 2022/06/30 23:45
PHST- 2022/03/17 00:00 [received]
PHST- 2022/06/08 00:00 [accepted]
PHST- 2022/06/30 23:45 [entrez]
PHST- 2022/07/01 06:00 [pubmed]
PHST- 2022/07/06 06:00 [medline]
AID - 10.1186/s12911-022-01899-2 [pii]
AID - 1899 [pii]
AID - 10.1186/s12911-022-01899-2 [doi]
PST - epublish
SO  - BMC Med Inform Decis Mak. 2022 Jun 30;22(1):171. doi: 10.1186/s12911-022-01899-2.

PMID- 35737143
OWN - NLM
STAT- MEDLINE
DCOM- 20220928
LR  - 20220929
IS  - 1433-7339 (Electronic)
IS  - 0941-4355 (Print)
IS  - 0941-4355 (Linking)
VI  - 30
IP  - 10
DP  - 2022 Oct
TI  - Anxiety, depression, health-related quality of life, and mortality among 
      colorectal patients: 5-year follow-up.
PG  - 7943-7954
LID - 10.1007/s00520-022-07177-1 [doi]
AB  - PURPOSE: Health-related quality of life (HRQoL) measurement represents an 
      important outcome in cancer patients. We describe the evolution of HRQoL over a 
      5-year period in colorectal cancer patients, identifying predictors of change and 
      how they relate to mortality. METHODS: Prospective observational cohort study 
      including colorectal cancer (CRC) patients having undergone surgery in nineteen 
      public hospitals who were monitored from their diagnosis, intervention and at 1-, 
      2-, 3-, and 5-year periods thereafter by gathering HRQoL data using the 
      EuroQol-5D-5L (EQ-5D-5L), European Organization for Research and Treatment of 
      Cancer's Quality of Life Questionnaire-Core 30 (EORTC-QLQ-C30), and Hospital 
      Anxiety and Depression Scale (HADS) questionnaires. Multivariable generalized 
      linear mixed models were used. RESULTS: Predictors of Euroqol-5D-5L (EQ-5D-5L) 
      changes were having worse baseline HRQoL; being female; higher Charlson index 
      score (more comorbidities); complications during admission and 1 month after 
      surgery; having a stoma after surgery; and needing or being in receipt of social 
      support at baseline. For EORTC-QLQ-C30, predictors of changes were worse baseline 
      EORTC-QLQ-C30 score; being female; higher Charlson score; complications during 
      admission and 1 month after admission; receiving adjuvant chemotherapy; and 
      having a family history of CRC. Predictors of changes in HADS anxiety were being 
      female and having received adjuvant chemotherapy. Greater depression was 
      associated with greater baseline depression; being female; higher Charlson score; 
      having complications 1 month after intervention; and having a stoma. A 
      deterioration in all HRQoL questionnaires in the previous year was related to 
      death in the following year. CONCLUSIONS: These findings should enable preventive 
      follow-up programs to be established for such patients in order to reduce their 
      psychological distress and improve their HRQoL to as great an extent as possible. 
      GOV IDENTIFIER: NCT02488161.
CI  - © 2022. The Author(s).
FAU - Orive, Miren
AU  - Orive M
AUID- ORCID: 0000-0003-1848-6638
AD  - Departamento Psicología Social. Facultad Farmacia, UPV/EHU, Vitoria, Spain. 
      Miren.orive@ehu.eus.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain. Miren.orive@ehu.eus.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain. Miren.orive@ehu.eus.
FAU - Anton-Ladislao, Ane
AU  - Anton-Ladislao A
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
FAU - Lázaro, Santiago
AU  - Lázaro S
AD  - Servicio de Cirugía General, Hospital Basurto, Bilbao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
FAU - Gonzalez, Nerea
AU  - Gonzalez N
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
FAU - Bare, Marisa
AU  - Bare M
AD  - Unidad de Epidemiología Clínica, Corporacio Parc Tauli, Barcelona, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
FAU - Fernandez de Larrea, Nerea
AU  - Fernandez de Larrea N
AD  - Centro Nacional de Epidemiología, ISCIII, Madrid, Spain.
AD  - CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AD  - Unidad de Investigación, Hospital Costa del Sol, Malaga, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
FAU - Bilbao, Amaia
AU  - Bilbao A
AD  - Unidad de Investigación, Hospital Basurto, Bilbao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
FAU - Sarasqueta, Cristina
AU  - Sarasqueta C
AD  - Unidad de Investigación, Hospital Donostia/BioDonostia, Donostia, Guipuzkoa, 
      Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
FAU - Aguirre, Urko
AU  - Aguirre U
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
FAU - Quintana, José M
AU  - Quintana JM
AD  - Unidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
AD  - Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), 
      Galdakao, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Bizkaia, Spain.
CN  - REDISSEC-CARESS/CCR group
LA  - eng
SI  - ClinicalTrials.gov/NCT02488161
GR  - PS09/00314/Instituto de Salud Carlos III/
GR  - PS09/00910/Instituto de Salud Carlos III/
GR  - PS09/00746/Instituto de Salud Carlos III/
GR  - PS09/00805/Instituto de Salud Carlos III/
GR  - PI09/90460/Instituto de Salud Carlos III/
GR  - PI09/90490/Instituto de Salud Carlos III/
GR  - PI09/90453/Instituto de Salud Carlos III/
GR  - PI09/90441/Instituto de Salud Carlos III/
GR  - PI09/90397/Instituto de Salud Carlos III/
GR  - 2010111098/Osasun Saila, Eusko Jaurlaritzako/
GR  - IT620-13/Eusko Jaurlaritza/
PT  - Journal Article
PT  - Observational Study
DEP - 20220623
PL  - Germany
TA  - Support Care Cancer
JT  - Supportive care in cancer : official journal of the Multinational Association of 
      Supportive Care in Cancer
JID - 9302957
SB  - IM
MH  - Anxiety/epidemiology/etiology/psychology
MH  - *Colorectal Neoplasms/psychology/surgery
MH  - Depression/epidemiology/etiology/psychology
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Prospective Studies
MH  - *Quality of Life/psychology
MH  - Surveys and Questionnaires
PMC - PMC9512719
OTO - NOTNLM
OT  - Cohort studies
OT  - Colorectal cancer
OT  - Health-related quality of life
OT  - Longitudinal studies
OT  - Patient-reported outcome measures
COIS- The authors declare no competing interests.
EDAT- 2022/06/24 06:00
MHDA- 2022/09/28 06:00
CRDT- 2022/06/23 11:17
PHST- 2022/02/15 00:00 [received]
PHST- 2022/05/25 00:00 [accepted]
PHST- 2022/06/24 06:00 [pubmed]
PHST- 2022/09/28 06:00 [medline]
PHST- 2022/06/23 11:17 [entrez]
AID - 10.1007/s00520-022-07177-1 [pii]
AID - 7177 [pii]
AID - 10.1007/s00520-022-07177-1 [doi]
PST - ppublish
SO  - Support Care Cancer. 2022 Oct;30(10):7943-7954. doi: 10.1007/s00520-022-07177-1. 
      Epub 2022 Jun 23.

PMID- 35692459
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2590-1362 (Electronic)
IS  - 2590-1362 (Linking)
VI  - 11
DP  - 2022 Aug
TI  - Knowledge about COVID-19 and vaccine acceptability among priority groups defined 
      for vaccination: A cross-sectional study in Araba/Alava, Spain, before the 
      vaccination against SARS-CoV-2.
PG  - 100176
LID - 10.1016/j.jvacx.2022.100176 [doi]
LID - 100176
AB  - BACKGROUND: The acceptability of COVID-19 vaccine varies depending on the time, 
      place, type of vaccine and information available at the time. Knowledge of 
      attitudes and practices towards COVID-19 among the population at high risk of 
      developing the disease would help to tailor the strategy to improve adherence to 
      vaccination recommendations. AIM: To analyze the willingness, knowledge and risk 
      perception of patients and health care workers (HCW) to get the vaccines against 
      SARS-CoV-2. METHODS: Cross-sectional survey in Araba/Álava province (Spain). 
      Subjects who met the criteria for the influenza vaccination in 2019 and HCWS from 
      the Basque Public Health Service were included. The participants answered a 
      questionnaire on the knowledge, attitudes and practices towards COVID-19 before 
      starting vaccination against SARS-CoV-2. The intention to vaccinate was compared 
      using the chi-squared test. RESULTS: 316 HCWs and 389 patients responded to the 
      survey. Around 90% of the patients and 80% of HCW would accept vaccination in all 
      scenarios according to the questionnaire (p < 0.001). Only 3-12% hesitated about 
      the COVID-19 vaccines. Compared to 40-70% of patients, 60-80% of HCWs perceived a 
      high risk of COVID-19 (p < 0.001). Statistically significant differences were 
      found in 10 of the 17 questions regarding the mechanism of transmission and 
      symptoms. CONCLUSION: HCWs had a better knowledge and risk perception of COVID-19 
      than the surveyed patients. They had a higher proportion of hesitancy to get 
      COVID-19 vaccine, probably related to doubts about the effectiveness of the new 
      vaccines and the scientific evidence.
CI  - © 2022 The Authors.
FAU - Parraza-Diez, Naiara
AU  - Parraza-Diez N
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Madrid, Spain.
FAU - Bermudez-Ampudia, Cristina
AU  - Bermudez-Ampudia C
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
FAU - Cobos-Campos, Raquel
AU  - Cobos-Campos R
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
FAU - Garmendia, Ines
AU  - Garmendia I
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
AD  - Health Department of Basque Government, Vitoria-Gasteiz, Spain.
FAU - Orruño, Estibalitz
AU  - Orruño E
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
FAU - Ojeda, Elena
AU  - Ojeda E
AD  - Health Promotion and Disease Prevention Department. Madrid Salud, Madrid, Spain.
FAU - Garitano, Ignacio
AU  - Garitano I
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
AD  - School of Human Sciences, University of Deusto, Bilbao, Spain.
FAU - Robledo, María
AU  - Robledo M
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
AD  - Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, 
      Spain.
FAU - Portu, Jose Joaquín
AU  - Portu JJ
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
AD  - Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, 
      Spain.
AD  - University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
FAU - Apiñaniz, Antxon
AU  - Apiñaniz A
AD  - Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
AD  - University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
AD  - Osakidetza Basque Health Service, Aranbizkarra I Health Centre, Vitoria-Gasteiz, 
      Spain.
LA  - eng
PT  - Journal Article
DEP - 20220606
PL  - England
TA  - Vaccine X
JT  - Vaccine: X
JID - 101748769
PMC - PMC9170284
OTO - NOTNLM
OT  - Attitudes
OT  - COVID-19
OT  - Healthcare workers
OT  - Knowledge
OT  - Practices
OT  - Vaccine
COIS- The authors reports financial support was provided by Caja Vital Foundation 
      (BAFV20-008).
EDAT- 2022/06/14 06:00
MHDA- 2022/06/14 06:01
CRDT- 2022/06/13 02:58
PHST- 2021/07/30 00:00 [received]
PHST- 2022/05/19 00:00 [revised]
PHST- 2022/06/02 00:00 [accepted]
PHST- 2022/06/14 06:00 [pubmed]
PHST- 2022/06/14 06:01 [medline]
PHST- 2022/06/13 02:58 [entrez]
AID - S2590-1362(22)00036-5 [pii]
AID - 100176 [pii]
AID - 10.1016/j.jvacx.2022.100176 [doi]
PST - ppublish
SO  - Vaccine X. 2022 Aug;11:100176. doi: 10.1016/j.jvacx.2022.100176. Epub 2022 Jun 6.

PMID- 35686727
OWN - NLM
STAT- MEDLINE
DCOM- 20220622
LR  - 20220716
IS  - 2050-084X (Electronic)
IS  - 2050-084X (Linking)
VI  - 11
DP  - 2022 Jun 10
TI  - Impact of the COVID-19 pandemic on breast cancer screening indicators in a 
      Spanish population-based program: a cohort study.
LID - 10.7554/eLife.77434 [doi]
LID - e77434
AB  - BACKGROUND: To assess the effect of the COVID-19 pandemic on performance 
      indicators in the population-based breast cancer screening program of Parc de 
      Salut Mar (PSMAR), Barcelona, Spain. METHODS: We conducted a before-and-after, 
      study to evaluate participation, recall, false positives, the cancer detection 
      rate, and cancer characteristics in our screening population from March 2020 to 
      March 2021 compared with the four previous rounds (2012-2019). Using multilevel 
      logistic regression models, we estimated the adjusted odds ratios (aORs) of each 
      of the performance indicators for the COVID-19 period, controlling by type of 
      screening (prevalent or incident), socioeconomic index, family history of breast 
      cancer, and menopausal status. We analyzed 144,779 invitations from 47,571women. 
      RESULTS: During the COVID-19 period, the odds of participation were lower in 
      first-time invitees (aOR = 0.90 [95% CI = 0.84-0.96]) and in those who had 
      previously participated regularly and irregularly (aOR = 0.63 [95% CI = 
      0.59-0.67] and aOR = 0.95 [95% CI = 0.86-1.05], respectively). Participation 
      showed a modest increase in women not attending any of the previous rounds (aOR = 
      1.10 [95% CI = 1.01-1.20]). The recall rate decreased in both prevalent and 
      incident screening (aOR = 0.74 [95% CI = 0.56-0.99] and aOR = 0.80 [95% CI = 
      0.68-0.95], respectively). False positives also decreased in both groups 
      (prevalent aOR = 0.92 [95% CI = 0.66-1.28] and incident aOR = 0.72 [95% CI = 
      0.59-0.88]). No significant differences were observed in compliance with recall 
      (OR = 1.26, 95% CI = 0.76-2.23), cancer detection rate (aOR = 0.91 [95% CI = 
      0.69-1.18]), or cancer stages. CONCLUSIONS: The COVID-19 pandemic negatively 
      affected screening attendance, especially in previous participants and newcomers. 
      We found a reduction in recall and false positives and no marked differences in 
      cancer detection, indicating the robustness of the program. There is a need for 
      further evaluations of interval cancers and potential diagnostic delays. FUNDING: 
      This study has received funding by grants PI19/00007 and PI21/00058, funded by 
      Instituto de Salud Carlos III (ISCIII) and cofunded by the European Union and 
      Grant RD21/0016/0020 funded by Instituto de Salud Carlos III and by the European 
      Union NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR).
CI  - © 2022, Bosch et al.
FAU - Bosch, Guillermo
AU  - Bosch G
AUID- ORCID: 0000-0001-5862-0913
AD  - Department of Epidemiology and Evaluation,IMIM (Hospital del Mar Medical Research 
      Institute), Barcelona, Spain.
AD  - Preventive Medicine and Public Health Training Unit PSMar-ASPB-UPF, Barcelona, 
      Spain.
FAU - Posso, Margarita
AU  - Posso M
AUID- ORCID: 0000-0002-5053-257X
AD  - Department of Epidemiology and Evaluation,IMIM (Hospital del Mar Medical Research 
      Institute), Barcelona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Louro, Javier
AU  - Louro J
AD  - Department of Epidemiology and Evaluation,IMIM (Hospital del Mar Medical Research 
      Institute), Barcelona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Roman, Marta
AU  - Roman M
AD  - Department of Epidemiology and Evaluation,IMIM (Hospital del Mar Medical Research 
      Institute), Barcelona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Porta, Miquel
AU  - Porta M
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
AD  - Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Spain.
AD  - Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), 
      Madrid, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Department of Epidemiology and Evaluation,IMIM (Hospital del Mar Medical Research 
      Institute), Barcelona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Universitat Autònoma de Barcelona, Barcelona, Spain.
FAU - Macià, Francesc
AU  - Macià F
AD  - Department of Epidemiology and Evaluation,IMIM (Hospital del Mar Medical Research 
      Institute), Barcelona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Barcelona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220610
PL  - England
TA  - Elife
JT  - eLife
JID - 101579614
SB  - IM
MH  - *Breast Neoplasms/diagnosis/epidemiology
MH  - *COVID-19/diagnosis/epidemiology
MH  - Cohort Studies
MH  - Early Detection of Cancer
MH  - Female
MH  - Humans
MH  - Mammography
MH  - Pandemics
PMC - PMC9212994
OTO - NOTNLM
OT  - COVID-19
OT  - breast neoplasm
OT  - early detection of cancer
OT  - epidemiology
OT  - global health
OT  - human
OT  - nonrandomized controlled trials
OT  - quality indicators
COIS- GB, MP, JL, MR, MP, XC, FM No competing interests declared
EDAT- 2022/06/11 06:00
MHDA- 2022/06/23 06:00
CRDT- 2022/06/10 07:52
PHST- 2022/01/29 00:00 [received]
PHST- 2022/06/09 00:00 [accepted]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/23 06:00 [medline]
PHST- 2022/06/10 07:52 [entrez]
AID - 77434 [pii]
AID - 10.7554/eLife.77434 [doi]
PST - epublish
SO  - Elife. 2022 Jun 10;11:e77434. doi: 10.7554/eLife.77434.

PMID- 35682418
OWN - NLM
STAT- MEDLINE
DCOM- 20220613
LR  - 20220716
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 11
DP  - 2022 Jun 2
TI  - Analysis of Clinical Parameters, Drug Consumption and Use of Health Resources in 
      a Southern European Population with Diabetes That Did Not Contract COVID-19: A 
      Longitudinal Big Data Study.
LID - 10.3390/ijerph19116835 [doi]
LID - 6835
AB  - The lockdown measures imposed to stop the spread of the virus have affected the 
      general population, but particularly people with chronic diseases such as 
      diabetes. An observational real world data pre-post study of 86,615 individuals 
      over the age of 16, having a medical history in the Aragon (Spain) Health Service 
      and diagnosed with diabetes, without COVID-19 infection was undertaken. Clinical, 
      pharmacological and health resource use variables were collected during the six 
      months prior to the onset of the lockdown and during the six months after the 
      lockdown ended. The Student's t-test was used to analyse differences in means. 
      Our study does not show clinically relevant changes six months following the end 
      of the strict lockdown. The consumption, by these patients, of hypoglycaemic 
      drugs and the use of health resources continue at below pre-pandemic levels, six 
      months later. The interruption in care for these patients and the lifestyle 
      change resulting from the pandemic do not appear to have had a significant impact 
      on the health of the diabetic population.
FAU - Lear-Claveras, Ana
AU  - Lear-Claveras A
AUID- ORCID: 0000-0003-3187-2242
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragon Health Research Institute, 50015 Zaragoza, 
      Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AUID- ORCID: 0000-0001-6565-9699
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragon Health Research Institute, 50015 Zaragoza, 
      Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AUID- ORCID: 0000-0001-9552-1260
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
AD  - I-Saúde Group, South Galicia Health Research Institute, 36201 Vigo, Spain.
AD  - Vigo Health Area, SERGAS, 36201 Vigo, Spain.
FAU - Couso-Viana, Sabela
AU  - Couso-Viana S
AUID- ORCID: 0000-0002-9802-6131
AD  - I-Saúde Group, South Galicia Health Research Institute, 36201 Vigo, Spain.
FAU - Botaya, Rosa Magallón
AU  - Botaya RM
AUID- ORCID: 0000-0002-5494-6550
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragon Health Research Institute, 50015 Zaragoza, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
AD  - Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, 50009 
      Zaragoza, Spain.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20220602
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Big Data
MH  - *COVID-19/epidemiology
MH  - Communicable Disease Control
MH  - *Diabetes Mellitus/epidemiology
MH  - Health Resources
MH  - Humans
PMC - PMC9180049
OTO - NOTNLM
OT  - COVID-19
OT  - diabetes
OT  - health resources
OT  - lifestyle
OT  - lockdown
COIS- The authors declare no conflict of interest.
EDAT- 2022/06/11 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/10 01:13
PHST- 2022/04/30 00:00 [received]
PHST- 2022/05/30 00:00 [revised]
PHST- 2022/05/31 00:00 [accepted]
PHST- 2022/06/10 01:13 [entrez]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
AID - ijerph19116835 [pii]
AID - ijerph-19-06835 [pii]
AID - 10.3390/ijerph19116835 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Jun 2;19(11):6835. doi: 
      10.3390/ijerph19116835.

PMID- 35681224
OWN - NLM
STAT- MEDLINE
DCOM- 20220613
LR  - 20220716
IS  - 1745-6215 (Electronic)
IS  - 1745-6215 (Linking)
VI  - 23
IP  - 1
DP  - 2022 Jun 9
TI  - Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with 
      multimorbidity and polypharmacy aimed at improving prescribing practices in 
      primary care: study protocol of a cluster randomized trial.
PG  - 479
LID - 10.1186/s13063-022-06293-x [doi]
LID - 479
AB  - BACKGROUND: The progressive ageing of the population is leading to an increase in 
      multimorbidity and polypharmacy, which in turn may increase the risk of 
      hospitalization and mortality. The enhancement of care with information and 
      communications technology (ICT) can facilitate the use of prescription evaluation 
      tools and support system for decision-making (DSS) with the potential of 
      optimizing the healthcare delivery process. OBJECTIVE: To assess the 
      effectiveness and cost-effectiveness of the complex intervention MULTIPAP Plus, 
      compared to usual care, in improving prescriptions for young-old patients 
      (65-74 years old) with multimorbidity and polypharmacy in primary care. 
      METHODS/DESIGN: This is a pragmatic cluster-randomized clinical trial with a 
      follow-up of 18 months in health centres of the Spanish National Health System. 
      Unit of randomization: family physician. Unit of analysis: patient. POPULATION: 
      Patients aged 65-74 years with multimorbidity (≥ 3 chronic diseases) and 
      polypharmacy (≥ 5 drugs) during the previous 3 months were included. SAMPLE SIZE: 
      n = 1148 patients (574 per study arm). INTERVENTION: Complex intervention based 
      on the ARIADNE principles with three components: (1) family physician (FP) 
      training, (2) FP-patient interview, and (3) decision-making support system. 
      OUTCOMES: The primary outcome is a composite endpoint of hospital admission or 
      death during the observation period measured as a binary outcome, and the 
      secondary outcomes are number of hospital admission, all-cause mortality, use of 
      health services, quality of life (EQ-5D-5L), functionality (WHODAS), falls, hip 
      fractures, prescriptions and adherence to treatment. Clinical and 
      sociodemographic factors will be explanatory variables. STATISTICAL ANALYSIS: The 
      main result is the difference in percentages in the final composite endpoint 
      variable at 18 months, with its corresponding 95% CI. Adjustments by the main 
      confounding and prognostic factors will be performed through a multilevel 
      analysis. All analyses will be carried out in accordance to the 
      intention-to-treat principle. DISCUSSION: It is important to prevent the cascade 
      of negative health and health care impacts attributable to the 
      multimorbidity-polypharmacy binomial. ICT-enhanced routine clinical practice 
      could improve the prescription process in patient care. TRIAL REGISTRATION: 
      ClinicalTrials.gov NCT04147130 . Registered on 22 October 2019.
CI  - © 2022. The Author(s).
FAU - Del Cura-González, Isabel
AU  - Del Cura-González I
AUID- ORCID: 0000-0002-3931-5304
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain. Isabel.cura@salud.madrid.org.
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain. Isabel.cura@salud.madrid.org.
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain. Isabel.cura@salud.madrid.org.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain. 
      Isabel.cura@salud.madrid.org.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain. 
      Isabel.cura@salud.madrid.org.
FAU - López-Rodríguez, Juan A
AU  - López-Rodríguez JA
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Ricardos General Health Center, Madrid Health Service, Madrid, Spain.
FAU - Leiva-Fernández, Francisca
AU  - Leiva-Fernández F
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Multiprofessional Family and Community Care Teaching Unit of the 
      Málaga-Guadalhorce Health District, Málaga, Spain.
AD  - Biomedical Research Institute of Malaga (IBIMA), Málaga, Spain.
AD  - University of Malaga, Malaga, Spain.
FAU - Gimeno-Feliu, Luis A
AU  - Gimeno-Feliu LA
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - San Pablo Primary Care Health Centre, Aragon Health Service, Zaragoza, Spain.
AD  - University of Zaragoza, Zaragoza, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - Pico-Soler, Victoria
AU  - Pico-Soler V
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Torrero-La Paz Primary Care Health Centre, Aragon Health Service (SALUD), 
      Zaragoza, Spain.
FAU - Bujalance-Zafra, Mª Josefa
AU  - Bujalance-Zafra MJ
AD  - Multiprofessional Family and Community Care Teaching Unit of the 
      Málaga-Guadalhorce Health District, Málaga, Spain.
AD  - La Victoria Health Center, Málaga-Guadalhorce Health District, Málaga, Spain.
FAU - Domínguez-Santaella, Miguel
AU  - Domínguez-Santaella M
AD  - Multiprofessional Family and Community Care Teaching Unit of the 
      Málaga-Guadalhorce Health District, Málaga, Spain.
AD  - La Victoria Health Center, Málaga-Guadalhorce Health District, Málaga, Spain.
FAU - Polentinos-Castro, Elena
AU  - Polentinos-Castro E
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - Ara-Bardají, Paula
AU  - Ara-Bardají P
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - Aza-Pascual-Salcedo, Mercedes
AU  - Aza-Pascual-Salcedo M
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Primary Care Pharmacy Service Zaragoza III, Aragon Health Service, Zaragoza, 
      Spain.
FAU - Rogero-Blanco, Marisa
AU  - Rogero-Blanco M
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Ricardos General Health Center, Madrid Health Service, Madrid, Spain.
FAU - Castillo-Jiménez, Marcos
AU  - Castillo-Jiménez M
AD  - Multiprofessional Family and Community Care Teaching Unit of the 
      Málaga-Guadalhorce Health District, Málaga, Spain.
AD  - Health Center Campillos, Malaga North District (Antequera), Málaga, Spain.
FAU - Lozano-Hernández, Cristina
AU  - Lozano-Hernández C
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Primary Health Care Research and Innovation Foundation FIIBAP, Madrid, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
FAU - González-Rubio, Francisca
AU  - González-Rubio F
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Delicias Sur Primary Care Health Centre, Aragon Health Service (SALUD, Zaragoza, 
      Spain.
FAU - Medina-García, Rodrigo
AU  - Medina-García R
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Ricardos General Health Center, Madrid Health Service, Madrid, Spain.
AD  - Primary Health Care Research and Innovation Foundation FIIBAP, Madrid, Spain.
FAU - González-Hevilla, Alba
AU  - González-Hevilla A
AD  - Multiprofessional Family and Community Care Teaching Unit of the 
      Málaga-Guadalhorce Health District, Málaga, Spain.
FAU - Gil-Conesa, Mario
AU  - Gil-Conesa M
AD  - Preventive Medicine Service, University Hospital Alcorcon Foundation, Madrid, 
      Spain.
FAU - Martín-Fernández, Jesús
AU  - Martín-Fernández J
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University, Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Madrid, Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Multiprofessional Family and Community Care Teaching Unit West, Madrid, Spain.
FAU - Valderas, José M
AU  - Valderas JM
AD  - Department of Family Medicine, National University Health System, Singapore, 
      Singapore.
FAU - Marengoni, Alessandra
AU  - Marengoni A
AD  - Department of Clinical and Experimental Sciences, University of Brescia, Brescia, 
      Italy.
FAU - Muth, Christiane
AU  - Muth C
AD  - Department of General Practice and Family Medicine, Medical Faculty OWL, 
      University of Bielefeld, Bielefeld, Germany.
FAU - Prados-Torres, J Daniel
AU  - Prados-Torres JD
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - Multiprofessional Family and Community Care Teaching Unit of the 
      Málaga-Guadalhorce Health District, Málaga, Spain.
AD  - Biomedical Research Institute of Malaga (IBIMA), Málaga, Spain.
AD  - University of Malaga, Malaga, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AD  - Research Network on Health Services in Chronic Diseases REDISSEC-ISCIII, Madrid, 
      Spain.
AD  - Research Networks Health Outcomes-Oriented Cooperative on Chronicity, Primary 
      Care and Health Promotion RICORS RICAPPS, ISCIII, Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
CN  - MULTIPAP PLUS Group
LA  - eng
SI  - ClinicalTrials.gov/NCT04147130
PT  - Clinical Trial Protocol
PT  - Journal Article
DEP - 20220609
PL  - England
TA  - Trials
JT  - Trials
JID - 101263253
SB  - IM
MH  - Aged
MH  - Chronic Disease
MH  - Humans
MH  - *Multimorbidity
MH  - *Polypharmacy
MH  - Primary Health Care/methods
MH  - Quality of Life
MH  - Randomized Controlled Trials as Topic
PMC - PMC9178530
OTO - NOTNLM
OT  - Cluster randomized controlled trial
OT  - Computer-assisted
OT  - Decision-making
OT  - Medication reconciliation
OT  - Multimorbidity
OT  - Patient-centred care
OT  - Polypharmacy
OT  - Primary health care
COIS- The authors declare that they have no competing interests.
FIR - Orellana-Lozano, Francisco Javier
IR  - Orellana-Lozano FJ
FIR - Sepúlveda-Muñoz, Jesús
IR  - Sepúlveda-Muñoz J
FIR - Sánchez-Jordán, Rafael
IR  - Sánchez-Jordán R
FIR - Escobar-Pérez, Amparo
IR  - Escobar-Pérez A
FIR - Rodríguez-García, Concepción
IR  - Rodríguez-García C
FIR - Peñuela-Ruiz, Trinidad
IR  - Peñuela-Ruiz T
FIR - Navarro-Martín, José Antonio
IR  - Navarro-Martín JA
FIR - Rodríguez-Rivera, María Rosario
IR  - Rodríguez-Rivera MR
FIR - Aguilar-Heredia, Yolanda
IR  - Aguilar-Heredia Y
FIR - Martínez-Sarmiento, Antonio Ignacio
IR  - Martínez-Sarmiento AI
FIR - Pascual-de-la-Pisa, Beatriz
IR  - Pascual-de-la-Pisa B
FIR - García-Lozano, María José
IR  - García-Lozano MJ
FIR - García-Carrera, Alejandro
IR  - García-Carrera A
FIR - Juan-Tordesillas, Noelia
IR  - Juan-Tordesillas N
FIR - Márquez-Chamizo, María Isabel
IR  - Márquez-Chamizo MI
FIR - Navarro-Jiménez, José Manuel
IR  - Navarro-Jiménez JM
FIR - Ruiz-Ciudad, María Carmen
IR  - Ruiz-Ciudad MC
FIR - Vázquez-Alarcón, Rubén Luciano
IR  - Vázquez-Alarcón RL
FIR - Navarro-Gallego, María Isabel
IR  - Navarro-Gallego MI
FIR - Ginel-Mendoza, Leovigildo
IR  - Ginel-Mendoza L
FIR - Ruiz-San-Basilio, José María
IR  - Ruiz-San-Basilio JM
FIR - Barceló-Garach, Elena
IR  - Barceló-Garach E
FIR - Alcantarilla-Reyes, Elisa María
IR  - Alcantarilla-Reyes EM
FIR - de Cienfuegos Hernández, Marta Álvarez
IR  - de Cienfuegos Hernández MÁ
FIR - Martínez-Ríos, Irene
IR  - Martínez-Ríos I
FIR - Orellana-Martín, Laura
IR  - Orellana-Martín L
FIR - Merino-Moyano, María Dolores
IR  - Merino-Moyano MD
FIR - Segura-Domínguez, Nuria
IR  - Segura-Domínguez N
FIR - Moral-Merchán, María Cristina
IR  - Moral-Merchán MC
FIR - Martín-Aurioles, Esther
IR  - Martín-Aurioles E
FIR - Rodríguez-González, María Inmaculada
IR  - Rodríguez-González MI
FIR - Hazañas-Ruiz, Sylvia
IR  - Hazañas-Ruiz S
FIR - Gallego-Castillo, Eva Noelia
IR  - Gallego-Castillo EN
FIR - Mora-García, Esperanza
IR  - Mora-García E
FIR - Cámara-Sola, Estefanía
IR  - Cámara-Sola E
FIR - Fons-Cañizares, Sergio
IR  - Fons-Cañizares S
FIR - Ortigosa-Arrabal, María Paz
IR  - Ortigosa-Arrabal MP
FIR - Quesada-Fernández, Teresa
IR  - Quesada-Fernández T
FIR - Rodríguez-Moreno, Silvia
IR  - Rodríguez-Moreno S
FIR - Sánchez-Silvestre, Ana
IR  - Sánchez-Silvestre A
FIR - Torrubia-Fernández, María Jesús
IR  - Torrubia-Fernández MJ
FIR - González-Vega, María José
IR  - González-Vega MJ
FIR - Almagro-Martín-Lomeña, María Victoria
IR  - Almagro-Martín-Lomeña MV
FIR - Serrano-González, Caridad
IR  - Serrano-González C
FIR - Leiva-Fernández, José
IR  - Leiva-Fernández J
FIR - Castillo-Romero, Virginia
IR  - Castillo-Romero V
FIR - Fernández-Vargas, Ana María
IR  - Fernández-Vargas AM
FIR - Serrano-Guerra, Francisco José
IR  - Serrano-Guerra FJ
FIR - Narbona-Carrión, Gabriel Francisco
IR  - Narbona-Carrión GF
FIR - Michel-Bertevas, Hervé
IR  - Michel-Bertevas H
FIR - Maqueda, Rafael Ángel
IR  - Maqueda RÁ
FIR - Domínguez-Santaella, Miguel
IR  - Domínguez-Santaella M
FIR - García-Agua-Soler, Nuria
IR  - García-Agua-Soler N
FIR - Del Pilar Barnestein-Fonseca, Maria
IR  - Del Pilar Barnestein-Fonseca M
FIR - Abadía-Taira, María Begoña
IR  - Abadía-Taira MB
FIR - Sánchez-Celaya-Del-Pozo, Carmen
IR  - Sánchez-Celaya-Del-Pozo C
FIR - Giménez-Baratech, Ana Carmen
IR  - Giménez-Baratech AC
FIR - Sanz-Burgos, Lara
IR  - Sanz-Burgos L
FIR - Abad-Royo, Mercedes
IR  - Abad-Royo M
FIR - Camats-Franco, Carmen
IR  - Camats-Franco C
FIR - Cortés-Pellicer, José Manuel
IR  - Cortés-Pellicer JM
FIR - Herrero-Solsona, Paula
IR  - Herrero-Solsona P
FIR - Moreno-Juste, Aida
IR  - Moreno-Juste A
FIR - Guiu-Campos, Miguel
IR  - Guiu-Campos M
FIR - Peyman-Fard-Shafi-Tabatabaei, Nima
IR  - Peyman-Fard-Shafi-Tabatabaei N
FIR - Delgado-Marroquín, Ma Teresa
IR  - Delgado-Marroquín MT
FIR - López-Echevarría, Mercedes
IR  - López-Echevarría M
FIR - Carmona-Pírez, Jonás
IR  - Carmona-Pírez J
FIR - Barrera-Linares, Fernando
IR  - Barrera-Linares F
FIR - Carrillo-Soria, Sandro Daniel
IR  - Carrillo-Soria SD
FIR - Esteban-Gimeno, Ana Belén
IR  - Esteban-Gimeno AB
FIR - López-Alonso, Beatriz
IR  - López-Alonso B
FIR - Hernández-Bono, Anabel
IR  - Hernández-Bono A
FIR - Martínez-Ayala, Enrique
IR  - Martínez-Ayala E
FIR - Martínez-Manero, Adriana
IR  - Martínez-Manero A
FIR - Martínez-Sánchez, Raquel
IR  - Martínez-Sánchez R
FIR - Naya-Mateu, Yolanda
IR  - Naya-Mateu Y
FIR - Clemente-Jiménez, María Lourdes
IR  - Clemente-Jiménez ML
FIR - Leon-Martínez, María Paz
IR  - Leon-Martínez MP
FIR - Mahuela, Liliana
IR  - Mahuela L
FIR - Sanjuan-Cortés, Ma Rosario
IR  - Sanjuan-Cortés MR
FIR - Salazar-González, Elisa Pilar
IR  - Salazar-González EP
FIR - Charte-Alegre, Ma Elena
IR  - Charte-Alegre ME
FIR - Mur-Lazuela, Ma Jesús
IR  - Mur-Lazuela MJ
FIR - Pascual-Franco, Mónica
IR  - Pascual-Franco M
FIR - Arizon-Deza, Pilar
IR  - Arizon-Deza P
FIR - García-Gutiérrez-Muñoz, Carmen
IR  - García-Gutiérrez-Muñoz C
FIR - García-Ruiz, Teresa
IR  - García-Ruiz T
FIR - Navarro-Aznárez, Gloria
IR  - Navarro-Aznárez G
FIR - Alcober-Pérez, Carlos
IR  - Alcober-Pérez C
FIR - Navarro-Tausiet, María Paz
IR  - Navarro-Tausiet MP
FIR - Lacasa-Serrano, Ma Elena
IR  - Lacasa-Serrano ME
FIR - Maza-Invernón, Ana Cristina
IR  - Maza-Invernón AC
FIR - Peleato-Sánchez, Jaime
IR  - Peleato-Sánchez J
FIR - Buñuel-Granados, José Miguel
IR  - Buñuel-Granados JM
FIR - Alonso-Valbuena, Ainara
IR  - Alonso-Valbuena A
FIR - Lasheras-Barrio, Mónica
IR  - Lasheras-Barrio M
FIR - Ibarrondo-Fernández-Ladreda, Isabel
IR  - Ibarrondo-Fernández-Ladreda I
FIR - López-Aylon, Rosa Ma
IR  - López-Aylon RM
FIR - Rodríguez-Fabre, María José
IR  - Rodríguez-Fabre MJ
FIR - Rubio-Gutiérrez, Isabel
IR  - Rubio-Gutiérrez I
FIR - Valverde-Aranda, Selma
IR  - Valverde-Aranda S
FIR - Bandrés-Liso, Ana Cristina
IR  - Bandrés-Liso AC
FIR - Poncel-Falcó, Antonio
IR  - Poncel-Falcó A
FIR - Bliek-Bueno, Kevin
IR  - Bliek-Bueno K
FIR - Cano-Del-Pozo, Mabel
IR  - Cano-Del-Pozo M
FIR - Clerencia-Sierra, Mercedes
IR  - Clerencia-Sierra M
FIR - Díez-Manglano, Jesús
IR  - Díez-Manglano J
FIR - Guerrero-Fernández-de-Alba, Inmaculada
IR  - Guerrero-Fernández-de-Alba I
FIR - Ioakeim-Skoufa, Ignatios
IR  - Ioakeim-Skoufa I
FIR - Marta-Moreno, Javier
IR  - Marta-Moreno J
FIR - Santos-Muñoz, David
IR  - Santos-Muñoz D
FIR - Viñuela-Benéitez, María Elisa
IR  - Viñuela-Benéitez ME
FIR - Miguel-Abanto, María De Los Angeles
IR  - Miguel-Abanto MLA
FIR - García-De-Blas, Francisca
IR  - García-De-Blas F
FIR - García-Álvarez, Juan Carlos
IR  - García-Álvarez JC
FIR - Redondo-de-Pedro, Sonia
IR  - Redondo-de-Pedro S
FIR - González-García, Carlos Fernando
IR  - González-García CF
FIR - Peláez-Laguno, Carolina
IR  - Peláez-Laguno C
FIR - Gomez-Suarez, Esther
IR  - Gomez-Suarez E
FIR - Morales-Ortiz, Fernanda
IR  - Morales-Ortiz F
FIR - Ferrer-Zapata, Isabel
IR  - Ferrer-Zapata I
FIR - Sánchez-Fernández, Yolanda Beatriz
IR  - Sánchez-Fernández YB
FIR - Fernández-Fernández, Yolanda
IR  - Fernández-Fernández Y
FIR - Barrio-Higelmo, Esther
IR  - Barrio-Higelmo E
FIR - Rioja-Delgado, Eva María
IR  - Rioja-Delgado EM
FIR - Lopez-Larrayoz, Irina
IR  - Lopez-Larrayoz I
FIR - Seara-Lozano, María Luz
IR  - Seara-Lozano ML
FIR - Fernández-Sánchez, Julio Cesar
IR  - Fernández-Sánchez JC
FIR - San-Miguel-Marinero, María Teresa
IR  - San-Miguel-Marinero MT
FIR - Fidalgo-Baz, María Jesus
IR  - Fidalgo-Baz MJ
FIR - Ares-Blanco, Sara
IR  - Ares-Blanco S
FIR - Gómez-Ciriano, Jorge Ignacio
IR  - Gómez-Ciriano JI
FIR - Garcés-Ranz, José Damián
IR  - Garcés-Ranz JD
FIR - Santos-Franco, Laura
IR  - Santos-Franco L
FIR - García-Galeano, María Celeste
IR  - García-Galeano MC
FIR - Mateo-Fernández, Raquel
IR  - Mateo-Fernández R
FIR - Morcillo-Cebolla, Sara
IR  - Morcillo-Cebolla S
FIR - Rossignoli-Fernández, Tomás
IR  - Rossignoli-Fernández T
FIR - Olmedo-Galindo, Jorge
IR  - Olmedo-Galindo J
FIR - Pinel-González, Marta
IR  - Pinel-González M
FIR - Redondo-Romero, Rosa María
IR  - Redondo-Romero RM
FIR - Estrada-Leon, Adnaloy Helena
IR  - Estrada-Leon AH
FIR - Muñoz-Gómez, Belén
IR  - Muñoz-Gómez B
FIR - Sanz-Pozo, Blanca
IR  - Sanz-Pozo B
FIR - López-Marcos, Claudia
IR  - López-Marcos C
FIR - Rodríguez-De-Mingo, Enrique
IR  - Rodríguez-De-Mingo E
FIR - Moreno-Fernández, Juan Carlos
IR  - Moreno-Fernández JC
FIR - Morales-Cobos, Luis Enrique
IR  - Morales-Cobos LE
FIR - Garcia-Garcia-Alcañiz, María Del Prado
IR  - Garcia-Garcia-Alcañiz MDP
FIR - Lorenzo-Borda, Marisol
IR  - Lorenzo-Borda M
FIR - González-García, Vera
IR  - González-García V
FIR - Muñoz-Molina, María Del Pilar
IR  - Muñoz-Molina MDP
FIR - Drak-Hernández, Yasmin
IR  - Drak-Hernández Y
FIR - Rabanal-Basalo, Alejandro
IR  - Rabanal-Basalo A
FIR - Abad-Esteban, Ana María
IR  - Abad-Esteban AM
FIR - Rollan-Hernández, María De Los Ángeles
IR  - Rollan-Hernández MLÁ
FIR - Fuster-Tozer, Mónica
IR  - Fuster-Tozer M
FIR - Carretero-Ramos, Raquel
IR  - Carretero-Ramos R
FIR - Mielgo-Salvador, Rebeca
IR  - Mielgo-Salvador R
FIR - Sosa-Alonso, Ana
IR  - Sosa-Alonso A
FIR - Muros-Muñoz, Carmen María
IR  - Muros-Muñoz CM
FIR - Sánchez-Yépez, Jeannet Dolores
IR  - Sánchez-Yépez JD
FIR - Cáceres-Cortés, María Cristina
IR  - Cáceres-Cortés MC
FIR - Morso-Peláez, María Paloma
IR  - Morso-Peláez MP
FIR - Pastor-Estebanez, María
IR  - Pastor-Estebanez M
FIR - Fernández-Girón, Mercedes
IR  - Fernández-Girón M
FIR - Pérez-De-Colosia-Zuil, Antonia
IR  - Pérez-De-Colosia-Zuil A
FIR - Pérez-Gutiérrez, Esteban
IR  - Pérez-Gutiérrez E
FIR - Tejero-García, Isabel
IR  - Tejero-García I
FIR - Innerarity-Martínez, Jaime
IR  - Innerarity-Martínez J
FIR - Álvarez-Villalba, Mar
IR  - Álvarez-Villalba M
FIR - Gómez-Barroso, Margarita
IR  - Gómez-Barroso M
FIR - Escobar-Gallegos, María Del Mar
IR  - Escobar-Gallegos MDM
FIR - Bedoya-Frutos, María Jesus
IR  - Bedoya-Frutos MJ
FIR - Del-Olmo-Ribagorda, Marta Inmaculada
IR  - Del-Olmo-Ribagorda MI
FIR - Cortés-Durán, Petra María
IR  - Cortés-Durán PM
FIR - Tardáguila-Lobato, Pilar
IR  - Tardáguila-Lobato P
FIR - Terrón-Barbosa, Raquel Yolanda
IR  - Terrón-Barbosa RY
FIR - Ramos-Blanco, Antonio
IR  - Ramos-Blanco A
FIR - López-Villalvilla, Aránzazu
IR  - López-Villalvilla A
FIR - Cinta-Bella, Beatriz
IR  - Cinta-Bella B
FIR - Varela-Varela, Cristian
IR  - Varela-Varela C
FIR - Garcia-Rodriguez, Francisca
IR  - Garcia-Rodriguez F
FIR - Saiz-Ladera, Gema María
IR  - Saiz-Ladera GM
FIR - López-Fernández, Guillermina
IR  - López-Fernández G
FIR - Orozco-Barrenechea, Lourdes
IR  - Orozco-Barrenechea L
FIR - Zafra-De-Gea, María Begoña
IR  - Zafra-De-Gea MB
FIR - García-Arpa, Nuria
IR  - García-Arpa N
FIR - Ewa-Barnas, Tamara
IR  - Ewa-Barnas T
FIR - Carbonero-Martín, Ana Isabel
IR  - Carbonero-Martín AI
FIR - Rojas-Giraldo, María José
IR  - Rojas-Giraldo MJ
FIR - Cotillas-Rodero, Alberto
IR  - Cotillas-Rodero A
FIR - López-Serrano, Beatriz
IR  - López-Serrano B
FIR - Rodriguez-Fernández, María Del Carmen
IR  - Rodriguez-Fernández MDC
FIR - Sanz-Velasco, Carmelina
IR  - Sanz-Velasco C
FIR - Aza-Pascual-Salcedo, Jose Ignacio
IR  - Aza-Pascual-Salcedo JI
FIR - Lopez-Olmeda, Carolina
IR  - Lopez-Olmeda C
FIR - Gutiérrez-Ocana, Estrella
IR  - Gutiérrez-Ocana E
FIR - García-Ocaña, Raquel
IR  - García-Ocaña R
FIR - Sanz-Cuesta, Teresa
IR  - Sanz-Cuesta T
FIR - Rodríguez-Barrientos, Ricardo
IR  - Rodríguez-Barrientos R
FIR - Rico-Blázquez, Milagros
IR  - Rico-Blázquez M
FIR - Ariza-Cardiel, Ma Gloria
IR  - Ariza-Cardiel MG
FIR - Mataix-San-Juan, Angel
IR  - Mataix-San-Juan A
FIR - Alcaraz-Borrajo, Marta
IR  - Alcaraz-Borrajo M
FIR - Rumayor-Zarzuelo, Mercedes
IR  - Rumayor-Zarzuelo M
FIR - Sánchez-Perruca, Luis
IR  - Sánchez-Perruca L
FIR - Azcoaga-Lorenzo, Amaya
IR  - Azcoaga-Lorenzo A
FIR - Hernández-Santiago, Virginia
IR  - Hernández-Santiago V
FIR - Rotaeche-Del-Campo, Rafael
IR  - Rotaeche-Del-Campo R
EDAT- 2022/06/11 06:00
MHDA- 2022/06/14 06:00
CRDT- 2022/06/10 00:39
PHST- 2022/02/18 00:00 [received]
PHST- 2022/04/09 00:00 [accepted]
PHST- 2022/06/10 00:39 [entrez]
PHST- 2022/06/11 06:00 [pubmed]
PHST- 2022/06/14 06:00 [medline]
AID - 10.1186/s13063-022-06293-x [pii]
AID - 6293 [pii]
AID - 10.1186/s13063-022-06293-x [doi]
PST - epublish
SO  - Trials. 2022 Jun 9;23(1):479. doi: 10.1186/s13063-022-06293-x.

PMID- 35629175
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221005
IS  - 2075-4426 (Print)
IS  - 2075-4426 (Electronic)
IS  - 2075-4426 (Linking)
VI  - 12
IP  - 5
DP  - 2022 May 6
TI  - How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in 
      Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP 
      Intervention.
LID - 10.3390/jpm12050752 [doi]
LID - 752
AB  - (1) Purpose: To investigate a complex MULTIPAP intervention that implements the 
      Ariadne principles in a primary care population of young-elderly patients with 
      multimorbidity and polypharmacy and to evaluate its effectiveness for improving 
      the appropriateness of prescriptions. (2) Methods: A pragmatic cluster-randomized 
      clinical trial was conducted involving 38 family practices in Spain. Patients 
      aged 65-74 years with multimorbidity and polypharmacy were recruited. Family 
      physicians (FPs) were randomly allocated to continue usual care or to provide the 
      MULTIPAP intervention based on the Ariadne principles with two components: FP 
      training (eMULTIPAP) and FP patient interviews. The primary outcome was the 
      appropriateness of prescribing, measured as the between-group difference in the 
      mean Medication Appropriateness Index (MAI) score change from the baseline to the 
      6-month follow-up. The secondary outcomes were quality of life (EQ-5D-5 L), 
      patient perceptions of shared decision making (collaboRATE), use of health 
      services, treatment adherence, and incidence of drug adverse events (all at 1 
      year), using multi-level regression models, with FP as a random effect. (3) 
      Results: We recruited 117 FPs and 593 of their patients. In the 
      intention-to-treat analysis, the between-group difference for the mean MAI score 
      change after a 6-month follow-up was -2.42 (95% CI from -4.27 to -0.59) and, 
      between baseline and a 12-month follow-up was -3.40 (95% CI from -5.45 to -1.34). 
      There were no significant differences in any other secondary outcomes. (4) 
      Conclusions: The MULTIPAP intervention improved medication appropriateness 
      sustainably over the follow-up time. The small magnitude of the effect, however, 
      advises caution in the interpretation of the results given the paucity of 
      evidence for the clinical benefit of the observed change in the MAI. Trial 
      registration: Clinicaltrials.gov NCT02866799.
FAU - Del Cura-González, Isabel
AU  - Del Cura-González I
AUID- ORCID: 0000-0002-3931-5304
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service 
      (Servicio Madrileño de Salud), 28035 Madrid, Spain.
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University (Universidad Rey Juan Carlos), 28922 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon IISGM, 28009 Madrid, Spain.
FAU - López-Rodríguez, Juan A
AU  - López-Rodríguez JA
AUID- ORCID: 0000-0002-4985-2314
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service 
      (Servicio Madrileño de Salud), 28035 Madrid, Spain.
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University (Universidad Rey Juan Carlos), 28922 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon IISGM, 28009 Madrid, Spain.
AD  - Ricardos General Health Center (Centro de Salud General Ricardos), 28019 Madrid, 
      Spain.
FAU - Leiva-Fernández, Francisca
AU  - Leiva-Fernández F
AUID- ORCID: 0000-0001-6919-4817
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Multiprofessional Family and Community Care Teaching Unit (Unidad Docente 
      Multiprofesional de Atención Familiar y Comunitaria) of the Málaga-Guadalhorce 
      Health District, 29016 Málaga, Spain.
AD  - Biomedical Research Institute of Malaga (Instituto de Investigación Biomédica de 
      Málaga-IBIMA), 29010 Málaga, Spain.
AD  - Department of Pharmacology and Paediatrics, School of Medicine, University of 
      Malaga (Universidad de Málaga), 29016 Málaga, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AUID- ORCID: 0000-0002-5440-1710
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AUID- ORCID: 0000-0002-5119-5093
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
FAU - López-Verde, Fernando
AU  - López-Verde F
AUID- ORCID: 0000-0001-7870-0793
AD  - Las Delicias Health Center (Centro de Salud las Delicias), Málaga-Guadalhorce 
      Health District, 29016 Málaga, Spain.
FAU - Lozano-Hernández, Cristina
AU  - Lozano-Hernández C
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service 
      (Servicio Madrileño de Salud), 28035 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon IISGM, 28009 Madrid, Spain.
AD  - Primary Health Care Research and Innovation Foundation (Fundación Investigación e 
      Innovación Biosanitaria en Atención Primaria), FIIBAP, 28003 Madrid, Spain.
FAU - Pico-Soler, Victoria
AU  - Pico-Soler V
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Torrero-La Paz Primary Care Health Centre, Aragon Health Service (SALUD), 50007 
      Zaragoza, Spain.
FAU - Bujalance-Zafra, Mª Josefa
AU  - Bujalance-Zafra MJ
AUID- ORCID: 0000-0002-4342-5530
AD  - La Victoria Health Center (Centro de Salud la Victoria), Málaga-Guadalhorce 
      Health District, 29013 Málaga, Spain.
FAU - Gimeno-Feliu, Luis A
AU  - Gimeno-Feliu LA
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - San Pablo Primary Care Health Centre, Aragon Health Service (SALUD), School of 
      Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
FAU - Aza-Pascual-Salcedo, Mercedes
AU  - Aza-Pascual-Salcedo M
AUID- ORCID: 0000-0002-8937-5559
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Primary Care Pharmacy Service Zaragoza III, Aragon Health Service (SALUD), 50009 
      Zaragoza, Spain.
FAU - Rogero-Blanco, Marisa
AU  - Rogero-Blanco M
AUID- ORCID: 0000-0002-8732-6120
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon IISGM, 28009 Madrid, Spain.
AD  - Ricardos General Health Center (Centro de Salud General Ricardos), 28019 Madrid, 
      Spain.
FAU - González-Rubio, Francisca
AU  - González-Rubio F
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Delicias Sur Primary Care Health Centre, Aragon Health Service (SALUD), 50009 
      Zaragoza, Spain.
FAU - García-de-Blas, Francisca
AU  - García-de-Blas F
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Dr Mendiguchia Carriche Health Center (Centro de Salud Dr Mendiguchia Carriche), 
      28914 Madrid, Spain.
FAU - Polentinos-Castro, Elena
AU  - Polentinos-Castro E
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service 
      (Servicio Madrileño de Salud), 28035 Madrid, Spain.
AD  - Department of Medical Specialties and Public Health, School of Health Sciences, 
      Rey Juan Carlos University (Universidad Rey Juan Carlos), 28922 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon IISGM, 28009 Madrid, Spain.
FAU - Sanz-Cuesta, Teresa
AU  - Sanz-Cuesta T
AUID- ORCID: 0000-0001-8791-8030
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service 
      (Servicio Madrileño de Salud), 28035 Madrid, Spain.
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañon IISGM, 28009 Madrid, Spain.
FAU - Castillo-Jimena, Marcos
AU  - Castillo-Jimena M
AD  - Coín Health Center (Centro de Salud de Coín), Málaga-Guadalhorce Health District, 
      29100 Málaga, Spain.
FAU - Alonso-García, Marcos
AU  - Alonso-García M
AD  - Preventive Medicine Unit, University Hospital Alcorcón Foundation (Hospital 
      Universitario Fundación Alcorcón), 28922 Madrid, Spain.
FAU - Calderón-Larrañaga, Amaia
AU  - Calderón-Larrañaga A
AUID- ORCID: 0000-0001-9064-9222
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Aging Research Center, Department of Neurobiology, Care Sciences and Society, 
      Karolinska Institutet and Stockholm University, 17165 Stockholm, Sweden.
FAU - Valderas, José M
AU  - Valderas JM
AUID- ORCID: 0000-0002-9299-1555
AD  - Department of Family Medicine, National University Health System and Department 
      of Medicine National University of Singapore, Singapore 119228, Singapore.
FAU - Marengoni, Alessandra
AU  - Marengoni A
AD  - Department of Clinical and Experimental Sciences, University of Brescia, 25123 
      Brescia, Italy.
FAU - Muth, Christiane
AU  - Muth C
AUID- ORCID: 0000-0001-8987-182X
AD  - Institute of General Practice, Johann Wolfgang Goethe University, 60323 Frankfurt 
      am Main, Germany.
AD  - Department of General Practice and Family Medicine, Medical Faculty OWL, 
      University of Bielefeld, 33615 Bielefeld, Germany.
FAU - Prados-Torres, Juan Daniel
AU  - Prados-Torres JD
AUID- ORCID: 0000-0001-5204-7781
AD  - Multiprofessional Family and Community Care Teaching Unit (Unidad Docente 
      Multiprofesional de Atención Familiar y Comunitaria) of the Málaga-Guadalhorce 
      Health District, 29016 Málaga, Spain.
AD  - Biomedical Research Institute of Malaga (Instituto de Investigación Biomédica de 
      Málaga-IBIMA), 29010 Málaga, Spain.
AD  - Department of Pharmacology and Paediatrics, School of Medicine, University of 
      Malaga (Universidad de Málaga), 29016 Málaga, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AUID- ORCID: 0000-0002-5704-6056
AD  - Research Network on Health Services in Chronic Diseases, Red de Investigación en 
      Servicios de Salud en Enfermedades Crónicas (REDISSEC)-Red de Investigación 
      Cooperativa Orientadas a Resultados en Salud (RICORS-RICAPPS), ISCIII, 28029 
      Madrid, Spain.
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
CN  - Multi-Pap Group
LA  - eng
SI  - ClinicalTrials.gov/NCT02866799
GR  - PI15/00276/Instituto de Salud Carlos III/
GR  - PI15/00276/Instituto de Salud Carlos III/
GR  - PI15/00996/Instituto de Salud Carlos III/
GR  - RD16/0001/0006/Instituto de Salud Carlos III/
GR  - RD16/0001/0005/Instituto de Salud Carlos III/
GR  - RD16/0001/0004/Instituto de Salud Carlos III/
PT  - Journal Article
DEP - 20220506
PL  - Switzerland
TA  - J Pers Med
JT  - Journal of personalized medicine
JID - 101602269
PMC - PMC9144280
OTO - NOTNLM
OT  - Ariadne principles
OT  - multimorbidity
OT  - polypharmacy
COIS- The authors declare no conflict of interest.
FIR - Ara Bardaji, Paula
IR  - Ara Bardaji P
FIR - Martín Fernández, Jesús
IR  - Martín Fernández J
FIR - Barnestein Fonseca, Maria del Pilar
IR  - Barnestein Fonseca MP
FIR - Dominguez Santaella, Miguel
IR  - Dominguez Santaella M
FIR - Garcia Agua Soler, Nuria
IR  - Garcia Agua Soler N
FIR - Marquez Chamizo, Maria Isabel
IR  - Marquez Chamizo MI
FIR - Ruiz San Basilio, Jose María
IR  - Ruiz San Basilio JM
FIR - Abad Diez, Jose María
IR  - Abad Diez JM
FIR - Alcaraz Borrajo, Marta
IR  - Alcaraz Borrajo M
FIR - Ariza Cardiel, Gloria
IR  - Ariza Cardiel G
FIR - Azcoaga Lorenzo, Amaya
IR  - Azcoaga Lorenzo A
FIR - Bandrés Liso, Ana Cristina
IR  - Bandrés Liso AC
FIR - Clerencia Sierra, Mercedes
IR  - Clerencia Sierra M
FIR - Marta Moreno, Javier
IR  - Marta Moreno J
FIR - Poncel Falcó, Antonio
IR  - Poncel Falcó A
FIR - González González, Ana Isabel
IR  - González González AI
FIR - Hernandez Santiago, Virginia
IR  - Hernandez Santiago V
FIR - Mataix San Juan, Angel
IR  - Mataix San Juan A
FIR - Rodriguez Barrientos, Ricardo
IR  - Rodriguez Barrientos R
FIR - Rumayor Zarzuelo, Mercedes
IR  - Rumayor Zarzuelo M
FIR - Sánchez Perruca, Luis
IR  - Sánchez Perruca L
FIR - Tello Bernabé, María Eugenia
IR  - Tello Bernabé ME
FIR - Martin Izquierdo, Javier
IR  - Martin Izquierdo J
FIR - Toro Sainz, Macarena
IR  - Toro Sainz M
FIR - Fernández Jiménez, María José
IR  - Fernández Jiménez MJ
FIR - Mora García, Esperanza
IR  - Mora García E
FIR - Navarro Jiménez, José Manuel
IR  - Navarro Jiménez JM
FIR - Ginel Mendoza, Leovigildo
IR  - Ginel Mendoza L
FIR - de la Mota Ybancos, Luz Pilar
IR  - de la Mota Ybancos LP
FIR - Sasporte Genafo, Jaime
IR  - Sasporte Genafo J
FIR - Alcaide Rodriguez, María José
IR  - Alcaide Rodriguez MJ
FIR - Barceló Garach, Elena
IR  - Barceló Garach E
FIR - Caffarena de Arteaga, Beatriz
IR  - Caffarena de Arteaga B
FIR - Gallego Parrilla, María Dolores
IR  - Gallego Parrilla MD
FIR - Sánchez Morales, Catalina
IR  - Sánchez Morales C
FIR - Loubet Chasco, María del Mar
IR  - Loubet Chasco MM
FIR - Martínez Ríos, Irene
IR  - Martínez Ríos I
FIR - Mateo Delgado, Elena
IR  - Mateo Delgado E
FIR - Martín Aurioles, Esther
IR  - Martín Aurioles E
FIR - Hazañas Ruiz, Sylvia
IR  - Hazañas Ruiz S
FIR - Nieves Muñoz Escalante, María Auxiliadora
IR  - Nieves Muñoz Escalante MA
FIR - Leonés Salido, Enrique
IR  - Leonés Salido E
FIR - Máximo Torres, María Antonia
IR  - Máximo Torres MA
FIR - Moya Rodríguez, María Luisa
IR  - Moya Rodríguez ML
FIR - Peláez Gálvez, María Encarnación
IR  - Peláez Gálvez ME
FIR - Ramírez Torres, José Manuel
IR  - Ramírez Torres JM
FIR - Trillo Fernández, Cristóbal
IR  - Trillo Fernández C
FIR - García Martínez Cañavate, María Dolores
IR  - García Martínez Cañavate MD
FIR - Gil Mellado, María del Mar
IR  - Gil Mellado MM
FIR - Muñoz Pradilla, María Victoria
IR  - Muñoz Pradilla MV
FIR - Clavijo Peña, María José
IR  - Clavijo Peña MJ
FIR - Leiva Fernández, José Manuel
IR  - Leiva Fernández JM
FIR - Castillo Romero, Virginia
IR  - Castillo Romero V
FIR - Vázquez Alarcón, Rubén
IR  - Vázquez Alarcón R
FIR - Maqueda, Rafael Ángel
IR  - Maqueda RÁ
FIR - Aycart Valdés, Gloria
IR  - Aycart Valdés G
FIR - Fernández Vargas, Ana María
IR  - Fernández Vargas AM
FIR - García Martínez Cañavate, Irene
IR  - García Martínez Cañavate I
FIR - González Rodríguez, Antonia
IR  - González Rodríguez A
FIR - Molina Mendaño, María Carmen
IR  - Molina Mendaño MC
FIR - Morales Naranjo, Juana
IR  - Morales Naranjo J
FIR - Serrano Guerra, Francisco
IR  - Serrano Guerra F
FIR - Sánchez Celaya del Pozo, Carmen
IR  - Sánchez Celaya del Pozo C
FIR - Torrente Garrido, José Ignacio
IR  - Torrente Garrido JI
FIR - García Aranda, Concepción
IR  - García Aranda C
FIR - Pinilla Lafuente, Marina
IR  - Pinilla Lafuente M
FIR - Delgado Marroquín, Mª Teresa
IR  - Delgado Marroquín MT
FIR - Gracia Molina, Mª José
IR  - Gracia Molina MJ
FIR - Cuartero Bernal, Javier
IR  - Cuartero Bernal J
FIR - Asin Martín, Mª Victoria
IR  - Asin Martín MV
FIR - García Domínguez, Susana
IR  - García Domínguez S
FIR - Bolea Gorbea, Carlos
IR  - Bolea Gorbea C
FIR - Oto Negre, Antonio Luis
IR  - Oto Negre AL
FIR - Galve Royo, Eugenio
IR  - Galve Royo E
FIR - Abadía Taira, Mª Begoña
IR  - Abadía Taira MB
FIR - Tomás Gutiérrez, José Fernando
IR  - Tomás Gutiérrez JF
FIR - Porta Quintana, José
IR  - Porta Quintana J
FIR - Martín Miguel, Valentina
IR  - Martín Miguel V
FIR - Mateo de las Heras, Esther
IR  - Mateo de las Heras E
FIR - Esteban Algora, Carmen
IR  - Esteban Algora C
FIR - Martín Nasarre de Letosa, María Teresa
IR  - Martín Nasarre de Letosa MT
FIR - Gascón del Prim, Elena
IR  - Gascón del Prim E
FIR - Sorrinas Delgado, Noelia
IR  - Sorrinas Delgado N
FIR - Sanjuan Cortés, María Rosario
IR  - Sanjuan Cortés MR
FIR - Corrales Sánchez, Teodoro
IR  - Corrales Sánchez T
FIR - Dendarieta Lucas, Eustaquio
IR  - Dendarieta Lucas E
FIR - Miguez Sorio, María del Pilar
IR  - Miguez Sorio MP
FIR - Cajal Marzal, Adolfo
IR  - Cajal Marzal A
FIR - Díaz García, Eduardo
IR  - Díaz García E
FIR - García Álvarez, Juan Carlos
IR  - García Álvarez JC
FIR - Guisado Pérez, Cristina
IR  - Guisado Pérez C
FIR - López García Franco, Alberto
IR  - López García Franco A
FIR - Viñuela Benitez, María Elisa
IR  - Viñuela Benitez ME
FIR - Ballarín González, Ana
IR  - Ballarín González A
FIR - Ferrer Zapata, María Isabel
IR  - Ferrer Zapata MI
FIR - Gómez Suárez, Esther
IR  - Gómez Suárez E
FIR - Morales Ortiz, Fernanda
IR  - Morales Ortiz F
FIR - Peláez laguno, Lourdes Carolina
IR  - Peláez laguno LC
FIR - Quintana Gómez, José Luis
IR  - Quintana Gómez JL
FIR - Revilla Pascual, Enrique
IR  - Revilla Pascual E
FIR - Miguel Abanto, Mª Ángeles
IR  - Miguel Abanto MÁ
FIR - Gutiérrez Teira, Blanca
IR  - Gutiérrez Teira B
FIR - Abellán López, Francisco Ramón
IR  - Abellán López FR
FIR - Casado Álvaro, Carlos
IR  - Casado Álvaro C
FIR - Cubero González, Paulino
IR  - Cubero González P
FIR - Machín Hamalainen, Santiago Manuel
IR  - Machín Hamalainen SM
FIR - Mateo Fernández, Raquel
IR  - Mateo Fernández R
FIR - Sánchez Arce, César
IR  - Sánchez Arce C
FIR - Olmedo Galindo, Jorge
IR  - Olmedo Galindo J
FIR - López Marcos, Claudia
IR  - López Marcos C
FIR - Lorenzo Borda, Soledad
IR  - Lorenzo Borda S
FIR - Moreno Fernández, Juan Carlos
IR  - Moreno Fernández JC
FIR - Muñoz Gómez, Belén
IR  - Muñoz Gómez B
FIR - Rodríguez De Mingo, Enrique
IR  - Rodríguez De Mingo E
FIR - Calvo Pascual, Juan Pedro
IR  - Calvo Pascual JP
FIR - Gómez Barroso, Margarita
IR  - Gómez Barroso M
FIR - López Serrano, Beatriz
IR  - López Serrano B
FIR - Morso Peláez, María Paloma
IR  - Morso Peláez MP
FIR - Sánchez Salvador, Julio
IR  - Sánchez Salvador J
FIR - Sánchez Yépez, Jeannet Dolores
IR  - Sánchez Yépez JD
FIR - Sosa Alonso, Ana
IR  - Sosa Alonso A
FIR - Álvarez Villalba, María del Mar
IR  - Álvarez Villalba MM
FIR - Magán Tapia, Purificación
IR  - Magán Tapia P
FIR - Fajardo Alcántara, María Angélica
IR  - Fajardo Alcántara MA
FIR - De Hoyos Alonso, María Canto
IR  - De Hoyos Alonso MC
FIR - Murciano Antón, María Aránzazu
IR  - Murciano Antón MA
FIR - Alonso Pérez, Manuel Antonio
IR  - Alonso Pérez MA
FIR - De Felipe medina, Ricardo
IR  - De Felipe medina R
FIR - López Laguna, Amaya Nuria
IR  - López Laguna AN
FIR - Martínez Cid de Rivera, Eva
IR  - Martínez Cid de Rivera E
FIR - Serrano Flores, Iliana
IR  - Serrano Flores I
FIR - Sousa Rodríguez, María Jesús
IR  - Sousa Rodríguez MJ
FIR - Núñez Isabel, María Soledad
IR  - Núñez Isabel MS
FIR - Redondo Sánchez, Jesús Mª
IR  - Redondo Sánchez JM
FIR - Sánchez Llanos, Pedro
IR  - Sánchez Llanos P
FIR - Visedo Campillo, Lourdes
IR  - Visedo Campillo L
EDAT- 2022/05/29 06:00
MHDA- 2022/05/29 06:01
CRDT- 2022/05/28 01:26
PHST- 2022/02/22 00:00 [received]
PHST- 2022/04/19 00:00 [revised]
PHST- 2022/04/26 00:00 [accepted]
PHST- 2022/05/28 01:26 [entrez]
PHST- 2022/05/29 06:00 [pubmed]
PHST- 2022/05/29 06:01 [medline]
AID - jpm12050752 [pii]
AID - jpm-12-00752 [pii]
AID - 10.3390/jpm12050752 [doi]
PST - epublish
SO  - J Pers Med. 2022 May 6;12(5):752. doi: 10.3390/jpm12050752.

PMID- 35624010
OWN - NLM
STAT- MEDLINE
DCOM- 20220621
LR  - 20220621
IS  - 2212-0289 (Electronic)
IS  - 1865-9217 (Linking)
VI  - 171
DP  - 2022 Jun
TI  - Shared decision-making in Spain in 2022: An updated revision of the current 
      situation.
PG  - 122-128
LID - S1865-9217(22)00068-X [pii]
LID - 10.1016/j.zefq.2022.04.018 [doi]
AB  - In Spain, there is not a national strategy to promote shared decision making 
      (SDM) in clinical practice, and it is still not a requisite for improving the 
      quality of health services, in either the legal norms or professionals' 
      educational curricula. However, several national strategies in specific health 
      areas increasingly include the principles of person centred care (PCC) and SDM 
      into their objectives, promoting patients' empowerment and activation. 
      Furthermore, several institutions continue to develop Patient Decision Aids 
      (PtDAs) and other resources to facilitate patients' involvement in their own 
      care; training programs for professionals; links between PtDAs and clinical 
      practice guidelines; as well as interventional studies assessing the impact of 
      PCC and SDM interventions in clinical practice. Initiatives to involve patients 
      in health research design and health technology assessment are also being 
      developed. We describe an update of the current state of research, policy and 
      implementation of SDM after five years of substantial advances in Spain. Many 
      challenges remain regarding national and regional policies on PCC and SDM, 
      implementation of SDM in real practice and educational curricula, development of 
      quality indicators and evaluation procedures.
CI  - Copyright © 2022. Published by Elsevier GmbH.
FAU - Perestelo-Perez, Lilisbeth
AU  - Perestelo-Perez L
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), Tenerife, Spain; 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Tenerife, Spain; Network of Agencies for Assessing National Health 
      System Technologies and Performance (RedETS), Tenerife, Spain. Electronic 
      address: lilisbethp@gmail.com.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Tenerife, Spain; Network of Agencies for Assessing National Health 
      System Technologies and Performance (RedETS), Tenerife, Spain; Canary Islands 
      Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Alvarez-Perez, Yolanda
AU  - Alvarez-Perez Y
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain; Network of Agencies for Assessing National Health System 
      Technologies and Performance (RedETS), Tenerife, Spain; Canary Islands Health 
      Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AD  - Network of Agencies for Assessing National Health System Technologies and 
      Performance (RedETS), Tenerife, Spain; Canary Islands Health Research Institute 
      Foundation (FIISC), Tenerife, Spain.
FAU - Ramos-García, Vanesa
AU  - Ramos-García V
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain; Network of Agencies for Assessing National Health System 
      Technologies and Performance (RedETS), Tenerife, Spain; Canary Islands Health 
      Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Torres-Castaño, Alezandra
AU  - Torres-Castaño A
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain; Network of Agencies for Assessing National Health System 
      Technologies and Performance (RedETS), Tenerife, Spain; Canary Islands Health 
      Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Abt-Sacks, Analía
AU  - Abt-Sacks A
AD  - Network of Agencies for Assessing National Health System Technologies and 
      Performance (RedETS), Tenerife, Spain; Canary Islands Health Research Institute 
      Foundation (FIISC), Tenerife, Spain.
FAU - Toledo-Chavarri, Ana
AU  - Toledo-Chavarri A
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Tenerife, Spain; Network of Agencies for Assessing National Health 
      System Technologies and Performance (RedETS), Tenerife, Spain; Canary Islands 
      Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Alonso-Coello, Pablo
AU  - Alonso-Coello P
AD  - Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau (IIB Sant 
      Pau-CIBERESP), Barcelona, Spain; Department of Clinical Epidemiology & 
      Biostatistics, McMaster University, Hamilton, Canada.
FAU - Orrego, Carola
AU  - Orrego C
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Tenerife, Spain; Fundació Avedis Donavedian, Barcelona, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Evaluation Unit of the Canary Islands Health Service (SESCS), Tenerife, Spain; 
      Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain; Network for Research on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS), Tenerife, Spain; Network of Agencies for Assessing National Health 
      System Technologies and Performance (RedETS), Tenerife, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220525
PL  - Netherlands
TA  - Z Evid Fortbild Qual Gesundhwes
JT  - Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
JID - 101477604
SB  - IM
MH  - *Decision Making
MH  - *Decision Making, Shared
MH  - Decision Support Techniques
MH  - Germany
MH  - Health Policy
MH  - Humans
MH  - Patient Participation
MH  - Spain
OTO - NOTNLM
OT  - Entscheidungshilfen für Patienten
OT  - Gemeinsame Entscheidungsfindung
OT  - National Health System
OT  - Nationales Gesundheitssystem
OT  - Patient decision aids
OT  - Person centred care
OT  - Personenzentrierte Pflege
OT  - Shared decision making
OT  - Spain
OT  - Spanien
EDAT- 2022/05/28 06:00
MHDA- 2022/06/22 06:00
CRDT- 2022/05/27 22:08
PHST- 2022/03/15 00:00 [received]
PHST- 2022/04/13 00:00 [revised]
PHST- 2022/04/15 00:00 [accepted]
PHST- 2022/05/28 06:00 [pubmed]
PHST- 2022/06/22 06:00 [medline]
PHST- 2022/05/27 22:08 [entrez]
AID - S1865-9217(22)00068-X [pii]
AID - 10.1016/j.zefq.2022.04.018 [doi]
PST - ppublish
SO  - Z Evid Fortbild Qual Gesundhwes. 2022 Jun;171:122-128. doi: 
      10.1016/j.zefq.2022.04.018. Epub 2022 May 25.

PMID- 35613699
OWN - NLM
STAT- MEDLINE
DCOM- 20220908
LR  - 20220920
IS  - 1552-4175 (Electronic)
IS  - 1099-8004 (Linking)
VI  - 24
IP  - 4
DP  - 2022 Oct
TI  - Occupational and Leisure Physical Activity on Cardiovascular Risk and Body 
      Composition Among Courier Workers.
PG  - 560-572
LID - 10.1177/10998004221105535 [doi]
AB  - OBJECTIVE: There is some controversy about the beneficial effects of occupational 
      physical activity (OPA) on cardiovascular risk (CVR). The main aim of this study 
      was to explore the effect of the combination of different frequencies of 
      leisure-time physical activity (LTPA) and two types of OPA on CVR and body 
      composition, and whether the association between physical activity (PA) and CVR 
      was mediated by visceral adipose tissue (VAT). METHODS: This cross-sectional 
      study included data from 2516 couriers living in Spain, delivering either by 
      motorbike or foot, and practicing LTPA never, occasionally, or regularly. 
      Couriers were classified into six categories according to LTPA and OPA; body 
      composition was assessed by Bioelectrical Impedance, and CVR by the Framingham 
      equation. General linear models were performed to explore the association between 
      different categories with each outcome (CVR and body composition) and the 
      possible role of VAT as a mediator between PA and CVR. RESULTS: Compared with the 
      most sedentary group (motorbike couriers that never practice PA), walking 
      couriers who practice regular PA presented the lowest CVR [β -1.58 (95% CI -2.31; 
      -0.85)] and the lowest VAT [β -2.86 (95% CI -3.74; -1.98) followed by the 
      motorbike couriers who practiced regular PA [β -0.51 (95% CI -1.00; -0.03) for 
      CVR and β -2.33 (95% CI -2.91; -1.75) for VAT]. The association between PA and 
      CVR was partially mediated by VAT. CONCLUSION: The present results indicated that 
      both OPA and LTPA are protective factors for CVR and play an important role on 
      VAT accumulation.
FAU - Galmes-Panades, Aina Maria
AU  - Galmes-Panades AM
AD  - CIBER Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud 
      Carlos III (ISCIII), Madrid, Spain.
AD  - Research Group on Nutritional Epidemiology & Cardiovascular Physiopathology 
      (NUTRECOR), 219656Health Research Institute of the Balearic Islands (IdISBa), 
      University Hospital Son Espases (HUSE), Palma, Spain.
FAU - Abbate, Manuela
AU  - Abbate M
AD  - Research Group on Global Health and Lifestyle (EVES), 219656Health Research 
      Institute of the Balearic Islands (IdISBa), University Hospital Son Espases 
      (HUSE), Palma, Spain.
FAU - Bennasar-Veny, Miquel
AU  - Bennasar-Veny M
AUID- ORCID: 0000-0003-1668-2141
AD  - Research Group on Global Health and Lifestyle (EVES), 219656Health Research 
      Institute of the Balearic Islands (IdISBa), University Hospital Son Espases 
      (HUSE), Palma, Spain.
AD  - Nursing and Physiotherapy Department, 16745Universitat de les Illes Balears, 
      Palma, Spain.
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), 117368Instituto de Salud 
      Carlos III (ISCIII), Madrid, Spain.
FAU - López-González, Angel Arturo
AU  - López-González AA
AUID- ORCID: 0000-0002-7439-8117
AD  - Prevention of Occupational Risks in Health Services, 88144Balearic Islands Health 
      Service, Palma, Spain.
AD  - Escuela Universitaria ADEMA, Palma, Illes Balears, Spain.
AD  - Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), 
      16745Universitat de les Illes Balears, Palma, Spain.
FAU - Vicente-Herrero, María Teófila
AU  - Vicente-Herrero MT
AD  - Occupational Health Service, Correos Group, Valencia, Spain.
AD  - Universidad Internacional de la Rioja, Madrid, Spain.
FAU - Busquets-Cortés, Carla
AU  - Busquets-Cortés C
AD  - Escuela Universitaria ADEMA, Palma, Illes Balears, Spain.
AD  - Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), 
      16745Universitat de les Illes Balears, Palma, Spain.
FAU - Leiva, Alfonso
AU  - Leiva A
AD  - Primary Care Research Unit of Mallorca, 88144Balearic Islands Health Services 
      (IbSalut), Palma, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Palma, Spain.
FAU - Yañez, Aina María
AU  - Yañez AM
AD  - Research Group on Global Health and Lifestyle (EVES), 219656Health Research 
      Institute of the Balearic Islands (IdISBa), University Hospital Son Espases 
      (HUSE), Palma, Spain.
AD  - Nursing and Physiotherapy Department, 16745Universitat de les Illes Balears, 
      Palma, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Palma, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220525
PL  - United States
TA  - Biol Res Nurs
JT  - Biological research for nursing
JID - 9815758
SB  - IM
MH  - Body Composition
MH  - *Cardiovascular Diseases/prevention & control
MH  - Cross-Sectional Studies
MH  - Exercise
MH  - Heart Disease Risk Factors
MH  - Humans
MH  - *Leisure Activities
MH  - Risk Factors
OTO - NOTNLM
OT  - cardiovascular disease risk
OT  - leisure-time physical activity
OT  - occupational physical activity
OT  - total body fat
OT  - total muscle mass
OT  - visceral adipose tissue
EDAT- 2022/05/26 06:00
MHDA- 2022/09/09 06:00
CRDT- 2022/05/25 19:32
PHST- 2022/05/26 06:00 [pubmed]
PHST- 2022/09/09 06:00 [medline]
PHST- 2022/05/25 19:32 [entrez]
AID - 10.1177/10998004221105535 [doi]
PST - ppublish
SO  - Biol Res Nurs. 2022 Oct;24(4):560-572. doi: 10.1177/10998004221105535. Epub 2022 
      May 25.

PMID- 35566539
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220517
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 11
IP  - 9
DP  - 2022 Apr 25
TI  - Predictive Performance of the FRAX Tool Calibrated for Spain vs. an Age and Sex 
      Model: Prospective Cohort Study with 9082 Women and Men Followed for up to 8 
      Years.
LID - 10.3390/jcm11092409 [doi]
LID - 2409
AB  - In Spain, the Fracture Risk Assessment Tool (FRAX) was adapted using studies with 
      a small number of patients, and there are only a few external validation studies 
      that present limitations. In this prospective cohort study, we compared the 
      performance of FRAX and a simple age and sex model. We used data from the ESOSVAL 
      cohort, a cohort composed of a Mediterranean population of 11,035 women and men 
      aged 50 years and over, followed for up to 8 years, to compare the 
      discrimination, calibration, and reclassification of FRAX calibrated for Spain 
      and a logistic model including only age and sex as variables. We found virtually 
      identical AUC, 83.55% for FRAX (CI 95%: 80.46, 86.63) and 84.10% for the age and 
      sex model (CI 95%: 80.91, 87.29), and there were similar observed-to-predicted 
      ratios. In the reclassification analyses, patients with a hip fracture that were 
      reclassified correctly as high risk by FRAX, compared to the age and sex model, 
      were -2.86%, using either the 3% threshold or the observed incidence, 1.54% 
      (95%CI: -8.44, 2.72 for the 3% threshold; 95%CI: -7.68, 1.97 for the incidence 
      threshold). Remarkably simple and inexpensive tools that are easily transferable 
      into electronic medical record environments may offer a comparable predictive 
      ability to that of FRAX.
FAU - García-Sempere, Aníbal
AU  - García-Sempere A
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
AD  - Spanish Network for Research in Primary Care and Chronicity (RICAPPS), 46020 
      Valencia, Spain.
FAU - Hurtado, Isabel
AU  - Hurtado I
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
AD  - Spanish Network for Research in Primary Care and Chronicity (RICAPPS), 46020 
      Valencia, Spain.
FAU - Peiró, Salvador
AU  - Peiró S
AUID- ORCID: 0000-0002-3902-569X
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
AD  - Spanish Network for Research in Primary Care and Chronicity (RICAPPS), 46020 
      Valencia, Spain.
FAU - Sánchez-Sáez, Francisco
AU  - Sánchez-Sáez F
AUID- ORCID: 0000-0002-3011-9884
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
FAU - Santaana, Yared
AU  - Santaana Y
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
FAU - Rodríguez-Bernal, Clara
AU  - Rodríguez-Bernal C
AUID- ORCID: 0000-0003-2617-8635
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
AD  - Spanish Network for Research in Primary Care and Chronicity (RICAPPS), 46020 
      Valencia, Spain.
FAU - Sanfélix-Gimeno, Gabriel
AU  - Sanfélix-Gimeno G
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
AD  - Spanish Network for Research in Primary Care and Chronicity (RICAPPS), 46020 
      Valencia, Spain.
FAU - Sanfélix-Genovés, José
AU  - Sanfélix-Genovés J
AD  - Foundation for the Promotion of Health and Biomedical Research of Valencia Region 
      (FISABIO), 46020 Valencia, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220425
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC9101808
OTO - NOTNLM
OT  - FRAX
OT  - calibration
OT  - clinical decision-making
OT  - epidemiological methods
OT  - real-world data
OT  - validation
COIS- The ESOSVAL research program was originally co-funded by the Instituto de Salud 
      Carlos III (Grants PS09/02500, PI11/00238 and PI13/01721) from the Spanish 
      Ministry of Health, the European Regional Development Fund, and by collaboration 
      agreements established by the Valencia Department of Health and FISABIO, a 
      non-profit research institution depending on the Valencia Dpt. of Health, with 
      MSD Spain (2009–2012) and AMGEN S.A. (2010–2013), to conduct training and 
      real-world research into musculoskeletal disorders and osteoporosis. The authors 
      declare no additional conflict of interest.
EDAT- 2022/05/15 06:00
MHDA- 2022/05/15 06:01
CRDT- 2022/05/14 01:25
PHST- 2022/04/04 00:00 [received]
PHST- 2022/04/19 00:00 [revised]
PHST- 2022/04/20 00:00 [accepted]
PHST- 2022/05/14 01:25 [entrez]
PHST- 2022/05/15 06:00 [pubmed]
PHST- 2022/05/15 06:01 [medline]
AID - jcm11092409 [pii]
AID - jcm-11-02409 [pii]
AID - 10.3390/jcm11092409 [doi]
PST - epublish
SO  - J Clin Med. 2022 Apr 25;11(9):2409. doi: 10.3390/jcm11092409.

PMID- 35565383
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2072-6694 (Print)
IS  - 2072-6694 (Electronic)
IS  - 2072-6694 (Linking)
VI  - 14
IP  - 9
DP  - 2022 Apr 30
TI  - Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer 
      Resistance.
LID - 10.3390/cancers14092255 [doi]
LID - 2255
AB  - Nowadays, the identification of new therapeutic targets that allow for the 
      development of treatments, which as monotherapy, or in combination with other 
      existing treatments can contribute to improve response rates, prognosis and 
      survival of oncologic patients, is a priority to optimize healthcare within 
      sustainable health systems. Recent studies have demonstrated the role of 
      Substance P (SP) and its preferred receptor, Neurokinin 1 Receptor (NK-1R), in 
      human cancer and the potential antitumor activity of NK-1R antagonists as an 
      anticancer treatment. In this review, we outline the relevant studies published 
      to date regarding the SP/NK-1R complex as a key player in human cancer and also 
      evaluate if the repurposing of already marketed NK-1R antagonists may be useful 
      in the development of new treatment strategies to overcome cancer resistance.
FAU - García-Aranda, Marilina
AU  - García-Aranda M
AUID- ORCID: 0000-0003-3759-4044
AD  - Research and Innovation Unit, Hospital Costa del Sol, Autovía A-7, km 187, 29603 
      Marbella, Spain.
AD  - Instituto de Investigación Biomédica de Málaga (IBIMA), C/Dr. Miguel Díaz Recio, 
      28, 29010 Málaga, Spain.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) 
      and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, 
      Spain.
AD  - Surgical Specialties, Biochemistry and Immunology Department, Faculty of 
      Medicine, University of Málaga, 29010 Málaga, Spain.
FAU - Téllez, Teresa
AU  - Téllez T
AUID- ORCID: 0000-0002-9935-5586
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) 
      and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, 
      Spain.
AD  - Surgical Specialties, Biochemistry and Immunology Department, Faculty of 
      Medicine, University of Málaga, 29010 Málaga, Spain.
FAU - McKenna, Lauraine
AU  - McKenna L
AD  - Research and Innovation Unit, Hospital Costa del Sol, Autovía A-7, km 187, 29603 
      Marbella, Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AUID- ORCID: 0000-0001-5559-4246
AD  - Research and Innovation Unit, Hospital Costa del Sol, Autovía A-7, km 187, 29603 
      Marbella, Spain.
AD  - Instituto de Investigación Biomédica de Málaga (IBIMA), C/Dr. Miguel Díaz Recio, 
      28, 29010 Málaga, Spain.
AD  - Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) 
      and Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, 
      Spain.
AD  - Surgical Specialties, Biochemistry and Immunology Department, Faculty of 
      Medicine, University of Málaga, 29010 Málaga, Spain.
LA  - eng
GR  - RH-0055-2020/Andalusian Health Service/
GR  - UMA20-FEDERJA-161/Consejería de Economía, Conocimiento, Empresas y Universidad. 
      Junta de Andalucía/
PT  - Journal Article
PT  - Review
DEP - 20220430
PL  - Switzerland
TA  - Cancers (Basel)
JT  - Cancers
JID - 101526829
PMC - PMC9102068
OTO - NOTNLM
OT  - NK-1R
OT  - cancer
OT  - drug repurposing
OT  - personalized medicine
OT  - resistance
OT  - tachykinin
OT  - tachykinin receptor
OT  - targeted treatment
COIS- The authors declare no conflict of interest.
EDAT- 2022/05/15 06:00
MHDA- 2022/05/15 06:01
CRDT- 2022/05/14 01:18
PHST- 2022/03/16 00:00 [received]
PHST- 2022/04/22 00:00 [revised]
PHST- 2022/04/28 00:00 [accepted]
PHST- 2022/05/14 01:18 [entrez]
PHST- 2022/05/15 06:00 [pubmed]
PHST- 2022/05/15 06:01 [medline]
AID - cancers14092255 [pii]
AID - cancers-14-02255 [pii]
AID - 10.3390/cancers14092255 [doi]
PST - epublish
SO  - Cancers (Basel). 2022 Apr 30;14(9):2255. doi: 10.3390/cancers14092255.

PMID- 35564781
OWN - NLM
STAT- MEDLINE
DCOM- 20220519
LR  - 20220527
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 9
DP  - 2022 Apr 28
TI  - Codesign and Feasibility Testing of a Tool to Evaluate Overweight and Obesity 
      Apps.
LID - 10.3390/ijerph19095387 [doi]
LID - 5387
AB  - BACKGROUND: Digital health interventions and mobile technologies can help to 
      reduce the rates of obesity and overweight conditions. Although weight management 
      apps are widely used, they usually lack professional content and evaluation, so 
      the quality of these apps cannot be guaranteed. The EVALAPPS project aims to 
      design and validate a tool to assess the safety and effectiveness of 
      health-related apps whose main goal is to manage and prevent obesity and 
      overweight conditions. OBJECTIVE: The aim of this paper is two-fold: (a) to 
      co-create and codesign the EVALAPPS assessment tool and (b) to pilot its 
      feasibility among overweight and obese individuals that use weight control apps. 
      METHODS: A mixed-methods approach was used. A multidisciplinary team (n = 12) 
      participated in a co-creation workshop to provide proposals and inputs about the 
      look and feel of the content, usability aspects, appearance, sections, and main 
      features of the EVALAPPS tool. The tool was tested for its feasibility among 31 
      overweight and obese individuals, attending the CP Endocrinologia i Nutrició SL 
      Clinic for the first time. Participants were asked to use a specific weight 
      control app [Yazio (YAZIO GmbH, Erfurt, Germany), My FitnessPal (MyFitnessPal, 
      Austin, TX, USA) or MyPlate (MyPlate, Santa Monica, CA, USA)] for two weeks and 
      then evaluate them by using the EVALAPPS (EVALAPPS, David Ganyan, Barcelona, 
      Spain) (June 2020, David Ganyan, Barcelona, Spain) tool. Seven participants were 
      phone interviewed to gain more insight into the use of the EVALAPPS tool. 
      RESULTS: The co-creation workshop allowed conceptualizing the EVALAPPS tool. The 
      feasibility study showed that all criteria from the Usability and Functionality 
      dimensions had valid answers, while Reliability, Security, Privacy, and Health 
      indicators were the dimensions with less valid answers. In all three apps, the 
      dimension with the highest score was Usability/functionality, followed by app 
      purpose. Clinical effectiveness and Development were the dimensions with the 
      lowest scores in all three tested weight control apps. CONCLUSIONS: The 
      participation of the multidisciplinary team and end-users in the 
      conceptualization and testing of a tool to assess health apps was feasible and 
      relevant for the usability of the tool.
FAU - Puigdomènech, Elisa
AU  - Puigdomènech E
AUID- ORCID: 0000-0002-1671-0248
AD  - Agència de Salut Pública de Barcelona (ASPB), 08023 Barcelona, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Barcelona, Spain.
AD  - eHealth Lab Research Group, Universitat Oberta de Catalunya, 08035 Barcelona, 
      Spain.
FAU - Robles, Noemi
AU  - Robles N
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Barcelona, Spain.
AD  - eHealth Lab Research Group, Universitat Oberta de Catalunya, 08035 Barcelona, 
      Spain.
AD  - eHealth Center, Universitat Oberta de Catalunya, 08018 Barcelona, Spain.
FAU - Balfegó, Mariona
AU  - Balfegó M
AD  - Clínica Sagrada Família, Cuatrecasas-Peitx Endocrinologia i Nutricio Societat 
      Limitada (CPEN SL) Servei d'Endocrinologia i Nutrició, 08022 Barcelona, Spain.
FAU - Cuatrecasas, Guillem
AU  - Cuatrecasas G
AD  - Clínica Sagrada Família, Cuatrecasas-Peitx Endocrinologia i Nutricio Societat 
      Limitada (CPEN SL) Servei d'Endocrinologia i Nutrició, 08022 Barcelona, Spain.
FAU - Zamora, Alberto
AU  - Zamora A
AUID- ORCID: 0000-0001-6907-0654
AD  - Corporació de Salut del Maresme i la Selva, Hospital de Blanes, 17300 Blanes, 
      Spain.
AD  - Grup de Medicina Traslacional i Ciències de la Decisió, Universitat de Girona, 
      17003 Girona, Spain.
FAU - Saigí-Rubió, Francesc
AU  - Saigí-Rubió F
AUID- ORCID: 0000-0001-9616-1551
AD  - Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), 08018 
      Barcelona, Spain.
AD  - Interdisciplinary Research Group on ICTs, Universitat Oberta de Catalunya (UOC), 
      08018 Barcelona, Spain.
FAU - Paluzié, Guillem
AU  - Paluzié G
AD  - Corporació de Salut del Maresme i la Selva, Hospital de Blanes, 17300 Blanes, 
      Spain.
FAU - Moharra, Montserrat
AU  - Moharra M
AD  - Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), 08005 Barcelona, 
      Spain.
AD  - Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, 
      Barcelona, Spain.
FAU - Carrion, Carme
AU  - Carrion C
AUID- ORCID: 0000-0003-1479-7551
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), Barcelona, Spain.
AD  - eHealth Lab Research Group, Universitat Oberta de Catalunya, 08035 Barcelona, 
      Spain.
AD  - eHealth Center, Universitat Oberta de Catalunya, 08018 Barcelona, Spain.
AD  - TransLab Research Group, Faculty of Health Sciences, Universitat de Girona (UdG), 
      17003 Girona, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220428
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Feasibility Studies
MH  - Humans
MH  - *Mobile Applications
MH  - Obesity/prevention & control
MH  - *Overweight
MH  - Reproducibility of Results
PMC - PMC9103883
OTO - NOTNLM
OT  - codesign
OT  - mHealth
OT  - obesity
OT  - overweight
OT  - participatory research
OT  - pilot testing
COIS- The authors declare no conflict of interest.
EDAT- 2022/05/15 06:00
MHDA- 2022/05/20 06:00
CRDT- 2022/05/14 01:14
PHST- 2022/02/21 00:00 [received]
PHST- 2022/04/24 00:00 [revised]
PHST- 2022/04/24 00:00 [accepted]
PHST- 2022/05/14 01:14 [entrez]
PHST- 2022/05/15 06:00 [pubmed]
PHST- 2022/05/20 06:00 [medline]
AID - ijerph19095387 [pii]
AID - ijerph-19-05387 [pii]
AID - 10.3390/ijerph19095387 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Apr 28;19(9):5387. doi: 
      10.3390/ijerph19095387.

PMID- 35536390
OWN - NLM
STAT- MEDLINE
DCOM- 20221118
LR  - 20230102
IS  - 1432-1084 (Electronic)
IS  - 0938-7994 (Linking)
VI  - 32
IP  - 11
DP  - 2022 Nov
TI  - Comparison of technical parameters and women's experience between 
      self-compression and standard compression modes in mammography screening: a 
      single-blind randomized clinical trial.
PG  - 7480-7487
LID - 10.1007/s00330-022-08835-y [doi]
AB  - OBJECTIVES: We compared the compression force, breast thickness, and glandular 
      dose, as well as the severity of discomfort and women's experience between the 
      patient-assisted compression (PAC) and standard compression (SC) modes. MATERIALS 
      AND METHODS: We conducted a prospective randomized controlled study at Hospital 
      del Mar in Barcelona, Spain. We included 448 asymptomatic women aged 50 to 69 
      years old, attending their screening round from December 2017 to December 2019. 
      Mammograms included the two bilateral views. In each woman, one breast was 
      studied with SC and the other with PAC. The mode used in each breast was selected 
      following a randomized list. Compression force, breast thickness, and average 
      glandular dose were obtained for each of the 1792 images. We also recorded the 
      degree of discomfort and women's experience, after mammogram acquisitions, using 
      a predefined survey. RESULTS: Higher compression forces were obtained with PAC 
      than with SC (99.27 N vs 83.25 N, p < 0.001). Breast thickness mode (56.11 mm vs 
      57.52 mm, p = 0.015) and glandular dose (1.34 mGy vs 1.37 mGy, p = 0.018) were 
      lower in PAC. The discomfort score was slightly higher with PAC (mean 3.94 vs 
      3.69, p = 0.042), but in the satisfaction survey, more women reported that PAC 
      caused less discomfort. Additionally, 63.2% of women (289/448) preferred PAC. 
      CONCLUSION: PAC achieved higher compression forces without impairing the other 
      technical imaging parameters and enhanced women's experience of screening 
      mammography. We believe there were no clinically significant differences in the 
      severity of discomfort between the two modes. KEY POINTS: • Self-compression 
      allows higher compression forces than the standard compression mode. • 
      Self-compression does not affect technical imaging parameters. • Self-compression 
      improved women's experience of screening mammography when standard compression 
      was used on one breast and self-compression on the other.
CI  - © 2022. The Author(s), under exclusive licence to European Society of Radiology.
FAU - Arenas, Natalia
AU  - Arenas N
AD  - Radiology Department, Hospital del Mar, Barcelona, Spain.
FAU - Alcantara, Rodrigo
AU  - Alcantara R
AD  - Radiology Department, Hospital del Mar, Barcelona, Spain.
FAU - Posso, Margarita
AU  - Posso M
AUID- ORCID: 0000-0002-5053-257X
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain. 
      mposso@parcdesalutmar.cat.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain. mposso@parcdesalutmar.cat.
FAU - Louro, Javier
AU  - Louro J
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Perez-Leon, Daniela
AU  - Perez-Leon D
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain.
AD  - Preventive Medicine and Public Health Training Unit PSMar-ASPB-UPF, Barcelona, 
      Spain.
FAU - Ejarque, Belén
AU  - Ejarque B
AD  - Radiology Department, Hospital del Mar, Barcelona, Spain.
FAU - Arranz, Mónica
AU  - Arranz M
AD  - Radiology Department, Hospital del Mar, Barcelona, Spain.
FAU - Maiques, Jose
AU  - Maiques J
AD  - Radiology Department, Hospital del Mar, Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Macià, Francesc
AU  - Macià F
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Román, Marta
AU  - Román M
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Passeig Maritím 25-29, 08003, Barcelona, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Rodríguez-Arana, Ana
AU  - Rodríguez-Arana A
AD  - Radiology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20220510
PL  - Germany
TA  - Eur Radiol
JT  - European radiology
JID - 9114774
SB  - IM
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Aged
MH  - *Mammography/methods
MH  - Early Detection of Cancer
MH  - Single-Blind Method
MH  - Prospective Studies
MH  - *Breast Neoplasms/diagnostic imaging
OTO - NOTNLM
OT  - Mammogram
OT  - Satisfaction
OT  - Screening
OT  - Self-compression
OT  - Women’s experience
EDAT- 2022/05/11 06:00
MHDA- 2022/11/19 06:00
CRDT- 2022/05/10 11:16
PHST- 2021/10/04 00:00 [received]
PHST- 2022/03/29 00:00 [accepted]
PHST- 2022/03/19 00:00 [revised]
PHST- 2022/05/11 06:00 [pubmed]
PHST- 2022/11/19 06:00 [medline]
PHST- 2022/05/10 11:16 [entrez]
AID - 10.1007/s00330-022-08835-y [pii]
AID - 10.1007/s00330-022-08835-y [doi]
PST - ppublish
SO  - Eur Radiol. 2022 Nov;32(11):7480-7487. doi: 10.1007/s00330-022-08835-y. Epub 2022 
      May 10.

PMID- 35522626
OWN - NLM
STAT- MEDLINE
DCOM- 20220510
LR  - 20220716
IS  - 1549-1676 (Electronic)
IS  - 1549-1277 (Print)
IS  - 1549-1277 (Linking)
VI  - 19
IP  - 5
DP  - 2022 May
TI  - Evaluation of a multicomponent intervention consisting of education and feedback 
      to reduce benzodiazepine prescriptions by general practitioners: The BENZORED 
      hybrid type 1 cluster randomized controlled trial.
PG  - e1003983
LID - 10.1371/journal.pmed.1003983 [doi]
LID - e1003983
AB  - BACKGROUND: Current benzodiazepine (BZD) prescription guidelines recommend 
      short-term use to minimize the risk of dependence, cognitive impairment, and 
      falls and fractures. However, many clinicians overprescribe BZDs and chronic use 
      by patients is common. There is limited evidence on the effectiveness of 
      interventions delivered by general practitioners (GPs) on reducing prescriptions 
      and long-term use of BZDs. We aimed to evaluate the effectiveness of a 
      multicomponent intervention for GPs that seeks to reduce BZD prescriptions and 
      the prevalence of long-term users. METHODS AND FINDINGS: We conducted a 
      multicenter two-arm, cluster randomized controlled trial in 3 health districts in 
      Spain (primary health centers [PHCs] in Balearic Islands, Catalonia, and 
      Valencian Community) from September 2016 to May 2018. The 81 PHCs were randomly 
      allocated to the intervention group (n = 41; 372 GPs) or the control group (n = 
      40; 377 GPs). GPs were not blinded to the allocation; however, pharmacists, 
      researchers, and trial statisticians were blinded to the allocation arm. The 
      intervention consisted of a workshop about the appropriate prescribing of BZDs 
      and tapering-off long-term BZD use using a tailored stepped dose reduction with 
      monthly BZD prescription feedback and access to a support web page. The primary 
      outcome, based on 700 GPs (351 in the control group and 349 in the intervention 
      group), compared changes in BZD prescriptions in defined daily doses (DDDs) per 
      1,000 inhabitants per day after 12 months. The 2 secondary outcomes were the 
      proportion of long-term users (≥6 months) and the proportion of long-term users 
      over age 65 years. Intention-to-treat (ITT) analysis was used to assess all 
      clinical outcomes. Forty-nine GPs (21 intervention group and 28 control group) 
      were lost to follow-up. However, all GPs were included in the ITT analysis. After 
      12 months, there were a statistically significant decline in total BZD 
      prescription in the intervention group compared to the control group (mean 
      difference: -3.24 DDDs per 1,000 inhabitants per day, 95% confidence interval 
      (CI): -4.96, -1.53, p < 0.001). The intervention group also had a smaller number 
      of long-term users. The adjusted absolute difference overall was -0.36 (95% CI: 
      -0.55, -0.16, p > 0.001), and the adjusted absolute difference in long-term users 
      over age 65 years was -0.87 (95% CI: -1.44, -0.30, p = 0.003). A key limitation 
      of this clustered design clinical trial is the imbalance of some baseline 
      characteristics. The control groups have a higher rate of baseline BZD 
      prescription, and more GPs in the intervention group were women, GPs with a 
      doctorate degree, and trainers of GP residents. CONCLUSIONS: A multicomponent 
      intervention that targeted GPs and included educational meeting, feedback about 
      BZD prescriptions, and a support web page led to a statistically significant 
      reduction of BZD prescriptions and fewer long-term users. Although the effect 
      size was small, the high prevalence of BZD use in the general population suggests 
      that large-scale implementation of this intervention could have positive effects 
      on the health of many patients. TRIAL REGISTRATION: ISRCTN ISRCTN28272199.
FAU - Vicens, Caterina
AU  - Vicens C
AUID- ORCID: 0000-0002-9387-625X
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, Palma, 
      Illes Balears, Spain.
AD  - Research Network on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS)-Balearic Islands Health Research Institute (IdISBa), Mallorca, Spain.
FAU - Leiva, Alfonso
AU  - Leiva A
AUID- ORCID: 0000-0001-5306-8533
AD  - Research Network on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS)-Balearic Islands Health Research Institute (IdISBa), Mallorca, Spain.
AD  - Balearic Health Service IbSalut, Reseach Unit Primary care Mallorca, Palma, Illes 
      Balears, Spain.
FAU - Bejarano, Ferran
AU  - Bejarano F
AUID- ORCID: 0000-0001-7875-4193
AD  - Catalan Institute of Health Cat-salut, DAP Camp de Tarragona, Tarragona, 
      Catalunya, Spain.
FAU - Sempere-Verdú, Ermengol
AU  - Sempere-Verdú E
AUID- ORCID: 0000-0002-1665-0732
AD  - Conselleria de Sanitat Universal i Salut Pública, Paterna Healthcare Centre, 
      Valencia, Comunitat Valenciana, Spain.
FAU - Rodríguez-Rincón, Raquel María
AU  - Rodríguez-Rincón RM
AD  - Balearic Health Service IbSalut Hospital Universitari Son Espases, Pharmacy 
      Department,Palma de Mallorca, Illes Balears, Spain.
FAU - Fiol, Francisca
AU  - Fiol F
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, Palma, 
      Illes Balears, Spain.
FAU - Mengual, Marta
AU  - Mengual M
AUID- ORCID: 0000-0002-2873-6461
AD  - Catalan Institute of Health Cat-salut, DAP Camp de Tarragona, Tarragona, 
      Catalunya, Spain.
FAU - Ajenjo-Navarro, Asunción
AU  - Ajenjo-Navarro A
AUID- ORCID: 0000-0002-8892-320X
AD  - Conselleria de Sanitat Universal i Salut Pública, Paterna Healthcare Centre, 
      Valencia, Comunitat Valenciana, Spain.
FAU - Do Pazo, Fernando
AU  - Do Pazo F
AUID- ORCID: 0000-0002-9793-1316
AD  - Balearic Health Service IbSalut Hospital Universitari Son Espases, Pharmacy 
      Department,Palma de Mallorca, Illes Balears, Spain.
FAU - Mateu, Catalina
AU  - Mateu C
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, Palma, 
      Illes Balears, Spain.
FAU - Folch, Silvia
AU  - Folch S
AUID- ORCID: 0000-0003-0964-3240
AD  - Catalan Institute of Health Cat-salut, DAP Camp de Tarragona, Tarragona, 
      Catalunya, Spain.
FAU - Alegret, Santiago
AU  - Alegret S
AD  - Balearic Health Service IbSalut Son Serra-La Vileta Healthcare Centre, Palma, 
      Illes Balears, Spain.
FAU - Coll, Jose Maria
AU  - Coll JM
AUID- ORCID: 0000-0003-1995-3752
AD  - Balearic Health Service IbSalut, Menorca Primary Care Management, Maó, Illes 
      Baleares, Spain.
FAU - Martín-Rabadán, María
AU  - Martín-Rabadán M
AD  - Balearic Health Service IbSalut, Can Misses Healthcare Centre Ibiza, Illes 
      Baleares, Spain.
FAU - Socias, Isabel
AU  - Socias I
AUID- ORCID: 0000-0002-0237-6592
AD  - Research Network on Chronicity, Primary Care, and Health Promotion 
      (RICAPPS)-Balearic Islands Health Research Institute (IdISBa), Mallorca, Spain.
AD  - Balearic Health Service IbSalut, Manacor Healthcare Centre, Manacor, Illes 
      Baleares, Spain.
LA  - eng
SI  - ISRCTN/ISRCTN28272199
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20220506
PL  - United States
TA  - PLoS Med
JT  - PLoS medicine
JID - 101231360
RN  - 12794-10-4 (Benzodiazepines)
SB  - IM
MH  - Aged
MH  - Benzodiazepines/adverse effects
MH  - Feedback
MH  - Female
MH  - *General Practitioners/education
MH  - Humans
MH  - Male
MH  - Prescriptions
MH  - Spain
PMC - PMC9075619
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/05/07 06:00
MHDA- 2022/05/11 06:00
CRDT- 2022/05/06 13:33
PHST- 2021/08/24 00:00 [received]
PHST- 2022/04/07 00:00 [accepted]
PHST- 2022/05/06 13:33 [entrez]
PHST- 2022/05/07 06:00 [pubmed]
PHST- 2022/05/11 06:00 [medline]
AID - PMEDICINE-D-21-03642 [pii]
AID - 10.1371/journal.pmed.1003983 [doi]
PST - epublish
SO  - PLoS Med. 2022 May 6;19(5):e1003983. doi: 10.1371/journal.pmed.1003983. 
      eCollection 2022 May.

PMID- 35478736
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220430
IS  - 1664-1078 (Print)
IS  - 1664-1078 (Electronic)
IS  - 1664-1078 (Linking)
VI  - 13
DP  - 2022
TI  - Analysis of Drug and Health Resource Use Before and After COVID-19 Lockdown in a 
      Population Undergoing Treatment for Depression or Anxiety.
PG  - 861643
LID - 10.3389/fpsyg.2022.861643 [doi]
LID - 861643
AB  - INTRODUCTION: The arrival of the COVID-19 pandemic modified the functions of 
      Primary Care (PC) teams, which were forced to focus their resources on the 
      diagnosis and treatment of SARS-CoV-2 infected patients. The disrupted healthcare 
      of individuals with pre-existing mental disorders (depression or anxiety), as 
      well as the psychological decompensation resulting from the lockdown caused by 
      the COVID-19 pandemic, may have modified the use of drugs and health resources by 
      these patients. The aim of this study is to determine the changes in these 
      parameters, between the 6 months prior to the lockdown (09/14/2019 to 03/15/2020) 
      and the 6 months following its end (05/03/2020 to 11/04/2020), in a population 
      undergoing active treatment for depression or anxiety, according to the 
      electronic clinical record. MATERIALS AND METHODS: Real world data observational 
      study of 110,694 individuals aged >16 years suffering from active or undergoing 
      treatment for depression or anxiety according to the electronic medical records 
      of the Aragon Regional Health Service (Spain). Pharmacological variables [daily 
      dose per inhabitant (DHD) dispensed by pharmacies of: anxiolytics, 
      hypnotics/sedatives, and antidepressants] and variables related to the use of 
      healthcare resources (number of primary and specialized healthcare visits) were 
      considered. Student's T-tests for paired samples were performed to analyze 
      differences between periods (pre-post). The level of significance was established 
      at 5% (p < 0.05). RESULTS: The use of anxiolytic drugs increased as compared to 
      its use over the 6 months prior to the lockdown. In contrast, the consumption of 
      antidepressants was found to decrease. The use of health resources continued to 
      be below pre-pandemic levels, 6 months post-lockdown end. CONCLUSION: Changes in 
      the use of health resources could have a negative impact on the parameters of 
      these diseases. The increase in drug use, especially benzodiazepines, may suggest 
      a worsening of the symptoms during the lockdown and in the subsequent months. It 
      is a worrying sign, which points to the growth of this public health problem and 
      the need for its prevention.
CI  - Copyright © 2022 Lear-Claveras, Clavería, Couso-Viana, Nabbe and Oliván-Blázquez.
FAU - Lear-Claveras, Ana
AU  - Lear-Claveras A
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AD  - I-Saúde Group, South Galicia Health Research Institute, Vigo, Spain.
AD  - Vigo Health Area, SERGAS, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Couso-Viana, Sabela
AU  - Couso-Viana S
AD  - Vigo Health Area, SERGAS, Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
FAU - Nabbe, Patrice
AU  - Nabbe P
AD  - Département Universitaire de Médecine Générale, ER 7479 SPURBO (Soins Primaires, 
      Santé Publique, Registre des Cancers de Bretagne Occidentale), Université de 
      Bretagne Occidentale, Brest, France.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AD  - Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Barcelona, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220405
PL  - Switzerland
TA  - Front Psychol
JT  - Frontiers in psychology
JID - 101550902
PMC - PMC9037328
OTO - NOTNLM
OT  - COVID-19
OT  - anxiety
OT  - depression
OT  - lifestyle
OT  - primary health care
OT  - quarantine
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/04/29 06:00
MHDA- 2022/04/29 06:01
CRDT- 2022/04/28 06:12
PHST- 2022/01/24 00:00 [received]
PHST- 2022/03/08 00:00 [accepted]
PHST- 2022/04/28 06:12 [entrez]
PHST- 2022/04/29 06:00 [pubmed]
PHST- 2022/04/29 06:01 [medline]
AID - 10.3389/fpsyg.2022.861643 [doi]
PST - epublish
SO  - Front Psychol. 2022 Apr 5;13:861643. doi: 10.3389/fpsyg.2022.861643. eCollection 
      2022.

PMID- 35478734
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 1664-1078 (Print)
IS  - 1664-1078 (Electronic)
IS  - 1664-1078 (Linking)
VI  - 13
DP  - 2022
TI  - Anxiety, Depression, and Concern About Employment Status of Hotel Housekeepers in 
      the Balearic Islands During the COVID-19 Pandemic: A Longitudinal Study.
PG  - 842335
LID - 10.3389/fpsyg.2022.842335 [doi]
LID - 842335
AB  - Tourism is a crucial economic sector in the Balearic Islands (Spain). COVID-19 
      pandemic might severely impact hotel housekeepers (HHs) due to their already 
      precarious employment situation. The purpose is to assess the evolution of the 
      concern about employment status, anxiety, and depression of HHs. This is a 
      longitudinal study conducted with a subset of participants from a primary care, 
      health promotion intervention study. Two additional visits were added 
      (March-April and October-December 2020) for the purpose of this study. We 
      recruited 290 HHs in March-April 2020; 237 were again interviewed during 
      October-December 2020. In the first visit, high level of concern about employment 
      was associated with age under 50, temporary contracts and external locus of 
      control (LOC). Moderate-severe anxiety was associated with low social support and 
      external LOC; moderate-severe depression was associated with low social support. 
      Regarding the second visit, age, years working as HH, type of contract, social 
      support, and LOC were not associated with concern about employment status, 
      anxiety, and depression. There was a larger proportion of HHs with 
      moderate-severe anxiety and depression among HHs with high degree of concern. 
      Concern increased significantly among HHs: over 50 years of age; with more than 
      15 years in the job, a recurring seasonal contract and normal social support. 
      After adjusting by age, type of contract, LOC, and social support, we found a 
      statistically significant increase (12.0%) of HHs highly concerned about their 
      job situation: compared to the first visit, HHs were 2.3 more likely to have a 
      high degree of concern in December 2020. In contrast, increases in 
      moderate-severe anxiety (0.3%) and depression (4.3%) between the two periods were 
      not significant. In HHs, the COVID-19 pandemic has caused significant concern 
      about employment status and symptoms of depression and anxiety. In the uncertain 
      times of the pandemic, mental wellbeing benefits from variables that confer 
      stability, such as internal LOC, perception of social support, and a stable job. 
      Longitudinal results point at long lasting effects of the COVID-19 pandemic on 
      mental health. It is crucial to allocate additional resources in primary care to 
      adequately address the anticipated influx of needs.
CI  - Copyright © 2022 Chela-Alvarez, Leiva, Gallardo-Alfaro, Bulilete, Vidal-Thomas 
      and Llobera.
FAU - Chela-Alvarez, Xenia
AU  - Chela-Alvarez X
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Leiva, Alfonso
AU  - Leiva A
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Gallardo-Alfaro, Laura
AU  - Gallardo-Alfaro L
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
FAU - Bulilete, Oana
AU  - Bulilete O
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Vidal-Thomas, MClara
AU  - Vidal-Thomas M
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
FAU - Llobera, Joan
AU  - Llobera J
AD  - Primary Care Research Unit of Mallorca, Balearic Islands Health Service, Palma, 
      Spain.
AD  - GrAPP-caIB - Health Research Institute of the Balearic Islands (IdISBa), Palma, 
      Spain.
AD  - RICAPPS- Red de Investigación Cooperativa de Atención Primaria y Promoción de la 
      Salud - Carlos III Health Institute (ISCIII), Madrid, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220405
PL  - Switzerland
TA  - Front Psychol
JT  - Frontiers in psychology
JID - 101550902
PMC - PMC9037287
OTO - NOTNLM
OT  - COVID-19
OT  - anxiety
OT  - depression
OT  - employment status
OT  - hotel housekeepers
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/04/29 06:00
MHDA- 2022/04/29 06:01
CRDT- 2022/04/28 06:12
PHST- 2021/12/23 00:00 [received]
PHST- 2022/03/03 00:00 [accepted]
PHST- 2022/04/28 06:12 [entrez]
PHST- 2022/04/29 06:00 [pubmed]
PHST- 2022/04/29 06:01 [medline]
AID - 10.3389/fpsyg.2022.842335 [doi]
PST - epublish
SO  - Front Psychol. 2022 Apr 5;13:842335. doi: 10.3389/fpsyg.2022.842335. eCollection 
      2022.

PMID- 35457686
OWN - NLM
STAT- MEDLINE
DCOM- 20220426
LR  - 20230308
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 8
DP  - 2022 Apr 15
TI  - Increased Patient Empowerment Is Associated with Improvement in Anxiety and 
      Depression Symptoms in Type 2 Diabetes Mellitus: Findings from the INDICA Study.
LID - 10.3390/ijerph19084818 [doi]
LID - 4818
AB  - Introduction. In cross-sectional analyses, higher levels of patient empowerment 
      have been related to lower symptoms of anxiety and depression. The aims of this 
      study are: (1) to assess if patient empowerment predicts anxiety and depression 
      symptoms after 12 and 24 months among patients with type 2 diabetes mellitus, and 
      (2) to analyze whether a change in patient empowerment is associated with a 
      change in anxiety and depression level. Methods. This is a secondary analysis of 
      the INDICA study, a 24 month-long, multi-arm randomized controlled trial. Patient 
      empowerment (DES-SF), depression (BDI-II), and state-anxiety (STAI-S) were 
      assessed at the baseline (pre-intervention) and after 12 and 24 months. 
      Multilevel mixed linear models with a random intercept were performed to correct 
      for our clustered data. Results. The multilevel regression models showed that the 
      baseline empowerment did not significantly predict anxiety and depression after 
      12 and 24 months. However, a higher increase in patient empowerment was 
      significantly associated with reductions of anxiety (p < 0.001) and depression 
      levels (p < 0.001). This association was not significantly different between the 
      two follow-ups. Conclusion. This study contributes to the knowledge on how to 
      reduce affective symptoms in patients with uncomplicated T2DM through 
      comprehensive patient-centered interventions, and it highlights patient 
      empowerment as a significant contributor.
FAU - Duarte-Díaz, Andrea
AU  - Duarte-Díaz A
AUID- ORCID: 0000-0003-1171-9945
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, 
      Spain.
AD  - Department of Clinical Psychology, Psychobiology and Methodology, Universidad de 
      La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AUID- ORCID: 0000-0001-6651-0693
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, 
      Spain.
FAU - Rivero-Santana, Amado
AU  - Rivero-Santana A
AUID- ORCID: 0000-0002-5067-3196
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, 
      Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 38109 El 
      Rosario, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 El Rosario, Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, 
      Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 38109 El 
      Rosario, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 El Rosario, Spain.
FAU - Perestelo-Pérez, Lilisbeth
AU  - Perestelo-Pérez L
AUID- ORCID: 0000-0002-6113-7313
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 38109 El 
      Rosario, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 El Rosario, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 El Rosario, 
      Spain.
FAU - Álvarez-Pérez, Yolanda
AU  - Álvarez-Pérez Y
AUID- ORCID: 0000-0002-6414-2863
AD  - Canary Islands Health Research Institute Foundation (FIISC), 38109 El Rosario, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 El Rosario, Spain.
FAU - Peñate, Wenceslao
AU  - Peñate W
AUID- ORCID: 0000-0001-9168-9920
AD  - Department of Clinical Psychology, Psychobiology and Methodology, Universidad de 
      La Laguna (ULL), 38200 San Cristóbal de La Laguna, Spain.
FAU - Carrion, Carme
AU  - Carrion C
AUID- ORCID: 0000-0003-1479-7551
AD  - eHealth Lab Research Group, School of Health Sciences, Universitat Oberta de 
      Catalunya (UOC), 08035 Barcelona, Spain.
FAU - Serrano-Aguilar, Pedro
AU  - Serrano-Aguilar P
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), 38109 El 
      Rosario, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      38109 El Rosario, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), 38109 El Rosario, 
      Spain.
FAU - On Behalf Of The Indica Team
AU  - On Behalf Of The Indica Team
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20220415
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Anxiety/psychology
MH  - Cross-Sectional Studies
MH  - Depression/psychology
MH  - *Diabetes Mellitus, Type 2/complications/psychology/therapy
MH  - Humans
MH  - Patient Participation
PMC - PMC9028935
OTO - NOTNLM
OT  - anxiety
OT  - depression
OT  - empowerment
OT  - patient-centered care
OT  - type 2 diabetes mellitus
COIS- The authors declare no conflict of interest.
EDAT- 2022/04/24 06:00
MHDA- 2022/04/27 06:00
CRDT- 2022/04/23 01:13
PHST- 2022/02/25 00:00 [received]
PHST- 2022/04/11 00:00 [revised]
PHST- 2022/04/13 00:00 [accepted]
PHST- 2022/04/23 01:13 [entrez]
PHST- 2022/04/24 06:00 [pubmed]
PHST- 2022/04/27 06:00 [medline]
AID - ijerph19084818 [pii]
AID - ijerph-19-04818 [pii]
AID - 10.3390/ijerph19084818 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Apr 15;19(8):4818. doi: 
      10.3390/ijerph19084818.

PMID- 35409489
OWN - NLM
STAT- MEDLINE
DCOM- 20220413
LR  - 20220513
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 7
DP  - 2022 Mar 23
TI  - Multimorbidity Profiles and Infection Severity in COVID-19 Population Using 
      Network Analysis in the Andalusian Health Population Database.
LID - 10.3390/ijerph19073808 [doi]
LID - 3808
AB  - Identifying the population at risk of COVID-19 infection severity is a priority 
      for clinicians and health systems. Most studies to date have only focused on the 
      effect of specific disorders on infection severity, without considering that 
      patients usually present multiple chronic diseases and that these conditions tend 
      to group together in the form of multimorbidity patterns. In this large-scale 
      epidemiological study, including primary and hospital care information of 166,242 
      patients with confirmed COVID-19 infection from the Spanish region of Andalusia, 
      we applied network analysis to identify multimorbidity profiles and analyze their 
      impact on the risk of hospitalization and mortality. Our results showed that 
      multimorbidity was a risk factor for COVID-19 severity and that this risk 
      increased with the morbidity burden. Individuals with advanced cardio-metabolic 
      profiles frequently presented the highest infection severity risk in both sexes. 
      The pattern with the highest severity associated in men was present in almost 
      28.7% of those aged ≥ 80 years and included associations between cardiovascular, 
      respiratory, and metabolic diseases; age-adjusted odds ratio (OR) 95% confidence 
      interval (1.71 (1.44-2.02)). In women, similar patterns were also associated the 
      most with infection severity, in 7% of 65-79-year-olds (1.44 (1.34-1.54)) and in 
      29% of ≥80-year-olds (1.35 (1.18-1.53)). Patients with mental health patterns 
      also showed one of the highest risks of COVID-19 severity, especially in women. 
      These findings strongly recommend the implementation of personalized approaches 
      to patients with multimorbidity and SARS-CoV-2 infection, especially in the 
      population with high morbidity burden.
FAU - Carmona-Pírez, Jonás
AU  - Carmona-Pírez J
AUID- ORCID: 0000-0002-6268-8803
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Delicias-Sur Primary Care Health Centre, Aragon Health Service (SALUD), 50009 
      Zaragoza, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - Ioakeim-Skoufa, Ignatios
AU  - Ioakeim-Skoufa I
AUID- ORCID: 0000-0002-6518-749X
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of 
      Public Health, NO-0213 Oslo, Norway.
AD  - Department of Drug Statistics, Division of Health Data and Digitalisation, 
      Norwegian Institute of Public Health, NO-0213 Oslo, Norway.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (SEMFYC), 08009 Barcelona, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AUID- ORCID: 0000-0002-5440-1710
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AUID- ORCID: 0000-0002-5119-5093
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - González-Rubio, Francisca
AU  - González-Rubio F
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (SEMFYC), 08009 Barcelona, Spain.
FAU - Muñoyerro-Muñiz, Dolores
AU  - Muñoyerro-Muñiz D
AD  - Subdirección Técnica Asesora de Gestión de la Información, Servicio Andaluz de 
      Salud (SAS), 41071 Seville, Spain.
FAU - Rodríguez-Herrera, Juliana
AU  - Rodríguez-Herrera J
AD  - Subdirección Técnica Asesora de Gestión de la Información, Servicio Andaluz de 
      Salud (SAS), 41071 Seville, Spain.
FAU - Goicoechea-Salazar, Juan Antonio
AU  - Goicoechea-Salazar JA
AD  - Subdirección Técnica Asesora de Gestión de la Información, Servicio Andaluz de 
      Salud (SAS), 41071 Seville, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AUID- ORCID: 0000-0002-5704-6056
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - Villegas-Portero, Román
AU  - Villegas-Portero R
AUID- ORCID: 0000-0003-0845-0172
AD  - Subdirección Técnica Asesora de Gestión de la Información, Servicio Andaluz de 
      Salud (SAS), 41071 Seville, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220323
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - *COVID-19/epidemiology
MH  - Female
MH  - Hospitalization
MH  - Humans
MH  - Male
MH  - Multimorbidity
MH  - Risk Factors
MH  - SARS-CoV-2
PMC - PMC8997853
OTO - NOTNLM
OT  - COVID-19
OT  - chronic diseases
OT  - disease burden
OT  - multimorbidity
OT  - network analysis
OT  - severity
COIS- The authors declare no conflict of interest.
EDAT- 2022/04/13 06:00
MHDA- 2022/04/14 06:00
CRDT- 2022/04/12 01:14
PHST- 2022/02/24 00:00 [received]
PHST- 2022/03/18 00:00 [revised]
PHST- 2022/03/21 00:00 [accepted]
PHST- 2022/04/12 01:14 [entrez]
PHST- 2022/04/13 06:00 [pubmed]
PHST- 2022/04/14 06:00 [medline]
AID - ijerph19073808 [pii]
AID - ijerph-19-03808 [pii]
AID - 10.3390/ijerph19073808 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Mar 23;19(7):3808. doi: 
      10.3390/ijerph19073808.

PMID- 35407360
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230308
IS  - 2077-0383 (Print)
IS  - 2077-0383 (Electronic)
IS  - 2077-0383 (Linking)
VI  - 11
IP  - 7
DP  - 2022 Mar 22
TI  - Impact of COVID-19 on Hospital Admissions and Healthcare Quality Indicators in 
      Non-COVID Patients: A Retrospective Study of the First COVID-19 Year in a 
      University Hospital in Spain.
LID - 10.3390/jcm11071752 [doi]
LID - 1752
AB  - Few studies have assessed the impact of the COVID-19 pandemic on non-COVID 
      diseases and healthcare quality. We aimed to evaluate changes in rates of 
      hospitalisations, complications, in-hospital mortality, and readmissions among 
      patients with non-COVID diseases during a one-year period after the pandemic 
      onset. From March 2018 to February 2021 a retrospective observational study of 
      hospital admissions in a university hospital in Spain was conducted. Non-COVID 
      hospitalisations admitted through the emergency department were compared between 
      the pre-COVID period (n = 28,622) and the COVID period (n = 11,904). We assessed 
      rate ratios (RaR), comparing the weekly number of admissions and risk ratios (RR) 
      to examine rates of complications, in-hospital mortality, readmissions, and 
      severity. Statistical significance was set at p < 0.05. The weekly admission rate 
      dropped by 20.8% during the complete lockdown. We observed significant reductions 
      in admissions related to diseases of the respiratory system and circulatory 
      system. Admissions for endocrine and metabolic diseases increased. The 
      complication rates increased (RR = 1.21, 95% CI: 1.05;1.4), while in-hospital 
      mortality rates held steady during the COVID period (RR = 1.09, 95% CI: 
      0.98;1.2). Hospital efforts to maintain quality and safety standards despite 
      disruptions translated into a moderate increase in complications but not in 
      in-hospital mortality. Reduced hospitalisations for conditions requiring timely 
      treatment may have significant public health consequences.
FAU - Domingo, Laia
AU  - Domingo L
AUID- ORCID: 0000-0003-4420-0891
AD  - Department of Epidemiology and Evaluation, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), RICAPPS, 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Comas, Mercè
AU  - Comas M
AD  - Department of Epidemiology and Evaluation, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), RICAPPS, 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Jansana, Anna
AU  - Jansana A
AUID- ORCID: 0000-0001-8504-1618
AD  - Department of Epidemiology and Evaluation, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), RICAPPS, 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Louro, Javier
AU  - Louro J
AUID- ORCID: 0000-0002-2985-3301
AD  - Department of Epidemiology and Evaluation, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), RICAPPS, 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Tizón-Marcos, Helena
AU  - Tizón-Marcos H
AUID- ORCID: 0000-0001-7942-9413
AD  - Department of Cardiology, Hospital del Mar-IMIM, 08003 Barcelona, Spain.
AD  - Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Cos, Maria Lourdes
AU  - Cos ML
AD  - Department of Internal Medicine, Hospital del Mar-IMIM, Universitat Autònoma de 
      Barcelona, 08003 Barcelona, Spain.
FAU - Roquer, Jaume
AU  - Roquer J
AD  - Neurology Department, Hospital del Mar-IMIM, 08003 Barcelona, Spain.
AD  - Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003 
      Barcelona, Spain.
FAU - Chillarón, Juan José
AU  - Chillarón JJ
AUID- ORCID: 0000-0002-8096-1703
AD  - Department of Endocrinology and Nutrition, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
FAU - Cirera, Isabel
AU  - Cirera I
AD  - Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003 
      Barcelona, Spain.
AD  - Emergency Department, Hospital del Mar-IMIM, 08003 Barcelona, Spain.
FAU - Pascual-Guàrdia, Sergi
AU  - Pascual-Guàrdia S
AD  - Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, 08003 
      Barcelona, Spain.
AD  - Pneumology Department, Hospital del Mar-IMIM, 08003 Barcelona, Spain.
AD  - Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Sala, Maria
AU  - Sala M
AD  - Department of Epidemiology and Evaluation, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), RICAPPS, 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
FAU - Castells, Xavier
AU  - Castells X
AUID- ORCID: 0000-0002-2528-0382
AD  - Department of Epidemiology and Evaluation, Hospital del Mar-IMIM, 08003 
      Barcelona, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), RICAPPS, 
      Instituto de Salud Carlos III, 28029 Madrid, Spain.
LA  - eng
GR  - RD16/0001/0013/Instituto de Salud Carlos III/
PT  - Journal Article
DEP - 20220322
PL  - Switzerland
TA  - J Clin Med
JT  - Journal of clinical medicine
JID - 101606588
PMC - PMC8999691
OTO - NOTNLM
OT  - COVID-19
OT  - complications
OT  - healthcare quality
OT  - hospital admissions
OT  - impact
OT  - in-hospital mortality
OT  - lockdown
COIS- The authors declare no conflict of interest.
EDAT- 2022/04/13 06:00
MHDA- 2022/04/13 06:01
CRDT- 2022/04/12 01:06
PHST- 2022/02/08 00:00 [received]
PHST- 2022/03/15 00:00 [revised]
PHST- 2022/03/18 00:00 [accepted]
PHST- 2022/04/12 01:06 [entrez]
PHST- 2022/04/13 06:00 [pubmed]
PHST- 2022/04/13 06:01 [medline]
AID - jcm11071752 [pii]
AID - jcm-11-01752 [pii]
AID - 10.3390/jcm11071752 [doi]
PST - epublish
SO  - J Clin Med. 2022 Mar 22;11(7):1752. doi: 10.3390/jcm11071752.

PMID- 35396305
OWN - NLM
STAT- MEDLINE
DCOM- 20220412
LR  - 20220531
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 12
IP  - 4
DP  - 2022 Apr 8
TI  - Cost-effectiveness of multicomponent interventions in type 2 diabetes mellitus in 
      a cluster randomised controlled trial: the INDICA study.
PG  - e058049
LID - 10.1136/bmjopen-2021-058049 [doi]
LID - e058049
AB  - OBJECTIVE: To analyse the cost-effectiveness of multicomponent interventions 
      designed to improve outcomes in type 2 diabetes mellitus (T2DM) in primary care 
      in the Canary Islands, Spain, within the INDICA randomised clinical trial, from 
      the public health system perspective. DESIGN: An economic evaluation was 
      conducted for the within-trial period (2 years) comparing the four arms of the 
      INDICA study. SETTING: Primary care in the Canary Islands, Spain. PARTICIPANTS: 
      2334 patients with T2DM without complications were included. INTERVENTIONS: 
      Interventions for patients (PTI), for primary care professionals (PFI), for both 
      (combined intervention arm for patients and professionals, CBI) and usual care 
      (UC) as a control group. OUTCOMES: The main outcome was the incremental cost per 
      quality-adjusted life-years (QALY). Only the intervention and the healthcare 
      costs were included. ANALYSIS: Multilevel models were used to estimate results, 
      and to measure the size and significance of incremental changes. Missed values 
      were treated by means of multiple imputations procedure. RESULTS: There were no 
      differences between arms in terms of costs (p=0.093), while some differences were 
      observed in terms of QALYs after 2 years of follow-up (p=0.028). PFI and CBI arms 
      were dominated by the other two arms, PTI and UC. The differences between the PTI 
      and the UC arms were very small in terms of QALYs, but significant in terms of 
      healthcare costs (p=0.045). The total cost of the PTI arm (€2571, 95% CI €2317 to 
      €2826) was lower than the cost in the UC arm (€2750, 95% CI €2506 to €2995), but 
      this difference did not reach statistical significance. Base case estimates of 
      the incremental cost per QALY indicate that the PTI strategy was the 
      cost-effective option. CONCLUSIONS: The INDICA intervention designed for patients 
      with T2DM and families is likely to be cost-effective from the public healthcare 
      perspective. A cost-effectiveness model should explore this in the long term. 
      TRIAL REGISTRATION NUMBER: NCT01657227.
CI  - © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - García-Pérez, Lidia
AU  - García-Pérez L
AUID- ORCID: 0000-0002-5626-8116
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain 
      lidia.garciaperez@sescs.es.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Ramallo-Fariña, Yolanda
AU  - Ramallo-Fariña Y
AUID- ORCID: 0000-0002-1541-3989
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - Vallejo-Torres, Laura
AU  - Vallejo-Torres L
AUID- ORCID: 0000-0001-5833-6066
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
FAU - Rodríguez-Rodríguez, Leticia
AU  - Rodríguez-Rodríguez L
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
FAU - González-Pacheco, Himar
AU  - González-Pacheco H
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Santos-Hernández, Beatriz
AU  - Santos-Hernández B
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - García-Bello, Miguel Angel
AU  - García-Bello MA
AD  - Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain.
FAU - Wägner, Ana María
AU  - Wägner AM
AD  - Department of Endocrinology and Nutrition, Insular University Hospital of Gran 
      Canaria, Las Palmas de Gran Canaria, Spain.
AD  - University Institute for Biomedical and Health Research (iUIBS), University of 
      Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
FAU - Carmona, Montserrat
AU  - Carmona M
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Health Technology Assessment Agency, Instituto de Salud Carlos III, Madrid, 
      Spain.
FAU - Serrano-Aguilar, Pedro G
AU  - Serrano-Aguilar PG
AD  - Research Network on Health Services in Chronic Diseases (REDISSEC), Tenerife, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Tenerife, Spain.
AD  - Evaluation Unit (SESCS), Canary Islands Health Service (SCS), Santa Cruz de 
      Tenerife, Spain.
CN  - INDICA team
LA  - eng
SI  - ClinicalTrials.gov/NCT01657227
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20220408
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Cluster Analysis
MH  - Cost-Benefit Analysis
MH  - Diabetes Mellitus, Type 2/*economics/*therapy
MH  - Humans
MH  - Primary Health Care
MH  - Quality of Life
MH  - Quality-Adjusted Life Years
MH  - Spain
PMC - PMC8995956
OTO - NOTNLM
OT  - diabetes & endocrinology
OT  - health economics
OT  - health informatics
OT  - primary care
OT  - quality in health care
COIS- Competing interests: None declared.
FIR - Rosa, Abraham Pérez de la
IR  - Rosa AP
FIR - Ríos, Alicia Pareja
IR  - Ríos AP
FIR - Perello, Andrés Sifre
IR  - Perello AS
FIR - Pérez, Ángela Trinidad Gutiérrez
IR  - Pérez ÁTG
FIR - León, Antonio Cabrera de
IR  - León AC
FIR - Quintana, Antonio García
IR  - Quintana AG
FIR - Domínguez, Armando Carrillo
IR  - Domínguez AC
FIR - Domínguez, Bernardo Eusebio Herrera
IR  - Domínguez BEH
FIR - Pérez, Carlos Sedeño
IR  - Pérez CS
FIR - Álamo, Carlos Ramírez
IR  - Álamo CR
FIR - Aguilar, Carmen Daranas
IR  - Aguilar CD
FIR - Marrero, Carolina Guerra
IR  - Marrero CG
FIR - Soto, Cecilia Lobos
IR  - Soto CL
FIR - Pérez, Cristina Padrón
IR  - Pérez CP
FIR - Martel, Dácil Alvarado
IR  - Martel DA
FIR - Obregón, Daniel Hernández
IR  - Obregón DH
FIR - Correa, Dulce N Hernández
IR  - Correa DNH
FIR - Pozuelo, Elsa Espinosa
IR  - Pozuelo EE
FIR - Mayor, Elsa Florido
IR  - Mayor EF
FIR - Domínguez, Engracia Pinilla
IR  - Domínguez EP
FIR - García, Fátima Herrera
IR  - García FH
FIR - Aguiar, Félix Bonilla
IR  - Aguiar FB
FIR - Álvarez, Fernando Montón
IR  - Álvarez FM
FIR - López, Francisco Cabrera
IR  - López FC
FIR - Torre, Gloria Guerra de la
IR  - Torre GG
FIR - Martín, Gregorio Muelas
IR  - Martín GM
FIR - Monzón, Guillermo
IR  - Monzón G
FIR - Merino, Héctor de la Rosa
IR  - Merino HR
FIR - Puente, Ignacio García
IR  - Puente IG
FIR - Segura, Ignacio Llorente Gómez de
IR  - Segura ILG
FIR - Calcerrada, Isabel García
IR  - Calcerrada IG
FIR - Rodríguez, Iván Castilla
IR  - Rodríguez IC
FIR - Pérez, Jacqueline Álvarez
IR  - Pérez JÁ
FIR - Page, Jorge Federico Aldunate
IR  - Page JFA
FIR - Dopico, Jose Antonio García
IR  - Dopico JAG
FIR - Hernández, Juan Andrés Báez
IR  - Hernández JAB
FIR - Valencia, Juan José Pérez
IR  - Valencia JJP
FIR - Wiebe, Julia Charlotte
IR  - Wiebe JC
FIR - Pérez, Lilisbeth Perestelo
IR  - Pérez LP
FIR - Martín, Leopoldo
IR  - Martín L
FIR - Majem, Lluis Serra
IR  - Majem LS
FIR - Herrera, Luis Morcillo
IR  - Herrera LM
FIR - Ramírez, Marcos Estupiñán
IR  - Ramírez ME
FIR - Ruano, Margarita Roldán
IR  - Ruano MR
FIR - Fernández, María Del Mar Romero
IR  - Fernández MDMR
FIR - Pérez, María Inmaculada González
IR  - Pérez MIG
FIR - Morales, María Isabel Visuerte
IR  - Morales MIV
FIR - Medina, María Pino Afonso
IR  - Medina MPA
FIR - Ruiz, Marta Riaño
IR  - Ruiz MR
FIR - Santana, Marta Tejera
IR  - Santana MT
FIR - Cortés, Mauro Boronat
IR  - Cortés MB
FIR - Medina, Mercedes Lorenzo
IR  - Medina ML
FIR - García, Miguel JuanMora
IR  - García MJ
FIR - Delgado, Nayra Pérez
IR  - Delgado NP
FIR - Martín, Pablo Pedrianez
IR  - Martín PP
FIR - Velasco, Pedro de Pablos
IR  - Velasco PP
FIR - Alba, Pilar Peláez
IR  - Alba PP
FIR - Valcárcel, Rafael
IR  - Valcárcel R
FIR - Sánchez, Remedios Castro
IR  - Sánchez RC
FIR - González, Rodrigo Abreu
IR  - González RA
FIR - Trujillo, Rosa Borges
IR  - Trujillo RB
FIR - González, Salvador Acosta
IR  - González SA
FIR - Girardot, Sybille Kaiser
IR  - Girardot SK
FIR - Sellarés, Víctor Lorenzo
IR  - Sellarés VL
EDAT- 2022/04/10 06:00
MHDA- 2022/04/13 06:00
CRDT- 2022/04/09 05:18
PHST- 2022/04/09 05:18 [entrez]
PHST- 2022/04/10 06:00 [pubmed]
PHST- 2022/04/13 06:00 [medline]
AID - bmjopen-2021-058049 [pii]
AID - 10.1136/bmjopen-2021-058049 [doi]
PST - epublish
SO  - BMJ Open. 2022 Apr 8;12(4):e058049. doi: 10.1136/bmjopen-2021-058049.

PMID- 35363172
OWN - NLM
STAT- MEDLINE
DCOM- 20220405
LR  - 20230103
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 101
IP  - 7
DP  - 2022 Feb 18
TI  - Health and access to healthcare in homeless people: Protocol for a mixed-methods 
      study.
PG  - e28816
LID - 10.1097/MD.0000000000028816 [doi]
LID - e28816
AB  - BACKGROUND: Homelessness is a more complex problem than the simple lack of a 
      place to live. Homeless people (HP) often suffer from poor health and premature 
      death due to their limited access healthcare, and are also deprived of basic 
      human and social rights. The study protocol described here aims to evaluate the 
      complex relationship between homelessness and health, and identify the barriers 
      and facilitators that impact access to healthcare by HP. METHODS: This is a 
      mixed-methods study that uses an explanatory sequential design. The first phase 
      will consist of a cross-sectional study of 300 HP. Specific health questionnaires 
      will be used to obtain information on health status, challenges during the 
      COVID-19 pandemic, self-reported use of healthcare, diagnoses and pharmacologic 
      treatments, substance abuse (DAST-10), diet quality (IASE), depression (PHQ-9), 
      and human basic needs and social support (SSQ-6). The second phase will be a 
      qualitative study of HP using the "life story" technique with purposive sampling. 
      We will determine the effects of different personal, family, and structural 
      factors on the life and health status of participants. The interviews will be 
      structured and defined using Nussbaum's capability approach. DISCUSSION: It is 
      well-known that HP experience poor health and premature death, but more 
      information is needed about the influence of the different specific social 
      determinants of these outcomes and about the barriers and facilitators that 
      affect the access of HP to healthcare. The results of this mixed methods study 
      will help to develop global health strategies that improve the health and access 
      to healthcare in HP.
CI  - Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
FAU - Bedmar, Miguel A
AU  - Bedmar MA
AD  - Research Group on Global Health & Human Development, University of the Balearic 
      Islands, Palma, Spain.
FAU - Bennasar-Veny, Miquel
AU  - Bennasar-Veny M
AUID- ORCID: 0000-0003-1668-2141
AD  - Research Group on Global Health & Human Development, University of the Balearic 
      Islands, Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands, 
      Palma, Spain.
AD  - Research Group on Global Health & Lifestyle, Health Research Institute of the 
      Balearic Islands (IdISBa), Palma, Spain.
AD  - CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
FAU - Artigas-Lelong, Berta
AU  - Artigas-Lelong B
AD  - Research Group on Global Health & Human Development, University of the Balearic 
      Islands, Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands, 
      Palma, Spain.
AD  - Research Group on Global Health & Lifestyle, Health Research Institute of the 
      Balearic Islands (IdISBa), Palma, Spain.
FAU - Salvà-Mut, Francesca
AU  - Salvà-Mut F
AD  - Department of Applied Pedagogy and Education Psychology, Institute for 
      Educational Research and Innovation, University of the Balearic Islands, Palma, 
      Spain.
FAU - Pou, Joan
AU  - Pou J
AD  - Primary Health Care, Balearic Islands Health Services, Palma, Spain.
FAU - Capitán-Moyano, Laura
AU  - Capitán-Moyano L
AD  - Research Group on Global Health & Human Development, University of the Balearic 
      Islands, Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands, 
      Palma, Spain.
FAU - García-Toro, Mauro
AU  - García-Toro M
AD  - Research Group on Global Health & Lifestyle, Health Research Institute of the 
      Balearic Islands (IdISBa), Palma, Spain.
AD  - Research Group on Mental Disorders of High Prevalence (TRAMAP), Research 
      Institute of Health Sciences (IUNICS), University of the Balearic Islands, Palma, 
      Illes Balears, Spain.
FAU - Yáñez, Aina M
AU  - Yáñez AM
AD  - Research Group on Global Health & Human Development, University of the Balearic 
      Islands, Palma, Spain.
AD  - Department of Nursing and Physiotherapy, University of the Balearic Islands, 
      Palma, Spain.
AD  - Research Group on Global Health & Lifestyle, Health Research Institute of the 
      Balearic Islands (IdISBa), Palma, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      Palma, Spain.
LA  - eng
GR  - OCDS-CUD2020/05/Universitat de les Illes Balears/
GR  - PI2020/0576/College of Nurses of Balearic Islands/
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - *COVID-19/epidemiology
MH  - Cross-Sectional Studies
MH  - Health Services Accessibility
MH  - *Ill-Housed Persons
MH  - Humans
MH  - Pandemics
PMC - PMC9282039
COIS- The authors have no conflicts of interest to disclose.
EDAT- 2022/04/02 06:00
MHDA- 2022/04/06 06:00
CRDT- 2022/04/01 12:21
PHST- 2022/01/24 00:00 [received]
PHST- 2022/01/25 00:00 [accepted]
PHST- 2022/04/01 12:21 [entrez]
PHST- 2022/04/02 06:00 [pubmed]
PHST- 2022/04/06 06:00 [medline]
AID - 00005792-202202180-00014 [pii]
AID - MD-D-22-00525 [pii]
AID - 10.1097/MD.0000000000028816 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2022 Feb 18;101(7):e28816. doi: 
      10.1097/MD.0000000000028816.

PMID- 35351100
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220402
IS  - 1472-6955 (Print)
IS  - 1472-6955 (Electronic)
IS  - 1472-6955 (Linking)
VI  - 21
IP  - 1
DP  - 2022 Mar 29
TI  - Health-related quality of life in caregivers of community-dwelling individuals 
      with disabilities or chronic conditions. A gender-differentiated analysis in a 
      cross-sectional study.
PG  - 69
LID - 10.1186/s12912-022-00845-x [doi]
LID - 69
AB  - BACKGROUND: Most care for people with chronic or disabling conditions living in 
      the community is provided in the family context, and this care is traditionally 
      provided by women. Providing informal care has a negative impact on caregivers' 
      quality of life, which adds to existing health inequalities associated with 
      gender. The aim of this study was to analyze factors associated with the 
      health-related quality of life of caregivers and to determine their differences 
      in a gender-differentiated analysis. METHODS: An observational, cross-sectional, 
      multicenter study was conducted in primary healthcare. A total of 218 caregivers 
      aged 65 years or older were included, all of whom assumed the primary 
      responsibility for caring for people with disabling conditions for at least 
      6 months per year and agreed to participate in the CuidaCare study. The dependent 
      variable was health-related quality of life, assessed with the EQ-5D. The 
      explanatory variables tested were grouped into sociodemographic variables, 
      subjective burden, caregiving role, social support and variables related to the 
      dependent person. The associations between these variables and health-related 
      quality of life were estimated by fitting robust linear regression models. 
      Separate analyses were conducted for women and men. RESULTS: A total of 72.8% of 
      the sample were women, and 27.2% were men. The mean score on the EQ-5D for female 
      caregivers was 0.64 (0.31); for male caregivers, it was 0.79 (0.23). There were 
      differences by gender in the frequency of reported problems in the dimensions of 
      pain/comfort and anxiety/depression. The variables that were associated with 
      quality of life also differed. Having a positive depression screening was 
      negatively associated with quality of life for both genders: -0.31 points (95% 
      CI: -0.47; -0.15) for female caregivers and -0.48 points (95% CI: -0.92; -0.03) 
      for male caregivers. Perceived burden was associated with quality of life in the 
      adjusted model for women (-0.12 points; 95% CI: -0.19; -0.06), and domestic help 
      was associated in the adjusted model for male caregivers (-0.12 points; 95% CI: 
      -0.19; -0.05). CONCLUSIONS: Gender differences are present in informal 
      caregiving. The impact of providing informal care is different for male and 
      female caregivers, and so are the factors that affect their perceived quality of 
      life. It could be useful it incorporates a gender perspective in the design of 
      nursing support interventions for caregivers to individualize care and improve 
      the quality of life of caregivers. TRIAL REGISTRATION: NCT01478295 [ 
      https://ClinicalTrials.gov ]. 23/11/2011.
CI  - © 2022. The Author(s).
FAU - Rico-Blázquez, Milagros
AU  - Rico-Blázquez M
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain. milagros.rico@salud.madrid.org.
AD  - Health Services Research On Chronic Patients Network (REDISSEC) and Research 
      Network On Chronicity, Primary Health Care and Health Promotion (RICORS-RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain. milagros.rico@salud.madrid.org.
AD  - Gregorio Marañon Health Research Institute, Madrid Health Service, Madrid, Spain. 
      milagros.rico@salud.madrid.org.
AD  - Doctoral Program in Epidemiology and Public Health (Interuniversity), Rey Juan 
      Carlos University, Madrid, Spain. milagros.rico@salud.madrid.org.
AD  - Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, Complutense 
      University of Madrid, Madrid, Spain. milagros.rico@salud.madrid.org.
FAU - Quesada-Cubo, Víctor
AU  - Quesada-Cubo V
AD  - Independent researcher, Preventive Medicine and Quality Management Service, 
      Gregorio Marañón General University Hospital, Madrid, Spain.
FAU - Polentinos-Castro, Elena
AU  - Polentinos-Castro E
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC) and Research 
      Network On Chronicity, Primary Health Care and Health Promotion (RICORS-RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
AD  - Gregorio Marañon Health Research Institute, Madrid Health Service, Madrid, Spain.
AD  - Preventive Medicine and Public Health Area, Health Sciences Faculty, Rey Juan 
      Carlos University, Alcorcón, Madrid, Spain.
FAU - Sánchez-Ruano, Raquel
AU  - Sánchez-Ruano R
AD  - Goya Healthcare Center, Primary Care Assistance Management, Madrid Health 
      Service, Madrid, Spain.
FAU - Rayo-Gómez, M Ángeles
AU  - Rayo-Gómez MÁ
AD  - Foundation for Biosanitary Research and Innovation in Primary Care of the 
      Community of Madrid (FIIBAP), PEJD-2018-PRE / BMD-9460, Madrid, Spain.
FAU - Del Cura-González, Isabel
AU  - Del Cura-González I
AD  - Research Unit, Primary Care Assistance Management, Madrid Health Service, Madrid, 
      Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC) and Research 
      Network On Chronicity, Primary Health Care and Health Promotion (RICORS-RICAPPS), 
      Instituto de Salud Carlos III, Madrid, Spain.
AD  - Gregorio Marañon Health Research Institute, Madrid Health Service, Madrid, Spain.
AD  - Preventive Medicine and Public Health Area, Health Sciences Faculty, Rey Juan 
      Carlos University, Alcorcón, Madrid, Spain.
CN  - CuidaCare Group
LA  - eng
SI  - ClinicalTrials.gov/NCT01478295
GR  - PI11/02132/Fondo de Investigaciones Sanitarias of the Instituto de Salud Carlos 
      III/
PT  - Journal Article
DEP - 20220329
PL  - England
TA  - BMC Nurs
JT  - BMC nursing
JID - 101088683
PMC - PMC8961096
OTO - NOTNLM
OT  - Caregivers
OT  - Chronic disease
OT  - Disabled persons
OT  - Gender roles
OT  - Informal care
OT  - Primary health care
OT  - Quality of life
COIS- The authors declare that they have no competing interests.
FIR - Rico-Blázquez, Milagros
IR  - Rico-Blázquez M
FIR - Almena-Martín, Rosario
IR  - Almena-Martín R
FIR - Almodovar-López, Ángeles
IR  - Almodovar-López Á
FIR - Alonso-Arcas, Julia
IR  - Alonso-Arcas J
FIR - Álvarez-Navarro, Elvira
IR  - Álvarez-Navarro E
FIR - Álvarez-Santos, Henar
IR  - Álvarez-Santos H
FIR - Andrés-Alonso, Begoña
IR  - Andrés-Alonso B
FIR - Antolín-Díaz, Virginia
IR  - Antolín-Díaz V
FIR - Araujo-Calvo, Mercedes
IR  - Araujo-Calvo M
FIR - Ayuso-Gil, Encarnación
IR  - Ayuso-Gil E
FIR - Barbero-Macías, Cynthia A
IR  - Barbero-Macías CA
FIR - Bermejo-Mayoral, Inés
IR  - Bermejo-Mayoral I
FIR - Berninches-Heredero, Ana
IR  - Berninches-Heredero A
FIR - Botanes-Peñafiel, Lourdes
IR  - Botanes-Peñafiel L
FIR - Cámara-González, Lorena
IR  - Cámara-González L
FIR - Careaga-González, Isabel
IR  - Careaga-González I
FIR - de-Casas-Albendea, Sergio
IR  - de-Casas-Albendea S
FIR - Castilla-Álvarez, Carmen
IR  - Castilla-Álvarez C
FIR - Castro-Sánchez, Belén
IR  - Castro-Sánchez B
FIR - Castro-Torrado, Noelia
IR  - Castro-Torrado N
FIR - Clemente-Del-Castillo, María J
IR  - Clemente-Del-Castillo MJ
FIR - Dávila-Moriña, Pilar
IR  - Dávila-Moriña P
FIR - Díaz-de-Espada-León, Juana
IR  - Díaz-de-Espada-León J
FIR - Domínguez-González, Analía
IR  - Domínguez-González A
FIR - Domínguez-Pérez, Lorena
IR  - Domínguez-Pérez L
FIR - Domínguez-Puebla, Dolores
IR  - Domínguez-Puebla D
FIR - Escribano-Zaera, Mónica
IR  - Escribano-Zaera M
FIR - Escudero-Muñoz, Luisa
IR  - Escudero-Muñoz L
FIR - Fernández-Arnaldo, Raquel
IR  - Fernández-Arnaldo R
FIR - Fernández-Del-Campo-Coca, Teresa
IR  - Fernández-Del-Campo-Coca T
FIR - Fernández-Ortega, Mercedes
IR  - Fernández-Ortega M
FIR - Fernández-Rodríguez, Rafaela
IR  - Fernández-Rodríguez R
FIR - García-Campo, Virginia
IR  - García-Campo V
FIR - García-Del-Río, Isabel
IR  - García-Del-Río I
FIR - García-Garrudo, María J
IR  - García-Garrudo MJ
FIR - García-Gómez-de-Cardiñanos, Elena
IR  - García-Gómez-de-Cardiñanos E
FIR - García-Ruíz, Juan
IR  - García-Ruíz J
FIR - García-San, Petra
IR  - García-San P
FIR - Geanini-Torres, Jorge
IR  - Geanini-Torres J
FIR - Gómez-Quevedo, Rosa
IR  - Gómez-Quevedo R
FIR - Gómez-Robledo, Eva
IR  - Gómez-Robledo E
FIR - Gómez-Pesquera, Carmen
IR  - Gómez-Pesquera C
FIR - González-Fernández, Begoña
IR  - González-Fernández B
FIR - González-Valls, Aranzazu
IR  - González-Valls A
FIR - Harris-de-la-Vega, Natalie
IR  - Harris-de-la-Vega N
FIR - Herrero-Yusta, Susana
IR  - Herrero-Yusta S
FIR - de-la-Iglesia-Moreno, Sonia
IR  - de-la-Iglesia-Moreno S
FIR - Jiménez-Maillo, Silvia
IR  - Jiménez-Maillo S
FIR - Juárez-Zapatero, Luisa
IR  - Juárez-Zapatero L
FIR - Juez-Pimienta, Raquel
IR  - Juez-Pimienta R
FIR - Lara-Bueno, Francisca
IR  - Lara-Bueno F
FIR - Lasala-Raso, Pilar
IR  - Lasala-Raso P
FIR - Letón-Gutiérrez, Lucía
IR  - Letón-Gutiérrez L
FIR - Leza-Leza, Margarita
IR  - Leza-Leza M
FIR - López-Del-Cid, Raquel
IR  - López-Del-Cid R
FIR - López-Kölmer, Laura
IR  - López-Kölmer L
FIR - Lozano-Fernández, Paz
IR  - Lozano-Fernández P
FIR - López-Serrano, Elisa
IR  - López-Serrano E
FIR - Martín-Ávila, Elena
IR  - Martín-Ávila E
FIR - Martín-Martín, María
IR  - Martín-Martín M
FIR - Martín-Martínez, Sara
IR  - Martín-Martínez S
FIR - Martínez-Arroyo, Anunciación
IR  - Martínez-Arroyo A
FIR - Martínez-Palomo, Carmen
IR  - Martínez-Palomo C
FIR - Martínez-Ruíz, Cristina
IR  - Martínez-Ruíz C
FIR - Martínez-Zafra, Pilar
IR  - Martínez-Zafra P
FIR - Mateo-Madurga, Alicia
IR  - Mateo-Madurga A
FIR - Méndez-Junco, Natalia
IR  - Méndez-Junco N
FIR - Minguito-Lobos, Antonia
IR  - Minguito-Lobos A
FIR - Molina-Gómez, Paloma
IR  - Molina-Gómez P
FIR - Moreno-Collado, Marina
IR  - Moreno-Collado M
FIR - Moreno-Moreno, Ana B
IR  - Moreno-Moreno AB
FIR - Olmos-Sancho, Cristina
IR  - Olmos-Sancho C
FIR - Peláez-Toré, Remedios
IR  - Peláez-Toré R
FIR - Pérez-Barrios, Raquel
IR  - Pérez-Barrios R
FIR - Pérez-García, Pérez-Barrios
IR  - Pérez-García PB
FIR - Pulido-López, Esmeralda
IR  - Pulido-López E
FIR - Ramírez-Puerta, Ana B
IR  - Ramírez-Puerta AB
FIR - Del Rey-Moya, Luz
IR  - Del Rey-Moya L
FIR - Rivera-Álvarez, Araceli
IR  - Rivera-Álvarez A
FIR - Rodrigo-Rodrigo, Paz
IR  - Rodrigo-Rodrigo P
FIR - Ruiz-Martín, María N
IR  - Ruiz-Martín MN
FIR - Serna-Urnicia, AnaI
IR  - Serna-Urnicia A
FIR - Sidera-Jiménez, Josefa
IR  - Sidera-Jiménez J
FIR - Tornay-Muñoz, Encarnación
IR  - Tornay-Muñoz E
FIR - Villanova-Cuadra, Laura
IR  - Villanova-Cuadra L
FIR - Villanueva-Alameda, Isabel
IR  - Villanueva-Alameda I
FIR - Villanueva-Sanz, Cristina
IR  - Villanueva-Sanz C
FIR - Villares-Motino, Emiliana
IR  - Villares-Motino E
EDAT- 2022/03/31 06:00
MHDA- 2022/03/31 06:01
CRDT- 2022/03/30 05:37
PHST- 2021/11/23 00:00 [received]
PHST- 2022/03/14 00:00 [accepted]
PHST- 2022/03/30 05:37 [entrez]
PHST- 2022/03/31 06:00 [pubmed]
PHST- 2022/03/31 06:01 [medline]
AID - 10.1186/s12912-022-00845-x [pii]
AID - 845 [pii]
AID - 10.1186/s12912-022-00845-x [doi]
PST - epublish
SO  - BMC Nurs. 2022 Mar 29;21(1):69. doi: 10.1186/s12912-022-00845-x.

PMID- 35329313
OWN - NLM
STAT- MEDLINE
DCOM- 20220331
LR  - 20220401
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 6
DP  - 2022 Mar 18
TI  - Non-Pharmacological Preventive Measures Had an Impact on COVID-19 in Healthcare 
      Workers before the Vaccination Effect: A Cohort Study.
LID - 10.3390/ijerph19063628 [doi]
LID - 3628
AB  - Healthcare workers have been and still are at the forefront of COVID-19 patient 
      care. Their infection had direct implications and caused important challenges for 
      healthcare performance. The aim of this study is to assess the impact of 
      non-pharmacological preventive measures against COVID-19 among healthcare 
      workers. This study is based on a dynamic cohort of healthcare workers (n = 5543) 
      who had been hired by a Spanish hospital for at least one week during 2020. 
      Negative binomial regression models were used to estimate the incidence rate and 
      the rate ratio (RR) between the two waves (defined from 15 March to 21 June and 
      from 22 June to 31 December), considering natural immunity during the first wave 
      and contextual variables. All models were stratified by socio-occupational 
      variables. The average COVID-19 incidence rate per 1000 worker-days showed a 
      significant reduction between the two waves, dropping from 0.82 (CI95%: 
      0.73-0.91) to 0.39 (0.35-0.44). The adjusted RR was 0.54 (0.48-0.87) when natural 
      immunity was acquired during the first wave, and contextual variables were 
      considered. The significant reduction of the COVID-19 incidence rate could be 
      explained mainly by improvement in the non-pharmacological preventive 
      interventions. It is needed to identify which measures were more effective. Young 
      workers and those with a replacement contract were identified as vulnerable 
      groups that need greater preventive efforts. Future preparedness plans would 
      benefit from these results.
FAU - Utzet, Mireia
AU  - Utzet M
AD  - Centre for Research in Occupational Health, Department of Medicine and Life 
      Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - CIBER of Epidemiology and Public Health, 28029 Madrid, Spain.
FAU - Benavides, Fernando G
AU  - Benavides FG
AD  - Centre for Research in Occupational Health, Department of Medicine and Life 
      Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - CIBER of Epidemiology and Public Health, 28029 Madrid, Spain.
FAU - Villar, Rocío
AU  - Villar R
AD  - Centre for Research in Occupational Health, Department of Medicine and Life 
      Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - CIBER of Epidemiology and Public Health, 28029 Madrid, Spain.
AD  - Occupational Health Service, Parc de Salut Mar, 08003 Barcelona, Spain.
FAU - Burón, Andrea
AU  - Burón A
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - Department of Epidemiology and Evaluation, Parc de Salut Mar, 08003 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      08003 Barcelona, Spain.
FAU - Sala, Maria
AU  - Sala M
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - Department of Epidemiology and Evaluation, Parc de Salut Mar, 08003 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      08003 Barcelona, Spain.
FAU - López, Luis-Eugenio
AU  - López LE
AD  - Consorci Mar Parc de Salut de Barcelona, 08003 Barcelona, Spain.
FAU - Gomar, Pau
AU  - Gomar P
AD  - Consorci Mar Parc de Salut de Barcelona, 08003 Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - Department of Epidemiology and Evaluation, Parc de Salut Mar, 08003 Barcelona, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      08003 Barcelona, Spain.
FAU - Diaz, Pilar
AU  - Diaz P
AD  - Centre for Research in Occupational Health, Department of Medicine and Life 
      Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - Occupational Health Service, Parc de Salut Mar, 08003 Barcelona, Spain.
FAU - Ramada, José María
AU  - Ramada JM
AD  - Centre for Research in Occupational Health, Department of Medicine and Life 
      Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - CIBER of Epidemiology and Public Health, 28029 Madrid, Spain.
AD  - Occupational Health Service, Parc de Salut Mar, 08003 Barcelona, Spain.
FAU - Serra, Consol
AU  - Serra C
AUID- ORCID: 0000-0001-8337-8356
AD  - Centre for Research in Occupational Health, Department of Medicine and Life 
      Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
AD  - IMIM-Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.
AD  - CIBER of Epidemiology and Public Health, 28029 Madrid, Spain.
AD  - Occupational Health Service, Parc de Salut Mar, 08003 Barcelona, Spain.
LA  - eng
GR  - XIV call for R&amp;D grants in occupational risk prevention 2020 -21./Fundacion 
      Prevent/
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220318
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - *COVID-19/epidemiology/prevention & control
MH  - Cohort Studies
MH  - Health Personnel
MH  - Humans
MH  - Models, Statistical
MH  - Vaccination
PMC - PMC8955756
OTO - NOTNLM
OT  - COVID-19
OT  - healthcare worker
OT  - incidence
OT  - non-pharmaceutical preventive measures
OT  - rate ratio
COIS- The authors declare no conflict of interest.
EDAT- 2022/03/26 06:00
MHDA- 2022/04/01 06:00
CRDT- 2022/03/25 01:09
PHST- 2022/03/02 00:00 [received]
PHST- 2022/03/13 00:00 [revised]
PHST- 2022/03/16 00:00 [accepted]
PHST- 2022/03/25 01:09 [entrez]
PHST- 2022/03/26 06:00 [pubmed]
PHST- 2022/04/01 06:00 [medline]
AID - ijerph19063628 [pii]
AID - ijerph-19-03628 [pii]
AID - 10.3390/ijerph19063628 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Mar 18;19(6):3628. doi: 
      10.3390/ijerph19063628.

PMID- 35329070
OWN - NLM
STAT- MEDLINE
DCOM- 20220419
LR  - 20220419
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 6
DP  - 2022 Mar 13
TI  - Chronic Pain and Work Conditions of Hotel Housekeepers: A Descriptive Study.
LID - 10.3390/ijerph19063383 [doi]
LID - 3383
AB  - OBJECTIVES: To estimate the prevalence of musculoskeletal pain of hotel 
      housekeepers (HHs) and to describe the work conditions and perception of health 
      in this occupational group in the Balearic Islands, Spain. METHODS: 
      Cross-sectional descriptive study with HHs of the Balearic Islands, performed in 
      primary care. Random sample of HHs who worked during the 2018 season. We 
      collected information on sociodemographic variables, job characteristics, 
      workload, pain, perceived health, and physical activity. After participants 
      signed the informed consent form, we conducted a face-to-face interview in the 
      primary care centre and accessed the participants' electronic health records. 
      RESULTS: 1043 HHs aged 43.3 ± 10 years and with 10.7 ± 9.1 years worked as HHs 
      were included. 51% (95% CI: 48-54%) reported chronic pain, mainly in the lower 
      back 28.7% (95% CI: 25.9-31.5%), hands/wrists 23.7% (95% CI: 21.1-26.4%), neck 
      21.6% (95% CI: 19.1-24.3%), shoulders 19.9% (95% CI: 17.4-22.4%), and back 17.8% 
      (95% CI: 15.4-20.2%). Pain was associated with older age, more years worked, more 
      beds made/day and difficulty in pushing the housekeeping cart. More than half HHs 
      reported that they did not incorporate occupational risk prevention measures 
      (ORPMs) into their routine; 17.3% (95% CI: 15.1-19.7%) HHs considered their 
      health as poor or very poor. Perception of health was worse in HHs with chronic 
      pain. CONCLUSIONS: A high percentage of HHs of the Balearic Islands reported 
      chronic pain, a low compliance with ORPMs and compared to women of the same 
      sociodemographic profile they perceive a worse health status.
FAU - Sánchez-Rodríguez, Cristian
AU  - Sánchez-Rodríguez C
AUID- ORCID: 0000-0003-4277-3610
AD  - Primary Care Research Unit of Mallorca, Public Health Service of the Balearic 
      Islands (Ibsalut), 07003 Palma, Spain.
AD  - Research Group on Global Health and Human Development, University of the Balearic 
      Islands (UIB), 07122 Palma, Spain.
FAU - Bulilete, Oana
AU  - Bulilete O
AUID- ORCID: 0000-0002-9264-5142
AD  - Primary Care Research Unit of Mallorca, Public Health Service of the Balearic 
      Islands (Ibsalut), 07003 Palma, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), 07003 Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
FAU - Chela-Alvarez, Xenia
AU  - Chela-Alvarez X
AUID- ORCID: 0000-0002-8270-6554
AD  - Primary Care Research Unit of Mallorca, Public Health Service of the Balearic 
      Islands (Ibsalut), 07003 Palma, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), 07003 Palma, Spain.
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
FAU - Velasco-Roldán, Olga
AU  - Velasco-Roldán O
AUID- ORCID: 0000-0003-2376-433X
AD  - Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
AD  - Research Institute of Health Sciences (IUNICS), Department of Nursing and 
      Physiotherapy, University of the Balearic Islands (UIB), 07122 Palma, Spain.
FAU - Llobera-Canaves, Joan
AU  - Llobera-Canaves J
AD  - Primary Care Research Unit of Mallorca, Public Health Service of the Balearic 
      Islands (Ibsalut), 07003 Palma, Spain.
AD  - Research Group in Primary Care and Promotion-Balearic Islands Community 
      (GRAPP-caIB), Network for Research on Chronicity, Primary Care, and Health 
      Promotion (RICAPPS), 07003 Palma, Spain.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220313
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - *Chronic Pain/epidemiology
MH  - Cross-Sectional Studies
MH  - Female
MH  - Household Work
MH  - Humans
MH  - *Musculoskeletal Pain/epidemiology
MH  - *Occupational Diseases/epidemiology
MH  - Prevalence
MH  - Risk Factors
MH  - Workload
PMC - PMC8950313
OTO - NOTNLM
OT  - hotel maids
OT  - musculoskeletal pain
OT  - occupational health
OT  - occupational risk
OT  - perceived health status
COIS- The authors declare that they have no conflict of interest.
EDAT- 2022/03/26 06:00
MHDA- 2022/04/20 06:00
CRDT- 2022/03/25 01:08
PHST- 2022/02/14 00:00 [received]
PHST- 2022/03/09 00:00 [revised]
PHST- 2022/03/10 00:00 [accepted]
PHST- 2022/03/25 01:08 [entrez]
PHST- 2022/03/26 06:00 [pubmed]
PHST- 2022/04/20 06:00 [medline]
AID - ijerph19063383 [pii]
AID - ijerph-19-03383 [pii]
AID - 10.3390/ijerph19063383 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Mar 13;19(6):3383. doi: 
      10.3390/ijerph19063383.

PMID- 35316642
OWN - NLM
STAT- MEDLINE
DCOM- 20220524
LR  - 20220629
IS  - 1877-783X (Electronic)
IS  - 1877-7821 (Linking)
VI  - 78
DP  - 2022 Jun
TI  - Prevalence and characteristics of hepatitis C virus-related hepatocellular 
      carcinoma in a Spanish university hospital.
PG  - 102142
LID - S1877-7821(22)00047-9 [pii]
LID - 10.1016/j.canep.2022.102142 [doi]
AB  - BACKGROUND: Hepatocellular Carcinoma (HCC) arises in chronic liver diseases, 
      particularly caused by hepatitis C virus (HCV) and alcohol in Europe. We aimed at 
      evaluating the characteristics and mortality of patients with HCV-related HCC as 
      compared to other HCC etiologies. METHODS: We retrospectively evaluated data from 
      887 patients with HCC identified through the Hospital del Mar Cancer Registry 
      (Barcelona, Spain), during the 2001-2020 period. We estimated crude and adjusted 
      hazard ratios (aHR) of dying and its 95% confidence interval (95%CI). RESULTS: 
      Among 887 patients with HCC, 617 (69.6%) were HCV-infected. Underlying cirrhosis 
      was more frequent in HCV-related HCC compared to other etiologies (97% vs. 89%, 
      p < 0.001). The prevalence of HCV-related HCC decreased from 79% in 2001-2005 to 
      55% in 2015-2020 (p < 0.001). HCV infection did not increase the hazard of death 
      [aHR 0.95 (CI95% 0.81-1.13)]. Mortality was independently related to age > 75 
      years, advanced BCLC stage at diagnosis, and diagnosis before 2010. CONCLUSION: 
      In our cohort, HCV-related HCC frequently occurred in a cirrhotic background, but 
      showed similar clinical characteristics and mortality as compared to other HCC 
      etiologies.
CI  - Copyright © 2022 Elsevier Ltd. All rights reserved.
FAU - Canillas, Lidia
AU  - Canillas L
AD  - Liver Section, Gastroenterology Department, Hospital del Mar, Barcelona, Spain; 
      IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
FAU - Parcerisa, Marçal
AU  - Parcerisa M
AD  - Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
FAU - Coll, Susanna
AU  - Coll S
AD  - Liver Section, Gastroenterology Department, Hospital del Mar, Barcelona, Spain; 
      IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
FAU - García-Retortillo, Montserrat
AU  - García-Retortillo M
AD  - Liver Section, Gastroenterology Department, Hospital del Mar, Barcelona, Spain; 
      IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
FAU - Macià, Francesc
AU  - Macià F
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Barcelona, Spain; Research Network on Chronicity, Primary 
      Care and Health Promotion (RICAPPS), Barcelona, Spain.
FAU - Bessa, Xavier
AU  - Bessa X
AD  - Liver Section, Gastroenterology Department, Hospital del Mar, Barcelona, Spain; 
      IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Barcelona, Spain; Research Network on Chronicity, Primary 
      Care and Health Promotion (RICAPPS), Barcelona, Spain.
FAU - Puigvehí, Marc
AU  - Puigvehí M
AD  - Liver Section, Gastroenterology Department, Hospital del Mar, Barcelona, Spain; 
      IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
FAU - Posso, Margarita
AU  - Posso M
AD  - Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical 
      Research Institute), Barcelona, Spain; Research Network on Chronicity, Primary 
      Care and Health Promotion (RICAPPS), Barcelona, Spain. Electronic address: 
      mposso@psmar.cat.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20220319
PL  - Netherlands
TA  - Cancer Epidemiol
JT  - Cancer epidemiology
JID - 101508793
SB  - IM
MH  - Aged
MH  - *Carcinoma, Hepatocellular/epidemiology/etiology
MH  - Hepacivirus
MH  - *Hepatitis C/complications/epidemiology
MH  - Hospitals
MH  - Humans
MH  - *Liver Neoplasms/etiology
MH  - Prevalence
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Characteristics
OT  - Hepatitis C virus
OT  - Hepatocellular carcinoma
OT  - Prognosis
OT  - Survival
EDAT- 2022/03/23 06:00
MHDA- 2022/05/25 06:00
CRDT- 2022/03/22 20:06
PHST- 2021/09/16 00:00 [received]
PHST- 2022/02/18 00:00 [revised]
PHST- 2022/03/09 00:00 [accepted]
PHST- 2022/03/23 06:00 [pubmed]
PHST- 2022/05/25 06:00 [medline]
PHST- 2022/03/22 20:06 [entrez]
AID - S1877-7821(22)00047-9 [pii]
AID - 10.1016/j.canep.2022.102142 [doi]
PST - ppublish
SO  - Cancer Epidemiol. 2022 Jun;78:102142. doi: 10.1016/j.canep.2022.102142. Epub 2022 
      Mar 19.

PMID- 35290544
OWN - NLM
STAT- MEDLINE
DCOM- 20220512
LR  - 20220716
IS  - 1573-7217 (Electronic)
IS  - 0167-6806 (Print)
IS  - 0167-6806 (Linking)
VI  - 193
IP  - 2
DP  - 2022 Jun
TI  - Adherence of long-term breast cancer survivors to follow-up care guidelines: a 
      study based on real-world data from the SURBCAN cohort.
PG  - 455-465
LID - 10.1007/s10549-022-06563-x [doi]
AB  - PURPOSE: To identify adherence to follow-up recommendations in long-term breast 
      cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, 
      using real-world data. METHODS: We conducted a retrospective study using 
      electronic health records from 2012 to 2016 of women diagnosed with incident 
      breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. 
      Adherence to basic follow-up recommendations, adherence according to risk of 
      recurrence, and overall adherence were calculated based on attendance at medical 
      appointments and imaging surveillance, by year of survivorship. Logistic 
      regression models were fitted to depict the association between adherence and its 
      determinants. RESULTS: A total of 2079 LTBCS were followed up for a median of 
      4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 
      79.5% of LTBCS were overall adherent to at least one visit and one imaging test. 
      Adherence to recommendations decreased over time and no differences were found 
      according to recurrence risk. Determinants of better overall adherence were 
      diagnosis in middle age (50-69 years old), living in a more-deprived area, having 
      fewer years of survival, receiving primary treatment, and being alive at the end 
      of follow-up. CONCLUSION: We identified women apparently not complying with 
      surveillance visits and tests. Special attention should be paid to the youngest 
      and eldest women at diagnosis and to those with longer survival.
CI  - © 2022. The Author(s).
FAU - Santiá, Paula
AU  - Santiá P
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
AD  - Preventive Medicine and Public Health Teaching Unit (Hospital del Mar - Barcelona 
      Public Health Agency - Pompeu Fabra University), Barcelona, Spain.
FAU - Jansana, Anna
AU  - Jansana A
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
AD  - European Higher Education Area Doctoral Program in Methodology of Biomedical 
      Research and Public Health in Department of Pediatrics, Obstetrics and 
      Gynecology, Preventive Medicine and Public Health, Autonomous University of 
      Barcelona (UAB), Bellaterra, Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
FAU - Del Cura, Isabel
AU  - Del Cura I
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
AD  - Primary Care Research Unit, Madrid Health Service, Calle San Martín de Porres, 
      6-5ª planta, 28035, Madrid, Spain.
AD  - Department of Preventive Medicine and Public Health, Rey Juan Carlos University, 
      Avenida de Atenas, 28922, Alcorcón, Madrid, Spain.
FAU - Padilla-Ruiz, Maria
AU  - Padilla-Ruiz M
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
AD  - Research Unit, Costa del Sol Hospital, Biomedical Research Institute of Málaga 
      (IBIMA), University of Málaga, Marbella, Spain.
FAU - Domingo, Laia
AU  - Domingo L
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
FAU - Louro, Javier
AU  - Louro J
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
FAU - Comas, Mercè
AU  - Comas M
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
FAU - Sanz, Teresa
AU  - Sanz T
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
AD  - Primary Care Research Unit, Madrid Health Service, Calle San Martín de Porres, 
      6-5ª planta, 28035, Madrid, Spain.
FAU - Duarte-Salles, Talita
AU  - Duarte-Salles T
AD  - Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut 
      Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
FAU - Redondo, Maximino
AU  - Redondo M
AD  - Research Unit, Costa del Sol Hospital, Biomedical Research Institute of Málaga 
      (IBIMA), University of Málaga, Marbella, Spain.
FAU - Ibañez, Berta
AU  - Ibañez B
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
AD  - Navarrabiomed, Hospital Complex of Navarra, Public University of Navarra, IdiSNA, 
      Irunlarrea, s/n, 31008, Pamplona, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
AD  - EpiChron Research Group On Chronic Diseases, Aragon Health Sciences Institute 
      (IACS), IIS Aragon, Miguel Servet University Hospital Pl +2, Paseo Isabel la 
      Católica 1-3, 50009, Saragossa, Spain.
FAU - Castells, Xavier
AU  - Castells X
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain.
AD  - Autonomous University of Barcelona (UAB), 08193, Bellaterra, Barcelona, Spain.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, Madrid, Spain.
FAU - Sala, Maria
AU  - Sala M
AUID- ORCID: 0000-0002-9955-8746
AD  - Department of Epidemiology and Evaluation, Hospital del Mar Medical Research 
      Institute (IMIM), Passeig Marítim, 25-29, 08003, Barcelona, Spain. 
      msalaserra@parcdesalutmar.cat.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), Institute of 
      Health Carlos III, Madrid, Spain. msalaserra@parcdesalutmar.cat.
AD  - Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      Institute of Health Carlos III, Madrid, Spain. msalaserra@parcdesalutmar.cat.
CN  - SURBCAN Group
LA  - eng
GR  - PI16/0024/Instituto de Salud Carlos III/
GR  - PI19/00056/Instituto de Salud Carlos III/
GR  - RD16/001/013/Research Network on Health Services in Chronic Diseases/
PT  - Journal Article
DEP - 20220315
PL  - Netherlands
TA  - Breast Cancer Res Treat
JT  - Breast cancer research and treatment
JID - 8111104
SB  - IM
MH  - Aftercare
MH  - Aged
MH  - *Breast Neoplasms/diagnosis/epidemiology/therapy
MH  - *Cancer Survivors
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Survivorship
PMC - PMC9090857
OTO - NOTNLM
OT  - Aftercare
OT  - Breast neoplasms
OT  - Cancer survivors
OT  - Guideline adherence
OT  - Long-term survivors
OT  - Mammography
COIS- The authors have no relevant financial or non-financial interests to disclose. 
      The funding institution took no part in the design, collection, analysis or 
      interpretation of data, drafting, or decision to submit this document for 
      publication.
EDAT- 2022/03/16 06:00
MHDA- 2022/05/14 06:00
CRDT- 2022/03/15 17:20
PHST- 2022/01/24 00:00 [received]
PHST- 2022/03/02 00:00 [accepted]
PHST- 2022/03/16 06:00 [pubmed]
PHST- 2022/05/14 06:00 [medline]
PHST- 2022/03/15 17:20 [entrez]
AID - 10.1007/s10549-022-06563-x [pii]
AID - 6563 [pii]
AID - 10.1007/s10549-022-06563-x [doi]
PST - ppublish
SO  - Breast Cancer Res Treat. 2022 Jun;193(2):455-465. doi: 
      10.1007/s10549-022-06563-x. Epub 2022 Mar 15.

PMID- 35259775
OWN - NLM
STAT- MEDLINE
DCOM- 20220405
LR  - 20220405
IS  - 1447-0594 (Electronic)
IS  - 1447-0594 (Linking)
VI  - 22
IP  - 4
DP  - 2022 Apr
TI  - Validation of the Spanish version of the Memory Failures of Everyday 
      questionnaire in older adults using Rasch analysis.
PG  - 332-337
LID - 10.1111/ggi.14364 [doi]
AB  - AIM: The Memory Failures of Everyday (MFE) is a widely used instrument for 
      assessing memory failure. The aim of the study was to analyze the MFE items using 
      the Rasch model in a sample of cognitively older adults in Spain. METHODS: A 
      cross-sectional validation study in a sample of 214 healthy people aged ≥60 years 
      who used centers for older people in Madrid (Spain). The MFE for the assessment 
      of memory complaints was used. The following properties of the Rasch model were 
      assessed: data fit, reliability, unidimensionality, local dependence and lack of 
      differential item functioning by gender, age and marital status. RESULTS: The MFE 
      showed a good fit to the Rasch model (χ(2) (140) = 160.2; P = 0.116) and high 
      reliability (person separation index = 0.808). The questionnaire was 
      unidimensional (6.54% t-test; IC binomial = 0.036-0.095). The items showed lack 
      of local dependence between them and differential item functioning. The MFE 
      scores were transformed into linear interval scores with a median of 44.31 and an 
      observed range of 17.9-89.2 (theoretical range: 0-100). CONCLUSIONS: The MFE is a 
      unidimensional, reliable instrument to assess memory complaints in cognitively 
      healthy older adults in Spain, with usefulness in clinical research and practice. 
      The construct validity of the MFE linear score could not be fully confirmed and 
      this deserves further investigation. Geriatr Gerontol Int 2022; 22: 332-337.
CI  - © 2022 Japan Geriatrics Society.
FAU - Rodríguez-Blázquez, Carmen
AU  - Rodríguez-Blázquez C
AUID- ORCID: 0000-0003-3829-0675
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.
AD  - Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, 
      CIBERNED, Madrid, Spain.
AD  - Instituto Mixto de investigación- Escuela Nacional de Sanidad (IMIENS), Madrid, 
      Spain.
FAU - Ayala-García, Alba
AU  - Ayala-García A
AD  - Universidad Carlos III de Madrid, Madrid, Spain.
AD  - REDISSEC and RICAPPS, Madrid, Spain.
FAU - Forjaz, Maria João
AU  - Forjaz MJ
AD  - Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.
AD  - Instituto Mixto de investigación- Escuela Nacional de Sanidad (IMIENS), Madrid, 
      Spain.
AD  - REDISSEC and RICAPPS, Madrid, Spain.
FAU - García-Herranz, Sara
AU  - García-Herranz S
AD  - Instituto Mixto de investigación- Escuela Nacional de Sanidad (IMIENS), Madrid, 
      Spain.
AD  - Facultad de Psicología, UNED, Madrid, Spain.
FAU - Venero, César
AU  - Venero C
AD  - Instituto Mixto de investigación- Escuela Nacional de Sanidad (IMIENS), Madrid, 
      Spain.
AD  - Facultad de Psicología, UNED, Madrid, Spain.
FAU - Rodríguez-Fernández, Raquel
AU  - Rodríguez-Fernández R
AD  - Instituto Mixto de investigación- Escuela Nacional de Sanidad (IMIENS), Madrid, 
      Spain.
AD  - Facultad de Psicología, UNED, Madrid, Spain.
FAU - Díaz-Mardomingo, María Del Carmen
AU  - Díaz-Mardomingo MDC
AD  - Instituto Mixto de investigación- Escuela Nacional de Sanidad (IMIENS), Madrid, 
      Spain.
AD  - Facultad de Psicología, UNED, Madrid, Spain.
LA  - eng
GR  - IMIENS-2017-004-PIC/Instituto Mixto de Investigación UNED-ISCIII/
GR  - RTI2018-094627-B-I00/Ministerio de Ciencia e Innovación/
GR  - AGL2014-56464-C3-2-R/Secretaría de Estado de Investigación, Desarrollo e 
      Innovación/
GR  - RTI2018-094627-B/Secretaría de Estado de Investigación, Desarrollo e Innovación/
PT  - Journal Article
DEP - 20220308
PL  - Japan
TA  - Geriatr Gerontol Int
JT  - Geriatrics & gerontology international
JID - 101135738
SB  - IM
MH  - Aged
MH  - Cross-Sectional Studies
MH  - *Health Status
MH  - Humans
MH  - Psychometrics
MH  - Reproducibility of Results
MH  - Spain
MH  - Surveys and Questionnaires
OTO - NOTNLM
OT  - Rasch model
OT  - memory complaints
OT  - memory failures
OT  - validation
EDAT- 2022/03/09 06:00
MHDA- 2022/04/06 06:00
CRDT- 2022/03/08 20:15
PHST- 2021/12/16 00:00 [revised]
PHST- 2021/05/28 00:00 [received]
PHST- 2022/02/06 00:00 [accepted]
PHST- 2022/03/09 06:00 [pubmed]
PHST- 2022/04/06 06:00 [medline]
PHST- 2022/03/08 20:15 [entrez]
AID - 10.1111/ggi.14364 [doi]
PST - ppublish
SO  - Geriatr Gerontol Int. 2022 Apr;22(4):332-337. doi: 10.1111/ggi.14364. Epub 2022 
      Mar 8.

PMID- 35206230
OWN - NLM
STAT- MEDLINE
DCOM- 20220321
LR  - 20220321
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 4
DP  - 2022 Feb 11
TI  - Applying the FAIR4Health Solution to Identify Multimorbidity Patterns and Their 
      Association with Mortality through a Frequent Pattern Growth Association 
      Algorithm.
LID - 10.3390/ijerph19042040 [doi]
LID - 2040
AB  - The current availability of electronic health records represents an excellent 
      research opportunity on multimorbidity, one of the most relevant public health 
      problems nowadays. However, it also poses a methodological challenge due to the 
      current lack of tools to access, harmonize and reuse research datasets. In 
      FAIR4Health, a European Horizon 2020 project, a workflow to implement the FAIR 
      (findability, accessibility, interoperability and reusability) principles on 
      health datasets was developed, as well as two tools aimed at facilitating the 
      transformation of raw datasets into FAIR ones and the preservation of data 
      privacy. As part of this project, we conducted a multicentric retrospective 
      observational study to apply the aforementioned FAIR implementation workflow and 
      tools to five European health datasets for research on multimorbidity. We applied 
      a federated frequent pattern growth association algorithm to identify the most 
      frequent combinations of chronic diseases and their association with mortality 
      risk. We identified several multimorbidity patterns clinically plausible and 
      consistent with the bibliography, some of which were strongly associated with 
      mortality. Our results show the usefulness of the solution developed in 
      FAIR4Health to overcome the difficulties in data management and highlight the 
      importance of implementing a FAIR data policy to accelerate responsible health 
      research.
FAU - Carmona-Pírez, Jonás
AU  - Carmona-Pírez J
AUID- ORCID: 0000-0002-6268-8803
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Delicias-Sur Primary Care Health Centre, Aragon Health Service (SALUD), 50009 
      Zaragoza, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AUID- ORCID: 0000-0002-5119-5093
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - Poncel-Falcó, Antonio
AU  - Poncel-Falcó A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
AD  - Aragon Health Service (SALUD), 50017 Zaragoza, Spain.
FAU - Rochat, Jessica
AU  - Rochat J
AD  - Division of Medical Information Sciences, Geneva University Hospitals, 1205 
      Geneva, Switzerland.
AD  - Department of Radiology and Medical Informatics, University of Geneva, 1205 
      Geneva, Switzerland.
FAU - Alvarez-Romero, Celia
AU  - Alvarez-Romero C
AUID- ORCID: 0000-0001-8647-9515
AD  - Group of Research and Innovation in Biomedical Informatics, Biomedical 
      Engineering and Health Economy, Institute of Biomedicine of Seville (IBiS), 
      Virgen del Rocío University Hospital/CSIC/University of Seville, 41013 Seville, 
      Spain.
FAU - Martínez-García, Alicia
AU  - Martínez-García A
AUID- ORCID: 0000-0001-5614-7747
AD  - Group of Research and Innovation in Biomedical Informatics, Biomedical 
      Engineering and Health Economy, Institute of Biomedicine of Seville (IBiS), 
      Virgen del Rocío University Hospital/CSIC/University of Seville, 41013 Seville, 
      Spain.
FAU - Angioletti, Carmen
AU  - Angioletti C
AUID- ORCID: 0000-0002-0341-1679
AD  - Department of Geriatric and Orthopedic Sciences, Catholic University of Sacred 
      Heart, 00168 Rome, Italy.
FAU - Almada, Marta
AU  - Almada M
AUID- ORCID: 0000-0001-6575-1698
AD  - Ucibio Requimte, Faculty of Pharmacy, University of Porto, Porto4Ageing, 4050-313 
      Porto, Portugal.
FAU - Gencturk, Mert
AU  - Gencturk M
AD  - SRDC Software Research & Development and Consultancy Corporation, Ankara 06800, 
      Turkey.
FAU - Sinaci, A Anil
AU  - Sinaci AA
AD  - SRDC Software Research & Development and Consultancy Corporation, Ankara 06800, 
      Turkey.
FAU - Ternero-Vega, Jara Eloisa
AU  - Ternero-Vega JE
AD  - Internal Medicine Department, Virgen del Rocío University Hospital, 41013 
      Seville, Spain.
FAU - Gaudet-Blavignac, Christophe
AU  - Gaudet-Blavignac C
AUID- ORCID: 0000-0001-6527-5898
AD  - Division of Medical Information Sciences, Geneva University Hospitals, 1205 
      Geneva, Switzerland.
AD  - Department of Radiology and Medical Informatics, University of Geneva, 1205 
      Geneva, Switzerland.
FAU - Lovis, Christian
AU  - Lovis C
AD  - Division of Medical Information Sciences, Geneva University Hospitals, 1205 
      Geneva, Switzerland.
AD  - Department of Radiology and Medical Informatics, University of Geneva, 1205 
      Geneva, Switzerland.
FAU - Liperoti, Rosa
AU  - Liperoti R
AD  - Department of Geriatric and Orthopedic Sciences, Catholic University of Sacred 
      Heart, 00168 Rome, Italy.
FAU - Costa, Elisio
AU  - Costa E
AUID- ORCID: 0000-0003-1158-1480
AD  - Ucibio Requimte, Faculty of Pharmacy, University of Porto, Porto4Ageing, 4050-313 
      Porto, Portugal.
FAU - Parra-Calderón, Carlos Luis
AU  - Parra-Calderón CL
AD  - Group of Research and Innovation in Biomedical Informatics, Biomedical 
      Engineering and Health Economy, Institute of Biomedicine of Seville (IBiS), 
      Virgen del Rocío University Hospital/CSIC/University of Seville, 41013 Seville, 
      Spain.
FAU - Moreno-Juste, Aida
AU  - Moreno-Juste A
AUID- ORCID: 0000-0002-8819-3278
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
AD  - Aragon Health Service (SALUD), 50017 Zaragoza, Spain.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AUID- ORCID: 0000-0002-5440-1710
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AUID- ORCID: 0000-0002-5704-6056
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, 50009 Zaragoza, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), ISCIII, 28029 
      Madrid, Spain.
AD  - Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud 
      (RICAPPS), ISCIII, 28029 Madrid, Spain.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20220211
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
SB  - IM
MH  - Algorithms
MH  - *Data Management
MH  - Electronic Health Records
MH  - *Multimorbidity
MH  - Privacy
PMC - PMC8872292
OTO - NOTNLM
OT  - FAIR principles
OT  - mortality
OT  - multimorbidity
OT  - pathfinder case study
OT  - privacy-preserving distributed data mining
OT  - research data management
COIS- The authors declare no conflict of interest.
EDAT- 2022/02/26 06:00
MHDA- 2022/03/22 06:00
CRDT- 2022/02/25 01:08
PHST- 2022/01/13 00:00 [received]
PHST- 2022/02/09 00:00 [revised]
PHST- 2022/02/10 00:00 [accepted]
PHST- 2022/02/25 01:08 [entrez]
PHST- 2022/02/26 06:00 [pubmed]
PHST- 2022/03/22 06:00 [medline]
AID - ijerph19042040 [pii]
AID - ijerph-19-02040 [pii]
AID - 10.3390/ijerph19042040 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Feb 11;19(4):2040. doi: 
      10.3390/ijerph19042040.

PMID- 35203866
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220228
IS  - 2079-6382 (Print)
IS  - 2079-6382 (Electronic)
IS  - 2079-6382 (Linking)
VI  - 11
IP  - 2
DP  - 2022 Feb 18
TI  - Interrupted Time Series Analysis of Pediatric Infectious Diseases and the 
      Consumption of Antibiotics in an Atlantic European Region during the SARS-CoV-2 
      Pandemic.
LID - 10.3390/antibiotics11020264 [doi]
LID - 264
AB  - The increasing concern about bacterial resistance has made the rational 
      prescription of antibiotics even more urgent. The non-pharmacological measures 
      established to reduce the impact of the SARS-CoV-2 pandemic have modified the 
      epidemiology of pediatric infections and, consequently, the use of antibiotics. 
      Interrupted time series (ITS) analyses are quasi-experimental studies that allow 
      for the estimation of causal effects with observational data in "natural 
      experiments", such as changes in health policies or pandemics. The effect of the 
      SARS-CoV-2 pandemic on the incidence of infectious diseases and the use of 
      antibiotics between 2018 and 2020 in the Health Area of Vigo (Galicia, Spain) was 
      quantified and analyzed. This paper outlines a real-world data study with 
      administrative records from primary care services provided for the pediatric 
      population. The records were related to episodes classified as infectious by the 
      International Classification of Primary Care (ICPC-2) and oral medication in the 
      therapeutic subgroup J01, corresponding to antibiotics for systemic use, 
      according to the World Health Organization's Anatomical Therapeutic Chemical 
      (ATC) classification system. The records were classified according to incident 
      episodes, age, dose per inhabitant, and year. Segmented regression models were 
      applied using an algorithm that automatically identifies the number and position 
      of the change points. During the SARS-CoV-2 pandemic, the number of infectious 
      diseases being transmitted between individuals, through the air and through the 
      fecal-oral route, significantly decreased, and a slight decrease in infections 
      transmitted via other mechanisms (urinary tract infections) was also found. In 
      parallel, during the months of the pandemic, there has been a marked and 
      significant reduction in antibacterial agent utilization, mainly of penicillins, 
      cephalosporins, and macrolides.
FAU - Clavería, Ana
AU  - Clavería A
AUID- ORCID: 0000-0001-9552-1260
AD  - Galicia South Health Research Institute, Health Area of Vigo, Galician Health 
      Service, 36201 Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
FAU - Delgado-Martín, María Victoria
AU  - Delgado-Martín MV
AUID- ORCID: 0000-0003-2937-9651
AD  - Moaña Health Center, Health Area of Vigo, Galician Health Service, 36950 Vigo, 
      Spain.
FAU - Goicoechea-Castaño, Ana
AU  - Goicoechea-Castaño A
AD  - Sárdoma Health Center, Health Area of Vigo, Galician Health Service, 36214 Vigo, 
      Spain.
FAU - Iglesias-Moreno, José Manuel
AU  - Iglesias-Moreno JM
AD  - Val Miñor Health Center, Health Area of Vigo, Galician Health Service, 36350 
      Vigo, Spain.
FAU - García-Cendón, Clara
AU  - García-Cendón C
AD  - Val Miñor Health Center, Health Area of Vigo, Galician Health Service, 36350 
      Vigo, Spain.
FAU - Martín-Miguel, María Victoria
AU  - Martín-Miguel MV
AUID- ORCID: 0000-0002-6982-8661
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
AD  - Vigo Family and Community Medicine and Nursing Teaching Unit, Health Area of 
      Vigo, Galician Health Service, 36201 Vigo, Spain.
FAU - Villarino-Moure, Rita
AU  - Villarino-Moure R
AD  - Sárdoma Health Center, Health Area of Vigo, Galician Health Service, 36214 Vigo, 
      Spain.
FAU - Barreiro-Arceiz, Carolina
AU  - Barreiro-Arceiz C
AD  - Baiona Health Center, Health Area of Vigo, Galician Health Service, 36201 Vigo, 
      Spain.
FAU - Rey-Gómez-Serranillos, Isabel
AU  - Rey-Gómez-Serranillos I
AD  - Pharmaceutical Services, Health Area of Vigo, Galician Health Service, 36201 
      Vigo, Spain.
FAU - Roca, Javier
AU  - Roca J
AUID- ORCID: 0000-0003-3107-4515
AD  - Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
AD  - Centro de Investigación e Tecnoloxía Matemática de Galicia (CITMAGA), Campus 
      Vida, 15782 Santiago de Compostela, Spain.
AD  - Department of Statistics and Operational Research, University of Vigo, 36310 
      Vigo, Spain.
LA  - eng
PT  - Journal Article
DEP - 20220218
PL  - Switzerland
TA  - Antibiotics (Basel)
JT  - Antibiotics (Basel, Switzerland)
JID - 101637404
PMC - PMC8868325
OTO - NOTNLM
OT  - SARS-CoV-2
OT  - Spain
OT  - antibacterial agents
OT  - drug utilization
OT  - infectious diseases
OT  - interrupted time series analysis
OT  - pediatric
COIS- The authors declare no conflict of interest.
EDAT- 2022/02/26 06:00
MHDA- 2022/02/26 06:01
CRDT- 2022/02/25 01:02
PHST- 2022/01/12 00:00 [received]
PHST- 2022/02/14 00:00 [revised]
PHST- 2022/02/15 00:00 [accepted]
PHST- 2022/02/25 01:02 [entrez]
PHST- 2022/02/26 06:00 [pubmed]
PHST- 2022/02/26 06:01 [medline]
AID - antibiotics11020264 [pii]
AID - antibiotics-11-00264 [pii]
AID - 10.3390/antibiotics11020264 [doi]
PST - epublish
SO  - Antibiotics (Basel). 2022 Feb 18;11(2):264. doi: 10.3390/antibiotics11020264.

PMID- 35181720
OWN - NLM
STAT- MEDLINE
DCOM- 20220225
LR  - 20220225
IS  - 2045-2322 (Electronic)
IS  - 2045-2322 (Linking)
VI  - 12
IP  - 1
DP  - 2022 Feb 18
TI  - Identifying multimorbidity profiles associated with COVID-19 severity in chronic 
      patients using network analysis in the PRECOVID Study.
PG  - 2831
LID - 10.1038/s41598-022-06838-9 [doi]
LID - 2831
AB  - A major risk factor of COVID-19 severity is the patient's health status at the 
      time of the infection. Numerous studies focused on specific chronic diseases and 
      identified conditions, mainly cardiovascular ones, associated with poor 
      prognosis. However, chronic diseases tend to cluster into patterns, each with its 
      particular repercussions on the clinical outcome of infected patients. Network 
      analysis in our population revealed that not all cardiovascular patterns have the 
      same risk of COVID-19 hospitalization or mortality and that this risk depends on 
      the pattern of multimorbidity, besides age and sex. We evidenced that negative 
      outcomes were strongly related to patterns in which diabetes and obesity stood 
      out in older women and men, respectively. In younger adults, anxiety was another 
      disease that increased the risk of severity, most notably when combined with 
      menstrual disorders in women or atopic dermatitis in men. These results have 
      relevant implications for organizational, preventive, and clinical actions to 
      help meet the needs of COVID-19 patients.
CI  - © 2022. The Author(s).
FAU - Carmona-Pírez, Jonás
AU  - Carmona-Pírez J
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain. jcarmona@iisaragon.es.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain. jcarmona@iisaragon.es.
AD  - Delicias-Sur Primary Care Health Centre, Aragon Health Service (SALUD), Zaragoza, 
      Spain. jcarmona@iisaragon.es.
FAU - Gimeno-Miguel, Antonio
AU  - Gimeno-Miguel A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain.
FAU - Bliek-Bueno, Kevin
AU  - Bliek-Bueno K
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Preventive Medicine and Public Health Teaching Unit, Miguel Servet University 
      Hospital, Zaragoza, Spain.
FAU - Poblador-Plou, Beatriz
AU  - Poblador-Plou B
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain.
FAU - Díez-Manglano, Jesús
AU  - Díez-Manglano J
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Internal Medicine Department, Royo Villanova Hospital, Zaragoza, Spain.
FAU - Ioakeim-Skoufa, Ignatios
AU  - Ioakeim-Skoufa I
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of 
      Public Health, NO-0213, Oslo, Norway.
AD  - Department of Drug Statistics, Division of Health Data and Digitalisation, 
      Norwegian Institute of Public Health, NO-0213, Oslo, Norway.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (SEMFYC), S08009, Barcelona, Spain.
FAU - González-Rubio, Francisca
AU  - González-Rubio F
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain.
AD  - Delicias-Sur Primary Care Health Centre, Aragon Health Service (SALUD), Zaragoza, 
      Spain.
AD  - Drug Utilization Work Group, Spanish Society of Family and Community Medicine 
      (SEMFYC), S08009, Barcelona, Spain.
FAU - Poncel-Falcó, Antonio
AU  - Poncel-Falcó A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain.
AD  - Aragon Health Service (SALUD), 50017, Zaragoza, Spain.
FAU - Prados-Torres, Alexandra
AU  - Prados-Torres A
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain.
FAU - Gimeno-Feliu, Luis A
AU  - Gimeno-Feliu LA
AD  - EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, 
      Miguel Servet University Hospital, Zaragoza, Spain.
AD  - Health Services Research On Chronic Patients Network (REDISSEC), Network for 
      Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, 
      Madrid, Spain.
AD  - San Pablo Primary Care Health Centre, Aragon Health Service (SALUD), University 
      of Zaragoza, Zaragoza, Spain.
CN  - PRECOVID Group
LA  - eng
GR  - B01_20R and DECRETO-LEY 3/2020/Gobierno de Aragón/
GR  - B01_20R and DECRETO-LEY 3/2020/Gobierno de Aragón/
GR  - B01_20R and DECRETO-LEY 3/2020/Gobierno de Aragón/
GR  - B01_20R and DECRETO-LEY 3/2020/Gobierno de Aragón/
GR  - B01_20R and DECRETO-LEY 3/2020/Gobierno de Aragón/
GR  - CM19/00164/Instituto de Salud Carlos III/
GR  - RD21/0016/0019/RICAPPS/
GR  - RD21/0016/0019/RICAPPS/
GR  - RD21/0016/0019/RICAPPS/
GR  - RD21/0016/0019/RICAPPS/
GR  - RD21/0016/0019/RICAPPS/
GR  - RD21/0016/0019/RICAPPS/
GR  - RD21/0016/0019/RICAPPS/
PT  - Journal Article
PT  - Observational Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20220218
PL  - England
TA  - Sci Rep
JT  - Scientific reports
JID - 101563288
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - COVID-19/*epidemiology
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Multimorbidity
MH  - Retrospective Studies
MH  - Spain/epidemiology
MH  - Young Adult
PMC - PMC8857317
COIS- The authors declare no competing interests.
FIR - Moreno-Juste, Aida
IR  - Moreno-Juste A
FIR - Cano-Del-Pozo, Mabel
IR  - Cano-Del-Pozo M
FIR - Bandrés-Liso, Ana Cristina
IR  - Bandrés-Liso AC
FIR - Pico-Soler, Victoria
IR  - Pico-Soler V
FIR - Aza-Pascual-Salcedo, Mercedes
IR  - Aza-Pascual-Salcedo M
FIR - Ara-Bardají, Paula
IR  - Ara-Bardají P
EDAT- 2022/02/20 06:00
MHDA- 2022/02/26 06:00
CRDT- 2022/02/19 05:29
PHST- 2021/09/10 00:00 [received]
PHST- 2022/02/07 00:00 [accepted]
PHST- 2022/02/19 05:29 [entrez]
PHST- 2022/02/20 06:00 [pubmed]
PHST- 2022/02/26 06:00 [medline]
AID - 10.1038/s41598-022-06838-9 [pii]
AID - 6838 [pii]
AID - 10.1038/s41598-022-06838-9 [doi]
PST - epublish
SO  - Sci Rep. 2022 Feb 18;12(1):2831. doi: 10.1038/s41598-022-06838-9.

PMID- 35172775
OWN - NLM
STAT- MEDLINE
DCOM- 20220223
LR  - 20220223
IS  - 1471-2393 (Electronic)
IS  - 1471-2393 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Feb 16
TI  - Effectiveness of a group educational intervention - prolact - in primary care to 
      promote exclusive breastfeeding: a cluster randomized clinical trial.
PG  - 132
LID - 10.1186/s12884-022-04394-8 [doi]
LID - 132
AB  - BACKGROUND: The rates of exclusive breastfeeding at 6 months in Spain are far 
      from recommended by the World Health Organization, which is 50% by 2025. Evidence 
      of the effectiveness of group interventions in late postpartum is limited. The 
      objective of this study was to evaluate the effectiveness of the PROLACT group 
      educational intervention for increasing the proportion of mother-child dyads with 
      exclusive breastfeeding at 6 months compared to the usual practice in primary 
      care. METHOD: Multicentre cluster randomized clinical trial. A total of 434 
      mother-child dyads who breastfed exclusively in the first 4 weeks of the 
      children's life and agreed to participate were included. The main outcome was 
      exclusive breastfeeding at 6 months. Secondary variables were type of 
      breastfeeding, reasons for abandonment, degree of adherence and satisfaction with 
      the intervention. To study the effectiveness, the difference in the proportions 
      of dyads with exclusive breastfeeding at 6 months was calculated, and the 
      relative risk (RR) and number needed to treat (NNT) were calculated with their 
      95% CIs. To study the factors associated with the maintenance of exclusive 
      breastfeeding at 6 months, a multilevel logistic regression model was fitted. All 
      analyses were performed to intention to treat. RESULTS: The percentage of dyads 
      with exclusive breastfeeding at 6 months was 22.4% in the intervention group and 
      8.8% in the control group. PROLACT intervention obtained an RR =2.53 (95% CI: 
      1.54-4.15) and an NNT = 7 (95%CI: 5-14). The factors associated with exclusive 
      breastfeeding at 6 months were the PROLACT intervention, OR = 3.51 (95%CI: 
      1.55-7.93); age > 39 years, OR = 2.79 (95%CI: 1.02-7.6); previous breastfeeding 
      experience, OR = 2.61 (95%CI: 1.29-5.29); income between 500 and 833.33 €, 
      OR = 3.52 (95%CI 1.47-8.47).); planning to start work before the infant was 
      6 months old, OR = 0.35 (0.19-0.63) . CONCLUSIONS: The PROLACT intervention in 
      primary care is more effective than the usual practice for maintaining exclusive 
      breastfeeding at 6 months, and can therefore be considered evidence-based 
      practice for implementation in standard practice. TRIAL REGISTRATION: The trial 
      was registered with ClinicalTrials.gov under code number NCT01869920 
      (03/06/2013).
CI  - © 2022. The Author(s).
FAU - Santamaría-Martín, María Jesús
AU  - Santamaría-Martín MJ
AD  - Centro de Salud Lucero, Gerencia Asistencial de Atención Primaria, Servicio 
      Madrileño de Salud, Madrid, Spain.
FAU - Martín-Iglesias, Susana
AU  - Martín-Iglesias S
AD  - Dirección Asistencial Sur.Gerencia Asistencial de Atención Primaria, Servicio 
      Madrileño de Salud, Madrid, Spain.
FAU - Schwarz, Christine
AU  - Schwarz C
AD  - Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, Spain.
FAU - Rico-Blázquez, Milagros
AU  - Rico-Blázquez M
AD  - Research Unit. Gerencia Asistencial Atención Primaria. Servicio Madrileño de 
      Salud, Calle San Martín de Porres 6, 28035, Madrid, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), RICORS (RICAPPS) 
      Instituto de Salud Carlos III, Madrid, Spain.
AD  - Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, Universidad 
      Complutense de Madrid, Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.
FAU - Portocarrero-Nuñez, Julián Alexander
AU  - Portocarrero-Nuñez JA
AD  - Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, Spain.
FAU - Diez-Izquierdo, Laura
AU  - Diez-Izquierdo L
AD  - Preventive Medicine. Hospital Infanta Sofia. San Sebastian de los Reyes, Madrid, 
      Spain.
FAU - Llamosas-Falcón, Laura
AU  - Llamosas-Falcón L
AD  - Preventive Medicine and Public Health, Hospital Universitario, 12 de Octubre, 
      28041, Madrid, Spain.
FAU - Rodríguez-Barrientos, Ricardo
AU  - Rodríguez-Barrientos R
AD  - Research Unit. Gerencia Asistencial Atención Primaria. Servicio Madrileño de 
      Salud, Calle San Martín de Porres 6, 28035, Madrid, Spain.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), RICORS (RICAPPS) 
      Instituto de Salud Carlos III, Madrid, Spain.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain.
FAU - Del-Cura-González, Isabel
AU  - Del-Cura-González I
AD  - Research Unit. Gerencia Asistencial Atención Primaria. Servicio Madrileño de 
      Salud, Calle San Martín de Porres 6, 28035, Madrid, Spain. 
      Isabel.cura@salud.madrid.org.
AD  - Health Services Research on Chronic Patients Network (REDISSEC), RICORS (RICAPPS) 
      Instituto de Salud Carlos III, Madrid, Spain. Isabel.cura@salud.madrid.org.
AD  - Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Madrid, Spain. 
      Isabel.cura@salud.madrid.org.
AD  - Department Medical specialties and Public Health, Universidad Rey Juan Carlos, 
      Alcorcón, Madrid, Spain. Isabel.cura@salud.madrid.org.
CN  - Grupo PROLACT
LA  - eng
SI  - ClinicalTrials.gov/NCT01869920
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
DEP - 20220216
PL  - England
TA  - BMC Pregnancy Childbirth
JT  - BMC pregnancy and childbirth
JID - 100967799
SB  - IM
MH  - Adult
MH  - *Breast Feeding
MH  - Female
MH  - Guidelines as Topic
MH  - Health Education/*methods
MH  - Health Promotion/*methods
MH  - Humans
MH  - Mothers/*education
MH  - Patient Compliance/*statistics & numerical data
MH  - Primary Health Care
MH  - *Program Evaluation
MH  - Spain
PMC - PMC8851786
OTO - NOTNLM
OT  - Breast-feeding
OT  - Clinical trial
OT  - Health education
OT  - Health promotion
OT  - Primary healthcare
COIS- The authors declare that they have no competing interests.
FIR - Martín-Llorente, Francisca
IR  - Martín-Llorente F
FIR - Casero-Perona, Leopoldo
IR  - Casero-Perona L
FIR - Plasencia-Plasencia, Paz
IR  - Plasencia-Plasencia P
FIR - Sánchez-Méndez, Marta Yolanda
IR  - Sánchez-Méndez MY
FIR - Santamaría-Medrano, Pilar
IR  - Santamaría-Medrano P
FIR - Mielgo-Salvador, Rebeca
IR  - Mielgo-Salvador R
FIR - Cañón-Cañón, Carolina
IR  - Cañón-Cañón C
FIR - Valor-Sánchez, Dolores
IR  - Valor-Sánchez D
FIR - Fernández-Fernández, Ramona
IR  - Fernández-Fernández R
FIR - López-Lozano, Soledad
IR  - López-Lozano S
FIR - Morales-Montalva, Marisol
IR  - Morales-Montalva M
FIR - Pérez-Mañanes, María Elena
IR  - Pérez-Mañanes ME
FIR - Durand-Rincón, Isabel
IR  - Durand-Rincón I
FIR - Valdecantos-Coscollano, Sara
IR  - Valdecantos-Coscollano S
FIR - Hernández-Hernández, Verónica
IR  - Hernández-Hernández V
FIR - Noceco-Paredes, Maria Dolores
IR  - Noceco-Paredes MD
FIR - Malde-García, Clara
IR  - Malde-García C
FIR - Miranda-Martín, Ma Ángeles
IR  - Miranda-Martín MÁ
FIR - de la Peña Antón, Nuria
IR  - de la Peña Antón N
FIR - Martín-Díaz, Elena
IR  - Martín-Díaz E
FIR - Robas-García, Dolores
IR  - Robas-García D
FIR - Parra-Moro, Manuel
IR  - Parra-Moro M
FIR - Ruiz-Del-Castillo, María Concepción
IR  - Ruiz-Del-Castillo MC
FIR - Geijo-Rincón, Maria Jesús
IR  - Geijo-Rincón MJ
FIR - Rivero-Garrido, Carmen
IR  - Rivero-Garrido C
FIR - Alameda-Hernández, María Gema
IR  - Alameda-Hernández MG
FIR - González-Macías, Miriam
IR  - González-Macías M
FIR - Coghen-Vigueras, Isabel
IR  - Coghen-Vigueras I
FIR - Arenas-Yaguez, Raquel
IR  - Arenas-Yaguez R
FIR - San Pablo-Campos, Carolina
IR  - San Pablo-Campos C
FIR - Prados-Bueno, Rosa M
IR  - Prados-Bueno RM
FIR - Bejarano-López, Ma Adoración
IR  - Bejarano-López MA
FIR - García-Ruiz, Natividad
IR  - García-Ruiz N
FIR - Magdaleno-Del-Rey, Gema
IR  - Magdaleno-Del-Rey G
FIR - Tirado-Jiménez, Lucía
IR  - Tirado-Jiménez L
FIR - Santamaria-Martín, Ma Jesús
IR  - Santamaria-Martín MJ
FIR - Reviriego-Gutierrez, Asunción
IR  - Reviriego-Gutierrez A
FIR - Soto-Almendro, Beatriz
IR  - Soto-Almendro B
FIR - García-Romero, Paula
IR  - García-Romero P
FIR - Zarco-Cid, Elena
IR  - Zarco-Cid E
FIR - Villa-Arranz, María
IR  - Villa-Arranz M
FIR - Fernández-de-Velasco, Alma Mejía
IR  - Fernández-de-Velasco AM
FIR - Anta-Rodríguez, Laura
IR  - Anta-Rodríguez L
FIR - Sánchez-Prieto-Emmanuel, María Isabel
IR  - Sánchez-Prieto-Emmanuel MI
FIR - Barrios-García, Luz Divina
IR  - Barrios-García LD
FIR - Lozano-Adeva, Carmen
IR  - Lozano-Adeva C
FIR - Casado-García, Luis Mariano
IR  - Casado-García LM
FIR - Gómez-Pérez, Lourdes
IR  - Gómez-Pérez L
FIR - Martínez-Sierra, Ma Dolores
IR  - Martínez-Sierra MD
FIR - Escobar-García, Martha Olga
IR  - Escobar-García MO
FIR - Guerra-Nieto, Ma Dolores
IR  - Guerra-Nieto MD
FIR - Azcona-Domínguez, Elena
IR  - Azcona-Domínguez E
FIR - Delgado-Domínguez, María Ángeles
IR  - Delgado-Domínguez MÁ
FIR - Verdugo-Hernández, Rafael
IR  - Verdugo-Hernández R
EDAT- 2022/02/18 06:00
MHDA- 2022/02/24 06:00
CRDT- 2022/02/17 05:28
PHST- 2021/02/05 00:00 [received]
PHST- 2021/12/21 00:00 [accepted]
PHST- 2022/02/17 05:28 [entrez]
PHST- 2022/02/18 06:00 [pubmed]
PHST- 2022/02/24 06:00 [medline]
AID - 10.1186/s12884-022-04394-8 [pii]
AID - 4394 [pii]
AID - 10.1186/s12884-022-04394-8 [doi]
PST - epublish
SO  - BMC Pregnancy Childbirth. 2022 Feb 16;22(1):132. doi: 10.1186/s12884-022-04394-8.

PMID- 35162380
OWN - NLM
STAT- MEDLINE
DCOM- 20220217
LR  - 20220531
IS  - 1660-4601 (Electronic)
IS  - 1661-7827 (Print)
IS  - 1660-4601 (Linking)
VI  - 19
IP  - 3
DP  - 2022 Jan 26
TI  - Analysis of Clinical Parameters, Drug Consumption and Use of Health Resources in 
      a Southern European Population with Alcohol Abuse Disorder during COVID-19 
      Pandemic.
LID - 10.3390/ijerph19031358 [doi]
LID - 1358
AB  - The disruption in healthcare attention to people with alcohol dependence, along 
      with psychological decompensation as a consequence of lockdown derived from the 
      COVID-19 pandemic could have a negative impact on people who suffer from alcohol 
      abuse disorder. Observational real world data pre-post study included 9966 men 
      aged >16 years registered as having the diagnosis of alcohol abuse disorder in 
      the electronic medical records (EMR) of the Aragon Regional Health Service 
      (Spain). Clinical (Glutamate-oxaloacetate -GOT-, Glutamate pyruvate -GPT-, 
      creatinine, glomerular filtration, systolic blood pressure -SBP-, diastolic blood 
      pressure -DBP-, total cholesterol, LDL, HDL, triglycerides, and body mass index 
      -BMI-), pharmacological (dose per inhabitant per day, DHD, of drugs used in 
      addictive disorders, benzodiazepines and antidepressants) and health resource use 
      variables (primary and specialized care) were considered. A Student's t-test for 
      matched samples was performed to analyze the changes in clinical variables 
      between alcohol abuse disorder patients with and without COVID-19. Only 
      creatinine and LDL showed a significant but clinically irrelevant change six 
      months after the end of the strict lockdown. The total number of DHDs for all 
      drugs included in the study (except for benzodiazepines), decreased. In the same 
      way, the use of health services by these patients also decreased. The impact of 
      COVID-19 among this group of patients has been moderate. The reorganization of 
      health and social services after the declaration of the state of alarm in our 
      country made possible the maintenance of care for this vulnerable population.
FAU - Lear-Claveras, Ana
AU  - Lear-Claveras A
AUID- ORCID: 0000-0003-3187-2242
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragon Health Research Institute, 50015 Zaragoza, 
      Spain.
FAU - González-Álvarez, Beatriz
AU  - González-Álvarez B
AUID- ORCID: 0000-0003-4497-3341
AD  - Biocomputing Department, Instituto Aragonés de Ciencias de la Salud, 50009 
      Zaragoza, Spain.
FAU - Couso-Viana, Sabela
AU  - Couso-Viana S
AUID- ORCID: 0000-0002-9802-6131
AD  - I-Saúde Group, South Galicia Health Research Institute, 36201 Vigo, Spain.
FAU - Clavería, Ana
AU  - Clavería A
AUID- ORCID: 0000-0001-9552-1260
AD  - I-Saúde Group, South Galicia Health Research Institute, 36201 Vigo, Spain.
AD  - Vigo Health Area, SERGAS, 36201 Vigo, Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
FAU - Oliván-Blázquez, Bárbara
AU  - Oliván-Blázquez B
AUID- ORCID: 0000-0001-6565-9699
AD  - Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en 
      Atención Primaria/GAIAP), Aragon Health Research Institute, 50015 Zaragoza, 
      Spain.
AD  - Network for Research on Chronicity, Primary Care and Health Promotion (RICAPPS), 
      08007 Barcelona, Spain.
AD  - Department of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, 
      Spain.
LA  - eng
GR  - DGACovid-01 project/Department for Science, Universities and the Knowledge 
      Society of the Government of Aragon, Spain/
PT  - Journal Article
PT  - Observational Study
DEP - 20220126
PL  - Switzerland
TA  - Int J Environ Res Public Health
JT  - International journal of environmental research and public health
JID - 101238455
RN  - 0 (Pharmaceutical Preparations)
SB  - IM
MH  - Adolescent
MH  - *Alcoholism/epidemiology
MH  - *COVID-19
MH  - Communicable Disease Control
MH  - Health Resources
MH  - Humans
MH  - Male
MH  - Pandemics
MH  - *Pharmaceutical Preparations
MH  - SARS-CoV-2
PMC - PMC8835241
OTO - NOTNLM
OT  - COVID-19
OT  - alcohol use disorder
OT  - health resources
OT  - lifestyle
OT  - lockdown
OT  - primary care
COIS- The authors declare that they have no conflict of interest.
EDAT- 2022/02/16 06:00
MHDA- 2022/02/19 06:00
CRDT- 2022/02/15 01:13
PHST- 2021/12/13 00:00 [received]
PHST- 2022/01/21 00:00 [revised]
PHST- 2022/01/24 00:00 [accepted]
PHST- 2022/02/15 01:13 [entrez]
PHST- 2022/02/16 06:00 [pubmed]
PHST- 2022/02/19 06:00 [medline]
AID - ijerph19031358 [pii]
AID - ijerph-19-01358 [pii]
AID - 10.3390/ijerph19031358 [doi]
PST - epublish
SO  - Int J Environ Res Public Health. 2022 Jan 26;19(3):1358. doi: 
      10.3390/ijerph19031358.

PMID- 35057451
OWN - NLM
STAT- MEDLINE
DCOM- 20220202
LR  - 20220202
IS  - 2072-6643 (Electronic)
IS  - 2072-6643 (Linking)
VI  - 14
IP  - 2
DP  - 2022 Jan 9
TI  - Effect of a Multicomponent mHealth Intervention on the Composition of Diet in a 
      Population with Overweight and Obesity-Randomized Clinical Trial EVIDENT 3.
LID - 10.3390/nu14020270 [doi]
LID - 270
AB  - A balanced diet can help in the prevention of chronic diseases. The aim of this 
      study was to evaluate the effect of an mHealth intervention on the distribution 
      of macronutrients and the intake of food groups. A total of 650 participants were 
      included in this multi-center, clinical, randomized, controlled trial (Evident 3 
      study). All participants were given brief advice about diet and exercise. The 
      intervention group received, in addition, an app (Evident 3) for the 
      self-recording of their diet and an activity tracker wristband for 3 months. 
      Follow-up visits were performed at 3 and 12 months to collect the diet 
      composition using the Food Frequency Questionnaire. There were decreases in the 
      intake of total calories, fat, protein and carbohydrates in both groups 
      throughout the study, without significant differences between them. The 
      intervention group reduced the intake of cholesterol (-30.8; 95% CI -59.9, -1.7) 
      and full-fat dairies (-23.3; 95% CI -42.8, -3.8) and increased the intake of 
      wholemeal bread (3.3; 95% CI -6.7, 13.3) and whole-grain cereals (3.4; 95% CI 
      -6.8, 13.7) with respect to the control group. No differences were found in the 
      rest of the nutritional parameters. The brief advice is useful to promote a 
      healthier diet, and the app can be a support tool to obtain changes in relevant 
      foods, such as integral foods, and the intake of cholesterol. Trial registration: 
      ClinicalTrials.gov with identifier NCT03175614.
FAU - Lugones-Sánchez, Cristina
AU  - Lugones-Sánchez C
AD  - Primary Care Research Unit of Salamanca (APISAL), Institute of Biomedical 
      Research of Salamanca (IBSAL), Health Service of Castilla y León (SACyL), 37005 
      Salamanca, Spain.
FAU - Recio-Rodríguez, José I
AU  - Recio-Rodríguez JI
AUID- ORCID: 0000-0002-3772-8746
AD  - Primary Care Research Unit of Salamanca (APISAL), Institute of Biomedical 
      Research of Salamanca (IBSAL), Health Service of Castilla y León (SACyL), 37005 
      Salamanca, Spain.
AD  - Department of Nursing and Physiotherapy, University of Salamanca, 37007 
      Salamanca, Spain.
FAU - Menéndez-Suárez, Marta
AU  - Menéndez-Suárez M
AD  - University Clinical Hospital of Valladolid, Health Service of Castilla y León 
      (SACyL), 47003 Valladolid, Spain.
FAU - Saz-Lara, Alicia
AU  - Saz-Lara A
AD  - Health and Social Research Center, University of Castilla-La Mancha, 16071 
      Cuenca, Spain.
FAU - Ramirez-Manent, José I
AU  - Ramirez-Manent JI
AD  - Calvià Primary Care Center, Balearic Islands Health Research Institute (IDIBSA), 
      Health Service of Balearic Islands, 07180 Calvià, Spain.
AD  - Department of Medicine, University of the Balearic Islands, 07122 Palma, Spain.
FAU - Sánchez-Calavera, María A
AU  - Sánchez-Calavera MA
AD  - Las Fuentes Norte Health Center, Aragonese Group of Primary Care Research 
      (GAIAP), Aragon Health Research Institute (IISA), Aragon Health Service, 50002 
      Zaragoza, Spain.
AD  - Department of Internal Medicine, Psychiatry and Dermatology, University of 
      Zaragoza, 50009 Zaragoza, Spain.
FAU - Gómez-Sánchez, Leticia
AU  - Gómez-Sánchez L
AD  - Primary Care Research Unit of Salamanca (APISAL), Institute of Biomedical 
      Research of Salamanca (IBSAL), Health Service of Castilla y León (SACyL), 37005 
      Salamanca, Spain.
FAU - Rodríguez-Sánchez, Emiliano
AU  - Rodríguez-Sánchez E
AD  - Primary Care Research Unit of Salamanca (APISAL), Institute of Biomedical 
      Research of Salamanca (IBSAL), Health Service of Castilla y León (SACyL), 37005 
      Salamanca, Spain.
AD  - Department of Medicine, University of Salamanca, 37007 Salamanca, Spain.
FAU - García-Ortiz, Luis
AU  - García-Ortiz L
AD  - Primary Care Research Unit of Salamanca (APISAL), Institute of Biomedical 
      Research of Salamanca (IBSAL), Health Service of Castilla y León (SACyL), 37005 
      Salamanca, Spain.
AD  - Department of Biomedical and Diagnostic Sciences, University of Salamanca, 37007 
      Salamanca, Spain.
FAU - Evident Investigators Group
AU  - Evident Investigators Group
AD  - EVIDENT Research Group, RICAPPS: Chronicity, Primary Care and Health Promotion 
      Research Network, 37005 Salamanca, Spain.
LA  - eng
SI  - ClinicalTrials.gov/NCT03175614
GR  - RD21/0016/0010/Instituto de Salud Carlos III/
GR  - RD21/0016/0005/Instituto de Salud Carlos III/
GR  - RD21/0016/0025/Instituto de Salud Carlos III/
GR  - RD21/0016/0009/Instituto de Salud Carlos III/
GR  - PI16/00101/Instituto de Salud Carlos III/
GR  - PI16/00952/Instituto de Salud Carlos III/
GR  - PI16/00765/Instituto de Salud Carlos III/
GR  - PI16/00659/Instituto de Salud Carlos III/
GR  - PI16/00421/Instituto de Salud Carlos III/
GR  - PI16/00170/Instituto de Salud Carlos III/
GR  - FI17/00040/Instituto de Salud Carlos III/
GR  - GRS 1277/B/16/Gerencia Regional de Salud de Castilla y Leon/
GR  - GRS 1580/B/17/Gerencia Regional de Salud de Castilla y Leon/
PT  - Journal Article
PT  - Multicenter Study
PT  - Randomized Controlled Trial
DEP - 20220109
PL  - Switzerland
TA  - Nutrients
JT  - Nutrients
JID - 101521595
RN  - 97C5T2UQ7J (Cholesterol)
SB  - IM
MH  - Adult
MH  - Cholesterol/administration & dosage
MH  - *Counseling
MH  - *Diet
MH  - Diet Surveys
MH  - Energy Intake
MH  - Exercise
MH  - *Feeding Behavior
MH  - Female
MH  - *Health Behavior
MH  - Health Promotion/*methods
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Mobile Applications
MH  - Nutrients/administration & dosage
MH  - Obesity/*diet therapy
MH  - Overweight/diet therapy
MH  - *Telemedicine
PMC - PMC8778755
OTO - NOTNLM
OT  - diet records
OT  - healthy diet
OT  - mobile app
OT  - obesity
OT  - telemedicine
COIS- The authors declare that they have no competing interest.
EDAT- 2022/01/22 06:00
MHDA- 2022/02/03 06:00
CRDT- 2022/01/21 01:17
PHST- 2021/11/28 00:00 [received]
PHST- 2021/12/28 00:00 [revised]
PHST- 2022/01/06 00:00 [accepted]
PHST- 2022/01/21 01:17 [entrez]
PHST- 2022/01/22 06:00 [pubmed]
PHST- 2022/02/03 06:00 [medline]
AID - nu14020270 [pii]
AID - nutrients-14-00270 [pii]
AID - 10.3390/nu14020270 [doi]
PST - epublish
SO  - Nutrients. 2022 Jan 9;14(2):270. doi: 10.3390/nu14020270.
